ACC12 Final Program w TOC Links

Final Program

www.accscientificsession.org/acc12

©2012 A

mer

ican

Col

lege

of C

ardi

olog

y A1

304

Join us for a whole new learning experience — in a whole new city — as we bring you the education that keeps you at the forefront of your profession and helps improve the quality of care for your patients.

www.accscientificsession.org

ACC.12 Final Program 1

TAB 1: General Information

General Meeting Information

Directory .......................................................... 27 – 28

Logistic Information ......................................... 29 – 37

Convention Center Map ............................................ 38

Poster Session Maps ........................................ 39 – 41

Hotel List and Map ........................................... 42 – 43

General Education Information ................................. 44 – 46

Disclosure of Financial Relationships ....................... 47 – 48

Scientific Session Descriptions ................................ 49 – 51

ACC.12 Expo

ACC.12 Expo Highlights .................................... 52 – 53

ACC.12 Exhibitor List ....................................... 54 – 56

ACC.12 Learning Destinations™ .............................. 57 – 59

Non-Accredited Educational Events ......................... 60 – 62

Independent CME/CNE-Certified Pre Conference & Evening Programs ................ 63 – 64

TAB 2: Your Road Map To ACC.12

Your Roadmap to ACC.12 ......................................... 65 – 69

Schedule-At-A-Glance ............................................. 70 – 71

Program-At-A-Glance

Daily Schedule ................................................. 72 – 86

Topic Schedule ............................................... 87 – 103

TAB 3: Friday, March 23 and Saturday, March 24

ACC.12 Educational Sessions Friday, March 23 ....... 105 – 106

ACC.12 Educational Sessions Satuday, March 24 ..... 107 – 131

Learning Destination™ Presentations ................... 131 – 132

TAB 4: Sunday, March 25

ACC.12 Educational Sessions ................................ 137 – 172

Learning Destination™ Presentations ................... 173 – 175

TAB 5: Monday, March 26

ACC.12 Educational Sessions ............................... 177 – 205

Learning Destination™ Presentations .................. 206 – 207

TAB 6: Tuesday, March 27

ACC.12 Educational Sessions ............................... 209 – 211

TAB 7: Author Index

Author Index ......................................................... 217 – 238

ACC.12

Table of ContentsWelcome to ACC.12 ................................................................................................................................................................... 3

ACC.12 Officials and Committees ................................................................................................................................................ 4

ACC.12 Acknowledgments .................................................................................................................................................. 6 – 10

ACC.12 Elite FIT Rising Star Acknowledgments .......................................................................................................................... 11

Grantor Acknowledgments ................................................................................................................................................. 12 – 15

ACCF Donor Recognition ................................................................................................................................................... 16 – 20

Access, Viewand PRINT!

ACC.11 Of�cials ACC.11 Acknowli2 Summit Of�ciai2 Summit Acknoi2 Summit Af�liaACC.11 Grantor A

©2012 American College of Cardiology. F1224

A M E R I C A N C O L L E G E o f C A R D I O L O G Y

Helping Cardiovascular Professionals Learn. Advance. Heal.

Join a network of CV professionals committed to quality cardiovascular care & advance your career:

- Physicians- Cardiovascular Administrators- Nurses- Physician Assistants- Cardiovascular Technicians- Pharmacists

Visit to join & discover the value of ACC membership!

ACC BOOTH #10027


Welcome to Chicago for the American College of Cardiology’s 61st Annual Scientific Session and ACC-i2 with TCT: Innovation in Intervention.

This year’s program reflects the passion for science, education and peer-to-peer networking that ACC President David R. Holmes, Jr., MD, FACC, has brought to his administration. We’ve enriched ACC.12 to enhance your learning experience and provide you with a dynamic, individualized experience that meets all your learning needs.

Don’t miss:• The new daily schedule — focus on science each morning with late-breakers,

poster abstracts and new findings, and focus on practical clinical applications each afternoon with case-based sessions, review sessions, and MOC.

• The Legends of Cardiovascular Medicine — a series of five sessions featuring true legends in the field of cardiology.

• The Innovators of Cardiology — an all-new closing session which brings together top leaders in cardiology to discuss driving forces behind innovation and creativity.

• Your chance to earn up to 70 MOC points with the Maintenance of Certification sessions and the Competency-Based Learning System —helping you select the sessions that best fill your knowledge gaps in the Lifelong Learning Pathway.

• Collaborative efforts with subspecialty societies to create a “Family of Cardiology” with co-branded sessions and abstracts throughout the meeting.

• Cutting-edge technology including a new ACC.12 eMeeting Planner App (search ACC.12 in your app marketplace), and ACC.12 Online — live webcasts of 60 sessions plus an additional 18 on demand sessions from the Legends of CV Medicine and Core Curriculum series — available to attendees for free during the meeting!

To learn more about these sessions and additional features of ACC.12 check out Your Road Map to ACC.12 (page 65).

Can’t make it to all the sessions you want to attend? Purchase iScience, a comprehensive digital library of presentations from ACC.12. Order iScience on site in Chicago to save $1,000 or more — visit the iScience sales kiosk in Grand Concourse Lobby, Level 3 or ACC Central, Booth #10027.

Welcome to ACC.12

4 GO for ACC.12!

The College is most grateful to all program participants who have given freely of their time to participate in the 60th Annual Scientific Session.

President, 2011 – 2012David R. Holmes, Jr., MD, FACC

President-ElectWilliam A. Zoghbi, MD, FACC

Co-chairs, Annual Scientific Session Program CommitteeRick A. Nishimura, MD, FACCPatrick T. O’Gara, MD, FACC

Annual Scientific Session Program Committee

Karthikeyan Ananthasubramaniam,

MBBS, FACC

Alex J. Auseon, DO, FACC

Alison Bailey, MD, FACC

Christie M. Ballantyne, MD, FACC

R. Michael Benitez, MD, FACC

Lisa Bergersen, MD, MPH, FACC

Tandeep Bhatti, MD, FACC

Michael S. Blum, MD, FACC

Biykem Bozkurt, MD, PhD, FACC

John E. Brush, Jr., MD, FACC

Matthew J. Budoff, MD, FACC

Jean A. Connor, NP

Rhonda M. Cooper-DeHoff, PharmD,

FACC

Salvatore P. Costa, MD, FACC

Michael H. Crawford, MD, FACC

Mark G. Davies, MB, BCh, PhD, FACC

James A. de Lemos, MD, FACC

G. William Dec, Jr., MD, FACC

Akshay S. Desai, MD, FACC

Caroline Lloyd Doherty, MSN, CRNP,

AACC

Maurice Enriquez-Sarano, MD, FACC

John P. Erwin, III, MD, FACC

Derek V. Exner, MD, FACC

Barbara Fletcher, RN

Federico Gentile, MD, FACC

Maya E. Guglin, MD, FACC

Melanie T. Gura, RN, MSN, CNS, CCDS,

AACC

Stephen C. Hammill, MD, FACC

Jerome L. Hines, MD, PhD, FACC

Julia H. Indik, MD, PhD, FACC

Elizabeth A. Jackson, MD, FACC

Henri Justino, MD, CM, FACC

Joshua Kanter, MD

Sanjay Kaul, MBBS, FACC

Jerry D. Kennett, MD, FACC

Amit Khera, MD, MSc, FACC

Henry E. Kim, MD, MPH, FACC

Annapoorna Subhash Kini, MBBS,

FACC

Ajay J. Kirtane, MD, FACC

Neal S. Kleiman, MD, FACC

Eva M. Kline-Rogers, RN

Jeffrey T. Kuvin, MD, FACC

Richard A. Lange, MD, FACC

Michele Langenfeld, RN, MS

Gregory M. Lanza, MD, FACC

Christine E. Lawless, MD, FACC

Randall J. Lee, MD, PhD, FACC

Byron Kwock Lee, MD, FACC

Ms. Carolyn Lekavich, NP

Gregory D. Lewis, MD

Jane A. Linderbaum, MS, CNP, AACC

Bruce D. Lindsay, MD, FACC

Janet B. Long, MSN, ACNP

Thomas M. Maddox, MD, MSc, FACC

Frederick A. Masoudi, MD, MSPH,

FACC

Michael A. Mathier, MD, FACC

Doff B. McElhinney, MD

Dennis M. McNamara, MD, FACC

Edward J. McNulty, MD, FACC

Issam A. Mikati, MD, FACC

Todd D. Miller, MD, FACC

David A. Morrow, MD, MPH, FACC

Debabrata Mukherjee, MD, FACC

ACC.12

Officials and Committees


Steve R. Ommen, MD, FACC

Narith Ou, PharmD

Ronald J. Oudiz, MD, FACC

Douglas L. Packer, MD, FACC

Hamang M. Patel, MD, FACC

Donna M. Polk, MD, MPH, FACC

Miguel A. Quinones, MD, FACC

Nalini Marie Rajamannan, MD, FACC

Sunil V. Rao, MD, FACC

George P. Rodgers, MD, FACC

Frances A. Rogers, NP

John S. Rumsfeld, MD, PhD, FACC

Thomas John Ryan, MD, FACC

Arwa Saidi, MB, BCh, FACC

Michael K. Schroyer, RN, AACC

Bindi K. Shah, MD, FACC

Prem Soman, MBBS, FACC

Paul Sorajja, MD, FACC

Anthony E. Steimle, MD, FACC

Karen K. Stout, MD, FACC

E. Murat Tuzcu, MD, FACC

Anne Marie Valente, MD, FACC

C. Michael Valentine, MD, FACC

Paul D. Varosy, MD, FACC

Hector O. Ventura, MD, FACC

Ralph J. Verdino, MD, FACC

Wanpen Vongpatanasin, MD, FACC

Mary Norine Walsh, MD, FACC

Andrew Wang, MD, FACC

Tracy Wang, MD, FACC

Suzanne J. Wingate, PhD, CRNP

Stephen D. Wiviott, MD, FACC

R. Scott Wright, MD, FACC

Robert W. Yeh, MD

ACC-i2 with TCT Program Executive Committee

E. Murat Tuzcu, MD, FACC, Chair

Gary S. Mintz, MD, FACC, Co-chair

George D. Dangas, MD, PhD, FACC

Howard C. Herrmann, MD, FACC

Martin B. Leon, MD, FACC

David J. Moliterno, MD, FACC

Gregg W. Stone, MD, FACC

Janet Fredal Wyman, MSN, NP, ACNS-

BC, AACC, Nurse Planner

ACC-i2 with TCT Program Committee


MBBS, FACC

Dominick J. Angiolillo, MD, PhD, FACC

Raoul Bonan, MD, FACC

Sorin J. Brener, MD, FACC

Emmanouil S. Brilakis, MD, PhD, FACC

Nora Brown, M.S.N., R.N.

Douglas E. Drachman, MD, FACC


AACC

William Fuller Fearon, MD, FACC

Lee R. Goldberg, MD, MPH, FACC

James Aaron Grantham, MD, FACC

Rebecca T. Hahn, MD, FACC

Robert A. Harrington, MD, FACC

James Bernard Hermiller, Jr, MD, FACC

Michael R. Jaff, DO, FACC

Ik-Kyung Jang, MD, PhD, F.A.C.C

Allen Jeremias, MD, FACC

David E. Kandzari, MD, FACC

Samir R. Kapadia, MBBS, FACC

A. Pieter Kappetein, MD, PhD

Saibal Kar, MD, FACC

Dean J. Kereiakes, MD, FACC

Carey D. Kimmelstiel, MD, FACC


Eva M. Kline-Rogers, RN, MS

Susheel K. Kodali, MD, FACC

Raghu Kolluri, MBBS, FACC

Michael J. Landzberg, MD, FACC

Michael J. Lim, MD, FACC

Jane A. Linderbaum, MS, CNP, AACC

Julie A. Logan, RN

Akiko Maehara, MD

Raj R. Makkar, MD, FACC

Tift Mann, III, MD, FACC

Roxana Mehran, MD, FACC

Venu Menon, MBBS, FACC

Jeffrey W. Moses, MD, FACC


Hilary M. Nierenberg, NP

Masahiko Ochiai, MD, Ph.D, FACC

Sandra M. Oliver‐McNeil, NP, AACC

John A. Ormiston, MB, ChB, FACC

Sahil A. Parikh, MD, FACC

Nicolo Piazza, MD

Duane S. Pinto, MD, MPH, FACC

Abhiram Prasad, MD, FRCP, FACC


Lisa A. Riggs, CNS, AACC

Charanjit S. Rihal, MD, FACC

Eric Roselli, MD

Timothy A. Sanborn, MD, FACC

Paul Schoenhagen, MD

Mehdi H. Shishehbor, DO, MPH

Frank E. Silvestry, MD, FACC

Lars G. Svensson, MBBCh, PhD, FACC

Jonathan M. Tobis, MD, FACC

Zoltan G. Turi, MD, FACC

Szilard Voros, MD, FACC

Christopher J. White, MD, FACC

Giora Weisz, MD, FACC

Mathew Williams, MD, FACC

Alan Zajarias, MD, MSc, FACC

Khaled M. Ziada, MD, FACC

ACC.12 • Officials and Committees

6 GO for ACC.12!

The ACC.12 and ACC-i2 with TCT Program Committees gratefully acknowledge the assistance of the following individuals as Abstract Reviewers and Chairs for the 61st Annual Scientific Session.

Suhny Abbara, MD

Aamer Abbas, MBBS, FACC

J. Dawn Abbott, MD, FACC

Alex Abou-Chebl, MD

Theodore P. Abraham, MBBS, FACC

Mazen S. Abu-Fadel, MD, FACC

Stephan Achenbach, MD, FACC

Michael John Ackerman, MD, PhD,

FACC

Evan C. Adelstein, MD, FACC

Ali Ahmed, MD, MPH

Karen P. Alexander, MD, FACC

Jeffrey D. Alexis, MD, FACC

Fernando Alfonso, MD, PhD

Imad A. Alhaddad, MBBS, FACC

Sana M. Al-Khatib, MD, FACC

Suhail Q. Allaqaband, MBBS, FACC

Larry A. Allen, MD, FACC

Mouaz H. Al-Mallah, MD, FACC

Carolyn A. Altman, MD, FACC

Aman M. Amanullah, MD, PhD, FACC

Zahid Amin, MBBS

Ezra A. Amsterdam, MD, FACC


MBBS, FACC

H. Vernon Anderson, MD, FACC

Jeffrey L. Anderson, MD, FACC

Dominick J. Angiolillo, MD, PhD, FACC

Christopher P. Appleton, MD, FACC

Joseph R. Aragon, MD, FACC

Andrew E. Arai, MD

Juan M. Aranda, Jr., MD, FACC

Paul Wayne Armstrong, MD, FACC

William F. Armstrong, MD, FACC

Herbert D. Aronow, MD, FACC

James A. Arrighi, MD, FACC

Gerard P. Aurigemma, MD, FACC

Richard G. Bach, MD, FACC

Jayant Bagai, MBBS, FACC

Aaron L. Baggish, MD

Alison Bailey, MD, FACC

C. Noel Bairey Merz, MD, FACC

Christie M. Ballantyne, MD, FACC

Gerald Barbeau, MD, FACC

Gregory W. Barsness, MD, FACC

John R. Bartholomew, III, MD, FACC

Riyaz Bashir, MBBS, FACC

Jean-Pierre L. Bassand, MD, FACC

Eric R. Bates, MD, FACC

Timothy A. Beaver, MD, FACC

Jeffrey S. Berger, MD, FACC

Lisa Bergersen, MD, MPH, FACC

Daniel S. Berman, MD, FACC

Colin Berry, MB, ChB, FACC

John F. Beshai, MD, FACC

Patricia J. M. Best, MD, FACC

Deepak L. Bhatt, MD, MPH, FACC

Tandeep Bhatti, MD, FACC

Vera Bittner, MD, FACC

Ron Blankstein, MD, FACC

David A. Bluemke, MD, PhD

Kay Blum, NP, PhD

Elizabeth D. Blume, MD, FACC

Xu Bo

William E. Boden, MD, FACC

John P. Boehmer, MD, FACC

Eric Boersma, PhD

Raoul Bonan, MD, FACC

Robert O. Bonow, MD, MACC

Jeffrey S. Borer, MD, FACC

Barry Borlaug, MD, FACC

Robert C. Bourge, MD, FACC

Biykem Bozkurt, MD, PhD, FACC

Peter A. Brady, FACC

Somjot Singh Brar, MD, FACC

Sorin J. Brener, MD, FACC

Emmanouil S. Brilakis, MD, PhD, FACC

Ralph G. Brindis, MD, MPH, MACC

Jeffrey A. Brinker, MD, FACC

David L. Brown, MD, FACC

John E. Brush, Jr., MD, FACC

Randall M. Bryant, MD

Matthew J. Budoff, MD, FACC

Hector Bueno, MD, PhD

James A. Burke, MD, FACC

Javed Butler, MBBS, FACC

David Calhoun, MD

Hugh Calkins, MD, FACC

David S. Cannom, MD, FACC

Christopher P. Cannon, MD, FACC

Warren J. Cantor, MD

Davide Capodanno, MD

Joseph Patrick Carrozza, Jr., MD, FACC

Ivan P. Casserly, MD, FACC

Ricardo Castillo, MD, FACC

Bojan Cercek, MD, FACC

Paul Chan, MD, MSc

Panithaya Chareonthaitawee, MD,

FACC

Sandra L. Chase, PharmD

Farooq A. Chaudhry, MD, FACC

Jersey Chen, MD

Jie Cheng, FACC

Stanley J. Chetcuti, MD, FACC

Alaide Chieffo, MD

ACC.12

Acknowledgments


Kenneth Chin, MBBS, FACC

Aram V. Chobanian, MD, FACC

George S. Chrysant, MD, FACC

Sumeet S. Chugh, MD, FACC

Joaquin E. Cigarroa, MD, FACC

Mehmet Cilingiroglu, MD, FACC

John G. F. Cleland, MD, FACC

David J. Cohen, MD

Mauricio G. Cohen, MD, FACC

Meryl S. Cohen, MD, FACC

Tyrone J. Collins, MD, FACC

John P. Cooke, MD, PhD

Joshua M. Cooper, MD, FACC

Leslie T. Cooper, MD, FACC

Salvatore P. Costa, MD, FACC

David Alan Cox, MD, FACC

Jesse W. Currier, MD, FACC

Jeptha P. Curtis, MD, FACC

Tillmann Cyrus, MD, FACC

George D. Dangas, MD, PhD, FACC

James P. Daubert, MD, FACC

Harold L. Dauerman, MD, FACC

Ravin Davidoff, MD, FACC

Charles J. Davidson, MD, FACC

Michael H. Davidson, MD, FACC

Mark G. Davies, MB, BCh, PhD, FACC

Robbert de Winter

Larry S. Dean, MD, FACC

G. William Dec, Jr., MD, FACC

Carole J. Decker, RN

Gregory J. Dehmer, MD, FACC

Ali E. Denktas, MD, FACC

David DeNofrio, MD, FACC

Akshay S. Desai, MD, FACC

Marcelo F. Di Carli, MD, FACC

Robert S. Dieter, MD, FACC

John P. DiMarco, MD, FACC

Alexios P. Dimas, MD, FACC

Germano DiSciascio, MD, FACC

Sanjay Dixit, MBBS, FACC


AACC

Hisham Dokainish, MD, FACC

James Douketis, MD

Douglas E. Drachman, MD, FACC

Mark H. Drazner, MD, FACC

Andre J. Duerinckx, FACC

Stephanie H. Dunlap, DO

Kim A. Eagle, MD, MACC

Robert T. Eberhardt, MD, FACC

Ramin Ebrahimi, MD, FACC

Andrew Jeffrey Einstein, MD, PhD,

FACC

Kenneth A. Ellenbogen, MD, FACC

Stephen G. Ellis, MD, FACC

Sammy Elmariah, MD

Andrew E. Epstein, MD, FACC

Raimund A Erbel, MD, FACC

N. A. Mark Estes, III, MD, FACC

Gregory A. Ewald, MD, FACC

Derek V. Exner, MD, FACC

Mitchell N. Faddis, MD, PhD, FACC

Thomas E. Fagan, MD, FACC

Peter S. Fail, MD, FACC

Bruno Farah, MD

Andrew Farb, MD, FACC

David P. Faxon, MD, FACC

William Fuller Fearon, MD, FACC

Frederick Feit, MD, FACC

Dmitriy N. Feldman, MD, FACC

Marc D. Feldman, MD, FACC

G. Michael Felker, MD, FACC

Keith C. Ferdinand, MD, FACC

Victor A. Ferrari, MD, FACC

Stephan D. Fihn, MD, MPH

Tim A. Fischell, MD, FACC

Scott D. Flamm, MD, FACC

Mark A. Fogel, MD, FACC

Gregg C. Fonarow, MD, FACC

Joanne M. Foody, MD, FACC

Paul Forfia, MD

Elyse Foster, MD, FACC

Wayne J. Franklin, MD, FACC

Robert P. Frantz, MD, FACC

James B. Froehlich, MD, MPH, FACC

Edward D. Frohlich, MD, FACC

Krishna K Gaddam, MD

Runlin Gao, MD, FACC

Lawrence A. Garcia, MD, FACC

Julius M. Gardin, MD, FACC

Marie D. Gerhard-Herman, MD, FACC

Anthony Gershlick, MD

Jalal K. Ghali, MD, FACC

Raymond J. Gibbons, MD, FACC

C. Michael Gibson, MD, FACC

Ian C. Gilchrist, MD, FACC

Anne M. Gillis, MD

Michael M. Givertz, MD, FACC

Michael Robert Gold, MD, PhD, FACC

Lee R. Goldberg, MD, MPH, FACC

Samuel Z. Goldhaber, MD, FACC

James A. Goldstein, MD, FACC

Sarah J. Goodlin, MD, FACC

Shaun G. Goodman, MD, FACC

Stephen S. Gottlieb, MD, FACC

Christopher B. Granger, MD, FACC

James Aaron Grantham, MD, FACC

Liliana R. Grinfeld, MD, FACC

Paul Michael Grossman, MD, FACC

Maya E. Guglin, MD, FACC

Rajiv Gulati, MD, FACC

Anuj Gupta, MD, FACC

Paul A. Gurbel, MD, FACC

Rory Hachamovitch, MD, FACC

David E. Haines, MD, FACC

Jonathan L. Halperin, MD, FACC

Kishore J. Harjai, MD, FACC

Robert A. Harrington, MD, FACC

Thomas H. Hauser, MD, FACC

Edward P. Havranek, MD, FACC

David L. Hayes, MD, FACC

Harvey S. Hecht, MD, FACC

ACC.12 • Acknowledgments

8 GO for ACC.12!

Paul A. Heidenreich, MD, FACC

Gary V. Heller, MD, PhD, FACC

Robert C. Hendel, MD, FACC

Timothy D. Henry, MD, FACC

James Bernard Hermiller, Jr., MD,

FACC

Adrian F. Hernandez, MD

Howard C. Herrmann, MD, FACC

William R. Hiatt, MD

Ziyad M. Hijazi, MBBS, MPH, FACC

Alan T. Hirsch, MD, FACC

Glenn A. Hirsch, MD, MHS, FACC

Kalon K. L. Ho, MD, FACC

Katherine J. Hoercher, RN

Udo Hoffmann, MD, MPH

Stefan H. Hohnloser, MD, FACC

Brian D. Hoit, MD, FACC

Thomas A. Holly, MD, FACC

David R. Holmes, Jr., MD, FACC

Ralf Holzer, MD

Shunichi Homma, MD, FACC

Susan D. Housholder-Hughes, NP,

AACC

Henry H. Hsia, MD, FACC

Eileen M. Hsich, MD, FACC

W. Gregory Hundley, MD, FACC

Judy W. Hung, MD

Mathew D. Hutchinson, MD, FACC

Adolph M. Hutter, Jr., MD, MACC

Julia H. Indik, MD, PhD, FACC

David Dunbar Ivy, MD, FACC

Warren M. Jackman, MD, FACC

Elizabeth A. Jackson, MD, FACC

Alice K. Jacobs, MD, FACC

Jeffrey P. Jacobs, MD, FACC

Farouc A. Jaffer, MD, PhD, FACC

Diwakar Jain, MD, FACC

Kenneth A. Jamerson, MD

Stefan K. James

Ik-Kyung Jang, MD, PhD, FACC

Allen Jeremias, MD, FACC

Robert H. Jones, MD, MACC

Ion S. Jovin, MD, FACC

Henri Justino, MD, CM, FACC

Jens J. Kaden, MD

Alan H. Kadish, MD, FACC

Mathew Samuel Kalarickal, MD

David E. Kandzari, MD, FACC

Samir R. Kapadia, MBBS, FACC

Aaron V. Kaplan, MD, FACC

Norman M. Kaplan, MD

Saibal Kar, MD, FACC

Ronald P. Karlsberg, MD, FACC

Andrew M. Kates, MD, FACC

Sanjay Kaul, MBBS, FACC

Dean J. Kereiakes, MD, FACC

Steven J. Keteyian, PhD

Amit Khera, MD, MSc, FACC

Henry E. Kim, MD, MPH, FACC

Carey D. Kimmelstiel, MD, FACC


Kyle W. Klarich, MD, FACC

Neal S. Kleiman, MD, FACC

Lloyd W. Klein, MD, FACC

George J. Klein, MD

Paul Kligfield, MD, FACC

Eva M. Kline-Rogers, RN

Bradley P. Knight, MD, FACC

Todd M. Koelling, MD, FACC

Michael C. Kontos, MD, FACC

Smadar Kort, MD, FACC

Mikhail Kosiborod, MD, FACC

Jan Kovac, II, MD, FACC

Jason Ciril Kovacic, MBBS, PhD, FACC

Sandor J. Kovacs, Jr., MD, PhD, FACC

Christopher M. Kramer, MD, FACC

Richard A. Krasuski, MD, FACC

Jacqueline Kreutzer, MD, FACC

Eric V. Krieger, MD

Harlan M. Krumholz, MD, SM, FACC

Aaron D. Kugelmass, MD, FACC

Sudhir S. Kushwaha, MD, FACC

Fred M. Kusumoto, MD, FACC

Michael A. Kutcher, MD, FACC

Jeffrey T. Kuvin, MD, FACC

Raymond Y. K. Kwong, MD, FACC

Nasser M. Lakkis, MD, FACC

Omosalewa O. Lalude, MBBS, FACC

Rachel J. Lampert, MD, FACC

Roberto M. Lang, MD, FACC

Richard A. Lange, MD, FACC

Alexandra J. Lansky, MD, FACC

Gregory M. Lanza, MD, PhD, FACC

Warren K. Laskey, MD, FACC

Steven B. Laster, MD, FACC

Christine E. Lawless, MD, FACC

Martin B. Leon, MD, FACC

Amir Lerman, MD, FACC

John R. Lesser, MD, FACC

Wayne C. Levy, MD, FACC

Gregory D. Lewis, MD

Joao A. C. Lima, MD, FACC

David Lin, MD, FACC

A. Michael Lincoff, MD, FACC

Bruce D. Lindsay, MD, FACC

Mark S. Link, MD, FACC

Christopher F. Liu, MD, FACC

Margaret A. Lloyd, MD

Thomas M. Maddox, MD, MSc, FACC

Akiko Maehara, MD

Francesco Maisano, MD

David J. Malenka, MD, FACC

Calin V. Maniu, MD, FACC

Francis E. Marchlinski, MD, FACC

Frank I. Marcus, MD, FACC

David W. Markham, MD

Larry Markham, MD

David Joel Maron, MD, FACC

Randolph P. Martin, MD, FACC

Alice M. Mascette, MD, FACC

Frederick A. Masoudi, MD, MSPH,

FACC

Barry M. Massie, MD, FACC

Acknowledgments • ACC.12


Paul J. Mather, MD, FACC

Verghese Mathew, MD, FACC

Mathew S. Maurer, MD

Robert D. McBane, II, MD, FACC

James K. McCord, MD

Doff B. McElhinney, MD

Dana P. McGlothlin, MD

Darren K. McGuire, MD, MHSc, FACC

Vallerie V. McLaughlin, MD, FACC

Dennis M. McNamara, MD, FACC

Robert L. McNamara, MD, MHS, FACC

David D. McPherson, MD, FACC

Jessica L Mega, MD

Julinda Mehilli

Roxana Mehran, MD, FACC

Shamir R. Mehta, MD, FACC

Bernhard Meier, MD, FACC

John C. Messenger, MD, FACC

David C. Metzger, MD, FACC

Alan B. Miller, MD, FACC

Fletcher A. Miller, Jr., MD, FACC

John M. Miller, MD, FACC

Gary S. Mintz, MD, FACC

Gregory J. Mishkel, MD, FACC

Suneet Mittal, MD, FACC

Emile R. Mohler, III, MD, FACC

David J. Moliterno, MD, FACC

Stephanie A. Moore, MD, FACC

David A. Morrow, MD, MPH, FACC

William R. Morrow, MD, FACC

Mauro Moscucci, MD, FACC

Jeffrey W. Moses, MD, FACC

Arthur J. Moss, MD, FACC

Joshua D. Moss, MD, FACC

Luis M. B. Moura, MD, PhD, FACC

Issam D. Moussa, MD, FACC


David W. M. Muller, MBBS, FACC

Srinivas Murali, MBBS, FACC

Robert J. Myerburg, MD, FACC

Gerald V. Naccarelli, MD, FACC

Sherif F. Nagueh, MD, FACC

Srihari S. Naidu, MD, FACC

Vijay Nambi, MBBS, FACC

Navin C. Nanda, MD, FACC

Shawna D. Nesbitt, MD

David E. Newby, MD, PhD, FACC

Eugenia Nikolsky, MD, PhD, FACC

Steven E. Nissen, MD, MACC

Rick A. Nishimura, MD, FACC

Kevin D. O’Brien, MD

Patrick T. O’Gara, MD, FACC

Masahiko Ochiai, MD, PhD, FACC

Jae K. Oh, MD, FACC

Erik Magnus Ohman, MD, FACC

Jeffrey W. Olin, DO, FACC

Brian Olshansky, MD, FACC

Suzanne Oparil, MD, FACC

Catherine M. Otto, MD, FACC

Ronald J. Oudiz, MD, FACC

Ramdas G. Pai, MBBS, FACC

Tullio Palmerini, MD

Salpy V. Pamboukian, MD, FACC

Julio A. Panza, MD, FACC

Seung-Jung Park, MD, PhD

Myung H. Park, MD, FACC

Alan S. Pearlman, MD, FACC

Patricia A. Pellikka, MD, FACC

Carl J. Pepine, MD, MACC

Eduardo Perna, MD

Eric D. Peterson, MD, MPH, FACC

Harry R. Phillips, MD, FACC

Gregory Piazza, MD, FACC

Philippe Pibarot, DVM, PhD, FACC

Michael H. Picard, MD, FACC

Augusto Pichard, MD, FACC

Ileana L. Pina, MD, FACC

Edward Plow, PhD

Donna M. Polk, MD, MPH, FACC

Michael Poon, MD, FACC

Brian D. Powell, MD, FACC

Abhiram Prasad, MD, FRCP, FACC

Matthew J. Price, MD, FACC

Miguel A. Quinones, MD, FACC

Gilbert Raff, MD, FACC

Paolo Raggi, MD, FACC

Michael Ragosta, MD, FACC

Shahbudin H. Rahimtoola, MD, MACC

Navin Rajagopalan, MD, FACC

Sanjay Rajagopalan, MD, FACC

Nalini Marie Rajamannan, MD, FACC

C. Venkata S. Ram, MBBS, FACC

Ravi N. Ramani, MD

Jesus Eduardo Rame, MD


Saif S. Rathore, MPH

Rita F. Redberg, MD, MSc, FACC

Bernhard Reimers

John F. Rhodes, Jr., MD, FACC

Vera H. Rigolin, MD, FACC

Michael P. Riley, MD, PhD

Michael J. Rinaldi, MD, FACC

Melissa R. Robinson, MD

Matthew T. Roe, MD, FACC

Joseph G. Rogers, MD, FACC

Anand Rohatgi, MD, FACC

Ivan Rokos, MD, FACC

Kerry L. Rosen, MD, FACC

Raphael Rosenhek, MD

Robert S. Rosenson, MD, FACC

Carlos E. Ruiz, MD, PhD, FACC

John S. Rumsfeld, MD, PhD, FACC

Jeremy N. Ruskin, MD, FACC

Stuart D. Russell, MD, FACC

Arwa Saidi, MB, BCh, FACC

Ernesto E. Salcedo, MD, FACC

Margaret M. Samyn, MD, FACC

Raul D. Santos, MD, DPhil

Lowell F. Satler, MD, FACC

William H. Sauer, MD, FACC

Sherry J. Saxonhouse, MD, FACC

Prof. Bruno Scheller

Nelson B. Schiller, MD, FACC

ACC.12 • Acknowledgments

10 GO for ACC.12!

Paul Schoenhagen, MD

Joachim Schofer

Benjamin M. Scirica, MD, MPH, FACC

Robert L. Scott, MD, PhD, FACC

Victor Serebruany, MD, PhD

Bindi K. Shah, MD, FACC

Pravin M. Shah, MD, MACC

Prediman K. Shah, MD, FACC

Esther Shao, MD, PhD

Samin K. Sharma, MBBS, FACC

Leslee J. Shaw, PhD, FACC

Mobeen Sheikh, MD, FACC

Richard J. Sheppard, MD, CM

Jerold S. Shinbane, MD, FACC

Mehdi H. Shishehbor, DO, MPH

Robert J. Siegel, MD, FACC

Horst Sievert, MD, FACC

Marc A. Silver, MD, FACC

Candice K. Silversides, MD

Daniel I. Simon, MD, FACC

Michael Hugh Sketch, Jr., MD, FACC

James N. Slater, MD, FACC

Christopher S. Snyder, MD

Scott D. Solomon, MD, FACC

Prem Soman, MBBS, FACC

Paul Sorajja, MD, FACC

David E. Sosnovik, MB, BCh, FACC

Laurence S. Sperling, MD, FACC

John A. Spertus, MD, MPH, FACC

Komandoor S. Srivathsan, MBBS, FACC

Bruce Sheldon Stambler, MD, FACC

Randall C. Starling, MD, MPH, FACC

Philippe Gabriel Steg, MD, FACC

James H. Stein, MD, FACC

Paul D. Stein, MD, FACC

Daniel Howard Steinberg, MD, FACC

Steven R. Steinhubl, MD, FACC

William J. Stewart, MD, FACC

Gregg W. Stone, MD, FACC

Neil J. Stone, MD, FACC

George A. Stouffer, MD, FACC

Karen K. Stout, MD, FACC

Takahiko Suzuki

Corrado Tamburino

Allen J. Taylor, MD, FACC

James E. Tcheng, MD, FACC

John R. Teerlink, MD, FACC

Jeffrey J. Teuteberg, MD

Paul D. Thompson, MD, FACC

Henry H. Ting, MD, FACC

Peter P. Toth, MD, PhD, FACC

Mark I. Travin, MD, FACC

Jennifer Tremmel, MD, FACC

Jeffrey C. Trost, MD, FACC

Robin J. Trupp, MSN, RN, ACNP

Etsuo Tsuchikane

Alexander G. Turpie, FACC

E. Murat Tuzcu, MD, FACC

Patricia A. Uber, PharmD

James E. Udelson, MD, FACC

Philip M. Urban, MD, FACC

Viola Vaccarino, MD, PhD

Alex S. Vahanian, MD

Anne Marie Valente, MD, FACC

Paul D. Varosy, MD, FACC

Hector O. Ventura, MD, FACC

Ralph J. Verdino, MD, FACC

Anil Verma, MD

Mladen I. Vidovich, MD, FACC

Todd C. Villines, MD, FACC

Salim S. Virani, MD

Renu Virmani, MD, FACC

Joseph A. Vita, MD, FACC

Pieter-Jan J. Vlaar

Szilard Voros, FACC

Ron Waksman, MD, FACC

Lars Wallentin, MD

Paul J. Wang, MD, FACC

Tracy Wang, MD, FACC

R. Parker Ward, MD, FACC

Michael A. Weber, MD, FACC

Mark W. I. Webster, MD

Bonnie H. Weiner, MD, FACC

Andrew R. Weintraub, MD, FACC

William S. Weintraub, MD, FACC

Raul Weiss, MD, FACC

Robert Matthew Weiss, MD

Neil J. Weissman, MD, FACC

Giora Weisz, MD

Francine K. Welty, MD, PhD, FACC

J. Marcus Wharton, MD

Grayson Wheatley, III, MD

Harvey D. White, DSc, FACC

Christopher J. White, MD, FACC

Harvey D. White, DSc, FACC

Susan E. Wiegers, MD, FACC

David J. Wilber, MD, FACC

Kim Allan Williams, Sr., MD, FACC

Peter Wilmshurst

Stephan Windecker, MD

Suzanne J. Wingate, PhD, CRNP

Michael D. Winniford, MD, FACC

Bernhard Witzenbichler, MD

Stephen D. Wiviott, MD, FACC

Wojciech Wojakowski

Shing-Chiu Wong, MD, FACC

Malissa Jane Wood, MD, FACC

Scott A. Wright, MD, FACC

Nina Wunderlich

Janet Fredal Wyman, MSN, NP,

ACNS-BC, AACC

Masahisa Yamane, MD, FACC

Phillip C. Yang, MD, FACC

Xiaoming Yang, MD, PhD

Robert W. Yeh, MD, FACC

Doron Zahger, MD

Alan Zajarias, MD, MSc, FACC

David Xiao-Ming Zhao, MD, FACC

Khaled M. Ziada, MD, FACC

Michael R. Zile, MD, FACC

Gilbert J. Zoghbi, MD, FACC

William A. Zoghbi, MD, FACC

ACC-i2 with TCT Affiliate Recognition:

VIVA 12: Vascular InterVentional

Advances

Acknowledgments • ACC.12


Please join us in acknowledging the work of your peers. The following Fellows in Training have been selected as part of an elite group of FIT “rising stars,” based upon their top scoring abstract or case submission for ACC.12.

Ahmad Jeroudi

Ali Alizadehsovari

Amit Amin

Amit Noheria

Andrew Choi

Anita Radhakrishnan

Benjamin Galper

Brian Davidson

Christopher Statile

Dan Sorajja

Danny Eapen

Dawn Scantlebury

Dharam Kumbhani

Dongngan Truong

Eric Rome

Evan Brittain

Farbod Raiszadeh

Haseeb Jafri

Jeffrey Testani

JoEllyn Abraham

John Dodson

John Lee

Jose Vargas

Karim Sallam

Khurram Nasir

Kumar Dharmarajan

Kyle Ulveling

Louai Razzouk

Manoj Kesarwani

Marnie Taylor

Matthew Solomon

Max Liebo

Megan Coylewright

Meredith Brisco

Michael Blaha

Michael Burke

Morteza Farasat

Mosi Bennett

Murali Senapathi

Nada Shaban

Neha Yadav

Nitesh Sood

Nitin Mahajan

Omar Khalique

Paaladinesh Thavendiranathan

Philip Green

Poulina Uddin

Quinn Pack

Raymond Chan

Raymond Chan

Robert Mentz

Robert Tunks

Sameer Jamal

Samir Thadani

Sandeep Goyal

Seshu Rao

Sharath Subramanian

Shikhar Agarwal

Siddharth Wayangankar

Sreedevi Gondi

Stacey Clegg

Tarek Mousa

Tomas Neilan

Yasmin Hamirani

Zubin Eapen

ACC.12

Elite FIT Rising Star Acknowledgments

*Grantors as of February 27, 2012 ©2012 American College of Cardiology. A12269

ACC.12 GRANTOR ACKNOWLEDGMENTS*

ACUTE CORONARY SYNDROMES PATHWAY

ARRHYTHMIAS PATHWAY

DIAGNOSTIC TESTING AND IMAGING PATHWAY

HEART FAILURE PATHWAY

PREVENTION/GENERAL CARDIOLOGY PATHWAY

PULMONARY HYPERTENSION PATHWAY

VALVULAR PATHWAY

*Grantors as of February 27, 2012©2012 American College of Cardiology. A12270

ACC-i2 with TCT GRANTOR ACKNOWLEDGMENTS*

CHAMPIONING CARE FOR THE PATIENT WITH AORTIC STENOSIS

FIRST LINE OF DEFENSE: RISK FACTORS AND PREVENTION IN THE CARDIOLOGY PRACTICE

INNOVATIONS IN TRANSLATION: ACS

INNOVATIONS IN TRANSLATION: ATRIAL FIBRILLATIONJOINT SESSION OF THE HEART RHYTHM SOCIETY AND ACC

MULTIDISCIPLINARY APPROACH TO THE HIGH RISK AORTIC STENOSIS PATIENTJOINT SESSION OF AATS, STS AND ACC

*Grantors as of February 27, 2012 ©2012 American College of Cardiology. A12271

ACC.12 CLINICAL FOCUS SESSIONS GRANTOR ACKNOWLEDGMENTS*

*Grantors as of February 27, 2012©2012 American College of Cardiology. A12294

ACC.12 SESSION GRANTOR ACKNOWLEDMENTS*

THE ROLE OF THERAPEUTIC HYPOTHERMIA IN THE TREATMENT OF CARDIAC ARREST

SESSION #263 - SUNDAY, MARCH 25, 4:30 P.M. – 6:00 P.M.

SUPPORTED BY EDUCATIONAL GRANTS FROM:

ANTITHROMBOTIC THERAPIES FOR ATRIAL FIBRILLATION: THE CURRENT STATE OF THE ART

SESSION #747 - TUESDAY, MARCH 27, 8:00 A.M. – 9:30 A.M.

IN PARTNERSHIP WITH THE TEAM-A INITIATIVE

SUPPORTED BY AN EDUCATIONAL GRANT FROM:

BRISTOL-MYERS SQUIBB AND PFIZER, INC.

16 GO for ACC.12!

The American College of Cardiology Foundation proudly recognizes our 2011 donors whose generosity demonstrates the spirit of giving that enables the College to foster optimal cardiovascular care.

The following donors are recognized for their gifts to ACCF initiatives between January 1, 2011 and December 31, 2011.

Margarita Abbey, NPArnold Abrams, MDArnold Adicoff, MD, FACCAshok Agarwal, MD, FACCAnwar Ahmad, MBBS, FACCWalter Allison III, MDJoseph Alpert, MD, FACC &

Helle Mathiasen, PhDArthur Anderson, MD, FACCPaul Anderson, MD, FACCLewis Anthony, MD, FACCEmanuel Arbel, MD, FACCSurya Artham, MD, MPHJames Asaph, MD, FACCManisha Ashar, MD, FACCJohn Auseon, DO, FACCCatherine Avgeropoulou, MDDarla Bakersmith-Hess, MD, FACCAjay Bali, MBBS, FACCScott Baron, MD, FACCHabib Bassil, MD, FACCAsish Basu, MBBS, FACCJennifer Ray Beckman & Jon BeckmanJohn Beeble, MDLinda Bell & Douglas BellGeorge Beller, MD, MACC &

Emily CouricPachalla Bhat, MD, FACCKathleen Blake, MD, FACCBoris Bogomilov, MD, FACCMarc Bois, MD, FACCMichael Boland, MD, FACCJohn Bowers, MD, FACCAhmet Bozer, MD, FACCJoseph Branconi, MD, FACC

Alan Brenner, MD, FACCCraig BrennerDrs. Ralph and Claire BrindisAllison Brooks, NP, AACCCarman Brooks, MD, FACCNathan Brown, MD, FACCChristine Browning, MDPeter Bruno, MD, FACCJohn Brush, Jr., MD, FACCHoward Buckley, MD, FACCMarcia Buckley Bull, MD, FACCCalvert Busch, MD, FACCHomobono Calleja, MD, FACC &

Cecilia Calleja TaufiqueJames Calvin, MD, FACCJoanne Ceimo, MD, FACCBernard R. Chaitman, MD, FACCSandra Chase, PharmDLeonid Chernov, MD, FACCDevyani Chowdhury, MBBS, FACCLalji Chudasama, MD, FACCCarolyn ClarkLianna CollingePeter Correnti, Jr., DOThelma Cote’ PeperDaniel Courtade, MD, FACCWilliam Crafford, Jr., MD, FACCL. Bruce Cronk, MD, FACCDeborah Croy, NP, AACCIra Dauber, MD, FACCG. William Dec, Jr., MD, FACCAnand Deshmukh, MDRobert Deutscher, MD, FACCMichael DeVita, DO, FACCQuinton Dickerson, Jr., MD, FACC

Vincent Donlon, MHAW. Daniel Doty, MD, FACCPamela Douglas, MD, MACC &

Geoffrey Ginsburg, MD, PhD, FACCAndrew Drakonakis, MD, FACCDenis Drew, MD, FACCJoseph Drozda, Jr., MD, FACCEric Drummer, MD, FACCAngelos Economou, MD, FACCHaskell Ellison, MD, FACCGeorg Emlein, MD, FACCRaimund Erbel, MD, FACCJohn Erwin III, MD, FACCSteven Ettinger, MD, FACCKameel Farag, MD, FACCJames Fasules, MD, FACCMeredith Filson-Perry, RNJeffrey Fisher, MD, FACCMichael Flynn, MD, FACCKenneth Forman, MDRobert Francis, MD, FACCMilton Frank III, MDWilliam Frankl, MD, FACCRoberto Fred Santana, MD, FACCLeon Friedman, MD, FACCEugene Fu, MD, FACCJuan Fuselli, MDJoseph Gaeta, MD, FACCJulius Gardin, MD, FACC &

Susan GardinRichard Gerber, MD, FACCMichael Gewitz, MD, FACCMichael Girolami, MD, FACCJulian Gladstone, MD, FACCTyler Gluckman, MD, FACC

ACCF Charitable Benefactors


Harry Goldberg, MD, FACCAlfredo Gonzalez, MD, FACCDavid Gooray, MD, FACCGabriel Gregoratos, MD, FACCJan Griffin, NPBhavdeep Gupta, MD, FACC &

Dolly GuptaEileen Handberg, PhD, ARNP, FACCBruce Handler, MD, FACCSyed Haq, MBBS, FACCMasood Haque, MD, FACCKishore Harjai, MD, FACCLawrence Harris, MD, FACCErhard Helmling, MDThomas Hennebry, MB, BCh, FACCShigeaki Hinohara, MD, FACCTetsuya Hirano, MD, PhD, FACCMurray Hoffman, MD, FACCDavid Holmes, Jr., MD, FACCMun Hong, MD, FACCDeepak Hooda, MDSusan Housholder-Hughes, NP, AACCVictor Howard, MD, FACCLarry Hurwitz, MD, FACCSaleem Husain, MD, FACCJohn Hutcherson, MD, FACCElisabeth Immanuel-Alexis, MBBS,

FACCDavid Jackson, MD, FACCLester Jacobson, MD, FACCMansoor Jelveh, MD, FACCThomas Johnson, MD, FACCZoe Jones, MD, FACCEdmundo Jordan-Morey, MD, FACCRobert KalmanAnna Kalynych, MD, FACCMurat Karatepe, MD, FACCSomeswarareddy Karri, MBBS, FACCJohn Kassotis, MD, FACCMaximiliaan Kaulbach, MD, FACCJulian Keil, PhD, FACCDennis Kelly, MD, FACCGabriel Khan, MD, FACCStephen Kiefer, MD, FACCWilliam Kimber, MD, FACCMarvin Kirsh, MD, FACCJay Kleiman, MD, FACC

Colette Kohler, MD, FACCRichard Kovacs, MD, FACC &

Roxanne KovacsFred Krainin, MD, FACCGerald Lackey, DO, PhD, FACCLawrence Laslett, MD, FACCFrancis Lau, MD, FACCRonald Lech, MD, PhD, FACCSidney Levitsky, MD, FACCRichard Lewis, MD, FACCShoa-Lin Lin, MD, FACCWilliam Lista, MD, FACCSteven Lloyd, MD, FACCJose Eugenio Lopez, MD, FACCLawrence Lubow, MD, FACCWalter Lucia, MDEugene Magnier, MD, PhD, FACCGeorge Maha, MDSabyasachi Mahapatra, MBBS, FACCTariq Malik, MBBS, FACCAmalendu Mandal, MD, FACCAndre Marquand, MD, FACCRaymond Massay, MBBS, DM, FACCAllan Mattern, MD, FACCManuel Mayor, MD, FACCGloria Mays, MD, FACCJohn McBride, MD, FACCJames McClurken, MD, FACCHerbert McDonald, MD, FACCMartin McGough, MD, FACCCharles McKay, MD, FACC &

Maleah Groover-McKayDaniel McMartin, MD, FACCJoseph Messer, MD, MACC &

Nancy L. KochDavid Messinger, MD, FACCKeith Miller, MD, PhD, FACCRonald Miller, MD, FACCMargo Minissian, ACNP-BC, MSN, CNSStephanie MitchellVijay Mittal, MD, FACCChitta Mohapatra, MD, FACCChristos Moschos, MD, FACCAshish MukherjeeNarayan Mulamalla, MD, FACCPramod Multani, MBBS, FACCStans Murad-Netto, MD, FACC

Maheswari Murugesan, NPMunir Nassar, MDRudolph Nisi, MD, FACCSteven Nissen, MD, MACCMichael Nocero, Jr., MD, MACCJacqueline Noonan, MD, FACCLester Nunnally, MD, FACCJohn Nwogu, MBBS, FACCPatrick O’Gara, MD, FACCPeter Odhiambo, MD, FACCWilliam Oetgen, MD, MBA, FACCLarry Osborn, MD, FACCYukio Ozawa, MD, FACCJohn Packard, MD, FACCVachaspathi Palakodeti, MBBS, FACCMadhava Pally, MBBS, FACCBipin Patadia, MBBS, FACCMrugesh B. PatelTimir Paul, MDPaul Piccini, MD, FACCDonna Polk, MD, MPH, FACCRichard Popp, MD, MACC & Janis PoppHerman Price, MD, FACCDavid Propert, MD, FACCWilliam Pryor, MD, FACCSatyavardhan Pulukurthy, MDJerome Radding, MD, FACCMartha Radford, MD, FACCAtul Ramachandran, MD, FACCNathaniel Reichek, MD, FACCJoseph Restivo, MD, FACCJames Reynolds, MD, FACCLarry Riedel, MDGaetan Ringuette, MD, FACCJanet Rippy, MD, FACC &

Fredrick HohltJose Rivera Del Rio, MD, FACCAbel Robertson, Jr., MD, PhD, FACCJerome Robinson, MD, FACCGeorge Rodgers, MD, FACC &

Leslie RodgersJoseph Romeo, MD, FACCFred Rose, MD, FACCJames Ross, MD, FACCDennis Rowe, MD, FACCJohn Rumsfeld, MD, PhD, FACCElayne Russek


18 GO for ACC.12!

Shelley Russek, PhD & David FarbSharon S. SadeghiniaJonathan Safren, MD, FACCBal Sahay, MBBS, FACCRosemarie Salerni, MD, FACCGeorge Sanders, MD, FACCJack Sanders, MD, FACCJoseph Saporito, MD, FACCBarry Saul II, MD, FACCWade Saunders III, MD, FACCJohn Schaeffer, MD, FACCGerold Schiebler, MD, FACCCarsten Schmalfuss, MD, FACCMark Schoenfeld, MD, FACCDouglas Schreck, MD, FACCJackie See, MD, FACCMarvin Segal, MD, FACCSamir Shah, MD, FACCJami Shakibi, MD, FACCAbdolhamid Sheikhzadeh, MD, FACCTianChu Shih, DO, FACCLeonard Silverman, MD, FACCSidney Smith, Jr., MD, FACC &

Lucy SmithSamuel Sobol, MD, FACCJames Spann, Jr., MD, FACCKurt Spriggs, DO, FACCJasbir Sra, MD, FACCBhaskaran Sreekumar, MD, FACCLawrence Staples, MD, FACC &

Marilyn StaplesEric Stern, MD, FACCW. Theodore Steudel, MD, FACCJames Stone, MD, PhD, FACCSiegfried Storz, MD, FACCRuth Strang, MD, FACCSamuel Suede, MD, FACCW. David Sullivan, MD, FACCMaria Arlene Sumido, RNJames Swan, MD, FACCAlexander Sytman, MD, FACCBurton Tabakin, MD, FACCKan Takayanagi, MD, PhD, FACCLinda Tavares, MS, RN, ACNP-BC,

AACCRichard Taylor

Madhusudan Thakur, MBBS, FACCGerasim Tikoff, MD, FACCPeter Tilkemeier, MD, FACCAlain Tocatjian, MD, FACCDorothy Tripodi, RNDeborah Tsunoda, NPE. Tuzcu, MD, FACCDavid Unterman, MD, FACCMucio Valenca, MD, FACCRomeo Vecht, MB, ChB, FACCRenu Virmani, MD, FACCRobert Vranian, MD, FACCEdwin Vyhmeister, MD, FACCStanley Wagner, MD, FACCStephen Wallenhaupt, MDHoward Walpole, Jr., MD, FACCJohn Wanamaker, MD, FACCHoward Warner, MD, FACCJames Warnock, Jr., MD, FACCIchiro Watanabe, MD, FACCSuzanne Waters, NPW. Douglas Weaver, MD, MACCJan Weber, MD, FACCHarry Weinrauch, MD, FACCMyron Weisfeldt, MD, FACC &

Linda WeisfeldtHarlan Weisman, MD, FACCArmisted L. WellfordEdward WestmarkDavid Wilber, MD, FACCJohn Williams, Jr., MD, MACC &

Jan WilliamsPatrick Williams, MD, FACCJohn Wilson, MDMichael Wolk, MD, MACCMaylene Wong, MD, FACCHarry Woske, MD, FACCMilford Wyman, MD, FACCVidya Yalamanchi, MBBS, FACCNoriaki Yamamoto, MDTakashi Yanaga, MD, FACCJames Yates, MD, FACCAlbert Zager, MD, FACC &

Marilouise ZagerIzhar Zahavi, MD, FACCAlex Zakharia, MD, FACC

Syamasundera Zampani, MD, FACCBujung Zen, MD, FACCDouglas Zipes, MD, MACC &

Joan ZipesNazih Zuhdi, MD, FACCAlan Zunamon, MD, FACCAssociation of Black Cardiologists, Inc.Baptist Memorial Medical GroupBlount Memorial Physician Group, Inc.California Cardiovascular Specialists Inc.California Pacific Medical CenterCardiology Consultants of NY, PCCardiology Services PSCCardiovascular Associates of

North Jersey, PCCardiovascular Care AssociatesCentral Coast Cardiology

A Medical CorporationDeTar Healthcare SystemDr. Jordan Cardiology Center, PSCEast Tennessee State UniversityEast Texas Cardiology, P.A.Easton Cardiovascular Associates, P.C.Fidelity Charitable Gift FundHeart Care Associates, P.S.C.Heart Center of Charlotte, PAHeartcare Associates of Bucks County, P.C.Imperial Valley Family Care Medical

Group A.P.C.Jefferson Medical AssociatesKitsap Cardiology Consultants, PLLCLearner’s Digest InternationalMidsouth Cardiovascular Center, PLLCMK & A CorporationNevada Heart & Vascular, LLPOcala Heart Clinic II LLCOcean Cardiovascular, LLCPartners HealthCarePittsburgh North CardiovascularSee Family Trust of MissouriSemma Medical PLLCSherman Heart Group, LLCThe Michael Wolk Heart Foundation, Inc.The Russek Foundation Inc.Virginia Cardiovascular Consultants PCWestern Slope Cardiology, P.C.



Donor Honoree

Surya Artham, MD, MPH In honor of Carl J. Lavie, MD, FACC Allison Brooks, NP, AACC In honor of John Dent, MD, FACC Christine Browning, MD In honor of Anthony J. Minisi, MD, FACC Deborah Croy, NP, AACC In honor of John Dent, MD, FACC Pamela Douglas, MD, MACC In honor of Richard L. Popp, MD, MACC John Erwin III, MD, FACC In honor of Rick A. Nishimura, MD, FACC

Cardiovascular Leadership InstituteThe following donors have honored a mentor or leader who has helped paved the way for the next generation of cardiovascular professionals. Donations were made to the ACCF’s Cardiovascular Leadership Institute.

The following donors are recognized for their gifts to the ACCF’s Eugene Braunwald Clinical Investigator Award.

Hafil Abdulgani, MD, FACCJoseph Alpert, MD, FACCWilliam H. BarryGeorge Beller, MD, MACCRoger Blumenthal, MD, FACCChristoph Bode, MD, PhD, FACCAlfred Bove, MD, PhD, MACCLawrence Boxt, MD, FACCCraig BrennerRalph Brindis, MD, MPH, FACCMarcia Buckley Bull, MD, FACCHugh Calkins, MD, FACCJoanne Ceimo, MD, FACCBernard R. Chaitman, MD, FACCCraig Clark, MD, DO, FACCGary Francis, MD, FACCJulius Gardin, MD, FACCJoan Gnadt, MD, FACCLester Jacobson, MD, FACC

Robert Jones, MD, MACCFred Krainin, MD, FACCPeter Libby, MD, FACCSabyasachi Mahapatra, MBBS, FACCPeter McCullough, MD, MPH, FACC, FACP, FAHA, FCCPChitta Mohapatra, MD, FACCJacqueline Noonan, MD, FACCMartha Radford, MD, FACCTsuguya Sakamoto, MD, FACCJasvinder Sidhu, MD, FACCRenu Virmani, MD, FACCMyron Weisfeldt, MD, FACCHarlan Weisman, MD, FACCJohn Williams, Jr, MD, MACCJames Young, MD, FACCDouglas Zipes, MD, MACCLearner’s Digest InternationalPartners HealthCareAnonymous Donor

Eugene Braunwald Clinical Investigator Award Endowment

20 GO for ACC.12!

Steven Ettinger, MD, FACC In honor of Charles E. Chambers, MD, FACC Kameel Farag, MD, FACC Eugene Fu, MD, FACC In honor of Kennenth A. Ellenbogen, MD, FACC Jan Griffin, NP In honor of John Dent, MD, FACC Bhavdeep Gupta, MD, FACC In honor of Michael P. Savage, MD, FACC Kishore Harjai, MD, FACC In honor of Cynthia L. Grines, MD, FACC Kishore Harjai, MD, FACC In honor of Gregg W. Stone, MD, FACC Mun Hong, MD, FACC In honor of Kenneth M. Kent, MD, PhD, FACC Mun Hong, MD, FACC In honor of Martin B. Leon, MD, FACC Lester Jacobson, MD, FACC Robert Kalman In honor of Monte Malach, MD, FACC James McClurken, MD, FACC In honor of Anthony J. Atala, MD James McClurken, MD, FACC In honor of Randolph Chitwood, Jr., MD, FACC James McClurken, MD, FACC In honor of Daniel E. Forman, MD, FACC James McClurken, MD, FACC In honor of John G. Harold, MD, MACC James McClurken, MD, FACC In honor of Robert H. Jones, MD, MACC James McClurken, MD, FACC In honor of Aaron D. Kugelmass, MD, FACC James McClurken, MD, FACC In honor of Scott Millikan, MD, FACC James McClurken, MD, FACC In honor of Marc E. Shelton, MD, FACC Margo Minissian, ACNP-BC, MSN, CNS In memory of James T. Dove, MD, MACC Vijay Mittal, MD, FACC In honor of Ajay Acharya, MD, FACC Maheswari Murugesan, NP In honor of John Dent, MD, FACC Michael Nocero, Jr., MD, MACC In honor of Leonard S. Dreifus, MD, MACC Timir Paul, MD In honor of Paul W. McMullan, Jr., MD, FACC Donna Polk, MD, MPH, FACC In honor of C. Noel Bairey Merz David Propert, MD, FACC Nathaniel Reichek, MD, FACC In honor of Joseph K. Perloff, MD, FACC Janet Rippy Hohlt, MD, FACC TianChu Shih, DO, FACC In honor of Felix J. Rogers, DO, FACC Linda Tavares, MS, RN, ACNP-BC, AACC In honor of John Dent, MD, FACC Richard Taylor In honor of Paula J. Schrank Peter Tilkemeier, MD, FACC In honor of Alfred F. Parisi, MD, FACC Howard Walpole, Jr., MD, FACC In honor of Douglas C. Morris, MD, FACC Suzanne Waters, NP In honor of John Dent, MD, FACC John Wilson, MD In honor of Alan H. Gradman John Wilson, MD In honor of Jerome E. Granato John Wilson, MD In honor of Indu G. Poornima John Wilson, MD In honor of Venkatraman Srinivasan Alex Zakharia, MD, FACC Alan Zunamon, MD, FACC In honor of Hadi Dizadji, MD, FACC Ocala Heart Clinic II LLC In honor of Ajay Acharya, MD, FACC Pittsburgh North Cardiovascular In honor of Ram L. Dhawan, MD, FACC

If you would like to participate in any of the American College of Cardiology Foundation’s giving programs, please email [email protected].

Donor Honoree

Cardiovascular Leadership Institute

Get Your DailY Dose of Quality at aCC.12

©2012 American College of Cardiology. E1204

Learn more about ACC’s quality improvement programs and how you

can get involved during ACC.12

aCC Central (Booth #10027)

ExpEriEncE

Special attendee pricing expires March 27, 2012. *Savings vary with registration category

A12

199

©20

12 A

mer

ican

Col

lege

of C

ardi

olog

y

Order iScience today at the following locations:

• SouthBuilding,GrandConcourseLobby,Level3

• ACCCentral,Booth#10027,intheExhibitHall

Ororderonlineatwww.CMEonCall.com/accEnteryourbadgenumbertoreceivethe

attendeediscount.

Order iScience, the Acc.12 Meeting on Demand, during the meeting, and save over $1,000*!

iScienceisacomprehensivedigitallibraryofpresentationsfromACC.12andincludesover400hoursofeducationalcontent.ItisthemostconvenientwaytoexperiencealltheeducationfromACC.12andallowsyoutowatchpresenters’slideswhilelisteningtofully-synchronizedaudioasifyouwereactuallyattendingeachsession. Features of iScience include:

• Onlineaccesstocontentwithin24hours

• ConvenientUSBdrivewithaccesstotheentireiSciencelibraryforofflineviewing

• StreamingcontentforviewingoniPad®andiPhone®devices.

• DownloadablePDF’sofpresenterslidesforconvenientreferenceandnotetaking

• DownloadableMP3filesforconvenienton-the-goaudio

• Plus,youcanearnadditionalCMEcreditwithiScience

Stay up-to-date with NEW official magazines of the American College of Cardiology — CardioSource WorldNews and CardioSource InterventionalNews! These complimentary, monthly magazines are edgy, provocative and deliver point and counter point perspectives on the latest in cardiovascular research, medicine and technology. Learn the latest advances with:

• Perspectivesfromthoughtleaders

• Debatesonthekeycontroversiesinmedicine

• Practicalinsightsintocomplexclinicaldata—implicationsforyourpractice

Visit www.cswnews.org and www.csinewslive.org to access the electronic versions today.

Stop by ACC CentrAl, booth #10027 to leArn more! ©

2012

American

College

ofC

ardiolog

y.G1

212

Chris’s CornerWelcome to CardioSource World NewsPAGE 2

Jack In The BackCreating the futurePAGE 48

Number CheckInteresting stats and tidbits to ponderPAGE 36

Patient FocusHow you can help your patients with obesity

PAGE 42

IN THIS ISSUE:

CLINICAL NEWS

JANUARY 2012VOLUME 1 | ISSUE 1

www.cswnews.org

PREMIER ISSUEYour Source for News and Views from the World of Cardiology

CardioSource WorldNews

THE

ISFUTURENOWHow new anticoagulants will impact stroke prevention in AF — PAGE 20

Gregg C. Fonarow, MD on Home Monitoring—page 13 Suzanne Oparil, MD

on JNC 8—page 31Steven E. Nissen, MD on Politics vs. Science—page 46

46%Reduction in Incidence of MI

50% Reduction in Sudden Cardiac Deaths

Cardiology Countdown 3JACC in a Flash 8Journal Scan 9ACCEL Summaries 10Hot Topic 13Special Meeting Coverage 14

George’s Take

Life after COURAGE

PAGE 2

Jack In The Back

Problems with

PCI reimbursement

PAGE 48

Number Check

New data points from

NCDR databases

PAGE 36

Novel Techniques:

Grasping transradial

access

PAGE 42

IN THIS ISSUE:

CLINICAL NEWS

MARCH 2012 VOLUME 1 | ISSUE 1

www.cswnews.org

PREMIER ISSUE

Your Source for News and Views from the World of Cardiology

CardioSource InterventionalNews

Stents

in the Elderly—page 18

What ACOs Mean

for Intervention—page 23

The Issue of

Clopidogrel Resistance —page 36

JACC in a Flash 8

Journal Scan 9

Cardiology Countdown 12

ACCEL Intervention 14

Hot Topic 15

The New Frontier:

Will Change Everything

How the Development of TAVI

Save 15% off select educational products and courses purchased on site!

Visit ACC Central, Booth #10027!

©2012 American College of Cardiology. J1204

Make MULTAQ® your fi rst-choice AAD

Keeps patients in sinus rhythm longer and reduces symptomatic AFib recurrence 1

of fi rst AFib recurrence (symptomatic or asymptomatic)1

– Absolute difference in recurrence rate of about 11% at 1 year (P<0.001; primary endpoint)

– Majority of fi rst recurrences were symptomatic

of patients treated with MULTAQ were free of symptomatic AFib recurrence vs 54% of patients on placebo at 1 year (P<0.001; secondary endpoint)1

Decreases risk of patients being hospitalized for AFib events 2

in CV hospitalization or mortality, the combined primary endpoint (P<0.0001, entirely attributable to reduced CV hospitalizations, principally hospitalizations related to AFib)2

RRR25%

RRR*24%

62.3%

In tune with your patients’ needs

Visit MULTAQ.com/hcp for more information.

Indication

MULTAQ is an antiarrhythmic drug indicated to reduce the risk of hospitalization for atrial fi brillation (AFib) in patients in sinus rhythm with a history of paroxysmal or persistent AFib.

Important Update: Boxed WARNING, contraindications, and warnings have been revised due to label change.

Important Safety Information for MULTAQ–Boxed WARNING

WARNING: INCREASED RISK OF DEATH, STROKE AND HEART FAILURE IN PATIENTS WITH DECOMPENSATED HEART FAILURE OR PERMANENT ATRIAL FIBRILLATION

MULTAQ is contraindicated in patients with symptomatic heart failure with recent decompensation requiring hospitalization or NYHA Class IV heart failure. MULTAQ doubles the risk of death in these patients.

MULTAQ is contraindicated in patients in atrial fi brillation (AFib) who will not or cannot be cardioverted into normal sinus rhythm. In patients with permanent AFib, MULTAQ doubles the risk of death, stroke, and hospitalization for heart failure.

Please see additional Important Safety Information and brief summary of full Prescribing Information, including boxed WARNING, on following pages.

400-mg tablet bid,with morning and evening mealsThe absolute bioavailability of MULTAQ increases when administered with a full meal

• NO hospital initiation required 2

• NO loading dose 2

• NO titration 2

* Relative risk reduction (RRR) observed over the study period (median 22-month treatment and follow-up; minimum 12 months, maximum 30 months).2,3

Tune in at Booth #14000

General Information

Important Safety Information for MULTAQ®

WARNING:INCREASED RISK OF DEATH, STROKE AND HEART FAILURE IN PATIENTS WITH DECOMPENSATED HEART FAILURE OR PERMANENT ATRIAL FIBRILLATION

MULTAQ is contraindicated in patients with symptomatic heart failure with recent decompensation requiring hospitalization or NYHA Class IV heart failure. MULTAQ doubles the risk of death in these patients.

MULTAQ is contraindicated in patients in atrial fi brillation (AFib) who will not or cannot be cardioverted into normal sinus rhythm. In patients with permanent AFib, MULTAQ doubles the risk of death, stroke, and hospitalization for heart failure.

MULTAQ is also contraindicated in patients:

• With second- or third-degree atrioventricular (AV) block or sick sinus syndrome (except when used in conjunction with a functioning pacemaker), bradycardia <50 bpm, QTc Bazett interval ≥500 ms or PR interval >280 ms

• Who are or may become pregnant (Category X) or nursing. MULTAQ may cause fetal harm when administered to a pregnant woman

• With concomitant use of strong CYP 3A inhibitors, such as ketoconazole, itraconazole, voriconazole, cyclosporine, telithromycin, clarithromycin, nefazodone, ritonavir, or drugs or herbal products that prolong the QT interval and might increase the risk of Torsade de Pointes, such as phenothiazine antipsychotics, tricyclic antidepressants, certain oral macrolide antibiotics, and Class I and III antiarrhythmics

• With liver toxicity related to the previous use of amiodarone• With severe hepatic impairment

Cardiovascular Death in NYHA Class IV or Decompensated Heart FailureMULTAQ is contraindicated in patients with NYHA Class IV heart failure or symptomatic heart failure with recent decompensation requiring hospitalization because it doubles the risk of death.

Cardiovascular Death and Heart Failure in Permanent AFibMULTAQ doubles the risk of cardiovascular death (largely arrhythmic) and heart failure events in patients with permanent AFib. Patients treated with MULTAQ should undergo monitoring of cardiac rhythm no less often than every 3 months. Cardiovert patients who are in AFib (if clinically indicated) or discontinue MULTAQ. MULTAQ offers no benefi t in subjects in permanent AFib.

Increased Risk of Stroke in Permanent AFibIn a placebo-controlled study in patients with permanent atrial fi brillation, dronedarone was associated with an increased risk of stroke, particularly in the fi rst two weeks of therapy. MULTAQ should only be initiated in patients in sinus rhythm who are receiving appropriate antithrombotic therapy.

New Onset or Worsening Heart FailureNew onset or worsening of heart failure has been reported during treatment with MULTAQ in the postmarketing setting. In a placebo-controlled study in patients with permanent AFib, increased rates of heart failure were observed in patients with normal left ventricular function and no history of symptomatic heart failure, as well as those with a history of heart failure or left ventricular dysfunction. Advise patients to consult a physician if they develop signs or symptoms of heart failure, such as weight gain, dependent edema, or increasing shortness of breath. If heart failure develops or worsens and requires hospitalization, discontinue MULTAQ.

Liver InjuryHepatocellular liver injury, including acute liver failure requiring transplant, has been reported in patients treated with MULTAQ in the postmarketing setting. Advise patients treated with MULTAQ to report immediately symptoms suggesting hepatic injury (such as anorexia, nausea, vomiting, fever, malaise, fatigue, right upper quadrant pain, jaundice, dark urine, or itching). Consider obtaining periodic hepatic serum enzymes, especially during the fi rst 6 months of treatment. It is not known whether routine periodic monitoring of serum enzymes will prevent the development of severe liver injury. If hepatic injury is suspected, promptly discontinue MULTAQ and test serum enzymes, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase, as well as serum bilirubin, to establish whether there is liver injury. If liver injury is found, institute appropriate treatment and investigate the probable cause. Do not restart MULTAQ in patients without another explanation for the observed liver injury.

Hypokalemia and Hypomagnesemia with Potassium-Depleting DiureticsHypokalemia and hypomagnesemia may occur with concomitant administration of potassium-depleting diuretics. Potassium levels should be within the normal range prior to administration of MULTAQ and maintained in the normal range during administration of MULTAQ.

QT Interval ProlongationMULTAQ induces a moderate (average of about 10 ms but much greater effects have been observed) QTc (Bazett) prolongation. If the QTc Bazett interval is ≥500 ms, discontinue MULTAQ.

Increase in CreatinineSmall increases in creatinine levels (about 0.1 mg/dL) following MULTAQ treatment initiation have been shown to be a result of inhibition of creatinine’s tubular secretion. The elevation has a rapid onset, reaches a plateau after 7 days and is reversible after discontinuation. Larger increases in creatinine after MULTAQ initiation have been reported in the postmarketing setting. Some cases also reported increases in blood urea nitrogen. In most cases, these effects appear to be reversible upon drug discontinuation. Monitor renal function periodically.

Women of Childbearing PotentialPremenopausal women who have not undergone a hysterectomy or oophorectomy must use effective contraception while using MULTAQ. Dronedarone caused fetal harm in animal studies at doses equivalent to recommended human doses. Counsel women of childbearing potential regarding appropriate contraceptive choices.

Drug-Drug Interactions• Treatment with Class I or III antiarrhythmics or drugs that are strong inhibitors

of CYP 3A must be stopped before starting MULTAQ (see Contraindications)• Patients should be instructed to avoid grapefruit juice beverages while

taking MULTAQ• Calcium channel blockers with depressant effects and beta-blockers could

increase the bradycardia effects of MULTAQ on conduction• Increased digoxin levels and gastrointestinal disorders have been observed

when MULTAQ was coadministered with digoxin. Digoxin can also potentiate the electrophysiologic effects of MULTAQ (such as decreased AV-node conduction); consider the need for continued digoxin therapy when prescribing MULTAQ. If digoxin treatment is continued, halve the dose of digoxin, monitor serum levels closely, and observe for toxicity

• Postmarketing cases of increased INR with or without bleeding events have been reported in warfarin-treated patients initiated with MULTAQ. Monitor INR after initiating MULTAQ in patients taking warfarin

• Statins: Follow statin label recommendations for use with CYP 3A and P-gP inhibitors such as MULTAQ

Adverse ReactionsIn studies, the most common adverse reactions observed with MULTAQ were diarrhea, nausea, abdominal pain, vomiting, and asthenia.

Please see brief summary of Prescribing Information, including boxed WARNING, on following pages.

References: 1. Singh BN, Connolly SJ, Crijns HJGM, et al; for the EURIDIS and ADONIS Investigators. Dronedarone for maintenance of sinus rhythm in atrial fi brillation or fl utter. N Engl J Med. 2007;357:987-999. 2. MULTAQ® (dronedarone) Prescribing Information. Sanofi -aventis U.S. LLC; 2011, Bridgewater, NJ. 3. Hohnloser SH, Crijns HJGM, van Eickels M, et al; for the ATHENA Investigators. Effect of dronedarone on cardiovascular events in atrial fi brillation. N Engl J Med. 2009;360:668-678.

US.DRO.11.12.032 December 2011 ©2011 sanofi -aventis U.S. LLC, A SANOFI COMPANY

Gene

ral I

nfor

mat

ion

MULTAQ® Rx Only(dronedarone) Tablets

Brief Summary of Prescribing Information

WARNING: INCREASED RISK OF DEATH, STROKE AND HEART FAILURE IN PATIENTSWITH DECOMPENSATED HEART FAILURE OR PERMANENT ATRIAL FIBRILLATION

In patients with symptomatic heart failure and recent decompensation requiringhospitalization or NYHA Class IV heart failure; MULTAQ doubles the risk of death. (14.3in the full prescribing information) MULTAQ is contraindicated in patients withsymptomatic heart failure with recent decompensation requiring hospitalization orNYHA Class IV heart failure. (4, 5.1)

In patients with permanent atrial fibrillation, MULTAQ doubles the risk of death, strokeand hospitalization for heart failure. (14.4 in the full prescribing information). MULTAQis contraindicated in patients in atrial fibrillation (AF) who will not or cannot becardioverted into normal sinus rhythm. (4, 5.2)

1 INDICATIONS AND USAGEMULTAQ® is indicated to reduce the risk of hospitalization for atrial fibrillation in patients in sinusrhythm with a history of paroxysmal or persistent atrial fibrillation (AF) [see Clinical Studies (14)in the full prescribing information].2 DOSAGE AND ADMINISTRATIONThe recommended dosage of MULTAQ is 400 mg twice daily in adults. MULTAQ should be takenas one tablet with the morning meal and one tablet with the evening meal.Treatment with Class I or III antiarrhythmics (e.g., amiodarone, flecainide, propafenone, quinidine,disopyramide, dofetilide, sotalol) or drugs that are strong inhibitors of CYP3A (e.g., ketoconazole)must be stopped before starting MULTAQ [see Contraindications (4)].4 CONTRAINDICATIONSMULTAQ is contraindicated in patients with:

• Permanent atrial fibrillation (patients in whom normal sinus rhythm will not or cannot berestored) [see Boxed Warning and Warnings and Precautions (5.2)]

• Symptomatic heart failure with recent decompensation requiring hospitalization or NYHA ClassIV symptoms [see Boxed Warning and Warnings and Precautions (5.1)]

• Second- or third-degree atrioventricular (AV) block, or sick sinus syndrome (except when usedin conjunction with a functioning pacemaker)

• Bradycardia <50 bpm• Concomitant use of strong CYP 3A inhibitors, such as ketoconazole, itraconazole, voricona-

zole, cyclosporine, telithromycin, clarithromycin, nefazodone, and ritonavir [see Drug Inter-actions (7.2)]

• Concomitant use of drugs or herbal products that prolong the QT interval and might increasethe risk of Torsade de Pointes, such as phenothiazine anti-psychotics, tricyclic antidepres-sants, certain oral macrolide antibiotics, and Class I and III antiarrhythmics

• Liver toxicity related to the previous use of amiodarone• QTc Bazett interval ≥500 ms or PR interval >280 ms• Severe hepatic impairment• Pregnancy (Category X): MULTAQ may cause fetal harm when administered to a pregnant

woman. MULTAQ is contraindicated in women who are or may become pregnant. If this drugis used during pregnancy, or if the patient becomes pregnant while taking this drug, the patientshould be apprised of the potential hazard to a fetus [see Use in Specific Populations (8.1)].

• Nursing mothers [see Use in Specific Populations (8.3)]5 WARNINGS AND PRECAUTIONS5.1 Cardiovascular Death in NYHA Class IV or Decompensated Heart FailureMULTAQ is contraindicated in patients with NYHA Class IV heart failure or symptomatic heartfailure with recent decompensation requiring hospitalization because it doubles the risk of death.5.2 Cardiovascular Death and Heart Failure in Permanent AFMULTAQ doubles the risk of cardiovascular death (largely arrhythmic) and heart failure events inpatients with permanent AF. Patients treated with dronedarone should undergo monitoring ofcardiac rhythm no less often than every 3 months. Cardiovert patients who are in atrial fibrillation(if clinically indicated) or discontinue MULTAQ. MULTAQ offers no benefit in subjects in permanentAF.5.3 Increased Risk of Stroke in Permanent AFIn a placebo-controlled study in patients with permanent atrial fibrillation, dronedarone wasassociated with an increased risk of stroke, particularly in the first two weeks of therapy [seeClinical Studies (14.4) in the full prescribing information]. MULTAQ should only be initiated inpatients in sinus rhythm who are receiving appropriate antithrombotic therapy [see Drug interac-tions (7.3)].5.4 New Onset or Worsening Heart FailureNew onset or worsening of heart failure has been reported during treatment with MULTAQ in thepostmarketing setting. In a placebo controlled study in patients with permanent AF increased ratesof heart failure were observed in patients with normal left ventricular function and no history ofsymptomatic heart failure, as well as those with a history of heart failure or left ventriculardysfunction.Advise patients to consult a physician if they develop signs or symptoms of heart failure, such asweight gain, dependent edema, or increasing shortness of breath. If heart failure develops orworsens and requires hospitalization, discontinue MULTAQ.5.5 Liver InjuryHepatocellular liver injury, including acute liver failure requiring transplant, has been reported inpatients treated with MULTAQ in the post-marketing setting. Advise patients treated with MULTAQto report immediately symptoms suggesting hepatic injury (such as anorexia, nausea, vomiting,fever, malaise, fatigue, right upper quadrant pain, jaundice, dark urine, or itching). Considerobtaining periodic hepatic serum enzymes, especially during the first 6 months of treatment, butit is not known whether routine periodic monitoring of serum enzymes will prevent the developmentof severe liver injury. If hepatic injury is suspected, promptly discontinue MULTAQ and test serumenzymes, aspartate aminotransferase (AST), alanine aminotransferase (ALT) and alkaline phos-phatase, as well as serum bilirubin, to establish whether there is liver injury. If liver injury is found,

institute appropriate treatment and investigate the probable cause. Do not restart MULTAQ inpatients without another explanation for the observed liver injury.5.6 Hypokalemia and Hypomagnesemia with Potassium-Depleting DiureticsHypokalemia or hypomagnesemia may occur with concomitant administration of potassium-depleting diuretics. Potassium levels should be within the normal range prior to administration ofMULTAQ and maintained in the normal range during administration of MULTAQ.5.7 QT Interval ProlongationDronedarone induces a moderate (average of about 10 ms but much greater effects have beenobserved) QTc (Bazett) prolongation [see Clinical Pharmacology (12.2) in the full prescribinginformation and Clinical Studies (14.1) in the full prescribing information]. If the QTc Bazett intervalis ≥500 ms, discontinue MULTAQ [see Contraindications (4)].5.8 Increase in Creatinine after Treatment InitiationSmall increases in creatinine levels (about 0.1 mg/dL) following dronedarone treatment initiationhave been shown to be a result of inhibition of creatinine’s tubular secretion. The elevation hasa rapid onset, reaches a plateau after 7 days and is reversible after discontinuation. Largerincreases in creatinine after dronedarone initiation have been reported in the postmarketing setting.Some cases also reported increases in blood urea nitrogen. In most cases, these effects appearto be reversible upon drug discontinuation. Monitor renal function periodically.5.9 Women of Childbearing PotentialPremenopausal women who have not undergone a hysterectomy or oophorectomy must useeffective contraception while using MULTAQ. Dronedarone caused fetal harm in animal studies atdoses equivalent to recommended human doses. Counsel women of childbearing potentialregarding appropriate contraceptive choices. [see Use in Specific Populations (8.1)].6 ADVERSE REACTIONSThe following safety concerns are described elsewhere in the label:

• New or worsening heart failure [see Warnings and Precautions (5.4)]• Liver Injury [see Warnings and Precautions (5.5)]• Hypokalemia and hypomagnesemia with potassium-depleting diuretics [see Warnings and

Precautions (5.6)]• QT prolongation [see Warnings and Precautions (5.7)]

6.1 Clinical Trials ExperienceThe safety evaluation of dronedarone 400 mg twice daily in patients with AF or AFL is based on5 placebo controlled studies, ATHENA, EURIDIS, ADONIS, ERATO and DAFNE. In these studies,a total of 6285 patients were randomized and treated, 3282 patients with MULTAQ 400 mg twicedaily, and 2875 with placebo. The mean exposure across studies was 12 months. In ATHENA, themaximum follow-up was 30 months.In clinical trials, premature discontinuation because of adverse reactions occurred in 11.8% of thedronedarone-treated patients and in 7.7% of the placebo-treated group. The most common reasonsfor discontinuation of therapy with MULTAQ were gastrointestinal disorders (3.2 % versus 1.8% inthe placebo group) and QT prolongation (1.5% versus 0.5% in the placebo group).The most frequent adverse reactions observed with MULTAQ 400 mg twice daily in the 5 studieswere diarrhea, nausea, abdominal pain, vomiting, and asthenia.Table 1 displays adverse reactions more common with dronedarone 400 mg twice daily than withplacebo in AF or AFL patients, presented by system organ class and by decreasing order offrequency. Adverse laboratory and ECG effects are presented separately in Table 2.

Table 1: Adverse Drug Reactions that Occurred in at Least 1% of Patients and WereMore Frequent than Placebo

Placebo Dronedarone 400mg twice daily

(N=2875) (N=3282)

Gastrointestinal

Diarrhea 6% 9%

Nausea 3% 5%

Abdominal pain 3% 4%

Vomiting 1% 2%

Dyspeptic signs and symptoms 1% 2%

General

Asthenic conditions 5% 7%

Cardiac

Bradycardia 1% 3%

Skin and subcutaneous tissue

Including rashes (generalized, macular,maculo-papular, erythematous), pruritus,eczema, dermatitis, dermatitis allergic

3% 5%

Photosensitivity reaction and dysgeusia have also been reported at an incidence less than 1% inpatients treated with MULTAQ.The following laboratory data/ECG parameters were reported with MULTAQ 400 mg twice daily.

Table 2: Laboratory data/ECG parameters not necessarily reported as adverse events

Placebo MULTAQ400 mg twice daily

(N=2875) (N=3282)

Early increases in creatinine ≥10% 21% 51%

(N=2237) (N=2701)

QTc prolonged 19% 28%

Assessment of demographic factors such as gender or age on the incidence of treatment-emergentadverse events did not suggest an excess of adverse events in any particular sub-group.6.2 Postmarketing ExperienceThe following adverse reactions have been identified during post-approval use of MULTAQ.Because these reactions are reported voluntarily from a population of an unknown size, it is notalways possible to reliably estimate their frequency or establish a causal relationship to drugexposure.Cardiac: New or worsening heart failure [see Warnings and Precautions (5.3)]Hepatic: Liver Injury [see Warnings and Precautions (5.5)]Respiratory: Postmarketing cases of interstitial lung disease including pneumonitis and pulmonaryfibrosis have been reported.7 DRUG INTERACTIONSDronedarone is metabolized primarily by CYP 3A and is a moderate inhibitor of CYP 3A and CYP2D6 [see Clinical Pharmacology (12.3) in the full prescribing information]. Dronedarone’s bloodlevels can therefore be affected by inhibitors and inducers of CYP 3A, and dronedarone caninteract with drugs that are substrates of CYP 3A and CYP 2D6.Dronedarone has no significant potential to inhibit CYP 1A2, CYP 2C9, CYP 2C19, CYP 2C8 andCYP 2B6. It has the potential to inhibit P-glycoprotein (P-gP) transport.Pharmacodynamic interactions can be expected with beta-blockers; calcium antagonists anddigoxin [see Drug Interactions (7.1)].In clinical trials, patients treated with dronedarone received concomitant medications includingbeta-blockers, digoxin, calcium antagonists (including those with heart rate-lowering effects),statins and oral anticoagulants.7.1 Pharmacodynamic InteractionsDrugs prolonging the QT interval (inducing Torsade de Pointes)Co-administration of drugs prolonging the QT interval (such as certain phenothiazines, tricyclicantidepressants, certain macrolide antibiotics, and Class I and III antiarrhythmics) is contraindi-cated because of the potential risk of Torsade de Pointes-type ventricular tachycardia [seeContraindications (4)].DigoxinDigoxin can potentiate the electrophysiologic effects of dronedarone (such as decreased AV-nodeconduction). In clinical trials, increased levels of digoxin were observed when dronedarone wasco-administered with digoxin. Gastrointestinal disorders were also increased.Because of the pharmacokinetic interaction [see Drug Interaction (7.3)] and possible pharmaco-dynamic interaction, consider the need for continued digoxin therapy. If digoxin treatment iscontinued, halve the dose of digoxin, monitor serum levels closely, and observe for toxicity.Calcium channel blockersCalcium channel blockers with depressant effects on the sinus and AV nodes could potentiatedronedarone’s effects on conduction.Give low doses of calcium channel blockers initially and increase only after ECG verification ofgood tolerability [see Drug Interactions (7.3)].Beta-blockersIn clinical trials, bradycardia was more frequently observed when dronedarone was given incombination with beta-blockers.Give low dose of beta-blockers initially, and increase only after ECG verification of good tolerability[see Drug Interactions (7.3)].7.2 Effects of Other Drugs on DronedaroneKetoconazole and other potent CYP 3A inhibitorsRepeated doses of ketoconazole, a strong CYP 3A inhibitor, resulted in a 17-fold increase indronedarone exposure and a 9-fold increase in Cmax. Concomitant use of ketoconazole as well asother potent CYP 3A inhibitors such as itraconazole, voriconazole, ritonavir, clarithromycin, andnefazodone is contraindicated [see Contraindications (4)].Grapefruit juiceGrapefruit juice, a moderate inhibitor of CYP 3A, resulted in a 3-fold increase in dronedaroneexposure and a 2.5-fold increase in Cmax. Therefore, patients should avoid grapefruit juicebeverages while taking MULTAQ.Rifampin and other CYP 3A inducersRifampin decreased dronedarone exposure by 80%. Avoid rifampin or other CYP 3A inducers suchas phenobarbital, carbamazepine, phenytoin, and St John’s wort with dronedarone because theydecrease its exposure significantly.Calcium channel blockersVerapamil and diltiazem are moderate CYP 3A inhibitors and increase dronedarone exposure byapproximately 1.4-to 1.7-fold [see Drug Interactions (7.1, 7.3)].PantoprazolePantoprazole, a drug that increases gastric pH, did not have a significant effect on dronedaronepharmacokinetics.7.3 Effects of Dronedarone on Other DrugsStatinsDronedarone increased simvastatin/simvastatin acid exposure by 4- and 2-fold, respectively.Because of multiple mechanisms of interaction with statins (CYPs and transporters), follow statinlabel recommendations for use with CYP 3A and P-gP inhibitors such as dronedarone.Calcium channel blockersDronedarone increases calcium channel blocker (verapamil, diltiazem or nifedipine) exposure by1.4- to 1.5-fold [see Drug Interactions (7.1)].Sirolimus, tacrolimus, and other CYP3A substrates with narrow therapeutic rangeDronedarone can increase plasma concentrations of tacrolimus, sirolimus, and other CYP 3Asubstrates with a narrow therapeutic range when given orally. Monitor plasma concentrations andadjust dosage appropriately.Beta-blockers and other CYP 2D6 substratesDronedarone increased propranolol exposure by approximately 1.3-fold following single doseadministration. Dronedarone increased metoprolol exposure by 1.6-fold following multiple doseadministration [see Drug Interaction (7.1)]. Other CYP 2D6 substrates, including other beta-blockers, tricyclic antidepressants, and selective serotonin reuptake inhibitors (SSRIs) may haveincreased exposure upon co-administration with dronedarone.P-glycoprotein substratesDigoxinDronedarone increased digoxin exposure by 2.5-fold by inhibiting the P-gP transporter [see DrugInteractions (7.1)].

DabigatranExposure to dabigatran is higher when it is administered with dronedarone than when it isadministered alone (1.7- to 2-fold).Other P-gP substrates are expected to have increased exposure when co-administered withdronedarone.Warfarin and losartan (CYP 2C9 substrates)LosartanNo interaction was observed between dronedarone and losartan.WarfarinWhen healthy subjects were administered dronedarone 600 mg twice daily, exposure to S-warfarinwas higher than when warfarin was administered alone (1.2-fold). Exposure to R-warfarin wasunchanged and there were no clinically significant increases in INR.More patients experienced clinically significant INR elevations (≥ 5) usually within 1 week afterstarting dronedarone vs. placebo in patients taking oral anticoagulants in ATHENA. However, noexcess risk of bleeding was observed in the dronedarone group.Postmarketing cases of increased INR with or without bleeding events have been reported inwarfarin-treated patients initiated on dronedarone. Monitor INR after initiating dronedarone inpatients taking warfarin.Theophylline (CYP 1A2 substrate)Dronedarone does not increase steady state theophylline exposure.Oral contraceptivesNo decreases in ethinylestradiol and levonorgestrel concentrations were observed in healthysubjects receiving dronedarone concomitantly with oral contraceptives.8 USE IN SPECIFIC POPULATIONS8.1 PregnancyPregnancy Category X [see Contraindications (4)]MULTAQ may cause fetal harm when administered to a pregnant woman. In animal studies,dronedarone was teratogenic in rats at the maximum recommended human dose (MRHD), and inrabbits at half the MRHD. If this drug is used during pregnancy or if the patient becomes pregnantwhile taking this drug, the patient should be apprised of the potential hazard to the fetus.When pregnant rats received dronedarone at oral doses greater than or equal to the MRHD (ona mg/m2 basis), fetuses had increased rates of external, visceral and skeletal malformations(cranioschisis, cleft palate, incomplete evagination of pineal body, brachygnathia, partially fusedcarotid arteries, truncus arteriosus, abnormal lobation of the liver, partially duplicated inferior venacava, brachydactyly, ectrodactylia, syndactylia, and anterior and/or posterior club feet). Whenpregnant rabbits received dronedarone, at a dose approximately half the MRHD (on a mg/m2

basis), fetuses had an increased rate of skeletal abnormalities (anomalous ribcage and vertebrae,pelvic asymmetry) at doses ≥20 mg/kg (the lowest dose tested and approximately half the MRHDon a mg/m2 basis).Actual animal doses: rat (≥80 mg/kg/day); rabbit (≥20 mg/kg)8.3 Nursing MothersIt is not known whether MULTAQ is excreted in human milk. Dronedarone and its metabolites areexcreted in rat milk. During a pre- and post-natal study in rats, maternal dronedarone administrationwas associated with minor reduced body-weight gain in the offspring. Because many drugs areexcreted in human milk and because of the potential for serious adverse reactions in nursinginfants from MULTAQ, discontinue nursing or discontinue the drug [see Contraindications (4)].8.4 Pediatric UseSafety and efficacy in children below the age of 18 years have not been established.8.5 Geriatric UseMore than 4500 patients with AF or AFL aged 65 years or above were included in the MULTAQclinical program (of whom more than 2000 patients were 75 years or older). Efficacy and safetywere similar in elderly and younger patients.8.6 Renal ImpairmentPatients with renal impairment were included in clinical studies. Because renal excretion ofdronedarone is minimal [see Clinical Pharmacology (12.3) in the full prescribing information], nodosing alteration is needed.8.7 Hepatic ImpairmentDronedarone is extensively metabolized by the liver. There is little clinical experience withmoderate hepatic impairment and none with severe impairment. No dosage adjustment isrecommended for moderate hepatic impairment [see Contraindications (4) and Clinical Pharma-cology (12.3) in the full prescribing information].10 OVERDOSAGEIn the event of overdosage, monitor the patient’s cardiac rhythm and blood pressure. Treatmentshould be supportive and based on symptoms.It is not known whether dronedarone or its metabolites can be removed by dialysis (hemodialysis,peritoneal dialysis or hemofiltration). There is no specific antidote available.

Issued December 2011

Manufactured by Sanofi Winthrop Industrie1, rue de la Vierge33440 Ambares, FranceIssue date: December 26, 2011

©sanofi-aventis, 2011All rights reserved.

MULTAQ is a trademark of sanofi-aventis.

The brands listed are the registered trademarks of their respective owners and are not trademarksof sanofi-aventis U.S. LLC.

sanofi-aventis U.S. LLCBridgewater, NJ 08807

DRO-BPLR-ACC-DEC11

MULTAQ®

(dronedarone) Tablets


ABIM Information Desk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S104b

ACC .12 Main Tent . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall B

ACC Central . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1, #10027

ACC Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S100a

ACCEL Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S100a

Business Center (FedEx Office) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 2 .5

CardioSmart Fun Run/Walk Kiosk . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 2 .5

Career Placement Center . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .North, Room N137

Coat Check . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall B

South, West Transportation Lobby

Grand Concourse Level 1 near Hyatt

Convocation

Convocation Ceremony . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall B

Convocation Office . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall B

Convocation Hoods, Gowns & Photography . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall B

Education Sessions & Information

E-Abstracts Self-Study Kiosks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Hall A1 near Posters

General Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Levels 1, 4, 5

North, Levels 2, 4

Heart Songs Learning Lab . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S406 Lobby

Meet the Experts/Lunchtime/International Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Levels 1, 4, 5

North, Levels 2, 4

Maintenance of Certification

MOC Education . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .South, Rooms S105a, S105d

MOC Lounge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S104b

MOC Simulation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S104a

Poster Sessions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2

Exhibitor Newsroom . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall C

Expo . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Halls A1 & A2

ACC Central . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1, #10027

CardioSmart Pavilion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1

ExpoSuites . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Halls A1 & A2

Health IT Pavilion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1

ACC.12

DirectoryAll activities are located in McCormick Place unless otherwise noted.

28 GO for ACC.12!

Interventional Pavilion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1

Public Service Area . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2

Publishers Showcase . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1

First Aid . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 2 .5

Heart Hubs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall B

South, West Transportation Lobby

Housing Assistance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Registration, Lakeside, Level 3

Information Kiosks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 3

West Transportation Lobby

Interfaith Prayer Room . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . N136

iScience Sales Counters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 3

Learning Destinations

CardioSmart Forum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2, CV Theater, #22097

CV Innovations Educational Forum . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2, CV Theater, #22097

Heart of Innovation Featured Learning Destination . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1, #1076

Industry-Expert Theater . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1, #22042

Interactive Learning Labs . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1, #22027, #22035, #23027

Lounges

ACC Member Lounge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A1, #22063

CCA Community Lounge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .North, Room N138

Faculty Lounge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S100a

FIT Community Lounge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .North, Room N139

International Lounge . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2, #15097

Lost and Found . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .North, Room N128

Medical Meetings Information Units . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 2 .5

Newsroom . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall C

Portfolio Pick-Up . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Registration, Lakeside, Level 3

West Transportation Lobby

Press Conference Room . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . North, Hall C

Registration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Lakeside, Level 3

Restaurants

Bistro ACC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2, #1100

Windy City Café & Tech Hub . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Hall A2, #22111

Restaurant Reservations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Grand Concourse Lobby, Level 3

Speaker Ready Room . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S100b

Speaker Registration . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . South, Room S100b

Directory • ACC.12


About McCormick PlaceACC .12 takes place in McCormick Place Convention Center . The street address is 2301 S . Lake Shore Drive, Chicago, IL 60616 . Be sure to allow enough time to get where you want to be . It can take up to 15 minutes to walk between some locations within the center .

ABIM Information DeskMcCormick Place South, Room S104bTelephone: 312-791-6740

Saturday, March 24 7:30 a .m . – 6:00 p .m .Sunday, March 25 7:30 a .m . – 6:00 p .m .Monday, March 26 8:00 a .m . – 5:30 p .m .

ABIM staff will be available on site in Room S104b to answer your questions regarding the ABIM’s Maintenance of Certification program and process . You must be enrolled in ABIM’s MOC program in order to attend the ACCF Study Sessions . If you are not a current enrollee, please go to the “Physician Login” at ABIM’s website, www.abim.org, and follow the instructions to enroll . You may also enroll in the ABIM MOC program on site by visiting staff in room S104b, but please allow sufficient time to do this prior to the start of the session .

For your convenience, there will be computer terminals in the ACC MOC Center, Room S104b, for you to take the ABIM MOC test after the study session, if desired .

Regarding the study sessions, you must arrive no later than 15 minutes before the start of the session . At that time, all reserved seats will be released and non-ticket holders will be allowed to occupy vacant seats on a first-come, first-served basis .

ACC.12 eMeeting PlannerMake the most out of ACC .12 with instant access to sessions, abstracts, exhibitors, maps and more! Plus, get access to the ACC .12 twitter feed, download eBooks of the Final Program, Program-At-A-Glance and the JACC Abstract Supplement, and read the daily newspaper — CardioSourceNews from ACC.12 . Download the app on your mobile device (available for Apple®, Android® and Kindle Fire® devices) .

Apple Android

Search ACC.12 in your app store or browse to: http://ativ.me/acc

ACC.12 OnlineACC .12 Online features live webcasts of 60 sessions and on demand webcasts of an additional 18 sessions from the Legends of Cardiovascular Medicine and Core Curriculum series — available to all ACC .12 attendees for free for the duration of the meeting .

Sessions marked with the ACC .12 Online icon within the Program-At-A-Glance (starting on page 72) are available on ACC .12 Online . To access ACC .12 Online and see a complete schedule of webcasts, go to: http://acc12online.cardiosource.org, and login with your email address and passcode: ACCONLINE

ACC CentralMcCormick Place South, Hall A1, #10027

At ACC Central you’ll find comprehensive information on ACC’s quality initiatives; NCDR® registries and research; self-assessment tools; live courses; membership opportunities; and ways to ensure practice viability and protect patient access . In addition, don’t miss the exciting new products and services designed to help you translate science into practice .

ACC OfficeMcCormick Place South, Room S100aTelephone: 312-791-6720Fax: 312-791-6722

Saturday, March 24 7:00 a .m . – 6:00 p .m .Sunday, March 25 7:00 a .m . – 6:00 p .m .Monday, March 26 7:00 a .m . – 5:30 p .m .Tuesday, March 27 7:00 a .m . – 9:30 a .m .

ACC.12

General Meeting Information

30 GO for ACC.12!

ACCEL OfficeMcCormick Place South, Room S100aTelephone: 312-791-6726

Saturday, March 24 1:00 p .m . – 5:00 p .m .Sunday, March 25 8:00 a .m . – 5:00 p .m .Monday, March 26 8:00 a .m . – 5:00 p .m .Tuesday, March 27 8:00 a .m . – 3:00 p .m .

Business CenterMcCormick Place South, Grand Concourse Level 2.5Telephone: 312-949-2100

The FedEx Office Print & Ship Center in McCormick Place offers you virtually everything you need to meet your convention exhibiting needs — from packing and shipping to signage, copying and last-minute office supplies .

Hours:Friday – Monday 8:30 a .m . – 5:00 p .m .

Car RentalTelephone: 1-800-654-2240

The ACC has arranged rental car discounts through Hertz . You can call the above number or go to www.hertz.com to make your reservation . Conference ID is CV#044W0006 . The closest Hertz office is at the Hyatt Regency McCormick Place, office number 312-567-0380 .

Career Placement CenterMcCormick Place North, Room N137Telephone: 312-808-2970


The ACC Cardiology Career Resource Center is the perfect venue for setting up interviews, posting jobs or résumés/CVs, and reviewing more than 300 positions listed on the College’s online job bank . The service is free to candidates and very economical for employers .

Certificate of Attendance and Claiming CME/CNE CreditThe online ACC .12/ACC-i2 with TCT CME/CNE Credit site will be available in real time for recording your session attendance and claiming credit . Please be sure to keep a

record of the session numbers you attended and know your badge number . You may enter your information at the conclusion of a session from any internet-enabled computer by visiting www.accscientificsession.org. Please allow time for the system to update if you registered the same day you are accessing the CME/CNE system .

Note: The CME/CNE system will give credit only for the total elapsed time spent in education sessions . Credit cannot be doubly awarded for sessions taking place concurrently .

ChildrenDuring Expo hours, children (defined as anyone under 18 years of age) will be permitted in the Expo Hall only if accompanied by an adult at all times . Children between 12 and 18 years of age are required to register for admission to the Exposition in the Family Member category at the posted rate . Under no circumstances will children be allowed in the Expo Hall during installation or dismantle periods . For reasons of insurance liability and safety, strollers and infant carriers are not permitted in the Expo Hall at any time . Infants must be held at all times . Because of limited seating capacity and the highly technical nature of the education program, children are not invited to attend presentations .

Coat CheckMcCormick Place North, Hall B; South, West Transportation Lobby; Grand Concourse Level 1 near Hyatt

Friday, March 23 7:00 a .m . – 6:30 p .m .Saturday, March 24 7:00 a .m . – 7:00 p .m .Sunday, March 25 7:00 a .m . – 7:00 p .m .Monday, March 26 7:00 a .m . – 10:00 p .m .Tuesday, March 27 7:00 a .m . – 12:30 p .m .

Attendees can check coats and/or luggage for $3 .00 per coat and $4 .00 per bag .

ConvocationConvocation CeremonyMcCormick Place North, Hall BMonday, March 26, 2012, 6:30 p.m.

The Convocation Ceremony, presided over by David R . Holmes, Jr ., President, MD, FACC, is one of the most exciting and prestigious events to take place during the Annual Scientific Session, honoring new Fellows (FACC), recognizing

General Meeting Information • ACC.12


Associates of the American College of Cardiology (AACC), distinguished guests, and the induction of William A . Zoghbi, MD, FACC, as president of the College .

Convocation OfficeMcCormick Place North, Hall BSaturday, March 24 8:00 a .m . – 5:00 p .m .Sunday, March 25 8:00 a .m . – 5:00 p .m .Monday, March 26 8:00 a .m . – 3:00 p .m .Tuesday, March 27 9:00 a .m . – 11:00 a .m .

Convocation Hoods and GownsMcCormick Place North, Hall BSaturday, March 24 8:00 a .m . – 5:00 p .m .Sunday, March 25 8:00 a .m . – 5:00 p .m .Monday, March 26 8:00 a .m . – 9:00 p .m .

Collect academic attire and sign the Convocation Register .

Convocation Portrait PhotographyMcCormick Place North, Hall B

To schedule an appointment:Friday, March 23 11:00 a .m . – 4:00 p .m .Saturday, March 24 10:00 a .m . – Noon

Portraits may be posted and photographed on:Saturday, March 24 1:00 p .m . – 5:00 p .m .Sunday, March 25 10:00 a .m . – 5:00 p .m .Monday, March 26 10:00 a .m . – 6:00 p .m .

Education Sessions and InformationE-Abstracts Learning StationAccepted abstracts are also available as e-abstracts online and may be viewed from the dedicated terminals in the Poster Sessions area, Hall A1 . For 24/7 perusal of the e-abstracts, visit www.accscientificsession.org .

Heart Songs Learning LabMcCormick Place South, Room S406 Lobby

A unique audio-visual program to refresh cardiac auscultation skills by listening to heart sounds while viewing phonocardiograms, echoes and more on an iPod® Touch, iPad® or laptop computer . This clinical skills workshop provides attendees with a choice of three sessions — basic, advanced and expert levels . Plus, a video program that

combines 3D echo images with the auscultation findings on 4 common valvular abnormalities . In addition, you’re able to test your knowledge with pre- and post-tests .

MOC Education RoomMcCormick Place South, Rooms S105a, S105d

For the Maintenance of Certification (MOC) study sessions, preregistered attendees must arrive no later than 15 minutes before the start of the session . At that time, all reserved seats will be released and non-ticket holders will be allowed to occupy vacant seats on a first-come, first-served basis .

MOC LoungeMcCormick Place South, Room S104b

See also ABIM Information Desk above for additional information . Attendees may use the computer terminals in the Lounge to take the ABIM, ACCSAP or ABP tests after the conclusion of the sessions .

MOC Simulation RoomMcCormick Place South, Room S104a

ABIM offers an option for interventional cardiology diplomats to earn credit toward completion of the Self-Evaluation of Medical Knowledge requirement for Maintenance of Certification . Interventional Cardiology Simulations is the first-ever ABIM-developed lab-based simulation that provides an opportunity to perform cases that mirror what an interventional cardiologist would typically face in daily practice . Medical Simulation Corporation’s SimSuite® technology replicates a real-life catheterization lab suit . Physicians complete the Interventional Cardiology Simulations on-site in room S104a .

Poster SessionsMcCormick Place South, Hall ATelephone: 312-791-6768

Posters will be displayed from 9:30 a .m . – 4:30 p .m . on Saturday and Sunday; 9:30 a .m . – 2:00 p .m . on Monday . Presenters will be available Saturday through Monday from 9:30 a .m . – 10:30 a .m . and 11:00 a .m . – noon . Come during the presenter hours, meet the presenters and view the poster boards facilitated by poster discussants . Best poster awards will be awarded to one winner in each of the clinical pathways .

ACC.12 • General Meeting Information

32 GO for ACC.12!

Exhibitor NewsroomMcCormick Place North, Hall CTelephone: 312-808-2015Fax: 312-808-2016

Saturday, March 24 7:30 a .m . – 5:00 p .m .Sunday, March 25 7:30 a .m . – 5:00 p .m .Monday, March 26 7:30 a .m . – 5:00 p .m .Tuesday, March 27 7:30 a .m . – 5:00 p .m .

The Exhibitor Newsroom provides members of the media with access to information from exhibiting companies and their representatives . The fee is $350 on site . An ACC .12 exhibitor may register a maximum of four individuals to the Exhibitor Newsroom . Use of the Exhibitor Newsroom is limited to ACC .12 exhibiting companies . Persons who wish to substitute for an advance registrant must present a letter of authorization from the exhibiting company’s primary contact .

ExpoMcCormick Place South, Halls A1 & A2

A vital part of your ACC education can be found in the ACC .12 Expo, where more than 300 exhibiting companies and organizations showcase the latest advances in pharmaceuticals, imaging, devices, technologies and the services that you need to help you provide high-quality patient care .

Don’t miss these key specialty areas in the Expo:• ACC Central: South, Hall A1, #10027• CardioSmart Pavilion: South, Hall A1• ExpoSuites: South, Halls A1 & A2•Health IT Pavilion: South, Hall A1• Interventional Pavilion: South, Hall A1• Public Service Area: South, Hall A2• Publishers Showcase: South, Hall A1

Fire Safety InformationSeating capacity has been maximized in all session rooms according to local fire regulations . Standing in the aisles or against the walls is not permitted . If overcrowding occurs, staff/security personnel will close the session . Further admittance will not be allowed until the next speaker change . Noncompliance may subject the session to be shut down by the Fire Marshal .

Inside the Session Room:• Find seats as far forward as possible•Move to the center of the row and fill all seats so chairs

are available for additional attendees• Store materials under chairs to maximize seating• Take all personal effects when exiting; re-entry to an

overcrowded session room may not be allowed

Outside the Session Room:• Step back from the entrance• Form a line; the next attendee in line will be admitted

into the session and escorted to an available seat

If space does not permit you to attend a session, a recording of the session may be available for purchase at the iScience sales desk .

Orderly conduct is appreciated. Thank you for your cooperation!

First AidMcCormick Place South, First Aid Room, Level 2.5


The first aid room in McCormick Place Convention Center will be operated and staffed by licensed medical professionals . The station will carry basic first aid supplies as well as over-the-counter medications available for distribution, oxygen and an AED .

Heart HubsMcCormick Place North, Hall BMcCormick Place South, West Transportation Lobby

Saturday, March 24 7:30 a .m . – 6:00 p .m .Sunday, March 25 7:30 a .m . – 6:00 p .m . Monday, March 26 7:30 a .m . – 5:30 p .m .Tuesday, March 27 7:30 a .m . – 11:45 a .m .

Relax with refreshments in a lounge setting while sessions from ACC .12 come to you on plasma screens . With two convenient locations in McCormick Place, this is the place to be for networking and news watching .



Housing AssistanceMcCormick Place, Lakeside, Level 3Telephone: 312-949-3207

J . Spargo & Associates, Inc . staff is available to assist with hotel reservations at official ACC .12 hotels .

Information StationsMcCormick Place South, Grand Concourse Lobby, Level 2.5; Level 3, West Transportation Lobby

At locations throughout the convention center you will find Information Stations where you can

• Access the internet• Browse the education sessions• Plan, save and print your itinerary• Locate attendees, exhibitors and products• View the Exposition floor plan

ACC.12 Information Stations compliments of Forest Pharmaceuticals, Inc., Janssen Pharmaceuticals, Inc. and Merck & Co., Inc.

iScience Sales DeskMcCormick Place South, Grand Concourse Lobby, Level 3 and ACC Central, Hall A1, #10027

Saturday, March 24 7:00 a .m . – 6:00 p .m .Sunday, March 25 7:00 a .m . – 6:00 p .m .Monday, March 26 7:00 a .m . – 6:00 p .m .Tuesday, March 27 7:00 a .m . – Noon

iScience, the ACC .12 Meeting on Demand, is a comprehensive digital library of presentations from ACC .12 and includes over 400 hours of educational content . It is the most convenient way to experience all the education from ACC .12 and allows you to watch presenters’ slides while listening to fully-synchronized audio as if you were actually attending each session . Purchase on site in Chicago and save $1,000 or more!

Learning DestinationsMcCormick Place South, Halls A1 and A2

Learning Destinations™ are diverse, non-accredited, educationally focused areas that offer new and creative ways to expand your educational experience . We invite you to visit these dynamic learning environments, located in the Expo Hall .

• CardioSmart Forum: South, Hall A2, CV Theater, #22097• CV Innovations Educational Forum: South, Hall A2, CV

Theater, #22097•Heart of Innovation Featured Learning Destination:

South, Hall A1, #1076• Interactive Learning Labs: South, Hall A1, #22027,

#22035, #23027• Industry-Expert Theater: South, Hall A1, #22042

Please see the Learning Destinations section on page 57 for additional information .

Lost and FoundMcCormick Place North, Room 128Telephone: 312-670-5312

If you lose or find an item, please contact the ACC Office .

LoungesACC Member LoungeMcCormick Place South, Hall A1, #22063

The ACC Member Lounge is open to ACC members during all Expo hours . Take time with colleagues to network and relax, check emails and enjoy a cup of coffee in this inviting atmosphere .

CCA Community LoungeMcCormick Place North, Room N138

Friday, March 23 Noon – 5:00 p .m .Informal Session Noon – 5:00 p .m .


Informal Session 2:00 p .m . – 5:00 p .m .

The ideal place to relax, check your email and touch base with your CCA peers .


34 GO for ACC.12!

Faculty LoungeMcCormick Place South, Room S100aTelephone: 312-791-6715

Saturday, March 24 7:00 a .m . – 6:00 p .m .Sunday, March 25 7:00 a .m . – 6:00 p .m . Monday, March 26 7:00 a .m . – 5:30 p .m .Tuesday, March 27 7:00 a .m . – 9:30 a .m .

Invited faculty for ACC .12 will receive a white “Faculty” ribbon that will give them access to the Faculty Lounge . Services in the Lounge include computer/internet and printer access, work and meeting space, food service and a comfortable lounge atmosphere for private faculty networking .

FIT Community LoungeMcCormick Place North, Room N139


The ideal place to relax, check your email and touch base with your FIT peers .

International LoungeMcCormick Place, Hall A1, #15097


The lounge is open to all attendees practicing outside the United States, offering the opportunity to network with colleagues, learn about the multitude of international ACC initiatives and partnerships, and find information regarding international membership in the ACC .

Medical InformationDentist800-DENTIST or www.1800DENTIST.COM

HospitalsMercy Hospital2525 South Michigan AvenueChicago, IL 60616312-567-2000www.mercy-chicago.org

Rush-Presbyterian — St. Luke’s Medical Center1653 W . Congress Pkwy .Chicago, IL 60612312-942-5000www.rush.edu

Consult your hotel concierge for additional services and locations .

Medical Meetings InformationMcCormick Place, Grand Concourse Lobby, Level 2.5

Information about other national and international medical meetings is available . Distribution of literature is confined to the publication bins provided; posters are not permitted .

For news and updates about ACC .12 look for the daily editions of the CardioSource News from ACC.12 displayed on racks throughout McCormick Place .

Name BadgesYour badge serves as your passport to education sessions, the Exposition and to complimentary shuttle service . You must wear your name badge at all times . For security reasons, persons without badges will not be permitted access to attend events .

Badge Colors:Dark Blue Stripe ACC .12 Professional Registrants

Grey Stripe One Day Only Registrants

Purple Stripe Exhibitor Full Access (Expo Hall and all official ACC .12 Education sessions), Consultant

Yellow Stripe Exhibitor (Expo Hall only), Exhibitor Newsroom

Green Stripe ACC Staff and Official Contractors

Orange Stripe Exhibits Only, Family Member

Red Stripe Media

We recommend for your safety that you do not wear your name badge in public .



NewsroomMcCormick Place North, Hall CTelephone: 312-808-2000


Arrangements for interview and inquiries concerning news releases and news conferences should be directed to Beth Casteel in the Newsroom .

ParkingMcCormick Place parking rate is $19 for up to 16 hours and $30 from 16 to 24 hours . There are no in-and-out privileges . Overnight parking is available in Lot A only . Lost tickets will pay the $30 fee per day . Parking fees can be paid by cash or credit card; Visa, MasterCard and American Express are accepted .

Places of WorshipChicago has an extremely diverse population and visitors can find any number of religious institutions throughout the city for just about any faith . For a brief listing of places of worship, visit the Chicago Convention and Tourism Bureau website at www.choosechicago.com and search for places for worship on their home page .

Portfolio Pick-UpMcCormick Place, Lakeside, Level 3McCormick Place South, West Transportation Lobby

Once at the convention center, proceed to Registration or to the Portfolio Pickup Station located in the West Transportation Lobby to receive your portfolio bag and JACC ACC.12 Abstract Supple- ment . The Final Program will be included in the portfolio bag .

Poster Info BoothMcCormick Place South, Hall ATelephone: 312-791-6767

Poster presenters may check the U-Search computer kiosks throughout the poster hall to reconfirm poster board information and session presentation times . Poster Discussants and Best Poster Judges may check-in with staff to receive

ribbons and instructions . Staff are available to assist presenters with disclosure compliance information and materials .

Public TransportationCTA & METRATelephone: 312-836-7000

The Chicago Transit Authority (CTA) offers fast, direct train service from both airports to downtown Chicago, convenient bus and train lines to major attractions, simple fare cards and easy-to-use maps and brochures . For route, fare and schedule information, call any day from 5:00 a .m . – 1:00 a .m . (CT) . The CTA system map and Downtown Sightseeing Guide are available at all train stations, both airports, visitor information centers and hotels . You can also plan your trip online by visiting http://www.transitchicago.com.

RegistrationMcCormick Place Lakeside, Level 3Telephone: 312-949-3205

Friday, March 23 7:00 a .m . – 5:00 p .m .Saturday, March 24 7:00 a .m . – 6:00 p .m . Sunday, March 25 7:00 a .m . – 6:00 p .m .Monday, March 26 7:00 a .m . – 5:00 p .m .Tuesday, March 27 7:00 a .m . – Noon

Registration Cancellations, Substitutions and RefundsAs printed in the Registration Instructions, registration fees are non-refundable after Feb . 15, 2012 . Cancelled registrations are non-transferable .

Restaurant Reservations ServiceMcCormick Place, Grand Concourse Lobby, Level 3

Saturday, March 24 10:30 a .m . – 6:30 p .m . Sunday, March 25 10:30 a .m . – 6:30 p .m .Monday, March 26 10:30 a .m . – 6:30 p .m .Tuesday, March 27 10:00 a .m . – 1:00 p .m .

Representatives are available to recommend and to confirm reservations at any of the area’s restaurants .


36 GO for ACC.12!

RestaurantsMcCormick Place South, Hall A2

Two restaurants satisfying a range of culinary tastes will be located in the Expo Hall . The restaurants each offer a large seating area where you can eat, network with colleagues and plan your schedule .

•Bistro ACC: An innovative dining option that is conveniently located at the back of the 4000 aisle . Assorted menu options include several fresh and healthy options, international cuisine and regional favorites . An all-inclusive lunch buffet costs $20 and includes your meal, beverages, dessert and tax . You can purchase lunch tickets in advance by going to www.bistroacc.com or visit the Bistro ACC ticket counter in the Grand Concourse just outside the Expo Hall .

•Windy City Café & Tech Hub: Join colleagues for a more upscale buffet-style dining experience at the Windy City Café & Tech Hub, located at the back of the 22000 aisle . The Windy City Café offers you a unique environment in which to relax and make plans for your continuing education and remaining time at ACC .12 . Charging stations will be available for your electronic devices — recharge your batteries and your phone’s batteries — all in one location!

Shuttle Bus ServiceShuttle service will operate daily from McCormick Place and the official hotels on a daily basis (except the Hyatt Regency McCormick Place, which is considered within walking distance) . Check the shuttle sign posted in the lobby of each hotel for additional information, changes, frequency of service and boarding locations .

Hours of OperationFriday, March 23 – Sunday, March 25Between hotels and McCormick Place6:00 a .m . – 6:45 p .m .*

Please note, on Sunday, March 25, there will be intermittent suspension of service and delays due to the Shamrock Shuffle 8K Race between the hours of 8 a.m. – noon. Please plan accordingly.

Monday, March 26, 2012Between hotels and McCormick Place6:00 a .m . – 10:00 p .m .*

Tuesday, March 27, 2012Between hotels and McCormick Place6:00 a .m . – 1:00 p .m .*

*Last motorcoach departs McCormick Place at this time . Last motorcoach departs the hotels approximately 90 minutes prior to this time . McCormick Place is the transfer point for all routes .

To make arrangements for a wheelchair-accessible shuttle, contact the shuttle supervisor at McCormick Place during shuttle hours .

Shuttle service information is current as of time of printing . Please check the route signs at McCormick Place and posted in the lobby of each hotel for updated information .

SmokingThe American College of Cardiology promotes a “No Smoking” policy . The use of tobacco products is strictly prohibited in the Convention Center and all hotel meeting rooms hosting ACC .12 events . Thank you for your compliance .

Speaker Ready RoomMcCormick Place South, Room S100bTelephone: 312-791-6728

Friday, March 23 7:00 a .m . – 5:00 p .m .Saturday, March 24 6:00 a .m . – 6:00 p .m .Sunday, March 25 6:00 a .m . – 6:00 p .m .Monday, March 26 6:00 a .m . – 5:30 p .m .Tuesday, March 27 6:00 a .m . – 10:00 a .m .

New this year: All invited faculty, including speakers, co-chairs and panelists, must check in at the Speaker Ready Room to confirm presentation times and review electronic files, even if they have uploaded their files in advance .

There will be one Speaker Ready Room to assist all presenters for both ACC .12 and ACC-i2 with TCT . We recommend presenters visit the Speaker Ready Room 24 hours before their presentation begins . However, presenters must go to the Speaker Ready Room at least 4 hours in advance to review and approve their presentations . Presenters who do not



check-in sufficiently in advance of their presentation may give the scheduled talk, but may not have visuals .

Speaker RegistrationMcCormick Place South, Room S100b

Friday, March 23 7:00 a .m . – 5:00 p .m .Saturday, March 24 6:00 a .m . – 6:00 p .m .Sunday, March 25 6:00 a .m . – 6:00 p .m .Monday, March 26 6:00 a .m . – 5:30 p .m .Tuesday, March 27 6:00 a .m . – 10:00 a .m .

This is the location for all faculty registration . All advance-registered faculty should have received a white faculty ribbon with the badge in the mail; otherwise they may be picked up in this office .

TransportationHertz: 800-654-2240 Airport Shuttle: 888-284-3826

TaxisAmerican-United Taxi: 773-248-7600Checker Cab: 312-243-2537Yellow Cab: 312-829-4222Flash Cab: 773-561-1444

Taxis are plentiful and easy-to-hail in downtown, and offer a convenient way to get around the city . Taxis charge a base rate of $2 .25 for the first 1/9 mile, plus, 20¢ for each additional 1/9 mile . If a gas surcharge is in effect, a sign will be displayed inside the taxicab and a surcharge may apply . Tolls are an extra charge; taxis charge $1 for the first additional passenger over age 12 and under age 65 . Each additional passenger after first passenger, over 12 and under 65 is $ .50 . It is standard to tip the driver about 15 – 20% of the fare, plus $1 – 2 per bag if the driver helps you with luggage .


38 GO for ACC.12!

ACC.12

McCormick Place Convention Center


ACC.12

Poster Hall Map Saturday, March 24, 2012

40 GO for ACC.12!

ACC.12

Poster Hall Map Sunday, March 25, 2012


ACC.12

Poster Hall Map Monday, March 26, 2012

42 GO for ACC.12!

Map Hotel Address Phone Fax

17 Allegro Chicago, A Kimpton Hotel 171 West Randolph Street Chicago, IL 60601 312-236-0123 312-236-0917

1 Amalfi Hotel Chicago 20 W Kinzie Street Chicago, IL 60654 312-395-9000 312-395-9001

18 Burnham, A Kimpton Hotel 1 West Washington Street Chicago, IL 60601 312-782-1111 312-762-3554

2 Chicago Marriott Downtown Magnificent Mile 540 North Michigan Avenue Chicago, IL 60611 312-836-0100 312-836-0100

3 Conrad Chicago 520 North Rush Street at Michigan Avenue Chicago, IL 60611 312-645-1500 312-645-1550

5 Courtyard by Marriott Magnificent Mile 165 East Ontario Street Chicago, IL 60611 312-573-0800 312-573-0573

4 Courtyard Chicago Downtown River North 30 East Hubbard Street Chicago, IL 60611 312-329-2500 312-329-0293

6 Dana Hotel and Spa 660 North State Street Chicago, IL 60654 312-202-6000 312-202-6033

7 Doubletree Chicago Magnificent Mile 300 East Ohio Street Chicago, IL 60611 312-787-6100 312-787-6259

9 Embassy Suites Chicago Downtown 600 North State Street Chicago, IL 60654 312-943-3800 312-943-7629

10 Embassy Suites Chicago Downtown Lakefront 511 North Columbus Drive Chicago, IL 60611 312-836-5900 312-839-5901

11 Fairfield Inn and Suites 216 East Ontario Street Chicago, IL 60611 312-787-3777 312-787-8714

13 Four Seasons 120 East Delaware Place Chicago, IL 60611 312-280-8800 312 280-1748

14 Hard Rock Hotel 230 North Michigan Avenue Chicago, IL 60601 312-345-1000 312-345-1012

15 Hilton Chicago 720 South Michigan Avenue Chicago, IL 60605 312-922-4400 312-922-5240

16 Holiday Inn Chicago Mart Plaza 350 West Mart Center Drive Chicago, IL 60654 312-836-5000 312-222-9508

19 Hotel Cass, A Holiday Inn Express 640 North Wabash Chicago, IL 60611 312-787-4030 312-787-1381

23 Hyatt Regency Chicago 151 East Wacker Drive Chicago, IL 60601 312-565-1234 312-239-4414

24 Hyatt Regency McCormick Place 2233 South Martin Luther King Drive Chicago, IL 60616 312-567-1234 312-528-4000

25 Inn of Chicago 162 East Ohio Street Chicago, IL 60611 312-787-3100 312-573-3136

26 InterContinental Chicago 505 North Michigan Avenue Chicago, IL 60611 312-944-4100 312-944-3050

28 JW Marriott 151 West Adams Street Chicago, IL 60604 312-660-8200 312-660-8201

20 Monaco Chicago, A Kimpton Hotel 225 North Wabash Avenue Chicago, IL 60601 312-960-8522 312-960-1883

29 Omni Chicago 676 North Michigan Avenue Chicago, IL 60611 312-944-6664 312-266-3017

30 Palmer House Hilton 17 East Monroe Street Chicago, IL 60603 312-726-7500 312-917-1707

21 Palomar Chicago, A Kimpton Hotel 505 North State Street Chicago, IL 60654 312-755-9703 312-755-9713

32 Renaissance Blackstone 636 South Michigan Avenue Chicago, IL 60605 312-447-0955 312-765-0545

33 Renaissance Chicago Hotel 1 West Wacker Drive Chicago, IL 60601 312-372-7200 312-372-0093

34 Residence Inn by Marriott Chicago Downtown River North 410 North Dearborn Street Chicago, IL 60610 312-494-9301 312-494-9302

35 Residence Inn by Marriott Magnificent Mile 201 East Walton Place Chicago, IL 60611 312-943-9800 312-943-8597

36 Ritz Carlton 160 East Pearson Street Chicago, IL 60611 312-266-1000 312-266-9498

22 Sax Chicago- A Thompson Hotel 333 North Dearborn Street Chicago, IL 60654 312-245-0333 312-923-2444

37 Sheraton Chicago Hotel and Towers 301 East North Water Street Chicago, IL 60611 312-464-1000 312-464-9140

38 Silversmith Hotel 10 South Wabash Avenue Chicago, IL 60603 312-795-6500 312-372-7320

39 Sofitel Chicago Water Tower 20 East Chestnut Street Chicago, IL 60611 312-324-4000 312-324-4025

40 Springhill Suites by Marriott Chicago Downtown River North 410 North Dearborn Street Chicago, IL 60654 312-644-4071 312-644-9302

41 Swissotel Chicago 323 East Wacker Drive Chicago, IL 60601 312-565-0565 312-268-8252

8 The Drake Hotel 140 East Walton Place Chicago, IL 60611 312-787-2200 312-787-1431

12 The Fairmont Chicago 200 North Columbia Drive Chicago, IL 60601 312-565-8000 312-856-1032

27 The James Hotel 55 East Ontario Chicago, IL 60611 312-337-1000 312-337-7217

31 The Peninsula Hotel 108 East Superior Street Chicago, IL 60611 312-337-2888 312-751-2888

42 theWit Hotel 201 North State Street Chicago, IL 60601 312-467-0200 312-673-8617

43 Westin Chicago River North 320 North Dearborn Street Chicago, IL 60654 312-744-1900 312-527-2650

44 Westin Michigan Avenue 909 North Michigan Avenue Chicago, IL 60611 312-943-7200 312-397-5580

45 Wyndham Chicago 633 North St . Clair Street Chicago, IL 60611 312-573-0300 312-274-0164

ACC.12

Hotels


ACC.12

Hotel Map

44 GO for ACC.12!

Accreditation InformationStatement of Need Cardiovascular disease (CVD) is the leading cause of death in the United States . It is estimated that 83 million Americans have one or more forms of CVD and on average, more than 2,200 Americans die of this disease each day . Members of the health care team provide care for patients with cardiovascular health needs in a wide variety of environments affecting the lives of countless patients and families . As the overall care of the patient with CVD becomes more complex, it is imperative that the cardiovascular professional remain current on the diagnosis, treatment and management of these diseases .

As in the past, this program will offer needs-based educational programming, including the comprehensive review of current established practice patterns as well as state-of-the-art updates, techniques and translational research in the diagnosis and treatment of cardiovascular disease in areas such as women’s health, vascular and valvular disease, imaging modalities, interventional cardiology, congenital cardiology, electrophysiology, pulmonary hypertension, STEMI, and addressing comorbidities . Additionally, to address the ongoing needs of our members, emphasis on performance in practice, as related to Maintenance of Certification (MOC) and Maintenance of Licensure (MOL), will be a focus for those requiring this educational emphasis .

Program GoalsTwo global goals for the Annual Scientific Session communicate a commitment by the College to provide needs-based education that is independent of commercial interests and fosters change in learners’ knowledge, competence and performance to ultimately improve patient outcomes .

1 . KNOWLEDGE — To disseminate knowledge of optimal cardiovascular care, disease prevention and improvements in overall patient outcomes .

• Educational strategies for attaining this goal within specific learning pathways are to:

• Offer a core curriculum of cardiovascular and interventional education, including comprehensive reviews of established practice patterns as well as state-of-the-art techniques in the diagnosis and treatment of CVD

• Provide updates of available pharmaceuticals, medical devices and management strategies for cardiovascular patients

• Present basic and clinical research findings, independent of commercial interests, to increase the evidence base related to the care of patients with cardiovascular disease

• Disseminate information related to practice management, quality of care, ethical practices and non-clinical topics that contribute to desired patient outcomes

• Provide a forum for analyzing and critiquing new approaches to non-surgical management of patients with cardiovascular disease

• Create opportunities for knowledge exchange between general cardiologists and interventionalists, as well as cross-discipline areas of cardiology (e .g ., cardiovascular surgery)

2 . COMPETENCE — To foster the translation of evidence-based cardiovascular science and interventional concepts and techniques into daily clinical practice .

Educational strategies for attaining this goal within specific learning pathways are to:

• Offer education to satisfy, in part, requirements for MOC in cardiovascular and interventional medicine

ACC.12

General Education Information


• Provide individualized training in clinical diagnostics and procedures, presented in self- paced and hands-on formats

• Promote professional exchanges between and within groups of cardiovascular care providers with similar clinical, geographic and/or educational interests

• Present best practices of cardiovascular specialists and related health care professionals working in multidisciplinary teams

• Create a forum for global collaboration and cooperation on issues in cardiovascular medicine to improve professional practices worldwide

ACC .12 program level objectives can be found on our website, www.accscientificsession.org, select Education, then Accreditation.

Target AudienceThe Annual Scientific Session is intended for all professionals involved in delivering cardiovascular care, with particular emphasis on physicians, scientists, nurse practitioners, clinical nurse specialists, physicians assistants, nurses, pharmacists and practice administrators . Medical students and trainees, technicians, dietitians and other health care professionals will also benefit .

AccreditationRequirements for successful completion and awarding of credit is attendance in sessions offering credit in their entirety and completion of the evaluation tool . Each participant should only claim the credit commensurate with the extent of their participation in each completed session .

While offering credits noted below, the program is not intended to provide extensive training or certification in the field .

Continuing Medical Education CreditThe American College of Cardiology Foundation is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians .

The ACCF designates the Annual Scientific Session (ACC .12) live educational activity for a maximum of 45 .75 AMA PRA Category 1 Credits™ .

Continuing Nurse Education CreditThe American College of Cardiology Foundation is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation .

The ACCF designates the Annual Scientific Session (ACC .12) educational activity for a maximum of 43 .25 continuing education hours .

Continuing Pharmacy Education CreditThe University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy

Education (ACPE) as a provider of continuing pharmacy education .

The ACPE Universal Program Numbers for ACC .12 can be found within the daily session listings starting on page 105 . This program has been designated as a Knowledge-Based Program and provides a maximum of 24 .75 contact hours of continuing education credit . Continuing education statements of credit will be mailed by the University of Florida College of Pharmacy in 4 – 6 weeks to participants who have attended the program and completed an activity evaluation form .

CME/CNE Credit SystemThe online ACC .12 CME/CNE Credit System will be available in real time for recording your session attendance and claiming credit . Please be sure to keep a record of the session numbers you attended and know your badge number. You may enter your information at the conclusion of a session through the ACC .12 eMeeting Planner or by visiting www.accscientificsession.org.

Note: The CME/CNE system will give credit only for the total elapsed time spent in education sessions . Credit can not be doubly awarded for sessions taking place concurrently . ACC .12 registrants in the following categories have access to the system: ACC Member, ACC International Associate, ACC Cardiac Care Team Member, ACC Cardiovascular Service Administrator Member, ACC FIT Member, ACC Emeritus Member, Nonmember Physician, Nonmember Trainee/Resident, Nonmember Nonphysician, Nonmember Government and One-Day . Those categories not eligible are Nonmember Administrator, Nonmedical, Exhibits, Exhibits Only and Family Member .

General Education Information • ACC.12

46 GO for ACC.12!

ACPE Credit ClaimingThis year for ACC .12, a maximum of 24 .75 contact hours of continuing education credit are available for pharmacists . In order to claim this credit, please complete the following steps:

• Log-in to the ACC .12 evaluation at www.accscientificsession.org and complete the overall evaluation

• After completing the overall evaluation, select the choice stating you are interested in claiming ACPE credits

•Open the link to claim credit in a separate window and fill in the appropriate information

• Continue with the ACC .12 evaluation to select your sessions and claim your certificate of attendance

• The ACPE credit claiming site will close in early May and continuing education statements of credit will be mailed by the University of Florida College of Pharmacy in 4 – 6 weeks to participants who have attended the program and completed an activity evaluation form

If you have any questions regarding this process, please contact Christina Chadwick at [email protected] .

DisclaimersThe American College of Cardiology Foundation does not warrant the completeness, accuracy or usefulness of any opinions, advices or other information provided through this activity . In no event will ACCF be liable for any decision made, or action take, in reliance upon the information provided through this activity .

Accredited status does not imply endorsement by the ACCF of any commercial products displayed in conjunction with the activity .

ACCF reserves the right to modify faculty and program without notice .

Abstracts of Original ContributionsMore than 2,100 oral and poster abstracts are scheduled to be presented at ACC .12 and ACC-i2 with TCT . The full text of the abstracts is contained in the supplement to the March 27, 2012 issue of JACC, which is distributed in print and CD format onsite in Chicago, and will be posted at onlinejacc.org, on Monday, March 26, 2012 . The abstracts will also be available as an e-book download and via the ACC .12

eMeeting Planner App . See additional information regarding download instructions, how to access these sites and online program planning at www.accscientificsession.org .

Learner Bill of RightsThe American College of Cardiology Foundation (ACCF) recognizes that you are a life-long learner who has chosen to engage in continuing medical education to identify or fill a gap in knowledge or skill; and to attain or enhance a desired competency . As part of ACCF’s duty to you as a learner, you have the right to expect that your continuing medical education experience with ACCF includes the following:

Content that:

• Promotes improvements or quality in healthcare • Is current, valid, reliable, accurate and evidence-based • Addresses the stated objectives or purpose • Is driven and based on independent survey and analysis

of learner needs, not commercial interests •Has been reviewed for bias and scientific rigor •Offers balanced presentations that are free of

commercial bias • Is vetted through a process that resolves any conflicts of

interest of planners and faculty • Is evaluated for its effectiveness in meeting the identified

educational need

A learning environment that:

• Is based on adult learning principles that support the use of various modalities

• Supports learners’ abilities to meet their individual needs • Respects and attends to any special needs of the

learners • Respects the diversity of groups of learners • Is free of promotional, commercial and/or sales activities

Disclosure of:

• Relevant financial relationships that planners, teachers and authors have with commercial interests related to the content of the activity

• Commercial support (funding or in-kind resources) of this activity

General Education Information • ACC.12


Joint Conflict of Interest (COI) and Relationship with Industry (RWI) Policies of the American College of Cardiology Foundation (ACCF) and the Cardiovascular Research Foundation (CRF)ACCF/CRF require and collect disclosure of relationships with industry (RWI) from all individuals who are in a position to control or influence educational content . This is done annually in conjunction with all of ACC’s meetings and educational offerings for which CME/CNE/CPE is offered (including the annual ACC Scientific Session) and all of CRF’s meetings and educational offerings for which CME is offered (including TCT, CRF’s major annual educational event) . All individuals involved in directing, planning, and delivering educational content for ACCF and CRF (course directors, planning committee members, faculty, staff, etc) are required to submit RWI disclosures prior to participation; otherwise their participation in the event is precluded . If disclosure of RWI information is not already on file at the inception of a new activity, that information is collected at confirmation of individual participation . This information is also confirmed and updated prior to the development of each CME/CNE/CPE activity to ensure that the most up-to-date information is collected and available . Likewise, nonphysician staff are required to complete RWI Disclosure Declaration forms .

ACCF requires that all faculty disclose their intent to discuss any unlabeled/unapproved uses of drugs and/or devices during their presentations .

COI (RWI) DeclarationThe online Required Faculty Disclosure Declaration form requires each individual to identify financial relationships that he or she and/or his or her spouse or partner have had with any organization within the preceding 12 months or that is anticipated in the next 12 months that could be perceived as a relevant conflict of interest . Any individual who does not complete the form is not permitted to participate; this includes course director(s) and planners (who are then excluded from planning the activity) as well as faculty . For a live activity, each faculty is required to check in upon arrival; and faculty who have not completed their RWI declarations are not allowed to enter the CME/CNE/CPE activity . For enduring activities, the CME/CNE/CPE product is not

published, either online or in print, until all declarations are completed .

COI ResolutionDirector(s) and planning committee members are required to complete the COI Resolution form prior to content development . In the event that a conflict of interest exists, the activity content is reviewed by course director(s), planning committee members, CME/CNE/CPE committee members, or designees who do not have conflicts of interest .

Speakers, Presenters, Moderators, Panelists and Live Case Operators who have declared a COI or RWI are required to complete a COI Resolution form online to agree that their conflict(s) will be resolved by any mechanisms recommended by ACCF/CRF including one or more of the following:

1 . Confirming that no patient care recommendations will be made to the learners regarding the use of drugs or devices from companies with which they have a financial relationship

2 . Confirming that if patient recommendations will be made to the learners regarding the use of drugs or devices from companies with which they have a financial relationship, the conflict will need to be resolved (see next paragraph)

3 . Submitting an alternate resolution of the conflict that is then reviewed by the CME/CNE/CPE Committee, course director(s) and/or planning committee, and if acceptable, approved

4 . Recommending an alternate speaker

5 . Agreeing to divest themselves of the financial relationship

Upon receipt of the COI Resolution form, the course director(s), planning committee members, or CME/CNE/CPE committee members or their designees review each COI Resolution form to determine the course of action, if any, necessary to resolve the conflict . Possible conflict resolution mechanisms, based on the educational design of the program, include using a variety of approaches including, but not limited to:

ACC.12

Disclosure of Financial Relationships

48 GO for ACC.12!

1 . Prior knowledge of speakers’ presentation history (for example, in the past has the individual participated in unbiased presentations, discussions, published literature, etc .)

2 . Knowledge of content and its relevance to the financial relationships

3 . Interview with speakers

4 . Slide peer review

5 . Abstract peer review

6 . Replacing the presenter

For ACCF and TCT annual scientific sessions where presentations number in the thousands, a committee is formed to review all faculty financial relationships to determine whether slide review is necessary; if so, slides are reviewed prior to presentation and, when necessary, changes are recommended and implemented up to and including presenter replacement .

Effective July 2010, in response to an ACCME/ANCC update, sessions with industry employee speakers are allowed to be certified under the following circumstances:

1 . If the content of the session DOES NOT relate to the business lines and products of the industry employer

2 . The presentation is about the scientific or discovery process itself

3 . The presentation is about products that have not yet entered the clinical arena (including products that are under investigation) at the level of biology or physics — but not about products

4 . Presentation slides are submitted at least 2 weeks before the start of the CME/CNE/CPE activity, and the presenter agrees in advance to any and all modifications requested by the CME/CNE/CPE committee

To view the ACC .12 Disclosure Digest which contains disclosure information for all ACC .12 and ACC-i2 with TCT speakers, please visit www.accscientificsession.org, and select Education, then Presenter Disclosures. Or, if your smart phone is enabled with a QR code reader, scan the code below:

Disclosure of Financial Relationships • ACC.12


ACC.12 has something for everyone, including 16 learning pathways designed to address the specific needs of our learners. Plus, ACC.12 features an integrated ACC-i2 with TCT Interventional Learning Pathway, promoting the continued collaboration between the general and interventional cardiology communities.

Please Note: Admission to all sessions is by permissible badge type only on a first-come, first-served basis.

Session FormatsSymposiaThis classic educational format offers detailed discussions of interest to both general cardiologists and subspecialists in various aspects of scientific, clinical and procedural cardiology . Sessions run for 90 minutes, and topics may include novel approaches to clinical issues as well as evidence-based data and/or clinical trial results . Individuals who have directly contributed information to the subject being discussed typically present these sessions .

Oral ContributionsEach year, the meetings feature oral contributions by the original author of some of the best abstracts accepted to the meeting . Groups of several oral abstracts focusing on a similar topic are offered in 90-minute sessions . The allotted time for each abstract is no more than 15 minutes . Many sessions feature a “Year in Review” talk that provides an overview of what has been accomplished in the past year .

Moderated Poster SessionsThis year’s poster abstract sessions feature over a thousand posters in the classic flat board format . Poster abstract sessions feature dedicated viewing hours, poster discussant faculty to facilitate questions/interaction, Best Poster Award judging, and an e-abstract self-directed learning/archival system .

All poster sessions will be moderated; and poster boards will group like subject matter together, fostering interaction between “poster discussants” and presenters/poster audience . There will be two daily dedicated poster presentation/attendee viewing hours: 9:30 a .m . – 10:30 a .m . and 11:00 a .m . – noon . Limited educational programming will

be scheduled during these times to encourage attendees to visit the poster sessions and interact with the presenters .

Poster sessions for ACC-i2 with TCT will be held from 9:30 a .m . to noon on Saturday, March 24 . New this year, all posters within a given pathway will be presented on the same day and will remain on display for the entire time that the Expo Hall is open .

New this year, one poster presentation from each pathway will be selected as a Best Poster Award winner . The presenter will receive a gift certificate good towards an ACCF educational product or program .

ACC.12 OnlineNew this year, attendees will experience ACC .12 Online for free! ACC .12 Online features some of the most critical, cutting-edge presentations from ACC .12 with live webcasts of 60 sessions and 18 on-demand programs from the Legends of CV Medicine Series and Core Curriculum sessions — available to attendees for free during the meeting . Choose to watch them from a Heart Hub or from your own mobile device — multi-tasking among the simultaneous presentations . To access ACC .12 Online and see a complete schedule of live broadcasts, go to: http://acc12online.cardiosource.org and login with your e-mail address and passcode: ACCONLINE

ACC-i2 with TCT Live and Taped CasesThree live and taped case sessions (one session each on Saturday, Sunday and Monday afternoons) allow attendees to watch an actual invasive cardiovascular procedure in progress via satellite feed from a clinical setting . Some pre-taped cases will also be presented .

ACC.12

Scientific Session Descriptions

50 GO for ACC.12!

International Lunch SymposiaACC is co-hosting a series of symposia held over lunchtime with 18 non-U .S .-based cardiovascular societies . These sessions focus on global clinical and patient management issues that can be presented from the perspective of U .S .-based physicians and non-U .S .-based physicians . Attendees are encouraged to bring their own lunch to the sessions . Food for purchase is available at nearby concessions outside of the symposia rooms .

Legends of Cardiovascular MedicineExpand your horizons with the Legends of Cardiovascular Medicine Lecture Series . Each Legend is an individual that is recognized by all cardiologists as a true leader and innovator and has been selected based on their outstanding contributions to the field of cardiovascular medicine . The Legends will share with the audience their unique professional history of accomplishments and contributions to the cardiovascular field; key milestones that changed practice in their area of expertise; and insights into the future of cardiovascular care . During the Q&A segment, the Legends will share biographical information, impressionable moments from mentors, guiding principles, lessons learned and other introspective thoughts from their own life stories .

Meet the Experts“Meet the Experts” are energizing, case-based, interactive sessions that emphasize scholarly discussion and debate in a lively, but informal small-group setting (maximum capacity of 150) . A specific topic is selected for each session and audience participation is encouraged . Provocative clinical case vignettes or organizational scenarios are typically presented with the case presenter and panelists each making their brief remarks and encouraging participant interaction . Audience response systems are available in each of the Meet the Experts rooms — bring your own personal mobile device to participate .

Special SessionsSpecial sessions are unique events that focus on activities of broad interest to many attendees . The Special Topics Learning Pathway highlights these offerings, which include the Opening Showcase, late-breaking clinical trials, the Young Investigators Awards, sessions designed expressly for fellows in training, the new and exciting Legends of Cardiovascular Medicine Lecture Series, the College business meeting, the

61st Annual Convocation, and the closing session, preceded by Innovators in Cardiology, featuring top leaders in the field .

Heart Songs Learning LabBack by popular demand is the highly rated Heart Songs Self-Paced Learning Lab — a unique audio-visual program to refresh cardiac auscultation skills . After a pre-test, attendees will then listen to Heart Sounds while viewing phonocardiograms, echoes, etc . on an iPod® Touch, an iPad® or laptop computer . Attendees can view the sessions and take both the pre-test and post-test on their own device or use devices provided in the room to document improvement in their auscultation skills . Each session takes approximately 30 minutes to complete . Sessions are self-paced and can start anytime from 9 a .m . to 5 p .m .

Lifelong LearningAgain this year, you can obtain Maintenance of Certification (MOC) points at ACC .12 by participating in daily study sessions approved by the American Board of Internal Medicine (ABIM) . You’ll find presentations geared to general cardiology, interventional cardiology and — new this year — electrophysiology . In addition, pediatric cardiologists will have the opportunity to participate in an interactive MOC study session with questions from the American Board of Pediatrics (ABP) . There is no cost for MOC sessions . They are included in your registration fee!

Also back by popular demand is the Cardiology Core Curriculum, offering a review of every major area of cardiology and helping you to prepare for board exams or refresh clinical knowledge and skills at any stage of your career .

Maintenance of CertificationStart with a new self-assessment session featuring clinically relevant guidelines and trials . Then look for 12 additional Recertification Made Easy review sessions, 2 in interventional cardiology, 2 in electrophysiology, and 8 in general cardiology (half based on ABIM home-study modules and half based on new ACC general cardiology modules) . After the study session, nearby computer workstations allow you to immediately take a post-test, each worth 10 MOC points . Earn up to 70 ABIM MOC points .

Scientific Session Descriptions • ACC.12


ACC.12 • Scientific Session Descriptions

All ABIM workshop participants must be registered for the session and enrolled in the ABIM MOC program to attend . ABIM staff will be available to assist with on-site enrollment and to answer MOC questions, but please arrive at the session 15 minutes prior to the start . Registrants who sign up for the new ACC general cardiology modules will be able to access them online through their CardioSource account .

Pediatric Cardiology MOCThis interactive session is based on a group of home study modules approved by the American Board of Pediatrics (ABP) . You’ll review with the experts, learn alongside your peers, challenge your medical knowledge with test questions, and get instant feedback with an audience response system . Remember to bring your laptop to the MOC review session . Configure it in advance to receive the convention center’s WiFi signal, and make sure you can access your ABP portfolio . During the program, you’ll submit ABP MOC module answers electronically through the portfolio on the ABP website .

The study session prepares you to earn 10 ABP MOC points . The credit approval period for this module is January 1, 2012 – December 31, 2012 . Participants must be an ABP diplomate and enrolled in the ABP MOC process at the time of the session . For information about enrolling in the ABP MOC process, please visit www.abp.org and log into My ABP Portfolio .

Cardiology Core CurriculumWith the constant growth in cardiovascular knowledge and technology, the need to learn doesn’t end once you enter practice . Update your knowledge, refresh your skills, or simply prepare for the board certification examination with ACC’s highly respected Lifelong Learning Cardiology Core Curriculum . Using the Competency-Based Learning System, you begin with an online pre-test that highlights your areas of educational need . Next, select the Core Curriculum sessions that fill your knowledge gaps . After passing an online post-test, you’ll receive 10 ABIM Part 2 MOC credits

52 GO for ACC.12!

Continue Your Education at the ACC.12 ExpoSouth Building, Level 3, Halls A1 and A2

A vital part of your ACC education can be found in the ACC .12 Expo . Gain an understanding of the latest advances in pharmaceuticals, imaging, devices, technologies and the services that you need to help you provide high-quality patient care .

The ACC .12 Expo features the largest gathering of innovative cardiovascular products and services being shown under one roof . More than 300 exhibiting companies and organizations showcase their products, technologies and services in these categories:

• Associations• Education• Food Service, Nutrition and Lifestyle•Hospital/Institution/Practice• Imaging• Information Technology•Medical Devices•Medical Equipment• Pharmaceuticals• Publishing• Research

You don’t have to miss a minute of education to explore the Expo Hall, located in the South Building, Level 3, Halls A1 and A2 . ACC .12 offers more than six hours of dedicated Expo time — unopposed by education sessions — to meet with industry and learn more about their offerings . Round out your day by discovering cutting-edge innovations as you enjoy morning and afternoon coffee breaks, sponsored by Sanofi US, in the Expo Hall . NEW for ACC.12! Join your colleagues for lunch in the Expo Hall on Monday, March 26, from noon to 2:00 p .m .

Expo HoursSaturday, March 24 9:30 a.m. – 4:30 p.m.Dedicated Expo HoursExpo Coffee Break 9:30 a .m . – 11:30 a .m .Expo Mid-Day Break* 11:30 a .m . – 2:00 p .m .Expo Coffee Break 3:30 p .m . – 4:30 p .m .

Sunday, March 25 9:30 a.m. – 4:30 p.m.Dedicated Expo HoursExpo Coffee Break 9:30 a .m . – 10:45 a .m .Expo Mid-Day Break* 12:15 p .m . – 2:00 p .m .Expo Coffee Break 3:30 p .m . – 4:30 p .m .

Monday, March 26 9:30 a.m. – 2:00 p.m.Dedicated Expo HoursExpo Coffee Break 9:30 a .m . – 10:30 a .m .Expo Mid-Day Break*and NEW for ACC .12!Lunch Hospitality Event Noon – 2:00 p .m .

ACC thanks Sanofi US for its sponsorship of the morning and afternoon coffee breaks .

*Limited ACC.12 lunchtime sessions run concurrently during these time periods

Specialty AreasWe help you maximize your time in the Expo Hall by gathering the vendors you want to see into specialty areas .

American College of Cardiology — ACC CentralMcCormick Place South, Hall A1, #10027

At ACC Central you’ll find comprehensive information on ACC’s quality initiatives; NCDR® registries and research; self-assessment tools; live courses; membership opportunities; and ways to ensure practice viability and protect patient access . In addition, don’t miss the exciting new products and services designed to help you translate science into practice .

ACC.12

Expo


CardioSmart PavilionMcCormick Place South, Hall A1

As society moves toward more heart-healthy products, ACC has teamed up with consumer companies to help guide physicians and patients to make healthier dietary and lifestyle choices . Visit the CardioSmart Pavilion and sample new heart-healthy options being offered by a variety of consumer companies .

Health IT PavilionMcCormick Place South, Hall A1

ACC is highly committed to assisting its members in the adoption and implementation of health IT to promote quality in cardiovascular care . The Health IT Pavilion is dedicated to showcasing health IT companies and consulting firms; their products, services and technologies; and the benefits to health care providers .

Interventional PavilionMcCormick Place South, Hall A1

Learn about groundbreaking products, services and technologies for interventional cardiology in the Interventional Pavilion . With many new devices and technologies coming into the marketplace, interventional and general cardiologists will want to ensure a visit to this pavilion is on their ACC meeting agendas .

Public Service AreaMcCormick Place South, Hall A2

The Public Service Area gathers cardiovascular societies and non-profit organizations into one location . Visit with these organizations for educational materials, market research and information about advocacy efforts in the U .S . and around the world .

Publishers ShowcaseMcCormick Place South, Hall A1

The very popular Publishers Showcase features publishers of medical texts, journals and other relevant materials . Books and subscriptions are also available for purchase in this area .

Networking AreasRelax and recharge as you network with your colleagues in these areas of the Expo Hall .

ACC Member LoungeMcCormick Place South, Hall A1, #22063

The ACC Member Lounge is open to ACC members during all Expo hours . Take time with colleagues to network and relax, check emails and enjoy a cup of coffee in this inviting atmosphere .

Bistro ACCMcCormick Place South, Hall A2, #1100

Bistro ACC is an innovative dining option offering several fresh and healthy menu choices, including international cuisine and regional favorites . An all-inclusive lunch buffet costs $20 and includes your meal, beverages, dessert and tax . You can purchase lunch tickets by visiting the Bistro ACC ticket counter in the Grand Concourse just outside the Expo Hall .

International LoungeMcCormick Place South, Hall A2, #15097

As a service to our international attendees, we offer a designated International Lounge, where you can join colleagues from around the world to discuss and share the latest science, research and treatment modalities in the field of cardiology . ACC membership materials are available in several languages .

Windy City Café & Tech HubMcCormick Place South, Hall A2, #22111

Join colleagues for a more upscale buffet-style dining experience at the Windy City Café & Tech Hub . The Windy City Café offers you a unique environment in which to relax and make plans for your continuing education and remaining time at ACC .12 . Charging stations will be available for your electronic devices — recharge your batteries and your phone’s batteries — all in one location!

Expo • ACC.12

54 GO for ACC.12!

Company Name Booth Number Company Name Booth Number Company Name Booth Number

Abbott . . . . . . . . . . . . . . . . . . . . . . 4040Abbott Vascular . . . . . . . . . . . . . . . 6048Abiomed, Inc . . . . . . . . . . . . . . . . . 9063ACC China Chapter . . . . . . . . . . . .17101ACC Egypt . . . . . . . . . . . . . . . . . . .18100ACC Pakistan Chapter . . . . . . . . . .18104ACC-Caribbean Chapter c/o

Caribbean Cardiac Society . . . .17102Access Closure, Inc . . . . . . . . . . . .10079Accreditation for Cardiovascular

Excellence . . . . . . . . . . . . . . . .19100Accumetrics, Inc . . . . . . . . . . . . . . .19007ACIST Medical Systems/Bracco

Diagnostics . . . . . . . . . . . . . . . 9048Actelion Pharmaceuticals

US, Inc . . . . . . . . . . . . . 8038, 10038Advanced Cardiac

Diagnostics LLC . . . . . . . . . . . .11085Agfa HealthCare . . . . . . . . . . . . . .12055AirStrip Technologies . . . . . . . . . . .13101Alere Home Monitoring . . . . . . . . .19085Amarin Corp . . . . . . . . . . . . . . . . .20015Amazing Charts . . . . . . . . . . . . . . 23020AME Publishing Company . . . . . . . .1005American College of Cardiology

Mexico Chapter . . . . . . . . . . . .17100American College of Cardiology —

ACC Central . . . . . . . . . . . . . 10027American College of Physicians/

Annals of Internal Medicine . . . .1038American College of Radiology . . . . .6101American Express OPEN . . . . . . . 20075American Heart Association . . . . . . 2040American Physician Institute . . . . . 12074American Society of

Echocardiography . . . . . . . . . . 19096American Society of Nuclear

Cardiology . . . . . . . . . . . . . . . 20096Amgen . . . . . . . . . . . . . . . . . . . . . .14036

Amyloidosis Foundation, Inc . . . . . .20102Angelini Pharmaceuticals . . . . . . . .15090AngioScore, Inc . . . . . . . . . . . . . . . 9077ANSAR Medical Technologies, Inc . 23021Aprima Medical Software . . . . . . .18032Arbor Pharmaceuticals, Inc . . . . . . .15089Arstasis Inc . . . . . . . . . . . . . . . . . . 10090Ascendian Healthcare Consulting . .18041Astellas Pharma US, Inc . . . . . . . . .10001AstraZeneca Pharmaceuticals . . . . .6012AtCor Medical, Inc . (USA) . . . . . . . .11089athenahealth, Inc . . . . . . . . . . . . . .17031Atherotech Diagnostics Lab . . . . . .19089Bard Medical Division . . . . . . . . . .18002Bard Peripheral Vascular . . . . . . . . 4048Baxter Healthcare . . . . . . . . . . . . .14082Berkeley HeartLab, Inc . . . . . . . . . .10042Best Vascular . . . . . . . . . . . . . . . . . .7073BG Medicine, Inc . . . . . . . . . . . . . . 19006BioMed Central . . . . . . . . . . . . . . .19049BMS/Pfizer . . . . . . . . . . . . . . . . . . 2001BodyPartChart LLC . . . . . . . . . . . .11087Boehringer Ingelheim . . . . . . . . . . . 6000Borgess Health . . . . . . . . . . . . . . .19078Boston Scientific . . . . . . . . . . . . . . 3063Brazilian Society of Cardiology . . . .18096British Cardiovascular Society . . . .17096Cambridge Heart, Inc . . . . . . . . . . .12081Cameron Health, Inc . . . . . . . . . . . . 2063Canadian Cardiovascular Society . .21107Cardiac CT Angiography Training . .19106CardiacAssist, Inc . . . . . . . . . . . . . . 9088Cardiology News . . . . . . . . . . . . . .17005Cardiology Today/SLACK

Incorporated . . . . . . . . . . . . . . . .1024Cardiomedix/Commwell . . . . . . . . .18000CardioMEMS, Inc . . . . . . . . . . . . . .15088CardioNet, Inc . . . . . . . . . . . . . . . . .11097Cardionics . . . . . . . . . . . . . . . . . . 20091

CardioPulse (formerly CAOS) . . . . 20049Cardiostim 2012/Reed

Expositions France . . . . . . . . . .18105Cardiovascular Business . . . . . . . .12096Cardiovascular Credentialing

International (CCI) . . . . . . . . . . .19105Cardiovascular Research

Foundation . . . . . . . . . . . . . . . . 2048Cardiovascular Systems, Inc . . . . . . 9078CardioVillage/University of

Virginia . . . . . . . . . . . . . . . . . . .15044Carle Physician Group . . . . . . . . . 20080CellAegis Devices Inc . . . . . . . . . . .10087Centers for Medicare &

Medicaid Services . . . . . . . . . .19076Centra . . . . . . . . . . . . . . . . . . . . . .21079Cerner Corporation . . . . . . . . . . . .18049CFI Medical Solutions . . . . . . . . . . 4097Cleveland Clinic . . . . . . . . . . . . . . .23019Cleveland Clinic Abu Dhabi . . . . . .13086Cleveland Clinic C5 Research . . . . .23016The Coca-Cola Company . . . . . . . .19063Community Health Systems . . . . . .10083Compulink Business

Systems, Inc . . . . . . . . . . . . . . .12087Contec Medical

Systems Co ., LTD . . . . . . . . . . 20048Cook Medical . . . . . . . . . . . . . . . . . 9057Corindus Vascular Robotics . . . . . . 3097Crescendo Systems Corp . . . . . . . .18030Cryolife . . . . . . . . . . . . . . . . . . . . 20009CVRx, Inc . . . . . . . . . . . . . . . . . . . 10063Cytokinetics, Inc . . . . . . . . . . . . . . .17083Daiichi Sankyo, Inc . . . . . . . . . . . . .14026Daiichi Sankyo, Inc . &

Lilly USA LLC . . . . . . . . . . . . . .18013DailyCare BioMedical Inc . . . . . . . . .1004Data Strategies, Inc . . . . . . . . . . . 20034Demos Medical Publishing . . . . . . . .1040

ACC.12

ExhibitorsExhibitors as of February 28, 2012. Please refer to the ACC .12 ExpoGuide and the ExpoGuide Addendum, available at the Expo Hall entrances and in your meeting bag, for the most updated list of exhibitors.


DesAcc, Inc . . . . . . . . . . . . . . . . . .19081Diagnosoft, Inc . . . . . . . . . . . . . . . .18026Diagnostic & Interventional

Cardiology . . . . . . . . . . . . . . . 10004DiaPharma Group, Inc . . . . . . . . . . . 11075Digisonics . . . . . . . . . . . . . . . . . . .10073The Doctors Company . . . . . . . . . 10043Dornier MedTech America, Inc . . . .10088DR Systems, Inc . . . . . . . . . . . . . . .18035DrFirst, Inc . . . . . . . . . . . . . . . . . . .19087Duke Clinical Research Institute . . .11063eCardio . . . . . . . . . . . . . . . . . . . . . 7097eClinicalWorks . . . . . . . . . . . . . . . .19039Edan Instruments, Inc . . . . . . . . . . . .6100Edwards Lifesciences . . . . . . . . . . 3048Ekos Corporation . . . . . . . . . . . . . . 9083Elsevier-ClinicalKey . . . . . . . . . . . . . 1011Emerge Clinical Solutions . . . . . . . 2054Endothelix, Inc . . . . . . . . . . . . . . . . .1055Endovascular Today . . . . . . . . . . . . 8072Epiphany Cardiography Products . .17037Epsilon Imaging, Inc . . . . . . . . . . . .20074ES Physician Agent . . . . . . . . . . . .18004Esaote North America . . . . . . . . . . .2019European Society of Cardiology . . .11080Fibromuscular Dysplasia Society

of America (FMDSA) . . . . . . . . .21105Flexible Informatics . . . . . . . . . . . . 6072Forest Pharmaceuticals . . . . . . . . .18063FUJIFILM Medical Systems

USA, Inc . . . . . . . . . . . . . . . . . .19053Gambro UF Solutions, Inc . . . . . . . .19088GE Healthcare . . . . . . . . . . . . . . . . .8013GEMMS . . . . . . . . . . . . . . . . . . . . 20027GeneDx . . . . . . . . . . . . . . . . . . . . . 6073Genentech and Roche . . . . . . . . . .15027Genway Biotech . . . . . . . . . . . . . . .15084Genzyme . . . . . . . . . . . . . . . . . . . .13083Gilead Sciences . . . . . . . . . 8000, 10006Glenmark Pharmaceuticals . . . . . .10041Guerbet . . . . . . . . . . . . . . . . . . . . . .8071Harvard Clinical Research

Institute . . . . . . . . . . . . . . . . . .16083The Healthcare Network . . . . . . . 20033Health Management Associates . . .21077

Health Outcomes Sciences . . . . . . 4096Heart Institute Diagnostic Lab . . . .20101The Heart Institute for Children,

Hope Children’s Hospital, Advocate Christ Medical Center . 20097

Heart Rhythm Society . . . . . . . . . .20105Heart Test Laboratories, Inc . . . . . .18085Heartbeat International . . . . . . . . 20098HeartSine Technologies, Inc . . . . . .15082HeartWare Inc . . . . . . . . . . . . . . . .11079Henry Schein MicroMD . . . . . . . . 20035Hershey Center for Health &

Nutrition® . . . . . . . . . . . . . . . . 20063Hitachi Aloka Medical . . . . . . . . . .12063HMP Communications, LLC . . . . . . 8049Hokanson . . . . . . . . . . . . . . . . . . 16004Hospital Corporation of America

(HCA) . . . . . . . . . . . . . . . . . . . 10096HRA Healthcare Research &

Analytics . . . . . . . . . . . . . . . . .11086Hypertrophic Cardiomyopathy

Association . . . . . . . . . . . . . . . .21100IEM . . . . . . . . . . . . . . . . . . . . . . . .10089INC Research . . . . . . . . . . . . . . . . .24018INDEC Systems Inc . . . . . . . . . . . . . 9056INFINITT North America . . . . . . . . .12088InfraReDx, Inc . . . . . . . . . . . . . . . . . 3054InspireMD . . . . . . . . . . . . . . . . . . . 2067Intelemage, LLC . . . . . . . . . . . . . . .14084International Society for

Cardiovascular Translational Research . . . . . . . . . . . . . . . . . 21101

Intersocietal Accreditation Commission (IAC) . . . . . . . . . . .20104

Intuitive Solutions . . . . . . . . . . . . 20038Israel Heart Society . . . . . . . . . . . .17104Itamar Medical . . . . . . . . . . . . . . .18016JAMA & Archives Journals . . . . . . . .1030Janssen Pharmaceuticals, Inc . . . . .10007Jaypee Highlights Medical Pub . . . . .1044John Welsh Cardiovascular

Diagnostic Laboratory . . . . . . .19104Jones & Bartlett Learning . . . . . . . .1034JTE Multimedia . . . . . . . . . . . . . . . .1006Kaneka . . . . . . . . . . . . . . . . . . . . 20087

Koven Technology, Inc . . . . . . . . . .11081Lantheus Medical Imaging, Inc . . . . 6099Laurel Bridge Software, Inc . . . . . . 6098Le Cardiologue . . . . . . . . . . . . . . . .1042LifeWatch Services, Inc . . . . . . . . .15083LipoScience . . . . . . . . . . . . . . . . . .18069Lippincott Williams & Wilkins/

Wolters Kluwer Health . . . . . . . .1017Littmann Stethoscopes . . . . . . . . .16001LUMEDX . . . . . . . . . . . . . . . . . . . .17007MAQUET Medical Systems . . . . . . 3096Mars Botanical . . . . . . . . . . . . . . .21063Mayo Clinic . . . . . . . . . . . . . . . . . .19001McGraw-Hill . . . . . . . . . . . . . . . . . .1010McKesson . . . . . . . . . . . . . . . . . . .18027MedActivus . . . . . . . . . . . . . . . . . .19079MedAxiom . . . . . . . . . . . . . . . . . . .12049MedCo Data LLC . . . . . . . . . . . . . 20045The Medical Roundtable

c/o FoxP2 Media LLC . . . . . . . . .1032Medical Simulation Corporation . . . .1051The Medicines Company . . . . . . . . 4054Mednet Healthcare Technologies . . 6097MEDRAD Interventional . . . . . . . . . 6062Medstreaming LLC . . . . . . . . . . . .18007Medtronic, Inc . . . . . . . . . . . . . . . . 6038The Mended Hearts, Inc . . . . . . . . .21069Merck . . . . . . . . . . . . . . . . . . . . . .14008Merge Healthcare . . . . . . . . . . . . .17043Methodist DeBakey Heart &

Vascular Center . . . . . . . . . . . .17082Met-Test, LLC . . . . . . . . . . . . . . . .17089Midmark Corporation . . . . . . . . . . .12080MiE America-Medical Imaging

Electronics . . . . . . . . . . . . . . . .10081Millar Instruments . . . . . . . . . . . . 10000Miller Pharmacal Group, Inc . . . . . . 7096Million Hearts™ . . . . . . . . . . . . . .21067Mortara Instrument . . . . . . . . . . . . 9026Mountain States Health Alliance . .19084National Death Index . . . . . . . . . . .21080National Heart, Lung and

Blood Institute (NHLBI) . . . . . . .16089Navigant,

formerly Paragon Health . . . . . 20051


ACC.12 • Exhibitors

56 GO for ACC.12!

ndd Medical Technologies . . . . . . .17003New England Journal of Medicine . 16000NextGen Healthcare . . . . . . . . . . . 19043NextServices Inc . . . . . . . . . . . . . . .19035Norav Medical . . . . . . . . . . . . . . . .18001NorthEast Monitoring, Inc . . . . . . . 20081Northwestern Medicine . . . . . . . . .14083Novartis Pharmaceuticals

Corporation . . . . . . . . . 16017, 18020Oklahoma Heart Hospital . . . . . . . .18099Oxford University Press . . . . . . . . . .1012Panasonic . . . . . . . . . . . . . . . . . . .18075PCNA Preventive Cardiovascular

Nurses Association . . . . . . . . . .21104Pediatric and Adult Interventional

Cardiac Symposium (PICS-AICS) . . . . . . . . . . . . . . 10084

Perkins Healthcare Technologies . .21091Philips . . . . . . . . . . . . . . . . . . . . . . .6076PhoneTree . . . . . . . . . . . . . . . . . . .21090PhysBiz Tech . . . . . . . . . . . . . . . . 20043Pie Medical Imaging . . . . . . . . . . . 9090Pikeville Medical Center . . . . . . . . .12086Pivotal Therapeutics Inc . . . . . . . . 24020PracticeLink .com . . . . . . . . . . . . . . 2004PracticeMax . . . . . . . . . . . . . . . . .17029Provation Medical-Wolters

Kluwer Health . . . . . . . . . . . . . 20053Pulmonary Hypertension

Association . . . . . . . . . . . . . . . .21082Pulse Biomedical, Inc . . . . . . . . . . .19082Pulse Medical Inc . . . . . . . . . . . . . .12072QGenda .com . . . . . . . . . . . . . . . . 20039Quaker Oats . . . . . . . . . . . . . . . . .21071Roche Diagnostics . . . . . . . . . . . . 16009Rush University Medical Center . . .10082Saint Alphonsus Health System . . 20076Sanofi . . . . . . . . . . . . . . . .12001, 14000

Saudi Heart Association . . . . . . . . .18102SCHILLER . . . . . . . . . . . . . . . . . . .11054ScImage . . . . . . . . . . . . . . . . . . . . 7063ScottCare Corporation . . . . . . . . . . .2013seca . . . . . . . . . . . . . . . . . . . . . . 20090Shape Medical Systems, Inc . . . . . .14089Shiel Medical Laboratory . . . . . . . .19075Shimadzu Medical Systems USA . . 8048Siemens Healthcare . . . . . . . . . . . . 2026Sim-e-Child . . . . . . . . . . . . . . . . . .18101Singulex, Inc . . . . . . . . . . . . . . . . . .18089Sociedad Latinoamericana

de Cardiologia Intervencionista (SOLACI) . . . . . . . . . . . . . . . . .18097

Sociedad Venezolana de Cardiologia . . . . . . . . . . . . .17105

Society for Cardiovascular Angiography and Interventions (SCAI) . . . . . . . . . 9082

Society for Heart Attack Prevention and Eradication (SHAPE) . . . . .21106

Society of Cardiovascular Computed Tomography . . . . . .19103

Society of Chest Pain Centers . . . 16044Spacelabs Healthcare . . . . . . . . . .11001Spanish Society of Cardiology . . . .21096Spartan Bioscience . . . . . . . . . . . . 9089Springer . . . . . . . . . . . . . . . . . . . . . .1026St . Jude Medical . . . . . . . . . . . . . . .3013St . Luke’s Health System . . . . . . . .19074StopAfib .org . . . . . . . . . . . . . . . . .21098SUBWAY . . . . . . . . . . . . . . . . . . . .21062Summit Doppler Systems . . . . . . . .11073Takeda Pharmaceuticals

North America . . . . . . . . . . . . .15037TeraRecon . . . . . . . . . . . . . . . . . . .18055Terumo Interventional Systems . . .21015Texas Children’s Hospital . . . . . . . .12078

theheart .org . . . . . . . . . . . . . . . . . .12073Thoratec Corporation . . . . . . . . . . .12097TIMI Study Group . . . . . . . . . . . . . .10050TomTec Imaging Systems GmbH . .10097Toshiba America Medical

Systems, Inc . . . . . . . . . . . . . . . 6026Total Vein Systems . . . . . . . . . . . .15045TransAmerican Medical Imaging . . 7098Transgenomic, Inc . . . . . . . . . . . . .11078Trinity Mother Frances Hospitals

& Clinics . . . . . . . . . . . . . . . . . 20084Turkish Society of Cardiology ACC

Istanbul Chapter Consortium . .17103TYRX Inc . . . . . . . . . . . . . . . . . . . . 9085Unfors RaySafe, Inc . . . . . . . . . . . . .1057Universal Medical Resources, Inc . .10039UpToDate . . . . . . . . . . . . . . . . . . . 20057Vascular Solutions . . . . . . . . . . . . . .1053Vasomedical, Inc . . . . . . . . . . . . . . .14097VectraCor . . . . . . . . . . . . . . . . . . .13090The VEINS Chicago 2012 . . . . . . . . 9076Velos, Inc . . . . . . . . . . . . . . . . . . . .12084Verathon Medical . . . . . . . . . . . . . .13089Vital Images . . . . . . . . . . . . . . . . . .11088Volcano Corporation . . . . . . . . . . . 8054W .A . Baum Co ., Inc . . . . . . . . . . . . 10045Weaver and Company . . . . . . . . . .18083Welch Allyn, Inc . . . . . . . . .16037, 16045Western Systems Research, Inc . . .13088Wiley-Blackwell . . . . . . . . . . . . . . . .1016WomenHeart: The National

Coalition for Women with Heart Disease . . . . . . . . . . . . . .21103

World Heart Federation . . . . . . . . .19097Yuma Regional Medical Center . . .19077ZHealth Publishing . . . . . . . . . . . . . .7072Z-Medica Corporation . . . . . . . . . . 8097ZOLL Medical Corporation . . . . . . . 8063

ACC has advised all exhibiting companies that it is each company’s responsibility to ensure adherence to FDA regulations, policies, practices and guidelines, and all other applicable industry guidelines, concerning the demonstration, discussion, use and/or display of products, technologies and/or services the ACC.12 Annual Scientific Session Exposition. Exhibiting companies have also been reminded of the FDA restrictions on the promotion of investigational and pre-approved drugs, devices and procedures. Information regarding FDA regulations should be obtained directly from the FDA.


Exhibitors • ACC.12


Learning Destinations™ are diverse, non-accredited, educationally focused areas that offer new and creative ways to expand your educational experience. We invite you to visit these dynamic learning environments, located in the Expo Hall (South Building, Level 3, Halls A1 and A2).

NEW for ACC.12! CardioSmart ForumMcCormick Place South, Hall A2, CV Theater, #22097

You know that behavioral change is one of the most important factors in your patients living a heart-healthy lifestyle . (They know that, too .) So how can you help your patients overcome their resistance to changing their eating behaviors for the better? And for the long term? Visit the CardioSmart Forum* on Saturday, March 24, from 11:15 a .m . to 12:15 p .m . for the presentation “Eat What You Love, Love What You Eat: How to Break Your Eat-Repent-Repeat Cycle .” Dr . Michelle May, author of the award-winning book of the same name, will deconstruct the “Mindful Eating Cycle” and explore the bio-psycho-social drivers of each decision point . You’ll learn a powerful and universal approach to the complex issues contributing to problematic eating behaviors and walk away with six unconventional strategies that promote heart-healthy lifestyles, which could help improve your patients’ outcomes . This presentation is part of the “CardioSmart: Hot Topics for Better Patient Outcomes” series .

CV Innovations Educational ForumMcCormick Place South, Hall A2, CV Theater, #22097

The ACC, in partnership with Elsevier Business Intelligence and the International Society for Cardiovascular Translational Research, will once again offer the CV Innovations Educational Forum*, featuring cutting-edge cardiovascular research and cardiovascular product development . Catch a glimpse of the future on Sunday, March 25, and Monday, March 26, as physicians, researchers, venture capitalists and investment bankers gather for presentations and panel discussions, and explore cardiovascular technologies in development . Refer to the “ACC .12 Learning Destination Presentations” pages at the end of each daily section for the scheduled presentations, speakers and descriptions .

Topics include:

•Device Development and Innovation• Current Approaches for Treating Calcified Peripheral

Arterial Disease• Challenges Associated with Treating Calcified Coronary

Artery Disease• The Role of Innovative Technologies in a Novel Strategy

to Prevent First Coronary Event• The Role of Nanotechnology in Cardiovascular Diseases• Cellular Therapy• Tissue Engineering• Personalized Medicine

NEW for ACC.12! The Heart of Innovation Featured Learning DestinationMcCormick Place South, Hall A1, #1076

In the spectrum of chronic cardiovascular diseases, two of the most significant challenges faced by cardiology professionals today are coronary artery disease and heart failure caused by valvular disease . In the Heart of Innovation Learning Destination*, you will explore the evolution of the standard of care for these two diseases through the lenses of Personalized Medicine, TechnoBiology, Minimally Invasive Procedures and Physician-Patient Engagement .

The Heart of Innovation will allow you to closely examine the protocols, approaches and advances that are driving better clinical outcomes today . To help you see the continuum of progress, you will revisit the innovators and innovations of the past, while exploring the exciting possibilities for the future and weighing in with your own opinions about how new

ACC.12

Learning Destinations™

58 GO for ACC.12!

techniques and technologies will impact your practice in years to come .

The adjoining Thought Leader Theater™ will feature clinically based presentations, as well as discussions with physicians and healthcare providers who are at the forefront of cardiovascular innovation . Refer to the “ACC .12 Learning Destination Presentations” pages at the end of each daily section for the scheduled presentations, speakers and descriptions .

ACC is grateful for the support of the Marquee Heart of Innovation Partner:

Helping you transform patient care through innovations and partnerships

ACC also thanks the following supporting companies:

bioMérieux

CFI Medical Solutions

Corindus Vascular Robotics

Edwards Lifesciences

International Society for Cardiovascular Translational Research

ACC also thanks the following participating companies:

Health Outcomes SciencesMAQUET Medical Systems USA

Medtronic, Inc .Terumo Interventional Systems

Industry-Expert TheaterMcCormick Place South, Hall A1, #22042

Connect with the experts in the Industry-Expert Theater* as presenters share the latest in cardiovascular practices, products, services and technologies while you enjoy refreshments or lunch — presentations are conveniently scheduled during the daily coffee and mid-day breaks . Refer to the “ACC .12 Learning Destination Presentations” pages at the end of each daily section for the scheduled presentations, speakers and descriptions .

• Antiplatelet Therapy Choices for High-Risk PCI Patients in the Era of Generic Clopidogrel: The Role of Platelet Reactivity Testing — Accumetrics

• Considerations for Radionuclide Myocardial Perfusion Imaging in Patients with COPD/Asthma — Astellas Pharma US, Inc.

• Pradaxa® (Dabigatran Etexilate Mesylate) Capsules — Boehringer Ingelheim Pharmaceuticals, Inc.

• A Stroke Prevention Option in Nonvalvular Atrial Fibrillation — Janssen Pharmaceuticals Inc.

•Managing Atherosclerotic Risk with a Particle Focus — New Recommendations and Emerging Data — LipoScience

•Next Generation DES: Evolving the Treatment Paradigm — Medtronic, Inc.

• Emerging Procedures Today, Future Standard of Care — Toshiba Medical Systems

• Treating a Patient at Risk for SCD after PCI — Implant an ICD, Right? The Considerations for Treatment Path Planning, Coverage, and the Role of the Wearable Cardioverter Defibrillator — ZOLL

Interactive Learning LabsMcCormick Place South, Hall A1, #22027, #22035 & #23027

Experience hands-on training and interactive didactic presentations in the Interactive Learning Labs*. This unique educational opportunity puts new technology in your hands and new information in your arsenal . Refer to the “ACC .12 Learning Destination Presentations” pages at the end of each daily section for the scheduled presentations, speakers and descriptions .

Actelion Pharmaceuticals US, Inc. (#23027)• Pulmonary Arterial Hypertension Associated with Adult

Congenital Heart Disease: An Interactive Program• PAH: A Case-Based Exploration of Management

Strategies

Philips Healthcare (#22035)• Speckle Tracking Today for Myocardial Deformation —

A Hands-On Guided Workshop•How Can Cardiology Informatics Enrich My Electronic

Health Records Strategy?• Clinical Application of Real-Time 3D TEE for

Percutaneous Structural Heart Interventions

Learning Destinations™ • ACC.12


ACC.12 • Learning Destinations™

•Hypothermia for Cardiac Protection in Acute Myocardial Infarction

• Cardiac CT — The Journey from Plaque Recognition to Prognosis

• Benefit of Cardiac Troponin Point-of-Care Testing in the Emergency Department

• Sleep, Breathing and the Heart: Cardiovascular Consequences of Sleep-Disordered Breathing

• Innovations in Cardiovascular Interventions

Terumo Interventional Systems/The Medicines Company (#22027)

• Educating to Help Improve Outcomes: Hands-On Radial Access Simulations

•Optimizing Your Outpatient PCI: What You Need to Know and Consider

* Presentations in the ACC.12 Learning Destinations are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees. Presentations in the ACC.12 Learning Destinations do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.

60 GO for ACC.12!

Friday, March 23, 5:30 p.m. – 9:30 p.m.Swissôtel Chicago323 East Wacker Drive

Optimizing PCI Outcomes: A Vision for 2012Sponsored by Cardiovascular Research Foundation

Course Directors:Martin B . Leon, MD — NewYork-Presbyterian Hospital/

Columbia University Medical Center; New York, NYGregg W . Stone, MD — NewYork-Presbyterian Hospital/

Columbia University Medical Center; New York, NY

Faculty:Antonio Colombo, MD — Columbus Hospital/San Raffaele

Hospital; Milan, ItalyGeorge D . Dangas, MD, PhD — Mount Sinai Medical Center;

New York, NYWilliam F . Fearon, MD — Stanford University Medical Center;

Stanford, CAC . Michael Gibson, MD — Beth Israel Deaconess Medical

Center; Boston, MAEberhard Grube, MD — University Hospital Bonn; Bonn,

GermanyAjay J . Kirtane, MD, SM — NewYork-Presbyterian Hospital/

Columbia University Medical Center; New York, NYYves Louvard, MD — Institut Hospitalier Jacques Cartier;

Massy, FranceAkiko Maehara, MD — Cardiovascular Research Foundation;

New York, NYBrij Maini, MD — Pinnacle Health System; Harrisburg, PARoxana Mehran, MD — Mount Sinai Medical Center; New

York, NYGary S . Mintz, MD — Cardiovascular Research Foundation;

Washington, DCE . Magnus Ohman, MD — Duke University Medical Center;

Durham, NCSeung-Jung Park, MD, PhD — Asan Medical Center; Seoul,

South Korea

Manesh R . Patel, MD — Duke University Medical Center; Durham, NC

Jeffrey J . Popma, MD — Beth Israel Deaconess Medical Center; Boston, MA

Erick Schampaert, MD — Hopital du Sacre-Coeur de Montreal; Montreal, Canada

Patrick W . Serruys, MD, PhD — Thoraxcenter; Rotterdam, The Netherlands

Paul S . Teirstein, MD — Scripps Clinic and Research Foundation; La Jolla, CA

Giora Weisz, MD — NewYork-Presbyterian Hospital/Columbia University Medical Center; New York, NY

Mathew Williams, MD — NewYork-Presbyterian Hospital/Columbia University Medical Center; New York, NY

Saturday, March 24, 6:30 p.m. – 9:00 p.m.Hyatt Regency McCormick Place (Grand Ballroom)2233 South Martin Luther King Drive

Evaluating Recent Clinical Trial Data in the Secondary Prevention of Acute Coronary Syndrome (ACS)Sponsored by theheart.org

Chair:C . Michael Gibson, MD — Chairman, PERFUSE Study Group;

Chairman, WikiDoc Foundation; Chief of Clinical Research CV Division, Beth Israel Deaconess Medical Center; Associate Professor of Medicine, Harvard Medical School; Consulting Professor in Medicine, Duke University School of Medicine; Durham, NC

Faculty:John H . Alexander, MD, MHS — Associate Professor of

Medicine, Division of Cardiovascular Medicine, Duke Clinical Research Institute, Duke University Medical Center; Durham, NC

Freek W . A . Verheugt, MD — Professor of Cardiology, Chairman, Department of Cardiology, Onze Lieve Vrouwe Gasthuis; Amsterdam, The Netherlands

ACC.12

Non-Accredited Educational EventsThese events are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees. These events do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.

Presentation schedules are current as of Feb. 28, 2012, and are subject to change. Please check the ACC .12 ExpoGuide and ExpoGuide Addendum, available at Expo Hall entrances and in your Official Meeting Bag, for updated information. More information is also available at www .expo .acc .org .


E . Magnus Ohman, MD — Professor of Medicine, Associate Director, Duke Heart Center - Cardiology Clinics; Director, Program for Advanced Coronary Disease, Duke Clinical Research Institute, Duke University Medical Center; Durham, NC

Sunday, March 25, 5:30 a.m. – 7:30 a.m.Hyatt Regency McCormick Place2233 South Martin Luther King Drive

Pathways of Disease Progression in Heart Failure — What Can Galectin-3 Tell Us?Sponsored by BG Medicine, Inc.

Chair:Professor John G .F . Cleland — University of Hull; United

Kingdom

Faculty:Inder Anand, MD, DPhil, FACC, FRCP — University of

Minnesota and Minneapolis VA Medical Center; Minneapolis, MN

Rudolf A . de Boer, MD, PhD — University of Groningen; The Netherlands

Jennifer E . Ho, MD — National Heart, Lung, and Blood Institute’s Framingham Heart Study; Framingham, MA

Kenneth Stein, MD, FACC — Senior Vice President and Chief Medical Officer, Cardiac Rhythm Management at Boston Scientific; Minneapolis, MN

Sunday, March 25, 5:30 a.m. – 7:30 a.m.Chicago Marriott Magnificent Mile540 North Michigan Avenue

3rd Annual Massachusetts General Hospital Optical Coherence Tomography (OCT) Symposium: A Comprehensive Review of OCT in Today’s Cath Lab EnvironmentSponsored by St. Jude Medical

Moderators:Ik Kyung Jang, MD, PhD, FACC — Professor of Medicine,

Harvard Medical School; Interventional Cardiology, Massachusetts General Hospital; Director, Cardiology Laboratory for Integrative Physiology & Imaging (CLIPI); Boston, MA

Jagat Narula, MD, PhD, FACC — Philip J. and Harriet L. Goodhart Chair in Cardiology, Professor of Medicine, Associate Dean for Global Health, Mount Sinai School of

Medicine; Director, Cardiovascular Imaging Program, Zena and Michael A. Wiener Cardiovascular Institute and Marie-Josée and Henry R. Kravis Center for Cardiovascular Health; New York, NY

Speakers:Marco A . Costa, MD, PhD, FACC, FSCAI — Professor of

Medicine; Director, Interventional Cardiovascular Center, Director, Center for Research and Innovation; Harrington-McLaughlin Heart and Vascular Institute; University Hospitals, Case Western Reserve University; Cleveland, OH

Koji Kato, MD, PhD — Research Fellow, Cardiology Division, Massachusetts General Hospital, Harvard Medical School; Boston, MA

Soo Joong Kim, MD, PhD — Associate Professor of Medicine, Kyung Hee University Hospital; Seoul, Korea; Research Fellow, Cardiology Division, Massachusetts General Hospital, Harvard Medical School; Boston, MA

Francesco Prati, MD — Interventional Cardiology, San Giovanni Hospital, CLI Foundation; Rome, Italy

Abhiram Prasad, MD — Professor of Medicine, Division of Cardiovascular Diseases, Mayo Clinic; Rochester, MN

Taishi Yonetsu, MD — Research Fellow, Cardiology Division, Massachusetts General Hospital, Harvard Medical School; Boston, MA

Sunday, March 25, 6:30 p.m. – 8:15 p.m.Four Seasons Hotel Chicago120 East Delaware Place

Baroreflex Activation Therapy (BAT) for Resistant Hypertension & Heart Failure: A Novel Approach to Cardiovascular TreatmentSponsored by CVRx, Inc.

Chairmen:Eugene Braunwald, MD — Distinguished Hersey Professor,

Harvard Medical School; Founding Chairman, TIMI Study Group, Brigham and Women’s Hospital

Alberto Zanchetti, MD — Scientific Director, Istituto Auxologico of Milan; Emeritus Professor of Internal Medicine, University of Milan

Speakers:Prof . John D . Bisognano, MD — Director of Outpatient

Cardiology, University of Rochester Medical CenterProf . George Bakris, MD — Director, Hypertension Center,

The University of Chicago Hospitals

ACC.12 • Non-Accredited Educational Events

62 GO for ACC.12!

Prof . Hermann Haller, MD — Director, Department of Nephrology at Hannover Medical School in Germany

Prof . Hani N . Sabbah, MD — Professor of Medicine, Wayne State University; Director of Cardiovascular Research, Henry Ford Health System

Prof . Uta Hoppe, MD — Director, Department of Internal Medicine II, Paracelsus University Salzburg, Austria

Prof . William T . Abraham, MD — Director, Division of Cardiovascular Medicine, The Ohio State University

Sunday, March 25, 6:30 p.m. – 9:00 p.m.InterContinental Chicago (Grand Ballroom, 7th Floor)505 North Michigan Avenue

SYMPLICITY HTN-3 Trial: Evaluating Renal Denervation for Resistant HypertensionSponsored by Medtronic, Inc.

Physician Panel: Henry Krum — SYMPLICITY HTN-1 Lead Author Murray Esler — SYMPLICITY HTN-2 Lead Author Suzanne Oparil — SYMPLICITY HTN-3 Steering Committee David Kandzari — SYMPLICITY HTN-3 Steering Committee

Non-Accredited Educational Events • ACC.12


Friday, March 23, 11:00 a.m. – 1:00 p.m.McCormick Place, Room S501

ECMO 2012: New Technologies and New Indications Sponsored by Methodist DeBakey Heart and Vascular Center

11:00 Registration and Lunch11:25 Welcome and Introductions — Wade L . Fischer, MD11:30 ECMO: History, Trials, and Utilization —

Faisal Masud, MD11:50 Use of ECMO in the Acute MI and ARDS Patient —

Wade L . Fischer, MD12:10 ECMO as the Bridge-to-Transplant —

Christian Bermudez, MD12:30 Future Considerations — Matthias Loebe, MD, PhD12:50 Question and Answer1:00 Adjourn

Friday, March 23, Noon – 3:00 p.m.McCormick Place, Room S502

Future Direction of Stem Cells in Cardiovascular DiseaseSponsored by Texas Heart Institute

12:00 Luncheon Buffet12:15 Welcome and Introductions12:20 Stem Cells in Cardiovascular Disease: Where Are

We Today? — James T . Willerson, MD12:40 Peripheral Vascular Disease and Stem Cell Therapy

— Emerson C . Perin, MD, PhD1:00 Cell Therapy of Acute ST Elevation Myocardial

Infarction — Andreas M . Zeiher, MD1:20 Break1:35 Case from Texas Heart Institute —

Emerson C . Perin, MD, PhD1:55 Stem Cell Transplantation for Ischemic

Cardiomyopathy — James T . Willerson, MD2:15 cKit Stem Cell Therapy of Ischemic Cardiomyopathy

— Piero Anversa, MD

2:35 From small-molecules to cardio-regenerative drugsfor heart repair — Jay Schneider, MD, PhD

2:50 Adjourn

Friday, March 23, 8:00 a.m. – 4:30 p.m.McCormick Place, Room N229

28th International Conference on Recent Advances in Echocardiography and Allied TechniquesSponsored by University of Alabama at Birmingham

Case Studies In Echocardiography7:30 Registration, Coffee/Tea7:55 Welcome and Course Orientation —

Dr . Navin Nanda8:00 Session I . Cardiomyopathy, Congenital Heart

Disease, CT/MRI, Intracardiac Echo, LV, Masses, Myocardial Infarction, Percutaneous Devices, Tissue Doppler Imaging, Valvar Heart Disease, Velocity Vector Imaging, 3D Echo, Miscellaneous Case Presentations and Discussion, Cases 1-15

10:00 Refreshment break10:15 Session II . Biventricular Pacing, Cardiomyopathy/

Myocarditis, Coronary Artery Disease, CT/MRI, Echo Quantification, Embolism, LV Diastolic Function, Masses, Post Intervention, Prosthetic Valves, Shunt Lesions, Valvar Heart Disease, 3D Echo . Case Presentations and Discussion, Cases 16-23

11:30 Session III . Aortic Pathologies, Cardiac Dyssynchrony, Congenital Heart Disease, Critical Care, CT/MRI, Masses, Pericarditis, Stress Echo, Valvar Heart Disease, Valve Repair, 3D Echo .

1:00 Lunch on your own2:00 Session IV . Cardiomyopathy/Myocarditis, CT/MRI,

Congenital Heart Disease, Endocarditis, Heart Failure, Post Intervention, Prosthetic Valves, Pulmonary Hypertension, RV Function, Strain and Strain Rate, Valve Repair and Surgery, 3D Echo .

Independent CME/CE-Certified Pre Conference & Evening ProgramsIndependent CME/CE-Certified Pre Conference or Evening Programs are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees.

Titles, times and/or locations are subject to change.

64 GO for ACC.12!

3:30 Session V . Cardiomyopathy/Myocarditis, Coronary Aneurysm, Embolism, Endocarditis, Heart Failure, Masses, Myocardial Infarction, Pericardial Disease, Peripheral Arterial Disease, Prosthetic Valves, RV Volume, Systemic Diseases, Trauma, Valvar Heart Disease, Valve Repair, 3D Echo, Miscellaneous .

4:30 Adjournment

Saturday, March 24, 6:30 p.m. – 8:45 p.m.Chicago Marriott Downtown540 North Michigan Avenue

Clinical Challenges in the Secondary Prevention of CADSponsored by Mayo Clinic

6:00 Registration6:30 Introduction6:45 Great Expectations: How to Meet Quality Indicators

for Secondary Prevention in CAD— Randal J . Thomas, MD

7:10 Early Onset CAD: Tests, Treatments, and Family Screening — Iftikhar J . Kullo, MD

7:35 LDL and Beyond: Challenges in Lipid Management for Secondary CAD Prevention — Thomas G . Allison, PhD

8:00 The Obesity Paradox in CAD: How to Assess and Reduce Obesity-Related CAD Risk — Jorge F . Trejo-Gutierrez, MD

8:25 Panel Discussion8:45 Adjourn

Sunday, March 25, 6:30 p.m. – 9:15 p.m.Chicago Marriott Downtown540 North Michigan Avenue

Hemodynamic Catheterization- HFpEF and BeyondSponsored by Mayo Clinic

6:00 Registration6:30 Heart Failure with Preserved EF - When and Why Do

You Need Invasive Hemodynamic Evaluation — Margaret M . Redfield, MD

6:45 Hemodynamic Evaluation of Dyspnea with Normal Ejection Fraction — Barry A . Borlaug, MD

7:15 Invasive Evaluation of Pulmonary Hypertension: Is it The Left Heart, Vasculature or Both — Robert P . Frantz, MD

7:45 Hemodynamic Assessment Pre and Post TAVR — Charanjit S . Rihal, MD

8:15 Jugular Distention and Edema: Myocardium, Pericardium, or Something Else — Barry A . Borlaug, MD

8:45 Hypertrophic Cardiomyopathy: What Cath Will Tell You That Echo Cannot — Paul Sorajja, MD

9:15 Adjourn

Independent CME/CE-Certified Pre Conference & Evening Programs • ACC.12

Your Roadmapto ACC.12

Your Roadmap to ACC.12

ExpEriEncE

Special attendee pricing expires March 27, 2012. *Savings vary with registration category

A12

199

©20

12 A

mer

ican

Col

lege

of C

ardi

olog

y

Order iScience today at the following locations:

• SouthBuilding,GrandConcourseLobby,Level3

• ACCCentral,Booth#10027,intheExhibitHall

Ororderonlineatwww.CMEonCall.com/accEnteryourbadgenumbertoreceivethe

attendeediscount.

Order iScience, the Acc.12 Meeting on Demand, during the meeting, and save over $1,000*!

iScienceisacomprehensivedigitallibraryofpresentationsfromACC.12andincludesover400hoursofeducationalcontent.ItisthemostconvenientwaytoexperiencealltheeducationfromACC.12andallowsyoutowatchpresenters’slideswhilelisteningtofully-synchronizedaudioasifyouwereactuallyattendingeachsession. Features of iScience include:

• Onlineaccesstocontentwithin24hours

• ConvenientUSBdrivewithaccesstotheentireiSciencelibraryforofflineviewing

• StreamingcontentforviewingoniPad®andiPhone®devices.

• DownloadablePDF’sofpresenterslidesforconvenientreferenceandnotetaking

• DownloadableMP3filesforconvenienton-the-goaudio

• Plus,youcanearnadditionalCMEcreditwithiScience

Your

Roa

dmap

to A

CC.1

2


Planning Tools: Your most important e-navigation tools!NEW! ACC.12 eMeeting Planner App

• Getinstantaccesstoinformationaboutsessions,abstracts,exhibitors,maps,theACC.12twitterfeed,andmore

• DownloadeBooksoftheFinal Program, Program-At-A-Glance andtheJACC Abstract Supplement

• Readthedailynewspaper—CardioSourceNews from ACC.12

SearchACC.12inyourappmarketplaceorbrowsetohttp://ativ.me/acc todownloadtheapponyourmobiledevice(availableforApple®,Android®andKindleFire®devices).

Apple Android

Web-Based Program PlannerGotowww.accscientificsession.org,andselect“PlanYourACC.12”tosearchforsessionsandbuildapersonalizeditinerary.

NEW! ACC.12 OnlineLivewebcastsof60sessionsand18ondemandwebcasts(LegendsandCoreCurriculumsessions)fromanywhereinChicago—availabletoattendeesforfreeduringthemeeting.

LookfortheACC.12OnlineiconintheProgram-At-A-Glance(page72).Gotohttp://acc12online.cardiosource.organdloginwithyoure-mailandpasscode:ACCONLINE.

Connect with Your ColleaguesACC.12 CommunityGotowww.accscientificsession.org/CommunityACC12tojoinindiscussionswithyourcolleaguesandfellowattendees.

Twitter at @ACC_2012Followusforthelatestnews,plus,searchforandusethehashtag#ACC12foreverythingACC.12.

ACC in Touch BlogAtblog.cardiosource.orgforcoverageofthemeetingfromACCleaders

ACC.12 Heart HubsStopbyNorth, Hall B, orSouth, West Transportation Lobby andrelaxwithrefreshmentsinaloungesettingwhilesessionsfromACC.12cometoyouonplasmascreens.

ACC.12 Session Highlights: Science in the Morning; Practical Clinical Application in the Afternoon!ACC.12 Opening Showcase and Late-Breakers

• Saturday,March24,8:00a.m.–10:00a.m.,HallB,ACC.12MainTent.

Legends of Cardiovascular Medicine Lecture SeriesFriday, March 23• Legends of Cardiovascular Medicine — Roundtable

Forum and Reception (ByInvitationOnly)1:30p.m.–5:30p.m.,RoomS100c

Saturday, March 24• 2012 Simon Dack Lecture (duringtheACC.12Opening

Showcase):EugeneBraunwald,MD,MACC—8:00a.m.–10:00a.m.,HallB,ACC.12MainTent

Your Road Map to ACC.12How to navigate and stay connected!

66 GO for ACC.12!

• 43rd Annual Bishop Lecture:MagdiH.Yacoub,MB,BCh,FACC—2:00p.m.–3:00p.m.,RoomN426

Sunday, March 25• 2012 Dan G. McNamara Lecture: JaneSomerville,MD,

FACC—2:00p.m.–3:30p.m.,RoomN228

• James T. Dove Lecture: ValentinFuster,MD,PhD,MACC—4:30p.m.–5:30p.m.,RoomN427

Monday, March 26• 2012 Maseri-Florio International Lecture:

AntonioColombo,MD,FACC—2:00p.m.–3:00p.m.,RoomN231

ACC.12 Closing Session: Innovators in CardiologyFeaturingRobertM.Califf,MD,MACC,KennethChien,MD,PhD,MartinB.Leon,MD,FACC,MichaelJ.Mack,MD,FACCandA.JamilTajik,MD,FACC—Tuesday,March27,9:45a.m.–11:45a.m.,HallB,ACC.12MainTent

Late-Breaking Clinical Trial Sessions—HallB,ACC.12MainTent

Saturday, March 24• ACC.12OpeningShowcaseandLate-Breakers—

8:00a.m.–10:00a.m.

Sunday, March 25 • Late-BreakingClinicalTrialsII—8:00a.m.–9:30a.m.

Monday, March 26• NEW!JointAmericanCollegeofCardiology/New England

Journal of MedicineLate-BreakingClinicalTrials—8:00a.m.–9:30a.m.

• Late-BreakingClinicalTrialsIV—10:30a.m.–Noon

Tuesday, March 27• NEW!JointAmericanCollegeofCardiology/Journal of

the American Medical AssociationLate-BreakingClinicalTrials—8:00a.m.–9:30a.m.

Maintenance of CertificationGetalltheMOCpointsyouneedwithLifelongLearningSessions!

• AttendABIM MOC sessionsworth10ABIMMOCpointsandABPMOCsessionworth10ABPMOCpoints—visittheMOCLoungeinRoomS104btolearnmoreandsign-up.Refertothefulllistingonpage96.

•Cardiology Core Curriculumsessionsofferareviewofeverymajorareaofcardiology.Takeanonlinepost-test,andreceive10ABIMPart2MOCcredits.Refertothefulllistingonpage96.

Joint Society Partner Sessions• CardiovascularResearchFoundation(CRF):TheACC-i2

withTCTpathwayhasbeenplannedanddevelopedincollaborationwithCRF—refertothefulllistingonpage87

• AmericanAssociationforClinicalChemistry—HowtoUseCardiacBiomarkers:Tuesday,March27,8:00a.m.–9:30a.m.,RoomN230

• AmericanAssociationofThoracicSurgeonsandSocietyforThoracicSurgeons—MultidisciplinaryApproachtotheHigh-riskAorticStenosisPatient—Monday,March26,5:45p.m.–9:05p.m.,RoomS401a

• AmericanSocietyofEchocardiography:Afull-dayofsessionsonSunday,March25inRoomS406a—refertothefulllistingonpage94

• AssociationofBlackCardiologists:EthnicandRacialDisparitiesinCardiovascularDisease—ACalltoAction—Sunday,March25,2:00p.m.–3:30p.m.,RoomN230

• HealthcareInformationManagementSystemsSociety(HIMMS):Atwo-partsessiononSunday,March25inRoomN227b—refertothefulllistingonpage98

• HeartFailureSocietyofAmerica:Afull-dayofsessionsonSunday,March25inRoomS406b—refertothefulllistingonpage94

• HeartRhythmSociety:Afull-dayofprogrammingonSunday,March25—refertothefulllistingonpage91

Road Map • ACC.12


• InternationalSocietyforCardiovascularTranslationalResearch(ISCTR):TranslationalResearchSymposium—Afull-dayofprogrammingonSaturday,March24inRoomN228

• PreventiveCardiovascularNursesAssociation—Monday,March26,10:30a.m.–Noon,RoomS105

• SocietyforVascularSurgery—AdvancesandControversiesinCarotid,AorticandPeripheralArterialDisease—Saturday,March24,4:30p.m.–6:00p.m.,RoomS103c

ACC.12 International SessionsFriday, March 23

• 4thAnnualInternationalCardiovascularConference:FocusontheMiddleEast—8:00a.m.–Noon,RoomS101a

Monday, March 26 • CardiovascularClinicalResearchandPracticeinChina

—8:00a.m.–9:30a.m.,RoomN229

• JointSessionwiththeEuropeanSocietyofCardiology—ManagementofHeartDiseaseinPregnancy—8:00a.m.–9:30a.m.,RoomN426

• 18internationallunchtimesymposia,jointlysponsoredwithcardiologysocietiesfromacrosstheglobe—Monday,March26from12:15p.m.–1:45p.m.—refertothefulllistingonpage83

• JointSymposiumoftheItalianFederationofCardiologyandthePennsylvaniaChapteroftheAmericanCollegeofCardiology:UpdateontheTreatmentofAtrialFibrillation—2:00p.m.–3:30p.m.,RoomN230

• JointSymposiumoftheBritishCardiovascularSocietyandtheCaliforniaChapteroftheAmericanCollegeofCardiology—3:45p.m.–5:15p.m.,RoomN230

•MediterraneanDietandItsProtectiveEffectonCardiovascularDisease—3:45p.m.–5:15p.m.,RoomS405

Tuesday, March 27• JointSessionwiththeEuropeanSocietyofCardiology

—ProsandConsofNewApproachesforAntiplateletandAnticoagulantTherapy—8:00a.m.–9:30a.m.,RoomN426

ACC-i2 with TCT Live CasesHallB,ACC.12MainTent

• LiveandTapedCaseSessionI:MultivesselPCI—PhysiologyandImaging—Saturday,March24,2:00p.m.–5:00p.m.

• LiveandTapedCaseSessionII:LeftMainandBifurcation—ComplexPCI—Sunday,March25,2:00p.m.–5:00p.m.

• LiveandTapedCaseSessionIII:ValvularHeartDisease—Monday,March26,12:30p.m.–2:30p.m.

Heart Songs Learning Lab Listentoheartsoundsonyourmobiledevicetoimproveyourcardiacauscultationskills—VistaRoomLobby,Saturday,March24–Monday,March26,9:00a.m.–5:00p.m.

ACC.12 Specialty SessionsEducating the EducatorsAbootcampforCardiologyFellowshipProgramDirectorsandCoordinators—Saturday,March24,RoomS405a—refertothefulllistingonpage100.

Pharmacology ProgramAfull-dayofprogramming—Saturday,March24,RoomN427

Master Clinician SessionsDiscusscomplexreal-worldcases—Sunday,March25,RoomS401a—refertothefulllistingonpage96

Congenital Cardiology SolutionsSessionsspanningallfourdaysfocusedonpatientcareacrossthecontinuumofCHD—includingcutting-edgelivecases—refertothefulllistingonpage92

The FIT ForumSessionsspanningthreedaysandpackedwithtipsonlaunchingandmaintainingasuccessfulcareer,plus,aspecialMix‘n’MinglejustforFITswithtopACCleaders—refertothefulllistingonpage100

ACC.12 •Road Map

68 GO for ACC.12!

ACC-i2 with TCT Fellows BootcampAfull-dayofprogrammingfocusingoninterventionaltreatmentofcoronaryandstructuralheartdisease—Monday,March26,RoomS103b—refertothefulllistingonpage88

Clinical Focus SessionsCertifiedeveningsessionsheldattheFairmontHotel(unlessotherwiseindicated)willaddressadditionalgapsinknowledge—limitedseatingavailable.

Saturday, March 24, 6:30 p.m. – 9:30 p.m.• FirstLineofDefense:RiskFactors&Preventioninthe

CardiologyPractice

• ChampioningCareforPatientswithAorticStenosis:TheRoleofCardiologistsandPrimaryCarefromRecognitiontoRecovery

Sunday, March 25, 6:30 p.m. – 9:30 p.m.• InnovationsinTranslation:AtrialFibrillation

• InnovationsinTranslation:ACS

Monday, March 26, 5:45 p.m. – 9:05 p.m.•MultidisciplinaryApproachtotheHighRiskAortic

StenosisPatient—ConventionCenter,RoomS401a

Networking OpportunitiesFriday, March 23

• CVTSectionMeeting:6:30p.m.,HiltonChicago,WaldorfRoom

• Sports&ExerciseCardiologySectionMeeting:7:00p.m.,HiltonChicago,MarquetteRoom

• CVTSectionReception:8:00p.m.,HiltonChicago,WillifordC

Saturday, March 24• PracticeAdministratorsWorkGroupMeeting:7:00a.m.,

HyattMcCormickPlace,FieldRoomA

• GeriatricCardiologySectionMeeting:6:00p.m.,HiltonChicago,MarquetteRoom

• ACPCSectionMeeting:6:30p.m.,HiltonChicago,ContinentalA/B

• GeriatricCardiologyReception:7:00p.m.,HiltonChicagoJoliet

Sunday, March 25•WICSectionMeeting:6:00p.m.,HiltonChicago,

WillifordA

• ImagingSectionMeeting:6:00p.m.,HyattMcCormickPlace,CC24A/B/C

• InterventionalSectionMeeting:6:00p.m.,HyattMcCormickPlace,CC23

• AcademicSectionMeeting:6:00p.m.,HyattMcCormickPlace,RegencyA

•WICReception:7:00p.m.,HiltonChicagoAstoria

Monday, March 26• EarlyCareerSectionMeeting:6:30a.m.,

HyattMcCormickPlace,CC12A/B

• 61stAnnualConvocation:6:30p.m.,HallB,ACC.12MainTentRoom

• ACC.12President’s,AllChapter,NewFellows’andAssociates’Reception:ImmediatelyfollowingConvocation

Road Map • ACC.12


ACC.12 Expo and Learning Destinations™Gainanunderstandingofthelatestadvancesinpharmaceuticals,imaging,devices,technologiesandtheservicesthatyouneedtohelpyouprovidehigh-qualitypatientcare.Learnmoreonpage52.

ExpanduponyoureducationinnewandcreativewaysintheACC.12LearningDestinations—diverse,non-accredited,educationallyfocusedareasthatoffernewandcreativevenuesforlearning.Learnmoreonpage57.

iScience, ACC.12 Meeting on DemandCan’tmakeittoallthesessionsyouwanttoattend?PurchaseiScience,acomprehensivedigitallibraryofpresentationsfromACC.12StopbyGrandConcourseLobby,Level3orACCCentral,Booth#10027,andsave$1,000ormore!

ACC.12 •Road Map

70 GO for ACC.12!

8 a.m. 9 a.m. 10 a.m. 11 a.m. 12 p.m. 1 p.m. 2 p.m.

SaturdayMarch 24

Sunday March 25

MondayMarch 26

TuesdayMarch 27

ACC.12 Opening Showcase & Late-Breakers

Scienti� c SessionsOral Abstracts

LunchtimeSessions

Maintenance of Certi� cation (MOC) Study Sessions

Expo Coffee Break Expo Mid-Day Break

Scienti� c Sessions


LunchtimeSessions


Expo Coffee BreakExpo Mid-Day

Break




Expo Open

Expo Coffee Break

Expo Mid-Day BreakLunch Hospitality Event

Poster Sessions



Joint InternationalLunchtime Sessions


ACC.12 Closing Session: Innovators in Cardiology

Expo Open

Poster Sessions

Poster Presentations



Expo Open

Poster Sessions







ACC.12

Schedule-At-A-GlanceAs of 1/3/2012— subject to changeAttendees will be arriving on Friday, March 23, to attend ACC.12, which opens on Saturday, March 24, at 8 a.m.


3 p.m. 4 p.m. 5 p.m. 6 p.m. 7 p.m. 8 p.m. 9 p.m. 10 p.m.



Expo Coffee Break



Expo Coffee Break



Convocation Reception

ACC Clinical Focus Session



72 GO for ACC.12!

Friday, March 23, 2012PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE

Morning SessionsLIFELONG MOC 801 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—

ACCSelfAssessmentSession:UpdateinClinicallyRelevantGuidelinesandTrials7:30a.m. 10:00a.m. S105a 105

SPECIAL Symposium 746 4thAnnualCardiovascularConference:FocusontheMiddleEast 8:00a.m. Noon S101a 105

Mid-day SessionsSPECIAL Legends 400 LegendsofCardiovascularMedicine—RoundtableForumandReception(ByInvitationOnly) 1:30p.m. 5:30p.m. S100c 106

Saturday, March 24, 2012PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE

8:00 a.m. – 9:30 a.m. (exceptions noted in bold)

ACC-i2/TCT Symposium 2644 InterventionalFeaturedClinicalStudiesI 8:00a.m. 9:30a.m. S102b 107

ACS Experts 200 ContemporaryManagementofUA/NSTEMI 8:00a.m. 9:30a.m. S504a 107

ACS Oral 902 P2Y12Antagonists:UnravelingtheMechanismsandOptimizingBenefit-Risk 8:00a.m. 9:30a.m. S406b 107

ACS Oral 903 NewTherapeuticOptionsinACS:FromAntiplateletstoAntibiotics 8:00a.m. 9:30a.m. S402 108

ARR Experts 201 HowtoManageaDevice/LeadAdvisory 8:00a.m. 9:30a.m. S503 108

CCS Symposium 202 ComplexIssuesFacingACHDPatients:ObstructiveLesions 8:00a.m. 9:30a.m. S105a 108

CCS MOC 802 ACCFStudySessionforMaintenanceofCertification:AmericanBoardofPediatrics(ABP)RecertificationMadeEasy—2011PediatricCardiologySubspecialtySelf-Assessment

8:00a.m. 10:00 a.m. S105d 109

HF Experts 203 TheLatestinHeartFailurewithPreservedEjectionFraction 8:00a.m. 9:30a.m. S502 109

HF Symposium 732 PharmacologyProgram:PharmacotherapyofChronicHeartFailure 8:00a.m. 9:30a.m. N427 109

HF Oral 905 PredictingOutcomesinHeartFailure:BiomarkersandBeyond 8:00a.m. 9:30a.m. S405 109

HF Oral 906 PathogenicandTherapeuticInsightsfromExperimentalHeartFailureModels 8:00a.m. 9:30a.m. S404 109

IMAG Experts 204 MultimodalityImaginginEvaluationofProstheticValveFunction 8:00a.m. 9:30a.m. S505 110

IMAG Oral 908 ABetterUnderstandingofIschemiaandFunction:InsightsfromCardiacMRI 8:00a.m. 9:30a.m. S403 110

IMAG Oral 909 NewImagingApproachestoAtherosclerosisandtheMicrocirculation 8:00a.m. 9:30a.m. N426 110

ISCHEM Oral 910 Sex,Scoring,Sadness,Statins,StentsandSurgery 8:00a.m. 9:30a.m. N227b 111

LIFELONG MOC 802 ACCFStudySessionforMaintenanceofCertification:AmericanBoardofPediatrics(ABP)RecertificationMadeEasy—2011PediatricCardiologySubspecialtySelf-Assessment

8:00a.m. 10:00 a.m. S105d 111

PRACTICE Symposium 600 CardiologyProcedures2012:HowtoCodeandGetReimbursed 8:00a.m. 9:30a.m. N231 112

QUAL Experts 205 AmIPlacingInappropriateICDsandStents?:RecentRegistrySurprises 8:00a.m. 9:30a.m. S501a 112

QUAL Symposium 601 Patient-CenteredCare:TheNewImperative 8:00a.m. 9:30a.m. N226 112

SPECIAL Special 300 ACC.12OpeningShowcaseandLate-BreakingClinicalTrials:Featuringthe LegendsofCardiovascularMedicineLectureSeries—SimonDackLecture

8:00a.m. 10:00 a.m. Hall B, ACC.12 Main Tent

112

TEST Symposium 602 TranslationalResearchSymposiumwiththeInternationalSocietyfor CardiovascularTranslationalResearch:NewBreakthroughsinCardiovascularGenomics—ApproachingtheClinic

8:00a.m. 9:30a.m. N228 113

TEST Symposium 603 ChallengingSportsCardiologyCasesinYoungerAthletes 8:00a.m. 9:30a.m. N230 113

ACC.12 •Program-At-A-Glance

Daily Schedule Friday, March 23 & Saturday, March 24, 2012

Sessionsarelistedalphabeticallybylearningpathwaybasedontimeblock.

iScienceiconindicatessessionsareincludedaspartofiScience2012:ACC.12MeetingonDemand

TheACC.12Onlineiconindicatessessionsareavailableasliveoron-demandwebcasts.

Pleaserefertopage65foradditionalinformationonaccessingthesefreesessions.


PATHWAY SESSION TYPE SESS. # TITLE START END ROOM PAGE

8:00 a.m. – 9:30 a.m. (continued — exceptions noted in bold)

VALV Self-Directed

1501 HeartSongsatACC.12:ASelf-PacedMultimediaLearningExperience 9:00 a.m. 5:00 p.m. Vista Room Lobby

113

VASC Oral 931 NewInsightsinPeripheralVascularDisease 8:00a.m. 9:30a.m. N229 113


ACC-i2/TCT Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.

9:30a.m. 10:30a.m. Hall A

IMAG Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.

9:30a.m. 10:30a.m. Hall A

VASC Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.

9:30a.m. 10:30a.m. Hall A

10:30 a.m. – Noon (exceptions noted in bold)

ACC-i2/TCT Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.

11:00 a.m. Noon Hall A

CCS Oral 901 FromTargetingErrorstoUNOS:HowQualityandDatabasesCanImpactClinicalCare 10:30a.m. Noon S105a 114

IMAG Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.


PREV Symposium 733 PharmacologyProgram:CardiovascularImplicationsofDietarySupplements 10:30a.m. Noon N427 114

VASC Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.


12:15 p.m. – 1:45 p.m (exceptions noted in bold)

ACC-i2/TCT Experts 2301 AtypicalThromboticACSCaseReviews 12:15p.m. 1:45p.m. S101a 114

ACC-i2/TCT Experts 2302 ChronicTotalOcclusionsandLeftMainCaseReviews 12:15p.m. 1:45p.m. S102b 114

ACC-i2/TCT Experts 2303 CoronaryImagingCaseReviews 12:15p.m. 1:45p.m. S103b 115

ACC-i2/TCT Symposium 2606 TAVR:ProceduralAspectsandBestPractices 12:15p.m. 1:45p.m. S102b 115

ACC-i2/TCT Symposium 2607 AcuteVenousThromboembolicDisease 12:15p.m. 1:45p.m. S103c 115

ACS Symposium 604 ControversiesinACS 12:15p.m. 1:45p.m. S404 115

ARR Experts 206 AlternativestoWarfarinforthePreventionofStrokeinAtrialFibrillation: HowtoDecide?

12:15p.m. 1:45p.m. S503 116

HF Experts 207 AtrialFibrillationandHeartFailure:ADynamicDuo 12:15p.m. 1:45p.m. S502 116

IMAG Experts 208 ImagingPatientswithPericardialDisease 12:15p.m. 1:45p.m. S505 116

IMAG Symposium 605 CardiovascularMagneticResonanceinMyocarditis 12:15p.m. 1:45p.m. S402 116

ISCHEM Symposium 606 RevascularizationinSIHD:IntegratingNewEvidence 12:15p.m. 1:45p.m. S401a 116

ISCHEM Symposium 734 PharmacologyProgram:PharmacologicConsiderationsintheSettingofPCI 12:15p.m. 1:45p.m. N427 116

LIFELONG Symposium 607 EverythingYouWantedtoKnowaboutABIMRecertification(andmore...) 12:15p.m. 1:45p.m. N226 116

LIFELONG MOC 803 ACCFStudySessionsforMaintenanceofCertification:ABIMRecertificationMadeEasy—CardiovascularDisease2010Update(A1-K)

12:30 p.m. 3:00 p.m. S105a 118

LIFELONG MOC 804 ACCFStudySessionsforMaintenanceofCertification:ABIMRecertificationMadeEasy—CardiovascularDisease2011Update(A1-L)

12:30 p.m. 3:00 p.m. S105d 118

PRACTICE Symposium 608 WomeninCardiology 12:15p.m. 1:45p.m. N229 116

PRACTICE Symposium 609 TheChallengesinDailyPractice 12:15p.m. 1:45p.m. N230 117

PREV Symposium 611 IsThereaRoleforHDLTherapy:AreWeAIMingTooHIGH? 12:15p.m. 1:45p.m. S100c 117

QUAL Experts 209 GettingAccesstoData:SuccessfulExamplesfromtheNCDR 12:15p.m. 1:45p.m. S501a 117

QUAL Symposium 610 TranslationalResearchSymposiumwiththeInternationalSocietyfor CardiovascularTranslationalResearch:MissionandStrategyinTranslationalResearch

12:15p.m. 1:45p.m. N228 117

SPECIAL Special 103 EducatingtheEducators:BootcampforCardiologyFellowshipProgram DirectorsandCoordinators

12:15p.m. 1:45p.m. S405a 117

SPECIAL Special 104 FitForumI:FindingtheRightF.I.T.inDevelopingaCareerPlan Part1:FindingtheRightJob

12:15p.m. 1:45p.m. N227b 117

ACC.12 • Daily Schedule • Saturday, March 24, 2012

74 GO for ACC.12!


12:15 p.m. – 1:45 p.m (continued — exceptions noted in bold)

VALV Experts 210 Organic Mitral Regurgitation Case-Management 12:15 p.m. 1:45 p.m. S504a 118

VALV Symposium 612 The Spectrum of Degenerative Mitral Valve: From Imaging to Treatment 12:15 p.m. 1:45 p.m. N426 118

2:00 p.m. – 3:30 p.m. (exceptions noted in bold)

ACC-i2/TCT Live/Taped Cases

2201 Live and Taped Case Session I: Multivessel PCI — Physiology and Imaging 2:00 p.m. 5:00 p.m. Hall B, ACC.12 Main Tent

119

ACC-i2/TCT Oral 2502 Acute Myocardial Infarction 2:00 p.m. 3:30 p.m. S103b 119

ACC-i2/TCT Symposium 2608 Intravascular Imaging: Restenosis, Thrombosis and Stent Follow-up I: Restenosis and Early Thrombosis

2:00 p.m. 3:30 p.m. S101a 119

ACC-i2/TCT Symposium 2609 Hemodynamics and Angiography I: Basic Issues 2:00 p.m. 3:30 p.m. S102b 120

ACC-i2/TCT Symposium 2610 Renal Interventions for Hypertension and Renal Function Preservation 2:00 p.m. 3:30 p.m. S103c 120

ACC-i2/TCT Symposium 2645 Interventional Featured Clinical Studies II 2:00 p.m. 3:30 p.m. S102c 120

ACS Experts 211 Optimal STEMI Management from Presentation to Post-Discharge Care 2:00 p.m. 3:30 p.m. S504a 121

ACS Symposium 613 State-of-the-Art in STEMI Care 2:00 p.m. 3:30 p.m. S404 121

ACS Symposium 618 Translational Research Symposium with the International Society for Cardiovascular Translational Research: Cellular Therapies

2:00 p.m. 3:30 p.m. N228 121

ARR Experts 212 Management of Difficult AF: When to Change Drugs, When to Give Up 2:00 p.m. 3:30 p.m. S503 121

ARR Symposium 614 Can Remote Disease Management Improve Clinical Outcomes? 2:00 p.m. 3:30 p.m. S406a 121

ARR Symposium 615 Challenges in the Management of Supraventricular Tachycardia 2:00 p.m. 3:30 p.m. S403 121

ARR Symposium 735 Pharmacology Program: Pharmacotherapy of New Antithrombotics 2:00 p.m. 3:30 p.m. N427 122

CCS Symposium 616 Quality, Safety and Resources Enhancing Pediatric Cardiovascular Care 2:00 p.m. 3:30 p.m. N231 122

HF Experts 213 From Shock to Recovery or Bridge to Transplanation: Role of Percutaneous VADs and Other Support Devices

2:00 p.m. 3:30 p.m. S502 122

HF Symposium 617 Cardiorenal Syndrome in Heart Failure: From Definition to Management 2:00 p.m. 3:30 p.m. S406b 122

IMAG Experts 214 Current Topics in Cardiac CT 2:00 p.m. 3:30 p.m. S505 122

IMAG Symposium 619 Multimodality Imaging of Hypertrophic Cardiomyopathy 2:00 p.m. 3:30 p.m. S402 122

ISCHEM Symposium 620 Stable Ischemic Heart Disease in Women: Are They Really from Venus? 2:00 p.m. 3:30 p.m. S401a 123

LIFELONG Core 805 Core Curriculum: Congenital Heart Disease 2:00 p.m. 3:30 p.m. N226 123

LIFELONG Core 806 Core Curriculum: Congestive Heart Failure 2:00 p.m. 3:30 p.m. N229 123

PRACTICE Symposium 621 ACC/MedAxiom/ACCA: Physician/Hospital Integration 101 2:00 p.m. 3:30 p.m. N230 123

PREV Symposium 622 Emerging Trends in Atherosclerosis 2:00 p.m. 3:30 p.m. S100c 123

QUAL Experts 215 When Should a Medicine or Device Stop Being Used in Practice? 2:00 p.m. 3:30 p.m. S501a 123

SPECIAL Special 106 Educating the Educators: Faculty Development for Cardiology Fellowship Program Directors and Coordinators

2:00 p.m. 3:30 p.m. S405a 123

SPECIAL Special 107 FIT Forum I: Finding the Right F.I.T. in Developing a Career Plan Part 2 — Launching a Successful Career

2:00 p.m. 3:15 p.m. N227b 124

SPECIAL Legends 401 Legends of Cardiovascular Medicine Lecture Series — 43rd Annual Louis F. Bishop Lecture

2:00 p.m. 3:00 p.m. N426 124


LIFELONG MOC 807 ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy — Cardiovascular Disease 2011 Update (A1-L)

3:30 p.m. 6:00 p.m. S105a 124

LIFELONG MOC 808 ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy — Cardiovascular Disease 2010 Update (A1-K)

3:30 p.m. 6:00 p.m. S105d 124

SPECIAL Special 107A FIT Forum I: Mix ‘n’ Mingle 3:30 p.m. 4:30 p.m. Hall A, Bistro ACC

125

Saturday, March 24, 2012 • Daily Schedule • ACC.12




ACC-i2/TCT Experts 2305 VascularAccessChallengesandComplicationsCaseReviews 4:30p.m. 6:00p.m. S102c 125

ACC-i2/TCT Experts 2306 UnusualCasesofACSCaseReviews 4:30p.m. 6:00p.m. S103b 125

ACC-i2/TCT Symposium 2611 IntravascularImaging:Restenosis,ThrombosisandStentFollow-upII: VeryLateStentThrombosisandLateCatch-up

4:30p.m. 6:00p.m. S101a 125

ACC-i2/TCT Symposium 2612 HemodynamicsII(HOCM) 4:30p.m. 6:00p.m. S102b 125

ACC-i2/TCT Symposium 2613 AdvancesandControversiesinCarotid,AorticandPeripheralArterialDisease: InCollaborationwiththeSocietyofVascularSurgery

4:30p.m. 6:00p.m. S103c 126

ACS Symposium 623 AdjunctivePharmacologyinACS:AnticoagulantsandAntiplateletAgents 4:30p.m. 6:00p.m. S404 126

ARR Experts 216 TheRiskversusBenefitofDFTTesting 4:30p.m. 6:00p.m. S503 126

ARR Symposium 624 ManagementofComplicationsofPacemakersandLeads 4:30p.m. 6:00p.m. S403 126

ARR Symposium 627 TranslationalResearchSymposiumwiththeInternationalSocietyfor CardiovascularTranslationalResearch:TissueEngineering

4:30p.m. 5:30 p.m. N228 127

ARR Symposium 736 PharmacologyProgram:PharmacologicConsiderationswith AntiarrhythmicDrugs,andDyslipidemiaandResidualRisk:WhenandHowDoYouAddtoStatinTherapy?

4:00 p.m. 6:00p.m. N427 125

CCS Symposium 625 UpdatesonCareintheCongenitalHeartDiseasePatients 4:30p.m. 6:00p.m. N231 127

HF Experts 217 HeartFailureDiseaseManagement:Issuesfor2012 4:30p.m. 6:00p.m. S502 127

HF Symposium 626 ManagementofAcuteDecompensatedHeartFailure:FromHemodynamic SubsetstoAppropriateTreatmentStrategies

4:30p.m. 6:00p.m. S406b 127

IMAG Experts 218 MyocardialPerfusionImaging:PickingtheRightTest 4:30p.m. 6:00p.m. S505 127

IMAG Symposium 628 Multi-ModalityImaging:ChestPainintheEmergencyDepartment 4:30p.m. 6:00p.m. S402 127

ISCHEM Symposium 629 StableIschemicHeartDisease:What’sNewintheGuidelines(AndWhatShouldBe)? 4:30p.m. 6:00p.m. S401a 128

LIFELONG Core 809 CoreCurriculum:Echocardiography 4:30p.m. 6:00p.m. N226 128

LIFELONG Core 810 CoreCurriculum:CardiacElectrophysiology 4:30p.m. 6:00p.m. N229 128

PRACTICE Symposium 630 InformationTechnology,MedicineandtheFuture 4:30p.m. 6:00p.m. N230 128

PREV Symposium 631 HypertensionGuidelines2012 4:30p.m. 6:00p.m. S100c 128

QUAL Experts 219 MeasuringandOptimizingQualityinyourOutpatientPractice: ThePINNACLERegistry

4:30p.m. 6:00p.m. S501a 128

SPECIAL Special 109 EducatingtheEducators:SymposiumforCardiologyFellowshipProgram DirectorsandCoordinators

4:30p.m. 6:30 p.m. S405a 128

SPECIAL Special 110 FITForumII:Jeopardy 4:30p.m. 6:00p.m. N227b 129

VALV Experts 220 IschemicMitralRegurgitation 4:30p.m. 6:00p.m. S504a 129

VALV Symposium 632 ValveRepair:HowtoAchieveSuccess 4:30p.m. 6:00p.m. N426 129

VALV Symposium 633 TranslationalResearchSymposiumwiththeInternationalSocietyfor CardiovascularTranslationalResearch:Devices

5:30 p.m. 6:50 p.m. N228 129

VASC Symposium 743 CarotidArteryDisease:IsthePictureClarifying? 4:30p.m. 6:00p.m. S406a 129


ARR Symposium 1601 CriticalLinksinAtrialFibrillation:PrioritiesinRiskAssessment,TreatmentandPatientEducation

6:30p.m. 9:00 p.m. Fairmont Hotel, International

Ballroom

129

PREV Clinical Focus

1602 FirstLineofDefense:RiskFactorsandPreventionintheCardiologyPractice—AMasterClassfortheCommunityCardiologist

6:30p.m. 9:30p.m. Fairmont Hotel, Gold Room

130

VALV Clinical Focus

1604 ChampioningCareforthePatientwithAorticStenosis:TheRoleofCardiologistsandPrimaryCarefromRecognitiontoRecovery

6:30p.m. 9:30p.m. Fairmont Hotel, Imperial Ballroom

130

ACC.12 • Daily Schedule • Saturday, March 24, 2012

76 GO for ACC.12!



ACC-i2/TCT Oral 2500 OutcomesinPatientsTreatedwithTAVR 8:00a.m. 9:30a.m. N227b 137

ACC-i2/TCT Oral 2501 AdjunctPharmacology 8:00a.m. 9:30a.m. S101a 137

ACC-i2/TCT Oral 2504 PCIinComplexLesions 8:00a.m. 9:30a.m. S103c 138

ACC-i2/TCT Oral 2505 PCIinComplexPatients 8:00a.m. 9:30a.m. S102c 138

ACC-i2/TCT Oral 2508 IntravascularDiagnostics 8:00a.m. 9:30a.m. S106b 139

ACC-i2/TCT Oral 2510 VascularAccess 8:00a.m. 9:30a.m. S103b 139

ACC-i2/TCT Symposium 2614 AbnormalitiesoftheAtrium 8:00a.m. 9:30a.m. S102b 140

ACS Experts 221 ComplicationsofAMI 8:00a.m. 9:30a.m. S504a 140

ACS Oral 916 WhatImpactsOutcomesinACS?FromGenestoPlaqueMorphologytoEnvironment 8:00a.m. 9:30a.m. S401a 140

ARR Experts 222 JointSymposiumoftheHeartRhythmSocietyandtheAmericanCollege ofCardiology:GeneticSyndromesfortheClinician(HCM,Brugada,LongQT)

8:00a.m. 9:30a.m. S503 141

ARR Oral 904 JointOralArrhythmiasSessionoftheHeartRhythmSocietyandtheAmericanCollegeofCardiology:ManagementofthePatientwithAtrialFibrillation—AnticoagulationandPreventionofStroke

8:00a.m. 9:30a.m. N426 141

CCS Symposium 634 PreoperativeAssessmentofPatientsontheSingleVentriclePathway: SpecialProblemsCreativeSolutions

8:00a.m. 9:30a.m. N231 141

HF Symposium 635 JointSymposiumoftheHeartFailureSocietyofAmericaandtheAmerican CollegeofCardiology:ContemporaryPharmacologicalTreatmentofSystolicandDiastolicHeartFailure

8:00a.m. 9:30a.m. S406b 141

IMAG Experts 223 CardiacPET:IncorporationintoDailyPractice 8:00a.m. 9:30a.m. S505 142

IMAG Oral 907 JointOralSessionoftheAmericanSocietyofEchocardiographyandtheAmericanCollegeofCardiology:NewestApplicationsofEchotoClinicalPractice

8:00a.m. 9:30a.m. S406a 142

LIFELONG Symposium 731 CCATeam-BasedMaintenanceofCertification 8:00a.m. 10:30 a.m. S105d 142

PHTN Oral 912 What’sNewinPulmonaryHypertension 8:00a.m. 9:30a.m. N226 142

PREV Oral 911 Prevention:FocusonLipids 8:00a.m. 9:30a.m. S100c 142

QUAL Experts 224 ToolstoImproveCareTransition:TheHospitaltoHome(H2H)Experience 8:00a.m. 9:30a.m. S501a 143

QUAL Oral 913 InsightsandInnovationstoImproveCardiacRisk 8:00a.m. 9:30a.m. N229 143

SPECIAL Special 304 Late-BreakingClinicalTrialsII 8:00a.m. 9:30a.m. Hall B, ACC.12 Main Tent

143

SPECIAL Special 405 YoungInvestigatorsAwardCompetition:ACCF/HermanK.GoldYoungInvestigatorsAwardinMolecularandCellularCardiology

8:00a.m. 9:30a.m. S105a 144

TEST Oral 914 DiagnosticTesting:SportsCardiology 8:00a.m. 9:30a.m. S402 144

VALV Oral 915 ValvularOralAbstracts 8:00a.m. 9:30a.m. N427 145

VALV Self-Directed

1502 HeartSongsatACC.12:ASelf-PacedMultimediaLearningExperience 9:00 a.m. 5:00 p.m. Vista Room Lobby

145


ACS Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.

9:30a.m. 10:30a.m. Hall A

CCS Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.

9:30a.m. 10:30a.m. Hall A

PERI Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.

9:30a.m. 10:30a.m. Hall A

PHTN Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.

9:30a.m. 10:30a.m. Hall A


Daily Schedule Sunday, March 25, 2012







9:30 a.m. – 10:30 a.m. (continued — exceptions noted in bold)

PREV Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.

9:30a.m. 10:30a.m. Hall A

TEST Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.

9:30a.m. 10:30a.m. Hall A

VALV Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.

9:30a.m. 10:30a.m. Hall A

10:45 a.m. – 12:15 p.m. (exceptions noted in bold)

ACC-i2/TCT Oral 2503 BioresorbableVascularScaffolds 10:45a.m. 12:15p.m. S106b 145

ACC-i2/TCT Oral 2506 Drug-elutingStents 10:45a.m. 12:15p.m. S101a 146

ACC-i2/TCT Oral 2507 ImaginginTAVR 10:45a.m. 12:15p.m. S102c 146

ACC-i2/TCT Oral 2509 PreventionandTreatementofRestenosis 10:45a.m. 12:15p.m. S103c 147

ACC-i2/TCT Oral 2511 OutcomesinPatientsTreatedwithPCI 10:45a.m. 12:15p.m. S103b 147

ACC-i2/TCT Symposium 2615 Congenital/Pediatric 10:45a.m. 12:15p.m. S102b 148

ACS Oral 917 ImprovingOutcomesinACS.InsightsfromBasicScienceandPreclinicalResearch. 10:45a.m. 12:15p.m. N227b 148

ACS Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.


ARR Oral 918 CardiacMRIfortheTreatmentandEvaluationofArrhythmias 10:45a.m. 12:15p.m. S404 148

ARR Oral 919 JointOralSessionoftheHeartRhythmSocietyandtheAmericanCollegeofCardiology:CardiacArrestandtheCareoftheICDPatient

10:45a.m. 12:15p.m. N426 149

CCS Symposium 637 Post-OperativeGlennsandFontans:NavigatingTurbulentWaters 10:45a.m. 12:15p.m. N231 149

CCS Oral 920 AdultswithCongenitalHeartDisease:ImagingPredictors,EvolvingTherapiesandOutcomes 10:45a.m. 12:15p.m. S402 149

CCS Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.


HF Experts 225 HeartFailureCarefortheVeryOld:WhatAretheKeyIssuesforSuccess? 10:45a.m. 12:15p.m. S502 150

HF Oral 921 JointOralSessionoftheHeartFailureSocietyofAmericaandtheAmericanCollegeofCardiology:IndividualizingPharmacologicalTherapyinHeartFailure

10:45a.m. 12:15p.m. S406b 150

HF Oral 922 ImprovingPatientSelectionforDevice-BasedTherapies 10:45a.m. 12:15p.m. S405 150

IMAG Symposium 638 JointSymposiumoftheAmericanSocietyofEchocardiographyand theAmericanCollegeofCardiology:Cardiomyopathy—AComprehensiveEchocardiographicApproach

10:45a.m. 12:15p.m. S406a 151

IMAG Oral 924 CardiacCT:TowardaBetterUnderstandingofCAD 10:45a.m. 12:15p.m. S403 151

ISCHEM Oral 923 WhoSaidThere’sNothingNew? 10:45a.m. 12:15p.m. N230 151

PERI Oral 925 AllThatGlittersinMyocardialandPericardialDisease 10:45a.m. 12:15p.m. N226 152

PERI Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.


PHTN Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.


PRACTICE Experts 226 ACC/MedAxiom/ACCA:Physician/HospitalIntegration:MakingItWork 10:45a.m. 12:15p.m. S505 152

PREV Experts 227 UpdateontheATPIVGuidelines 10:45a.m. 12:15p.m. S501a 152

PREV Oral 926 Prevention:RenalSympatheticDenervation—ANovelTherapyforHypertension? 10:45a.m. 12:15p.m. N228 153

PREV Oral 927 Prevention:CardiovascularRiskAssessmentandRehabilitation 10:45a.m. 12:15p.m. S401a 153

PREV Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.


QUAL Symposium 650 U.S.HealthSystemReform:What’sMissing? 10:45a.m. 12:15p.m. S100c 153

QUAL Oral 928 ImprovingPCIOutcomes 10:45a.m. 12:15p.m. N229 153

SPECIAL Special 406 YoungInvestigatorsAwardCompetition:Physiology,Pharmacology,andPathology 10:45a.m. 12:15p.m. S105a 154

TEST Oral 929 DiagnosticTesting:ECGandCardiopulmonaryExerciseTesting 10:45a.m. 12:15p.m. S503 154

TEST Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.


VALV Oral 930 ValvularOralAbstracts 10:45a.m. 12:15p.m. N427 155

ACC.12 • Daily Schedule • Sunday, March 25, 2012

78 GO for ACC.12!


10:45 a.m. – 12:15 p.m. (continued — exceptions noted in bold)

VALV Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.


VASC Oral 932 NewInsightsinPerpheralVascularDiseaseandYearinReview 10:45a.m. 12:15p.m. S504a 155


ACC-i2/TCT Symposium 646 InterventionalCardiovascularMedicinein2012:AnUpdateforthe Non-InterventionalistandtheDouglasP.Zipes,M.D.,DistinguishedYoungScientistAwardeeLecture

12:15 p.m. 1:45p.m. N228 155

ACC-i2/TCT Special 2101 CardiacCareTeamSessionI:KeynoteAddress 12:30p.m. 1:00 p.m. S103b 156

ACC-i2/TCT Special 2102 CardiacCareTeamSessionII:CathLabofTomorrow—Pathwaytoa High-riskAorticValveProgram

1:00 p.m. 2:30 p.m. S103b 160

ACC-i2/TCT Experts 2308 AorticValveCaseReviews 12:30p.m. 1:45p.m. S101a 156

ACC-i2/TCT Experts 2309 CoronaryComplicationsCaseReviews 12:30p.m. 1:45p.m. S102b 156

ACC-i2/TCT Experts 2310 MultivesselandHemodynamicSupportCaseReviews 12:30p.m. 1:45p.m. S102c 156

ACC-i2/TCT Symposium 2616 EndovascularInterventionforVenousDisease 12:30p.m. 1:45p.m. S103c 156

ACC-i2/TCT Symposium 2617 PlateletInhibitionin2012:WhatYouNeedToKnow 12:30p.m. 1:45p.m. S106b 156

ACS Symposium 639 TheFutureofACSClinicalTrials 12:30p.m. 1:45p.m. S404 156

ARR Symposium 640 JointSymposiumoftheHeartRhythmSocietyandtheAmericanCollege ofCardiology:InvestigationandManagementofSyncope

12:30p.m. 1:45p.m. N426 157

CCS Special 301 Career&MentoringSessionforPediatricandCongenitalCardiologists 12:30p.m. 1:45p.m. N231 157

HF Experts 228 CardiacMRfortheEvaluationoftheHeartFailurePatient 12:30p.m. 1:45p.m. S502 157

HF Symposium 641 JointSymposiumoftheHeartFailureSocietyofAmericaandtheAmerican CollegeofCardiology:ContemporaryIssuesintheDiagnosisandTreatmentofChronicAmbulatoryHeartFailure

12:30p.m. 1:45p.m. S406b 157

HF Symposium 642 CardiotoxicityofCancerChemotherapy:MolecularBasisandStrategiesfor EarlyDetectionandPrevention

12:30p.m. 1:45p.m. S405 157

IMAG Symposium 643 JointSymposiumoftheAmericanSocietyofEchocardiographyandthe AmericanCollegeofCardiology:InterventionalEchocardiography—EvolvingRoleinPatientManagement

12:30p.m. 1:45p.m. S406a 158

IMAG Symposium 644 Cost-EffectiveImaginginPatientswithChronicCAD 12:30p.m. 1:45p.m. S403 158

ISCHEM Symposium 645 ManagingHigh-riskPatientswithStableIschemicHeartDisease 12:30p.m. 1:45p.m. S401a 158

LIFELONG MOC 811 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ACCGeneralCardiologyModulePartA

12:30p.m. 3:00 p.m. S105a 158

LIFELONG MOC 812 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ACCGeneralCardiologyModulePartB

12:30p.m. 3:00 p.m. S105d 158

PERI Experts 229 GraspingtheComplexityofMyocardialandPericardialDiseases 12:30p.m. 1:45p.m. S505 159

PERI Symposium 648 TheNewHypertrophicCardiomyopathyPracticeGuidelines 12:30p.m. 1:45p.m. N226 159

PHTN Symposium 649 EmergingApproachestoPulmonaryHypertensionwithLeftVentricularDysfunction 12:30p.m. 1:45p.m. S402 159

PRACTICE Symposium 647 JointSessionoftheHealthcareInformationandManagementSystemsSociety andtheAmericanCollegeofCardiology:HealthInformationTechnologyPartI:MakingtheElectronicHealthRecordMeaningfulandUseful—AWashingtonPerspective

12:30p.m. 1:45p.m. N227b 159

PREV Experts 230 ManagementofHypertensionintheElderly 12:30p.m. 1:45p.m. S501a 159

SPECIAL Special 111 FITForumIII:HowtoWriteandEvaluateMedicalJournalArticles 12:30p.m. 1:45p.m. N229 159

TEST Symposium 651 RoleofExerciseTreadmillTestingin2012 12:30p.m. 1:45p.m. N230 160

VALV Symposium 652 ControversiesinValveDiseaseI 12:30p.m. 1:45p.m. N427 160

Sunday, March 25, 2012 • Daily Schedule • ACC.12




ACC-i2/TCT Special 2131 AnatomyandTranscatheterTherapyfortheStructuralHeartInterventionalistI: MitralandAorticValve(withRemoteDemonstrationsfromtheSeattleScienceFoundation)

2:00p.m. 3:30p.m. S102c 160


2202 LiveandTapedCaseSessionII:LeftMainandBirfucation—ComplexPCI 2:00p.m. 5:00 p.m. Hall B, ACC.12 Main Tent

161

ACC-i2/TCT Symposium 2618 ImagingTranscatheterAorticValveProceduresI:Intra-andPost-ProceduralImaging 2:00p.m. 3:30p.m. S101a 161

ACC-i2/TCT Symposium 2619 EmergingTechnologies 2:00p.m. 3:30p.m. S102b 161

ACC-i2/TCT Symposium 2620 PeripheralArteryDisease:SuperficialFemoralArtery 2:00p.m. 3:30p.m. S103c 161

ACC-i2/TCT Symposium 2621 ChronicTotalOcclusions 2:00p.m. 3:30p.m. S106b 162

ACC-i2/TCT Special 2103 CardiacCareTeamSessionIII:MedicationsandOtherTechniquesto ManagethePatientintheCathLab

2:30 p.m. 3:30p.m. S103b 165

ACS Experts 231 ManagementofChestPainintheEmergencyDepartment 2:00p.m. 3:30p.m. S504a 162

ACS Symposium 653 State-of-the-ArtinNonSTElevationAcuteCoronarySyndromes 2:00p.m. 3:30p.m. S404 162

ARR Experts 232 JointSymposiumoftheHeartRhythmSocietyandtheAmericanCollegeof Cardiology:OptimizingtheManagementofthePatientwithImplantableDevices

2:00p.m. 3:30p.m. S503 162

ARR Symposium 654 JointSymposiumoftheHeartRhythmSocietyandtheAmericanCollegeof Cardiology:AtrialFibrillation—PreventionofStroke

2:00p.m. 3:30p.m. N426 162

CCS Legends 402 LegendsinCardiovascularMedicineLectureSeries—2012DanG.McNamaraLecture 2:00p.m. 3:30p.m. N228 162

HF Symposium 655 JointSymposiumoftheHeartFailureSocietyofAmericaandtheAmerican CollegeofCardiology:TheGrowingRoleofDevicesinHeartFailureManagement—ICD,CRT,HemodynamicMonitoringandUltrafiltration

2:00p.m. 3:30p.m. S406b 163

HF Symposium 656 TheNHLBIHeartFailureClinicalTrialsNetwork:ANewParadigmfor InvestigationandTraining

2:00p.m. 3:30p.m. S405 163

IMAG Experts 233 RoleofCMRinValvularHeartDisease 2:00p.m. 3:30p.m. S505 163

IMAG Symposium 657 JointSymposiumoftheAmericanSocietyofEchocardiographyandthe AmericanCollegeofCardiology:HealthcareReform—ImpactonImaging

2:00p.m. 3:30p.m. S406a 163

IMAG Symposium 658 RadionuclideImagingintheHeartFailurePatient 2:00p.m. 3:30p.m. S403 163

ISCHEM Experts 234 HeartFailureInStableIschemicHeartDisease:NotfortheWeakofHeart 2:00p.m. 3:30p.m. S502 163

LIFELONG Symposium 659 MasterClinicianI:DiscussionofThreeComplexRealWorldCases 2:00p.m. 3:30p.m. S401a 163

LIFELONG Core 813 CoreCurriculum:GeneralCardiology 2:00p.m. 3:30p.m. N226 164

LIFELONG Core 814 CoreCurriculum:ValvularHeartDisease 2:00p.m. 3:30p.m. N229 164

PERI Symposium 661 ControversiesinHypertrophicCardiomyopathy 2:00p.m. 3:30p.m. N427 164

PHTN Symposium 662 PulmonaryHypertensionManagementinSpecialPopulations 2:00p.m. 3:30p.m. S402 164

PRACTICE Symposium 660 JointSessionoftheHealthcareInformationandManagementSystems SocietyandtheAmericanCollegeofCardiology:HealthInformationTechnologyPartII:EHRImplementation…LessonsfromtheTrenches

2:00p.m. 3:30p.m. N227b 164

PREV Experts 235 DietaryApproachesforCVDPrevention:MatchingtheDiettothePatient 2:00p.m. 3:30p.m. S501a 164

PREV Symposium 663 ResistantHypertension 2:00p.m. 3:30p.m. S100c 165

QUAL Symposium 664 JointSymposiumoftheAssociationofBlackCardiologistsandtheAmericanCollege ofCardiology:EthnicandRacialDisparitiesinCardiovascularDisease—ACalltoAction

2:00p.m. 3:30p.m. N230 165

SPECIAL Special 302 BusinessMeetingoftheCollege 3:00 p.m. 3:15 p.m. ACC Member Lounge

165


ACC-i2/TCT Special 2104 CardiacCareTeamSessionIV:SameDayDischargeforPCI 3:30 p.m. 5:00 p.m. S103b 165

ACC-i2/TCT Special 2105 CardiacCareTeamV:StructuralHeartDisease—MitralValve 5:00 p.m. 6:00p.m. S103b 171

ACC-i2/TCT Experts 2311 EndovascularCaseReviews 4:30p.m. 6:00p.m. S102b 166

ACC-i2/TCT Symposium 2622 ImagingTranscatheterMitralValveProcedures 4:30p.m. 6:00p.m. S101a 166

ACC-i2/TCT Symposium 2623 PeripheralArteryDisease:CriticalLimbIschemia 4:30p.m. 6:00p.m. S103c 166

ACC-i2/TCT Symposium 2624 VascularAccessandOutcomesfollowingPCIforACS:WhatYouShouldKnow 4:30p.m. 6:00p.m. S106b 167

ACS Symposium 665 LiteratureInterpretationandStatisticalPitfallsinACSTrials 4:30p.m. 6:00p.m. S402 167

ACC.12 • Daily Schedule • Sunday, March 25, 2012

80 GO for ACC.12!


4:30 p.m. – 6:00 p.m. (continued — exceptions noted in bold)

ARR Symposium 666 JointSymposiumoftheHeartRhythmSocietyandtheAmericanCollege ofCardiology:AtrialFibrillation—ManagementoftheArrhythmia

4:30p.m. 6:00p.m. N426 167

CCS Symposium 667 TheGreatDebates 4:30p.m. 6:00p.m. N231 167

CCS Symposium 668 ACHDfortheGeneralCardiologist 4:30p.m. 6:00p.m. N230 168

HF Symposium 669 JointSymposiumoftheHeartFailureSocietyofAmericaandtheAmerican CollegeofCardiology:ManagementofAdvancedHeartFailureandTransplantation

4:30p.m. 6:00p.m. S406b 168

HF Symposium 670 HeartTransplantation:Challengesin2012 4:30p.m. 6:00p.m. S405 168

HF Symposium 671 PersonalizedMedicineandtheFutureofMedicalCare 4:30p.m. 6:00p.m. S404 168

IMAG Symposium 672 JointSymposiumoftheAmericanSocietyofEchocardiographyandthe AmericanCollegeofCardiology:Echoin2012—WhatYouNeedtoKnowtoKeepUp

4:30p.m. 6:00p.m. S406a 168

LIFELONG Symposium 737 MasterClinician:ClinicalCasesII 4:30p.m. 6:00p.m. S401a 169

LIFELONG MOC 815 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ACCGeneralCardiologyModulePartB

3:30 p.m. 6:00p.m. S105a 165

LIFELONG MOC 816 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ACCGeneralCardiologyModulePartA

3:30 p.m. 6:00p.m. S105d 166

LIFELONG Core 817 CoreCurriculum:CoronaryArteryDisease 4:30p.m. 6:00p.m. N226 169

LIFELONG Core 818 CoreCurriculum:NuclearCardiology 4:30p.m. 6:00p.m. N229 169

PERI Experts 236 GeneticEvaluationofCardiomyopathy 4:30p.m. 6:00p.m. S505 169

PRACTICE Symposium 673 FutureCompensationUnderHealthCareReform 4:30p.m. 6:00p.m. N227b 169

PREV Experts 237 ReducingDisparitiesinCardiovascularPreventiveCare 4:30p.m. 6:00p.m. S501a 169

PREV Symposium 675 What’sNewintheACCF/AHAGuidelines 4:30p.m. 6:00p.m. N228 169

PREV Symposium 730 TheDifficult-to-ManageLipidPatient 4:30p.m. 6:00p.m. S100c 170

SPECIAL Experts 263 TheRoleofTherapeuticHypothermiaintheTreatmentofCardiacArrest 4:30p.m. 6:00p.m. S502 170

SPECIAL Legends 403 LegendsofCardiovascularMedicineLectureSeries— 3rdAnnualJamesT.DoveLecture

4:30p.m. 5:30 p.m. N427 170

SPECIAL Symposium 744a ClinicalDecision-MakingforFellowsinTraining:PartA 4:30p.m. 5:50 p.m. S403 170

SPECIAL Symposium 744b ClinicalDecision-MakingforFellowsinTraining:PartB 4:30p.m. 6:00p.m. S403 170

TEST Experts 261 CardiacDilemmasinAthletes 4:30p.m. 6:00p.m. S503 171

VALV Experts 238 AorticStenosisCaseManagement 4:30p.m. 6:00p.m. S504a 171


ACS Clinical Focus 1605 InnovationsinTranslation:ACS 6:30p.m. 9:30p.m. Fairmont Hotel,

Imperial Ballroom

171

ARR Clinical Focus 1603 JointSessionoftheHeartRhythmSocietyofAmericaandtheAmericanCollegeofCardiology—InnovationsinTranslation:AtrialFibrillation

6:30p.m. 9:30p.m. Fairmont Hotel,

International Ballroom

172

Sunday, March 25, 2012 • Daily Schedule • ACC.12




ACC-i2/TCT Special 2111 FellowsBootcamp:CoronaryI 8:00a.m. 9:30a.m. S103b 177

ACC-i2/TCT Special 2121 Multi-DisciplinaryManagementoftheFailingHeart:TeamBasedEvaluation andTherapyofAdvancedHeartDiseaseI

8:00a.m. 9:30a.m. S102c 177

ACC-i2/TCT Symposium 2625 LeftMainDisease:RoleofImagingforAssessment,TreatmentandFollow-Up 8:00a.m. 9:30a.m. S101a 177

ACC-i2/TCT Symposium 2626 TAVRComplications:Incidence,ManagementandAvoidance 8:00a.m. 9:30a.m. S102b 177

ACC-i2/TCT Symposium 2627 ManagementofRenovascularHypertension 8:00a.m. 9:30a.m. S103c 177

ACC-i2/TCT Symposium 2628 LeftMainCoronaryIntervention:State-of-the-Art 8:00a.m. 9:30a.m. S106b 178

ACS Symposium 676 ShockinACS 8:00a.m. 9:30a.m. S401a 178

ARR Experts 239 Case-OrientedGapsintheGuidelines:WhoShouldGetanICD? 8:00a.m. 9:30a.m. S504a 178

ARR Symposium 677 ClinicalManagementoftheAFPatient:TreatingthePatientand theHealthCareProvider

8:00a.m. 9:30a.m. N226 178

CCS Symposium 678 PulmonaryArteryStenosisCurrentTherapyandFutureDirections:LiveCase 8:00a.m. 9:30a.m. N231 178

CCS Symposium 679 WomenwithCongenitalHeartDisease:Fertility,PregnancyandMenopause 8:00a.m. 9:30a.m. S501a 179

HF Experts 240 Myocarditis:WhentoBiopsy,WhotoTreat,WhichTherapy? 8:00a.m. 9:30a.m. S502 179

HF Symposium 680 ControversiesintheManagementofHeartFailure 8:00a.m. 9:30a.m. S406b 179

HF Symposium 681 SurgicalTherapyofHeartFailure 8:00a.m. 9:30a.m. S404 179

IMAG Experts 241 ImagingtheRightVentricle 8:00a.m. 9:30a.m. S505 179

IMAG Symposium 682 AdvancedLVDysfunction:AMultimodalityApproach 8:00a.m. 9:30a.m. S405 179

IMAG Symposium 683 FutureDirectionsforCardiacCT 8:00a.m. 9:30a.m. S403 180

LIFELONG Boot Camp 112 CCAResearchBootcampSessionI:MethodsforEngaginginResearch 8:00a.m. 9:30a.m. S105d 180

PRACTICE Symposium 684 ACC/MedAxiom/ACCA:CardiovascularServiceLines 8:00a.m. 9:30a.m. S105a 180

PREV Symposium 685 ACCChinaChapterSession:CardiovascularClinicalResearchandPracticeinChina 8:00a.m. 9:30a.m. N229 180

PREV Symposium 686 GlobalCVDPrevention:HeartDiseaseandRiskFactorsinSpecificPopulations 8:00a.m. 9:30a.m. S100c 180

QUAL Symposium 687 WhereWillCardiologyBein2015? 8:00a.m. 9:30a.m. N427 180

SPECIAL Special 305 JointAmericanCollegeofCardiology/New England Journal of Medicine Late-BreakingClinicalTrials

8:00a.m. 9:30a.m. Hall B, ACC.12 Main Tent

181

SPECIAL Special 407 YoungInvestigatorsAwardCompetition:ClinicalInvestigations,CongenitalHeartDiseaseandCardiovascularSurgery

8:00a.m. 9:30a.m. N230 181

SPECIAL Symposium 738 JointSessionoftheEuropeanSocietyofCardiologyandtheAmerican CollegeofCardiologyI:ManagementofHeartDiseaseinPregnancy

8:00a.m. 9:30a.m. N426 181

TEST Symposium 688 ChallengingSportsCardiologyCasesinOlderAthletes 8:00a.m. 9:30a.m. N227b 182

VALV Experts 242 TricuspidValveDiseaseCaseManagement 8:00a.m. 9:30a.m. S503 182

VALV Symposium 674 ValvularHeartDiseaseintheOlderAdult(withManyDRGCodes): NavigatingtheOptions

8:00a.m. 9:30a.m. S402 182

VALV Self-Directed 1503 HeartSongsatACC.12:ASelf-PacedMultimediaLearningExperience 9:00 a.m. 5:00 p.m. Vista Room Lobby

182


Daily Schedule Monday, March 26, 2012





82 GO for ACC.12!



ARR Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.

9:30a.m. 10:30a.m. Hall A

HF Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.

9:30a.m. 10:30a.m. Hall A

ISCHEM Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.

9:30a.m. 10:30a.m. Hall A

QUAL Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.

9:30a.m. 10:30a.m. Hall A

10:30 a.m. – Noon (exceptions noted in bold)

ACC-i2/TCT Special 2112 FellowsBootcamp:CoronaryII 10:30a.m. Noon S103b 182

ACC-i2/TCT Special 2122 Multi-DisciplinaryManagementoftheFailingHeart:Team-based EvaluationandTherapyofAdvancedHeartDiseaseII

10:30a.m. Noon S102c 183

ACC-i2/TCT Symposium 2629 EstablishingaCardiacCatheterizationImaging/PhysiologyProgram 10:30a.m. Noon S101a 183

ACC-i2/TCT Symposium 2630 HemodynamicsIII(PVLandASDClosure) 10:30a.m. Noon S102b 183

ACC-i2/TCT Symposium 2631 AllYouNeedtoKnowaboutCarotidArteryStenting 10:30a.m. Noon S103c 183

ACC-i2/TCT Symposium 2632 DES:FutureDirections 10:30a.m. Noon S106b 184

ACS Symposium 689 ImprovingSTEMIOutcomes:SavingMyocardiumandAttenuatingRemodeling 10:30a.m. Noon S401a 184

ARR Experts 243 PerioperativeManagementofPatientswithCardiacImplantableElectronicDevice 10:30a.m. Noon S504a 184

ARR Symposium 690 ControversiesinDeviceTherapy 10:30a.m. Noon S406a 184

ARR Symposium 691 TheGeneticsofSuddenCardiacDeath:WhatDoWeKnowand HowBesttoEvaluateandManageSuchPatients

10:30a.m. Noon N226 184

ARR Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.


CCS Symposium 692 PulmonaryVeinStenosis:WhatAreRealisticExpectations? 10:30a.m. Noon N229 184

CCS Symposium 693 ChallengingImagingIssuesinCongenitalHeartDisease 10:30a.m. Noon N231 185

HF Symposium 694 LVADasDestinationTherapyforAdvancedHeartFailure 10:30a.m. Noon S406b 185

HF Symposium 695 ManagementofPeripartumCardiomyopathy:Update2012 10:30a.m. Noon S404 185

HF Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.


IMAG Symposium 696 CardiacCTin2012:State-of-the-Art 10:30a.m. Noon S405 185

IMAG Symposium 697 RoleofEchointheEvaluationandManagementofPatientswithMitralRegurgitation 10:30a.m. Noon S403 185

ISCHEM Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.


PRACTICE Experts 244 LeadershipandGovernance 10:30a.m. Noon S503 185

PREV Experts 245 Women’sCardiovascularHealth 10:30a.m. Noon S501a 185

PREV Symposium 698 VitaminsandSupplementsinCardiovascularDiseasePrevention 10:30a.m. Noon S100c 186

PREV Symposium 699 JointSymposiumofthePreventiveCardiovascularNursesAssociation andtheAmericanCollegeofCardiology

10:30a.m. Noon S105d 186

QUAL Symposium 700 Lies,DamnedLiesandStatistics:PitfallsinLiteratureInterpretation 10:30a.m. Noon N427 186

QUAL Symposium 742 TheFutureofCardiovascularDiseases:WhereAreWeGoing(andWhere DoWeWanttoGo)

10:30a.m. Noon N426 186

QUAL Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.


SPECIAL Special 306 Late-BreakingClinicalTrialsIV 10:30a.m. Noon Hall B, ACC.12 Main Tent

186

SPECIAL Special 408 YoungInvestigatorsAwardCompetition:CardiovascularHealthOutcomesandPopulationGenetics

10:30a.m. Noon N230 187

SPECIAL Symposium 741 IntegrativeMedicine 10:30a.m. Noon N227b 187

TEST Experts 262 ECGsinAthletes:TheGreatECGScreeningDebateandChallengingCases 10:30a.m. Noon S502 187

VALV Experts 246 ComplicationsofInterventionsforValvularHeartDisease 10:30a.m. Noon S505 187

VASC Experts 264 ChallengingCasesinAnticoagulationManagement:Spotlightonthe NovelAnticoagulants

10:30a.m. Noon S105a 187

Monday, March 26, 2012 • Daily Schedule • ACC.12




ACC-i2/TCT Intl. Lunch 502 JointSessionoftheArgentineSocietyofCardiologyandtheAmericanCollege ofCardiology:Carotids

12:15p.m. 1:45p.m. N226 188

ACC-i2/TCT Intl. Lunch 503 JointSessionoftheBrazilianSocietyofCardiologyandtheAmericanCollege ofCardiology:Drug-elutingStents—FromtheEarlyBeginningtoNewStentPlatforms

12:15p.m. 1:45p.m. N426 188

ACC-i2/TCT Intl. Lunch 505 JointSessionoftheChineseSocietyofCardiologyandtheAmericanCollege ofCardiology:CoronaryTotalOcclusions

12:15p.m. 1:45p.m. N228 188

ACC-i2/TCT Intl. Lunch 511 JointSessionoftheKoreanSocietyofCardiologyandtheAmericanCollege ofCardiology:TreatingComplexLesions

12:15p.m. 1:45p.m. N229 188

ACC-i2/TCT Intl. Lunch 518 JointSessionoftheTurkishSocietyofCardiologyandtheAmerican CollegeofCardiology:Devices—ASD’s,VSD’s,PerivalvularLeaks

12:15p.m. 1:45p.m. S505 189

ACC-i2/TCT MOC 819 ACCFStudySessionsforMaintenanceofCertification:ABIMRecertificationMadeEasy—InterventionalCardiology2010Update(B2-K)

12:15p.m. 2:45 p.m. S105a 189

ACC-i2/TCT Special 2113 FellowsBootcamp:CaseReviews 12:15p.m. 1:45p.m. S103b 194


2203 LiveandTapedCaseSesionIII:ValvularHeartDisease 12:30 p.m. 2:30 p.m. Hall B, ACC.12 Main Tent

194

ACC-i2/TCT Experts 2313 Non-coronaryComplicationsCaseReviews 12:15p.m. 1:45p.m. S101a 189

ACC-i2/TCT Experts 2314 StructuralCaseReviews 12:15p.m. 1:45p.m. S102b 189

ACC-i2/TCT Experts 2315 ShockandHemodynamicSupportCaseReviews 12:15p.m. 1:45p.m. S102c 189

ACC-i2/TCT Symposium 2633 ControversiesinVascularandEndovascularMedicine 12:15p.m. 1:45p.m. S103c 189

ACC-i2/TCT Symposium 2634 Non-ST-ElevationACSin2012:WhatYouNeedToKnow 12:15p.m. 1:45p.m. S106b 190

ACS Intl. Lunch 513 JointSessionoftheMexicanSocietyofCardiologyandtheAmerican CollegeofCardiology:ImprovingOutcomes

12:15p.m. 1:45p.m. S404 190

ARR Intl. Lunch 501 JointSessionoftheJapaneseCollegeofCardiologyandtheAmerican CollegeofCardiology:RiskStratificationforSuddenCardiacDeath

12:15p.m. 1:45p.m. S403 190

ARR Intl. Lunch 509 JointSessionoftheCardiologicalSocietyofIndiaandtheAmerican CollegeofCardiology:AF—Medical,EP,SurgicalOptions

12:15p.m. 1:45p.m. S401a 190

CCS Intl. Lunch 506 JointSessionoftheEgyptianSocietyofCardiologyandtheAmericanCollege ofCardiology:AdultCongenitalHeartDisease—WhereWeCameFromandWhereWeAre

12:15p.m. 1:45p.m. N231 191

HF Intl. Lunch 517 JointSessionoftheSpanishSocietyofCardiologyandtheAmericanCollege ofCardiology:HeartFailure—DevicestoTransplantation

12:15p.m. 1:45p.m. S501a 191

IMAG Intl. Lunch 507 JointSessionoftheGermanCardiacSocietyandtheAmericanCollege ofCardiology:Imaging—EvolvingStrategies

12:15p.m. 1:45p.m. S406b 191

ISCHEM Intl. Lunch 508 JointSessionoftheBritishCardiovascularSocietyandtheAmericanCollege ofCardiology:NICEGuidelines

12:15p.m. 1:45p.m. N427 191

LIFELONG MOC 819 ACCFStudySessionsforMaintenanceofCertification:ABIMRecertificationMadeEasy—InterventionalCardiology2010Update(B2-K)

12:15p.m. 2:45 p.m. S105a 192

LIFELONG MOC 820 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ClinicalCardiacElectrophysiology2010Update(B3-K)

12:15p.m. 2:45 p.m. S105d 192

PREV Intl. Lunch 512 JointSessionoftheNationalHeartAssociationofMalaysiaandtheAmerican CollegeofCardiology:ResistantHypertension

12:15p.m. 1:45p.m. S504a 192

PREV Intl. Lunch 516 JointSessionoftheSouthAmericanSocietyofCardiologyandtheAmerican CollegeofCardiology:Prevention—AssessingandEducatingAcrossRegions

12:15p.m. 1:45p.m. S502 192

PREV Symposium 701 RoleofPhysicalActivityinCVDPrevention 12:15p.m. 1:45p.m. S100c 193

QUAL Intl. Lunch 510 JointSessionoftheIsraelHeartSocietyandtheAmericanCollegeofCardiology:PCI 12:15p.m. 1:45p.m. N230 193

QUAL Intl. Lunch 515 JointSessionoftheSaudiHeartAssociationandtheAmericanCollegeof Cardiology:QualityRegistries

12:15p.m. 1:45p.m. N227b 193

SPECIAL Special 113 FITForumIV:GuidancefortheFirstStepsofYourCardiologyCareer 12:15p.m. 1:45p.m. S402 193

VALV Intl. Lunch 504 JointSessionoftheCanadianCardiovascularSocietyandtheAmericanCollegeof Cardiology:Repairs/Replacement:Catheter-basedor(MinimallyInvasive)Surgery

12:15p.m. 1:45p.m. S405 193

VASC Intl. Lunch 514 JointSessionofthePakistanCardiacSocietyandtheAmericanCollege ofCardiology:Vascular—VTE,PHTN

12:15p.m. 1:45p.m. S503 194

ACC.12 • Daily Schedule • Monday, March 26, 2012

84 GO for ACC.12!



ACC-i2/TCT MOC 823 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—InterventionalCardiology2011Update(B2-L)

3:00 p.m. 5:30 p.m. S105a 200

ACC-i2/TCT Special 2114 FellowsBootcamp:StructuralHeart 2:00p.m. 3:30p.m. S103b 194

ACC-i2/TCT Special 2132 AnatomyandTranscatheterTherapyfortheStructuralHeart InterventionalistII:LeftAtrialAppendageClosure,PFO,ASDandTransseptalPuncture(withRemoteDemonstrationsfromtheSeattleScienceFoundation)

2:00p.m. 3:30p.m. S102c 195

ACC-i2/TCT Symposium 2635 ImagingTranscatheterAorticValveProceduresII:SelectingtheBestPatient, ValveandVascularApproach

2:00p.m. 3:30p.m. S101a 195

ACC-i2/TCT Symposium 2636 SpotlightSessiononTAVR 2:00p.m. 3:30p.m. S102b 195

ACC-i2/TCT Symposium 2637 ManagementofSymptomaticSevereCarotidArteryDisease 2:00p.m. 3:30p.m. S103c 195

ACC-i2/TCT Symposium 2638 State-of-the-ArtSTEMI:AllYouNeedtoKnow 2:00p.m. 3:30p.m. S106b 196

ARR Symposium 702 SuddenCardiacDeathRiskStratificationinHeartFailure:Past,Present andFutureDirections

2:00p.m. 3:30p.m. S406a 196

ARR Symposium 703 SyncopeinSpecialPopulations 2:00p.m. 3:30p.m. N227b 196

CCS Experts 247 AcquiredHeartDiseaseinChildhoodEpidemiology:CurrentandFutureManagement 2:00p.m. 3:30p.m. S501a 196

HF Symposium 704 CardiacResynchronizationTherapy:WhomtoReferforImplantation? 2:00p.m. 3:30p.m. S406b 196

HF Symposium 705 UnderstandingtheComplexityoftheRightVentricle:ChallengesandProgress 2:00p.m. 3:30p.m. S404 196

HF Symposium 706 JointSymposiumoftheItalianFederationofCardiologyandthePennsylvania ChapteroftheAmericanCollegeofCardiology:UpdateontheTreatmentofAtrialFibrillation

2:00p.m. 3:30p.m. N230 197

IMAG Symposium 707 ManagementofthePatientwithValvularHeartDisease:RoleofEcho 2:00p.m. 3:30p.m. S405 197

IMAG Symposium 708 AdvancesinNuclearCardiology:CurrentandFutureApplications 2:00p.m. 3:30p.m. S403 197

ISCHEM Symposium 709 TransitioningfromACStoStableIschemicHeartDisease 2:00p.m. 3:30p.m. S401a 197

LIFELONG Core 821 CoreCurriculum:CardiacCatheterization 2:00p.m. 3:30p.m. N226 197

LIFELONG Core 822 CoreCurriculum:PreventiveCardiology 2:00p.m. 3:30p.m. N229 198

LIFELONG MOC 823 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—InterventionalCardiology2011Update(B2-L)

3:00 p.m. 5:30 p.m. S105a 200

LIFELONG MOC 824 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ClinicalCardiacElectrophysiology2011Update(B3-L)

3:00 p.m. 5:30 p.m. S105d 200

PHTN Experts 249 PearlsandCaveatsinManagingPatientswithPulmonaryHypertension 2:00p.m. 3:30p.m. S505 198

PRACTICE Experts 248 IssuesThatHaveCausedMedicalProfessionalLiabilityClaims:AreYouatRisk? ASpecialPresentationfromTheDoctorsCompany

2:00p.m. 3:30p.m. S504a 198

PRACTICE Symposium 710 ImpactofHealthcarePolicyontheAcademicCardiovascularMission 2:00p.m. 5:30 p.m. S402 198

PREV Experts 250 LabileHypertension:EvaluationandManagement 2:00p.m. 3:30p.m. S502 198

PREV Symposium 711 JointSymposiumoftheAmericanAssociationofClinicalEndocrinologists andtheAmericanCollegeofCardiology:CardiologistsasEndocrinologists—EmergingManagementoftheDiabeticPatient

2:00p.m. 3:30p.m. S100c 199

QUAL Symposium 712 BringingEvidencetotheBedside:MakingGuidelinesMoreAccessibletoClinicians 2:00p.m. 3:30p.m. N427 199

QUAL Symposium 713 MakingaDifference:CardiologyLeadershipintheCommunityandtheWorld 2:00p.m. 3:35 p.m. N228 199

SPECIAL Legends 404 LegendsofCardiovascularMedicineLectureSeries—11thAnnualMaseri-FlorioInternationalLecture

2:00p.m. 3:00 p.m. N231 199

VALV Experts 251 ComplexValvularHeartDisease 2:00p.m. 3:30p.m. S503 199

VALV Symposium 714 CalcificAorticStenosis:DiagnosisandTreatmentinthe21stCentury 2:00p.m. 3:30p.m. N426 199


ACC-i2/TCT Symposium 2639 ControversiesinIntravascularImaging 3:45p.m. 5:15p.m. S101a 202

ACC-i2/TCT Symposium 2640 MitralInterventions 3:45p.m. 5:15p.m. S102b 200

ACC-i2/TCT Symposium 2641 ImportanceofBleedinginPatientswithCVDisease: APersonalizedApproachforTreatmentStrategies

3:45p.m. 5:15p.m. S103b 200

ACC-i2/TCT Symposium 2642 EndovascularManagementofErectileDysfunction 3:45p.m. 5:15p.m. S103c 201

ACC-i2/TCT Symposium 2643 ACS:NewInsightsandNovelTherapies 3:45p.m. 5:15p.m. S106b 201

ARR Symposium 715 ChallengesintheManagementofVentricularArrhythmias 3:45p.m. 5:15p.m. S406a 201

Monday, March 26, 2012 • Daily Schedule • ACC.12



3:45 p.m. – 5:15 p.m. (continued — exceptions noted in bold)

ARR Symposium 716 IssuesinCardiacResynchronizationTherapy 3:45p.m. 5:15p.m. N227b 201

CCS Experts 252 GoldenMoments:WhenIstheRightTimetoInterveneinCongenitalHeartDisease? 3:45p.m. 5:15p.m. S501a 201

HF Symposium 717 ImprovingOutcomesandReducingHeartFailureReadmissions 3:45p.m. 5:15p.m. S406b 202

HF Symposium 718 ControversiesinTreatmentofComorbiditiesinHeartFailure:Paradoxesand ChallengesinTreatment

3:45p.m. 5:15p.m. S404 202

IMAG Symposium 719 EmergingApplicationsofCMR 3:45p.m. 5:15p.m. S403 202

LIFELONG Core 825 CoreCurriculum:VascularDisease 3:45p.m. 5:15p.m. N226 202

LIFELONG Core 826 CoreCurriculum:LandmarkTrials 3:45p.m. 5:15p.m. N229 203

PERI Experts 253 ChallengesinHypertrophicCardiomyopathy:CaseStudies 3:45p.m. 5:15p.m. S505 203

PERI Symposium 720 NewDirectionsintheEvaluationandManagementoftheCardiomyopathies 3:45p.m. 5:15p.m. N231 203

PHTN Experts 254 PulmonaryHypertensionToolsfortheCardiologist 3:45p.m. 5:15p.m. S504a 203

PREV Symposium 729 BeyondStatins:LDLManagementintheChallengingPatient 3:45p.m. 5:15p.m. S100c 203

PREV Symposium 745 WorldHellenicBiomedicalAssociation,theHellenicCardiologicalSociety, theCyprusSocietyofCardiologyandtheAmericanCollegeofCardiology:MediterraneanDietandItsProtectiveEffectonCardiovascularDisease

3:45p.m. 5:15p.m. S405 203

QUAL Symposium 721 TransformingHealthCareDeliverythroughCVRegistries 3:45p.m. 5:15p.m. N427 204

QUAL Symposium 722 ApplyingNewerCardiovascularAgentstoOlderAdults 3:45p.m. 5:15p.m. N228 204

SPECIAL Symposium 740 JointSymposiumoftheBritishCardiovascularSocietyandtheCalifornia ChapteroftheAmericanCollegeofCardiology

3:45p.m. 5:15p.m. N230 204

TEST Experts 255 StressTestinginWomen 3:45p.m. 5:15p.m. S502 204

VALV Experts 256 AdvancedHemodynamicsforValvularHeartDisease 3:45p.m. 5:15p.m. S503 204

VALV Symposium 723 ImportanceofRegistriesforValveDisease:AGlimpseintotheACCFuture 3:45p.m. 5:15p.m. N426 204


ACC-i2/TCT Clinical Focus 1607 JointSessionoftheAmericanAssociationforThoracicSurgery,theSocietyofThoracicSurgeonsandtheAmericanCollegeofCardiology:MultidisciplinaryApproachtotheHigh-riskAorticStenosisPatient

5:45p.m. 9:05 p.m. S401a 205

SPECIAL Special 307 61stAnnualConvocation 6:30 p.m. 8:00 p.m. Hall B, ACC.12 Main Tent

205

ACC.12 • Daily Schedule • Monday, March 26, 2012

86 GO for ACC.12!



ACS Symposium 728 JointSymposiumoftheAmericanAssociationforClinicalChemistryand theAmericanCollegeofCardiology:HowtoUseCardiacBiomarkers

8:00a.m. 9:30a.m. N230 209

ARR Symposium 747 AntithromboticTherapiesforAtrialFibrillation:CurrentStateoftheArt 8:00a.m. 9:30a.m. S404 209

CCS Symposium 724 ComplexConotruncalMalformations:WhattheSurgeonNeedstoKnowand HowtoGettheInformation

8:00a.m. 9:30a.m. N229 209

CCS Symposium 725 ComingofAge:TheHLHSTurns21 8:00a.m. 9:30a.m. N231 209

HF Experts 257 CardiacAmyloidosis 8:00a.m. 9:30a.m. S502 209

IMAG Experts 258 EchoinAssessmentofLowGradientAorticStenosis 8:00a.m. 9:30a.m. S505 210

ISCHEM Experts 259 InnovationsinNoninvasiveEvaluationofStableIschemicHeartDisease 8:00a.m. 9:30a.m. S503 210

LIFELONG Boot Camp 114 CCAResearchBootcampSessionII:SuccessfulResearchExecution andDissemination

8:00a.m. 9:30a.m. S105d 210

PHTN Symposium 726 SesionConjuntaConLaSociedadEspanoladeCardiologíaSociedad InteramericadeCardiología/AmericanCollegeofCardiology:ProblemasRelevantesenCardiología—2012

8:00a.m. 9:30a.m. S403 210

PREV Symposium 727 JointSymposiumoftheAmericanSocietyofHypertensionandtheAmerican CollegeofCardiology:HypertensionintheCriticallyIllPatient

8:00a.m. 9:30a.m. S406a 210

SPECIAL Special 308 JointAmericanCollegeofCardiology/Journal of the American Medical Association Late-BreakingClinicalTrials

8:00a.m. 9:30a.m. Hall B, ACC.12 Main Tent

210

SPECIAL Symposium 739 JointSessionoftheEuropeanSocietyofCardiologyandtheAmericanCollege ofCardiologyII:ProsandConsofNewApproachesforAntiplateletandAnticoagulantTherapy

8:00a.m. 9:30a.m. N426 211

VALV Experts 260 AorticRegurgitation/BAV 8:00a.m. 9:30a.m. S504a 211


SPECIAL Special 309 ACC.12ClosingSession:InnovatorsinCardiology 9:45a.m. 11:45a.m. Hall B, ACC.12 Main Tent

211


Daily Schedule Tuesday, March 27, 2012






ACC-i2 wITh TCTSESSIONTYPE SESS.# TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012Symposium 2644 InterventionalFeaturedClinicalStudiesI 8:00a.m. 9:30a.m. S102b 107

Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement to JACC: Abstracts of Original Contributionsforacompletelisting.

9:30a.m. 10:30a.m. hall A


11:00a.m. Noon hall A

Symposium 734 PharmacologyProgram:PharmacologicConsiderationsintheSettingofPCI 12:15p.m. 1:45p.m. N427 116

Experts 2301 AtypicalThromboticACSCaseReviews 12:15p.m. 1:45p.m. S101a 114

Experts 2302 ChronicTotalOcclusionsandLeftMainCaseReviews 12:15p.m. 1:45p.m. S102c 114

Experts 2303 CoronaryImagingCaseReviews 12:15p.m. 1:45p.m. S103b 115

Symposium 2606 TAVR:ProceduralAspectsandBestPractices 12:15p.m. 1:45p.m. S102b 115

Symposium 2607 AcuteVenousThromboembolicDisease 12:15p.m. 1:45p.m. S103c 115

Live/Taped Cases

2201 LiveandTapedCaseSessionI:MultivesselPCI—PhysiologyandImaging 2:00p.m. 5:00p.m. hall B, ACC.12 Main Tent

119

Oral 2502 AcuteMyocardialInfarction 2:00p.m. 3:30p.m. S103b 119

Symposium 2608 IntravascularImaging:Restenosis,ThrombosisandStentFollow-upI: RestenosisandEarlyThrombosis

2:00p.m. 3:30p.m. S101a 119

Symposium 2609 HemodynamicsandAngiographyI:BasicIssues 2:00p.m. 3:30p.m. S102b 120

Symposium 2610 RenalInterventionsforHypertensionandRenalFunctionPreservation 2:00p.m. 3:30p.m. S103c 120

Symposium 2645 InterventionalFeaturedClinicalStudiesII 2:00p.m. 3:30p.m. S102c 120

Experts 2305 VascularAccessChallengesandComplicationsCaseReviews 4:30p.m. 6:00p.m. S102c 125

Experts 2306 UnusualCasesofACSCaseReviews 4:30p.m. 6:00p.m. S103b 125

Symposium 2611 IntravascularImaging:Restenosis,ThrombosisandStentFollow-upII: VeryLateStentThrombosisandLateCatch-up

4:30p.m. 6:00p.m. S101a 125

Symposium 2612 HemodynamicsII(HOCM) 4:30p.m. 6:00p.m. S102b 125

Symposium 2613 AdvancesandControversiesinCarotid,AorticandPeripheralArterialDisease: InCollaborationwiththeSocietyofVascularSurgery

4:30p.m. 6:00p.m. S103c 126

SuNDAy, MARCh 25, 2012Oral 2500 OutcomesinPatientsTreatedwithTAVR 8:00a.m. 9:30a.m. N227b 137

Oral 2501 AdjunctPharmacology 8:00a.m. 9:30a.m. S101a 137

Oral 2504 PCIinComplexLesions 8:00a.m. 9:30a.m. S103c 138

Oral 2505 PCIinComplexPatients 8:00a.m. 9:30a.m. S102c 138

Oral 2508 IntravascularDiagnostics 8:00a.m. 9:30a.m. S106b 139

Oral 2510 VascularAccess 8:00a.m. 9:30a.m. S103b 139

Symposium 2614 AbnormalitiesoftheAtrium 8:00a.m. 9:30a.m. S102b 140

Oral 2503 BioresorbableVascularScaffolds 10:45a.m. 12:15p.m. S106b 145

Oral 2506 Drug-elutingStents 10:45a.m. 12:15p.m. S101a 146

Oral 2507 ImaginginTAVR 10:45a.m. 12:15p.m. S102c 146

Oral 2509 PreventionandTreatementofRestenosis 10:45a.m. 12:15p.m. S103c 147


Topic ScheduleSessionsarelistedalphabeticallybylearningpathwaybasedontimeblock.




88 GO for ACC.12!


SuNDAy, MARCh 25, 2012 (continued)

Oral 2511 OutcomesinPatientsTreatedwithPCI 10:45a.m. 12:15p.m. S103b 147

Symposium 2615 Congenital/Pediatric 10:45a.m. 12:15p.m. S102b 148

Symposium 646 InterventionalCardiovascularMedicinein2012:AnUpdatefortheNon-Interventionalist andtheDouglasP.Zipes,M.D.,DistinguishedYoungScientistAwardeeLecture

12:15p.m. 1:45p.m. N228 155

Special 2101 CardiacCareTeamSessionI:KeynoteAddress 12:30p.m. 1:00p.m. S103b 156

Experts 2308 AorticValveCaseReviews 12:30p.m. 1:45p.m. S101a 156

Experts 2309 CoronaryComplicationsCaseReviews 12:30p.m. 1:45p.m. S102b 156

Experts 2310 MultivesselandHemodynamicSupportCaseReviews 12:30p.m. 1:45p.m. S102c 156

Symposium 2616 EndovascularInterventionforVenousDisease 12:30p.m. 1:45p.m. S103c 156

Symposium 2617 PlateletInhibitionin2012:WhatYouNeedtoKnow 12:30p.m. 1:45p.m. S106b 156

Special 2102 CardiacCareTeamSessionII:CathLabofTomorrow—PathwaytoaHigh-risk AorticValveProgram

1:00p.m. 2:30p.m. S103b 160

Special 2131 AnatomyandTranscatheterTherapyfortheStructuralHeartInterventionalistI:Mitraland AorticValve(withRemoteDemonstrationsfromtheSeattleScienceFoundation)

2:00p.m. 3:30p.m. S102c 160

Live/Taped Cases

2202 LiveandTapedCaseSessionII:LeftMainandBirfucation—ComplexPCI 2:00p.m. 5:00p.m. hall B, ACC.12 Main Tent

161

Symposium 2618 ImagingTranscatheterAorticValveProceduresI:Intra-andPost-ProceduralImaging 2:00p.m. 3:30p.m. S101a 161

Symposium 2619 EmergingTechnologies 2:00p.m. 3:30p.m. S102b 161

Symposium 2620 PeripheralArteryDisease:SuperficialFemoralArtery 2:00p.m. 3:30p.m. S103c 161

Symposium 2621 ChronicTotalOcclusions 2:00p.m. 3:30p.m. S106b 162

Special 2103 CardiacCareTeamSessionIII:MedicationsandOtherTechniquestoManagethe PatientintheCathLab

2:30p.m. 3:30p.m. S103b 165

Special 2104 CardiacCareTeamSessionIV:SameDayDischargeforPCI 3:30p.m. 5:00p.m. S103b 165

Experts 2311 EndovascularCaseReviews 4:30p.m. 6:00p.m. S102b 166

Symposium 2622 ImagingTranscatheterMitralValveProcedures 4:30p.m. 6:00p.m. S101a 166

Symposium 2623 PeripheralArteryDisease:CriticalLimbIschemia 4:30p.m. 6:00p.m. S103c 166

Symposium 2624 VascularAccessandOutcomesfollowingPCIforACS:WhatYouShouldKnow 4:30p.m. 6:00p.m. S106b 167

Special 2105 CardiacCareTeamV:StructuralHeartDisease—MitralValve 5:00p.m. 6:00p.m. S103b 171

MONDAy, MARCh 26, 2012Special 2111 FellowsBootcamp:CoronaryI 8:00a.m. 9:30a.m. S103b 177

Special 2121 Multi-DisciplinaryManagementoftheFailingHeart:TeamBasedEvaluationand TherapyofAdvancedHeartDiseaseI

8:00a.m. 9:30a.m. S102c 177

Symposium 2625 LeftMainDisease:RoleofImagingforAssessment,Treatment,andFollow-up 8:00a.m. 9:30a.m. S101a 177

Symposium 2626 TAVRComplications:Incidence,ManagementandAvoidance 8:00a.m. 9:30a.m. S102b 177

Symposium 2627 ManagementofRenovascularHypertension 8:00a.m. 9:30a.m. S103c 177

Symposium 2628 LeftMainCoronaryIntervention:State-of-the-Art 8:00a.m. 9:30a.m. S106b 178

Special 2112 FellowsBootcamp:CoronaryII 10:30a.m. Noon S103b 182

Special 2122 Multi-DisciplinaryManagementoftheFailingHeart:TeamBasedEvaluationand TherapyofAdvancedHeartDiseaseII

10:30a.m. Noon S102c 183

Symposium 2629 EstablishingaCardiacCatheterizationImaging/PhysiologyProgram 10:30a.m. Noon S101a 183

Symposium 2630 HemodynamicsIII(PVLandASDClosure) 10:30a.m. Noon S102b 183

Symposium 2631 AllYouNeedtoKnowaboutCarotidArteryStenting 10:30a.m. Noon S103c 183

Symposium 2632 DES:FutureDirections 10:30a.m. Noon S106b 184

Intl. Lunch 502 JointSessionoftheArgentineSocietyofCardiologyandtheAmericanCollege ofCardiology:Carotids

12:15p.m. 1:45p.m. N226 188

Intl. Lunch 503 JointSessionoftheBrazilianSocietyofCardiologyandtheAmericanCollegeof Cardiology:Drug-elutingStents—FromtheEarlyBeginningtoNewStentPlatforms

12:15p.m. 1:45p.m. N426 188

Topic Schedule • Program-At-A-Glance • ACC.12



MONDAy, MARCh 26, 2012 (continued)

Intl. Lunch 505 JointSessionoftheChineseSocietyofCardiologyandtheAmericanCollegeof Cardiology:CoronaryTotalOcclusions

12:15p.m. 1:45p.m. N228 188

Intl. Lunch 511 JointSessionoftheKoreanSocietyofCardiologyandtheAmericanCollegeof Cardiology:TreatingComplexLesions

12:15p.m. 1:45p.m. N229 188

Intl. Lunch 518 JointSessionoftheTurkishSocietyofCardiologyandtheAmericanCollegeof Cardiology:Devices—ASD’s,VSD’s,PerivalvularLeaks

12:15p.m. 1:45p.m. S505 189

MOC 819 ACCFStudySessionsforMaintenanceofCertification:ABIMRecertificationMadeEasy—InterventionalCardiology2010Update(B2-K)

12:15p.m. 2:45p.m. S105a 189

Special 2113 FellowsBootcamp:CaseReviews 12:15p.m. 1:45p.m. S103b 194

Experts 2313 Non-coronaryComplicationsCaseReviews 12:15p.m. 1:45p.m. S101a 189

Experts 2314 StructuralCaseReviews 12:15p.m. 1:45p.m. S102b 189

Experts 2315 ShockandHemodynamicSupportCaseReviews 12:15p.m. 1:45p.m. S102c 189

Symposium 2633 ControversiesinVascularandEndovascularMedicine 12:15p.m. 1:45p.m. S103c 189

Symposium 2634 Non-ST-ElevationACSin2012:WhatYouNeedtoKnow 12:15p.m. 1:45p.m. S106b 190

Live/Taped Cases

2203 LiveandTapedCaseSessionIII:ValvularHeartDisease 12:30p.m. 2:30p.m. hall B, ACC.12 Main Tent

194

Special 2114 FellowsBootcamp:StructuralHeart 2:00p.m. 3:30p.m. S103b 194

Special 2132 AnatomyandTranscatheterTherapyfortheStructuralHeartInterventionalistII: LeftAtrialAppendageClosure,PFO,ASDandTransseptalPuncture(withRemoteDemonstrationsfromtheSeattleScienceFoundation)

2:00p.m. 3:30p.m. S102c 195

Symposium 2635 ImagingTranscatheterAorticValveProceduresII:SelectingtheBestPatient, ValveandVascularApproach

2:00p.m. 3:30p.m. S101a 195

Symposium 2636 SpotlightSessiononTAVR 2:00p.m. 3:30p.m. S102b 195

Symposium 2637 ManagementofSymptomaticSevereCarotidArteryDisease 2:00p.m. 3:30p.m. S103c 195

Symposium 2638 State-of-the-ArtSTEMI:AllYouNeedtoKnow 2:00p.m. 3:30p.m. S106b 196

MOC 823 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—InterventionalCardiology2011Update(B2-L)

3:00p.m. 5:30p.m. S105a 200

Symposium 2639 ControversiesinIntravascularImaging 3:45p.m. 5:15p.m. S101a 202

Symposium 2640 MitralInterventions 3:45p.m. 5:15p.m. S102b 200

Symposium 2641 ImportanceofBleedinginPatientswithCVDisease:APersonalizedApproach forTreatmentStrategies

3:45p.m. 5:15p.m. S103b 200

Symposium 2642 EndovascularManagementofErectileDysfunction 3:45p.m. 5:15p.m. S103c 200

Symposium 2643 ACS:NewInsightsandNovelTherapies 3:45p.m. 5:15p.m. S106b 201

Clinical Focus 1607 JointSessionoftheAmericanAssociationforThoracicSurgery,theSocietyofThoracicSurgeryandtheAmericanCollegeofCardiology:MultidisciplinaryApproachtotheHighRiskAorticStenosisPatient

5:45p.m. 9:05p.m. S401a 205

ACC.12 •Program-At-A-Glance •Topic Schedule

90 GO for ACC.12!

ACuTE CORONARy SyNDROMESSESSIONTYPE SESS.# TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012Experts 200 ContemporaryManagementofUA/NSTEMI 8:00a.m. 9:30a.m. S504a 107

Oral 902 P2Y12Antagonists:UnravelingtheMechanismsandOptimizingBenefit-Risk 8:00a.m. 9:30a.m. S406b 107

Oral 903 NewTherapeuticOptionsinACS:FromAntiplateletstoAntibiotics 8:00a.m. 9:30a.m. S402 108

Symposium 604 ControversiesinACS 12:15p.m. 1:45p.m. S404 115

Experts 211 OptimalSTEMIManagementfromPresentationtoPost-DischargeCare 2:00p.m. 3:30p.m. S504a 121

Symposium 613 State-of-the-ArtinSTEMICare 2:00p.m. 3:30p.m. S404 121

Symposium 618 TranslationalResearchSymposiumwiththeInternationalSocietyforCardiovascular TranslationalResearch:CellularTherapies

2:00p.m. 3:30p.m. N228 121

Symposium 623 AdjunctivePharmacologyinACS:AnticoagulantsandAntiplateletAgents 4:30p.m. 6:00p.m. S404 126

SuNDAy, MARCh 25, 2012Experts 221 ComplicationsofAMI 8:00a.m. 9:30a.m. S504a 140

Oral 916 WhatImpactsOutcomesinACS?FromGenestoPlaqueMorphologytoEnvironment 8:00a.m. 9:30a.m. S401a 140


9:30a.m. 10:30a.m. hall A

Oral 917 ImprovingOutcomesinACS:InsightsfromBasicScienceandPreclinicalResearch 10:45a.m. 12:15p.m. N227b 148



Symposium 639 TheFutureofACSClinicalTrials 12:30p.m. 1:45p.m. S404 156

Experts 231 ManagementofChestPainintheEmergencyDepartment 2:00p.m. 3:30p.m. S504a 162

Symposium 653 State-of-the-ArtinNonSTElevationAcuteCoronarySyndromes 2:00p.m. 3:30p.m. S404 162

Symposium 665 LiteratureInterpretationandStatisticalPitfallsinACSTrials 4:30p.m. 6:00p.m. S402 167

Clinical Focus 1605 InnovationsinTranslation:ACS 6:30p.m. 9:30p.m. Fairmont hotel, Imperial

Ballroom

171

MONDAy, MARCh 26, 2012Symposium 676 ShockinACS 8:00a.m. 9:30a.m. S401a 178

Symposium 689 ImprovingSTEMIOutcomes:SavingMyocardiumandAttenuatingRemodeling 10:30a.m. Noon S401a 184

Intl. Lunch 513 JointSessionoftheMexicanSocietyofCardiologyandtheAmericanCollegeof Cardiology:AcuteCoronarySyndromes—ImprovingOutcomes

12:15p.m. 1:45p.m. S404 190

TuESDAy, MARCh 27, 2012Symposium 728 JointSymposiumoftheAmericanAssociationforClinicalChemistryandthe

AmericanCollegeofCardiology:HowtoUseCardiacBiomarkers8:00a.m. 9:30a.m. N230 209



ARRhyThMIASSESSIONTYPE SESS.# TITLE START END ROOM PAGE

Saturday, March 24, 2012Experts 201 HowtoManageaDevice/LeadAdvisory 8:00a.m. 9:30a.m. S503 108

Experts 206 AlternativestoWarfarinforthePreventionofStrokeinAtrialFibrillation:HowtoDecide? 12:15p.m. 1:45p.m. S503 116

Experts 212 ManagementofDifficultAF:WhentoChangeDrugs,WhentoGiveUp 2:00p.m. 3:30p.m. S503 121

Symposium 614 CanRemoteDiseaseManagementImproveClinicalOutcomes? 2:00p.m. 3:30p.m. S406a 121

Symposium 615 ChallengesintheManagementofSupraventricularTachycardia 2:00p.m. 3:30p.m. S403 121

Symposium 735 PharmacologyProgram:PharmacotherapyofNewAntithrombotics 2:00p.m. 3:30p.m. N427 122

Symposium 736 PharmacologyProgram:PharmacologicConsiderationswithAntiarrhythmicDrugs, andDyslipidemiaandResidualRisk:WhenandHowDoYouAddtoStatinTherapy?

4:00p.m. 6:00p.m. N427 125

Experts 216 TheRiskversusBenefitofDFTTesting 4:30p.m. 6:00p.m. S503 126

Symposium 624 ManagementofComplicationsofPacemakersandLeads 4:30p.m. 6:00p.m. S403 126

Symposium 627 TranslationalResearchSymposiumwiththeInternationalSocietyforCardiovascular TranslationalResearch:TissueEngineering

4:30p.m. 5:30p.m. N228 127

Symposium 1601 ANewERAinAtrialFibrillation:StrategiesforImplementingNewTherapies 6:30p.m. 10:00p.m. Fairmont Hotel, International

Ballroom

129

SuNDAy, MARCh 25, 2012Experts 222 JointSymposiumoftheHeartRhythmSocietyandtheAmericanCollegeof

Cardiology:GeneticSyndromesfortheClinician(HCM,Brugada,LongQT)8:00a.m. 9:30a.m. S503 141

Oral 904 JointOralArrhythmiasSessionoftheHeartRhythmSocietyandtheAmericanCollegeofCardiology:ManagementofthePatientwithAtrialFibrillation—AnticoagulationandPreventionofStroke

8:00a.m. 9:30a.m. N426 141

Oral 918 CardiacMRIfortheTreatmentandEvaluationofArrhythmias 10:45a.m. 12:15p.m. S404 148

Oral 919 JointOralSessionoftheHeartRhythmSocietyandtheAmericanCollegeofCardiology:CardiacArrestandtheCareoftheICDPatient

10:45a.m. 12:15p.m. N426 149

Symposium 640 JointSymposiumoftheHeartRhythmSocietyandtheAmericanCollegeof Cardiology:InvestigationandManagementofSyncope

12:30p.m. 1:45p.m. N426 157

Experts 232 JointSymposiumoftheHeartRhythmSocietyandtheAmericanCollegeof Cardiology:OptimizingtheManagementofthePatientwithImplantableDevices

2:00p.m. 3:30p.m. S503 162

Symposium 654 JointSymposiumoftheHeartRhythmSocietyandtheAmericanCollegeof Cardiology:AtrialFibrillation—PreventionofStroke

2:00p.m. 3:30p.m. N426 162

Symposium 666 JointSymposiumoftheHeartRhythmSocietyandtheAmericanCollegeof Cardiology:AtrialFibrillation—ManagementoftheArrhythmia

4:30p.m. 6:00p.m. N426 167

Clinical Focus 1603 JointSessionoftheHeartRhythmSocietyofAmericaandtheAmericanCollegeofCardiology:InnovationsinTranslation—AtrialFibrillation

6:30p.m. 9:30p.m. Fairmont hotel, International

Ballroom

172

MONDAy, MARCh 26, 2012Experts 239 Case-OrientedGapsintheGuidelines:WhoShouldGetanICD? 8:00a.m. 9:30a.m. S504a 178

Symposium 677 ClinicalManagementoftheAFPatient:TreatingthePatientandtheHealthCareProvider 8:00a.m. 9:30a.m. N226 178


9:30a.m. 10:30a.m. hall A

Experts 243 PerioperativeManagementofPatientswithCardiacImplantableElectronicDevice 10:30a.m. Noon S504a 184

Symposium 690 ControversiesinDeviceTherapy 10:30a.m. Noon S406a 184

Symposium 691 TheGeneticsofSuddenCardiacDeath:WhatDoWeKnowandHowBestto EvaluateandManageSuchPatients

10:30a.m. Noon N226 184



Intl. Lunch 501 JointSessionoftheJapaneseCollegeofCardiologyandtheAmericanCollege ofCardiology:RiskStratificationforSuddenCardiacDeath

12:15p.m. 1:45p.m. S403 190

Intl. Lunch 509 JointSessionoftheCardiologicalSocietyofIndiaandtheAmericanCollege ofCardiology:AF—Medical,EP,SurgicalOptions

12:15p.m. 1:45p.m. S401a 190

Symposium 702 SuddenCardiacDeathRiskStratificationinHeartFailure:Past,Presentand FutureDirections

2:00p.m. 3:30p.m. S406a 196


92 GO for ACC.12!

ARRhyThMIASSESSIONTYPE SESS.# TITLE START END ROOM PAGE


Symposium 703 SyncopeinSpecialPopulations 2:00p.m. 3:30p.m. N227b 196

Symposium 715 ChallengesintheManagementofVentricularArrhythmias 3:45p.m. 5:15p.m. S406a 201

Symposium 716 IssuesinCardiacResynchronizationTherapy 3:45p.m. 5:15p.m. N227b 201

TuESDAy, MARCh 27, 2012Symposium 747 AntithromboticTherapiesforAtrialFibrillation:CurrentStateoftheArt 8:00a.m. 9:30a.m. S404 209

CONGENITAL CARDIOLOGy SOLuTIONSSESSIONTYPE SESS.# TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012Symposium 202 ComplexIssuesFacingACHDPatients:ObstructiveLesions 8:00a.m. 9:30a.m. S105a 108

Oral 901 FromTargetingErrorstoUNOS:HowQualityandDatabasesCanImpactClinicalCare 10:30a.m. Noon S105a 114

Symposium 616 Quality,SafetyandResourcesEnhancingPediatricCardiovascularCare 2:00p.m. 3:30p.m. N231 122

Symposium 625 UpdatesonCareintheCongenitalHeartDiseasePatients 4:30p.m. 6:00p.m. N231 127

SuNDAy, MARCh 25, 2012Symposium 634 PreoperativeAssessmentofPatientsontheSingleVentriclePathway:

SpecialProblemsCreativeSolutions8:00a.m. 9:30a.m. N231 141

MOC 802 ACCFStudySessionforMaintenanceofCertification:AmericanBoardofPediatrics(ABP)RecertificationMadeEasy—2011PediatricCardiologySubspecialtySelf-Assessment

8:00a.m. 10:00a.m. S105d 109


9:30a.m. 10:30a.m. hall A

Symposium 637 Post-OperativeGlennsandFontans:NavigatingTurbulentWaters 10:45a.m. 12:15p.m. N231 149

Oral 920 AdultswithCongenitalHeartDisease:ImagingPredictors,EvolvingTherapiesandOutcomes 10:45a.m. 12:15p.m. S402 149



Special 301 Career&MentoringSessionforPediatricandCongenitalCardiologists 12:30p.m. 1:45p.m. N231 157

Legends 402 LegendsinCardiovascularMedicineLectureSeries—2012DanG.McNamaraLecture 2:00p.m. 3:30p.m. N228 162

Symposium 667 TheGreatDebates 4:30p.m. 6:00p.m. N231 167

Symposium 668 ACHDfortheGeneralCardiologist 4:30p.m. 6:00p.m. N230 168

MONDAy, MARCh 26, 2012Symposium 678 PulmonaryArteryStenosisCurrentTherapyandFutureDirections:LiveCase 8:00a.m. 9:30a.m. N231 178

Symposium 679 WomenwithCongenitalHeartDisease:Fertility,PregnancyandMenopause 8:00a.m. 9:30a.m. S501a 179

Symposium 692 PulmonaryVeinStenosis:WhatAreRealisticExpectations? 10:30a.m. Noon N229 184

Symposium 693 ChallengingImagingIssuesinCongenitalHeartDisease 10:30a.m. Noon N231 185

Intl. Lunch 506 JointSessionoftheEgyptianSocietyofCardiologyandtheAmericanCollegeof Cardiology:AdultCongenitalHeartDisease:WhereWeCameFromandWhereWeAre

12:15p.m. 1:45p.m. N231 191

Experts 247 AcquiredHeartDiseaseinChildhoodEpidemiology:CurrentandFutureManagement 2:00p.m. 3:30p.m. S501a 196

Experts 252 GoldenMoments:WhenIstheRightTimetoInterveneinCongenitalHeartDisease? 3:45p.m. 5:15p.m. S501a 201

TuESDAy, MARCh 27, 2012Symposium 724 ComplexConotruncalMalformations:WhattheSurgeonNeedstoKnowand

HowtoGettheInformation8:00a.m. 9:30a.m. N229 209

Symposium 725 ComingofAge:TheHLHSTurns21 8:00a.m. 9:30a.m. N231 209



hEART FAILuRESESSIONTYPE SESS.# TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012Experts 203 TheLatestinHeartFailurewithPreservedEjectionFraction 8:00a.m. 9:30a.m. S502 109

Symposium 732 PharmacologyProgram:PharmacotherapyofChronicHeartFailure 8:00a.m. 9:30a.m. N427 109

Oral 905 PredictingOutcomesinHeartFailure:BiomarkersandBeyond 8:00a.m. 9:30a.m. S405 109

Oral 906 PathogenicandTherapeuticInsightsfromExperimentalHeartFailureModels 8:00a.m. 9:30a.m. S404 109

Experts 207 AtrialFibrillationandHeartFailure:ADynamicDuo 12:15p.m. 1:45p.m. S502 116

Experts 213 FromShocktoRecoveryorBridgetoTransplanation:RoleofPercutaneousVADs andOtherSupportDevices

2:00p.m. 3:30p.m. S502 122

Symposium 617 CardiorenalSyndromeinHeartFailure:FromDefinitiontoManagement 2:00p.m. 3:30p.m. S406b 122

Experts 217 HeartFailureDiseaseManagement:Issuesfor2012 4:30p.m. 6:00p.m. S502 127

Symposium 626 ManagementofAcuteDecompensatedHeartFailure:FromHemodynamic SubsetstoAppropriateTreatmentStrategies

4:30p.m. 6:00p.m. S406b 127

SuNDAy, MARCh 25, 2012Symposium 635 JointSymposiumoftheHeartFailureSocietyofAmericaandtheAmericanCollege

ofCardiology:ContemporaryPharmacologicalTreatmentofSystolicandDiastolicHeartFailure8:00a.m. 9:30a.m. S406b 141

Experts 225 HeartFailureCarefortheVeryOld:WhatAretheKeyIssuesforSuccess? 10:45a.m. 12:15p.m. S502 150

Oral 921 JointOralSessionoftheHeartFailureSocietyofAmericaandtheAmericanCollegeofCardiology:IndividualizingPharmacologicalTherapyinHeartFailure

10:45a.m. 12:15p.m. S406b 150

Oral 922 ImprovingPatientSelectionforDevice-BasedTherapies 10:45a.m. 12:15p.m. S405 150

Experts 228 CardiacMRfortheEvaluationoftheHeartFailurePatient 12:30p.m. 1:45p.m. S502 157

Symposium 641 JointSymposiumoftheHeartFailureSocietyofAmericaandtheAmericanCollege ofCardiology:ContemporaryIssuesintheDiagnosisandTreatmentofChronicAmbulatoryHeartFailure

12:30p.m. 1:45p.m. S406b 157

Symposium 642 CardiotoxicityofCancerChemotherapy:MolecularBasisandStrategiesfor EarlyDetectionandPrevention

12:30p.m. 1:45p.m. S405 157

Symposium 655 JointSymposiumoftheHeartFailureSocietyofAmericaandtheAmericanCollege ofCardiology:TheGrowingRoleofDevicesinHeartFailureManagement—ICD,CRT,HemodynamicMonitoringandUltrafiltration

2:00p.m. 3:30p.m. S406b 163

Symposium 656 TheNHLBIHeartFailureClinicalTrialsNetwork:ANewParadigmforInvestigation andTraining

2:00p.m. 3:30p.m. S405 163

Symposium 669 JointSymposiumoftheHeartFailureSocietyofAmericaandtheAmericanCollege ofCardiology:ManagementofAdvancedHeartFailureandTransplantation

4:30p.m. 6:00p.m. S406b 168

Symposium 670 HeartTransplantation:Challengesin2012 4:30p.m. 6:00p.m. S405 168

Symposium 671 PersonalizedMedicineandtheFutureofMedicalCare 4:30p.m. 6:00p.m. S404 168

MONDAy, MARCh 26, 2012Experts 240 Myocarditis:WhentoBiopsy,WhotoTreat,WhichTherapy? 8:00a.m. 9:30a.m. S502 179

Symposium 680 ControversiesintheManagementofHeartFailure 8:00a.m. 9:30a.m. S406b 179

Symposium 681 SurgicalTherapyofHeartFailure 8:00a.m. 9:30a.m. S404 179


9:30a.m. 10:30a.m. hall A

Symposium 694 LVADasDestinationTherapyforAdvancedHeartFailure 10:30a.m. Noon S406b 185

Symposium 695 ManagementofPeripartumCardiomyopathy:Update2012 10:30a.m. Noon S404 185



Intl. Lunch 517 JointSessionoftheSpanishSocietyofCardiologyandtheAmericanCollegeof Cardiology:HeartFailure—DevicestoTransplantation

12:15p.m. 1:45p.m. S501a 191

Symposium 704 CardiacResynchronizationTherapy:WhomtoReferforImplantation? 2:00p.m. 3:30p.m. S406b 196

Symposium 705 UnderstandingtheComplexityoftheRightVentricle:ChallengesandProgress 2:00p.m. 3:30p.m. S404 196

Symposium 706 JointSymposiumoftheItalianFederationofCardiologyandthePennsylvaniaChapter oftheAmericanCollegeofCardiology:UpdateontheTreatmentofAtrialFibrillation

2:00p.m. 3:30p.m. N230 197


94 GO for ACC.12!

hEART FAILuRESESSIONTYPE SESS.# TITLE START END ROOM PAGE


Symposium 717 ImprovingOutcomesandReducingHeartFailureReadmissions 3:45p.m. 5:15p.m. S406b 202

Symposium 718 ControversiesinTreatmentofComorbiditiesinHeartFailure:Paradoxesand ChallengesinTreatment

3:45p.m. 5:15p.m. S404 202

TuESDAy, MARCh 27, 2012Experts 257 CardiacAmyloidosis 8:00a.m. 9:30a.m. S502 209

IMAGINGSESSIONTYPE SESS.# TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012Experts 204 MultimodalityImaginginEvaluationofProstheticValveFunction 8:00a.m. 9:30a.m. S505 110

Oral 908 ABetterUnderstandingofIschemiaandFunction:InsightsfromCardiacMRI 8:00a.m. 9:30a.m. S403 110

Oral 909 NewImagingApproachestoAtherosclerosisandtheMicrocirculation 8:00a.m. 9:30a.m. N426 110


9:30a.m. 10:30a.m. hall A



Experts 208 ImagingPatientswithPericardialDisease 12:15p.m. 1:45p.m. S505 116

Symposium 605 CardiovascularMagneticResonanceinMyocarditis 12:15p.m. 1:45p.m. S402 116

Experts 214 CurrentTopicsinCardiacCT 2:00p.m. 3:30p.m. S505 122

Symposium 619 MultimodalityImagingofHypertrophicCardiomyopathy 2:00p.m. 3:30p.m. S402 122

Experts 218 MyocardialPerfusionImaging:PickingtheRightTest 4:30p.m. 6:00p.m. S505 127

Symposium 628 Multi-ModalityImaging:ChestPainintheEmergencyDepartment 4:30p.m. 6:00p.m. S402 127

SuNDAy, MARCh 25, 2012Experts 223 CardiacPET:IncorporationintoDailyPractice 8:00a.m. 9:30a.m. S505 142

Oral 907 JointOralSessionoftheAmericanSocietyofEchocardiographyandtheAmericanCollegeofCardiology:NewestApplicationsofEchotoClinicalPractice

8:00a.m. 9:30a.m. S406a 142

Symposium 638 JointSymposiumoftheAmericanSocietyofEchocardiographyandtheAmerican CollegeofCardiology:Cardiomyopathy—AComprehensiveEchocardiographicApproach

10:45a.m. 12:15p.m. S406a 151

Oral 924 CardiacCT:TowardaBetterUnderstandingofCAD 10:45a.m. 12:15p.m. S403 151

Symposium 643 JointSymposiumoftheAmericanSocietyofEchocardiographyandtheAmerican CollegeofCardiology:InterventionalEchocardiography—EvolvingRoleinPatientManagement

12:30p.m. 1:45p.m. S406a 158

Symposium 644 Cost-EffectiveImaginginPatientswithChronicCAD 12:30p.m. 1:45p.m. S403 158

Experts 233 RoleofCMRinValvularHeartDisease 2:00p.m. 3:30p.m. S505 163

Symposium 657 JointSymposiumoftheAmericanSocietyofEchocardiographyandtheAmerican CollegeofCardiology:HealthcareReform—ImpactonImaging

2:00p.m. 3:30p.m. S406a 163

Symposium 658 RadionuclideImagingintheHeartFailurePatient 2:00p.m. 3:30p.m. S403 163

Symposium 672 JointSymposiumoftheAmericanSocietyofEchocardiographyandtheAmerican CollegeofCardiology:Echoin2012—WhatYouNeedtoKnowtoKeepUp

4:30p.m. 6:00p.m. S406a 168



IMAGINGSESSIONTYPE SESS.# TITLE START END ROOM PAGE

MONDAy, MARCh 26, 2012Experts 241 ImagingtheRightVentricle 8:00a.m. 9:30a.m. S505 179

Symposium 682 AdvancedLVDysfunction:AMultimodalityApproach 8:00a.m. 9:30a.m. S405 179

Symposium 683 FutureDirectionsforCardiacCT 8:00a.m. 9:30a.m. S403 180

Symposium 696 CardiacCTin2012:State-of-the-Art 10:30a.m. Noon S405 185

Symposium 697 RoleofEchointheEvaluationandManagementofPatientswithMitralRegurgitation 10:30a.m. Noon S403 185

Intl. Lunch 507 JointSessionoftheGermanCardiacSocietyandtheAmericanCollegeof Cardiology:Imaging—EvolvingStrategies

12:15p.m. 1:45p.m. S406b 191

Symposium 707 ManagementofthePatientwithValvularHeartDisease:RoleofEcho 2:00p.m. 3:30p.m. S405 197

Symposium 708 AdvancesinNuclearCardiology:CurrentandFutureApplications 2:00p.m. 3:30p.m. S403 197

Symposium 719 EmergingApplicationsofCMR 3:45p.m. 5:15p.m. S403 202

TuESDAy, MARCh 27, 2012Experts 258 EchoinAssessmentofLowGradientAorticStenosis 8:00a.m. 9:30a.m. S505 210

ChRONIC CAD/STABLE ISChEMIC hEART DISEASESESSIONTYPE SESS.# TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012Oral 910 Sex,Scoring,Sadness,Statins,StentsandSurgery 8:00a.m. 9:30a.m. N227b 111

Symposium 606 RevascularizationInSIHD:IntegratingNewEvidence 12:15p.m. 1:45p.m. S401a 116

Symposium 620 StableIschemicHeartDiseaseinWomen:AreTheyReallyfromVenus? 2:00p.m. 3:30p.m. S401a 123

Symposium 629 StableIschemicHeartDisease:What’sNewintheGuidelines(AndWhatShouldBe)? 4:30p.m. 6:00p.m. S401a 128

SuNDAy, MARCh 25, 2012Oral 923 WhoSaidThere’sNothingNew? 10:45a.m. 12:15p.m. N230 151

Symposium 645 ManagingHigh-riskPatientswithStableIschemicHeartDisease 12:30p.m. 1:45p.m. S401a 158

Experts 234 HeartFailureinStableIschemicHeartDisease:NotfortheWeakofHeart 2:00p.m. 3:30p.m. S502 163

MONDAy, MARCh 26, 2012Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement

to JACC: Abstracts of Original Contributionsforacompletelisting.9:30a.m. 10:30a.m. hall A



Intl. Lunch 508 JointSessionoftheBritishCardiovascularSocietyandtheAmericanCollege ofCardiology:NICEGuidelines

12:15p.m. 1:45p.m. N427 191

Symposium 709 TransitioningfromACStoStableIschemicHeartDisease 2:00p.m. 3:30p.m. S401a 197

TuESDAy, MARCh 27, 2012Experts 259 InnovationsinNoninvasiveEvaluationofStableIschemicHeartDisease 8:00a.m. 9:30a.m. S503 210


96 GO for ACC.12!

LIFELONG LEARNINGSESSIONTYPE SESS.# TITLE START END ROOM PAGE

FRIDAy, MARCh 23, 2012MOC 801 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ACCSelf

AssessmentSession:UpdateinClinicallyRelevantGuidelinesandTrials7:30a.m. 10:00a.m. S105a 105

SATuRDAy, MARCh 24, 2012MOC 802 ACCFStudySessionforMaintenanceofCertification:AmericanBoardofPediatrics(ABP)Recertification

MadeEasy—2011PediatricCardiologySubspecialtySelf-Assessment8:00a.m. 10:00a.m. S105d 111

Symposium 607 EverythingYouWantedtoKnowaboutABIMRecertification(andmore...) 12:15p.m. 1:45p.m. N226 116

MOC 803 ACCFStudySessionsforMaintenanceofCertification:ABIMRecertificationMadeEasy—CardiovascularDisease2010Update(A1-K)

12:30p.m. 3:00p.m. S105a 118

MOC 804 ACCFStudySessionsforMaintenanceofCertification:ABIMRecertificationMadeEasy—CardiovascularDisease2011Update(A1-L)

12:30p.m. 3:00p.m. S105d 118

Core 805 CoreCurriculum:CongenitalHeartDisease 2:00p.m. 3:30p.m. N226 123

Core 806 CoreCurriculum:CongestiveHeartFailure 2:00p.m. 3:30p.m. N229 123

MOC 807 ACCFStudySessionsforMaintenanceofCertification:ABIMRecertificationMadeEasy—CardiovascularDisease2011Update(A1-L)

3:30p.m. 6:00p.m. S105a 124

MOC 808 ACCFStudySessionsforMaintenanceofCertification:ABIMRecertificationMadeEasy—CardiovascularDisease2010Update(A1-K)

3:30p.m. 6:00p.m. S105d 127

Core 809 CoreCurriculum:Echocardiography 4:30p.m. 6:00p.m. N226 128

Core 810 CoreCurriculum:CardiacElectrophysiology 4:30p.m. 6:00p.m. N229 128

SuNDAy, MARCh 25, 2012Symposium 731 CCATeam-BasedMaintenanceofCertification 8:00a.m. 10:30a.m. S105d 142

MOC 811 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ACCGeneralCardiologyModulePartA

12:30p.m. 3:00p.m. S105a 158

MOC 812 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ACCGeneralCardiologyModulePartB

12:30p.m. 3:00p.m. S105d 158

Symposium 659 MasterClinicianI:DiscussionofThreeComplexRealWorldCases 2:00p.m. 3:30p.m. S401a 163

Core 813 CoreCurriculum:GeneralCardiology 2:00p.m. 3:30p.m. N226 164

Core 814 CoreCurriculum:ValvularHeartDisease 2:00p.m. 3:30p.m. N229 164

MOC 815 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ACCGeneralCardiologyModulePartB

3:30p.m. 6:00p.m. S105a 165

MOC 816 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ACCGeneralCardiologyModulePartA

3:30p.m. 6:00p.m. S105d 166

Symposium 737 MasterClinician:ClinicalCasesII 4:30p.m. 6:00p.m. S401a 169

Core 817 CoreCurriculum:CoronaryArteryDisease 4:30p.m. 6:00p.m. N226 169

Core 818 CoreCurriculum:NuclearCardiology 4:30p.m. 6:00p.m. N229 169

MONDAy, MARCh 26, 2012Boot Camp 112 CCAResearchBootcampSessionI:MethodsforEngaginginResearch 8:00a.m. 9:30a.m. S105d 180

MOC 819 ACCFStudySessionsforMaintenanceofCertification:ABIMRecertificationMadeEasy—InterventionalCardiology2010Update(B2-K)

12:15p.m. 2:45p.m. S105a 192

MOC 820 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ClinicalCardiacElectrophysiology2010Update(B3-K)

12:15p.m. 2:45p.m. S105d 192

Core 821 CoreCurriculum:CardiacCatheterization 2:00p.m. 3:30p.m. N226 197

Core 822 CoreCurriculum:PreventiveCardiology 2:00p.m. 3:30p.m. N229 198

MOC 823 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—InterventionalCardiology2011Update(B2-L)

3:00p.m. 5:30p.m. S105a 200

MOC 824 ACCFStudySessionforMaintenanceofCertification:ABIMRecertificationMadeEasy—ClinicalCardiacElectrophysiology2011Update(B3-L)

3:00p.m. 5:30p.m. S105d 200



LIFELONG LEARNINGSESSIONTYPE SESS.# TITLE START END ROOM PAGE


Core 825 CoreCurriculum:VascularDisease 3:45p.m. 5:15p.m. N226 202

Core 826 CoreCurriculum:LandmarkTrials 3:45p.m. 5:15p.m. N229 203

TuESDAy, MARCh 27, 2012Boot Camp 114 CCAResearchBootcampSessionII:SuccessfulResearchExecutionandDissemination 8:00a.m. 9:30a.m. S105d 210

PERICARDIAL/MyOCARDIAL DISEASESESSIONTYPE SESS.# TITLE START END ROOM PAGE

SuNDAy, MARCh 25, 2012Poster Posterpresentationswillbefeaturedinthislearningpathway.RefertotheSupplement

to JACC: Abstracts of Original Contributionsforacompletelisting.9:30a.m. 10:30a.m. hall A

Oral 925 AllThatGlittersinMyocardialandPericardialDisease 10:45a.m. 12:15p.m. N226 152



Experts 229 GraspingtheComplexityofMyocardialandPericardialDiseases 12:30p.m. 1:45p.m. S505 159

Symposium 648 TheNewHypertrophicCardiomyopathyPracticeGuidelines 12:30p.m. 1:45p.m. N226 159

Symposium 661 ControversiesinHypertrophicCardiomyopathy 2:00p.m. 3:30p.m. N427 164

Experts 236 GeneticEvaluationofCardiomyopathy 4:30p.m. 6:00p.m. S505 169

MONDAy, MARCh 26, 2012Experts 253 ChallengesinHypertrophicCardiomyopathy:CaseStudies 3:45p.m. 5:15p.m. S505 203

Symposium 720 NewDirectionsintheEvaluationandManagementoftheCardiomyopathies 3:45p.m. 5:15p.m. N231 203

PuLMONARy hyPERTENSIONSESSIONTYPE SESS.# TITLE START END ROOM PAGE

SuNDAy, MARCh 25, 2012Oral 912 What’sNewinPulmonaryHypertension 8:00a.m. 9:30a.m. N226 142


9:30a.m. 10:30a.m. hall A



Symposium 649 EmergingApproachestoPulmonaryHypertensionwithLeftVentricularDysfunction 12:30p.m. 1:45p.m. S402 159

Symposium 662 PulmonaryHypertensionManagementinSpecialPopulations 2:00p.m. 3:30p.m. S402 164

MONDAy, MARCh 26, 2012Experts 249 PearlsandCaveatsinManagingPatientswithPulmonaryHypertension 2:00p.m. 3:30p.m. S505 198

Experts 254 PulmonaryHypertensionToolsfortheCardiologist 3:45p.m. 5:15p.m. S504a 203

TuESDAy, MARCh 27, 2012Symposium 726 SesionConjuntaConLaSociedadEspanoladeCardiologíaSociedadInteramericade

Cardiología/AmericanCollegeofCardiology:ProblemasRelevantesenCardiología—20128:00a.m. 9:30a.m. S403 210


98 GO for ACC.12!

PRACTICE PERFORMANCE, IMPROvEMENT AND ADMINISTRATIONSESSIONTYPE SESS.# TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012Symposium 600 CardiologyProcedures2012:HowtoCodeandGetReimbursed 8:00a.m. 9:30a.m. N231 112

Symposium 608 WomeninCardiology 12:15p.m. 1:45p.m. N229 116

Symposium 609 TheChallengesinDailyPractice 12:15p.m. 1:45p.m. N230 117

Symposium 621 ACC/MedAxiom/ACCA:Physician/HospitalIntegration101 2:00p.m. 3:30p.m. N230 123

Symposium 630 InformationTechnology,MedicineandtheFuture 4:30p.m. 6:00p.m. N230 128

SuNDAy, MARCh 25, 2012Experts 226 ACC/MedAxiom/ACCA:Physician/HospitalIntegration:MakingitWork 10:45a.m. 12:15p.m. S505 152

Symposium 647 JointSessionoftheHealthcareInformationandManagementSystemsSocietyand theAmericanCollegeofCardiology:HealthInformationTechnologyPartI:MakingtheElectronicHealthRecordMeaningfulandUseful—AWashingtonPerspective

12:30p.m. 1:45p.m. N227b 159

Symposium 660 JointSessionoftheHealthcareInformationandManagementSystemsSocietyand theAmericanCollegeofCardiology:HealthInformationTechnologyPartII:EHRImplementation…LessonsfromtheTrenches

2:00p.m. 3:30p.m. N227b 164

Symposium 673 FutureCompensationunderHealthCareReform 4:30p.m. 6:00p.m. N227b 169

MONDAy, MARCh 26, 2012Symposium 684 ACC/MedAxiom/ACCA:CardiovascularServiceLines 8:00a.m. 9:30a.m. S105a 180

Experts 244 LeadershipandGovernance 10:30a.m. Noon S503 185

Experts 248 IssuesthatHaveCausedMedicalProfessionalLiabilityClaims:AreYouatRisk? ASpecialPresentationfromTheDoctorsCompany

2:00p.m. 3:30p.m. S504a 198

Symposium 710 ImpactofHealthcarePolicyontheAcademicCardiovascularMission 2:00p.m. 5:30p.m. S402 198

PREvENTIONSESSIONTYPE SESS.# TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012Symposium 733 PharmacologyProgram:CardiovascularImplicationsofDietarySupplements 10:30a.m. Noon N427 114

Symposium 611 IsThereaRoleforHDLTherapy:AreWeAIMingTooHIGH? 12:15p.m. 1:45p.m. S100c 117

Symposium 622 EmergingTrendsinAtherosclerosis 2:00p.m. 3:30p.m. S100c 123

Symposium 631 HypertensionGuidelines2012 4:30p.m. 6:00p.m. S100c 128

Clinical Focus 1602 FirstLineofDefense:RiskFactorsandPreventionintheCardiologyPractice—AMasterClassfortheCommunityCardiologist

6:30p.m. 9:30p.m. Fairmont hotel, Gold

Room

130

SuNDAy, MARCh 25, 2012Oral 911 Prevention:FocusonLipids 8:00a.m. 9:30a.m. S100c 142


9:30a.m. 10:30a.m. hall A

Experts 227 UpdateontheATPIVGuidelines 10:45a.m. 12:15p.m. S501a 157

Oral 926 Prevention:RenalSympatheticDenervation—ANovelTherapyforHypertension? 10:45a.m. 12:15p.m. N228 153

Oral 927 Prevention:CardiovascularRiskAssessmentandRehabilitation 10:45a.m. 12:15p.m. S401a 153



Experts 230 ManagementofHypertensionintheElderly 12:30p.m. 1:45p.m. S501a 159

Experts 235 DietaryApproachesforCVDPrevention:MatchingtheDiettothePatient 2:00p.m. 3:30p.m. S501a 164



PreventionSESSION TYPE SESS. # TITLE START END rooM PAGE

SUnDAY, MArCH 25, 2012 (continued)

Symposium 663 Resistant Hypertension 2:00 p.m. 3:30 p.m. S100c 165

Experts 237 Reducing Disparities in Cardiovascular Preventive Care 4:30 p.m. 6:00 p.m. S501a 169

Symposium 675 What’s New in the ACCF/AHA Guidelines 4:30 p.m. 6:00 p.m. n228 169

Symposium 730 The Difficult-to-Manage Lipid Patient 4:30 p.m. 6:00 p.m. S100c 170

MonDAY, MArCH 26, 2012Symposium 685 ACC China Chapter Session: Cardiovascular Clinical Research and Practice in China 8:00 a.m. 9:30 a.m. n229 180

Symposium 686 Global CVD Prevention: Heart Disease and Risk Factors in Specific Populations 8:00 a.m. 9:30 a.m. S100c 180

Experts 245 Women’s Cardiovascular Health 10:30 a.m. Noon S501a 185

Symposium 698 Vitamins and Supplements in Cardiovascular Disease Prevention 10:30 a.m. Noon S100c 186

Symposium 699 Joint Symposium of the Preventive Cardiovascular Nurses Association and the American College of Cardiology

10:30 a.m. Noon S105d 186

Intl. Lunch 512 Joint Session of the National Heart Association of Malaysia and the American College of Cardiology: Resistant Hypertension

12:15 p.m. 1:45 p.m. S504a 192

Intl. Lunch 516 Joint Session of the South American Society of Cardiology and the American College of Cardiology: Prevention — Assessing and Educating Across Regions

12:15 p.m. 1:45 p.m. S502 192

Symposium 701 Role of Physical Activity in CVD Prevention 12:15 p.m. 1:45 p.m. S100c 193

Experts 250 Labile Hypertension: Evaluation and Management 2:00 p.m. 3:30 p.m. S502 198

Symposium 711 Joint Symposium of the American Association of Clinical Endocrinologists and the American College of Cardiology: Cardiologists as Endocrinologists — Emerging Management of the Diabetic Patient

2:00 p.m. 3:30 p.m. S100c 199

Symposium 729 Beyond Statins: LDL Management in the Challenging Patient 3:45 p.m. 5:15 p.m. S100c 203

Symposium 745 World Hellenic Biomedical Association, the Hellenic Cardiological Society, the Cyprus Society of Cardiology and the American College of Cardiology: Mediterranean Diet and Its Protective Effect on Cardiovascular Disease

3:45 p.m. 5:15 p.m. S405 203

tUeSDAY, MArCH 27, 2012Symposium 727 Joint Symposium of the American Society of Hypertension and the American

College of Cardiology: Hypertension in the Critically Ill Patient8:00 a.m. 9:30 a.m. S406a 210

QUAlitY of CAre AnD oUtCoMeSSESSION TYPE SESS. # TITLE START END rooM PAGE

SAtUrDAY, MArCH 24, 2012Experts 205 Am I Placing Inappropriate ICDs and Stents? Recent Registry Surprises 8:00 a.m. 9:30 a.m. S501a 112

Symposium 601 Patient-Centered Care: The New Imperative 8:00 a.m. 9:30 a.m. n226 112

Experts 209 Getting Access to Data: Successful Examples from the NCDR 12:15 p.m. 1:45 p.m. S501a 117

Symposium 610 Translational Research Symposium with the International Society for Cardiovascular Translational Research: Mission and Strategy in Translational Research

12:15 p.m. 1:45 p.m. n228 117

Experts 215 When Should a Medicine or Device Stop Being Used in Practice? 2:00 p.m. 3:30 p.m. S501a 123

Experts 219 Measuring and Optimizing Quality in your Outpatient Practice: The PINNACLE Registry 4:30 p.m. 6:00 p.m. S501a 128

SUnDAY, MArCH 25, 2012Experts 224 Tools to Improve Care Transition: The Hospital to Home (H2H) Experience 8:00 a.m. 9:30 a.m. S501a 143

Oral 913 Insights and Innovations to Improve Cardiac Risk 8:00 a.m. 9:30 a.m. n229 143

ACC.12 • Program-At-A-Glance • Topic Schedule

100 GO for ACC.12!

QuALITy OF CARE AND OuTCOMESSESSIONTYPE SESS.# TITLE START END ROOM PAGE

SuNDAy, MARCh 25, 2012 (continued)

Symposium 650 U.S.HealthSystemReform:What’sMissing? 10:45a.m. 12:15p.m. S100c 153

Oral 928 ImprovingPCIOutcomes 10:45a.m. 12:15p.m. N229 153

Symposium 664 JointSymposiumoftheAssociationofBlackCardiologistsandtheAmericanCollege ofCardiology:EthnicandRacialDisparitiesinCardiovascularDisease—ACalltoAction

2:00p.m. 3:30p.m. N230 165

MONDAy, MARCh 26, 2012Symposium 687 WhereWillCardiologyBein2015? 8:00a.m. 9:30a.m. N427 180


9:30a.m. 10:30a.m. hall A

Symposium 700 Lies,DamnedLiesandStatistics:PitfallsinLiteratureInterpretation 10:30a.m. Noon N427 186

Symposium 742 TheFutureofCardiovascularDiseases:WhereAreWeGoing(andWhereDoWeWanttoGo) 10:30a.m. Noon N426 186



Intl. Lunch 510 JointSessionoftheIsraelHeartSocietyandtheAmericanCollegeofCardiology:PCI 12:15p.m. 1:45p.m. N230 193

Intl. Lunch 515 JointSessionoftheSaudiHeartAssociationandtheAmericanCollegeofCardiology: QualityRegistries

12:15p.m. 1:45p.m. N227b 193

Symposium 712 BringingEvidencetotheBedside:MakingGuidelinesMoreAccessibletoClinicians 2:00p.m. 3:30p.m. N427 199

Symposium 713 MakingaDifference:CardiologyLeadershipintheCommunityandtheWorld 2:00p.m. 3:35p.m. N228 199

Symposium 721 TransformingHealthCareDeliverythroughCVRegistries 3:45p.m. 5:15p.m. N427 204

Symposium 722 ApplyingNewerCardiovascularAgentstoOlderAdults 3:45p.m. 5:15p.m. N228 204

SPECIAL TOPICSSESSIONTYPE SESS.# TITLE START END ROOM PAGE

FRIDAy, MARCh 23, 2012Symposium 746 4thAnnualCardiovascularConference:FocusontheMiddleEast 8:00a.m. Noon S101a 105

Legends 400 LegendsofCardiovascularMedicine—RoundtableForumandReception(ByInvitationOnly) 1:30p.m. 5:30p.m. S100c 106

SATuRDAy, MARCh 24, 2012Special 300 ACC.12OpeningShowcaseandLate-BreakingClinicalTrials:FeaturingtheLegendsof

CardiovascularMedicineLectureSeries—SimonDackLecture8:00a.m. 10:00a.m. hall B, ACC.12

Main Tent112

Special 103 EducatingtheEducators:BootcampforCardiologyFellowshipProgram DirectorsandCoordinators

12:15p.m. 1:45p.m. S405a 117

Special 104 FitForumI:FindingtheRightF.I.T.inDevelopingaCareerPlan Part1:FindingtheRightJob

12:15p.m. 1:45p.m. N227b 117

Special 106 EducatingtheEducators:FacultyDevelopmentforCardiologyFellowship ProgramDirectorsandCoordinators

2:00p.m. 3:30p.m. S405a 123

Special 107 FITForumI:FindingtheRightF.I.T.inDevelopingaCareerPlan Part2:LaunchingaSuccessfulCareer

2:00p.m. 3:15p.m. N227b 124

Legends 401 LegendsofCardiovascularMedicineLectureSeries—43rdAnnualLouisF.BishopLecture 2:00p.m. 3:00p.m. N426 124

Special 107A FITForumI:Mix‘n’Mingle 3:30p.m. 4:30p.m. hall A, Bistro ACC

125

Special 109 EducatingtheEducators:SymposiumforCardiologyFellowshipProgram DirectorsandCoordinators

4:30p.m. 6:30p.m. S405a 128

Special 110 FITForumII:Jeopardy 4:30p.m. 6:00p.m. N227b 129



SPECIAL TOPICSSESSIONTYPE SESS.# TITLE START END ROOM PAGE

SuNDAy, MARCh 25, 2012Special 304 Late-BreakingClinicalTrialsII 8:00a.m. 9:30a.m. hall B, ACC.12

Main Tent143

Special 405 YoungInvestigatorsAwardCompetition:ACCF/HermanK.GoldYoungInvestigatorsAwardinMolecularandCellularCardiology

8:00a.m. 9:30a.m. S105a 144

Special 406 YoungInvestigatorsAwardCompetition:Physiology,Pharmacology,andPathology 10:45a.m. 12:15p.m. S105a 154

Special 111 FITForumIII:HowtoWriteandEvaluateMedicalJournalArticles 12:30p.m. 1:45p.m. N229 159

Special 302 BusinessMeetingoftheCollege 3:00p.m. 3:15p.m. ACC Member Lounge

165

Experts 263 TheRoleofTherapeuticHypothermiaintheTreatmentofCardiacArrest 4:30p.m. 6:00p.m. S502 170

Legends 403 LegendsofCardiovascularMedicineLectureSeries—ThirdAnnualJamesT.DoveLecture 4:30p.m. 5:30p.m. N427 170

Symposium 744a ClinicalDecisionMakingforFellowsinTraining:PartA 4:30p.m. 5:50p.m. S403 170

Symposium 744b ClinicalDecisionMakingforFellowsinTraining:PartB 4:30p.m. 6:00p.m. S403 170

MONDAy, MARCh 26, 2012Special 305 JointAmericanCollegeofCardiology/New England Journal of Medicine

Late-BreakingClinicalTrials8:00a.m. 9:30a.m. hall B, ACC.12

Main Tent181

Special 407 YoungInvestigatorsAwardCompetition:ClinicalInvestigations,CongenitalHeartDiseaseandCardiovascularSurgery

8:00a.m. 9:30a.m. N230 181

Symposium 738 JointSessionoftheEuropeanSocietyofCardiologyandtheAmericanCollege ofCardiologyI:ManagementofHeartDiseaseinPregnancy

8:00a.m. 9:30a.m. N426 181

Special 306 Late-BreakingClinicalTrialsIV 10:30a.m. Noon hall B, ACC.12 Main Tent

186

Special 408 YoungInvestigatorsAwardCompetition:CardiovascularHealthOutcomesandPopulationGenetics 10:30a.m. Noon N230 187

Symposium 741 IntegrativeMedicine 10:30a.m. Noon N227b 187

Special 113 FITForumIV:GuidancefortheFirstStepsofYourCardiologyCareer 12:15p.m. 1:45p.m. S402 193

Legends 404 LegendsofCardiovascularMedicineLectureSeries—11thAnnualMaseri-FlorioInternational 2:00p.m. 3:00p.m. N231 199

Symposium 740 JointSymposiumoftheBritishCardiovascularSocietyandtheCalifornia ChapteroftheAmericanCollegeofCardiology

3:45p.m. 5:15p.m. N230 204

Special 307 61stAnnualConvocation 6:30p.m. 8:00p.m. hall B, ACC.12 Main Tent

205

TuESDAy, MARCh 27, 2012Special 308 JointAmericanCollegeofCardiology/Journal of the American Medical Association

Late-BreakingClinicalTrials8:00a.m. 9:30a.m. hall B, ACC.12

Main Tent210

Symposium 739 JointSessionoftheEuropeanSocietyofCardiologyandtheAmericanCollegeof CardiologyII:ProsandConsofNewApproachesforAntiplateletandAnticoagulantTherapy

8:00a.m. 9:30a.m. N426 211

Special 309 ACC.12ClosingSession:InnovatorsinCardiology 9:45a.m. 11:45a.m. hall B, ACC.12 Main Tent

211


102 GO for ACC.12!

DIAGNOSTIC TESTING: ECG ExERCISE AND SPORTSSESSIONTYPE SESS.# TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012Symposium 602 TranslationalResearchSymposiumwiththeInternationalSocietyforCardiovascular

TranslationalResearch:NewBreakthroughsinCardiovascularGenomics—ApproachingtheClinic8:00a.m. 9:30a.m. N228 113

Symposium 603 ChallengingSportsCardiologyCasesinYoungerAthletes 8:00a.m. 9:30a.m. N230 113

SuNDAy, MARCh 25, 2012Oral 914 DiagnosticTesting:SportsCardiology 8:00a.m. 9:30a.m. S402 144


9:30a.m. 10:30a.m. hall A

Oral 929 DiagnosticTesting:ECGandCardiopulmonaryExerciseTesting 10:45a.m. 12:15p.m. S503 154



Symposium 651 RoleofExerciseTreadmillTestingin2012 12:30p.m. 1:45p.m. N230 160

Experts 261 CardiacDilemmasinAthletes 4:30p.m. 6:00p.m. S503 171

MONDAy, MARCh 26, 2012Symposium 688 ChallengingSportsCardiologyCasesinOlderAthletes 8:00a.m. 9:30a.m. N227b 182

Experts 262 ECGsinAthletes:TheGreatECGScreeningDebateandChallengingCases 10:30a.m. Noon S502 187

Experts 255 StressTestinginWomen 3:45p.m. 5:15p.m. S502 204

vALvuLAR hEART DISEASESESSIONTYPE SESS.# TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012Self-Directed 1501 HeartSongsatACC.12:ASelf-PacedMultimediaLearningExperience 9:00a.m. 5:00p.m. vista Room

Lobby113

Experts 210 OrganicMitralRegurgitationCase-Management 12:15p.m. 1:45p.m. S504a 118

Symposium 612 TheSpectrumofDegenerativeMitralValve:FromImagingtoTreatment 12:15p.m. 1:45p.m. N426 118

Experts 220 IschemicMitralRegurgitation 4:30p.m. 6:00p.m. S504a 129

Symposium 632 ValveRepair:HowtoAchieveSuccess 4:30p.m. 6:00p.m. N426 129

Symposium 633 TranslationalResearchSymposiumwiththeInternationalSocietyfor CardiovascularTranslationalResearch:Devices

5:30p.m. 6:50p.m. N228 129

Clinical Focus 1604 ChampioningCareforthePatientwithAorticStenosis:TheRoleofCardiologistsandPrimaryCarefromRecognitiontoRecovery

6:30p.m. 9:30p.m. Fairmont hotel, Imperial Ballroom

130

SuNDAy, MARCh 25, 2012Oral 915 ValvularOral 8:00a.m. 9:30a.m. N427 145

Self-Directed 1502 HeartSongsatACC.12:ASelf-PacedMultimediaLearningExperience 9:00a.m. 5:00p.m. vista Room Lobby

145


9:30a.m. 10:30a.m. hall A

Oral 930 ValvularOral 10:45a.m. 12:15p.m. N427 155



Symposium 652 ControversiesinValveDiseaseI 12:30p.m. 1:45p.m. N427 160

Experts 238 AorticStenosisCaseManagement 4:30p.m. 6:00p.m. S504a 171



vALvuLAR hEART DISEASESESSIONTYPE SESS.# TITLE START END ROOM PAGE

MONDAy, MARCh 26, 2012Experts 242 TricuspidValveDiseaseCaseManagement 8:00a.m. 9:30a.m. S503 182

Symposium 674 ValvularHeartDiseaseintheOlderAdult(withManyDRGCodes):NavigatingtheOptions 8:00a.m. 9:30a.m. S402 182

Self-Directed 1503 HeartSongsatACC.12:ASelf-PacedMultimediaLearningExperience 9:00a.m. 5:00p.m. vista Room Lobby

182

Experts 246 ComplicationsofInterventionsforValvularHeartDisease 10:30a.m. Noon S505 187

Intl. Lunch 504 JointSessionoftheCanadianCardiovascularSocietyandtheAmericanCollegeof Cardiology:Repairs/Replacement—CatheterBasedor(MinimallyInvasive)Surgery

12:15p.m. 1:45p.m. S405 193

Experts 251 ComplexValvularHeartDisease 2:00p.m. 3:30p.m. S503 199

Symposium 714 CalcificAorticStenosis:DiagnosisandTreatmentinthe21stCentury 2:00p.m. 3:30p.m. N426 199

Experts 256 AdvancedHemodynamicsforValvularHeartDisease 3:45p.m. 5:15p.m. S503 204

Symposium 723 ImportanceofRegistriesforValveDisease:AGlimpseintotheACCFuture 3:45p.m. 5:15p.m. N426 204

TuESDAy, MARCh 27, 2012Experts 260 AorticRegurgitation/BAV 8:00a.m. 9:30a.m. S504a 211

PERIPhERAL vASCuLAR, AORTIC AND CAROTID DISEASESESSIONTYPE SESS.# TITLE START END ROOM PAGE

SATuRDAy, MARCh 24, 2012Oral 931 NewInsightsinPeripheralVascularDisease 8:00a.m. 9:30a.m. N229 113


9:30a.m. 10:30a.m. hall A



Symposium 743 CarotidArteryDisease:IsthePictureClarifying? 4:30p.m. 6:00p.m. S406a 129

SuNDAy, MARCh 25, 2012Oral 932 NewInsightsinPerpheralVascularDiseaseandYearinReview 10:45a.m. 12:15p.m. S504a 155

MONDAy, MARCh 26, 2012Experts 264 ChallengingCasesinAnticoagulationManagement:SpotlightontheNovelAnticoagulants 10:30a.m. Noon S105a 187

Intl. Lunch 514 JointSessionofthePakistanCardiacSocietyandtheAmericanCollegeofCardiology:Vascular—VTE,PHTN

12:15p.m. 1:45p.m. S503 194


Visit us at ACC Central

Booth 10027

quality chasm?quality chasm?WHAT

Achieving quality care is your challenge.

Take it on with NCDR.

With guidelines-focused clinical registries from the NCDR®,

you’ll always know which quality improvement steps to take and when to take them.

NCDR® is an initiative of the American College of Cardiology Foundation®, with partnering support from the following organizations: CARE Registry®—The Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, American Academy of Neurology, American Association of Neurological Surgeons/Congress of Neurological Surgeons, Society for Vascular Medicine, and Society of Vascular and Interventional Neurology; CathPCI Registry®—The Society for Cardiovascular Angiography and Interventions; ICD Registry™—Heart Rhythm Society; IMPACT Registry®—The Society for Cardiovascular Angiography and Interventions and American Academy of Pediatrics; PINNACLE Registry®—MedAxiom; STS/ACC TVT Registry™—An initiative of The Society of Thoracic Surgeons and the American College of Cardiology Foundation; ACTION Registry®–GWTG™—An initiative of the American College of Cardiology Foundation and the American Heart Association, with partnering support from Society of Chest Pain Centers, The American College of Emergency Physicians, and The Society of Hospital Medicine.© 2012 American College of Cardiology Foundation. All rights reserved. B12016

www.ncdr.com/takeiton

ACC.12

Friday, March 23 & Saturday, March 24

Fri., March 23 & Sat., M

arch 24


Morning SeSSionS

LIFELONG

MOC

801

ACCF Study Session for Maintenance of Certification: ABIM Recertification Made Easy — ACC Self Assessment Session: Update in Clinically Relevant Guidelines and TrialsFriday, March 23, 2012, 7:30 a.m. – 10:00 a.m.McCormick Place South, S105aCME/CNE Hours: 2.5

ACCF’s Maintenance of Certification Sessions allows you to easily obtain ABIM’s Maintenance of Certification (MOC) points during at ACC.12. Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an “open seating” policy will apply.

Attendees must be enrolled in the ABIM’s MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment.

For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may ‘power up’ to access relevant question modules.

Access to the online modules will also be available for participants for a short period of time following the annual meeting.

Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module.

Co-Chairs: Patrick T. O’Gara, Boston, MA Rick A. Nishimura, Rochester, MN

Question James Fang, Cleveland, OH Moderators: Steve R. Ommen, Rochester, MN

SPECIAL

SyMPOSIUM

746

4th Annual Cardiovascular Conference Focus on the Middle EastFriday, March 23, 2012, 8:00 a.m. – NoonMcCormick Place South, S101aCME/CNE Hours: 3.75

Co-Chairs: Aaron D. Kugelmass, Springfield, MA Mohamed Sobhy Aly, Alexandria, Egypt

8:00 Introduction, Overview, Reflection on Program — Huon Gray, Southampton, United Kingdom, David R. Holmes, Jr., Rochester, MN, Aaron D. Kugelmass, Springfield, MA, Mohamed Sobhy Aly, Alexandria, Egypt

8:15 Plenary Lecture: Sudden Death: What Do We Know? — Douglas P. Zipes, Indianapolis, IN

Session I: Global Challenge and Success in CHF —

Co-Chairs: William A. Zoghbi, Houston, TX Hani Najm, Riyadh, Saudi Arabia

Panelists: Farida Al Habib, Sharq, Kuwait, Mohamad B. Bdeir, Riyadh, Saudi Arabia, Mahmoud Hassanein, Cairo, Egypt, Douglas L. Mann, Saint Louis, MO

8:45 Myocardial Regeneration and Repair — Jonathan Leor, Tel Hashomer, Israel

9:00 What’s on the Horizon for Decompensated CHF — Hani N. Sabbah, Detroit, MI

9:15 Middle Eastern Models for Heart Failure Clinics and Centers — Alessandro Salustri, Abu Dhabi, United Arab Emirates

9:30 Community Wide Management of Heart Failure — the Dangers of Siloed Metrics Focused on Hospitals — Robert M. Califf, Durham, NC

9:45 Panel Discussion: Global Challenge and Success in CHF

10:00 Break

Session II: Cardiometabolic Syndrome: An Epidemic that Ignores Borders, Time Zones, and Religion

Co-Chairs: Nanette Kass Wenger, Atlanta, GA Chaim Lotan, Jerusalem, Israel

Panelists: Ziyad Ghazzal, Atlanta, GA, Feridoun Noohi Bezanjani, Tehran, Islamic Republic of Iran, Adel El Etriby, Cairo, Egypt, Paul D. Thompson, Hartford, CT

10:15 Cardiometabolic Syndrome in the Middle East: A Growing Import from the West — Incidence, Trends, and Regional Challenges — Jassim M. S. Al Suwaidi, Doha, Qatar

10:30 Lifestyle Modification in Cardiometabolic Syndrome — Alison Bailey, Lexington, KY

10:45 The Crucial Role of Women in Addressing This Challenge — Azin Alizadehasl, Tabriz, Islamic Republic of Iran

11:00 Children Should be the Target to Reverse This Challenge — Michele Mietus-Snyder, Washington, DC

11:15 Panel Discussion: Cardiometabolic Syndrome — An Epidemic That Ignores Borders, Time Zones and Religion

11:30 Introduction to Collaborative Research Project — Omar Mahmoud Lattouf, Atlanta, GA

11:45 Wrap Up — Aaron D. Kugelmass, Springfield, MA, Mohamed Sobhy Aly, Alexandria, Egypt, William A. Zoghbi, Houston, TX, Hani Najm, Riyadh, Saudi Arabia, Nanette Kass Wenger, Atlanta, GA, Chaim Lotan, Jerusalem, Israel

ACC.12 Scientific Session

Friday, March 23, 2012Please Note: The following sessions are listed alphabetically by learning pathway abbreviation based on session start time.

Morning

106 GO for ACC.12!

AFTE

RNOO

N

Afternoon SeSSionS

SPECIAL

LEGENDS

400

Legends of Cardiovascular Medicine: Roundtable Forum and Reception (By Invitation Only)Friday, March 23, 2012, 1:30 p.m. – 5:30 p.m.McCormick Place South, S100cCME/CNE Hours: 3

Chair: Anthony N. DeMaria, San Diego, CA

1:30 Introduction of Eugene Braunwald, MD, MACC

1:35 Presentation by Eugene Braunwald, MD, MACC — Eugene Braunwald, Boston, MA

1:55 Introduction of Antonio Colombo, MD, FACC

2:00 Presentation by Antonio Colombo, MD, FACC — Antonio Colombo, Milan, Italy

2:20 Introduction of Valentin Fuster, MD, PhD, MACC

2:25 Presentation by Valentin Fuster, MD, PhD, MACC — Valentin Fuster, New York, NY

2:45 Introduction of Jane Somerville, MD, FACC

2:50 Presentation by Jane Somerville, MD, FACC — Jane Somerville, London, United Kingdom

3:10 Introduction of Magdi H. yacoub, MB, BCh, FACC

3:15 Presentation by Magdi H. yacoub, MB, BCh, FACC — Magdi H. Yacoub, Harefield, Middlesex, United Kingdom

3:35 Panel Discussion and Audience Question and Answer

4:30 Private Reception Immediately Follows in Faculty Lounge S100a

Friday, March 23, 2012 • ACC.12


Morning SeSSionS

ACC-i2/TCT

SyMPOSIUM

2644

Interventional Featured Clinical Studies ISaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S102bCME/CNE Hours: 1.5

Co-Chairs: George D. Dangas, New York, NY Ted Feldman, Evanston, IL

Panelists: Matthew J. Price, La Jolla, CA, Jan Kovac, Leicestershire, UK

8:00 Pharmacodynamic Effects of Switching Therapy in PCI Patients with High on Treatment Platelet Reactivity and Genotype Variation: High Clopidogrel Dose versus Prasugrel (RESET Trial) — GENNARO SARDELLA, Simone Calcagno, Carlotta De Carlo, Mauro Pennacchi, Filippo Placentino, Rocco Stio, Massimo Mancone, Luigi Lucisano, Emanuele Canali, Francesco Fedele, Dept.Cardiovascular Sciences,Policlinico Umberto I, Rome, Italy

8:10 Panel Discussion

8:15 A New Strategy for Discontinuation of Dual Antiplatelet Therapy: Real Safety and Efficacy of 3-months Dual Antiplatelet Therapy following Endeavor Zotarolimus-eluting Stent Implantation — Myeong-Ki Hong, Byeong-Keuk Kim, Dong-Ho Shin, Young-Guk Ko, Donghoon Choi, Jung-Han Yoon, Hyuck-Moon Kwon, Yangsoo Jang, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea


8:30 Treatment of High Risk Aortic Stenosis Patients with Transcatheter Medtronic CoreValve Implantation: Results from the International Multi-center ADVANCE Study — Axel Linke, Ulrich Gerckens, Peter Wenaweser, Corrado Tamburino, Johan Bosmans, Stephen Brecker, Robert Bauernschmitt, University of Leipzig Heart Center, Leipzig, Germany


8:45 First Pharmacogenomic Analysis Using Whole Exome Sequencing to Identify Novel Genetic Determinants of Clopidogrel Response Variability: Results of the Genotype Information and Functional Testing (GIFT) EXOME Study — Matthew J. Price, Andrew R. Carson, Sarah S. Murray, Tierney Phillips, Lee Janel, Rebecca Tisch, Eric Topol, Samuel Levy, Scripps Translational Science Institute, La Jolla, CA, Scripps Clinic, La Jolla, CA


9:00 Long-term Outcomes following Transcatheter Aortic Valve Implantation: Insights on Prognostic Factors and Valve Durability from the Canadian Multicenter Experience — Josep Rodes-Cabau, John Webb,

Anson Cheung, Jian Ye, Eric Dumont, Feindel Chris, mark osten, Madhu Natarajan, James L. Velianou, Giussepe Martucci, Benoit DeVarennes, Chris R. Thompson, Robert Chisholm, Mark Peterson, Samuel Lichtenstein, Stefan Toggweiler, Daniel Doyle, Robert DeLarochellière, Jean Dumesnil, Kevin Teoh, Victor Chu, Asim Cheema, David Wood, Philippe Pibarot, Eric Horlick, Quebec Heart and Lung Institute, Quebec, Canada, St. Paul’s Hospital, Vancouver, Canada


9:15 A Double-blind Randomized Study to Evaluate the Efficacy of Bindarit in Preventing Coronary Stent Restenosis — Antonio Colombo, Ugo Limbruno, corrado lettieri, Ernesto Lioy, Angelo Guglielmotti, Marco Calabresi, Marco Valgimigli, Daniela Pierucci, San Raffaele Hospital, Milan, Italy


ACS

EXPERTS

200

Contemporary Management of UA/NSTEMISaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S504aCME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-065-L01-P

Chair: Keith A. A. Fox, Edinburgh, Scotland, United Kingdom

Case Presenter: Vamsi Krishna, Los Angeles, CA

Panelists: Eric R. Bates, Ann Arbor, MI, James M. Brophy, Montreal, Canada, Roxana Mehran, New York, NY, Charanjit S. Rihal, Rochester, MN

ACS

ORAL

902

P2y12 Antagonists: Unraveling the Mechanisms and Optimizing Benefit-RiskSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S406bCME/CNE Hours: 1.5

Co-Chairs: Anthony Gershlick, Leicester LE3 9QP, United Kingdom, Glenn A. Hirsch, Baltimore, MD

8:00 902–3 Timing and Clinical Setting of Cardiovascular Death or Myocardial Infarction following PCI for ACS: Observations from the TRITON-TIMI 38 Trial — Benjamin Scirica, David Morrow, Elliott Antman, Marc Bonaca, Sabina Murphy, Eugene Braunwald, Stephen Wiviott, TIMI Study Group, Boston, MA, Brigham and Women’s Hospital, Boston, MA

8:13 902–4 Prasugrel 5 Mg in Low Body Weight Patients Reduces Platelet Reactivity to a Similar Extent as Prasugrel 10 Mg in Higher Body Weight Patients: Results from the FEATHER Trial — David Erlinge, Jurrien Ten Berg, David Foley, Dominick Angiolillo, Patricia Brown, Henrik Wagner, Chunmei Zhou, Joe Jakubowski, Thomas Bergmeijer, Stefan James, Kenneth Winters, Department of Cardiology, Lund, Sweden


Saturday, March 24, 2012Please Note: The following sessions are listed alphabetically by learning pathway abbreviation based on session start time.

Morning

108 GO for ACC.12!

Mor

ning

8:26 902–5 Discharge Aspirin Dose and Clinical Outcomes in Patients with ACS: An Analysis from the TRITON-TIMI 38 Study — Payal Kohli, Jacob Udell, Sabina Murphy, Elliott Antman, Eugene Braunwald, Stephen Wiviott, TIMI Study Group, Boston, MA, Brigham & Women’s Hospital, Boston, MA

8:39 902–6 Restoring Platelet Function Ex Vivo by Adding Fresh Platelets within 24-hours of a Prasugrel 60 mg Loading Dose — M. Urooj Zafar, Carlos Santos-Gallego, David Vorchheimer, Juan Viles-Gonzalez, Sammy Elmariah, Chiara Giannarelli, David Small, Joseph Jakubowski, Valentin Fuster, Juan Badimon, Mount Sinai School of Medicine, New York, NY, Eli Lilly and Company, Indianapolis, IN

8:52 902–7 Adenosine May Mediate Ticagrelor-Induced Dyspnea — Li-ming Gan, Ann Wittfeldt, Hakan Emanuelsson, Sven Nylander, Jenny Jonasson, Institute of Clinical and Molecular Medicine, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden

9:05 902–8 Effect of Upstream Clopidogrel Treatment on Infarct Size and Microvascular Obstruction Assessed by CMR in Patients with STEMI Undergoing Primary PCI — Suzanne de Waha, Ingo Eitel, Steffen Desch, Georg Fuernau, Philipp Lurz, Gerhard Schuler, Holger Thiele, University of Leipzig – Heart Center, Department of Internal Medicine – Cardiology, Leipzig, Germany

ACS

ORAL

903

New Therapeutic Options in ACS: From Antiplatelets to AntibioticsSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S402CME/CNE Hours: 1.5

Co-Chairs: David P. Faxon, Boston, MA Shamir R. Mehta, Hamilton, Canada

8:00 903–3 Intracoronary Stem Cell Therapy in Patients with Acute Myocardial Infarction: 36-month Results of a Randomized, Double-blind, Placebo Controlled Trial with Serial MRI Follow-ups — Jochen Woehrle, Fabian von Scheidt, Sinisa Markovic, Peter Schauwecker, Klaus Schwarz, Markus Wiesneth, Hubert Schrezenmeier, Vinzenz Hombach, Wolfgang Rottbauer, Peter Bernhardt, University of Ulm, Ulm, Germany

8:15 903–4 Transradial versus Transulnar Artery Coronary Interventions: A Randomized Study — George Hahalis, Ioanna Xanthopoulou, Grigorios Tsigkas, Theodora E. Plakomyti, Anastasia Galati, Periklis Davlouros, Christos Pappas, Nikolaos Grapsas, Dimitrios Alexopoulos, Patras University Hospital, Patras, Greece

8:30 903–5 Panacea or Personalized Medicine? Optimizing Antiplatelet Therapy in Acute Coronary Syndrome: A Cost-effectiveness Analysis — Dhruv Kazi, Alan M. Garber, Rashmee Shah, Ceron Rhee, Solomon Moshkevich, Matthew W. Mell, MD, Derek Boothroyd, Douglas K. Owens, Mark Hlatky, Stanford University, Stanford, CA, Veterans Affairs Medical Center, Palo Alto, CA

8:45 903–6 Early Short-term Doxycycline Therapy in Patients with Acute Myocardial Infarction and Left Ventricular Dysfunction and the Ominous Progression to Adverse Remodeling (TIPTOP): A Randomized Controlled Trial — Giampaolo Cerisano, Piergiovanni Buonamici, Renato Valenti, Roberto Sciagrà, Silvia Raspanti, Nazario Carrabba, Alberto Santini, Emilio Vincenzo Dovellini, David Antoniucci, Careggi Hospital, Florence, Italy

9:00 903–7 Ticagrelor versus Prasugrel in Acute Coronary Syndrome Patients with High on Clopidogrel Treatment Platelet Reactivity Post PCI: A Pharmacodynamic Study — Dimitrios Alexopoulos, Ioanna Xanthopoulou, Eleni Mavronasiou, Anastasia Galati, George Kassimis, Konstantinos C. Theodoropoulos, George Makris, Anastasia Damelou, Grigorios Tsigkas, Periklis Davlouros, George Hahalis, Patras University Hospital, Patras, Greece

9:15 903–8 Pharmacodynamics of Vorapaxar, a Platelet PAR-1 Antagonist, and Its Interaction with P2y12 Receptor Pathway in the TRA·CER Trial — Lisa K. Jennings, David Moliterno, Robert Storey, Edward Hord, Jayaprakash Kotha, Richard Becker, Susan Smyth, Luis Providencia, Tiziano Moccetti, Marco Valgimigli, Jean-Pierre Dery, J.H. Cornel, Gregory Thomas, Kurt Huber, Edmond Chen, John Strony, Tyrus Rorick, Pierluigi Tricoci, Kenneth Mahaffey, CirQuest Labs and the Department of Medicine, University of Tennessee Health Science Center, Memphis, TN

ARR

EXPERTS

201

How to Manage a Device/Lead AdvisorySaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S503CME/CNE Hours: 1.5

Chair: Robert G. Hauser, Minneapolis, MN

Case Presenter: Kenneth A. Ellenbogen, Richmond, VA

Panelists: Andrew E. Epstein, Philadelphia, PA, David L. Hayes, Rochester, MN, Randall J. Lee, San Francisco, CA

CCS

SyMPOSIUM

202

Complex Issues Facing ACHD Patients: Obstructive LesionsSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S105aCME/CNE Hours: 1.5

Co-Chairs: Curtis J. Daniels, Columbus, OH Gary D. Webb, Cincinnati, OH, Eric V. Krieger, Boston, MA

Case Presenter: Eric V. Krieger, Boston, MA

Panelists: Michael Earing, Milwaukee, WI, Wayne J. Franklin, Houston, TX, Michelle Gurvitz, Boston, MA, Craig S. Broberg, Portland, OR, Angela T. Yetman, Salt Lake City, UT

Saturday, March 24, 2012 • ACC.12


Morning

CCS

MOC

802

ACCF Study Session for Maintenance of Certification: American Board of Pediatrics (ABP) Recertification Made Easy — 2011 Pediatric Cardiology Subspecialty Self-AssessmentSaturday, March 24, 2012, 8:00 a.m. – 10:00 a.m.McCormick Place South, S105dCME Hours: 2

Please refer to the full session listing, listed on page 111, for additional session information.

HF

EXPERTS

203

The Latest in Heart Failure with Preserved Ejection FractionSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S502CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-067-L01-P

Chair: James C. Fang, Cleveland, OH

Case Presenter: David Aguilar, Houston, TX

Panelists: Barry Borlaug, Rochester, MN, Anita Deswal, Houston, TX, William Little, Winston Salem, NC, Margaret M. Redfield, Rochester, MN, Patricia Uber, Baltimore, MD

HF

SyMPOSIUM

732

Pharmacology Program: Pharmacotherapy of Chronic Heart FailureSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N427CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-148-L04-P

Co-Chairs: Joseph S. Alpert, Tucson, AZ David Parra, West Palm Beach, FL

Panelists: Jesus Almendral, New Brunswick, NJ, Akshay S. Desai, Boston, MA, Narith Ou, Rochester, MN, Jo E. Rodgers, Chapel Hill, NC

8:00 Pharmacotherapy of Chronic Heart Failure — David Parra, West Palm Beach, FL


HF

ORAL

905

Predicting Outcomes in Heart Failure: Biomarkers and BeyondSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S405CME/CNE Hours: 1.5

Chair: Maya E. Guglin, Tampa, FL

8:00 905–3 Galectin-3, a Marker of Cardiac Fibrosis, Predicts Incident Heart Failure in the Community — Jennifer Ho, Chunyu Liu, Asya Lyass, Paul Courchesne, Michael Pencina, Vasan Ramachandran, martin larson, Daniel Levy, Framingham Heart Study, Framingham, MA

8:15 905–4 Long-term Trajectory of Two Unique Cardiac Biomarkers and Subsequent Left Ventricular Structural Pathology and Risk of Incident Heart Failure in Community Dwelling Older Adults — Christopher R. DeFilippi, Danielle Glick, Robert Christenson, John Gottdiener, Stephen Seliger, University of Maryland School of Medicine, Baltimore, MD

8:30 905–5 Association of Total and High-Molecular-Weight Adiponectin with New-Onset Heart Failure in Older Adults: The Cardiovascular Health Study — Maria G. Karas, David Benkeser, Alice M. Arnold, Luc Djousse, Susan Zieman, Kenneth J. Mukamal, Russell Tracy, Christos S. Mantzoros, David Siscovick, John Gottdiener, Joachim Ix, Jorge Kizer, Weill Cornell Medical College, New York, NY

8:45 905–6 Echocardiographic and Biomarker Phenotype of Heart Failure with Preserved Ejection Fraction (HFPEF) in Older Individuals in Comparison to Hypertension without Heart Failure (HTN), Elderly with Risk Factors and Healthy Aging: Importance of Myocyte Injury, Fibrosis, LV Hypertrophy and Diastolic Load — John S. Gottdiener, Traci Bartz, Christopher DeFilippi, Willem Kop, Dalane Kitzman, Eddy Barasch, Stephen Seliger, Donald Lloyd-Jones, University of Maryland School of Medicine, Baltimore, MD

9:00 905–7 Post-Exercise Levels of Biomarkers of Cardiomyocyte Stress Improve Prediction of Adverse Outcomes in Patients with Advanced Heart Failure — Petr Jarolim, Michael J. Conrad, David Morrow, John Rozehnal, Martin Kotrc, Josef Kautzner, Vojtech Melenovsky, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, Institute of Clinical and Experimental Medicine, Prague, Czech Republic

9:15 905–8 Concentric Left Ventricular Hypertrophy as Independent Predictor of 1-year Rehospitalization and Mortality in Patients Hospitalized for Acute Heart Failure and Preserved Ejection Fraction — Liang Zhong, Yee How Lau, Ling Ling Sim, David Sim, Bernard Kwok, Terrance Chua, Raymond Lee, Ru-San Tan, National Heart Centre Singapore, Singapore, Singapore, Novena Heart Centre Singapore, Singapore

HF

ORAL

906

Pathogenic and Therapeutic Insights from Experimental Heart Failure ModelsSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S404CME/CNE Hours: 1.5

Co-Chairs: Biykem Bozkurt, Houston, TX Javed Butler, Atlanta, GA

8:00 906–3 Connexin43 Expression Is Essential for Functional Cardiomyogenic Differentiation of Human Fetal Mesenchymal Stem Cells — Arti Ramkisoensing, Daniël Pijnappels, Martin Schalij, Antoine de Vries, Douwe Atsma, Leiden University Medical Center, Leiden, The Netherlands

8:15 906–4 An Injectable Acellular Capillary Hydrogel Improves Left Ventricular Function after Myocardial Infarction — Domenico G. Della Rocca, Bradley J. Willenberg, Leonardo F. Franklin, Stacy L. Porvasnik, John W. Petersen, Prateek S. Wate, Eileen M. Handberg, Gregory Schultz, Francesco Romeo, Christopher D. Batich, Barry J. Byrne, Carl J. Pepine, University of Florida, Gainesville, FL

ACC.12 • Saturday, March 24, 2012

110 GO for ACC.12!

Mor

ning

8:30 906–5 Characterization and Biocompatibility of Perfusion-Decellularized Human Heart Matrix: Toward Bioengineering Perfusable Human Heart Grafts — Pedro L Sanchez, Mª Eugenia Fernandez-Santos, Salvatore Costanza, Hugo Rodríguez-Abella, Stefan Kren, Gregorio Garrido, Jose Luis Escalante, Rafael Matesanz, Doris Taylor, Fernandez-Aviles Francisco, Hospital General Universitario Gregorio Marañon, Madrid, Spain, University of Minnesota, Minneapolis, MN

8:45 906–6 Mechanical Unloading with Left Ventricular Assist Device after Acute Myocardial Infarction Prevents Adverse Cardiac Remodeling — Xufeng Wei, Department of Surgery, University of Maryland School of Medicine, Baltimore, MD

9:00 906–7 Calcium Cycling Protein S100A1 Does not Recover Following Continuous-flow Left Ventricular Assist Device Support of the Failing Human Heart — Mosi Kadin Bennett, Wendy Sweet, Wai Hong Tang, Maria Mountis, Randall Starling, Christine Moravec, Cleveland Clinic, Cleveland, OH

9:15 906–8 Lack of Cardiac Myosin Binding Protein-C Phosphorylation Is a Model of Heart Failure with Preserved Ejection Fraction — Carl Wei-Chan Tong, Mohamed I. Abdalla, Xin Wu, yang liu, Mariappan Muthuchamy, Richard Moss, Texas A&M Health Science Center College of Medicine, Temple, TX, University of Wisconsin School of Medicine and Public Health, Madison, WI

IMAG

EXPERTS

204

Multimodality Imaging in Evaluation of Prosthetic Valve FunctionSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S505CME/CNE Hours: 1.5

Chair: James G. Jollis, Durham, NC

Case Presenters: Julie Damp, Nashville, TN, Jennifer Dickerson, Columbus, OH

Panelists: Paul A. Grayburn, Dallas, TX, Fletcher A. Miller, Rochester, MN, David Orsinelli, Columbus, OH

IMAG

ORAL

908

A Better Understanding of Ischemia and Function: Insights from Cardiac MRISaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S403CME/CNE Hours: 1.5

Co-Chairs: Rosario Freeman, Seattle, WA Issam A. Mikati, Chicago, IL

8:00 908–3 Quantification of Absolute Myocardial Perfusion in Patients with Coronary Artery Disease: Comparison between Cardiac Magnetic Resonance and Positron Emission Tomography — Geraint Morton, Amedeo Chiribiri, Masaki Ishida, Shazia Hussain, Andreas Schuster, Andreas Indermuehle, Divaka Perera, Erik Hedstrom, Sally Barrington, Eike Nagel, King’s College London, London, United Kingdom

8:15 908–4 Prevalence and Significance of Coronary Microvascular Dysfunction in Hypertrophic Cardiomyopathy: A Cardiovascular Magnetic

Resonance Study — Tevfik Fehmi Ismail, Andrew Jabbour, Francisco D. Alpendurada, Niraj Mistry, Benjamin Hewins, Amy Mallorie, Natasha Davendralingam, Ankur Gulati, Ricardo Wage, Dudley Pennell, Sanjay Prasad, Royal Brompton Hospital, London, United Kingdom

8:30 908–5 Infarct Heterogeneity Is an Independent and Incremental Predictor of Mortality in Patients with Severe Ischemic Cardiomyopathy — Lisa Asamoto, Rory Hachamovitch, Zoran Popovic, Randall Starling, Scott Flamm, Thomas Marwick, Deborah Kwon, Cleveland Clinic, Cleveland, OH

8:45 908–6 Necrosis and Ischemia for Risk Stratification in Patients with Known or Suspected Ischemic Cardiomyopathy: Study with Stress Cardiac Magnetic Resonance — Clara Bonanad, Vicente Bodi, Mª Pilar López, JVicente Monmeneu, Juan Sanchis, Julio Nunez, Fabian Chaustre, Angel Llacer, Clara Bonanad, Valencia, Spain

9:00 908–7 Fractional Flow Reserve Correlates with Blood Oxygen Level-Dependent (BOLD) Magnetic Resonance Imaging in Coronary Artery Disease — Peter Bernhardt, Wolfgang Rottbauer, Jochen Woehrle, University of Ulm, Ulm, Germany

9:15 908–8 Aortic Biomechanics by MRI: Relation with Age, Gender and Traditional Cardiovascular Risk Factors — A Cross-sectional and Longitudinal Study: The Multi-Ethnic Study of Atherosclerosis (MESA) — Gisela Teixido, Atul Chugh, Alban Redheuil, Chia Ying Liu, Richard Stacey, Colin Wu, Harry Dietz, Antoinette Gomes, Martin Prince, Artur Evangelista, Greg Hundley, David Bluemke, Joao Lima, Hospital Universitari vall d’Hebron, Barcelona, Spain, Johns Hopkins Hospital, Baltimore, MD

IMAG

ORAL

909

New Imaging Approaches to Atherosclerosis and the MicrocirculationSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N426CME/CNE Hours: 1.5

Co-Chairs: Robert W.W. Biederman, Pittsburgh, PA Prem Soman, Pittsburgh, PA

8:00 909–3 Assessing Mild Coronary Atherosclerosis by Means of Transthoracic Enhanced Doppler Echocardiography in Convergent Color Doppler Mode: A Validation Study versus Intravascular Ultrasound — Carlo Caiati, Mario Lepera, Daniela Santoro, Marco Marzullo, Stefano Giuseppe Primitivo, Paolo Pollice, Caterina Rizzo, Filippo Masi, Donato Guagliara, Stefano Favale, Bari, Italy

8:15 909–4 Arrest of Atherosclerotic Progression and Reduction in Inflammatory Burden by Long-term Apocynin Treatment: Molecular and Ultrasound Imaging of Vascular Phenotype — Ya Ni Liu, Brian Davidson, Qi Yue, Yan Zhao, Todd Belcik, Aris Xie, Yoichi Inaba, Ruggeri M. Zaverio, Beat Kaufmann, Jonathan Lindner, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, People’s Republic of China, Oregon Health and Science University, Portland, OR



Morning

8:30 909–5 Correlation of Vasa Vasorum and Plaque Progression and Response to Atorvastatin Therapy an a Rabbit Model of Atherosclerosis: In Vivo Intravascular Ultrasound and Contrast-Enhanced Ultrasound Imaging Study — JinWei Tian, Sining Hu, Haibo Jia, Jingbo Hou, Shaosong Zhang, Bo Yu, Ik-Kyung Jang, The Second Affiliated Hospital of Harbin Medical University, Haerbin, People’s Republic of China, Massachusetts General Hospital, Harvard Medical School, Boston, MA

8:45 909–6 Incremental Diagnostic Value of Dynamic CT-based Myocardial Perfusion Imaging for the Detection of Hemodynamic Relevant Coronary Artery Stenosis as Determined by Fractional Flow Reserve — Alexander Becker, Fabian Bamberg, Martin Greif, Franz von Ziegler, Christoph Becker, University of Munich, Munich, Germany

9:00 909–7 Early Detection of Severe Microvascular Dysfunction with Multidetector Computed Tomography Immediately after Primary Angioplasty in Patients with Acute Myocardial Infarction — Koichi Tamita, Shuichiro Kaji, Toshiharu Iwamura, Mika Maeda, Toshiki Fujiwara, Junichi Yoshikawa, Nishinomiya Watanabe Cardiovascular Center, Nishinomiya, Japan, Kobe City Medical Center General Hospital, Kobe, Japan

9:15 909–8 Computed Tomography Angiography-Derived Coronary Plaque Arc Calcification is Associated with Culprit Lesion Status in Acute Coronary Syndromes — Rani K. Hasan, Andrea Vavere, Carlos Rochitte, Armin Arbab-Zadeh, Ilan Gottlieb, John Texter, Marc Dewey, Hiroyuki Niinuma, Melvin Clouse, Joao Lima, Jeffrey Brinker, Julie Miller, Johns Hopkins University, Baltimore, MD

ISCHEM

ORAL

910

Sex, Scoring, Sadness, Statins, Stents and SurgerySaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N227bCME/CNE Hours: 1.5

Co-Chairs: Joaquin Cigarroa, Portland, OR Adolph M. Hutter, Boston, MA

8:00 910–3 Gender Effects on Coronary Microvascular Dysfunction in Patients with Suspected Coronary Artery Disease — Venkatesh Murthy, Masanao Naya, Sharmila Dorbala, Ron Blankstein, Marcelo Di Carli, Brigham & Women’s Hospital, Boston, MA

8:15 910–4 Combined Anatomical and Clinical Factors for the Risk Stratification of Patients Undergoing Percutaneous Coronary Intervention: The Logistic Clinical SyNTAX Score — Vasim Farooq, Yvonne Vergouwe, Lorenz Raber, Pascal Vrancx, Hector Garcia, Salvatore Brugaletta, A. Kappetein, Marie-angèle Morel, Ton de Vries, Michael Swart, Keith Dawkins, Marco Valgimigli, Stephan Windecker, Ewout W. Steyerberg, Patrick Serruys, Thorax Center, Rotterdam, The Netherlands

8:30 910–5 Do Behavioral Risk Factors Explain the Association Between Depressive Symptoms and Cardiovascular Risk In Individuals with Coronary Heart Disease? Report from the Reasons for

Geographic and Racial Differences in Stroke (REGARDS) Study — Siqin Ye, Paul Muntner, Daichi Shimbo, Joshua Richman, Suzanne Judd, Karina Davidson, Monika Safford, Columbia University Medical Center, New York, NY, University of Alabama at Birmingham, Birmingham, AL

8:45 910–6 The Clinical Benefit of Therapies That Raise High-density Lipoprotein Cholesterol Added to Treatment with a Statin — Brian Anthony Ference, Nitin Mahajan, Wonsuk Yoo, Luis Afonso, John Flack, Wayne State University School of Medicine, Detroit, MI

9:00 910–7 Long-term Mortality following Coronary Artery Bypass Graft Surgery and Stenting with Drug-eluting Stents — Chuntao Wu, Songyang Zhao, Fabian T. Camacho, Edward Hannan, Penn State Hershey College of Medicine, Hershey, PA, University at Albany School of Public Health, State University of New York, Rensselar, NY

9:15 910–8 Impact of Interventional versus Conservative Approach on 5-year Mortality of Patients with Stable Angina and Documented Coronary Artery Disease in Clinical Practice: Results of the STAR-Registry — Anselm K. Gitt, Uwe Zeymer, Andrea Papp, Ralf Zahn, Jochen Senges, STAR-Study-Group, Herzzentrum Ludwigshafen, Ludwigshafen, Germany, Institut f. Herzinfarktforschung Ludwigshafen an der Universitaet Heidelberg, Ludwigshafen, Germany

LIFELONG

MOC

802

ACCF Study Session for Maintenance of Certification: American Board of Pediatrics (ABP) Recertification Made Easy — 2011 Pediatric Cardiology Subspecialty Self-AssessmentSaturday, March 24, 2012, 8:00 a.m. – 10:00 a.m.McCormick Place South, S105dCME/CNE Hours: 2

The American College of Cardiology Foundation (ACCF) and the American Board of Pediatrics have joined forces to help pediatric cardiologists attending ACC.12 earn Maintenance of Certification (MOC) credit.

Tickets are required for entrance to the session and attendance is limited. If you have not registered in advance, please visit the session in advance of the session to check to availability.

Participants must be registered as an ABP diplomate and enrolled at the time of the session in the ABP MOC process. For information about enrolling as an ABP diplomate in the ABP MOC process, please visit www.abp.org and log into My ABP Portfolio.

Each session registrant must bring his/her own laptop, set up to receive Wi-Fi access. All attendees should program and test the laptop prior to the ABP MOC session to ensure 1) the laptop will receive the convention center’s wireless signal 2) the attendee’s ABP portfolio can be accessed. During the program, each attendee will submit ABP MOC module answers electronically through the ABP website.

Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may ‘power up’ to access relevant question modules. No


112 GO for ACC.12!

Mor

ning

paper copies of the module will be provided. Attendees will not be able to leave the room with notes, answers or other relevant session discussion. 10 MOC credits are available for this activity.

Chair: Steven R. Neish, San Antonio, TX

MOC Faculty: Mark B. Lewin, Seattle, WA, Karen K. Stout, Seattle, WA

PRACTICE

SyMPOSIUM

600

Cardiology Procedures 2012: How to Code and Get ReimbursedSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N231CME/CNE Hours: 1.5

Co-Chairs: James C. Blankenship, Danville, PA Kenneth P. Brin, Loves Park, IL

8:00 What’s New in Coding? CPT Codes for 2012 — Robert N. Piana, Nashville, TN

8:20 Questions and Answers

8:25 Getting Paid in 2012: Upcoming Changes in Reimbursement — James C. Blankenship, Danville, PA


8:50 Breaking the Code: Tips and Tricks on Coding and Reimbursement — Linda Gates-Striby, Indianapolis, IN


9:15 Peek into the Future: Coding and Reimbursement Initiatives in 2013 — Kenneth P. Brin, Loves Park, IL

QUAL

EXPERTS

205

Am I Placing Inappropriate ICDs and Stents?: Recent Registry SurprisesSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S501aCME/CNE Hours: 1.5

Chair: Frederick A. Masoudi, Denver, CO

Case Presenter: Paul D. Varosy, Denver, CO

Panelists: Paul Chan, Kansas City, MO, Manesh R. Patel, Durham, NC, Khether E. Raby, Stoneham, MA, Bruce L. Wilkoff, Cleveland, OH

QUAL

SyMPOSIUM

601

Patient-Centered Care: The New ImperativeSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N226CME/CNE Hours: 1.5

Co-Chairs: Blair D. Erb, Bozeman, MT Mary Norine Walsh, Indianapolis, IN

8:00 Patients are More than a P-value — Bray Patrick-Lake, Boulder, CO

8:16 CardioSmart: An Extension of your Practice — Joanne M. Foody, Boston, MA

8:32 Engaging Patients through the Community — Andrew M. Freeman, Denver, CO

8:48 Partnering with your Patient — Suzanne Hughes, Hudson, OH

9:04 Shared Decision Making for Patients — William R. Lewis, Cleveland, OH

9:20 Question and Answer

SPECIAL

SPECIAL

300

ACC.12 Opening Showcase and Late-Breaking Clinical TrialsSaturday, March 24, 2012, 8:00 a.m. – 10:00 a.m.McCormick Place North, Hall B, ACC.12 Main TentCME/CNE/CPE Hours: 2 ACPE No. 0012-9999-12-132-L04-P

Join us for the ACC.12 Opening Showcase session, which welcomes attendees to Chicago! The session will feature the Presidential Address from David R. Holmes, Jr., MD, FACC. The 2012 Simon Dack Lecture will be presented, as part of our Legends of Cardiovascular Medicine Series, by Eugene Braunwald, MD, MACC.

In addition, you won’t want to miss the ground-breaking late-breaking clinical trials presented as part of this exciting showcase session.

8:00 Opening Video and National Anthem

8:04 Welcome, Introductions and Acknowledgements — David R. Holmes, Jr., Rochester, MN

8:10 Introduction of Keynote Lecturer — David R. Holmes, Jr., Rochester, MN

8:12 Simon Dack Lecture: The Treatment of Acute Myocardial Infarction — Into the Second Century — Eugene Braunwald, Boston, MA

8:37 ACC Presidential Address — David R. Holmes, Jr., Rochester, MN

9:00 Late-Breaking Clinical Trial Presentations

Chair: David R. Holmes, Jr., Rochester, MN

Panelists: Roberto Bolli, Louisville, KY, Robert M. Califf, Durham, NC, Eduardo Marban, Los Angeles, CA, Andreas M. Zeiher, Frankfurt, Germany

9:05 Opening Remarks — David R. Holmes, Jr., Rochester, MN

9:08 Effect of Transendocardial Autologous Bone Marrow Mononuclear Cell Delivery on Functional Capacity, Left Ventricular Function and Perfusion in Chronic Ischemic Heart Failure: The FOCUS Randomized Trial — Emerson C. Perin, James Willerson, Stephen Ellis, Timothy Henry, Carl Pepine, David Zhao, Dejian Lai, Barry Byrne, Antonis Hatzopoulos, Marc Penn, Jay Traverse, Adrian Gee, Marvin Kronenberg, Daniel Martin, James Thomas, Doris Taylor, Christopher Cogle, Sonia Skarlatos, Lem Moye, Robert Simari, Cardiovascular Cell Therapy Research Network (CCTRN), Houston, TX


9:30 Evaluation of a Novel Antiplatelet Agent for Secondary Prevention in Patients with Atherosclerotic Disease: Results of the Thrombin Receptor Antagonist in Secondary Prevention of Atherothrombotic Ischemic Events (TRA 2°P) — TIMI 50 Trial — David A. Morrow, Brigham & Women’s Hospital, Boston, MA


9:53 Closing Remarks — David R. Holmes, Jr., Rochester, MN



Morning

TEST

SyMPOSIUM

602

Translational Research Symposium with the International Society for Cardiovascular Translational Research: New Breakthroughs in Cardiovascular Genomics: Approaching the ClinicSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N228CME/CNE Hours: 1.5

Chair: Jennifer L. Hall, Minneapolis, MN

8:00 9p21: A Major Genetic Predictor of Cardiovascular Disease — Function and Application — Robert Roberts, Ottawa, Canada

8:20 Genetic Testing: How it All Fits — Robert Superko, Alameda, CA, Geoffrey S. Ginsburg, Durham, NC

8:30 Advances in Genomic Biomarkers and Diagnostics — Geoffrey S. Ginsburg, Durham, NC

8:40 Proteomics Role in Personalized Medicine — Jennifer Van Eyk, Baltimore, MD


TEST

SyMPOSIUM

603

Challenging Sports Cardiology Cases in younger AthletesSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N230CME/CNE Hours: 1.5

Co-Chairs: Anne M. Dubin, Palo Alto, CA Reginald L. Washington, Denver, CO

8:00 Case Presentation: 17 year-old Collegiate Soccer Player with Long QT — Martin O’Riordan, Ardmore, PA

8:05 Abnormal ECGs in Adolescent Athletes: Long QT, WPW, Brugada — Anne M. Dubin, Palo Alto, CA

8:30 Case Presentation: 35 year-old Rugby Player with Syncope and Frequent PVC/NSVT — Mike Slawnych, Calgary, Canada

8:35 Sports Cardiology for the Faint-Hearted: The Athlete with Syncope — Domenico Corrado, Padova, Italy

9:00 Case Presentation: 21 year-old Male Basketball Player with Hyper Trabeculated LV — Joseph Jenkins Thompson, Lexington, KY

9:05 Is It Athletic Heart Syndrome or Pathological Hypertrophy? — Aaron L. Baggish, Boston, MA

VASC

ORAL

931

New Insights in Peripheral Vascular DiseaseSaturday, March 24, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N229CME/CNE Hours: 1.5

Chair: James B. Froehlich, Ann Arbor, MI

8:00 931–3 Long-term Coffee Consumption Is Associated with Improved Endothelial Function in Elderly Individuals: Ikaria Study — Evangelos Oikonomou, Gerasimos Siasos, Christine Chrysohoou, Dimitris Tousoulis, Marina Zaromitidou, Elias Gialafos, Konstantinos Zisimos, Stamatios Kioufis, Georgios Marinos, Nikolaos Papageorgiou, Athanasios G. Papavassiliou, Christos Pitsavos, Christodoulos Stefanadis, University of Athens Medical School, Department of Cardiology, Hippokration General Hospital, Athens, Greece

8:15 931–4 Long-term Efficacy of Endovascular Treatment for Patients with Critical Limb Ischemia Due to Isolated below the Knee Lesions — Kiyonori Nanto, Osamu iida, Yoshimitsu Soga, Kenji Suzuki, Terutoshi Yamaoka, Nobuhiro Suematsu, Yusuke Miyashita, Junichi Tazaki, Kansai Rosai Hospital, Amagasaki, Japan

8:30 931–5 Dual Antiplatelet Therapy Responsiveness in Patients Undergoing Percutaneous Revascularization for Peripheral Arterial Occlusive Disease — Chad Kliger, Anvar Babaev, Binita Shah, Frederick Feit, James Slater, Michael Attubato, Lenox Hill Heart and Vascular Institute, New York, NY, New York University School of Medicine, New York, NY

8:45 931–6 Impact of Perioperative Complication after Aortoiliac Stenting for Patients with Peripheral Artery Disease — Kei Sato, Osamu iida, Yoshimitsu Soga, Kenji Suzuki, Terutoshi Yamaoka, Nobuhiro Suematsu, Yusuke Miyashita, Junichi Tazaki, Masaaki Uematsu, Kansai Rosai Hospital Cardiovascular Center, Amagasaki, Japan

9:00 931–7 The S Curve: A Novel Morphological Finding in the Internal Carotid Artery in Patients with Fibromuscular Dysplasia — Sanjum S. Sethi, Joe Lau, Phillip Erwin, Susan Gustavson, Jeffrey Olin, Zena and Michael A. Wiener Cardiovascular Institute, Mount Sinai School of Medicine, New York, NY

9:15 931–8 Peripheral Artery Dissection in Patients with Fibromuscular Dysplasia: A Report from the United States Fibromuscular Dysplasia Patient Registry — Jeffrey W. Olin, Xiaokui Gu, James Froehlich, J. Michael Bacharach, Kim Eagle, Bruce Gray, Mark Grise, Michael Jaff, Soo Hyun Kim, Eva Kline-Rogers, Pamela Mace, Alan Matsumoto, Robert McBane, Heather Gornik, Mount Sinai School of Medicine, New York, NY

VALV

SELF-DIRECTED

1501

Heart Songs at ACC.12: A Self-Paced Multimedia Learning ExperienceSaturday, March 24, 2012, 9:00 a.m. – 5:00 p.m.McCormick Place, Vista Room LobbyCME/CNE Hours: 2

Back by popular demand is the highly rated Heart Songs Self-Paced Learning Lab — a unique audio-visual program to refresh cardiac auscultation skills. After a pre-test, attendees will listen to Heart Sounds while viewing phonocardiograms, echoes, and more, on an iPod® Touch, iPad® or laptop computer. Attendees can view the sessions and take both the pre-test and post-test on their own device, or use devices provided in the room, to document improvement in their auscultation skills. This clinical skills workshop provides attendees with a choice of three sessions: the first on 5 common heart murmurs and the second on more advanced sounds including bicuspid aortic valve, mitral valve prolapse and hypertrophic cardiomyopathy, among others. The third session is for experts on topics such as combined aortic stenosis and regurgitation; and combined mitral stenosis and regurgitation. In addition, there will be a 3-D echo/auscultation training program available in the Self-Paced Learning Lab. This video


114 GO for ACC.12!

Mor

ning

program will combine 3-D echo images with the auscultation findings on 4 common valvular abnormalities. Studies have shown that the range of repetition needed to acquire auditory skills can vary four fold. This workshop will tailor the learning to each individual’s need for repetition. Each session takes approximately 30 minutes to complete. This workshop will appeal to cardiovascular specialists and cardiac care team members who want to improve their auscultation skill in both common and more advanced heart sounds.

Co-Chairs: Michael J. Barrett, Blue Bell, PA, Ginger K. O’Sullivan, Allentown, PA, Matthew W. Martinez, Allentown, PA, Justin Roberts, Allentown, PA

CCS

ORAL

901

From Targeting Errors to UNOS: How Quality and Databases Can Impact Clinical CareSaturday, March 24, 2012, 10:30 a.m. – NoonMcCormick Place South, S105aCME/CNE Hours: 1.5

Co-Chairs: Robert H. Beekman, Cincinnati, OH Ralf Holzer, Columbus, OH

10:30 901–3 Improving Survival By Targeting Errors — Frederic Jacques, Osami Honjo, Michael-Alice Moga, Francesco Grasso, Kenji Baba, Edward Hickey, Tilman Humpl, Steven Schwartz, Christopher Caldarone, Andrew Redington, Glen Van Arsdell, The Hospital for Sick Children (SickKids), Toronto, Canada

10:45 901–4 Vitamin D Status in Neonates Undergoing Cardiac Operations: Relationship to Cardiopulmonary Bypass and Outcomes — Eric Matthew Graham, Sarah N. Taylor, Sinai Zyblewski, Bethany Wolf, Scott Bradley, Bruce W. Hollis, Francis X. McGowan, Jr, Andrew Atz, Medical University of South Carolina, Charleston, SC

11:00 901–5 Progressive Left Ventricular Changes Predict the Likelihood of Survival in Pediatric Dilated Cardiomyopathy: Findings from the Pediatric Cardiomyopathy Registry — Paul Fraser Kantor, Endel Orav, James Wilkinson, Steven Webber, Charles Canter, Steven Colan, Jeffrey Towbin, Melanie Everitt, Elfriede Pahl, Stephanie Ware, Beth Kaufman, Paolo Rusconi, Jacqueline Lamour, John Jefferies, Linda Addonizio, Steven Lipshultz, University of Miami, Miller School of Medicine, Miami, FL, Hospital for Sick Children, Toronto, Canada

11:15 901–6 Pediatric Heart Transplantation from Donors with Depressed Ventricular Function: An Analysis of the United Network of Organ Sharing Database — Joseph William Rossano, Kimberly Lin, Stephen Paridon, J. William Gaynor, Robert Shaddy, Beth Kaufman, Children’s Hospital of Philadelphia, Philadelphia, PA, University of Pennsylvania, Philadelphia, PA

11:30 901–7 Identified Mortality Risk Factors Associated with Presentation, Initial Hospitalization, and Interstage Period for the Norwood Operation: A Report from the Joint Council on Congenital Heart Disease National Quality Improvement Collaborative — Russell R. Cross, Ashraf Harahsheh, Robert McCarter, Gerard Martin, Children’s National Medical Center, Washington, DC

11:45 901–8 IMPACT Registry™ (IMproving Pediatric and Adult Congenital Treatment): First Data Report — Gerard R. Martin, Lisa Bergersen, Lee Benson, Robert Beekman, Ralf Holzer, Frank Ing, Kathy Jenkins, John Moore, Richard Ringel, Jonathan Rome, Carlos Ruiz, Robert Vincent, Children’s National Medical Center, Washington, DC, Children’s Hospital, Boston, MA

PREV

SyMPOSIUM

733

Pharmacology Program: Cardiovascular Implications of Dietary SupplementsSaturday, March 24, 2012, 10:30 a.m. – NoonMcCormick Place North, N427CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-149-L04-P


Panelists: Lynne Braun, Chicago, IL, Steven P. Dunn, Charlottesville, VA, Arshad Jahangir, Phoenix, AZ

10:30 Cardiovascular Implications of Dietary Supplements — Rhonda M. Cooper-Dehoff, Gainesville, FL


noon SeSSionS

ACC-i2/TCT

EXPERTS

2301

Atypical Thrombotic ACS Case ReviewsSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S101aCME/CNE Hours: 1.5

Co-Chairs: Richard C. Becker, Durham, NC A. Michael Lincoff, Cleveland, OH

Case Ali Ataya, Cleveland, OH, Daniel Gutteridge, Flint, MI,Presenters: Nael Hawwa, Cleveland, OH, Taiyeb M. Khumri ,

Kansas City, MO, Yukio Mizuguchi, Kobe, Japan

Panelists: David J. Moliterno, Lexington, KY, Peter B. Berger, Danville, PA

ACC-i2/TCT

EXPERTS

2302

Chronic Total Occlusions and Left Main Case ReviewsSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S102cCME/CNE Hours: 1.5

Co-Chairs: David E. Kandzari, Atlanta, GA Patrick L. Whitlow, Cleveland, OH

Case Stephen Y. Chen, Augusta, GA, Michael E. Halkos,Presenters: Atlanta, GA, Tesfaldet T. Michael, Dallas, TX, Koyu

Sakai, Kitakyushu, Japan

Panelists: James Aaron Grantham, Kansas City, MO, Corrado Tamburino, Catania, Italy, Davide Capodanno, Catania, Italy


noon


NooN

ACC-i2/TCT

EXPERTS

2303

Coronary Imaging Case ReviewsSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S103bCME/CNE Hours: 1.5

Co-Chairs: John McB Hodgson, Wilkes-Barre, PA Morton J. Kern, Orange, CA

Case Joon Hyung Doh, Goyang, South Korea, Yu Kataoka, Presenters: Cleveland, OH, Paula de Lima Santos Eryazici,

Chicago, IL, Syed Rab, Atlanta, GA, Hiroyuki Nagai, Osaka, Japan

Panelists: Akiko Maehara, New York, NY, Marco A. Costa, Cleveland, OH, Giulio G. Guagliumi, Bergamo, Italy

ACC-i2/TCT

SyMPOSIUM

2606

TAVR: Procedural Aspects and Best PracticesSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S102bCME/CNE Hours: 1.5

Co-Chairs: Steven J. Yakubov, Columbus, OH E. Murat Tuzcu, Cleveland, OH

12:15 Debate: General Anesthesia is Best — Balthasar Eberle, Bern, Switzerland

12:20 Debate: Conscious Sedation is Better — Augusto Pichard, Washington, DC


12:30 Debate: Location — Hybrid OR — Todd M. Dewey, Dallas, TX

12:35 Debate: Location — Cardiac Cath Lab — Helen Eltchaninoff, Rouen, France


12:45 Debate: Imaging with Flouro is Sufficient — G. Alain Cribier, Rouen, France

12:50 Debate: Echo Imaging is Required — Mark J. Monaghan, London, United Kingdom


1:05 Assessing Results: VARC and RE-VARC — Patrick W. Serruys, Rotterdam, Netherlands

1:15 Durability and Valve-in-Valve — Josep Rodes-Cabau, Quebec, Canada

1:25 The Low-risk Patient: New Trials — Martin B. Leon, New York, NY

1:35 Nursing Considerations — Maria Held, Cleveland, OH

ACC-i2/TCT

SyMPOSIUM

2607

Acute Venous Thromboembolic DiseaseSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S103cCME/CNE Hours: 1.5

Co-Chairs: Raghu Kolluri, Springfield, IL Samuel Z. Goldhaber, Boston, MA

12:15 VTE Treatment Guidelines: What a Venous Interventionalist Must Know — The American Heart Association Consensus Statement — Are they Different from the American College of Chest Physician Guidelines? — M. Sean McMurtry, Edmonton, AB

12:27 Thrombolysis & Anticoagulation for Extensive DVT: The Science & Clinical Practice — Anthony J. Comerota, Toledo, OH

12:39 Appropriate Patient Selection and Access Site Selection for Venous Intervention: Tips and Tricks — Mahmood K. Razavi, Orange, CA

12:51 Pharmaco-Mechanical Thrombectomy Devices: When to Use What — Gregory J. Mishkel, Springfield, IL

1:03 Central Venous Occlusions and Upper Extremity Venous Interventions — Tino Pena, Miami, FL

1:13 IVC Filters: What Are the Indications and Implications — Robert Schainfeld, Waltham, MA

1:25 Interventional Management of Acute Pulmonary Embolism — Appropriate Patient Selection — Speaker TBD


ACS

SyMPOSIUM

604

Controversies in ACSSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S404CME/CNE Hours: 1.5

Debate: Radial versus Femoral Access for ACS Patients Undergoing Early Invasive Strategy

Co-Chairs: Ajay J. Kirtane, New York, NY Sunil V. Rao, Durham, NC

12:15 Femoral Access Is Tried and True: No Need to Change Now — David Alan Cox, Allentown, PA

12:27 Radial Access Is Preferred in the ACS Patient — David E. Kandzari, Atlanta, GA

12:39 Debate Summary — Ajay J. Kirtane, New York, NY

Debate: Platelet Reactivity and Genotype Testing: An Aid to Clinical Decision-making or an Investigational Tool

Chair: Gregg W. Stone, New York, NY

12:45 Time for Personalized Medicine Is Now — Paul A. Gurbel, Baltimore, MD

12:57 Not Ready for Prime Time — Sanjay Kaul, Los Angeles, CA

1:09 Debate Summary — Gregg W. Stone, New York, NY

Debate: Therapeutic Hypothermia: Cooling Heads and Hearts Improves Outcomes

Co-Chairs: William W. O’Neill, Miami, FL Ivan Rokos, Altadena, CA

1:15 Evidence Is Clearcut — Timothy D. Henry, Minneapolis, MN

1:27 Evidence Is Shaky — Benjamin M. Scirica, Boston, MA

1:39 Debate Summary — William W. O’Neill, Miami, FL


116 GO for ACC.12!

NooN

ARR

EXPERTS

206

Alternatives to Warfarin for the Prevention of Stroke in Atrial Fibrillation: How to Decide?Saturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S503CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-068-L01-P

Chair: Michael M. Ezekowitz, Wynnewood, PA

Case Presenter: Peter Kowey, Wynnewood, PA

Panelists: John Eikelboom, Hamilton, Canada, Gerald V. Naccarelli, Hershey, PA, Salim Yusuf, Hamilton, Canada

HF

EXPERTS

207

Atrial Fibrillation and Heart Failure: A Dynamic DuoSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S502CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-069-L01-P

Chair: Denis Roy, Montreal, Canada

Case Presenter: Maya E. Guglin, Tampa, FL

Panelists: John G. F. Cleland, Cottingham, United Kingdom, Anne B. Curtis, Buffalo, NY, Prakash C. Deedwania, Fresno, CA, Bengt Herweg, Tampa, FL, J. Marcus Wharton, Charleston, SC

IMAG

EXPERTS

208

Imaging Patients with Pericardial DiseaseSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S505CME/CNE Hours: 1.5

Chair: Allan L. Klein, Cleveland, OH

Case Presenter: K. Maganti, Chicago, IL

Panelists: Ron Blankstein, Boston, MA, James C. Carr, Chicago, IL, Jae K. Oh, Rochester, MN

IMAG

SyMPOSIUM

605

Cardiovascular Magnetic Resonance in MyocarditisSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S402CME/CNE Hours: 1.5

Co-Chairs: Robert W. W. Biederman, Pittsburgh, PA Raymond J. Kim, Durham, NC

12:15 Role of CMR in Children with Myocarditis — Michael D. Taylor, Cincinnati, OH

12:33 CMR Tissue Characterization in Myocarditis — Matthias Friedrich, Calgary, Canada

12:51 CMR and Prognosis in Myocarditis — Raymond Y. K. Kwong, Boston, MA

1:09 Future Developments in CMR Imaging Sequences for Myocarditis — Andrew E. Arai, Bethesda, MD

1:27 Clinical Evaluation of the Patient with Myocarditis — Dennis M. McNamara, Pittsburgh, PA

ISCHEM

SyMPOSIUM

606

Revascularization in SIHD: Integrating New EvidenceSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S401aCME/CNE Hours: 1.5

Co-Chairs: Cindy L. Grines, Royal Oak, MI Michael J. Mack, Plano, TX

12:15 Revascularization (Or Not) in the Patient with Heart Failure? — Robert O. Bonow, Chicago, IL


12:45 Revascularization in Diabetics: Back to the Drawing Board? — Robert H. Jones, Durham, NC


1:15 Revascularization in the Patient with Normal LV Function: Who, How and When? — David R. Holmes, Jr., Rochester, MN


ISCHEM

SyMPOSIUM

734

Pharmacology Program: Pharmacologic Considerations in the Setting of PCISaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N427CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-150-L04-P


Panelists: Paul Dobesh, Omaha, NE, Douglas E. Drachman, Boston, MA

12:15 Pharmacologic Considerations in the Setting of PCI — Sarah A. Spinler, Philadelphia, PA


LIFELONG

SyMPOSIUM

607

Everything you Wanted to Know about ABIM Recertification (and more...)Saturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N226CME Hours: 1.5

Chair: Steve R. Ommen, Rochester, MN

12:15 Why Maintenance of Certification (MOC)? — Steve R. Ommen, Rochester, MN

12:25 Current MOC Part IV Requirements and How to Achieve Them — William J. Oetgen, Alexandria, VA

12:55 Evolutions in MOC: What to Expect in the Future — John Gordon Harold, Los Angeles, CA

1:25 What the College Can Do to Help: Question and Answer

PRACTICE

SyMPOSIUM

608

Women in CardiologySaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N229CME/CNE Hours: 1.5

Can’t get everything done? Constantly overwhelmed? During this special session with acclaimed life coach, Jill Farmer, WIC members will learn how to be more productive, peaceful, and connected to the things that really matter. Ms. Farmer’s 45-minute talk will



NooN

be followed by a Q & A Session moderated by members of the ACC’s Women in Cardiology Council.

Chair: Carol Warnes, Rochester, MN

12:15 There’s Not Enough Time!… And Other Lies We Tell Ourselves — Jill Farmer, Saint Louis, MO


PRACTICE

SyMPOSIUM

609

The Challenges in Daily PracticeSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N230CME/CNE Hours: 1.5

Co-Chairs: Blair D. Erb, Bozeman, MT Michael K. Schroyer, Zionsville, IN

12:15 MOC and MOL: Where Are We Headed? — John Gordon Harold, Los Angeles, CA

12:33 Who Decides What Quality Is? — John E. Brush, Norfolk, VA

12:51 Core Measure and Beyond — Michael K. Schroyer, Zionsville, IN

1:09 Data Collection for Beginners — Cathleen Biga, Woodridge, IL

1:27 Pinnacle, AUC and Beyond: Making the ACC Tools Work for you — Blair D. Erb, Bozeman, MT

PREV

SyMPOSIUM

611

Is There a Role for HDL Therapy: Are We AIMing Too HIGH?Saturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S100cCME/CNE Hours: 1.5

Co-Chairs: Michael H. Davidson, Chicago, IL Richard H. Karas, Boston, MA

12:15 AIM-HIGH: Case Closed for HDL? — William E. Boden, Buffalo, NY

12:30 AIM HIGH in Context: From ARBITER to HPS2-THRIVE — Allen J. Taylor, Washington, DC

12:45 Should We Reconsider Fibrates? — Michael H. Davidson, Chicago, IL

1:00 Current Status of CETP Inhibitors — Christie M. Ballantyne, Houston, TX

1:15 HDL Form and Function — Prediman K. Shah, Los Angeles, CA

1:30 Apo A1 Mimetics and HDL Infusions — Prediman K. Shah, Los Angeles, CA

QUAL

EXPERTS

209

Getting Access to Data: Successful Examples from the NCDRSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S501aCME/CNE Hours: 1.5

Chair: Tracy Wang, Durham, NC

Case Presenter: Robert W. Yeh, Boston, MA

Panelists: Paul Chan, Kansas City, MO, Thomas M. Maddox, Denver, CO, Amy Leigh Miller, Boston, MA, John S. Rumsfeld, Denver, CO, Thomas Tehsin Tsai, Denver, CO

QUAL

SyMPOSIUM

610

Translational Research Symposium with the International Society for Cardiovascular Translational Research: Mission and Strategy in Translational ResearchSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N228CME/CNE Hours: 1.5

Co-Chairs: Anthony N. DeMaria, San Diego, CA Spencer B. King, Atlanta, GA

12:15 Keynote Address: Trends and Direction in Cardiovascular Medicine — David R. Holmes, Jr., Rochester, MN

12:40 Translation Clinical Research in Clinical Practice — Anthony N. DeMaria, San Diego, CA

1:00 ISCTR/ACC’s Mission in Cardiovascular Translational Research — Nabil Dib, Gilbert, AZ

1:15 Challenges and Opportunities in Cardiovascular Translational Research — Jack Lewin, Washington, DC

1:30 ISCTR/ACC Translational Research Scholarship — Spencer B. King, Atlanta, GA

SPECIAL

SPECIAL

103

Educating the Educators: Bootcamp for Cardiology Fellowship Program Directors and CoordinatorsSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S405aCME Hours: 1.5

Co-Chairs: Jeffrey T. Kuvin, Boston, MA Chittur A. Sivaram, Oklahoma City, OK

12:15 Welcome and Overview — Marcia J. Jackson, Santee, SC, Jeffrey T. Kuvin, Boston, MA, Chittur A. Sivaram, Oklahoma City, OK

12:30 Focus on ACC Education — Rick A. Nishimura, Rochester, MN, Patrick T. O’Gara, Boston, MA, Mary Ellen Beliveau, Washington, DC

12:45 ACGME and the 2012 Requirements — James A. Arrighi, Povidence, RI

1:30 Heart Failure: ABIM and ACGME Updates — Marvin A. Konstam, Boston, MA

SPECIAL

SPECIAL

104

Fit Forum I: Finding the Right F.I.T. in Developing a Career Plan — Part 1: Finding the Right JobSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N227bCME Hours: 1.5

12:15 Pros and Cons: Large Academic Medical Center — Charanjit S. Rihal, Rochester, MN

12:30 Pros and Cons: Large Private Practice Group, Self-Owned — C. Michael Valentine, Lynchburg, VA

12:45 Pros and Cons: Hospital-Owned Cardiology Group — Thomas D. Stuckey, Greensboro, NC, B. Hadley Wilson, Charlotte, NC

1:00 Pros and Cons: Solo Practitioner — Eric B. Carlson, Greenville, NC

1:15 Pros and Cons: Non-Traditional Practice — Michael R. Bristow, Aurora, CO

1:30 Discussion with Audience Question and Answer


118 GO for ACC.12!

NooN

VALV

EXPERTS

210

Organic Mitral Regurgitation Case-ManagementSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S504aCME/CNE Hours: 1.5

Co-Chairs: Robert J. Siegel, Los Angeles, CA Thoralf M. Sundt, Boston, MA

Case Harold M. Burkhart, Rochester, MN, Amar Presenters: Krishnaswamy, Cleveland, OH, Vuyisile Nkomo,

Rochester, MN

Panelists: Blase A. Carabello, Houston, TX, Robert J. Siegel, Los Angeles, CA

VALV

SyMPOSIUM

612

The Spectrum of Degenerative Mitral Valve: From Imaging to TreatmentSaturday, March 24, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N426CME/CNE Hours: 1.5

Co-Chairs: Elyse Foster, San Francisco, CA Brian P. Griffin, Cleveland, OH

12:15 New Insights into the Pathophysiology of MVP — Albert Alain Hagege, Paris, France

12:33 Asymptomatic Degenerative MR: Who Should Undergo Valve Repair? — Maurice Enriquez-Sarano, Rochester, MN

12:51 Role of 3-D TEE in the Operating Room for Mitral Repair — Salvatore Costa, Lebanon, NH

1:09 Repair of Degenerative MR: A Perfect Solution? — Rakesh Suri, Rochester, MN

1:27 E-Clip of MVP Is Useful in My Practice — Francesco Maisano, Milan, Italy

LIFELONG

MOC

803

ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy — Cardiovascular Disease 2010 Update (A1-K)Saturday, March 24, 2012, 12:30 p.m. – 3:00 p.m.McCormick Place South, S105aCME Hours: 2.5





Attendees may not claim CME credits from ABIM as it is against ACCME and AMA guidelines to claim credit twice for the same activity. MOC credit is available from the ABIM after completion of the MOC module; CME credit only (no CNE credit) is available from ACC.

Chair: Paul Sorajja, Rochester, MN

MOC Faculty: Elizabeth A. Jackson, Ann Arbor, MI, Sherry Saxonhouse, Charlotte, NC

LIFELONG

MOC

804

ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy — Cardiovascular Disease 2011 Update (A1-L)Saturday, March 24, 2012, 12:30 p.m. – 3:00 p.m.McCormick Place South, S105dCME Hours: 2.5






Chair: Ralph J. Verdino, Philadelphia, PA

MOC Faculty: Emmanouil S. Brilakis, Dallas, TX, Jesus Almendral, New Brunswick, NJ



AFTERNOON

Afternoon SeSSionS

ACC-i2/TCT

CASE REVIEW

2201

Live and Taped Case Session I: Multivessel PCI- Physiology and ImagingSaturday, March 24, 2012, 2:00 p.m. – 5:00 p.m.McCormick Place North, Hall B, ACC.12 Main TentCME/CNE Hours: 3

Co-Chairs: Gary S. Mintz, Washington, DC William Fuller Fearon, Stanford, CA

Panelists: Sigmund Silber, Zell, Germany, Ajay J. Kirtane, New York, NY, Eric R. Bates, Ann Arbor, MI, Marco A. Costa, Cleveland, OH, Manish Parikh, New York, NY, Alan C. Yeung, Palo Alto, CA, David J. Moliterno, Lexington, KY, John McB Hodgson, Wilkes-Barre, PA

2:00 Live Case from Northwestern Memorial Hospital, Chicago, IL — Charles J. Davidson, Chicago, IL

3:30 FFR after FAME-I and FAME-II: The Appropriate Use of Physiology in the Cath Lab in 2012 — William Fuller Fearon, Stanford, CA

3:45 The Exploding World of Intravascular Imaging: IVUS, OCT, NIRS, etc — Practical Use during PCI — Gary S. Mintz, Washington, DC


4:15 Taped Case from the University of Texas Southwestern Medical Center, Dallas, TX — Emmanouil S. Brilakis, Dallas, TX

ACC-i2/TCT

ORAL

2502

Acute Myocardial InfarctionSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S103bCME/CNE Hours: 1.5

Co-Chairs: Stephen G. Ellis, Cleveland, OH Jose P. Henriques, Amsterdam, Netherlands

Panelists: Dmitriy N. Feldman, New York, NY, Timothy A. Sanborn, Evanston, IL, Bimmer E. Claessen, Amsterdam, Netherlands

2:00 year in Review — Speaker TBD

2:15 2502–7 Initial Ambulance Transport of ST-Elevation Myocardial Infarction (STEMI) to Rural Hospitals Leads to Better Door In-Door Out and First Door to Balloon Reperfusion Times within 90 Minutes — B. Hadley Wilson, Angela Humphrey, Robert Haber, William Downey, John Cedarholm, Glen Kowalchuk, Michael Rinaldi, Denise Miller, Jennifer Sarafin, Kevin Collier, J. Garvey, Sanger Heart & Vascular Institute at Carolinas Medical Center, Charlotte, NC

2:25 2502–8 Panel Discussion

2:30 2502–9 The Role of Primary Multivessel Intervention in Acute Myocardial Infarction Complicated by Cardiogenic Shock — Darren Mylotte, Thierry Lefevre, Hélène Eltchaninoff, Nicolas Briole, Karim Tazarourte, Alain Margenet, Dominique Thébert, Yves Louvard, Marie-Claude Morice, Philippe Garot, Institut Cardiovasculaire Paris Sud, Massy, France


2:45 2502–11 Outcomes of Culprit versus Multivessel Intervention in Patients with Multivessel Coronary

Artery Disease Presenting with Acute Myocardial Infarction Complicated by Cardiogenic Shock — Matthew Cavender, Penny Houghtaling, Elizabeth Lieber, Michael Kiernan, Melanie Maytin, Andrew Rassi, Patrick Whitlow, Venu Menon, Stephen Ellis, Mehdi Shishehbor, Cleveland Clinic, Cleveland, OH


3:00 2502–13 Reference Coronary Flow Velocity Reserve Determined after Primary Percutaneous Coronary Intervention for a First Acute Anterior Myocardial Infarction is an Independent Predictor of Cardiac Mortality at Long Term Follow-up — Tim P. van de Hoef, Matthijs Bax, Martijn Meuwissen, Peter Damman, Ronak Delewi, Robbert de Winter, Karel Th Koch, Carl Schotborgh, José Henriques, Jan Tijssen, Jan Piek, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands, Haga Teaching Hospital, The Hague, The Netherlands


3:15 2502–15 Impact of Bivalirudin and Paclitaxel-eluting Stents in Patients with STEMI Undergoing Primary PCI of the Left Anterior Descending Artery: The HORIZONS-AMI Trial — Jochen Woehrle, Helen Parise, Roxana Mehran, Gregg Stone, University of Ulm, Ulm, Germany, Columbia University Medical Center and Cardiovascular Research Foundation, New York, NY


ACC-i2/TCT

SyMPOSIUM

2608

Intravascular Imaging: Restenosis, Thrombosis and Stent Follow-up I: Restenosis and Early ThrombosisSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S101aCME/CNE Hours: 1.5

Co-Chairs: Steven R. Bailey, San Antonio, TX Alan C. Yeung, Palo Alto, CA

2:00 Mechanisms and Findings in Restenosis and Early Stent Thrombosis: IVUS, VH-IVUS, OCT, Spectroscopy, and Beyond — Lisette Jensen, Odense, Denmark

2:12 Does Acute Stent Malapposition Cause Restenosis or Early Stent Thrombosis? — Neil J. Weissman, Washington, DC

2:24 IVUS Predictors of Restenosis and Early Stent Thrombosis: What are the Ideal Stent-Implantation Endpoints? — Soo-Jin Kang, Suwon, Republic of Korea

2:36 OCT Predictors of Restenosis and Early Stent Thrombosis: Including an Update from the MGH-OCT Registry — Ik-Kyung Jang, Boston, MA

2:48 Is there a Role for CT Angiography in Long-term Stent Assessment (Restenosis and/or Stent Thrombosis)? — Szilard Voros, Atlanta, GA

3:00 When and How Should In-stent Restenosis Be Treated? FFR, IVUS and Other Data — Habib Samady, Atlanta, GA


120 GO for ACC.12!

AFTE

RNOO

N

3:10 Case Presentation — Jinman Cho, Seoul, Republic of Korea

3:15 Case Presentation — William J. Kostis, Boston, MA

3:20 Case Presentation — Ozgur Bayturan, Izmir, Turkey


ACC-i2/TCT

SyMPOSIUM

2609

Hemodynamics and Angiography I (Basic Issues)Saturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S102bCME/CNE Hours: 1.5

Co-Chairs: Maurice Enriquez-Sarano, Rochester, MN, John W. Hirshfeld, Philadelphia, PA

2:00 Hemodynamics of MR Pre- and Post-Percutaneous Therapy — Ted Feldman, Evanston, IL

2:15 Pitfalls in the Assessment of AS Severity — Zachary Gertz, Havertown, PA

2:30 Cath Assessment of TAVR, BAV, and Complications — Raj R. Makkar, Los Angeles, CA

2:45 Integrating Echo into the Percutaneous Valve Procedures — Frank E. Silvestry, Wayne, PA

3:00 Hemodynamics of IABP, Mitral, Tricuspid and Pulmonary Stenosis — Morton J. Kern, Orange, CA

3:15 Hemodynamic Pitfalls — Zoltan G. Turi, Camden, NJ

ACC-i2/TCT

SyMPOSIUM

2610

Renal Interventions for Hypertension and Renal Function PreservationSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S103cCME/CNE Hours: 1.5

Co-Chairs: Gregory J. Mishkel, Springfield, IL Douglas E. Drachman, Boston, MA

2:00 CORAL, ASTRAL & STAR: Good News, Bad News — Jeffrey W. Olin, New York, NY

2:15 eGFR Is Not a Valid Estimate of Renal Function in Patients with Atherosclerotic Renal Artery Disease — Ryan Madder, Troy, MI

2:30 How to Predict Improved Blood Pressure after Renal Stenting — Jason H. Rogers, Sacramento, CA

2:45 How to Predict Improved Renal Function after Renal Stenting — Stephen Textor, Rochester, MN

3:00 Is Renal Sympathetic Denervation a Viable Option for Treating Hypertension — Krishna J. Rocha-Singh, Springfield, IL


ACC-i2/TCT

SyMPOSIUM

2645

Interventional Featured Clinical Studies IISaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S102cCME/CNE Hours: 1.5

Co-Chairs: Hector M. Garcia, Rotterdam, Netherlands Giora Weisz, New York, NY

Panelists: Ron Waksman, Washington, DC, Daniel J. McCormick, Moorestown, NJ

2:00 A Prospective Randomized Study Using Optical Coherence Tomography to Assess Endothelial Coverage and Neointimal Proliferation at 6-months after Implantation of a Coronary Everolimus-eluting Stent Compared with a Bare Metal Stent Postdilated with a Paclitaxel-Eluting Balloon (OCTOPUS Trial) — Tudor C. Poerner, Sylvia Otto, Florian Janiak, Johannes Gassdorf, Hans R. Figulla, University Hospital of Jena, Jena, Germany


2:15 Visual-Functional Mismatch between Coronary Angiography and Fractional Flow Reserve — Seung-Jung Park, Soo-Jin Kang, Jung-Min Ahn, Eun-Bo Shim, Young-Tae Kim, Sung-Cheol Yoon, Haegeun Song, Jong-Young Lee, Won-Jang Kim, Duk-Woo Park, Seung-Whan Lee, Young-Hak Kim, Cheol Whan Lee, Seong-Wook Park, Seong-Wook Park, Asan Medical Center, Seoul, South Korea, Kangwon National University, Chuncheon, South Korea


2:30 Sirolimus-eluting Stent with Biodegradable Polymer versus Sirolimus Eluting Stent with Durable Polymer for the Treatment of Patients with de novo Coronary Artery Lesions (EVOLUTION): A Randomized Non-inferiority Trial — Junbo Ge, Lei Ge, Juying Qian, Guosheng Fu, Huiliang Liu, Genshan Ma, Yitong Ma, Weiyi Fang, Hui Li, Yujie Zhou, Yongwen Qin, Yigang Li, Lianqun Cui, Chengzhi Lu, Bin Liu, Jifei Tang, Zheng Zhang, Meixiang Xiang, Xuefeng Guang, Dadong Zhang, Qing He, Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, People’s Republic of China


2:45 Late Benefit of Intra-Aortic Balloon Counterpulsation during High-risk Percutaneous Coronary Intervention: Long-term Mortality Data from the Balloon Pump-assisted Coronary Intervention Study (BCIS-1) — Divaka Perera, Rod Stables, Kalpa DeSilva, Matthew Lumley, Daša Zugwitz, Lucy Clack, Martyn Thomas, Simon Redwood, Kings College London, London, United Kingdom, Liverpool Heart and Chest Hospital, Liverpool, United Kingdom


3:00 Biodegradable Polymer Drug-eluting Stents versus Durable Polymer Sirolimus-eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: A Pooled Analysis of Individual Patient Data from the ISAR-TEST 3, ISAR-TEST 4, and LEADERS Randomized Trials at 4-years — Robert A. Byrne, Giulio Stefanini, Patrick Serruys, Antoinette de Waha, Bernhard Meier, Steffen Massberg, Peter Juni, Stephan Windecker, Adnan Kastrati, Deutches Herzzentrum, Munich, Germany, Bern University Hospital, Bern, Switzerland


3:15 2-year Clinical Outcomes from the Pivotal RESOLUTE US Study — Laura Mauri, Martin Leon, Donald Cutlip, Jeffrey Popma, Peter Fitzgerald, Joseph Massaro, Alan Yeung, Brigham and Women’s



AFTERNOON

Hospital, Boston, MA, Stanford University Medical Center, Palo Alto, CA


ACS

EXPERTS

211

Optimal STEMI Management from Presentation to Post-Discharge CareSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S504aCME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-072-L01-P

Chair: Charanjit S. Rihal, Rochester, MN

Case Presenter: Tamim Nazif, New York, NY

Panelists: Somjot Singh Brar, Los Angeles, CA, Bojan Cercek, Los Angeles, CA, Cindy L. Grines, Royal Oak, MI, Freek W. A. Verheugt, Amsterdam, Netherlands

ACS

SyMPOSIUM

613

State-of-the-Art in STEMI CareSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S404CME/CNE Hours: 1.5

Co-Chairs: C. Michael Gibson, Boston, MA Ajay J. Kirtane, New York, NY

2:00 Pre-hospital Triage and Emergency Medical System Activation for STEMI: The Clock Starts Ticking Early — Ivan Rokos, Altadena, CA

2:12 Time to Reperfusion across Systems of Care: The Role of PCI, Lytics, Transfer and Adjunctive Therapies — Duane S. Pinto, Boston, MA, Timothy D. Henry, Minneapolis, MN

2:36 Guidelines Debate

2:36 ACC/AHA Guidelines Are Evidence-based, User-friendly and Pragmatic — Elliott M. Antman, Boston, MA, Jean-Pierre L. Bassand, Besancon, France, Paul Wayne Armstrong, Edmonton, Canada

3:06 Featured Lecture: Progress in STEMI — What’s Next? — Valentin Fuster, New York, NY

3:21 Moderated Summary — C. Michael Gibson, Boston, MA

ACS

SyMPOSIUM

618

Translational Research Symposium with the International Society for Cardiovascular Translational Research: Cellular TherapiesSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N228CME/CNE Hours: 1.5

Co-Chairs: Andreas M. Zeiher, Frankfurt, Germany Andre Terzic, Rochester, MN

2:00 Regeneration Enhancement in Acute Myocardical Infarction: Advancing Stem Call Therapy — Andreas M. Zeiher, Frankfurt, Germany

2:10 Refractory Angina: A Stem Cell Approach from Bench to Phase 3 Clinical Trials — Douglas W. Losordo, Chicago, IL

2:20 Cardiac-derived Stem Cells: From Product Development to Clinical Application — Eduardo Marban, Los Angeles, CA

2:30 Promoting Cardiopoiesis to Enhance Cell Therapy in Chronic Heart Failure — Andre Terzic, Rochester, MN

2:40 Does the Route of Application Matter for Clinical Effects of Cell Therapy — Nabil Dib, Gilbert, AZ

2:50 Pathway to IND — Steve Winitsky, Silver Spring, MD


ARR

EXPERTS

212

Management of Difficult AF: When to Change Drugs, When to Give UpSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S503CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-073-L01-P

Chair: Leslie A. Saxon, Los Angeles, CA

Case Presenter: Brian Powell, Rochester, MN

Panelists: David Callans, Philadelphia, PA, Robert C. Kowal, Dallas, TX, Andrea Natale, Austin, TX

ARR

SyMPOSIUM

614

Can Remote Disease Management Improve Clinical Outcomes?Saturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S406aCME/CNE Hours: 1.5

Co-Chairs: Christopher Liu, New York, NY Niraj Varma, Cleveland, OH

2:00 What Is the Evidence from Clinical Trials? — George H. Crossley, Nashville, TN

2:18 Utilization of Heart Failure Diagnostics: Can We Minimize Heart Failure Admissions? — William T. Abraham, Columbus, OH

2:36 How to Use Monitoring Technologies in the Management of Atrial Fibrillation — Paul A. Levine, Sylmar, CA

2:54 Monitoring Outcomes Using Remote Monitoring Databases — David L. Hayes, Rochester, MN

3:12 Cost-Benefit Ratio — Mark H. Schoenfeld, New Haven, CT

ARR

SyMPOSIUM

615

Challenges in the Management of Supraventricular TachycardiaSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S403CME/CNE Hours: 1.5

Chair: Bindi K. Shah, Philadelphia, PA

2:00 Atrial Flutter — Sei Iwai, Stony Brook, NY

2:12 Atrial Tachycardia Arising from Pulmonary Veins — Atul Verma, Toronto, Canada

2:18 AV Nodal Re-Entry Tachycardia — Melvin M. Scheinman, San Francisco, CA

2:36 SVT in the Presence of an Accessory Pathway — Eric N. Prystowsky, Indianapolis, IN

2:54 Focal Atrial Tachycardia — Bradley P. Knight, Chicago, IL


122 GO for ACC.12!

AFTE

RNOO

N

ARR

SyMPOSIUM

735

Pharmacology Program: Pharmacotherapy of New AntithromboticsSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N427CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-151-L04-P


2:00 Pharmacotherapy of New Antithrombotics — Joseph S. Alpert, Tucson, AZ


Panelists: Jonathan L. Halperin, New York, NY, Michael Gulseth, Sioux Falls, SD

CCS

SyMPOSIUM

616

Quality, Safety and Resources Enhancing Pediatric Cardiovascular CareSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N231CME/CNE Hours: 1.5

Co-Chairs: Jean A. Connor, Boston, MA Gerard Martin, Washington, DC

2:00 Increasing Access to Care and Evaluation of Quality for Pediatric Nurse Practitioner Managed Cardiac Clinics — Theresa A. Saia, Boston, MA

2:15 Radiation Risk for Pediatric Patients in the Catheterization Laboratory, the Evidence and Measurement of Risk — Ralf Holzer, Columbus, OH

2:30 Optimizing Growth of the Cardiovascular Infant — Jeffrey Anderson, Cincinnati, OH

2:45 Enhancing a Distraction Free Environment the Redzone Medication Safety Initiative — Jeanne Ahern, Boston, MA

3:00 Clinical Handoffs: Models That Can Be Safely and Practically Implemented — Kshitij P. Mistry, Charlotte, NC

3:15 Quality Improvement amongst Cardiovascular Programs in Developing Countries — Kathy J. Jenkins, Boston, MA

HF

EXPERTS

213

From Shock to Recovery or Bridge to Transplanation: Role of Percutaneous VADs and Other Support DevicesSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S502CME/CNE Hours: 1.5

Chair: Mariell Jessup, Philadelphia, PA

Case Presenter: Jeffrey Teuteberg, Pittsburgh, PA

Panelists: Michael A. Acker, Philadelphia, PA, David DeNofrio, Boston, MA, William W. O’Neill, Miami, FL, Francis D. Pagani, Ann Arbor, MI

HF

SyMPOSIUM

617

Cardiorenal Syndrome in Heart Failure: From Definition to ManagementSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S406bCME/CNE Hours: 1.5

Co-Chairs: Wai Hong Wilson Tang, Cleveland, OH Maya E. Guglin, Tampa, FL

2:00 What Truly Is Cardiorenal Syndrome? Novel Insights into the Pathophysiology and Subtypes of Cardiorenal Syndrome — Javed Butler, Atlanta, GA


2:18 Predictors of Response to ADHF Treatment and Development of Cardiorenal Syndrome — Gregg C. Fonarow, Los Angeles, CA


2:36 Aggressive versus Conservative Diuresis in Treatment of ADHF: The Benefit versus Risk — G. Michael Felker, Durham, NC


2:54 What Changes during Therapy of ADHF? From Patient Symptoms to Physical Findings and Biomarkers — Biykem Bozkurt, Houston, TX


3:12 Novel Therapeutic Targets and Strategies for Nonresponders to Initial ADHF Therapy — Maria Rosa Costanzo, Naperville, IL


IMAG

EXPERTS

214

Current Topics in Cardiac CTSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S505CME/CNE Hours: 1.5

Chair: Joao A. C. Lima, Baltimore, MD

Case Presenters: Mouaz H. Al-Mallah, Riyadh, Saudi Arabia, John P. Reilly, New Orleans, LA

Panelists: C. Richard Conti, Gainesville, FL, Richard T. George, Monkton, MD, Harvey S. Hecht, New York, NY, Robert C. Hendel, Miami, FL

IMAG

SyMPOSIUM

619

Multimodality Imaging of Hypertrophic CardiomyopathySaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S402CME/CNE Hours: 1.5

Co-Chairs: Barry J. Maron, Minneapolis, MN Steve R. Ommen, Rochester, MN

2:00 Cardiac MR in Diagnosis and Management of HCM — Karin Dill, Chicago, IL

2:18 Catheterization and Hemodynamics in Diagnosis and Management of HCM — Rick A. Nishimura, Rochester, MN

2:36 Echocardiography in the Diagnosis and Management of HCM — Sherif F. Nagueh, Houston, TX

2:54 Nuclear Imaging in the Diagnosis and Management of HCM — Vasken Dilsizian, Baltimore, MD

3:12 Computed Tomography in the Diagnosis and Managment of HCM — Milind Y. Desai, Cleveland, OH



AFTERNOON

ISCHEM

SyMPOSIUM

620

Stable Ischemic Heart Disease in Women: Are They Really from Venus?Saturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S401aCME/CNE Hours: 1.5

Co-Chairs: Sharon L. Mulvagh, Rochester, MN Carl Pepine, Gainesville, FL

2:00 What Does Ischemia without Obstructive CAD Really Mean? — Martha Gulati, Columbus, OH


2:22 Autoimmune Disorders in Women and Their Role in CAD — Rekha Mankad, Rochester, MN


2:45 Treating Women and Men: What’s Different and What’s the Same? — C. Noel Bairey Merz, Los Angeles, CA


3:07 Putting it All Together: How to Choose the Best Test — Leslee J. Shaw, Atlanta, GA


LIFELONG

CORE

805

Core Curriculum: Congenital Heart DiseaseSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N226CME/CNE Hours: 1.5

Chair: Alex J. Auseon, Columbus, OH

2:00 Congenital Heart Disease I: Simple — M. Regina Lantin-Hermoso, Houston, TX

2:25 Congenital Heart Disease II: Complex — Jennifer Grando-Ting, Hummelstown, PA

2:50 Cardiovascular Disease and Pregnancy — Karen K. Stout, Seattle, WA


LIFELONG

CORE

806

Core Curriculum: Congestive Heart FailureSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N229CME/CNE Hours: 1.5

Chair: John A. McPherson, Nashville, TN

2:00 Evaluation and Management of Acute Decompensated CHF: Systolic and Diastolic — Akshay S. Desai, Boston, MA

2:25 Evaluation and Management of Chronic CHF: Systolic and Diastolic — Larry A. Allen, Aurora, CO

2:50 PHTN: Evaluation and Management — Anne Marie Valente, Boston, MA


PRACTICE

SyMPOSIUM

621

ACC/MedAxiom/ACCA: Physician/Hospital Integration 101Saturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N230CME/CNE Hours: 1.5

Co-Chairs: Jerome L. Hines, Hinsdale, IL Dipti Itchhaporia, Newport Beach, CA

2:00 Contracts 2012: What Models Exist to Integrate with My Hospital — Suzette Jaskie, Grand Rapids, MI

2:15 Negotiating 101: Defining Physician Value — Matthew Phillips, Austin, TX

2:30 Creating Value through Integration — Charles L. Brown, III, Atlanta, GA

2:45 Avoiding Pitfalls — Cathleen Biga, Woodridge, IL

3:00 The Fallout of Integration on Patients — C. Michael Valentine, Lynchburg, VA

3:15 Renegotiating the Contract — Howard T. Walpole, Nashville, TN

PREV

SyMPOSIUM

622

Emerging Trends in AtherosclerosisSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S100cCME/CNE Hours: 1.5

Co-Chairs: Peter Ganz, San Francisco, CA Roxana Mehran, New York, NY

2:00 Multimodality Plaque Imaging — Valentin Fuster, New York, NY

2:15 Prevention Strategies — William S. Weintraub, Newark, DE

2:30 Risk Factor Control — Sidney Smith, Jr., Chapel Hill, NC

2:45 Invasive Imaging of Subclinical Disease — Gregg W. Stone, New York, NY

3:00 Pathogenesis of Atherosclerosis — Renu Virmani, Gaithersburg, MD

3:15 Evaluation of Vascular Function — Joseph A. Vita, Boston, MA

QUAL

EXPERTS

215

When Should a Medicine or Device Stop Being Used in Practice?Saturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S501aCME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-075-L01-P

Chair: Robert W. Yeh, Boston, MA

Case Presenter: Scott Wright, Rochester, MN

Panelists: Robert G. Hauser, Minneapolis, MN, Steven E. Nissen, Cleveland, OH, Frederic S. Resnic, Boston, MA, Paul D. Varosy, Denver, CO

SPECIAL

SPECIAL

106

Educating the Educators: Faculty Development for Cardiology Fellowship Program Directors and CoordinatorsSaturday, March 24, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S405aCME Hours: 1.5

Co-Chairs: Jeffrey T. Kuvin, Boston, MA Chittur A. Sivaram, Oklahoma City, OK

2:00 Faculty Development — Joseph S. Green, Washington, DC, Marcia J. Jackson, Santee, SC


124 GO for ACC.12!

AFTE

RNOO

N

2:00 Satellite Session for Fellowship Program Coordinators — Tabitha Fineberg, Boston, MA Faculty Lounge, S100, Conference Room A

3:00 Self Assessment — David Davis, Washington, DC

SPECIAL

SPECIAL

107

FIT Forum I: Finding the Right F.I.T. in Developing a Career Plan — Part 2: Launching a Successful CareerSaturday, March 24, 2012, 2:00 p.m. – 3:15 p.m.McCormick Place North, N227bCME Hours: 1.25

2:00 Early Career Funding Opportunities — C. William Balke, San Francisco, CA


2:25 Social Media to Promote Clinical Research — Robert A. Harrington, Durham, NC


2:50 Evolution of Technology and Medicine: Using Handheld Technology to Improve Patient Care — Kirk T. Spencer, Chicago, IL

3:00 Evolution of Technology and Medicine: How IT Can be Used to Improve Patient Care — Amy Leigh Miller, Boston, MA


SPECIAL

LEGENDS

401

Legends of Cardiovascular Medicine Lecture Series — 43rd Annual Louis F. Bishop LectureSaturday, March 24, 2012, 2:00 p.m. – 3:00 p.m.McCormick Place North, N426CME/CNE Hours: 1

Chair: Lawrence H. Cohn, Boston, MA

2:00 Introduction of Dr. Magdi H. yacoub — Lawrence H. Cohn, Boston, MA

2:05 43rd Annual Louis F. Bishop Lecture: In Search of Excellence — Magdi H. Yacoub, Harefield, Middlesex, United Kingdom

2:35 One-on-One Interview with Dr. Magdi H. yacoub — Lawrence H. Cohn, Boston, MA

2:50 Audience Question and Answer

LIFELONG

MOC

807

ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy — Cardiovascular Disease 2011 Update (A1-L)Saturday, March 24, 2012, 3:30 p.m. – 6:00 p.m.McCormick Place South, S105aCME Hours: 2.5


Attendees must be enrolled in the ABIM’s MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite

to answer your MOC questions and help with enrollment.





MOC Faculty: James C. Fang, Cleveland, OH, Samuel Asirvatham, Rochester, MN

LIFELONG

MOC

808

ACCF Study Sessions for Maintenance of Certification: ABIM Recertification Made Easy — Cardiovascular Disease 2010 Update (A1-K)Saturday, March 24, 2012, 3:30 p.m. – 6:00 p.m.McCormick Place South, S105dCME Hours: 2.5






Chair: Andrew Wang, Durham, NC

MOC Faculty: Julia H. Indik, Tucson, AZ, Mehdi H. Shishehbor, Cleveland, OH



AFTERNOON

SPECIAL

SPECIAL

107A

FIT Forum I: Mix ‘n’ MingleSaturday, March 24, 2012, 3:30 p.m. – 4:30 p.m.McCormick Place South, Hall A, Bistro ACCCME/CNE Hours: 0

ARR

SyMPOSIUM

736

Pharmacology Program: Pharmacologic Considerations with Antiarrhythmic Drugs, and Dyslipidemia and Residual Risk: When and How Do you Add to Statin Therapy?Saturday, March 24, 2012, 4:00 p.m. – 6:00 p.m.McCormick Place North, N427CME/CNE/CPE Hours: 2 ACPE No. 0012-9999-152-04-P


4:00 Pharmacologic Considerations with Antiarrhythmic Drugs — James Tisdale, Indianapolis, IN


Panelists: Melanie T. Gura, OH, Kristen K. Patton, Seattle, WA, Cynthia Sanoski, Philadelphia, PA

5:00 Dyslipidemia and Residual Risk: When and How Do you Add to Statin Therapy? — Matthew K. Ito, San Diego, CA


Panelists: Robert Lee Page, II, Aurora, CO, Janet B. Long, Providence, RI, Karol E. Watson, Redondo Beach, CA

ACC-i2/TCT

EXPERTS

2305

Vascular Access Challenges and Complications Case ReviewsSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S102cCME/CNE Hours: 1.5

Co-Chairs: Tift Mann, Raleigh, NC Robert J. Applegate, Winston-Salem, NC

Case Robert Dieter, Chicago, IL, Shigenori Ito, Nagoya, Japan, Presenters: Sangeeta Mandapaka, Charleston, WV, Gopi

Manthripragada, Los Angeles, CA, Mohammad Reza Movahed, Tucson, AZ

Panelists: Ian C. Gilchrist, Hershey, PA,Harold L. Dauerman, Shelburne, VT, James C. Blankenship, Danville, P

ACC-i2/TCT

EXPERTS

2306

Unusual Cases of Acute Coronary Syndromes Case ReviewsSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S103bCME/CNE Hours: 1.5

Co-Chairs: John W. Hirshfeld, Philadelphia, PA, William J. French, Torrance, CA

Case Natasha Purai Arora, Detroit, MI, Sam Mcelwee,Presenters: Birmingham, AL, Syed Tanveer Rab, Atlanta, GA,

Adurthy Ananth Shankar, Syracuse, NY, Lauren Simprini, Washington, DC

Panelists: Neal S. Kleiman, Houston, TX, James E. Tcheng, Durham, NC, A. Michael Lincoff, Cleveland, OH

ACC-i2/TCT

SyMPOSIUM

2611

Intravascular Imaging: Restenosis, Thrombosis and Stent Follow-up II: Very Late Stent Thrombosis and Late Catch-upSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S101aCME/CNE Hours: 1.5

Co-Chairs: Renu Virmani, Gaithersburg, MD Evelyn Regar, Rotterdam, Netherlands

4:30 Comparative Mechanisms of Early, Late and Very Late Stent Thrombosis: Findings from IVUS Studies — Yasuhiro Honda, Stanford, CA

4:42 Comparative Mechanisms of Early, Late and Very Late Stent Thrombosis: Findings from OCT Studies — Ik-Kyung Jang, Boston, MA

4:54 In-stent Neoatherosclerosis: Time Course, Pathologic Findings in BMS and DES, and Pathologic Validation of OCT Studies — Gaku Nakazawa, Isehara, Japan

5:06 In-stent Neoatherosclerosis in BMS — Mitsuyasu Terashima, Kobe, Japan

5:18 In-stent Neoatherosclerosis in DES — Soo-Jin Kang, Suwon, Republic of Korea

5:30 Bioabsorbable Stents: IVUS, RF-IVUS, OCT, CT Angiographic, and Physiologic Assessment — John A. Ormiston, Auckland, New Zealand

5:42 Case Presentation — Masamichi Takano, Chiba, Japan

5:47 Case Presentation — Jingbo Hou, Harbin, China


ACC-i2/TCT

SyMPOSIUM

2612

Hemodynamics II (HOCM)Saturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S102bCME/CNE Hours: 1.5

Co-Chairs: Srihari S. Naidu, New York, NY Ulrich Sigwart, Geneva, Switzerland

4:30 Hemodynamic Assessment of HOCM — Michael A. Fifer, Boston, MA

4:45 Case Presentation: HOCM, Ideal for Surgery — Milind Y. Desai, Cleveland, OH

5:00 Myomectomy Should be the First Choice for Most Patients — Nicholas G. Smedira, Cleveland, OH

5:15 Case Presentation: HOCM, Ideal for Alcohol Septal Ablation — Quang T. Bui, Philadelphia, PA

5:30 Why Alcohol Septal Ablation Should be the First Choice for Most Patients — Carey D. Kimmelstiel, Boston, MA



126 GO for ACC.12!

AFTE

RNOO

N

ACC-i2/TCT

SyMPOSIUM

2613

Advances and Controversies in Carotid, Aortic and Peripheral Arterial Disease: In Collaboration with the Society of Vascular SurgerySaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S103cCME/CNE Hours: 1.5

Co-Chairs: Michael R. Jaff, Boston, MA Peter Gloviczki, Rochester, MN

4:30 Controversies in Carotid Stenting vs. Carotid Endarterectomy in Patients with Symptomatic Carotid Artery Disease: The Cardiologist’s Perspective — William A. Gray, New York, NY

4:40 Controversies in Carotid Stenting vs. Carotid Endarterectomy in Patients with Symptomatic Carotid Artery Disease: The SVS Guidelines — John J. Ricotta, Washington, DC

4:50 Indications for Endovascular vs. Open Repair of Abdominal Aortic Aneurysms in 2012 — Peter Gloviczki, Rochester, MN

5:00 Indications for Endovascular vs. Open Repair of Abdominal Aortic Aneurysms in 2012 — Robert M. Bersin, Seattle, WA

5:10 The Future of Endovascular Repair of Thoracic and Thoracoabdominal Aneurysms — Gustavo Oderich, Rochester, MN

5:20 Endovascular, Hybrid or Open Treatment of TASC C and D Iliac Lesions: The Cardiologist’s Perspective — John R. Laird, El Macero, CA

5:30 Endovascular, Hybrid or Open Treatment of TASC C and D Iliac Lesions: The SVS Perspective — Sean Lyden, Cleveland, OH

5:40 Endovascular First for Infrainguinal Peripheral Arterial Disease? The SVS Perspective — Michael S. Conte, San Francisco, CA

5:50 Endovascular First for Infrainguinal Peripheral Arterial Disease? The Cardiologist’s Perspective — Michael R. Jaff, Boston, MA

ACS

SyMPOSIUM

623

Adjunctive Pharmacology in ACS: Anticoagulants and Antiplatelet AgentsSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S404CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-134-L04-P

Co-Chairs: Peter B. Berger, Danville, PA Hyeon-Cheol Gwon, Seoul, Republic of Korea

4:30 Optimal Anticoagulant: Overview of UFH — Marc Cohen, Newark, NJ

4:36 Optimal Anticoagulant: Overview of Bivalirudin — Gregg W. Stone, New York, NY

4:42 Optimal Anticoagulant: Overview of LMWH — Gilles Montalescot, Paris, France

4:48 Moderated Discussion

5:00 Optimal Antiplatelet: Overview of Clopidogrel — Malcolm Bell, Rochester, MN

5:06 Optimal Antiplatelet: Overview of Prasugrel — Stephen D. Wiviott, Boston, MA

5:12 Optimal Antiplatelet: Overview of Ticagrelor — Stefan K. James, Uppsala, Sweden


5:30 Agents on the Horizon: Back to the Future (Current Role of GP IIb/IIIa Receptor Antagonists) — Sarah A. Spinler, Philadelphia, PA

5:36 Agents on the Horizon: Novel Oral Agents (Anti-Xa or IIa, TRA) — William Dager, San Francisco, CA

5:42 Agents on the Horizon: Novel Intravenous Agents (P2y12 Antagonists, Elinogrel, Aptamer) — David J. Moliterno, Lexington, KY


ARR

EXPERTS

216

The Risk versus Benefit of DFT TestingSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S503CME/CNE Hours: 1.5

Chair: Andrea M. Russo, Moorestown, NJ

Case Presenter: Noel G. Boyle, Los Angeles, CA

Panelists: Martin C. Burke, Chicago, IL, Jeanne E. Poole, WA, William H. Sauer, Aurora, CO

ARR

SyMPOSIUM

624

Management of Complications of Pacemakers and LeadsSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S403CME/CNE Hours: 1.5

Co-Chairs: Charles L. Byrd, Fort Lauderdale, FL Laurence Mark Epstein, Boston, MA

4:30 What Can Go Wrong with the Implantation of a Device? — Laurence Mark Epstein, Boston, MA

4:48 Clinical Presentation, Diagnostic Clues and Management of Late Perforations — Alaa A. Shalaby, Pittsburgh, PA

5:06 Management of Device Infections: When Is Medical Therapy Appropriate? — David L. Hayes, Rochester, MN

5:24 Potential Complications/Ramifications Associated with Lead Extraction — Charles L. Byrd, Fort Lauderdale, FL

5:42 Optimal Strategies for the Management of Antiplatelet and Anticoagulation Medications Prior to Cardiac Device Implantation in Patients with Atrial Fibrillation or Prosthetic Valves — Christine Tompkins, Baltimore, MD



AFTERNOON

ARR

SyMPOSIUM

627

Translational Research Symposium with the International Society for Cardiovascular Translational Research: Tissue EngineeringSaturday, March 24, 2012, 4:30 p.m. – 5:30 p.m.McCormick Place North, N228CME/CNE Hours: 1

Co-Chairs: Karen L. Christman, La Jolla, CA Magdi H. Yacoub, Harefield, Middlesex, United Kingdom

4:30 Role of Tissue Engineering in Cardiovascular Medicine — Magdi H. Yacoub, Harefield, Middlesex, United Kingdom

4:45 Tissue Engineering Approaches to Cardiovascular Devices: From Bench to Bedside — Todd McAllister, Navoto, CA

4:55 Materials for Cardiac Repair: The Product and the Animal Model — William Wagner, Pittsburgh, PA

5:05 Injectable Materials for Treating Myocardial Infarction and Peripheral Artery Disease — Karen L. Christman, La Jolla, CA


CCS

SyMPOSIUM

625

Updates on Care in the Congenital Heart Disease PatientsSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N231CME/CNE Hours: 1.5

Co-Chairs: Randall M. Bryant, Jacksonville, FL Michael Earing, Milwaukee, WI

4:30 Newer Antiarrhythmic and Anticoagulant Therapy and Potential Applications for Adults with Congenital Heart Disease — Karen K. Stout, Seattle, WA

4:48 The Use of Leadless Subcutaneous Defibrillators in Congenital Heart Disease — Charles Berul, Washington, DC

5:06 Update on the Changing Approaches and Outcomes for Immunosuppression in Heart Transplant Patients — Lori West, Edmonton, Canada

5:24 Outcomes after Wider Application of the Cone Reconstruction for the Tricuspid Insufficiency: What Do We Know and What Do We Need to Know? — Joseph A. Dearani, Rochester, MN

5:42 Ventricular Assist Device: Current Indications and Options — David Morales, TX

HF

EXPERTS

217

Heart Failure Disease Management: Issues for 2012Saturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S502CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-084-L01-P

Chair: Robin Trupp, Tampa, FL

Case Presenter: Paul A. Heidenreich, Palo Alto, CA

Panelists: Gregg C. Fonarow, Los Angeles, CA, Sara Paul, Hickory, NC, Ileana L. Pina, Cleveland Heights, OH, Kismet Rasmusson, Salt Lake City, UT

HF

SyMPOSIUM

626

Management of Acute Decompensated Heart Failure: From Hemodynamic Subsets to Appropriate Treatment StrategiesSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S406bCME/CNE Hours: 1.5

Chair: Mihai Gheorghiade, Chicago, IL

4:30 Classification and Subclassification of ADHF — Anju Nohria, Boston, MA


4:48 Is There a Role for Hemodynamic Characterization in ADHF — Biykem Bozkurt, Houston, TX


5:06 Role of Biomarkers in Management of ADHF — Wai Hong Wilson Tang, Cleveland, OH


5:24 Current Strategies in Volume Management of ADHF — G. Michael Felker, Durham, NC


5:42 Inotropes, Vasodilators and Novel Treatment Strategies in ADHF — John R. Teerlink, San Francisco, CA


IMAG

EXPERTS

218

Myocardial Perfusion Imaging: Picking the Right TestSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S505CME/CNE Hours: 1.5

Chair: John R. Lesser, Minneapolis, MN

Case Presenter: Julius M. Gardin, Hackensack, NJ

Panelists: Richard T. George, Monkton, MD, Rory Hachamovitch, Cleveland, OH, W. Gregory Hundley, Winston Salem, NC, Joao A. C. Lima, Baltimore, MD

IMAG

SyMPOSIUM

628

Multi-Modality Imaging: Chest Pain in the Emergency DepartmentSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S402CME/CNE Hours: 1.5

Co-Chairs: Sanjiv Kaul, Portland, OR Leslee J. Shaw, Atlanta, GA

4:30 Case Presentation — Michael C. Kontos, Glen Allen, VA

4:36 Let’s Start with a CTA... — Harvey S. Hecht, New York, NY

4:54 Myocardial Perfusion Imaging for the Emergency Department Patient — Raymond J. Gibbons, Rochester, MN

5:12 A Stress Echo, of Course — Farooq A. Chaudhry, New York, NY

5:30 What about Radiation Safety? — Gilbert Raff, Royal Oak, MI

5:42 Panel Discussion/Question and Answer


128 GO for ACC.12!

AFTE

RNOO

N

ISCHEM

SyMPOSIUM

629

Stable Ischemic Heart Disease: What’s New in the Guidelines (and What Should Be)?Saturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S401aCME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-135-L04-P

Co-Chairs: Joaquin Cigarroa, Portland, OR Wanpen Vongpatanasin, Dallas, TX

4:30 BP: How Low Should We Go and How Do We Get There? — Rhonda M. Cooper-DeHoff, Gainesville, FL

4:48 Dyslipidemia: Recent Trials That Should Change the Guidelines — Robert P. Giugliano, Boston, MA

5:06 PCI: Too Much, Too Little, or Too Late? — John Bittl, Ocala, FL

5:24 CABG: When Is Cold Steel the Best Deal? — Michael Jessen, Dallas, TX

5:42 SIHD: Is There Really Anything New? — Joanne M. Foody, Boston, MA

LIFELONG

CORE

809

Core Curriculum: EchocardiographySaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N226CME/CNE Hours: 1.5


4:30 Cardiomyopathies and Pericardial Disease — Sangeeta B. Shah, New Orleans, LA

4:55 Valvular Heart Disease — Rosario Freeman, Seattle, WA

5:20 Diastology — Issam A. Mikati, Chicago, IL


LIFELONG

CORE

810

Core Curriculum: Cardiac ElectrophysiologySaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N229CME/CNE Hours: 1.5

Chair: Bindi K. Shah, Philadephia, PA

4:30 Atrial Fibrillation and the SVT’s — Sherry Saxonhouse, Charlotte, NC

4:55 Sudden Cardiac Death: Epidemiology, Evaluation and Management — Ralph J. Verdino, Philadelphia, PA

5:20 Pacing and AICD Device Therapy Guidelines — Oussama M. Wazni, Solon, OH


PRACTICE

SyMPOSIUM

630

Information Technology, Medicine and the FutureSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N230CME/CNE Hours: 1.5

Co-Chairs: Cathleen Biga, Woodridge, IL Frank Leonard Mikell, Springfield, IL

4:30 I Hate My EHR: Is There a Better System? — Michael J. Mirro, Fort Wayne, IN

4:48 Meaningful Use: What It Means for the Practicing Cardiologist — Cathleen Biga, Woodridge, IL

5:06 ICD-10: Can They Make This Any More Complicated? — Linda Gates-Striby, Indianapolis, IN

5:24 CPOE: The Good, the Bad, and the Ugly — Frank Leonard Mikell, Springfield, IL


PREV

SyMPOSIUM

631

Hypertension Guidelines 2012Saturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S100cCME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-136-L04-P

Co-Chairs: Thomas D. Giles, Metairie, LA Suzanne Oparil, Birmingham, AL

4:30 Updates and New Guidelines for Hypertension Management in 2012 — Suzanne Oparil, Birmingham, AL

4:45 Initial Drug Choices in Low-risk and High-risk Populations — Kenneth A. Jamerson, Ann Arbor, MI

5:00 Should Target Blood Pressure Change in the New Guidelines? — William C. Cushman, Memphis, TN

5:15 Treatment of Hypertension in Diabetes and Chronic Kidney Disease — George L. Bakris, Chicago, IL

5:30 Lifestyle Modification — John D. Bisognano, Rochester, NY

5:45 Hypertension in Ethnic Minorities — Ronald G. Victor, Los Angeles, CA

QUAL

EXPERTS

219

Measuring and Optimizing Quality in your Outpatient Practice: The PINNACLE RegistrySaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S501aCME/CNE Hours: 1.5

Chair: John E. Brush, Norfolk, VA

Case Presenter: William J. Oetgen, Alexandria, VA

Panelists: Suzanne V. Arnold, Kirkwood, MO, Blair D. Erb, Bozeman, MT, David Crockett May, Lewisville, TX, Thomas M. Maddox, Denver, CO

SPECIAL

SPECIAL

109

Educating the Educators: Symposium for Cardiology Fellowship Program Directors and CoordinatorsSaturday, March 24, 2012, 4:30 p.m. – 6:30 p.m.McCormick Place South, S405aCME Hours: 2

Chair: Chittur A. Sivaram, Oklahoma City, OK

4:30 ABIM Milestones and Competencies — William Iobst, Philadelphia, PA, Eric S. Williams, Indianapolis, IN

5:10 Research Training during Fellowship — Joseph A. Hill, Dallas, TX, Chittur A. Sivaram, Oklahoma City, OK , Sunil V. Rao, Durham, NC

5:40 Fellowship Match Changes, Fellow Learning Portfolio and In-Training Examination — Jeffrey T. Kuvin, Boston, MA

6:10 Follow-Up On Previous Projects



AfternooneVening

6:25 Wrap-Up — Jeffrey T. Kuvin, Boston, MA, Chittur A. Sivaram, Oklahoma City, OK, Marcia J. Jackson, Santee, SC

SPECIAL

SPECIAL

110

FIT Forum II: JeopardySaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N227bCME Hours: 1.5

Judges: Kyle W. Klarich, Rochester, MN, Marvin A. Konstam, Boston, MA, Padmini Varadarajan, Redlands, CA

VALV

EXPERTS

220

Ischemic Mitral RegurgitationSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S504aCME/CNE Hours: 1.5

Chair: Vuyisile Nkomo, Rochester, MN

Case John Gorcsan, Pittsburgh, PA, Judy W. Hung, Boston,Presenters: MA, Saibal Kar, Los Angeles, CA

Panelists: Steven F. Bolling, Ann Arbor, MI, Paul A. Grayburn, Dallas, TX, Suzanne J. Wingate, Silver Spring, MD

VALV

SyMPOSIUM

632

Valve Repair: How to Achieve SuccessSaturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N426CME/CNE Hours: 1.5

Co-Chairs: Maurice Enriquez-Sarano, Rochester, MN Patrick M. McCarthy, Chicago, IL

4:30 Echo to Select Patients for Mitral and Aortic Repair — Sunil V. Mankad, Rochester, MN

5:06 Durability of Mitral Repair: What Is the Truth? — David H. Adams, New York, NY

5:24 Thorascopic Mitral Repair Is the Easiest — Clark Hargrove, Philadelphia, PA

4:48 Mitral Regurgitation with Atrial Fibrillation: Worth the Repair and MAZE? — Patrick M. McCarthy, Chicago, IL

5:42 What Is an Advanced Valve Repair Center? — Harold M. Burkhart, Rochester, MN

VASC

SyMPOSIUM

743

Carotid Artery Disease: Is the Picture Clarifying?Saturday, March 24, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S406aCME/CNE Hours: 1.5

Co-Chairs: Ruth Bush, Temple, TX Jonathan L. Halperin, New York, NY

4:30 Stroke Risk in the Symptomatic and Asymptomatic Internal Carotid Artery. Where Are We Today? — Naomi Hamburg, Boston, MA

4:45 Novel Technologies in the Assessment of Stroke Risk in Asymptomatic Carotid Artery Disease — Ahmed A. Tawakol, Boston, MA

5:00 Hostile Necks: What Defines the High Surgical Risk and High Stent Risk Patient? — Sriram S. Iyer, New York, NY

5:15 After CREST, Is it the Procedure or the Operator? Should All In-practice Interventionists Be Allowed

to Place Carotid Stents? — William A. Gray, New York, NY

5:30 Do We Need More Carotid Revascularization Clinical Trials? — Joshua A. Beckman, Boston, MA


VALV

SyMPOSIUM

633

Translational Research Symposium with the International Society for Cardiovascular Translational Research: DevicesSaturday, March 24, 2012, 5:30 p.m. – 6:50 p.m.McCormick Place North, N228CME/CNE Hours: 1.5

Co-Chairs: Nicolas A. F. Chronos, Atlanta, GA Mitchell W. Krucoff, Durham, NC

5:30 Percutaneous and Other Approaches to Aortic Vavle Replacement: From Bench to Bedside — James Fonger, Atlanta, GA

5:40 Percuteanous Mitral Valve Repair: From Bench to Bedside — David Reuter, Kirkland, WA

5:50 Wireless Approaches to Physiological Monitoring: From Bench to Bedside — Jay S. Yadav, Atlanta, GA

6:00 Removing Barriers to Device Innovation — Mitchell W. Krucoff, Durham, NC

6:10 Pathway to IDE and 510K — Bram D. Zuckerman, Rockville, MD


6:40 Summary and Closing Remarks — Anthony N. DeMaria, San Diego, CA

ARR

SyMPOSIUM

1601

Critical Links in Atrial Fibrillation: Priorities in Risk Assessment, Treatment and Patient EducationSaturday, March 24, 2012, 6:00 p.m. – 9:00 p.m.Fairmont Hotel, International BallroomCME/CNE Hours: 2.5

Co-Chairs: Jonathan L. Halperin, New York, NY Stuart A. Winston, Ann Arbor, MI

6:00 Dinner

6:30 Welcome and Overview — Jonathan L. Halperin, New York, NY

6:45 The New Science of Atrial Fibrillation Pharmacotherapy — Christopher B. Granger, Durham, NC

7:10 Using Performance and Medical Record Data to Improve Practice — Patrick J. Daley, Jr., Fort Wayne, IN

7:25 Current and Future Performance Measures for Atrial Fibrillation: What is Expected Now and How Will Expectations Change in the Future? — N.A. Mark Estes, III, Boston, MA

7:45 A New ERA for the Physician: How Performance Improvement CME Enhances Atrial Fibrillation Risk Assessment and Treatment — Joseph P. Drozda, Jr., St. Louis, MO


130 GO for ACC.12!

eVen

ing

8:05 The Impact of Improved Communication and Educational Tools on Patient Outcomes — Stuart A. Winston, Ann Arbor, MI

8:20 Case-Based Panel Discussion and Q&A

8:50 Concluding Remarks

9:00 Adjournment

PREV

CLINICAL FOCUS

1602

First Line of Defense: Risk Factors and Prevention in the Cardiology Practice — A Master Class for the Community CardiologistSaturday, March 24, 2012, 6:30 p.m. – 9:30 p.m.Fairmont Hotel, Gold RoomCME/CNE Hours: 2.5

Tickets are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an “open seating” policy will apply.

Chair: Nanette Kass Wenger, Atlanta, GA

6:30 Registration and Dinner

7:00 Introduction and General Remarks — Nanette Kass Wenger, Atlanta, GA

7:05 Hypertension Management in Contemporary Practice — Suzanne Oparil, Birmingham, AL

7:20 Case Discussion/Questions and Answers

7:40 Managing Dyslipidemia and Atherosclerotic Risk — Michael H. Davidson, Chicago, IL


8:15 Managing Cardiovascular Risk in Patients with Type2 Diabetes — Mark Stolar, Chicago, IL


8:50 Stable Ischemic Heart Disease : Risk Recognition and Assessment, Diagnosis and Treatment — Benjamin M. Scirica, Boston, MA


9:25 Concluding Remarks — Nanette Kass Wenger, Atlanta, GA

VALV

CLINICAL FOCUS

1604

Championing Care for the Patient with Aortic Stenosis: The Role of Cardiologists and Primary Care from Recognition to RecoverySaturday, March 24, 2012, 6:30 p.m. – 9:30 p.m.Fairmont Hotel, Imperial BallroomCME/CNE Hours: 2.5



7:00 Introduction — Aaron Kugelmass, Boston, MA

7:10 Aortic Stenosis in 2012 — Has the Paradigm Changed? Natural History and Therapeutic Options — Blase Carabello, Houston, TX

7:40 “Appropriate Use” of Echocardiography for Aortic Stenosis — Robert Hendel, Miami, FL

8:05 A Surgeon’s Perspective on Treating Aortic Stenosis: What is Acceptable Risk for Open Surgical Replacement? — Michael Mack, Dallas, TX

8:30 TAVR: An Expert’s Perspective and Case Studies — E. Murat Tuczu, Cleveland, OH

8:55 The Asymptomatic Patient with Severe Aortic Stenosis — Patrick O’Gara, Boston, MA

9:20 Concluding Remarks — Aaron Kugelmass, Boston, MA



CardioSmart ForumSouth Building, Hall A2, CV Theater, #22097

11:15 a.m. – 12:15 p.m.Eat What you Love, Love What you Eat: How to Break your Eat-Repent-Repeat Cycle — Part of the “CardioSmart: Hot Topics for Better Patient Outcomes” Series — Michelle May, MD, CSP, Phoenix, AZ — Founder and CEO, Am I Hungry?® Mindful Eating Workshops

The Heart of Innovation Featured Learning Destination South Building, Hall A1, #1076

9:30 a.m. – 10:15 a.m.Educational content including taped cases, physician interviews, panel discussions and more

10:15 a.m. – 10:35 a.m.Autologus Stem Cells Therapy for the Treatment of Refractory Angina — Timothy D. Henry, MD, FACC, Minneapolis, MN — Director of Research, Minneapolis Heart Institute Foundation; Interventional Cardiologist, Minneapolis Heart Institute/Abbott Northwestern Hospital; Professor of Medicine, University of Minnesota School of Medicine

10:35 a.m. – 10:55 a.m.Stem Cells and Biomatrixes — Anthony N. DeMaria, MD, MACC, San Diego, CA — Judith and Jack White Chair in Cardiology, Founding Director, Sulpizio Cardiovascular Center, University of California San Diego

10:55 a.m. – 11:15 a.m.The Regulatory Pathway of Cellular Therapy — Steve Winitsky, MD, Rockville, MD — Medical Officer, U.S. Food and Drug Administration, CBER/OCTGT/DCEPT

11:15 a.m. – 11:35 a.m.ePHR COPE — The Use of PHR to Engage Patients Post-Coronary Revascularization — Michael J. Mirro, MD, FACC, Fort Wayne, IN — Cardiologist, Fort Wayne Cardiology

11:35 a.m. – 11:55 a.m.Role of Real-Time 3D TEE Integration for Complex Transcatheter SHD Repairs — John D. Carroll, MD, FACC, FSCAI, Aurora, CO — Professor of Medicine, Director of Interventional Cardiology, University of Colorado; Medical Director, Cardiac and Vascular Center, University of Colorado Hospital

11:55 a.m. – 12:15 p.m.Digital Intervention — JoAnne M. Foody, MD, FACC, FAHA, Boston, MA — Medical Director, Cardiovascular Wellness Program, Brigham and Women’s Hospital

12:15 p.m. – 12:35 p.m.Applying Personalized Medicine in the Cath Lab by Tailoring Treatment to Patient Risks — John A. Spertus, MD, MPH, FACC, Kansas City, MO — Professor, Daniel J. Lauer Missouri Endowed Chair in Metabolism and Vascular Disease Research, University of Missouri, Kansas City; Director, Cardiovascular Education and Outcomes Research, Mid America Heart Institute

12:35 p.m. – 12:55 p.m.Robotic-Assisted PCI: Opportunities for Improved Precision and Efficiency — George W. Vetrovec, MD, FACC, FSCAI, Richmond, VA — Professor of Medicine, VCU Pauley Heart Center at Virginia Commonwealth University; Executive of Board of Directors, Virginia Commonwealth University Health System

12:55 p.m. – 1:15 p.m.Heart-Derived Cells for the Treatment of Acute Myocardial Infarction — Eduardo Marbán, MD, PhD, FACC, Los Angeles, CA — Director, Cedars-Sinai Heart Institute, Mark S. Siegel Family Professor

1:15 p.m. – 1:45 p.m.Genetic Testing 101: What Are the Benefits?

Jeffrey A. Towbin, MD, FACC, FAAP, FAHA, Cincinnati, OH — Executive Co-Director, The Heart Institute; Kindervelt-Samuel Kaplan Professor and Chief, Pediatric Cardiology, Cincinnati Children's Hospital Medical Center

1:45 p.m. – 3:45 p.m.Educational content including taped cases, physician interviews, panel discussions and more

3:45 p.m. – 4:15 p.m.Moderated Discussion: Viability of Robotic TECAB

Moderator: James B. McClurken, MD, FACC, FACS, FCCP, FESC, Philadelphia, PA — Professor of Surgery, Director of Performance Improvement, Cardiothoracic Surgery, Temple University Health System

Panelists: Johannes O. Bonatti, MD, FETCS, Baltimore, MD — Professor of Surgery, Director of Coronary Surgery and Advanced Coronary Interventions, University of Maryland Medical Center; Ralph J. Damiano, Jr., MD, FACC, St. Louis, MO — John M. Shoenberg Professor of Surgery, Chief of Cardiac Surgery, Washington University in St. Louis School of Medicine


ACC.12 Learning Destination™ Presentations

Saturday, March 24, 2012Learning Destinations™ are diverse, non-accredited, educationally focused areas that offer new and creative venues in which you can expand your educational experience.*

Presentation schedules are current as of Feb. 29, 2012, and are subject to change. For more information, please check the ACC.12 ExpoGuide and ExpoGuide Addendum, available at Expo Hall entrances and in your official meeting bag, and the Heart of Innovation Resource Guide, available at the Heart of Innovation Learning Destination (South Building, Hall A1, #1076) and in your official meeting bag.

132 GO for ACC.12!

Industry-Expert TheaterSouth Building, Hall A1, #22042

10:15 a.m. – 11:15 a.m. (Morning Coffee Break) Pradaxa® (Dabigatran Etexilate Mesylate) Capsules — Alan K. Jacobson, MD, Loma Linda, CA — Director, Anticoagulation Services and Staff Cardiologist, Loma Linda VA Medical Center, Loma Linda University School of MedicinePresented by Boehringer Ingelheim Pharmaceuticals, Inc.

12:30 p.m. – 1:30 p.m. (Mid-Day Break)Next Generation DES: Evolving the Treatment Paradigm — Peter J. Fitzgerald, MD, PhD, FACC, Palo Alto, CA — Director, Center for Cardiovascular Technology, Stanford University; Alan Yeung, MD, Palo Alto, CA — Professor — Med Center Line, Medicine — Cardiovascular Medicine, Stanford University; Krishna Rocha-Singh, MD, FACC, Springfield, IL — Medical Director, Prairie Education & Research CooperativePresented by Medtronic, Inc.

3:30 p.m. – 4:30 p.m. (Afternoon Coffee Break)Treating a Patient at Risk for SCD after PCI — Implant an ICD, Right? The Considerations for Treatment Path Planning, Coverage, and the Role of the Wearable Cardioverter Defibrillator — Sunil V. Rao, MD, Durham, NC — Associate Professor of Medicine, Duke University Medical Center; Director, Cardiac Catheterization Laboratories, Durham VA Medical CenterPresented by ZOLL

Interactive Learning LabsSouth Building, Hall A1, #22027, #22035, #23027

Actelion Pharmaceuticals US, Inc.Interactive Learning Lab #23027

9:30 a.m. – 11:30 a.m.Pulmonary Arterial Hypertension Associated with Adult Congenital Heart Disease: An Interactive Program — Wayne J. Franklin, MD, FACC, Houston, TX — Director, Texas Adult Congenital Heart Program, Texas Children’s Hospital; Assistant Professor of Medicine and Pediatrics, Baylor College of Medicine; Richard A. Krasuski, MD, FACC, FAHA, Cleveland, OH — Director of Adult Congenital Heart Disease Services, Cleveland Clinic Foundation; Michael J. Landzberg, MD, Boston, MA — Director, Boston Adult Congenital Heart Service, Children’s Hospital, Brigham & Women’s Hospital, Harvard Medical School

12:30 p.m. – 2:15 p.m.PAH: A Case-Based Exploration of Management Strategies — Michael Earing, MD, Milwaukee, WI — Medical College of Wisconsin; Ramagopal Tumuluri, MD, Milwaukee, WI — Aurora St. Luke’s Medical Center

Philips HealthcareInteractive Learning Lab #22035

9:30 a.m. – 10:30 a.m.Speckle Tracking Today for Myocardial Deformation — A Hands-On Guided Workshop — Roberto M. Lang, MD, FACC, FAHA, FASE, FESC, FRCP, Chicago, IL — Professor of Medicine and Radiology; Director, Noninvasive Cardiac Imaging Laboratories; Associate Director, Cardiology Fellowship Program; University of Chicago Medical Center; Ivan Salgo, MD, Andover, MA — Senior Director, Cardiology; Philips Healthcare

11:00 a.m. – NoonHow Can Cardiology Informatics Enrich My Electronic Health Records Strategy? — James E. Tcheng, MD, FACC, Durham, NC — Professor of Medicine; Professor of Community and Family Medicine (Informatics); Duke University Health System

12:30 p.m. – 1:30 p.m.Discussing Optimizing Patient Safety and Radiation Exposure with Use of XperSwing with Radial Artery Access for Coronary Angiography — John C. Messenger, MD, FACC, FSCAI, Denver, CO — Associate Professor of Medicine, Director, Cardiac Catheterization Labs, University of Colorado Hospital

3:30 p.m. – 4:30 p.m.Clinical Application of Real-Time 3D TEE for Percutaneous Structural Heart Interventions — David Liang, MD, PhD, Palo Alto, CA — Associate Professor, Cardiovascular Medicine, Stanford University School of Medicine; Robert J. Siegel, MD, Los Angeles, CA — Director, Cardiac Noninvasive Laboratory, Cedars-Sinai Medical Center

Terumo Interventional Systems and The Medicines CompanyInteractive Learning Lab #22027

9:30 a.m. – 10:30 a.m.Hands-On Radial Access Simulation


Noon – 1:00 p.m.Optimizing your Outpatient PCI: What you Need to Know and Consider

1:00 p.m. – 2:00 p.m.Hands-On Radial Access Simulation

2:30 p.m. – 3:30 p.m.Hands-On Radial Access Simulation

* Learning Destination presentations are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees. Learning Destination presentations do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.


Mobile AppPowered by Skyscape

FREE CardioSource Mobile App

The American College of Cardiology and Skyscape are pleased to offer a comprehensive suite of trusted resources for cardiovascular professionals!

Download CardioSource’s most popular and clinically relevant content on your mobile device today for FREE!

Scan the Microsoft Tag or visit http://bit.ly/csapp on your mobile device.

Visit ACC Central, Booth #10027

CardioSource©

2012

Am

eric

an C

olle

ge o

f Car

diol

ogy.

W12

05

©2012 American College of Cardiology. X1253

ACC is Your CardioSourceACC is Your CardioSourceCardioSourceYou can trust the ACC to provide information that helps you be the best cardiovascular professional you can be. And ACC Central is the place that brings it all to you.

Visit ACC Central, Booth 10027, to � nd out about:

• Lifelong Learning: Learn how to take an individualized approach to cardiovascular education. Improve your performance. Impact your patients.

• Advancing Quality: Get the latest data collection and quality improvement tools and resources to help you demonstrate excellence in your hospital or practice.

• Member Center: Learn how ACC membership can help you advance your career & apply on site! Current members can � nd out how to get more involved, discover the newest membership bene� ts, pay dues and more.

• Advocacy and Practice Support: Learn more about the ACC’s efforts to set a new standard for health care delivery and get the tools you need to ensure patient access to the right care at the right time.

• Mobile Applications: Get your free CardioSource Mobile Applications designed to put the latest science directly at your � ngertips. Also, learn

about other applications available for those on the go.

Fast. Informative. Convenient.

Visit ACC Central at Booth 10027


SAVE

15% off Select

Self-Assessment Tools and Live Courses

©2012 A

mer

ican

Col

lege

of C

ardi

olog

y A1

304

Join us for a whole new learning experience — in a whole new city — as we bring you the education that keeps you at the forefront of your profession and helps improve the quality of care for your patients.

www.accscientificsession.org

TM


Help Shape the Future of CardioSmart (and win a free iPad!)� e ACC is re-launching CardioSmart, and we want your input. � e new CardioSmart will provide tools to improve the patient-clinician relationship.

If you’re a practicing clinician, come and tell us what you need. It only takes � ve minutes. We’ll give you a token of our appreciation and enter you in a drawing to win an iPad!

ACC.12

SundayMarch 25

Sunday, March 25

©2012 American College of Cardiology. X1253

ACC is Your CardioSourceACC is Your CardioSourceCardioSourceYou can trust the ACC to provide information that helps you be the best cardiovascular professional you can be. And ACC Central is the place that brings it all to you.

Visit ACC Central, Booth 10027, to � nd out about:

• Lifelong Learning: Learn how to take an individualized approach to cardiovascular education. Improve your performance. Impact your patients.

• Advancing Quality: Get the latest data collection and quality improvement tools and resources to help you demonstrate excellence in your hospital or practice.

• Member Center: Learn how ACC membership can help you advance your career & apply on site! Current members can � nd out how to get more involved, discover the newest membership bene� ts, pay dues and more.

• Advocacy and Practice Support: Learn more about the ACC’s efforts to set a new standard for health care delivery and get the tools you need to ensure patient access to the right care at the right time.

• Mobile Applications: Get your free CardioSource Mobile Applications designed to put the latest science directly at your � ngertips. Also, learn

about other applications available for those on the go.

Fast. Informative. Convenient.



SAVE

15% off Select

Self-Assessment Tools and Live Courses

Sund

ay, M

arch

25


Morning SeSSionS

ACC-i2/TCT

OrAl

2500

Outcomes in Patients Treated with TAVrSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N227bCME/CNE Hours: 1.5

Co-Chairs: Stephen R. Ramee, New Orleans, LA Allan Schwartz, New York, NY

Panelists: Ganesh Manoharan, Belfast, United Kingdom, Nicolas Dumonteil, Toulouse, France, Jan Kovac, Leicestershire, United Kingdom

8:00 2500–6 Year in review — Martin B. Leon, New York, NY

8:15 2500–7 The Importance of Vascular Complications after Trans-Femoral Trans-catheter Aortic Valve replacement (TAVr): Insights from the PArTNEr Trial — Philippe Genereux, John Webb, Jeffrey Moses, Susheel Kodali, Mathew Williams, Michael Mack, D. Craig Miller, Lars Svensson, E. Murat Tuzcu, Craig Smith, Martin Leon, for the PARTNER Trial Investigators, Columbia University Medical Center and The Cardiovascular Research Foundation, New York, NY


8:30 2500–9 Incidence, Predictors and Impact of Bleeding Events after Transcatheter Aortic Valve replacement (TAVr) Compared to Surgical Aortic Valve replacement (SAVr): Insights from the PArTNEr Trial — Philippe Genereux, Lars Svensson, Susheel Kodali, Mathew Williams, Jeffrey Moses, Michael Mack, D. Craig Miller, E. Murat Tuzcu, John Webb, Craig Smith, Martin Leon, for the PARTNER Trial Investigators, Columbia University Medical Center and The Cardiovascular Research Foundation, New York, NY


8:45 2500–11 Incidence and Impact of Acute Kidney Injury (AKI) Post Trans-catheter Aortic Valve replacement (TAVr) Using the New Valve Academic research Consortium (VArC) Criteria — Philippe Genereux, Susheel Kodali, Martin Leon, A. Garvey Rene, Benoit Daneault, Jean-Michel Paradis, Philip Green, Isaac George, Rebecca Hahn, Ajay Kirtane, Jeffrey Moses, Craig Smith, Mathew Williams, Columbia University Medical Center and The Cardiovascular Research Foundation, New York, NY


9:00 2500–13 Transcatheter Aortic Valve Implantation for Patients with Bicuspid Severe Aortic Valve Stenosis — Kentaro Hayashida, Thierry Lefèvre, Bernard Chevalier, Thomas Hovasse, Mauro Romano, Philippe Garot, Arnaud Farge, Patrick Donzeau-Gouge, Erik Bouvier, Bertrand Cormier, Marie-Claude Morice, Institut Cardiovasculaire Paris Sud, Massy, France


9:15 2500–15 Prevalence and Impact of Myocardial Injury following Transfemoral and Transapical Transcatheter Aortic Valve replacement — Israel Barbash, Itsik Ben-Dor, Danny Dvir, Paul Corso, Steven Boyce, Steven Goldstein, Zuyue Wang, Rebecca Torguson, Lowell Satler, Augusto Pichard, Ron Waksman, MedStar Health Research Institute, Washington, DC


ACC-i2/TCT

OrAl

2501

Adjunct PharmacologySunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S101aCME/CNE Hours: 1.5

Chair: George W. Vetrovec, Richmond, VA

Panelists: Kimberly A. Skelding, Danville, PA, Peter B. Berger, Danville, PA, Usman Baber, New York, NY

8:00 2501–6 Dual Antiplatelet Therapy and long-term Clinical Outcomes after Primary PCI: The HOrIZONS-AMI Trial — Georgios J. Vlachojannis, Roxana Mehran, Bernhard Witzenbichler, Giulio Guagliumi, Jan Z. Peruga, Bruce Brodie, Martin Fahy, Ran Kornowski, Bernard Gersh, Helen Parise, George Dangas, Gregg Stone, Cardiovascular Research Foundation, New York, NY, Mount Sinai Medical Center, New York, NY


8:15 2501–8 Individualized Bleeding risk Estimates Prior to PCI Impact Physicians’ Use of Bivalirudin in High-risk Patients — Seshu Rao, Adnan Chhatriwalla, kevin kennedy, Carole Decker, Elizabeth Gialde, John Spertus, Steven Marso, Saint Luke’s Mid America Heart Institute, Kansas City, MO, University of Missouri Kansas City, Kansas City, MO


8:30 2501–10 Impact of Ejection Fraction on Mortality in Patients Undergoing PCI: A Patient-level Pooled Analysis from the rEPlACE-2, ACUITY and HOrIZONS-AMI Trials — Jennifer Yu, George Dangas, Usman Baber, Georgios Vlachojannis, Tim Clayton, Stuart Pocock, Frederick Feit, David Cox, Bruce Brodie, A. Lincoff, Efthymios Deliargyris, Bernard Gersh, C. Michael Gibson, Roxana Mehran, Gregg Stone, Mount Sinai Medical Center, New York, NY, Cardiovascular Research Foundation, New York, NY


8:45 2501–12 The loss-of-function Impact of CYP2C19*2 vs. *3 Allele in Patients Undergoing PCI Treated with High Maintenance-dose Clopidogrel of 150 mg/day: The results of the ACCEl-DOUBlE-2N3 Study — Young-Hoon Jeong, udaya tantry, Yonghwi Park, Seok-Jae Hwang, Kevin Bliden, Choong Hwan Kwak, Jin-Yong Hwang, Paul Gurbel, Sinai Center for Thrombosis Research, Baltimore, MD, Gyeongsang Natl Univ Hosp, Jinju, South Korea


Sunday, March 25, 2012Please Note: The following sessions are listed alphabetically by learning pathway abbreviation based on session start time.

Morning

138 GO for ACC.12!

Mor

ning


9:05 2501–14 Impact of Point-of-Care Platelet Function Testing among Patients with and without ACS Undergoing PCI with Drug-Eluting Stents: An ADAPT-DES Sub-study — Ajay J. Kirtane, Michael Rinaldi, Helen Parise, Bernhard Witzenbichler, Giora Weisz, Franz-Josef Neumann, David Metzger, Timothy Henry, David Cox, Peter Duffy, Bruce Brodie, Thomas Stuckey, Ernest Mazzaferri, Ecaterina Cristea, Roxana Mehran, Gregg Stone, Columbia University Medical Center / New York-Presbyterian Hospital, New York, NY, Cardiovascular Research Foundation, New York, NY


9:20 2501–16 Does Platelet Function Testing Add Significant Incremental risk Stratification to Unselected Patients Undergoing DES Implantation? The ADAPT-DES Study — Ajay J. Kirtane, Helen Parise, Bernhard Witzenbichler, Giora Weisz, Michael Rinaldi, Franz-Josef Neumann, David Metzger, Timothy Henry, David Cox, Peter Duffy, Bruce Brodie, Thomas Stuckey, Ernest Mazzaferri, Ecaterina Cristea, Roxana Mehran, Gregg Stone, Columbia University Medical Center / New York-Presbyterian Hospital, New York, NY, Cardiovascular Research Foundation, New York, NY


ACC-i2/TCT

OrAl

2504

PCI in Complex lesionsSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S103cCME/CNE Hours: 1.5

Co-Chairs: Samin K. Sharma, New York, NY Etsuo Tsuchikane, Toyohashi, Japan

Panelists: Panayiotis Avraamides, Nicosia, Cyprus, Robert Pyo, Bayside, NY, Emmanouil S. Brilakis, Dallas, TX

8:00 2504–6 Year in review — David E. Kandzari, Atlanta, GA

8:15 2504–7 A report from Japanese Multicenter registry Data for Clinical results of retrograde Approach in Percutaneous Coronary Interventions for Chronic Total Occlusions — ATSUNORI OKAMURA, Masahisa Yamane, Makoto Muto, Tsutomu Fujita, Tetsuo matsubara, Yasumi Igarashi, Shigeru Nakamura, Toshiya Muramatsu, Mitsunori Abe, Etsuo Tsuchikane, Toyohashi Heart Center, Toyohashi, Japan, Sakurabashi Watanabe Hospital, Osaka, Japan


8:30 2504–9 Natural History of Side Branch Jailed By Drug Eluting Stent — Masahiro Yamawaki, Toshiya Muramatsu, Yasunari Sakamoto, Hideyuki Takimura, Hiroshi Ishimori, Reiko Tsukahara, Saiseikai Yokohama City Eastern, Yokohama, Japan


8:45 2504–11 Is Double Stenting the Optimal Treatment for Complex Coronary Bifurcation lesions? — Ricardo A. Costa, Fausto Feres, Rodolfo Staico,

J. Ribamar Costa, Jr, Dimytri Siqueira, Alexandre Abizaid, Luiz F. Tanajura, Amanda Sousa, J. Eduardo Sousa, Antonio Colombo, Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil, EMO GVM Centro Cuore Columbus, Milan, Italy


9:00 2504–13 long-term Clinical results of Adverse Outcomes after Drug-eluting Stent Implantation for Bifurcation lesions in a real-World Practice — results from the COBIS (Coronary Bifurcation Stenting) II registry — Jeong Hoon Yang, Pil Sang Song, Young Bin Song, Joo-Yong Hahn, Seung-Hyuk Choi, Jin-Ho Choi, Hyo-Soo Kim, Seung-Woon Rha, Cheol Woong Yu, Jong-Seon Park, Jin-Ok Jeong, Hyeon-Cheol Gwon, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea


9:15 2504–15 The ESTrOFA-lM registry: Comparison of Paclitaxel-eluting Stents and Everolimus-eluting Stents in left Main Coronary Artery Disease — results at 3-years Follow-up — Jose de la Torre Hernandez, Angel Sanchez-Recalde, Bruno Garcia del Blanco, Manuel Jimenez Navarro, Federico Gimeno, Ramon Calvino, Neus Salvatella, Tamara Garcia Camarero, Felipe Hernandez, Fernando Rivero, Jose Moreu, Jose R. Rumoroso, Francisco Bosa, Monica Masotti, Victoria Martin, Juan A. Bullones, Arsenio Gallardo, Jose A. Fernandez Diaz, Victor Aragon, ESTROFA study group, Spain, Spain


ACC-i2/TCT

OrAl

2505

PCI in Complex PatientsSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S102cCME/CNE Hours: 1.5

Co-Chairs: Carlo Di Mario, London, United Kingdom Corrado Tamburino, Catania, Italy

Panelists: William S. Weintraub, Newark, DE, Brian P. O’Neill, Miami, FL, Eugenia Nikolsky, Haifa, Israel

8:00 2505–6 Characteristics and Outcomes of Patients Undergoing Percutaneous Coronary Intervention within One-year of Coronary Artery Bypass Grafting Surgery — Mark A. Kotowycz, Anirban Choudhury, Lauren M. Morrison, mark osten, Vladimir Dzavik, Chris Overgaard, Peter Munk Cardiac Centre, University Health Network, Toronto General Hospital, Toronto, Canada


8:15 2505–8 CorPath-PrECISE: Final results of the First Pivotal Study for robotically-enhanced PCI — Giora Weisz, Christopher Metzger, Ronald Caputo, Juan Granada, J. Marshall, Mark Reisman, George Vetrovec, Ron Waksman, Jeffrey Moses, Joseph Carrozza, NewYork Presbyterian Hospital - Columbia University Medical Center, New York, NY


Sunday, March 25, 2012 • ACC.12


Morning

8:30 2505–10 Periprocedural Glycemic Control in Patients Undergoing Coronary Angiography and Intervention — Binita Shah, Nicholas Amoroso, Xingchen Mai, Jeffrey Lorin, Ann Danoff, Steven Sedlis, New York University School of Medicine, New York, NY, VA New York Harbor Healthcare System, New York Campus, New York, NY


8:45 2505–12 The Impact of Anemia on 6-month Angiographic and 1-year Clinical Outcomes in Acute Myocardial Infarction Patients Undergoing Percutaneous Coronary Intervention — Ji Young Park, Seung-Woon Rha, Amro Elnagar, Byoung Geol Choi, sung il Im, Sunwon Kim, Jin Oh Na, Seongwoo Han, Cheol Ung Choi, Hong Euy Lim, Jin Won Kim, Eung Ju Kim, Hong-Seog Seo, Chang Gyu Park, Dong Joo Oh, Cardiology Department, Eulji General Hospital, Seoul, South Korea, Cardiovascular Center, Korea University Guro Hospital, Seoul, South Korea


9:00 2505–14 Characteristics, In-Hospital and long-term Clinical Outcomes of Nonagenarian AMI Patients Compared with Octogenarian AMI Patients — Ki Hong Lee, Young Keun Ahn, Myung Ho Jeong, Donghan Kim, Shung Chull Chae, Young Jo Kim, Jei Keon Chae, Myeong Chan Cho, Chong Jin Kim, Chonnam National University Hospital, Gwangju, South Korea, Heart Research Center of Chonnam National University Hospital, Gwangju, South Korea


9:15 2505–16 The Effect of Drug-eluting Stents on Clinical and Angiographic Outcomes in renal Failure Patients with Dialysis: Multicenter registry in Asia — Sunao Nakamura, Hisao Ogawa, Jang-Ho Bae, Hans Yeo, Wasan Udayachalerm, Damras Tresukosol, Sudaratana Tansuphaswadikul, New Tokyo Hospital, Chiba, Japan


ACC-i2/TCT

OrAl

2508

Intravascular DiagnosticsSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S106bCME/CNE Hours: 1.5

Co-Chairs: Alexandra J. Lansky, New Haven, CT Jagat Narula, New York, NY

Panelists: Elias Sanidas, New York, NY, Jennifer Yu, New York, NY

8:00 2508–6 Does Aggressive Statin Therapy reduce Coronary Atherosclerotic Plaque lipid Content? results from reduction in YEllow Plaque by Aggressive lipid lOWering Therapy (YEllOW) Trial — Annapoorna Subhash Kini, Pedro Moreno, Jason Kovacic, Atul Limaye, Ziad Ali, Joseph Sweeny, Usman Baber, George Dangas, Samin Sharma, Mount Sinai Medical Center, New York City, NY


8:15 2508–7 The Impact of Sex Differences on Fractional Flow reserve-Guided Percutaneous Coronary Intervention: A FAME Substudy — Hyun-Sook Kim,

Pim Tonino, Bernard De Bruyne, Andy Yong, Jennifer Tremmel, Nico Pijls, William Fearon, Stanford University Medical Center, Palo Alto, CA, Hallym University Sacred Heart Hospital, Anyang, South Korea


8:30 2508–9 A New Method for Assessing Neointimal Coverage after Drug-eluting Stent Implantation Using Three-dimensional Optical Coherence Tomography — Byeong-Keuk Kim, Jinyong Ha, Jung-Sun Kim, Dong-Ho Shin, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Myeong-Ki Hong, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, South Korea


8:45 2508–11 Coronary Computed Tomographic Angiography Morphologic Characteristics of lipid-core Plaques Identified by Intracoronary Near-infrared Spectroscopy — James L. Smith, Ryan Madder, A Neil Bilolikar, Simon Dixon, James Goldstein, William Beaumont Hospital, Royal Oak, MI, Spectrum Health, Grand Rapids, MI


9:00 2508–13 Spectroscopic Detection of Fibrous Cap Thickness Overlying lipid Core Coronary Plaques with a Catheter-Based Near-infrared Spectroscopy System — Sean Madden, Joel Raichlen, James Muller, Infraredx, Inc., Burlington, MA


9:15 2508–15 Impact of Early and late Stent Malapposition on long-term Clinical Outcomes: Three-year Follow-up from the HOrIZONS-AMI IVUS Sub-study — Tadayuki Yakushiji, Gary Mintz, Bernhard Witzenbichler, Giulio Guagliumi, Ecaterina Cristea, Ovidiu Dressler, Roxana Mehran, Gregg Stone, Akiko Maehara, Cardiovascular Research Foundation, New York, NY


ACC-i2/TCT

OrAl

2510

Vascular AccessSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S103bCME/CNE Hours: 1.5

Co-Chairs: Mehdi H. Shishehbor, Cleveland, OH Robert J. Applegate, Winston-Salem, NC

Panelists: Jason H. Rogers, Sacramento, CA, Alexios P. Dimas, Athens, Greece, Samir B. Pancholy, Chinchilla, PA

8:00 2510–6 Year in review — Zoltan G. Turi, Camden, NJ

8:15 2510–7 Economic Impact of Transradial Percutaneous Coronary Intervention — David M. Safley, Dmitri Baklanov, Rebecca Mills, John House, Steven Marso, Saint Luke’s Mid America Heart Institute, Kansas City, MO, University of Missouri - Kansas City, Kansas City, MO


8:30 2510–9 Adequate Screening Can reduce radial Access Failure rates in ST-Elevation Myocardial Infarction Patients Undergoing Primary

ACC.12 • Sunday, March 25, 2012

140 GO for ACC.12!

Mor

ning

Percutaneous Coronary Intervention — Jean-Pierre Dery, Marie-Pier Bouchard, Ugo Dery, Melanie Roy, Josep Rodes-Cabau, Stephane Rinfret, Eric Larose, Gerald Barbeau, Jacques Rouleau, Louis Roy, Bernard Noel, can nguyen, Onil Gleeton, Guy Proulx, Jean-Rock Boudreault, Robert DeLa Rochellière, Sunil Rao, Olivier Bertrand, Quebec Heart and Lung Institute, Quebec City, Canada, Duke University Clinical Research Institute, Durham, NC


8:45 2510–11 risk of Brain Injury related to Silent Cerebral Embolization during Diagnostic Coronary Angiography: Direct Comparison between right radial and left radial Approach — Andrea Pacchioni, Antonio Mugnolo, Carlo Penzo, Dimitrios Nikas, Salvatore Saccà, Luca Favero, Bernhard Reimers, Francesco Versaci, Divisione di Cardiologia, Ospedale Civile, Mirano, Italy


9:00 2510–13 large-bore Common Femoral Arterial Access Using Fluoroscopic Guidance with Computed Tomographic Angiography Overlay: Safe Entry and Exit — Bryce Einhorn, Chad Kliger, Vladimir Jelnin, Leandro Maranan, Howard Cohen, Itzhak Kronzon, Carlos Ruiz, Lenox Hill Heart and Vascular Institute, New York, NY


9:15 2510–15 Major Bleeding Impacts Death Following Percutaneous Coronary Intervention: Insights from the NCDr® — Adnan Chhatriwalla, Amit Amin, kevin kennedy, John House, Sunil Rao, John Messenger, David Cohen, Steven Marso, Saint Luke’s Mid America Heart Institute, Kansas City, MO


ACC-i2/TCT

SYMPOSIUM

2614

Abnormalities of the AtriumSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S102bCME/CNE Hours: 1.5

Co-Chairs: Jonathan M. Tobis, Los Angeles, CA Maurice Buchbinder, La Jolla, CA

8:00 Conditions Associated with PFO — Speaker TBD

8:15 Pros and Cons of Closure for Stroke — Anthony Furlan, Cleveland, OH

8:30 Pros and Cons of Closure for Migraine with Aura — Jonathan Tobis, Los Angeles, CA

8:45 lAA Device Closure PrO: Preferred Therapy for AF — Ken Huber, Kansas City, MO

9:00 lAA Device Closure CON: It Should Not be Done — Sanjay Kaul, Los Angeles, CA


ACS

ExPErTS

221

Complications of AMISunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S504aCME/CNE Hours: 1.5

Chair: Prediman K. Shah, Los Angeles, CA

Case Presenter: Steven M. Stevens, Los Angeles, CA

Panelists: Judith S. Hochman, New York, NY, Roger J. Laham, Boston, MA, Melchior Seyfarth, Muenchen, Germany, Holger Thiele, Leipzig, Germany

ACS

OrAl

916

What Impacts Outcomes in ACS? From Genes to Plaque Morphology to Environment.Sunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S401aCME/CNE Hours: 1.5

Co-Chairs: Venu Menon, Cleveland, OH Doron Zahger, Beer Sheva, Israel

8:00 916–3 The Year in review — Robert P. Giugliano, Boston, MA

8:15 916–4 Characteristics and Clinical Significance of Angiographically Mild lesions in ACS: Insights from the PrOSPECT Study — Sorin J. Brener, Gary Mintz, Ecaterina Cristea, Giora Weisz, Akiko Maehara, John McPherson, Steven Marso, Naim Farhat, Hans E. Botker, Ovidiu Dressler, Ke Xu, Barry Templin, Zhen Zhang, Alexandra Lansky, Bernard de Bruyne, Patrick Serruys, Gregg Stone, New York Methodist Hospital, Brooklyn, NY, Cardiovascular Research Foundation, New York, NY

8:30 916–5 Timing of Angiography and Clinical Outcomes after Fibrinolysis: A Patient-level Analysis of randomized Early Invasive Clinical Trials — Mina Madan, Mary Tan, Sigrun halvorsen, Cynthia M. Westernout, Warren Cantor, Michel R. Le May, Francesco Borgia, Federico Piscione, Carlo Di Mario, Bruno Scheller, Paul Armstrong, Francisco Fernandez-Aviles, Pedro L. Sanchez, John Graham, Andrew Yan, Shaun Goodman, Sunnybrook Health Sciences Centre, Toronto, Canada, Canadian Heart Research Centre, Toronto, Canada

8:45 916–6 The Effects of Hurricane Katrina on Acute Myocardial Infarction Five Years after the Storm — John Moscona, Sumit Tiwari, Kartik Munshi, Sudesh Srivastav, Patrice Delafontaine, Anand Irimpen, Tulane University Heart and Vascular Institute, New Orleans, LA

9:00 916–7 Coronary Plaque Characteristics in Patients with Diabetes Mellitus Who Presented with Acute Coronary Syndrome: Optical Coherence Tomography Study — Jingbo Hou, Lei Xing, Haibo Jia, zhigang han, Shuang Yang, Lingbo Meng, Koji Kato, Tiashi Yonetsu, Soo Joong Kim, Hang Lee, Shaosong Zhang, Yu Bo, Ik-Kyung Jang, Department of Cardiology, 2nd Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of China, Cardiology Division, Massachusetts General Hospital, Harvard Medical School, Boston, MA

9:15 916–8 Telomere length and Cardiovascular Outcomes — Christian T. Ruff, Jessica Mega, David



Morning

Morrow, Benjamin Scirica, Edward C. Frackelton, Hakon Hakonarson, Kevin Crowley, Charles Contant, Christopher Cannon, Eugene Braunwald, Marc Sabatine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

Arr

ExPErTS

222

Joint Symposium of the Heart rhythm Society and the American College of Cardiology: Genetic Syndromes for the Clinician (HCM, Brugada, long QT)Sunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S503CME/CNE Hours: 1.5

Chair: Jeffrey A. Towbin, Cincinnati, OH

Panelists: Michael J. Ackerman, Rochester, MN, Bernard J. Gersh, Rochester, MN, Arthur J. Moss, Rochester, NY

Arr

OrAl

904

Joint Oral Arrhythmias Session of the Heart rhythm Society and the American College of Cardiology: Management of the Patient with Atrial Fibrillation — Anticoagulation and Prevention of Stroke — Sunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N426CME/CNE Hours: 1.5

Co-Chairs: Anne M. Gillis, Calgary, Canada Julia H. Indik, Tucson, AZ

8:00 904–3 The Year in review — Anne M. Gillis, Calgary, Canada

8:15 904–4 Stroke risk in Post-menopausal Women with Atrial Fibrillation in the Women’s Health Initiative: A Validation and Comparison of the CHADS2 and CHA2DS2-VASc risk Scores — JoEllyn Carol Moore M. Abraham, Sylvia Wassertheil-Smoller, Joseph Larson, Mina Chung, J. D. Curb, Anne Curtis, Kamakshi Lakshminarayan, Jonathan Newman, Marco Perez, Kathryn Rexrode, Nawar Shara, Allen Solomon, Marcia L. Stefanick, James C. Torner, Bruce Wilkoff, Cleveland Clinic, Cleveland, OH, Women’s Health Initiative, Bethesda, MD

8:27 904–5 The CHA2DS2-VASc Score Identifies AF Patients with A CHADS2 Score of 0 or 1 Treated with Antiplatelet Therapy Who Are Unlikely to Benefit from Oral Anticoagulant Therapy — Michiel Coppens, John Eikelboom, Robert Hart, Salim Yusuf, Gregory Lip, Paul Dorian, Olga Shestakovska, Stuart Connolly, Population Health Research Institute, McMaster University, Hamilton, Canada

8:39 904–6 Dabigatran and Myocardial Infarction, Drug or Class Effect: Meta-Analysis of randomized Trials with Oral Direct Thrombin Inhibitors — Ramin Artang, Eric Rome, Humberto Vidaillet, University of Nebraska Medical Center, Omaha, NE, Marshfield Clinic, Marshfield, WI

8:51 904–7 Bleeding with Aspirin and Apixaban in Patients Unsuitable for Vitamin K Antagonist Therapy: The AVErrOES Study — Greg C. Flaker, John Eikelboom, Stuart Connolly, Salim Yusuf, Gregory Lip, Robert Hart, University of Missouri,

Columbia, MO, McMaster University and Hamilton Health Scineces, Hamilton, Canada

9:03 904–8 Evaluation of recombinant Activated Factor Vii, Prothrombin Complex Concentrate and Fibrinogen Concentrate to reverse Apixaban in a rabbit Model — Martin Anne-Céline, Le-Bonniec Bernard, Lecompte thomas, Fischer Anne-Marie, Emmerich Joseph, Samama Charles marc, Godier Anne, HIA val de grâce, Paris, France, INSERM 765, Paris, France

9:15 904–9 Efficacy and Safety of Apixaban Compared with Warfarin According to CHADS2 and HASBlED risk Scores for Stroke Prevention in Atrial Fibrillation — Renato D. Lopes, Sana Al-Khatib, Lars Wallentin, Hongqiu Yang, Jack Ansell, J. Donald Easton, Cetin Erol, Justin Ezekowitz, Bernard Gersh, Stefan Hohnloser, Elaine Hylek, Cecilia Bahit, John Horowitz, Raffaele De Caterina, Puneet Mohan, Dragos Vinereanu, Christopher Granger, John Alexander, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC

CCS

SYMPOSIUM

634

Preoperative Assessment of Patients on the Single Ventricle Pathway: Special Problems, Creative SolutionsSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N231CME/CNE Hours: 1.5

Co-Chairs: John F. Rhodes, Durham, NC Mark Scheurer, Charleston, SC

8:00 Case Presentation — Joshua Kanter, DC

8:10 Pre-Glenn Assessment in the Current Era: Significance of the Sano and Hybrid Stage 1 Modifications — Henri Justino, Houston, TX

8:30 Systemic-to-Pulmonary Arterial Collaterals: Do They Matter and What Should We Do About Them? — Mathew Gillespie, Philadelphia, PA

8:50 Considerations in Single Ventricle Patients with Heterotaxy — Doff B. McElhinney, Boston, MA

9:10 Non-Invasive Pre-Glenn and Pre-Fontan Assessment: When Is Catheterization Not Indicated? — David W. Brown, Boston, MA

HF

SYMPOSIUM

635

Joint Symposium of the Heart Failure Society of America and the American College of Cardiology: Contemporary Pharmacological Treatment of Systolic and Diastolic Heart FailureSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S406bCME/CNE Hours: 1.5

Co-Chairs: William H. Gaasch, Burlington, MA Dennis M. McNamara, Pittsburgh, PA

8:00 Stage A — Thomas J. Wang, Boston, MA

8:20 Stage B — Marvin A. Konstam, Boston, MA

8:40 Stage C — Barry H. Greenberg, San Diego, CA

9:00 HF-PEF — Michael R. Zile, Charleston, SC



142 GO for ACC.12!

Mor

ning

IMAG

ExPErTS

223

Cardiac PET: Incorporation into Daily PracticeSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S505CME/CNE Hours: 1.5

Chair: Sharmila Dorbala, Boston, MA

Case Presenter: Ritesh Dhar, Detroit, MI

Panelists: Karthikeyan Ananthasubramaniam, West Bloomfield, MI, Timothy M. Bateman, Kansas City, MO, Rob S. B. Beanlands, Ottawa, Canada, Panithaya Chareonthaitawee, Rochester, MN, Marcelo F. Di Carli, Boston, MA

IMAG

OrAl

907

Joint Oral Session of the American Society of Echocardiography and the American College of Cardiology: Newest Applications of Echo to Clinical PracticeSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S406aCME/CNE Hours: 1.5

Co-Chairs: Theodore P. Abraham, Baltimore, MD Susan E. Wiegers, Philadelphia, PA

8:00 907–3 The Year in review – Imaging — Jonathan R. Lindner, Portland, OR

8:15 907–4 Diastolic Function and Survival in Patients with Severe Aortic Stenosis and Normal left Ventricular Ejection Fraction — Omar Khalique, Yat Wa Li, Robert Belkin, MD, Wilbert Aronow, Cesare Russo, Chul Ahn, Mala Sharma, Columbia University Medical Center, New York, NY, New York Medical College, Valhalla, NY

8:30 907–5 Deformation Imaging Is an Independent Predictor of Outcomes in Asymptomatic Aortic Stenosis with Normal Ejection Fraction — Teerapat Yingchoncharoen, Gibby Conrad, Brian Griffin, L. Leonardo Rodriguez, Richard Grimm, Thomas Marwick, Cleveland Clinic, Cleveland, OH

9:00 907–7 Activation Imaging: A Novel Approach to Three-dimensional Mechanical Mapping Using Speckle Tracking Strain — Toshinari Onishi, Tetsuari Onishi, Mohamed Ahmed, Josef Marek, Samir Saba, David Schwartzman, John Gorcsan, University of Pittsburgh, Pittsburgh, PA

9:15 907–8 Accurate Quantification of Chronic Mitral regurgitation by Automated True 3-D Proximal Isovelocity Surface Area Using real-Time Volume Color Flow Doppler Transthoracic Echocardiography: In Vitro and Clinical Validation — Paaladinesh Thavendiranathan, Shizhen Liu, Saurabh Datta, Thomas Ryan, Stephen Igo, Matthew S. Jackson, Nathalie De Michelis, Stephen Little, Mani Vannan, The Ohio State University, Columbus, OH, The Methodist DeBakey Heart & Vascular Center, Houston, TX

lIFElONG

SYMPOSIUM

731

CCA Team-Based Maintenance of CertificationSunday, March 25, 2012, 8:00 a.m. – 10:30 a.m.McCormick Place South, S105dCME/CNE/CPE Hours: 2.5 ACPE No. 0012-9999-12-080-l04-P

Chair: Jane A. Linderbaum, Rochester, MN

Co-Chair: Michael G. Clark, Bedford, TX

MOC Faculty: Rhonda M. Cooper-DeHoff, Gainesville, FL, Eileen M. Handberg, Gainesville, FL

PHTN

OrAl

912

What’s New in Pulmonary HypertensionSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N226CME/CNE Hours: 1.5

Co-Chairs: Gautam V. Ramani, Baltimore, MD Stacy Mandras, New Orleans, LA

8:00 912–3 The Year in review — Pulmonary Hypertension — Michael A. Mathier, Pittsburgh, PA

8:15 912–4 Effect of Obesity on Mortality in Pulmonary Arterial Hypertension: A retrospective Analysis — Marwan Badri, Wajeeha Saeed, Ankush Lahoti, Jason Salamon, Eric Gnall, Ronald Zolty, Rizwan Sardar, Lankenau Medical Center, Wynnewood, PA, Montefiore Medical Center, New York, NY

8:30 912–5 Does Obesity Affect Brain Natriuretic Peptide levels in Patients with Pulmonary Arterial Hypertension? — Omar Batal, Kyle Buchanan, Andrea Elliott, Jonathon Wertz, Matthew Lander, Anthi Katsouli, David Ishizawar, Michael Mathier, Angel Lopez-Candales, University of Pittsburgh Medical Center, Pittsburgh, PA

8:45 912–6 Prognostic Factors in Pulmonary Hypertension: The Obesity Paradox — Barak Zafrir, Waseem Shehadeh, Nabia Salman, Yochai Adir, Offer Amir, Lady Davis Carmel Medical Center, Haifa, Israel, Lin Medical Center, Haifa, Israel

9:00 912–7 The Prognostic Ability of Pulmonary Arterial Capacitance Exceeds that of Pulmonary Vascular resistance in Advanced left-sided Heart Failure — Matthias Dupont, Wilfried Mullens, Yuping Wu, Wai Hong Tang, Cleveland Clinic Foundation, Cleveland, OH, Cleveland State University, Cleveland, OH

9:15 912–8 Impaired Global right Ventricular longitudinal Strain Predicts long-term Adverse Outcomes in Patients with Primary Pulmonary Hypertension — Jae-Hyeong Park, Margaret Park, Samar Farha, Jacqueline Sharp, Erika Lundgrin, Suzy Comhair, Wai Hong Tang, Serpil C. Erzurum, James Thomas, Cleveland Clinic, Cleveland, OH

PrEV

OrAl

911

Prevention: Focus on lipidsSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S100cCME/CNE Hours: 1.5

Co-Chairs: James A. De Lemos, Dallas, TX Neil Stone, Winnetka, IL

8:00 911–3 The Year in review — Prevention — Christie M. Ballantyne, Houston, TX



Morning

8:12 911–4 Safety Profile of Statin-Treated Patients with lDl-C < 30mg/dl — Brendan Everett, Samia Mora, Joseph Grossbard, Jean MacFadyen, Paul Ridker, Brigham and Women’s Hospital, Boston, MA, Harvard Medical School, Boston, MA

8:25 911–5 The Effects of Co-administering a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 9 Serine Protease, rEGN727/SAr236553, with 10 and 80 mg Atorvastatin Compared to 80 mg Atorvastatin Alone in Patients with Primary Hypercholesterolemia (NCT: 01288469) — Eli M. Roth, James McKenney, Corinne Hanotin, Gaelle Asset, Evan Stein, Sanofi-aventis US, Inc, Bridgewater, NJ, Regeneron Pharmaceuticals, Inc, Tarrytown, NY

8:38 911–6 lack of Association between Polymorphisms in the SLCO1B1 Gene and Clinical Myalgia following rosuvastatin Therapy — Jacqueline Suk Danik, Jean MacFadyen, Fredrik Nyberg, Paul Ridker, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, AstraZeneca, MoIndal, Sweden

8:51 911–7 The Association between lower levels of low-density lipoprotein Cholesterol and Cancer Predates the Diagnosis of Cancer by 18 Years — Paul Michael Lavigne, Haseeb Jafri, Richard Karas, Tufts Medical Center, Boston, MA, Johns Hopkins University, Baltimore, MD

9:04 911–8 lipid Transfer to High Density lipoproteins in Type 2 Diabetic Patients with and without Coronary Artery Disease — Marília C O Sprandel, Whady Hueb, Antonio Casella-Filho, Alexandre Segre, Paulo Cury Rezende, Ana L O Carvalho, Desiderio Favarato, Raul C. Maranhão, Jose Ramires, Roberto Kalil-Filho, Heart Institute University of Sao Paulo, Sao Paulo, Brazil

9:17 911–9 The Effect of Statins on Skeletal Muscle Function — Beth A. Parker, Jeffrey A. Capizzi, Adam Grimaldi, Donna Polk, Priscilla M. Clarkson, Stephanie M. Cole, Justin Keadle, Stuart Chipkin, Linda S. Pescatello, Kathleen Simpson, C. Michael White, Paul Thompson, Hartford Hospital, Hartford, CT

9:30 911–10 ETC-1002 lowers lDl-C and Beneficially Modulates Other Cardio-Metabolic risk Factors in Hypercholesterolemic Subjects with Either Normal or Elevated Triglycerides — Christie M. Ballantyne, Michael Davidson, Diane MacDougall, Janice Margulies, Lorenzo DiCarlo, Roger Newton, Baylor College of Medicine, Houston, TX, Esperion Therapeutics, Inc., Plymouth, MI

QUAl

ExPErTS

224

Tools to Improve Care Transition: The Hospital to Home (H2H) ExperienceSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S501aCME/CNE Hours: 1.5

Chair: Harlan M. Krumholz, New Haven, CT

Case Presenter: John E. Brush, Norfolk, VA

Panelists: Larry A. Allen, Aurora, CO, Ileana L. Pina, Cleveland Heights, OH, Adrian F. Hernandez, Durham, NC, Mary N. Walsh, Indianapolis, IN

QUAl

OrAl

913

Insights and Innovations to Improve Cardiac riskSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N229CME/CNE Hours: 1.5

Co-Chairs: Thomas M. Maddox, Denver, CO John S. Rumsfeld, Denver, CO

8:00 913–3 The Year in review — Quality of Care — John S. Rumsfeld, Denver, CO

8:15 913–4 Impact of Massachusetts Health reform on Preventable Admissions for the Previously Insured — Karen Joynt, David C. Chan, Ashish K. Jha, Brigham and Women’s Hospital, Boston, MA, Harvard School of Public Health, Boston, MA

8:30 913–5 Total Medical Costs Avoided with Apixaban versus Aspirin Treatment among Atrial Fibrillation Patients Unable or Unwilling to Take Warfarin: Based on the Averroes Trial results — Alpesh N. Amin, Steven Deitelzweig, Yonghua Jing, Dinara Makenbaeva, Daniel Wiederkehr, Jay Lin, John Graham, University of California, Irvine, Orange, CA

8:45 913–6 Immediate Impact of a 10–week Middle School Intervention to Improve Health Behaviors and reduce Cardiovascular risk Factors: Project Healthy Schools in Michigan — Taylor F. Eagle, Roopa Gurm, Cydni Smith, Nicole Corriveau, Jean Du-Russel-Weston, LaVaughn Palma-Davis, Susan Aaronson, Caren Goldberg, Eva Kline-Rogers, Elizabeth Jackson, Kim Eagle, University of Michigan, Ann Arbor, MI

9:00 913–7 Patterns of Early Thienopyridine Use among Contemporary STEMI and NSTEMI Patients in the US: Insights from ACTION registry-Get with the Guidelines — Matthew William Sherwood, Tracy Wang, Matthew Roe, Pankaj Madan, Szu-Po Peng, James de Lemos, Eric Peterson, Stephen Wiviott, Duke University Medical Center, Durham, NC, Brigham and Women’s Hospital/Harvard Medical School, Boston, MA

9:15 913–8 Effectiveness of a Clinical Decision Support System Incorporating a Validated QT Interval Prolongation risk Score for reducing the risk of QT Interval Prolongation in Hospitalized Patients — James Tisdale, Heather Wroblewski, Joanna Kingery, Brian Overholser, Tate N. Trujillo, Richard Kovacs, Purdue University, Indianapolis, IN, Indiana University, Indianapolis, IN

SPECIAl

SPECIAl

304

late-Breaking Clinical Trials IISunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, Hall B, ACC.12 Main TentCME/CNE Hours: 1.5

Co-Chairs: George D. Dangas, New York, NY Robert A. Harrington, Durham, NC

Panelists: Gilles Montalescot, Paris, France, Erik Magnus Ohman, Durham, NC, Philippe Gabriel Steg, Paris, France, Alexander G. Turpie, Dundas, Canada

8:00 Outcomes of Non-Primary PCI at Hospitals with and without On-site Cardiac Surgery: CPOrT-E Trial — Final Medical Outcomes — Thomas Aversano, Johns Hopkins University, Baltimore, MD


144 GO for ACC.12!

Mor

ning


8:22 INFUSE-AMI: A 2x2 Factorial, Multicenter, Prospective, randomized Evaluation of Intracoronary Abciximab and Aspiration Thrombectomy in Patients Undergoing Primary PCI for Anterior STEMI — Gregg W. Stone, Akiko Maehara, Bernhard Witzenbichler, Jan Godlewski, Ecaterina Cristea, Helen Parise, Jan Henk Dembrink, Andrzej Ochala, Steven Wolff, Saqib Chowdhary, Magdi El-Omar, Thomas D Neunteuff, D. Christopher Metzger, C. Michael Gibson, Columbia University Medical Center and the Cardiovascular Research Foundation, New York, NY


8:44 randomized Comparison of Adding Cilostazol versus Doubling the Dose of Clopidogrel after receiving Percutaneous Coronary Intervention: The HOST-ASSUrE randomized Trial — Kyung Woo Park, Hyo Soo Kim, Hyun-Jae Kang, Bon-Kwon Koo, In-Ho Chae, Seoul National University Hospital, Seoul, South Korea


9:06 A Multifaceted Intervention to Narrow the Evidence-Based Gap in the Treatment of ACS: Main results from the BrIDGE-ACS Cluster randomized Trial — Otavio Berwanger, Helio Guimaraes, Alexandre Cavalcanti, Ligia Laranjeira, Eliana Santucci, Ana Zazula, Uri Flato, Marcos Tenuta, Alessandra Kodama, Elivane Victor, Mariana Carballo, Vera Mira, Luiz Mota, Eric Peterson, Renato Lopes, Research Institute of Cardiac Hospital (HCor), Sao Paulo, Brazil, Brazilian Clinical Research Institute, Sao Paulo, Brazil


SPECIAl

SPECIAl

405

Young Investigators Award Competition: ACCF/Herman K. Gold Young Investigators Award in Molecular and Cellular CardiologySunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S105aCME/CNE Hours: 1.5

Chair: Douglas Sawyer, Nashville, TN

Judges: Michael T. Chin, Seattle, WA Cam Patterson, Chapel Hill, NC

Funding for the ACCF/Herman K. Gold Young Investigator’s Award in Molecular and Cellular Cardiology session was provided by a grant from CVPath Institute and the family of Herman K. Gold

8:00 405–4 Correlation between Circulating Angiogenic Cell Mobilizations and recovery of Coronary Flow reserve in Patients with Acute Myocardial Infarction — Han Saem Jeong, Soon Jun Hong, Jae Hyoung Park, Jong-Ho Kim, Seung Cheol Choi, Chul-Min Ahn, Je Sang Kim, Do-Sun Lim, Department of Cardiology, Cardiovascular Center, Korea University Anam Hospital, Seoul, South Korea

8:15 405–5 Novel role of Anticoagulant Heparan Sulfate in Antithrombin Anti-Inflammatory Signaling — Nicole C. Smits, Dartmouth Medical School, Hanover, NH

8:30 405–6 Protein Kinase-C Beta Activation Contributes to Impaired Endothelial Insulin Signaling in Humans with Diabetes Mellitus — Corey E. Tabit, Sherene M. Shenouda, Monika Holbrook, Alissa A. Frame, Matthew A. Kluge, Mai-Ann Duess, Brian H. Kim, Aaron D. Levit, Aaron Held, James L. Rosenzweig, Neil B. Ruderman, Joseph A. Vita, Naomi M. Hamburg, Boston University School of Medicine, Boston, MA

8:45 405–7 Telethonin Mutations Associated with Brugada Syndrome reduce Cardiac Sodium Currents — Isik Turker, Takeru Makiyama, Takeshi Ueyama, Wataru Shimizu, Minoru Horie, Matteo Watta, Peng-Sheng Chen, Tomohiko Ai, Indiana University, Indianapolis, IN

TEST

OrAl

914

Diagnostic Testing: Sports CardiologySunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S402CME/CNE Hours: 1.5

Co-Chairs: Rachel J. Lampert, New Haven, CT Brian Olshansky, Iowa City, IA

8:00 914–3 The Year in review — Diagnostic Testing: Sports — Barry J. Maron, Minneapolis, MN

8:15 914–4 re-appraisal of Electrocardiogram Interpretation in Young Athletes: Should Axis Deviation and Voltage Criterion for Atrial Enlargement Be Catergorised as Abnormal in Athletes — Sabiha Gati, Saqib Ghani, Abbas Zaidi, Nabeel Sheikh, Michael Papadakis, nicolene van nierkerk, lucia chen, matthew reed, Sanjay Sharma, St. George’s University, London, United Kingdom

8:30 914–5 left Ventricular Dimensions Derived by Echocardiography Correlate with Body Mass Index in a large Population of Multiethnic Athletes Screened in the Texas Adolescent Athlete Heart Screening registry (TAAHSr) — Silvana M. Lawrence, Harold W. Kohl, III, Patrick W. Austin, Kim A. Frost, Jennifer Y. Hutchings, Arnold Fenrich, Eva M. Garcia, James Guerrero, George P. Rodgers, Baylor College of Medicine, Houston, TX, Championship Hearts Foundation, Austin, TX

8:45 914–6 Global longitudinal Strain by Speckle Tracking in Middle Aged Athletically Trained Subjects with ECG repolarization Abnormalities during Exercise Stress Test — Emilia E. D’Elia, Silvia Celada, Daniele Poggio, Valentina Casali, Carla Auguadro, Giuseppe Specchia, Monza Polyclinic, Monza, Italy

9:00 914–7 Do We Need Ethnicity-Specific Guidelines for Pre-participation Screening of Athletes? — Nabeel Sheikh, Michael Papadakis, Saqib Ghani, Abbas Zaidi, Sabiha Gati, Navin Chandra, Rachel Bastiaenen, Lynne Millar, Noel Emmanuel, Sanjay Sharma, St. George’s University of London, London, United Kingdom



Morning

9:15 914–8 The Impact of Exercise Training on left Ventricular Torsion is Sport-Specific: A New Twist on the Morganroth Hypothesis — Rory B. Weiner, Adolph Hutter, Gregory Lewis, Francis Wang, Brant Berkstresser, Thomas Wang, Michael Picard, Aaron Baggish, Massachusetts General Hospital, Boston, MA, Harvard University Health Services, Cambridge, MA

VAlV

OrAl

915

Valvular OralSunday, March 25, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N427CME/CNE Hours: 1.5

Co-Chairs: Joseph Maalouf, Rochester, MN David Messika-Zeitoun, Paris, France

8:00 915–3 The Year in review – Valvular — Maurice Enriquez-Sarano, Rochester, MN

8:15 915–4 Transcatheter Aortic Valve Implantation (TAVI) in Patients with low-Flow, low-Gradient Aortic Stenosis — Alexander Lauten, Ralf Zahn, Jochen Senges, Hans R. Figulla, on behalf of the German Transcatheter Aortic ValveInterventions-Registry Investigators, University Heart Center Jena, Department of Cardiology, Jena, Germany, Institut fuer Herzinfarktforschung, Ludwigshafen, Germany

8:30 915–5 long-term Survival following Aortic Valve replacement among High-risk Elderly Patients in the United States: Insights from the STS Adult Cardiac Surgery Database, 1991 - 2007 — J. Matthew Brennan, Fred Edwards, Yue Zhao, Sean O’Brien, Pamela Douglas, eric D. peterson, Duke Clinical Research Institute, Durham, NC

8:45 915–6 Predictive Factors and Clinical Consequences of Persistent left Bundle Branch Block following Transcatheter Aortic Valve Implantation with a Balloon-expandable Valve — Marina Urena, Michael Mok, Luis Nombela-Franco, Robert DeLarochellière, Daniel Doyle, Eric Larose, Ignacio Ignacio Amat-Santos, Mélanie Côté, Philippe Pibarot, François Philippon, Eric Dumont, Josep Rodés-Cabau, Laval Heart&Lung Institute, Québec, Canada

9:00 915–7 Prognostic Value of Brain Natriuretic Peptide in Elderly Patients with Aortic Stenosis (The COFrASA-GENErAC Study) — Claire Cimadevilla, Caroline Cueff, Nadia Berjeb, Bernard Iung, Alex Vahanian, David Messika-Zeitoun, Bichat Hospital, Paris, France

9:15 915–8 Aortic Valve Calcium Score by Computed Tomography in Predicting Perivalvular Aortic Insufficiency Post Transcatheter Aortic Valve Implantation (TAVI) — Junsoo Alex Lee, Tania Singh, Itsik Ben Dor, Rebecca Torguson, Petros Okubagzi, Lowell Satler, Steven Goldstein, Allen Taylor, William Guy Weigold, Augusto Pichard, Zuyue Wang, Gaby Weissman, Ron Waksman, Washington Hospital Center, Washington, DC, Georgetown University Hospital, Washington, DC

VAlV

SElF-DIrECTED

1502

Heart Songs at ACC.12: A Self-Paced Multimedia learning ExperienceSunday, March 25, 2012, 9:00 a.m. – 5:00 p.m.McCormick Place, Vista Room LobbyCME/CNE Hours: 2

Back by popular demand is the highly rated Heart Songs Self-Paced Learning Lab — a unique audio-visual program to refresh cardiac auscultation skills. After a pre-test, attendees will listen to Heart Sounds while viewing phonocardiograms, echoes, and more, on an iPod® Touch, iPad® or laptop computer. Attendees can view the sessions and take both the pre-test and post-test on their own device, or use devices provided in the room, to document improvement in their auscultation skills. This clinical skills workshop provides attendees with a choice of three sessions: the first on 5 common heart murmurs and the second on more advanced sounds including bicuspid aortic valve, mitral valve prolapse and hypertrophic cardiomyopathy, among others. The third session is for experts on topics such as combined aortic stenosis and regurgitation; and combined mitral stenosis and regurgitation. In addition, there will be a 3-D echo/auscultation training program available in the Self-Paced Learning Lab. This video program will combine 3-D echo images with the auscultation findings on 4 common valvular abnormalities. Studies have shown that the range of repetition needed to acquire auditory skills can vary four fold. This workshop will tailor the learning to each individual’s need for repetition. Each session takes approximately 30 minutes to complete. This workshop will appeal to cardiovascular specialists and cardiac care team members who want to improve their auscultation skill in both common and more advanced heart sounds.

Co-Chairs: Michael J. Barrett, Blue Bell, PA Larry E. Jacobs, Allentown, PA Andrew M. Freeman, Denver, CO Tyler Seto, Los Angeles, CA Bruce A. Feldman, Allentown, PA

ACC-i2/TCT

OrAl

2503

Bioresorbable Vascular ScaffoldsSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S106bCME/CNE Hours: 1.5

Co-Chairs: Ron Waksman, Washington, DC Patrick Serruys, Rotterdam, Netherlands

Panelists: Alaide Chieffo, Milan, Italy, Juan Granada, Orangeburg, NY

10:45 2503–6 The Year in review — Patrick W. Serruys, Rotterdam, Netherlands

11:00 2503–7 Comparisons of Safety Profile between Durable and Biodegradable Polymer Based Drug- eluting Stents in Porcine Coronary Artery Model — Takeshi Ijichi, Gaku Nakazawa, Toshiro Shinke, Daisuke Matsumoto, Hiromasa Otake, Sho Torii, Ayako Yoshikawa, Junya Shite, Yuji Ikari, Tokai University School of Medicine, Isehara, Kanagawa, Japan



146 GO for ACC.12!

Mor

ning

11:10 2503–9 Differential Vascular Healing Patterns with rapid Absorption Biodegradable Polymer Sirolimus-eluting Stents versus Durable Polymer Everolimus-eluting Stents — Tomohisa Tada, Robert Byrne, Rezarta Cuni, Lamin King, Michael Joner, Albert Schomig, Adnan Kastrati, Deutsches Herzzentrum Munchen, Munich, Germany


11:25 2503–11 First Sequential Assessment at 6-months and 2-years of the 2nd Generation Absorb Everolimus-eluting Bioresorbable Scaffold: A Multi-Imaging Modality Study — Yoshinobu Onuma, Cecile Dorange, Karine Miquel-Hebert, Patrick W. Serruys, the ABSORB B investigators, Thorax centre, Rotterdam, The Netherlands, Abbott Vascular Belgium, Diegem, Belgium


11:45 2503–13 Vascular response of the Segments Adjacent to the Proximal and Distal Edges of the ABSOrB Everolimus-eluting Bioresorbable Vascular Scaffold: 6-months and 1-year Follow-up Assessment: A Serial Intravascular Ultrasound radiofrequency Data Analysis from the First in Man ABSOrB Cohort B Trial — Bill D. Gogas, Patrick W. Serruys, Vasim Farooq, Salvatore Brugaletta, Maria Radu, Jung Ho Heo, Robert Jan M. van Geuns, Evelyn Regar, Bernard de Bruyne, Bernard Chevalier, Leif Thuesen, Jacques Koolen, Stefan Windecker, Karine Miquel-Hebert, Cecile Dorange, Richard Rapoza, John Ormiston, Thoraxcenter, Erasmus University Medical Center, Rotterdam, The Netherlands


12:00 2503–15 Evaluation of the ABSOrB Everolimus-eluting Bioresorbable Vascular Scaffold (ABSOrB BVS) in the Treatment of Patients with de Novo Native Coronary Artery lesions: 2-year Clinical results of ABSOrB Cohort B Trial — Dariusz Dudek, Jagiellonian University Medical College, Krakow, Poland


ACC-i2/TCT

OrAl

2506

Drug-eluting StentsSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S101aCME/CNE Hours: 1.5

Co-Chairs: Andreas M. Zeiher, Frankfurt, Germany Gennaro Sardella, Rome, Italy

Panelists: Didier Carrie, Toulouse, France, Ozgen Dogan, Brooklyn, NY

10:45 2506–6 The Year in review — Matthew J. Price, La Jolla, CA

11:00 2506–7 longitudinal Stent Deformation: Quantitative Coronary Angiographic Analysis from the Perseus WH and Platinum WH randomized Controlled Clinical Trials — Dean J. Kereiakes, Louis Cannon, David Kandzari, Carey Kimmelstiel, Ian Meredith, Jeffrey Popma, Gregg Stone, Paul Teirstein, Stefan Verheye, Dominic Allocco, Keith Dawkins, Christ Hospital Heart & Vascular Center/

Lindner Center for Research & Education at The Christ Hospital, Cincinnati, OH


11:15 2506–9 Stent Thrombosis: Insights on Outcomes, Predictors and Impact of Dual Antiplatelet Therapy Interruption from the SPIrIT II, SPIrIT III, SPIrIT IV and COMPArE Trials — Elvin Kedhi, Gregg Stone, Dean Kereiakes, Patrick Serruys, Helen Parise, Martin Fahy, Charles Simonton, Krishnan Sudhir, Poornima Sood, Pieter Smits, Maasstad Hospital, Rotterdam, The Netherlands


11:30 2506–11 Definite and Probable Stent Thrombosis after revascularization with Everolimus- and Sirolimus-eluting Stents: From the SOrT OUT IV Trial — Lisette Okkels Jensen, Per Thayssen, Michael Maeng, Hans-Henrik Tilsted, Anne Kaltoft, Knud Hansen, Evald Christiansen, Anders Junker, Jan Ravkilde, Leif Thuesen, Jens Lassen, Odense University Hospital, Odense, Denmark


11:45 2506–13 Two-year results of the PlATINUM randomized Trial Comparing Platinum Chromium PrOMUS Element and Cobalt Chromium PrOMUS/xIENCE V Everolimus-eluting Stents in de Novo Coronary Artery lesions — Gregg W. Stone, Paul Teirstein, Ian Meredith, Alain Bouchard, Didier Carrié, Helge Möllmann, Keith Oldroyd, Jack Hall, Dominic Allocco, Keith Dawkins, Columbia University Medical Center, New York, NY


12:00 2506–15 Ten-year Follow-up of the Desire registry: A Single-center Perspective on Drug-eluting Stents a Decade later — José de Ribamar Costa, Amanda Sousa, Adriana Moreira, Ricardo Costa, Manuel Cano, Galo Maldonado, Bruno Palmieri, J. Eduardo Sousa, Hospital do Coração, Sao Paulo, Brazil


ACC-i2/TCT

OrAl

2507

Imaging in TAVrSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S102cCME/CNE Hours: 1.5

Co-Chairs: Eric Van Belle, F-59037 Lille, France James K. Min, New York, NY

Panelist: Bernhard Reimers, Mirano, Italy

10:45 2507–6 The Year in review — Rebecca T. Hahn, New York, NY

11:05 2507–9 Integrated 3D Echo-x-ray Image Guidance for Structural Heart Interventions — Stacey D. Clegg, James Chen, Ernesto Salcedo, Robert Quaife, John Carroll, University of Colorado Hospital, Aurora, CO


11:20 2507–11 reduction of Para-Valvular regurgitation with Post-Dilatation following Balloon-Expandable Transcatheter Aortic Valve replacement — Benoit Daneault, Elana Koss, Rebecca Hahn, Susheel Kodali,



Morning

Mathew Williams, Philippe Genereux, Jean-Michel Paradis, Isaac George, Craig Smith, Jeffrey Moses, Martin Leon, Columbia University Medical Center, New York, NY


11:35 2507–13 Differences in Clinical Outcomes Based on Adherence to Valve Sizing Criteria Using 2D Echocardiography or 3D Computed Tomography in Patients Undergoing Transcatheter Aortic Valve Implantation — Nicolo Piazza, Alexander Hill, Gernot Brockmann, Anke Opitz, Domenico Mazzitelli, Yacine Elhmidi, Hendrik Ruge, Sabine Bleiziffer, Rudiger Lange, German Heart Centre, Munich, Germany, Medtronic, Inc., Mounds View, MN


11:50 2507–15 regional Apical Motion Abnormality Early after Transapical Aortic Valve replacement: Prevalence and Outcome — Israel Barbash, Itsik Ben-Dor, Danny Dvir, Paul Corso, Steven Boyce, Steven Goldstein, Zuyue Wang, Rebecca Torguson, Ana Laynez Carnicero, Lowell Satler, Augusto Pichard, Ron Waksman, MedStar Health Research Institute, Washington, DC


ACC-i2/TCT

OrAl

2509

Prevention and Treatment of restenosisSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S103cCME/CNE Hours: 1.5

Co-Chairs: Christodoulos Stefanadis, Athens, Greece David J. Moliterno, Lexington, KY

Panelists: Tayo A. Addo, Dallas, TX, Manish Parikh, New York, NY, Emilia Solinas, Italy

10:45 2509–6 The Year in review — Alexandre Abizaid, Sao Paulo, Brazil

11:00 2509–7 Compassionate Use of a Paclitaxel Coated Balloon Catheter in Patients with refractory Coronary In-stent restenosis — Yvonne P. Clever, Bruno Scheller, Michael Böhm, Bodo Cremers, Klinik fuer Innere Medizin III, Universitaetsklinikum des Saarlandes, Homburg/Saar, Germany


11:15 2509–9 Sequent Please World Wide registry: Efficacy of Paclitaxel Coated Balloon Angioplasty for Treatment of Drug-eluting Stent restenosis Compared with Bare-metal Stent restenosis — Jochen Woehrle, Wolfgang Motz, Sven Moebius-Winkler, Matthias Leschke, Christian Opitz, Waqas Ahmed, Paul Barragan, Jean-Philippe Simon, Graham Cassel, Luis Elbal, Bruno Scheller, University of Ulm, Ulm, Ghana


11:30 2509–11 long-term Quantitative Coronary Angiographic Assessment of Sirolimus-eluting Stents in Very late Target lesion revascularization — David Anthony Burke, Alexandra Almonacid, Jeffrey Popma, Beth Israel Deaconess Medical Center, Boston, MA


11:45 2509–13 Statin reduces late Tlr (beyond 1-year) “late Catch-up Phenomenon” as well as early Tlr (within 1-year) after Sirolimus-eluting StentIimplantation: From J-Cypher registry — Yoshihiro Katoh, Masahiro Natsuaki, Yoshihisa Nakagawa, Takeshi Kimura, Saiseikai Noe Hospital, Osaka, Japan, Department of the Cardiology, Kyoto, Japan


12:00 2509–15 A Novel Method for Capturing Endothelial Progenitor Cells (EPCs) by Coronary Stents: Application of Vascular Endothelial Growth Factor (VEGF)-bound Platform — Shu Takabatake, Toshinari Tsubokawa, Takehisa Matsuda, Masakazu Yamagishi, Division of Cardiovascular Medicine, Kanazawa University Graduate School of Medical Science, Kanazawa, Japan, Kanazawa Institute of Technology, Kanazawa, Japan


ACC-i2/TCT

OrAl

2511

Outcomes in Patients Treated with PCISunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S103bCME/CNE Hours: 1.5

Co-Chairs: Hugo A. Katus, Heidelberg, Germany Jan Kovac, Leicestershire, United Kingdom

Panelists: Issam D. Moussa, Jacksonville, FL, Davide Capodanno, Jacksonville, FL, Germano DiSciascio, Rome, Italy

10:45 Year in review — Laura Mauri, Boston, MA

11:00 2511–7 CrP levels 180 Days after PCI for ACS, but Not Earlier, Predict late Adverse Cardiac Events Independent of Plaque Characteristics: The PrOSPECT Study — Christopher Kelly, Giora Weisz, Akiko Maehara, Gary Mintz, John McPherson, Stefan Verheye, Ke Xu, Martin Fahy, Barry Templin, Bernard De Bruyne, Patrick Serruys, Gregg Stone, NewYork-Presbyterian Hospital / Columbia University Medical Center, New York, NY, Cardiovascular Research Foundation, New York, NY


11:15 2511–9 Acute Complications of Non-primary PCI at Hospitals with and without On-site Cardiac Surgery: Cport-E Project — Thomas Aversano, Johns Hopkins University, Baltimore, MD


11:30 2511–11 Contemporary Incidence and Predictors of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Interventions: Insights from the NCDr Cath-PCI registry — Thomas Tsai, Uptal Patel, Tara I. Chang, Kevin F. Kennedy, Frederick Masoudi, Michael Matheny, Mikhail Kosiborod, John Messenger, John Rumsfeld, John Spertus, Denver VA Medical Center / U of Colorado Denver, Denver, CO, Mid America Heart Institute, Kansas City, MO


11:45 2511–13 Cost-Effectiveness of Transradial Percutaneous Coronary Intervention:


148 GO for ACC.12!

Mor

ning

A Decision-analytic Model — Amit P. Amin, Steven P. Marso, Adnan Chhatriwalla, David Safley, kevin kennedy, John House, Rebecca Mills, Adam Salisbury, John Spertus, David Cohen, Dmitri Baklanov, Mid America Heart Institute, Saint Lukes Hospital, Kansas City, MO


12:00 2511–15 The Epidemiology and Outcomes of Percutaneous Coronary Intervention before High-risk Non-cardiac Surgery: Insights from the BMC2 registry — Palaniappan Muthappan, Dean Smith, Herbert Aronow, Kim Eagle, David Wohns, James Fox, David Share, Hitinder Gurm, University of Michigan Cardiovascular Center, Ann Arbor, MI


ACC-i2/TCT

SYMPOSIUM

2615

Congenital/PediatricSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S102bCME/CNE Hours: 1.5

Co-Chairs: Michael J. Landzberg, Boston, MA William E. Hellenbrand, New York, NY

10:45 Spectrum/Overview of Pulmonary Valve Disorders — Jeffrey Meadows, Boston, MA

10:57 Outcomes of Melody Valve Implantation in the rVOT — Doff B. McElhinney, Boston, MA

11:09 Outcomes of Sapien Valve Implantation in the rVOT — Ziyad M. Hijazi, Chicago, IL

11:21 Device Closure of Congenital VSD — Wolfgang A. K. Radtke, Wilmington, DE

11:33 PDA in Children and Adults — Johnn W. M. Moore, San Diego, CA

11:45 Coarctation: Percutaneous Therapy Should be First line — Daniel S. Levi, Los Angeles, CA

11:57 Coarctation: Surgery remains the Preferred Option — Joseph A. Dearani, Rochester, MN


ACS

OrAl

917

Improving Outcomes in ACS. Insights from Basic Science and Preclinical research.Sunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place North, N227bCME/CNE Hours: 1.5

Co-Chairs: Aamer Abbas, El Paso, TX Jesse Currier, Los Angeles, CA

10:45 917–3 Ultrasound-induced Stimulation of Microbubbles reduces Scar Formation and Improves left-ventricular Function after Acute Myocardial Infarction in Mice — Alexander Ghanem, Jonas Dörner, Georg Nickenig, Dept. of Cardiology, Univ. of Bonn, Bonn, Germany

11:00 917–4 Human Umbilical Vein Endothelial Cells Attenuate the left Ventricular remodeling after Acute Myocardial Infarction in rats via a regulation of Matrix Metalloproteinases/Tissue Inhibitor of Metalloproteinases Balance by Endothelial Nitric Oxide Synthase — Young Keun Ahn, Jin-Sook Kwon,

Yong Sook Kim, Ae Shin Cho, Hyang Hee Cho, Jeong Sook Kim, Moon Hwa Hong, Wan Seok Kang, Jang-Whan Bae, Myung Ho Jeong, Myeong-Chan Cho, Chonnam National University Hospital, Gwangju, South Korea, Heart Research Center of Chonnam National University Hospital, Gwangju, South Korea

11:15 917–5 No Association of Paraoxonase-1 Q192r and Thrombotic Events during Dual Anti-platelet Therapy in Patients after Acute Myocardial Infarction — Jeffrey JW Verschuren, Helèn Boden, Judith A. Wessels, B. L. van der Hoeven, Henk-Jan Guchelaar, Martin Schalij, Johan Jukema, Leiden University Medical Center, Leiden, The Netherlands

11:45 917–7 Novel role for Bioactive lipids in Stem Cell Mobilization during Myocardial Ischemia: A Potential Therapeutic Target — Ahmed Abdel-Latif, Anush K. Karapetyan, Khaled Ziada, Manjula Sunkara, Ewa K. Zuba-Surma, Samy Selim, Susan Smyth, Mariusz Z. Ratajczak, Andrew J. Morris, University of Kentucky, Lexington, KY, University of Louisville, Louisville, KY

12:00 917–8 Development of Ultrasound responsive Thrombus-targeting Drug Delivery System for Coronary Thrombolysis — Hiroyuki Kawata, Tsunenari Soeda, Yasuhiro Takemoto, Ji-Hee Sung, Yoshiko Uesugi, Yasuhiko Tabata, Keiji Kato, Kenichi Ishigami, Manabu Horii, Shiro Uemura, Yoshihiko Saito, Nara Medical University, Kashihara, Japan

Arr

OrAl

918

Cardiac MrI for the Treatment and Evaluation of ArrhythmiasSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S404CME/CNE Hours: 1.5

Co-Chairs: Aiden Abidov, Tucson, AZ Kristen K. Patton, Seattle, WA

10:45 918–3 The role of Magnetic resonance Imaging in Identifying Patients with Cardiac Sarcoidosis and Preserved left Ventricular Function in Predicting Future Ventricular Arrhythmias — Thomas Crawford, Sinan Sarsam, Gisela Mueller, Sanjaya Gupta, Timir Baman, Karl Ilg, Diego Belardi, Mohamad Sinno, William Sauer, Khaled Abdul-Nour, Henry Kim, Mouaz AI-Mallah, Joseph Schuller, Fred Morady, Frank Bogun, University of Michigan Health System, Ann Arbor, MI, Henry Ford Hospital, Detroit, MI

11:00 918–4 Myocardial Infarct Heterogeneity Assessed by late Gadolinium-enhanced Cardiovascular Magnetic resonance (lGE-CMr) Is Associated with the Development of Ventricular Tachycardias after Acute Myocardial Infarction — Lourens Robbers, Ronak Delewi, Michiel Kemme, Robin Nijveldt, Aernout Beek, Alexander Hirsch, Anja Van Der Laan, Pieter van der Vleuten, Jan Piek, Felix Zijlstra, Albert van Rossum, VU University Medical Center, Amsterdam, The Netherlands, Interuniversity Cardiology Institute of the Netherlands, Utrecht, The Netherlands

11:15 918–5 Mitral regurgitation recovery and Atrial reverse remodeling following Pulmonary Vein Isolation Procedure in Patients with Atrial Fibrillation: A Proof of Concept Clinical Observation



Morning

Cardiac MrI Study — Sahadev T. Reddy, M, William Belden, Mark Doyle, Diane Vido, Ronald Williams, M, June Yamrozik, Moneal Shah, Robert Biederman, The Gerald McGinnis Cardiovascular Institute, Allegheny General Hospital, Pittsburgh, PA

11:30 918–6 Indication of Fat Pad Modification for Patients with Atrial Fibrillation: An Approach by the Extent of Fibrosis on left Atrium Obtained from late Gadolinium Enhancement MrI — Koji Higuchi, Mehmet Akkaya, Joshua Blauer, Kavitha Damal, Chankevin Tek, Nathan Burgon, Eugene Kholmovski, Rob MacLeod, Nassir Marrouche, Comprehensive Arrhythmia Research & Management Center, University of Utah, Salt Lake City, UT

11:45 918–7 Catheter Ablation Guided By real-time Magnetic resonance Imaging: Initial Clinical Applications — Peter Nordbeck, Meinrad Beer, Mark E. Ladd, Harald H. Quick, Wolfgang R. Bauer, Oliver Ritter, University Hospital Wuerzburg, Wuerzburg, Germany

12:00 918–8 Acute Identification of Gaps in Atrial radiofrequency Ablation lesion Sets Using MrI — Ravi Ranjan, Eugene Kholmovski, Sathya Vijayakumar, Joshua Blauer, Kamal Vij, Rob MacLeod, Nassir F. Marrouche, University of Utah, Salt Lake City, UT

Arr

OrAl

919

Joint Oral Session of the Heart rhythm Society and the American College of Cardiology: Cardiac Arrest and the Care of the ICD PatientSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place North, N426CME/CNE Hours: 1.5

Co-Chairs: Sana Al-Khatib, Durham, NC Paul J. Wang, Stanford, CA

11:00 919–4 Temporal Trends in Quality of Care among ICD recipients: Insights from the NCDr ICD registry — John A. Dodson, Jeptha P. Curtis, Yongfei Wang, Stephen C. Hammill, Paul Varosy, Rachel Lampert, Yale University School of Medicine, New Haven, CT

11:15 919–5 Inappropriate Therapy for Atrial Flutter/Fibrillation Is lower with Dual- than Single-Chamber ICD in MADIT-CrT — Nitesh Sood, Arthur Moss, Scott Mcnitt, Christopher Clyne, University of Connecticut/Hartford Hospital, Hartford, CT, University of Rochester, Rochester, NY

11:30 919–6 Gender Differences in Inappropriate Device Therapies from MADIT — Christine Tompkins, Scott McNitt, James Daubert, Paul Wang, Arthur Moss, Wojciech Zareba, University of Rochester Medical Center, Rochester, NY

11:45 919–7 riata ICD lead Failure: results of the Manufacturers Analysis of returned leads — Robert G. Hauser, Linda Kallinen, Minneapolis Heart Institute Foundation, Minneapolis, MN

12:00 919–8 Follow-up riata Screening in Northern Ireland — Emily Hodkinson, Vivek Kodoth, Kyle Ashfield, Carol Wilson, Ernest Lau, David McEneaney, Michael Roberts, Royal Victoria Hospital, Belfast, United Kingdom, Craigavon Cardiac Centre, Craigavon, United Kingdom

CCS

SYMPOSIUM

637

Post-Operative Glenns and Fontans: Navigating Turbulent WatersSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place North, N231CME/CNE Hours: 1.5

Co-Chairs: Andrew Atz, Charleston, SC Jacqueline Kreutzer, Pittsburgh, PA

10:45 Case Presentation — Henri Justino, Houston, TX

10:55 Take Action When the Post Operative Fontan Isn’t What You Hoped For — Jacqueline Kreutzer, Pittsburgh, PA

11:15 Outcomes: Update from the Pediatric Heart Network (PHN) Single Ventricle reconstruction (SVr) Trial — John F. Rhodes, Durham, NC

11:35 The Blue Glenn — Aimee K. Armstrong, Ann Arbor, MI

11:55 role of the Catheterization lab for the Failing Fontan — Joshua Kanter, Washington, DC

CCS

OrAl

920

Adults with Congenital Heart Disease: Imaging Predictors, Evolving Therapies and OutcomesSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S402CME/CNE Hours: 1.5

Co-Chairs: Michael H. Crawford, San Francisco, CA William R. Davidson, Hershey, PA

10:45 920–3 The Year in review — Congenital Cardiology Solutions — Thomas P. Graham, Jr., Franklin, TN

11:00 920–4 Cancer in Adults with Congenital Heart Disease Compared to the General Population — Michelle Gurvitz, Louise Pilote, Patrick Lawler, Mark Eisenberg, Raluca Ionescu-Ittu, Ariane Marelli, Children’s Hospital Boston, Boston, MA

11:15 920–5 Echocardiographic Predictors of Outcome in Eisenmenger Syndrome — Pamela Moceri, Konstantinos Dimopoulos, Emmanouil Liodakis, Aleksander Kempny, Gerhard-Paul Diller, Wei Li, Michael Gatzoulis, Royal Brompton Hospital, London, United Kingdom, University Hospital of Nice, Nice, France

11:30 920–6 Can Selective Pulmonary Vasodilator Therapy Be Used to Target Pulmonic regurgitation? results of the Pinot Noir Trial — Stephen A. Hart, Ganesh Devendra, Yuli Kim, Vidyasagar Kalahasti, Scott Flamm, Richard Krasuski, Cleveland Clinic, Cleveland, OH

11:45 920–7 Is Pregnancy Associated with Adverse right Ventricular remodeling in Women with repaired Tetralogy of Fallot? — Gabriele Egidy Assenza, Anne Marie Valente, Daiana Cassater, Jenna Schreier, Katherine Economy, Dionne Graham, Massimo Volpe, Nancy Barker, Tal Geva, Michael Landzberg, Anne Marie Valente, Children’s Hospital Boston, Boston, MA

12:00 920–8 right Atrial Size Predicts Arrhythmia and Death in Patients with repaired Tetralogy of Fallot — Beatrice Bonello, Aleksander Kempny, Anselm Uebing, Wei Li, Philip Kilner, Dudley J. Pennell, Michael Gatzoulis, Gerhard-Paul Diller, Sonya Babu-Narayan, BRU Ressearch Unit, Royal Brompton Hospital, London, United Kingdom


150 GO for ACC.12!

Mor

ning

HF

ExPErTS

225

Heart Failure Care for the Very Old: What Are the Key Issues for Success?Sunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S502CME/CNE Hours: 1.5

Chair: Suzanne J. Wingate, Silver Spring, MD

Case Presenter: Sarah J. Goodlin, Salt Lake City, UT

Panelists: Ali Ahmed, Birmingham, AL, Jalal K. Ghali, Detroit, MI, Robert Lee Page, II, Aurora, CO, Michael W. Rich, Saint Louis, MO

HF

OrAl

921

Joint Oral Session of the Heart Failure Society of America and the American College of Cardiology: Individualizing Pharmacological Therapy in Heart FailureSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S406bCME/CNE Hours: 1.5

Co-Chairs: Akshay S. Desai, Boston, MA Barry M. Massie, San Francisco, CA

10:45 921–3 The Year in review – Heart Failure — Barry M. Massie, San Francisco, CA

11:00 921–4 Beta-1 Adrenergic receptor Genotype Ser49Gly Is Associated with Beta-Blocker Survival Benefit in Patients with Heart Failure — Jasmine Talameh, Amanda Garrand, Jalal Ghali, Ron M. Oren, Stephanie Dunlap, Adrian Van Bakel, Ileana Pina, J. Herbert Patterson, Carla Sueta, Frank McGrew, Alan Miller, Todd Schwartz, Kirkwood Adams, University of North Carolina-Chapel Hill, Chapel Hill, NC

11:15 921–5 The Association of Beta-blocker Use and Selectivity with Outcomes in Heart Failure Patients with Chronic Obstructive Pulmonary Disease: Findings from the Organized Program to Initiate life-saving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) — Robert J. Mentz, Daniel Wojdyla, Mona Fiuzat, Karen Chiswell, Tariq Ahmad, Gregg Fonarow, Christopher O’Connor, Duke University Medical Center, Durham, NC, Duke Clinical Research Institute, Durham, NC

11:30 921–6 Influence of Baseline and Worsening renal Function on Efficacy of Spironolactone in Patients with Severe Heart Failure Enrolled in the randomized Aldactone Evaluation Study — Orly Vardeny, Faiez Zannad, Bertram Pitt, Scott Solomon, University of Wisconsin, Madison, WI, Brigham and Women’s Hospital, Boston, MA

11:45 921–7 Autologous CD133+ Bone Marrow Cells and Bypass Grafting for regeneration of Ischemic Myocardium: results of the Cardio133 Trial — Boris Alexander Nasseri, Marian Kukucka, Michael Dandel, Wolfram Ebell, Roland Hetzer, Christof Stamm, Deutsches Herzzentrum Berlin, Berlin, Germany, Berlin Center for Regenerative Therapies, Berlin, Germany

12:00 921–8 ranolazine for the Treatment of Diastolic Heart Failure in Patients with Preserved Ejection Fraction: results from the rAlI-DHF Study — Lars Maier, Rolf Wachter, Frank Edelmann, Beth

Layug, Ewa Karwatowska-Prokopczuk, Luiz Belardinelli, Gerd Hasenfuss, Claudius Jacobshagen, University of Goettingen, Goettingen, Germany, Gilead, Foster City, Palo Alto, CA

HF

OrAl

922

Improving Patient Selection for Device-Based TherapiesSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S405CME/CNE Hours: 1.5

Co-Chairs: Mark H. Drazner, Dallas, TX Scott Silvestry, Philadephia, PA

10:45 922–3 The Impact of Myocardial Scar by Cardiac Magnetic resonance in Patients with Non-Ischemic Dilated Cardiomyopathy referred for an Implantable Cardioverter Defibrillator for Primary Prevention of Sudden Cardiac Death — Tomas G. Neilan, Otavio Coelho-Filho, Stephan Danik, Daniel J. Verdini, Tokuda Michifumi, Ravi Shah, Usha Tedrow, William Stevenson, Michael Jerosch-Herold, Brian Ghoshhajra, Raymond Kwong, Brigham and Women’s Hospital, Boston, MA, Massachusettes General Hospital, Boston, MA

11:00 922–4 Baseline Burden of Heart Failure limits Duration of Benefit of ICD for Medicare recipients — Soko Setoguchi, Chih-Ying Chen, Lynne Stevenson, John Seeger, Lauren Williams, Jessica Jalbert, Andrew Rothman, Garrick Stewart, Brigham and Women’s Hospital, Boston, MA, Duke Clinical Research Institute, Durham, NC

11:15 922–5 Impact of remote, Wireless Pulmonary Artery Hemodynamic Monitoring in Patients with Atrial Fibrillation and Chronic Heart Failure: Insights from the CHAMPION Trial — Alan B. Miller, John Teerlink, Peter Carson, Wayne Levy, Eugene Chung, Edward Gilbert, Brad Jeffries, Jay Yadav, Susan Neville, Pam Cowart, Phillip Adamson, William Abraham, university of florida, jacksonville, FL

11:30 922–6 Cardiac resynchronization Therapy Benefits Patients Eighty-years of Age or Older — Evan C. Adelstein, John Gorcsan, Sandeep Jain, Samir Saba, University of Pittsburgh, Pittsburgh, PA

11:45 922–7 Improvement in Ejection Fraction Predicts Survival following Cardiac resynchronization Therapy in Patients with Both left Bundle and Non-left Bundle Branch Block Morphologies — Jack Rickard, Bruce Lindsay, Niraj Varma, Mina Chung, Greg Jackson, Bryan Baranowski, Wai Hong Tang, Bruce Wilkoff, Cleveland Clinic, Cleveland, OH

12:00 922–8 Impact of AV- and VV-Delay Optimization in Patients Treated with Cardiac resynchronization Therapy: A Meta-Analysis — Dominique Auger, Ulas Höke, Jeroen Bax, Eric Boersma, Victoria Delgado, LUMC, Leiden, The Netherlands, Centre Hospitalier de l’Université de Montréal, Montreal, Canada



Morning

IMAG

SYMPOSIUM

638

Joint Symposium of the American Society of Echocardiography and the American College of Cardiology: Cardiomyopathy — A Comprehensive Echocardiographic ApproachSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S406aCME/CNE Hours: 1.5

Co-Chairs: Alex J. Auseon, Columbus, OH James D. Thomas, Cleveland, OH

10:45 Insights into lV Mechanics Using Advanced Echo Imaging — James D. Thomas, Cleveland, OH

11:00 Importance of Diastolic Function in Patients with Cardiomyopathy — Sherif F. Nagueh, Houston, TX

11:15 Don’t Forget the right Ventricle — Lawrence G. Rudski, Montreal, Canada

11:30 Echo Assessment of the left Atrium as reservoir, Pump and Embolic — Teresa S.M. Tsang, Vancouver, Canada

11:45 Echocardiography in Guiding Cardiac resynchronization Therapy — Theodore P. Abraham, Baltimore, MD

12:00 Echo Is the Only Test Needed in Assessment of Patients with Cardiomyopathy: Comparison with Other Imaging Modalities — Mario J. Garcia, Bronx, NY

IMAG

OrAl

924

Cardiac CT: Toward a Better Understanding of CADSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S403CME/CNE Hours: 1.5

Co-Chairs: Dipan J. Shah, Houston, TX Eric J. Velazquez, Durham, NC

10:45 924–3 The Significance of Non-Obstructive Coronary Artery Disease upon Multi-Detector Computed Tomography in Patients Presenting with Acute Chest Pain — Roy Beigel, Sella Brosh, Orly Goitein, Einat Gutman, Amit Segev, Eli Konen, Dan Oieru, Hanoch Hod, Shlomi Matetzky, The Leviev Heart Center, Sheba Medical Center, Tel Hashomer, Israel, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

11:00 924–4 A Comparison of Outcomes with Coronary Artery Calcium in Unselected Populations: The Multi-ethnic Study of Atherosclerosis (MESA) and Heinz Nixdorf recall Study (HNr) — Matthew J. Budoff, Stefan Möhlenkamp, Robyn McClelland, Joseph Delaney, Marcus Bauer, Heinz Karl Jockel, Hagen Kalsch, Richard Kronmal, Khurram Nasir, Susanne Moebus, Raimund Erbel, Los Angeles Biomedical Research Institute, Torrance, CA, University of Duisburg-Essen, Essen, Germany

11:15 924–5 Does Noncalcified Plaque Improve the Diagnostic and Prognostic Utility of Coronary CT Angiography? A Study of Propensity-Matched Individuals with Similar Coronary Calcium Scores from the Prospective Multicenter International CONFIrM registry — Rine Nakanishi, Heidi Gransar, Daniel S. Berman, Victor Cheng, Damini Dey, Troy LaBounty, Fay Lin, Stephan Achenbach, Mouaz

Al-Mallah, Matthew J. Budoff, Filippo Cademartiri, Tracy Callister, Kavitha Chinnaiyan, Benjamin J. W. Chow, Augustin Delago, Martin Hadamitzky, Joerg Hausleiter, Gilbert Raff, Todd Villines, Leslee J. Shaw, Allison Dunning, James K. Min, Departments of Imaging and Medicine, Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA

11:30 924–6 A Previously Validated Peripheral Gene Expression Score is Mostly Determined by Non-Calcified Plaque and luminal Stenosis as Assessed by Quantitative, 3-Dimensional Measurements by CT Angiography in the Multi-Center, Prospective COMPASS Study — Szilard Voros, Gregory Thomas, Alexandra Lansky, John McPherson, Michael Elashoff, Sarah Rinehart, Andrea Johnson, Steven Rosenberg, Integrated Cardiovascular Research Group, Atlanta, GA, CardioDx, Palo Alto, CA

11:45 924–7 Hypertensive Individuals Have an Increased Prevalence of Coronary Artery Disease and risk of Adverse Events: A Comparison of 15,091 Individuals from CONFIrM (Coronary Computed Tomographic Angiography Evaluation for Clinical Outcomes: An International Multicenter registry) — Troy M. LaBounty, Stephan Achenbach, Mouaz Al-Mallah, Daniel Berman, Matthew Budoff, Filippo Cademartiri, Tracy Callister, Victor Cheng, Kavitha Chinnaiyan, Benjamin Chow, Augustin DeLago, Allison Dunning, Millie Gomez, Martin Hadamitzky, Joerg Hausleiter, Philipp Kaufmann, Fay Lin, Gilbert Raff, Leslee Shaw, Todd Villines, James Min, Cedars-Sinai Medical Center, Los Angeles, CA

12:00 924–8 Prospective Evaluation of the Updated 2010 ACCF Cardiac CT Appropriate Use Criteria — William Guy Weigold, Michael Rich, Daisuke Utsunomiya, Lauren Simprini, Gaby Weissman, Allen Taylor, Washington Hospital Center and MedStar Health Research Institute, Washington, DC, Georgetown University School of Medicine, Washington, DC

ISCHEM

OrAl

923

Who Said There’s Nothing New?Sunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place North, N230CME/CNE Hours: 1.5

Co-Chairs: Subhash Banerjee, Dallas, TX Ellen Keeley, Charlottesville, VA

10:45 923–3 The Year in review — Chronic Coronary Artery Disease/Stable Ischemic Heart Disease — Steven R. Bailey, San Antonio, TX

11:00 923–4 Effects of AMG 145, a Fully Human Monoclonal Antibody Against PCSK9, on low-Density lipoprotein Cholesterol in Subjects Taking Statins: A Phase 1, randomized, Double-blind, Placebo-controlled, Ascending Multiple-dose Study — Clapton Dias, Adam Shaywitz, Blaire Cooke, Stephen Uy, Maurice Emery, John Gibbs, Caroline Crispino, Karen Smirnakis, Brian Smith, Bing Gao, Scott Wasserman, Evan Stein, Amgen Inc, Thousand Oaks, CA, Metabolic and Atherosclerosis Research Center, Cincinnati, OH

11:12 923–5 Sustained Clinical Improvements after Intramyocardial Injection of Mesenchymal Stromal


152 GO for ACC.12!

Mor

ning

Cells in Patients with Severe Stable Coronary Artery Disease: 24-months Follow-up — Anders Bruun Mathiasen, Mandana Haack-Sørensen, Erik Jorgensen, Jens Kastrup, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

11:24 923–6 Instantaneous Wave-free ratio (iFr) Has a Similar Diagnostic Efficiency to Fractional Flow reserve (FFr) in Single and Multi-vessel Disease: Secondary Analysis of Advise (Adenosine Vasodilator Independent Stenosis Evaluation) Study — Justin E. Davies, Sayan Sen, Javier Escaned, Carlo Di Mario, Rafael Mila, Iqbal Malik, Darrel Francis, Alun Hughes, Jamil Mayet, Imperial College, London, United Kingdom, Hospital Clinico San Carlos, Madrid, Spain

11:36 923–7 Sitagliptin Improves regional Myocardial Function during Dobutamine Stress in Type 2 Diabetes Mellitus and Coronary Artery Disease — Liam M. McCormick, Anna Kydd, Philip Read, Stephen Hoole, David Dutka, Department of Cardiovascular Medicine, University of Cambridge, Cambridge, United Kingdom

11:48 923–8 A Peripheral Blood Gene Expression Score for Coronary Artery Disease in Non-diabetic Patients Identifies Patients at low-risk for Major Cardiovascular Events and Interventional Procedures in the Next 12 Months — William E. Kraus, Szilard Voros, Robert S. Schwartz, Stephen Ellis, Ron Waksman, Naeem Tahirkheli, Hsiao Lieu, Michael R. Elashoff, Steven Rosenberg, John McPherson, Alexandra Lansky, Eric Topol, Duke University, Durham, NC, CardioDx, Inc., Palo Alto, CA

12:00 923–9 Comparison of Fractional Flow reserve versus Instant Wave-Free ratio for Assessment of Coronary Artery Stenosis Severity in routine Practice — Colin Berry, Marcel van’t Veer, William Fearon, Petr Kala, Nils Witt, Stelios Pyxaras, Pim Tonino, Bernard De Bruyne, Nico Pijls, Keith Oldroyd, University of Glasgow, Glasgow, United Kingdom

PErI

OrAl

925

All That Glitters in Myocardial and Pericardial DiseaseSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place North, N226CME/CNE Hours: 1.5

Chair: Patricia A. Uber, Baltimore, MD

10:45 925–3 The Year in review – Pericardial/Myocardial Disease — Leslie T. Cooper, Rochester, MN

11:00 925–4 Female Gender Is Associated with Major Adverse Cardiovascular Events in Patients with Hypertrophic Cardiomyopathy — Susie N. Hong-Zohlman, Raymond Chan, Barry Maron, iacopo olivotto, Gabriele E. Assenza, John Lesser, Tammy Haas, Christiane Gruner, Andrew Crean, Harry Rakowski, James Udelson, Ethan Rowin, Benedetta Tomberli, Paolo Spirito, Francesco Formisano, Elena Biagini, Claudio Rapezzi, Carlo Nicola De Cecco, Camillo Autore, E. Francis Cook, Thomas Hauser, C. Michael Gibson, Warren Manning, Evan Appelbaum, Martin Maron, Beth Israel Deaconess Medical Center, Boston, MA, Tufts Medical Center, Boston, MA

11:15 925–5 Prognostic Utility of Contrast-enhanced Cardiovascular Magnetic resonance in Hypertrophic Cardiomyopathy: An International Multicenter Study — Raymond H. Chan, Barry Maron, iacopo olivotto, Gabriele Assenza, M, Susie Hong, John Lesser, Tammy Haas, Christiane Gruner, Andrew Crean, Harry Rakowski, James Udelson, Ethan Rowin, Benedetta Tomberli, Paolo Spirito, Francesco Formisano, Elena Biagini, Claudio Rapezzi, Carlo Nicola De Cecco, Camillo Autore, Earl Francis Cook, Thomas Hauser, C. Michael Gibson, Warren Manning, Evan Appelbaum, Martin Maron, Beth Israel Deaconess Medical Center/PERFUSE Core Laboratories, Boston, MA, Tuft’s Medical Center, Boston, MA

11:30 925–6 The Impact of Colchicine on the Incidence and recurrence of Pericardial Inflammation: A Comprehensive Meta-Analysis of All randomized Clinical Trials — Mahboob Alam, Salman Bandeali, Waleed Kayani, henry huang, Salim Virani, Kodangudi Ramanathan, Hani Jneid, Memphis Veterans Affairs Medical Center / University of Tennessee Health Sciences Center, Memphis, TN, Baylor College of Medicine, Houston, TX

11:45 925–7 Characteristics of 2067 Patients Hospitalized with Peripartum Cardiomyopathy — David Peter Kao, Eileen Hsich, Joann Lindenfeld, University of Colorado School of Medicine, Aurora, CO, Cleveland Clinic, Cleveland, OH

12:00 925–8 Heart rate Variability and the Substrate for Ventricular Tachycardia in Arrhythmogenic right Ventricular Cardiomyopathy — Pasquale Santangeli, Antonio Dello Russo, Michela Casella, Gemma Pelargonio, Luigi Di Biase, Pietro Santarelli, Stefano Bartoletti, Rong Bai, Prasant Mohanty, Sanghamitra Mohanty, Agnes Pump, Andrea Natale, Texas Cardiac Arrhythmia Institute, Austin, TX, Catholic University of the Sacred Heart, Rome, Italy

PrACTICE

ExPErTS

226

ACC/MedAxiom/ACCA: Physician/Hospital Integration: Making It WorkSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S505CME/CNE Hours: 1.5

Co-Chairs: Jerome L. Hines, Hinsdale, IL Marc E. Shelton, Springfield, IL

Panelists: Marc E. Shelton, Springfield, IL, Howard T. Walpole, Nashville, TN, Donald E. Casey, Morristown, NJ, R. Terry Heath, Indianapolis, IN

PrEV

ExPErTS

227

Update on the ATP IV GuidelinesSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S501aCME/CNE Hours: 1.5

Co-Chairs: Christie M. Ballantyne, Houston, TX Neil Stone, Winnetka, IL

Case Presenters: James H. Stein, Madison, WI, Salim S. Virani, Bellaire, TX

Panelists: C. Noel Bairey Merz, Los Angeles, CA, Patrick E. McBride, Madison, WI, Jennifer Robinson, Iowa City, IA, Neil Stone, Winnetka, IL



Morning

PrEV

OrAl

926

renal Sympathetic Denervation: A Novel Therapy for Hypertension?Sunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place North, N228CME/CNE Hours: 1.5

Co-Chairs: George L. Bakris, Chicago, IL Suzanne Oparil, Birmingham, AL

10:45 926–3 long-term Follow-up of Catheter-based renal Sympathetic Denervation for resistant Hypertension Confirms Durable Blood Pressure reduction — Henry Krum, Neil Barman, Markus Schlaich, Paul Sobotka, Murray Esler, Felix Mahfoud, Monash University and The Alfred Hospital, Melbourne, Australia

11:00 926–4 renal Sympathetic Denervation for Treatment of resistant Hypertension: One-year results from the Symplicity HTN-2 randomized Controlled Trial — Murray D. Esler, Henry Krum, Markus Schlaich, Roland Schmieder, Michael Bohm, Paul Sobotka, Baker IDI Heart and Diabetes Institute, Melbourne, Australia

11:15 926–5 6-months Follow-up in a real life Situation after renal Denervation — Willemien Verloop, Wilko Spiering, Pierfrancesco Agostoni, Pieter Stella, Kevin Onsea, P. Doevendans, Michiel voskuil, UMC Utrecht, Utrecht, The Netherlands

11:30 926–6 Effects of renal Sympathetic Denervation on 24-hour Blood Pressure Variability — Axel Bauer, Christine Zuern, Konstantinos Rizas, Christian Eick, Meinrad Gawaz, Eberhard-Karls-Universität Tübingen, Tuebingen, Germany

11:45 926–7 Percutaneous renal Denervation for resistant Hypertension: real World Outcomes — Darren Mylotte, Hakim Benamer, Thierry Unterseeh, Yves Louvard, Marie Claude Morice, Philippe GArot, Thierry Lefevre, Institut Cardiovasculaire Paris Sud, Paris, France

12:00 926–8 Chronic Effects of Percutaneous renal Sympathetic Denervation on renal Hemodynamics and Plasma Norepinephrine levels Using a Novel Catheter for radiofrequency Ablation — I. Tatsis, Konstantinos P. Tsioufis, Vasilios Papademetriou, K. Dimitriadis, D. Tsiachris, C. Thomopoulos, Euljoon Park, C. Stefanadis, First Cardiology Clinic, University of Athens, Hippokration Hospital, Athens, Greece

PrEV

OrAl

927

Cardiovascular risk Assessment and rehabilitationSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S401aCME/CNE Hours: 1.5

Co-Chairs: Alison Bailey, Lexington, KY Elizabeth A. Jackson, Ann Arbor, MI

10:45 927–3 The Association of Anthropometric Obesity Measures with CT-measured Non-alcoholic Fatty liver Disease in the Multi-ethnic Study of Atherosclerosis — Geoffrey H. Tison, Michael Blaha, Khurram Nasir, Roger Blumenthal, Moyses Szklo, Jingzhong Ding, Matthew Budoff, Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, MD

11:00 927–4 Comparative Effectiveness of U.S. Population Screening Strategies for Coronary Heart Disease (CHD): Evaluation of Framingham risk Score (FrS), Society for Heart Attack Prevention and Education (SHAPE), Texas Heart Attack Prevention Bill, JUPITEr, and Treat-All Approaches — Benjamin Z. Galper, Y. Claire Wang, Andrew J. Einstein, Brigham and Women’s Hospital Department of Cardiovascular Medicine, Boston, MA, Columbia University Medical Center, Department of Cardiology, New York, NY

11:15 927–5 Is Body Fat Protective in a Population with Preserved Ejection Fraction? — Alban De Schutter, Carl Lavie, Dharmendrakumar Patel, Richard Milani, Ochsner Health System, New Orleans, LA, Cleveland Clinic Florida, Weston, FL

11:30 927–6 Cardiac rehabilitation reduces Mortality following Coronary Artery Bypass: A 10-year Community Study — Quinn R. Pack, Kashish Goel, Brian Lahr, Kevin Greason, Ray Squires, Randal Thomas, Mayo Clinic, Rochester, MN

11:45 927–7 lifetime risk Algorithm Identifies More Patients with Carotid and Femoral Plaques than 10-year or 30-year Framingham risk Algorithms — John Postley, Yanting Luo, Nathan Wong, Julius Gardin, Columbia University, New York, NY

12:00 927–8 Optimizing the Incremental Predictive Value of Coronary Calcium: MESA versus Framingham 10-year or lifetime Cardiovascular risk? — Allen J. Taylor, Todd Villines, Medstar Heart Institute, Washington, DC, Walter Reed National Military Medical Center, Washington, DC

QUAl

SYMPOSIUM

650

U.S. Health System reform: What’s Missing?Sunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S100cCME/CNE Hours: 1.25

Chair: Jack Lewin, Washington, DC

Panelists: Richard E. Anderson, Napa, CA, James W. Fasules, Washington, DC, Jerry D. Kennett, Columbia, MO, Kavita Patel, Washington, DC

10:45 Introduction: U.S. Health System reform — What’s Missing? — Jack Lewin, Washington, DC

10:50 Medical liability reform — Richard E. Anderson, Napa, CA

11:15 Payment reform — Kavita Patel, Washington, DC


QUAl

OrAl

928

Improving PCI OutcomesSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place North, N229CME/CNE Hours: 1.5

Co-Chairs: David J. Cohen, Kansas City, MO Paul D. Varosy, Denver, CO

10:45 928–3 Prevalence and Outcomes of radial and Femoral Approaches to Percutaneous Coronary Intervention: Insights from the National Veterans Affairs Clinical Assessment, reporting and Tracking Program — Antonio Gutierrez, Thomas Tsai, Maggie Stanislawski, Mladen Vidovich, Walter


154 GO for ACC.12!

Mor

ning

Woody, Christopher Bryson, Deepak Bhatt, John Rumsfeld, Sunil Rao, Duke Clinical Research Institute, Durham, NC

11:00 928–4 Non-system reasons for Delay in Door-to-Balloon Time and In-hospital Mortality: A report from the National Cardiovascular Data registry® — Rajesh V. Swaminathan, Tracy Wang, Lisa Kaltenbach, Luke Kim, Robert Minutello, Dmitriy Feldman, New York Presbyterian Hospital, Weill Cornell Medical College, New York, NY, Duke Clinical Research Institute, Durham, NC

11:15 928–5 Do Extreme risk Cases Impact Hospitals’ risk-Adjusted PCI Mortality ratings? results from the NCDr® — Eric D. Peterson, Dadi (David) Dai, Sean O’Brien, J. Matthew Brennan, Kalon Ho, Frederick Masoudi, John Messenger, W. Douglas Weaver, Duke Clinical Research Institute, Durham, NC

11:30 928–6 Gender and Bleeding risk following Percutaneous Coronary Interventions: A Contemporary report from the NCDr® — Stacie L. Daugherty, Sunghee Kim, Lauren Thompson, Sunil Rao, Sumeet Subherwal, Thomas Tsai, John Messenger, Frederick Masoudi, University of Colorado Denver, Aurora, CO

11:45 928–7 Geospatial Analysis of Percutaneous Coronary Intervention Hospitals — James R. Langabeer, Timothy Henry, Jami Delli Fraine, Jamie Emert, Richard King, Leilani Stuart, Wendy Segrest, University of Texas Health Science Center, Houston, TX

12:00 928–8 Hospital Characteristics Associated with Providing Optimal Medical Therapy for Percutaneous Coronary Intervention Patients: A report from the NCDr® — William Borden, John Spertus, Alvin I. Mushlin, Matthew Roe, Lisa Kaltenbach, Rita Redberg, Weill Cornell Medical College, New York, NY

SPECIAl

SPECIAl

406

Young Investigators Award Competition: Physiology, Pharmacology and PathologySunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S105aCME/CNE Hours: 1.5

Chair: Sanjay Rajagopalan, Columbus, OH

Judges: Daniel A. Duprez, Minneapolis, MN Arshed A. Quyyumi, Atlanta, GA

10:45 406–4 Platelet Inhibitory Effect of Clopidogrel in Patients Treated with Omeprazole, Pantoprazole or Famotidine: A Prospective randomized Crossover Study — Yaron Arbel, tasmc cardiology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

11:00 406–5 Mitral leaflet Changes following Myocardial Infarction: Evidence for Maladaptive remodeling Favoring Ischemic Mitral regurgitation — Jonathan Beaudoin, Jacob Dal-Bianco, Elena Aikawa, Joyce Bischoff, Luis Guerrero, Suzanne Sullivan, Jill Wylie-Sears, Jacob Aaron, Robert A. Levine, Massachusetts General Hospital, Boston, MA, Harvard Medical School, Boston, MA

11:15 406–6 right to left Shunting through Patent Foramen Ovale during Simulated Episodes of Obstructive Sleep Apnea — Tomas Konecny, Amber D. Khann, Jan Novak, Abdi A. Jama, Jan Bukartyk, Marek Orban, Tomas Kara, Barry A. Borlaug, Virend K. Somers, Guy Reeder, Mayo Clinic, Rochester, MN

11:30 406–7 QT-rr Hysteresis is Caused by Differential Autonomic States during Exercise and recovery — Daniel J. Pelchovitz, Jason Ng, Alexandru B. Chicos, Daniel W. Bergner, Jeffrey J. Goldberger, Northwestern University Feinberg School of Medicine, Chicago, IL

11:45 406–8 Traumatic lower Extremity Amputations Cause Disturbed Blood Flow in The Infrarenal Aorta leading to Abdominal Aortic Aneurisms — Alexander V. Smolensky, Stephanie Clement-Guinaudeau, John N. Oshinski, William R. Taylor, Emory University School of Medicine, Atlanta, GA

TEST

OrAl

929

Diagnostic Testing; ECG and Cardiopulmonary Exercise TestingSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S503CME/CNE Hours: 1.5

Co-Chairs: Paul Kligfield, New York, NY John Wells Askew, Rochester, MN

10:45 929–3 The Year in review — Diagnostic Testing — Michael S. Lauer, Bethesda, MD

11:00 929–4 Determinants of VE/VCO2 Slope in Normal Individuals: Ventilatory Efficiency Is Modifiable with Endurance Training — Ryan M. Murphy, Rory B. Weiner, Stacyann S. Hough, Paul P. Pappagianopoulos, David M. Systrom, Adolph M. Hutter, Aaron L. Baggish, Gregory D. Lewis, Massachusetts General Hospital, Boston, MA

11:15 929–5 Heart rate versus rr Interval recovery after Exercise: Which Is More Physiologic? — Jeffrey J. Goldberger, Haris Subacius, Jason Ng, Northwestern University, Chicago, IL

11:30 929–6 Validation of a Cardiopulmonary Exercise Test Score in Heart Failure — Jonathan N. Myers, Ricardo Oliveira, Marco Guazzi, Paul Chase, Daniel Bensimhon, Euan Ashley, Daniel Forman, Mary Ann Peberdy, Erin West, Ross Arena, VA Palo Alto Health Care System, Palo Alto, CA

11:45 929–7 Cardiorespiratory Fitness and Short-term Outcomes with Coronary Artery Bypass Graft Surgery — James L. Smith, Thomas A. Verrill, Judy A. Boura, Marc P. Sakwa, Francis L. Shannon, Barry Franklin, William Beaumont Hospital, Royal Oak, MI

12:00 929–8 Impact of Utilizing a Women-based Formula for the Calculation of Chronotropic response during Exercise Treadmill Testing in Women: long-term Outcome — Sahar S. Abdelmoneim, Sharon Mulvagh, Laurie Barr, Quinn Pack, Martha Gulati, Thomas Allison, Mayo Clinic, Rochester, MN, The Ohio State University, Columbus, OH



Morning

VAlV

OrAl

930

Valvular OralSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place North, N427CME/CNE Hours: 1.5

Co-Chairs: Arsene J. Basmadjian, Montreal, Canada Vuyisile Nkomo, Rochester, MN

10:45 930–3 ACCESS EUrOPE: A Post-market Study of the MitraClip System for the Treatment of Significant Mitral regurgitation (Mr) in Europe: Analysis of Outcomes at 6-months — Francesco Maisano, Olaf Franzen, Stephan Baldus, Joerg Hausleiter, Christian Butter, Ulrich Schafer, Giovanni Pedrazzini, Gian Paolo Ussia, Horst Sievert, Lars Soendergaard, Wolfgang Schillinger, on behalf of the ACCESS EUROPE Investigators, San Rafaelle Hospital, Milano, Italy

11:00 930–4 The relationship between the Magnitude of reduction in Mitral regurgitation Severity and left Ventricular and left Atrial Volumes Post-Treatment with the MitraClip Device — Paul Grayburn, Chithra Sangli, Joseph Massaro, Laura Mauri, Neil Weissman, Donald Glower, Ted Feldman, Elyse Foster, on behalf of the EVEREST II Investigators, Baylor Univ Medical Center, Dallas, TX

11:15 930–5 long-term Impact of repeat Percutaneous Mitral Commissurotomy on the Need for Surgery in Mitral Stenosis: Insights from a Series of 912 Patients with a 20-year Follow-up — Claire Bouleti, Bernard Iung, Dominique Himbert, David Messika-Zeitoun, Eric Brochet, eric garbarz, Alex Vahanian, Bichat Hospital, Paris, France

11:30 930–6 Mitral regurgitation of Degenerative as Opposed to Functional Origin Negatively Impacts Outcomes of MitraClip Therapy: Single-Center Experience with 255 Consecutive Patients — Volker Rudolph, Edith Lubos, Daniel Lubs, Malgorzata Knap, Michael Schlüter, Stefan Blankenberg, Stefan Blankenberg, Stephan Baldus, University Heart Center Hamburg, Hamburg, Germany

11:45 930–7 risk Factors for Progression of Mitral Annulus Calcification: The Multi-ethnic Study of Atherosclerosis — Sammy Elmariah, Matthew Budoff, Joseph AC Delaney, Khurram Nasir, Yasmin Hamirani, Richard Kronmal, Valentin Fuster, Jonathan Halperin, Kevin O’Brien, Massachusetts General Hospital, Boston, MA

12:00 930–8 Prevalence of Significant Tricuspid regurgitation and Its Clinical Significance in Patients with Successful Percutaneous Mitral Valvuloplasty for Mitral Stenosis: results from 12-year Follow-up of One Center Prospective registry — Seung-Pyo Lee, Hyung-Kwan Kim, Kyung-Hee Kim, Ji-Hyun Kim, Hyo Eun Park, Yong-Jin Kim, Dae Won Sohn, Seoul National University Hospital, Seoul, South Korea

VASC

OrAl

932

New Insights in Perpheral Vascular Disease and Year in reviewSunday, March 25, 2012, 10:45 a.m. – 12:15 p.m.McCormick Place South, S504aCME/CNE Hours: 1.5

Co-Chairs: Joshua A. Beckman, Boston, MA Soo Hyun Kim, Avon, OH

10:45 932–3 The Year in review — Vascular — Michael R. Jaff, Boston, MA

11:00 932–4 Two Methods of Calculating Ankle Brachial Index: Differences in Predicting Peripheral Arterial Disease Burden — Bassem M. Chehab, Vinodh Jeevanantham, Sravanthi Nagavalli, Edgar Austria, Rakesh Shrivastava, Mark Wiley, Peter Tadros, Jayant Nath, Buddhadeb Dawn, Kamal Gupta, University of Kansas Medical Center, Kansas City, KS

11:15 932–5 Is There a Smoking Gun? The Impact of Tobacco Use on Peripheral Vascular Intervention Indications and Outcomes: Observations from Blue Cross Blue Shield of Michigan Cardiovascular Consortium — Shea Elizabeth Hogan, Khan Munir, Hitinder Gurm, Jeffrey Rubin, M. Ashraf Mansour, P. Michael Grossman, University of Michigan, Ann Arbor, MI, Harper University Hospital, Detroit, MI

11:30 932–6 Vulnerable Plaque in Atherosclerosis Is Characterized by Microvasculature Involving the Vessels Derived from “Vasa Vasorum Interna” — Mie Kurata, Ehime University Graduate School of Medicine, Toon city, Ehime, Japan

11:45 932–7 National Institute of Health Stroke Scale (NIHSS) Should be the Outcome Measure of Choice When Utilizing the Care registry — John H. Lee, kevin kennedy, Christopher White, Ochsner Heart and Vascular Institute, New Orleans, LA

noon SeSSionS

ACC-i2/TCT

SYMPOSIUM

646

Interventional Cardiovascular Medicine in 2012: An Update for the Non-Interventionalist and the Douglas P. Zipes, MD, Distinguished Young Scientist Awardee lectureSunday, March 25, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N228CME/CNE Hours: 1.5

Co-Chairs: Gregg W. Stone, New York, NY E. Murat Tuzcu, Cleveland, OH

12:15 Introduction to the Douglas P. Zipes, MD, Distinguished Young Scientist Awardee lecture — Douglas P. Zipes, Indianapolis, IN

12:20 Douglas P. Zipes, MD, Distinguished Young Scientist lecture: Incidence, Mechanisms, Predictors and Clinical Significance of Periprocedural Myocardial Infarction Due to Percutaneous Coronary Intervention — Duk-Woo Park, Seoul, Republic of Korea,

12:40 Discussion

12:45 Coronary Artery Disease Intervention in the Patient with Stable Angina — George D. Dangas, New York, NY

noon


156 GO for ACC.12!

NooN

12:57 ACS, Optimal Adjunct Pharmacology — Dean J. Kereiakes, Cincinnati, OH

1:09 Imaging and Physiology — Gary S. Mintz, Washington, DC

1:21 Endovascular Intervention — Michael R. Jaff, Boston, MA

1:33 Adult Structural and Valvular Intervention — Alan Zajarias, Saint Louis, MO

ACC-i2/TCT

SPECIAl

2101

Cardiac Care Team Session I: Keynote AddressSunday, March 25, 2012, 12:30 p.m. – 1:00 p.m.McCormick Place South, S103bCME/CNE Hours: 1

Chair: Janet Fredal Wyman, Detroit, MI

12:30 Keynote Address: Team-based Care — David R. Holmes, Jr., Rochester, MN

12:50 Discussion

ACC-i2/TCT

ExPErTS

2308

Aortic Valve Case reviewsSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S101aCME/CNE Hours: 1.5

Co-Chairs: John G. Webb, Vancouver, Canada Allan Schwartz, New York, NY

Case Itsik Ben-Dor, Washington, DC, Sammy Elmariah,Presenters: Boston, MA, Amar Krishnaswamy, Cleveland, OH,

Atman P. Shah, Chicago, IL

Panelists: Vasilis Babaliaros, Atlanta, GA, Raoul Bonan, Montreal, Canada, Raj R. Makkar, Los Angeles, CA

ACC-i2/TCT

ExPErTS

2309

Coronary Complications Case reviewsSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S102bCME/CNE Hours: 1.5

Co-Chairs: Paul S. Teirstein, La Jolla, CA Jeffrey J. Popma, Newton, MA

Case Hajime Iwama, Nara, Japan, Gautam Kumar, Atlanta, Presenters: GA, Sunil Naik, Southfield, MI, Sowmya Sreekanth,

New York, NY, Sergio Gustavo Tarbine, Curitiba, Brazil

Panelists: David Alan Cox, Allentown, PA, Stephen G. Ellis, Cleveland, OH,James Bernard Hermiller, Indianapolis, IN

ACC-i2/TCT

ExPErTS

2310

Multivessel and Hemodynamic Support Case reviewsSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S102cCME/CNE Hours: 1.5

Co-Chairs: Igor F. Palacios, Boston, MA Zoltan G. Turi, Camden, NJ

Case David Bartov, Mineola, NY, Carlos Deluca, Buenos Presenters: Aires, Argentina, Sammy Elmariah, Boston, MA,

Saurabh Kumar Gupta, New Delhi, India, Suresh Vijaybasappa Patted, Belgaum, India

Panelists: John Hirschfeld, Philadelphia, PA, Nicola Corjava, Stamford, CT, Charles J. Davidson, Chicago, IL

ACC-i2/TCT

SYMPOSIUM

2616

Endovascular Intervention for Venous DiseaseSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S103cCME/CNE Hours: 1.5

Co-Chairs: John Rundback, Teaneck, NJ Kenneth Rosenfield, Boston, MA

12:30 Patient Selection and Indications for Endovascular Intervention in Acute DVT — Kenneth Rosenfield, Boston, MA

12:43 Debate: Provisional Stenting is the Treatment of Choice for Acute DVT — Stephan Wicky, Boston, MA

12:55 Debate: Primary Stenting is the Treatment of Choice for Acute DVT — Mohsen Sharifi, Mesa, AZ

1:07 IVC Filter Placement and retrieval: Indication, Types and Technique — Tino Pena, Miami, FL

1:20 Endoluminal Ablative Therapy of Saphenous Venous System — Step-by-Step — laser or rF, or Does it Matter — Raghu Kolluri, Springfield, IL

1:33 Case Presentation: Endovascular Intervention to Treat Acute Venous Thromboembolism — Robert Schainfeld, Waltham, MA

ACC-i2/TCT

SYMPOSIUM

2617

Platelet Inhibition in 2012: What You Need To KnowSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S106bCME/CNE Hours: 1.5

Co-Chairs: C. Michael Gibson, Boston, MA Neal S. Kleiman, Houston, TX

12:30 Debate: Genotyping and Point of Care Platelet Function Testing Are ready for Prime Time — Dominick J. Angiolillo, Jacksonville, FL

12:40 Debate: Genotyping and Point of Care Platelet Function Testing Are Not Yet Clinically Useful — Marc Steven Sabatine, Boston, MA

12:50 Optimizing DAPT — Matthew J. Price, La Jolla, CA

1:00 DAPT: Issues regarding Duration, Safe Interruption and Discontinuation — Laura Mauri, Boston, MA

1:10 Triple Therapy: DAPT plus Thrombin Inhibition — Harvey D. White, Auckland 1142, New Zealand

1:20 New Insights into Drug-Drug Interactions — Paul A. Gurbel, Baltimore, MD

1:30 Novel Strategies for Anticoagulation and Platelet Inhibition — David J. Moliterno, Lexington, KY


ACS

SYMPOSIUM

639

The Future of ACS Clinical TrialsSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S404CME/CNE Hours: 1.25

Co-Chairs: Paul Wayne Armstrong, Edmonton, Canada Robert A. Harrington, Durham, NC

12:30 Clinical Trial Endpoints Today and Tomorrow — Sunil V. Rao, Durham, NC



NooN

12:42 Clinical Trials in the Age of Comparative Effectiveness — Sanjay Kaul, Los Angeles, CA

12:54 The Current and Future State of Clinical Trial Funding: The role of Industry and Non-Industry Sources — Robert A. Harrington, Durham, NC

1:07 Clinical Trials in the Trenches: Is it Worth Being a Site in a Trial Any More? US Perspective — Giora Weisz, New York, NY

1:20 Clinical Trials in the Trenches: OUS Perspective — Lars Wallentin, Uppsala, Sweden

1:32 Summary — Paul Wayne Armstrong, Edmonton, Canada

Arr

SYMPOSIUM

640

Joint Symposium of the Heart rhythm Society and the American College of Cardiology: Investigation and Management of SyncopeSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place North, N426CME/CNE Hours: 1.25

Co-Chairs: Julia H. Indik, Tucson, AZ Robert S. Sheldon, Calgary, Canada

12:30 risk Stratification of the Patient who Presents with Syncope — David G. Benditt, Minneapolis, MN

12:45 The role of Tilt Table Testing and Ilrs — Andrew D. Krahn, London, Canada

1:00 Management of Neuromediated Syncope — Carlos A. Morillo, Hamilton, Canada

1:15 Treatment of Postural Tachycardia Syndrome (POTS) — Satish Raj, Nashville, TN


CCS

SPECIAl

301

Career & Mentoring Session for Pediatric and Congenital CardiologistsSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place North, N231CME/CNE Hours: 1.25

Chair: Jeffrey A. Towbin, Cincinnati, OH

Panelists: Charles Berul, Washington, DC, Mark B. Lewin, Seattle, WA, Lloyd Y. Tani, Salt Lake City, UT

12:30 Welcome and Introduction — Jeffrey A. Towbin, Cincinnati, OH

12:35 How Do You Choose a Fourth Year Fellowship? — Mark B. Lewin, Seattle, WA

12:45 How I Found the right Mentor — John L. Jefferies, Cincinnati, OH

12:55 Financing and Health Care reform — James W. Fasules, Washington, DC

1:05 How Do I Interview for a Job? — Girish S. Shirali, Charleston, SC

1:15 Panel Discussion: Choosing a Job and lasting in It


HF

ExPErTS

228

Cardiac Mr for the Evaluation of the Heart Failure PatientSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S502CME/CNE Hours: 1.25

Chair: Subha V. Raman, Columbus, OH

Case Presenter: Erik Schelbert, Pittsburgh, PA

Panelists: Sanjeev A. Francis, Boston, MA, Mario J. Garcia, Bronx, NY, Matthias Friedrich, Calgary, Canada

HF

SYMPOSIUM

641

Joint Symposium of the Heart Failure Society of America and the American College of Cardiology: Contemporary Issues in the Diagnosis and Treatment of Chronic Ambulatory Heart FailureSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S406bCME/CNE Hours: 1.25

Co-Chairs: David DeNofrio, Boston, MA G. Michael Felker, Durham, NC

12:30 Imaging the Heart Failure Patient: Which Patients and What Modality: Echo — Scott D. Solomon, Boston, MA

12:45 Imaging the Heart Failure Patient: Which Patients and What Modality: Nuclear — James E. Udelson, Boston, MA

1:00 Imaging the Heart Failure Patient: Which Patients and What Modality: Mr — Joao A. C. Lima, Baltimore, MD

1:15 The Evolving role of Biomarkers in the Management of Heart Failure Patients — James L. Januzzi, Jr., Boston, MA

1:30 Exercise and the Heart Failure Patient: Why, Who and How? — Ileana L. Pina, Cleveland Heights, OH

HF

SYMPOSIUM

642

Cardiotoxicity of Cancer Chemotherapy: Molecular Basis and Strategies for Early Detection and PreventionSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S405CME/CNE/CPE Hours: 1.25 ACPE No. 0012-9999-12-137-l01-P

Co-Chairs: Anceta Fadol, Houston, TX Edward T. Yeh, Houston, TX

12:30 Cardiotoxicity of Cancer Chemotherapeutic Agents: The Extent and Magnitude of Problem and Clinical Evidence — Daniel J. Lenihan, Nashville, TN

12:45 Cellular Basis of Myocardial Injury and left Ventricular Dysfunction with Cancer Chemotherapy — Raymond R. Russell, New Haven, CT

1:00 Monitoring of left Ventricular Function during Chemotherapy — Davinder Jassal, Winnipeg, Canada

1:15 Biomarkers for Cardiotoxicity — Bonnie Ky, Philadelphia, PA

1:30 Novel Methods to Prevent and Image Cardiotoxicity — Ban-An Khaw, Boston, MA


158 GO for ACC.12!

NooN

IMAG

SYMPOSIUM

643

Joint Symposium of the American Society of Echocardiography and the American College of Cardiology: Interventional Echocardiography — Evolving role in Patient ManagementSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S406aCME/CNE Hours: 1.25

Co-Chairs: Issam A. Mikati, Chicago, IL Patricia A. Pellikka, Rochester, MN

12:30 Echo in the EP lab (lAA Closure Devices) — Frank E. Silvestry, Wayne, PA

12:46 Echo in the Cath lab (Mr, TAVI, Perivalvular regurgitation Closure) — Rebecca T. Hahn, New York, NY

1:02 Echo in Assessment of Heart Failure Devices — Jerry Estep, Houston, TX

1:18 Echo in the Interventional ACHD lab (ASD, VSD) — Frank E. Silvestry, Wayne, PA


IMAG

SYMPOSIUM

644

Cost-Effective Imaging in Patients with Chronic CADSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S403CME/CNE Hours: 1.25

Co-Chairs: Kirsten E. Fleischmann, San Francisco, CA R. Parker Ward, Chicago, IL

12:30 What Is Cost-Effective Imaging? — Rita F. Redberg, San Francisco, CA

12:45 role of CMr — Christopher M. Kramer, Charlottesville, VA

1:00 role of Nuclear Imaging — Rory Hachamovitch, Cleveland, OH

1:15 role of CT — Matthew J. Budoff, Torrance, CA

1:30 role of Echo — Pamela S. Douglas, Durham, NC

ISCHEM

SYMPOSIUM

645

Managing High-risk Patients with Stable Ischemic Heart DiseaseSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S401aCME/CNE/CPE Hours: 1.25 ACPE No. 0012-9999-12-138-l04-P

Co-Chairs: Bernard J. Gersh, Rochester, MN Rhondalyn McLean, Baltimore, MD

12:30 Diabetic Patients: replacing Fallacies with Facts — Darren K. McGuire, Dallas, TX


12:48 Chronic Kidney Disease: What Should I Do for These Patients? — Amy W. Williams, Rochester, MN


1:07 Elderly Patients: Treatment Pearls and Pitfalls — Karen P. Alexander, Durham, NC


1:26 Minorities: How Does race/Ethnicity Affect Our Approach? — Keith C. Ferdinand, Atlanta, GA


lIFElONG

MOC

811

ACCF Study Session for Maintenance of Certification: ABIM recertification Made Easy — ACC General Cardiology Module Part ASunday, March 25, 2012, 12:30 p.m. – 3:00 p.m.McCormick Place South, S105aCME Hours: 2.5






Chair: Jeffrey J. Cavendish, San Diego, CA

MOC Faculty: Maya E. Guglin, Tampa, FL, John A. McPherson, Nashville, TN

lIFElONG

MOC

812

ACCF Study Session for Maintenance of Certification: ABIM recertification Made Easy — ACC General Cardiology Module Part BSunday, March 25, 2012, 12:30 p.m. – 3:00 p.m.McCormick Place South, S105dCME Hours: 2.5



For convenience, there will be computer terminals in the ACC MOC Center onsite in Room S104b for attendees to take the ABIM MOC test after the study



NooN

session concludes, if desired. Electrical power is provided in the classrooms so that attendees who wish to bring their own devices may ‘power up’ to access relevant question modules.



Chair: Kyle W. Klarich, Rochester, MN

MOC Faculty: Douglas E. Drachman, Boston, MA, Jeffrey T. Kuvin, Boston, MA

PErI

ExPErTS

229

Grasping the Complexity of Myocardial and Pericardial DiseasesSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S505CME/CNE Hours: 1.25

Chair: Jae K. Oh, Rochester, MN

Case Alex J. Auseon, Columbus, OH, Scott Silvestry, Presenters: Philadephia, PA, Mauricio Velez, Detroit, MI

Panelists: William Little, Winston Salem, NC, Sunil V. Mankad, Rochester, MN

PErI

SYMPOSIUM

648

The New Hypertrophic Cardiomyopathy Practice GuidelinesSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place North, N226CME/CNE Hours: 1.25

Co-Chairs: Harry M. Lever, Solon, OH Steve R. Ommen, Rochester, MN

12:30 Genetic Testing: The Basics and What You and Your Patient Need to Know — Michael J. Ackerman, Rochester, MN

12:42 Echocardiography: 2-D, Doppler and Strain Imaging — Milind Y. Desai, Cleveland, OH

12:55 Cardiac MrI: Diagnosis and risk Stratification — Martin S. Maron, Boston, MA

1:07 The Importance of Myocardial Ischemia — Perry M. Elliott, London, United Kingdom

1:20 risk Stratification: Who Gets an ICD? — Matthew W. Martinez, Allentown, PA

1:32 Septal reduction Therapy: Surgery or Ablation? — Paul Sorajja, Rochester, MN

PHTN

SYMPOSIUM

649

Emerging Approaches to Pulmonary Hypertension with left Ventricular DysfunctionSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S402CME/CNE Hours: 1.25

Co-Chairs: Teresa De Marco, San Francisco, CA Michael A. Mathier, Pittsburgh, PA

12:30 Prevalence and Significance of Pulomary Hypertension in left Ventricular Dysfunction — Selma Mohammed, Rochester, MN

12:45 Approach to the Dyspneic Patient with Echocardiographic Evidence of Pulmonary Hypertension: PAH, HFpEF or Both? — Paul Forfia, Philadelphia, PA

1:00 Characterization of PH in lVD: Beyond resting Hemodynamic Measurements — Gregory D. Lewis, Boston, MA

1:15 lessons learned from Continuous Pulmonary Arterial Pressure Measurements in Heart Failure Patients: Emerging roles for Implantable Monitoring Devices — Robert C. Bourge, Birmingham, AL

1:30 Targeted Therapy for Pulmonary Hypertension in left Ventricular Dysfunction — Marc J. Semigran, Boston, MA

PrACTICE

SYMPOSIUM

647

Joint Session of the Healthcare Information and Management Systems Society and the American College of Cardiology: Health Information Technology Part I: Making the Electronic Health record Meaningful and Useful — A Washington PerspectiveSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place North, N227bCME/CNE Hours: 1.25

Chair: John R. Windle, Omaha, NE

Panelists: Alfred A. Bove, Philadelphia, PA, Michael J. Mirro, Fort Wayne, IN, James E. Tcheng, Durham, NC

12:30 Introduction to Keynote Speaker — Jack Lewin, Washington, DC

12:35 A View from the Top: Meaningful Use Present and Future — Farzad Mostashari, Washington, DC


PrEV

ExPErTS

230

Management of Hypertension in the ElderlySunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place South, S501aCME/CNE/CPE Hours: 1.25 ACPE No. 0012-9999-12-128-l01-P

Chair: George L. Bakris, Chicago, IL

Case Presenter: Michael Chen, Seattle, WA

Panelists: Stanley S. Franklin, Irvine, CA, Carey D. Kimmelstiel, Boston, MA, Marvin Moser, Scarsdale, NY

SPECIAl

SPECIAl

111

FIT Forum III: How to Write and Evaluate Medical Journal ArticlesSunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place North, N229CME/CNE Hours: 1.25

Chair: Anthony N. DeMaria, San Diego, CA

12:30 How to Write Publishable Papers (with Examples of Do’s and Don’ts) — Anthony N. DeMaria, San Diego, CA



160 GO for ACC.12!

NooN

12:55 How to revise Your Manuscript — Jagat Narula, New York, NY


1:20 Evaluating a research Paper: What Constitutes a Good review — Spencer B. King, Atlanta, GA


TEST

SYMPOSIUM

651

role of Exercise Treadmill Testing in 2012Sunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place North, N230CME/CNE Hours: 1.25

Co-Chairs: Brian G. Abbott, East Greenwich, RI Gerald F. Fletcher, Jacksonville, FL

12:30 Standard Treadmill Assessment: What’s the role for a low-Tech Test in a High-Tech World? — Todd D. Miller, Rochester, MN

12:42 risk Stratification: looking Beyond the ECG during Stress Testing — Michael S. Lauer, Bethesda, MD

12:54 Pearls and Pitfalls in Exercise Testing — Daniel E. Forman, Boston, MA

1:06 Approach to Stress Testing in Patients with Pacemakers, Defibrillators and resynchronization Devices — Derek V. Exner, Calgary, Canada

1:18 Cardiopulmonary Exercise Testing: Indications and Utility — Ross Arena, Albuquerque, NM


VAlV

SYMPOSIUM

652

Controversies in Valve Disease ISunday, March 25, 2012, 12:30 p.m. – 1:45 p.m.McCormick Place North, N427CME/CNE Hours: 1.25

Co-Chairs: Blase A. Carabello, Houston, TX William A. Zoghbi, Houston, TX

12:30 TAVI Should Be reserved for Inoperable Patients — Thoralf Sundt, Boston, MA

12:43 TAVI Should Not Be reserved for Inoperable Patients — Martin B. Leon, New York, NY

1:02 Summary

1:08 Mitral E-Clip Is a reasonable Option for Functional Mr — Saibal Kar, Los Angeles, CA

1:21 Mitral E-Clip Is Not a reasonable Option for Functional Mr — Robert Dion, Belgium

1:40 Summary

Afternoon SeSSionS

ACC-i2/TCT

SPECIAl

2102

Cardiac Care Team Session II: Cath lab of Tomorrow — Pathway to a High-risk Aortic Valve ProgramSunday, March 25, 2012, 1:00 p.m. – 2:30 p.m.McCormick Place South, S103bCME/CNE Hours: 1

Co-Chairs: Marian Hawkey, New York, NY Janet Fredal Wyman, Detroit, MI

1:00 Setting up an Aortic Valve Program — Sandra Lauck, Vancouver, Canada

1:12 Who is the Severe Aortic Stenosis Patient? — Marian Hawkey, New York, NY

1:24 Gathering the Data/Coordinating the Assessment Process — Jasminka Stegic, Los Angeles, CA

1:36 Psychosocial Issues with High risk Aortic Stenosis — Martina Speight, Stanford, CA

1:48 Inter-professional Decision-making: Playing in the Same Sandbox — Todd M. Dewey, Dallas, TX

2:00 Preparing Your Cath lab for an Aortic Valve Program — Michael Guiry, New York, NY

2:12 Anticipating Post-procedure Needs Pre-procedure — Susan Schnell, New York, NY


ACC-i2/TCT

SPECIAl

2131

Anatomy and Transcatheter Therapy for the Structural Heart Interventionalist I: Mitral and Aortic Valve (with remote Demonstrations from the Seattle Science Foundation)Sunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S102cCME/CNE Hours: 1.5

Remote Mark Reisman, Seattle, WADemonstrator:

Co-Chairs: Nicolo Piazza, Montreal, Canada Ted Feldman, Evanston, IL

Panelists: Saibal Kar, Los Angeles, CA, Frank E. Silvestry, Wayne, PA

2:00 Mitral Valve Anatomy — Mark Reisman, Seattle, WA

2:15 Mitral Valve Case Presentation — Speaker TBD

2:20 Case Presentation: Mitral Annuloplasty — Steven L. Goldberg, Seattle, WA

2:25 Mitral Valve Devices — Mark Reisman, Seattle, WA

2:40 Aortic Valve Anatomy — Mark Reisman, Seattle, WA

2:55 Case Presentation: Transfemoral of Balloon Expandable TAVr — Susheel Kodali, New York, NY

3:00 Case Presentation: Transapical of Balloon Expanding TAVr — Michael J. Mack, Plano, TX

3:05 Anatomical Prespectives for a Balloon Expandable Aortic Valve — Mark Reisman, Seattle, WA

3:20 Case Presentation: Transfemoral of a Self Expandable TAVr — Nicolo Piazza, Montreal, Canada

3:25 Anatomical Perspectives for a Self Expandable TAVr — Mark Reisman, Seattle, WA

Afte

rnoo

n



AFTERNOON

ACC-i2/TCT

CASE rEVIEW

2202

live and Taped Case Session II: left Main and Bifurcation- Complex PCISunday, March 25, 2012, 2:00 p.m. – 5:00 p.m.McCormick Place North, Hall B, ACC.12 Main TentCME/CNE Hours: 3

Co-Chairs: Dean J. Kereiakes, Cincinnati, OH Raj R. Makkar, Los Angeles, CA

Panelists: Alexandre Abizaid, Sao Paulo, Brazil, Manish Parikh, New York, NY, Alaide Chieffo, Milan, Italy, Matthew J. Price, La Jolla, CA, John A. Ormiston, Auckland, New Zealand, John M. Lasala, Saint Louis, MO, Seung-Jung Park, Seoul, Republic of Korea

2:00 live Case from the University of Pennsylvania, Philadelphia, PA — Howard C. Herrmann, Philadelphia, PA

3:30 Surgery versus PCI for lMCA revascularization: The Surgeon’s Perspective — David Taggart, Oxford, United Kingdom

3:40 Surgery versus PCI for lMCA revascularization: The Interventionalist’s Perspective — David E. Kandzari, Atlanta, GA


4:00 Practical Approach to Non-left Main Bifurcation Disease: Techniques and Outcomes — Corrado Tamburino, Catania, Italy

4:15 Taped Case from Baylor, Houston, Tx — Neal S. Kleiman, Houston, TX

ACC-i2/TCT

SYMPOSIUM

2618

Imaging Transcatheter Aortic Valve Procedures I: Intra- and Post-procedural ImagingSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S101aCME/CNE Hours: 1.5

Co-Chairs: William J. Stewart, Cleveland, OH Victoria Delgado, Leiden, Netherlands

2:00 Multi-modality Imaging for Intra-procedural THV Positioning: Balloon-expandable THV — Susheel Kodali, New York, NY

2:10 Multi-modality Imaging for Intra-procedural THV Positioning: Self-expanding THV — Nicolo Piazza, Montreal, Canada

2:20 Multi-modality Imaging for Intra-procedural THV Positioning: Is TEE Necessary for TAVr? — Sherif F. Nagueh, Houston, TX

2:30 Predicting and Managing TAVr Complications: Nuances in Evaluation and Management of Perivalvular leak — Stamatios Lerakis, Atlanta, GA

2:40 Predicting and Managing TAVr Complications: Hemodynamic Emergencies — the role of TEE — Rebecca T. Hahn, New York, NY

2:50 Post-procedural Imaging of Embolic Events: CT, MrI, Transcranial Doppler — TBD

3:00 Post-procedural CT Evaluation: What Have We learned? — Jonathan Leipsic, Vancouver, Canada

3:10 Panel Discussion: THV Misadventures and Their Management

ACC-i2/TCT

SYMPOSIUM

2619

Emerging TechnologiesSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S102bCME/CNE Hours: 1.5

Co-Chairs: Mathew Williams, New York, NY Alan Zajarias, Saint Louis, MO

2:00 large Bore Femoral Artery Closure — Vasilis Babaliaros, Atlanta, GA

2:10 Percutaneous Transapical TAVr/Closure Devices — Lars G. Svensson, Cleveland, OH

2:20 Embolic Protection during TAVr — John G. Webb, Vancouver, Canada

2:30 New Mitral repair and replacement Technology — Jason H. Rogers, Sacramento, CA

2:40 PFO and lAA Devices — Horst Sievert, Frankfurt, Germany

2:50 New Aortic Valves: Transfemoral — Steven R. Bailey, San Antonio, TX

3:00 New Aortic Valves: Transapical — Thomas Walther, Bad Nauheim, Germany

3:10 New Imaging Technology: Echo 4-D, ICE — Itzhak Kronzon, New York, NY

3:20 Minimally Invasive Aortic repair and replacement — Eric Roselli, Cleveland, OH

ACC-i2/TCT

SYMPOSIUM

2620

Peripheral Artery Disease: Superficial Femoral ArterySunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S103cCME/CNE Hours: 1.5

Co-Chairs: D. Christopher Metzger, Kingsport, TN Peter Angelopoulos, Garden City, NY

2:00 What is the role of Covered Stents for Iliac and Fem-Pop Stenosis/Occlusions in 2012? — Matthew T. Menard, Boston, MA

2:15 Debate: Provisional Stenting is the Treatment of Choice for 7–10 cm Fem-Pop lesions — Speaker TBD

2:30 Debate: Primary Stenting is the Treatment of Choice for 7–10 cm Fem-Pop lesions — Mehdi H. Shishehbor, Cleveland, OH

2:45 Step-by-Step Approach to long Superficial Femoral Artery Occlusion: What Are the Options? — Ivan P. Casserly, Aurora, CO

3:00 Drug Eluting Balloons: Where Do We Stand in 2012? — Herbert Aronow, Ypsilanti, MI

3:15 Case-based Presentation: How to Manage In-stent restenosis and Complications Associated with Fem-Pop Endovascular Intervention — Peter Angelopoulos, Garden City, NY


162 GO for ACC.12!

AFTE

RNOO

N

ACC-i2/TCT

SYMPOSIUM

2621

Chronic Total OcclusionsSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S106bCME/CNE Hours: 1.5

Co-Chairs: Jeffrey W. Moses, New York, NY Masahiko Ochiai, Kanagawa, Japan

2:00 Accessory Imaging (MSCT and/or IVUS) in Procedural Planning and Execution — Yuji Oikawa, Tokyo, Japan

2:15 Step-by-Step Moderately Difficult Antegrade Techniques — Alfredo R. Galassi, Aicastello, Italy

2:30 Step-by-Step retrograde Techniques — Etsuo Tsuchikane, Toyohashi, Japan

2:45 Dissection and re-entry Facilitated CTO-PCI — James Aaron Grantham, Kansas City, MO

3:00 A Multitechnique Case (the Hybrid Approach) — William L. Lombardi, Bellingham, WA

3:15 Complications and Pitfalls of CTO-PCI — TBD

ACS

ExPErTS

231

Management of Chest Pain in the Emergency DepartmentSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S504aCME/CNE Hours: 1.5

Chair: Ezra A. Amsterdam, Sacramento, CA

Case Presenter: Mario Goessl, Rochester, MN

Panelists: Kim A. Eagle, Ann Arbor, MI, Judd Hollander, Philadelphia, PA, James K. Min, New York, NY

ACS

SYMPOSIUM

653

State-of-the-Art in Non ST Elevation ACSSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S404CME/CNE Hours: 1.5

Co-Chairs: James A. De Lemos, Dallas, TX Shaun G. Goodman, Toronto, Canada

2:00 Emerging Tools for risk Assessment in NSTE ACS — Bertil Lindahl, Uppsala, Sweden

2:15 Navigating Antiplatelet and Antithrombotic Choices in the Generic Clopidogrel Era — Stefan K. James, Uppsala, Sweden

2:30 Selection and Timing for Invasive Therapy in NSTE ACS — Alexandra J. Lansky, New York, NY

2:45 Safety Cost and Quality Are the New Drivers of NSTE ACS Care — Matthew T. Roe, Durham, NC

3:00 ACS Guidelines Are Evidence-Based, User-Friendly and Practical — Alice K. Jacobs, Boston, MA

3:10 ACS Guidelines Are Not Evidence-Based, User-Friendly and Practical — James M. Brophy, Montreal, Canada

3:20 Discussion

Arr

ExPErTS

232

Joint Symposium of the Heart rhythm Society and the American College of Cardiology: Optimizing the Management of the Patient with Implantable DevicesSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S503CME/CNE Hours: 1.5

Chair: Bruce L. Wilkoff, Cleveland, OH

Panelists: Kenneth A. Ellenbogen, Richmond, VA, Derek V. Exner, Calgary, Canada, Bernard Thibault, Montreal, Canada

Arr

SYMPOSIUM

654

Joint Symposium of the Heart rhythm Society and the American College of Cardiology: Atrial Fibrillation — Prevention of StrokeSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N426CME/CNE Hours: 1.5

Co-Chairs: Richard I. Fogel, Carmel, IN Anne M. Gillis, Calgary, Canada

2:00 role of Anticoagulants — Michael M. Ezekowitz, Wynnewood, PA

2:20 risk Stratification for Stroke: CHADs2 versus CHA2DS2-VASc — A. John Camm, London, United Kingdom

2:40 risk Stratification for Bleeding Complications: HASBlED vs. ATrIA Study — Greg C. Flaker, Columbia, MO

3:00 Implementing the AF Guidelines into Clinical Practice — Eric N. Prystowsky, Indianapolis, IN


CCS

lEGENDS

402

legends of Cardiovascular Medicine lecture Series — 2012 Dan G. McNamara lectureSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N228CME/CNE Hours: 1.5

Co-Chairs: Kathy J. Jenkins, Boston, MA Roberta G. Williams, Los Angeles, CA

2:00 Welcome and Overview of Session — Kathy J. Jenkins, Boston, MA

2:05 reflecting on McNamara lecture — Daniel J. Murphy, Palo Alto, CA

2:10 Introduction of Dr. Jane Somerville — Roberta G. Williams, Los Angeles, CA

2:15 2012 Dan G. McNamara lecture: Fifty Years with Cardiac Surgeons — Jane Somerville, London, United Kingdom

2:45 Question and Answer — Carole A. Warnes, Rochester, MN

3:05 Panel Discussion: lifelong Care of the CHD Patient

Chair: Kathy J. Jenkins, Boston, MA

Panelists: Gerard R. Martin, Washington, DC, Daniel J. Murphy, Palo Alto, CA, Jane Somerville, London, United Kingdom, James S. Tweddell, Milwaukee, WI, Carole A. Warnes, Rochester, MN, Roberta G. Williams, Los Angeles, CA



AFTERNOON

HF

SYMPOSIUM

655

Joint Symposium of the Heart Failure Society of America and the American College of Cardiology: The Growing role of Devices in Heart Failure Management — ICD, CrT, Hemodynamic Monitoring and UltrafiltrationSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S406bCME/CNE Hours: 1.5

Co-Chairs: Andrew E. Epstein, Philadelphia, PA Mandeep R. Mehra, Baltimore, MD

2:00 Current Indications and Outcomes with ICD Therapy — Arthur J. Moss, Rochester, NY

2:20 Optimal Use of Cardiac resynchronization Therapy — Jagmeet Singh, Boston, MA

2:40 Current and Future role of Implantable Hemodynamic Monitoring — William T. Abraham, Columbus, OH

3:00 Advantages and Pitfalls of Ultrafiltration Therapy — Bradley Bart, Minneapolis, MN


HF

SYMPOSIUM

656

The NHlBI Heart Failure Clinical Trials Network: A New Paradigm for Investigation and TrainingSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S405CME/CNE Hours: 1.5

Co-Chairs: Eugene Braunwald, Boston, MA Alice M. Mascette, Bethesda, MD

2:00 The Changing Face of Heart Failure in the United States and Implications for Clinical Trials — Douglas L. Mann, Saint Louis, MO

2:15 The Structure and Mission of the NHlBI Network — Alice M. Mascette, Bethesda, MD

2:30 Study Design and Outcome Analysis in Clinical Heart Failure Trials: Selecting Meaningful Endpoints — Kerry Lee, Durham, NC

2:45 Clinical Implications of Competed Network Clinical Trials (DOSE-HF, rElAx, CArESS) — Margaret M. Redfield, Rochester, MN

3:00 Ongoing and Planned Network Clinical Trials: Focus on Innovative Therapies — Elizabeth Ofili, Atlanta, GA

3:15 Ancillary Studies and Biomarkers in Network Trials — Robb D. Kociol, Durham, NC

IMAG

ExPErTS

233

role of CMr in Valvular Heart DiseaseSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S505CME/CNE Hours: 1.5

Chair: Raymond J. Kim, Durham, NC

Case Tandeep K. Bhatti, New York, NY, Lubna Choudhury, Presenters: Chicago, IL

Panelists: Mario J. Garcia, Bronx, NY, Seth Uretsky, New York, NY

IMAG

SYMPOSIUM

657

Joint Symposium of the American Society of Echocardiography and the American College of Cardiology: Healthcare reform — Impact on ImagingSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S406aCME/CNE Hours: 1.5

Chair: Thomas John Ryan, Columbus, OH

2:00 Impact of HCr on Imaging: Current Status — Benjamin F. Byrd, III, Nashville, TN

2:15 What to Expect and What to do About It — Michael H. Picard, Boston, MA

2:30 Appropriate Use Criteria, Quality and the Available Evidence — Neil J. Weissman, Washington, DC

2:45 HCr: Impact on Technology — Patricia A. Pellikka, Rochester, MN


IMAG

SYMPOSIUM

658

radionuclide Imaging in the Heart Failure PatientSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S403CME/CNE Hours: 1.5

Co-Chairs: James E. Udelson, Boston, MA Kim Allan Williams, Detroit, MI

2:00 Myocardial Perfusion Imaging in the Heart Failure Patient — Gary V. Heller, Hartford, CT

2:18 Assessment of lV Function in the Heart Failure Patient — E. Gordon DePuey, III, New York, NY

2:36 Selecting Patients for Coronary revascularization: Should We Assess Viability? — Robert O. Bonow, Chicago, IL

2:54 Guiding Device Therapy in Heart Failure — Mark I. Travin, Pleasantville, NY

3:12 Molecular Imaging in the Heart Failure Patient — Vasken Dilsizian, Baltimore, MD

ISCHEM

ExPErTS

234

Heart Failure in Stable Ischemic Heart Disease: Not for the Weak of HeartSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S502CME/CNE Hours: 1.5

Chair: Brooks Edwards, Rochester, MN

Case Mustafa Ahmed, Jacksonville, FL, Erin Bohula, Presenters: Boston, MA, J. Jacob Mancuso, San Antonio, TX

Panelists: Juan M. Aranda, Gainesville, FL, Akshay S. Desai, Boston, MA, James C. Fang, Cleveland, OH, Daniel P. Judge, Baltimore, MD

lIFElONG

SYMPOSIUM

659

Master Clinician I: Discussion of Three Complex real World CasesSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S401aCME/CNE Hours: 1.5

Co-Chairs: James B. McClurken, Philadelphia, PA Marc E. Shelton, Springfield, IL


164 GO for ACC.12!

AFTE

RNOO

N

Panelists: R. Michael Benitez, Baltimore, MD, Allan S. Jaffe, Rochester, MN, Joseph V. Messer, Chicago, IL, Shahbudin H. Rahimtoola, Los Angeles, CA, Stephen D. Wiviott, Boston, MA

2:00 Case Presentation: MI or Not? — Allan S. Jaffe, Rochester, MN


2:30 Case Presentation: Complex Mr — James B. McClurken, Philadelphia, PA


3:00 Case Presentation: Apical Ballooning? — Marc E. Shelton, Springfield, IL


lIFElONG

COrE

813

Core Curriculum: General CardiologySunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N226CME/CNE Hours: 1.5

Chair: Bindi K. Shah, Philadephia, PA

2:00 Pre-Operative Cardiac risk Stratification — Joshua A. Beckman, Boston, MA

2:25 Basic Concepts of Stress Testing: When, Which Test and What Do the results Tell You — Karthikeyan Ananthasubramaniam, West Bloomfield, MI

2:50 Interventional Cardiology for the Non-Interventionalist — Sunil V. Rao, Durham, NC


lIFElONG

COrE

814

Core Curriculum: Valvular Heart DiseaseSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N229CME/CNE Hours: 1.5


2:00 Aortic Stenosis/ Aortic Insufficiency — Maurice Enriquez-Sarano, Rochester, MN

2:25 Mitral Stenosis/Mitral regurgitation — Stephen H. Little, Houston, TX

2:50 Selection and Management Issues of the Prosthetic Valve — Salvatore Costa, Lebanon, NH


PErI

SYMPOSIUM

661

Controversies in Hypertrophic CardiomyopathySunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N427CME/CNE Hours: 1.5


2:00 HCM Is Predominantly a Disease of lVOT Obstruction — Martin S. Maron, Boston, MA

2:15 The Devil Is in Diastole in HCM — William McKenna, London, United Kingdom

2:30 Medical Therapy for Difficult Symptoms — Mark V. Sherrid, Mamaroneck, NY

2:45 The Case for Surgical Myectomy — Joseph A. Dearani, Rochester, MN

3:00 The role of Alcohol Septal Ablation — Paul Sorajja, Rochester, MN

3:15 The Utility of the ICD — Bernard J. Gersh, Rochester, MN

PHTN

SYMPOSIUM

662

Pulomary Hypertension Management in Special PopulationsSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S402CME/CNE Hours: 1.5

Co-Chairs: Hamang M. Patel, New Orleans, LA Frances A. Rogers, Philadelphia, PA

2:00 Pulmonary Hypertension in Congenital Heart Disease — Michael Landzberg, Boston, MA

2:20 Chronic Thromboembolic Pulmonary Hypertension — William R. Auger, San Diego, CA

2:40 Pulmonary Hypertension in Pregnancy — Dianne Lynn Zwicke, Milwaukee, WI

3:00 Pulmonary Hypertension in Connective Tissue Disease — Hunter Clay Champion, Pittsburg, PA


PrACTICE

SYMPOSIUM

660

Joint Session of the Healthcare Information and Management Systems Society and the American College of Cardiology: Health Information Technology Part II: EHr Implementation… lessons from the TrenchesSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N227bCME/CNE Hours: 1.5

Chair: James E. Tcheng, Durham, NC

Panelists: Jay H. Alexander, Deerfield, IL, Lee R. Goldberg, Philadelphia, PA, R. Jeffrey Westcott, Seattle, WA

2:00 Cardiology Private Practice EHr lessons — Jay H. Alexander, Deerfield, IL

2:20 large Hospital System Implementation — Lee R. Goldberg, Philadelphia, PA

2:40 Epic and Centricity EHrs — R. Jeffrey Westcott, Seattle, WA


PrEV

ExPErTS

235

Dietary Approaches for CVD Prevention: Matching the Diet to the PatientSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S501aCME/CNE Hours: 1.5

Chair: Michael J. Wong, Los Angeles, CA

Case Erin Michos, Baltimore, MD, Malissa Jane Wood, Presenters: Boston, MA

Panelists: Catherine Christie, Jacksonville, FL, Amy Locke, Ann Arbor, MI, Elif Oral, Ann Arbor, MI, Neil Stone, Winnetka, IL



AFTERNOON

PrEV

SYMPOSIUM

663

resistant HypertensionSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S100cCME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-139-l04-P

Co-Chairs: Thomas D. Giles, Metairie, LA William B. White, Farmington, CT

2:00 How to Detect Pseudo resistance and White Coat Hypertension — William B. White, Farmington, CT

2:15 Detection and Management of Hyperaldosteronism — Wanpen Vongpatanasin, Dallas, TX

2:30 When and How to Assess for renovascular Disease — Stephen Textor, MN

2:45 role of New vs Old Anti-hypertensive Drug Classes — William Elliott, Yakima, WA

3:00 Baroreflex Activation Therapy and renal Sympathetic Denervation — Henry Krum, Prahran, Victoria, Australia

3:15 Use of Generic Medications in the Management of resistant Hypertension — Rhonda M. Cooper-DeHoff, Gainesville, FL

QUAl

SYMPOSIUM

664

Joint Symposium of the Association of Black Cardiologists and the American College of Cardiology: Ethnic and racial Disparities in Cardiovascular Disease — A Call to ActionSunday, March 25, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N230CME/CNE Hours: 1.5

Co-Chairs: T. David Gbadebo, Chattanooga, TN Hector O. Ventura, New Orleans, LA

2:00 Pharmacogenomics of Heart Failure in African-Americans — Dennis M. McNamara, Pittsburgh, PA


2:15 Cardiovascular Disease in Hispanics: Special Considerations — Carlos Jose Rodriguez, Winston-Salem, NC


2:30 racial and Ethnic Disparities in the Complications of Atrial Fibrillation — David E. Bush, Baltimore, MD


2:45 The Importance of registries in reducing Cardiovascular Disparities — Eric Peterson, Durham, NC


3:00 Cardiovascular Disparities under Health Care reform: What Have We learned? — Michelle Albert, Boston, MA


3:15 Keeping PACE Initiative — Karol E. Watson, Los Angeles, CA


ACC-i2/TCT

SPECIAl

2103

Cardiac Care Team Session III: Medications and Other Techniques to Manage the Patient in the Cath labSunday, March 25, 2012, 2:30 p.m. – 3:30 p.m.McCormick Place South, S103bCME/CNE Hours: 1

Chair: Lisa A. Riggs, Kansas City, MO

2:30 Antiplatelet Therapy: Which One, When? — Laura Mauri, Boston, MA

2:50 The Dos and Don’ts of Beta Blockers in AMI Non-pharmacologic Techniques in Your Nursing Toolkit for Pain and Anxiety — David J. Moliterno, Lexington, KY

3:10 Non-pharmacologic Interventions to reduce Cardiac Procedure Stress — Timm Reed, Ft. Wayne, IN

SPECIAl

SPECIAl

302

Business Meeting of the CollegeSunday, March 25, 2012, 3:00 p.m. – 3:15 p.m.McCormick Place, ACC Member LoungeCME/CNE Hours: 0

Co-Chairs: David R. Holmes, Jr., Rochester, MN Thad Waites, Hattiesburg, MS Richard A. Chazal, Fort Myers, FL Alfred A. Bove, Philadelphia, PA

ACC-i2/TCT

SPECIAl

2104

Cardiac Care Team Session IV: Same Day Discharge for PCISunday, March 25, 2012, 3:30 p.m. – 5:00 p.m.McCormick Place South, S103bCME/CNE Hours: 1

Co-Chairs: Caroline Lloyd Doherty, Philadelphia, PA Sandra M. Oliver-McNeil, Farmington Hills, MI

3:30 State of the Evidence of Outpatient PCI — Gregory J. Dehmer, Temple, TX

3:45 Teamwork to Same Day Discharge: Developing the Program — Denise A. Rhodes, Hershey, PA

4:05 Case Selection: Vascular and Coronary Anatomy Issues — David Wohns, Grand Rapids, MI

4:25 A Cost and “Sense” Analysis: Is Outpatient PCI a Win-Win? — Denise K. Busman, Grand Rapids, MI


lIFElONG

MOC

815

ACCF Study Session for Maintenance of Certification: ABIM recertification Made Easy — ACC General Cardiology Module Part BSunday, March 25, 2012, 3:30 p.m. – 6:00 p.m.McCormick Place South, S105aCME Hours: 2.5


Attendees must be enrolled in the ABIM’s MOC program to claim MOC points. If you are not enrolled,


166 GO for ACC.12!

AFTE

RNOO

N

please allow sufficient time to do this prior to the start of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment.




Chair: Sunil V. Mankad, Rochester, MN

MOC Faculty: Brian Powell, Rochester, MN, Allen J. Taylor, Washington, DC

lIFElONG

MOC

816

ACCF Study Session for Maintenance of Certification: ABIM recertification Made Easy — ACC General Cardiology Module Part ASunday, March 25, 2012, 3:30 p.m. – 6:00 p.m.McCormick Place South, S105dCME Hours: 2.5






Chair: Biykem Bozkurt, Houston, TX

MOC Faculty: Andrew D. Krahn, London, Canada, Matthew W. Martinez, Allentown, PA

ACC-i2/TCT

ExPErTS

2311

Endovascular Case reviewsSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S102bCME/CNE Hours: 1.5

Co-Chairs: William A. Gray, New York, NY Christopher J. White, New Orleans, LA

Case Karthik Challa, Charleston, WV, Suresh Davis,Presenters Hyderabad, India, Takayuki Ishihara, Amagasaki,

Japan, Michael Nuyles, Dyer, IN, Yoshimitsu Soga, Kitakyushu, Japan

Panelists: John R. Laird, El Macero, CA , Mehdi H. Shihehbor, Cleveland, OH

ACC-i2/TCT

SYMPOSIUM

2622

Imaging Transcatheter Mitral Valve ProceduresSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S101aCME/CNE Hours: 1.5

Co-Chairs: Robert J. Siegel, Los Angeles, CA Frank E. Silvestry, Wayne, PA

4:30 Mitral Valve Imaging and Anatomy for Percutaneous Intervention: What do Interventionalists really Need to Know/See? — Frank E. Silvestry, Wayne, PA

4:45 3D Imaging in the Cath lab: What Does it really Add? Do We really Need It? — Rebecca T. Hahn, New York, NY

5:00 Mitral Valve repair Cases: Mitraclip (Best, Worst, Complications) — Saibal Kar, Los Angeles, CA

5:15 Imaging for Percutaneous repair of Mr in Europe: lessons learned from Functional and High-risk Cases — Olaf Franzen, Copenhagen, Denmark

5:30 Challenges in Assessment of Percutaneous MV repair (before, during, after), How Do We really Know if We Fixed the Problem? — Elyse Foster, San Francisco, CA


ACC-i2/TCT

SYMPOSIUM

2623

Peripheral Artery Disease: Critical limb IschemiaSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S103cCME/CNE Hours: 1.5

Co-Chairs: Tyrone J. Collins, New Orleans, LA Matthew T. Menard, Boston, MA

4:30 Critical limb Ischemia — Open vs Endo: What Does the Data Tell Us? — Michael S. Conte, San Francisco, CA

4:45 Debate: Drug-eluting Coronary Stents are the Treatment of Choice for Below-knee lesions — Andrew J. Feiring, Milwaukee, WI

5:00 Debate: Drug-eluting Coronary Stents are NOT the Treatment of Choice for Below-knee lesions — TBD

5:15 Peripheral Stem Cell Therapy: Clinical Trial results for Critical limb Ischemia — Douglas W. Losordo, Chicago, IL



AFTERNOON

5:30 Management of Complications Associated with Endovascular Intervention for Tibial Artery Disease — Nicholas J. Ruggiero, II, Philadelphia, PA

5:45 Case-based Presentation: Tips and Tricks for Pedal, Tibial and Antegrade Access — TBD

ACC-i2/TCT

SYMPOSIUM

2624

Vascular Access and Outcomes following PCI for ACS: What You Should KnowSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S106bCME/CNE Hours: 1.5

Co-Chairs: Thierry Lefevre, Massy, France Tift Mann, Raleigh, NC

4:30 Does Access Site Influence Bleeding Complication rates and Mortality following PCI for ACS — Sunil V. Rao, Durham, NC

4:42 Are There Specific Patient Cohorts Where radial Access is Preferred? Insights from the rIVAl and Other Trials — Sanjit S. Jolly, West Hamilton, Canada

4:54 Defining the Transradial learning Curve: Should low Volume Operators Utilize this Technique? — Ian C. Gilchrist, Hershey, PA

5:06 Complications and Pitfalls of Transradial Access: Multiple Illustrative Case Examples — Jean-Pierre Dery, Quebec, Canada

5:18 In Search of the Optimal Vascular Access for PCI in ACS: radial is Best — Harold L. Dauerman, Shelburne, VT

5:28 In Search of the Optimal Vascular Access for PCI in ACS: Femoral is Better — Shing-Chiu Wong, New York, NY

5:38 Debate: Vascular Closure Devices — VCD are Useful for Improving Patient Satisfaction and Clinical Outcomes — Timothy A. Sanborn, Evanston, IL

5:49 Debate: Vascular Closure Devices — VCD are Clinically Unproven with Added Costs — Zoltan G. Turi, Camden, NJ

ACS

SYMPOSIUM

665

literature Interpretation and Statistical Pitfalls in ACS TrialsSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S402CME/CNE Hours: 1.5

Co-Chairs: Sanjay Kaul, Los Angeles, CA Debabrata Mukherjee, El Paso, TX

Panelists: David J. Cohen, Kansas City, MO, Ajay J. Kirtane, New York, NY, Helen Parise, New York, NY

4:30 Playing with P Values: Misplaced Emphasis on Significance Testing — Sanjay Kaul, Los Angeles, CA


4:45 Composite Endpoints: How to Interpret Them? — Stuart Pocock, London, United Kingdom


5:00 Subgroup Analyses: Informative or a Minefield of Optical Illusions? — Salim Yusuf, Hamilton, Canada


5:15 Making Sense of Comparative Effectiveness and Noninferiority Analysis — Helen Parise, New York, NY


5:30 Meta-analyses and Observational Studies: Where do They Belong in the Evidentiary Hierarchy? — Peter Juni, Berne, Switzerland


5:45 Balancing Benefit-risk Tradeoffs: Qualitative Judgment or Quantitative Precision? — Sanjay Kaul, Los Angeles, CA

5:55 Panel DIscussion

Arr

SYMPOSIUM

666

Joint Symposium of the Heart rhythm Society and the American College of Cardiology: Atrial Fibrillation — Management of the ArrhythmiaSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N426CME/CNE Hours: 1.5

Co-Chairs: Hugh Calkins, Baltimore, MD Richard L. Page, Seattle, WA

4:30 rate Control: Targets and Drug Choices — Mario Talajic, Montreal, QC

4:50 rhythm Control: Selecting the Appropriate Anti-arrhythmic Drug — Richard I. Fogel, Carmel, IN

5:10 Upstream Therapies for Prevention: Is There a role? — Anne M. Gillis, Calgary, Canada

5:30 Ablation of AF: Who and When to refer? — Douglas L. Packer, Rochester, MN


CCS

SYMPOSIUM

667

The Great DebatesSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N231CME/CNE Hours: 1.5

Co-Chairs: Bryan C. Cannon, Rochester, MN Arwa S. Saidi, Gainesville, FL

4:30 Digoxin Is First line Therapy for Newborns with SVT — Stephen P. Seslar, Seattle, WA

4:42 Digoxin Is Not the First line Therapy for Newborns with SVT — Edward P. Walsh, Boston, MA

5:00 Indications for Pulmonary Valve replacement in Tetralogy of Fallot Apply to Pulmonary regurgitation after Balloon Valvuloplasty — David M. Harrild, Boston, MA

5:12 Indications for Pulmonary Valve replacement in Tetralogy of Fallot Do Not Apply to Pulmonary regurgitation after Balloon Valvuloplasty — Judith Therrien, Canada

5:30 Stimulants Can Be Used in Patients with Congenital Heart Disease — John Kugler, NE

5:42 Stimulants Can Not Be Used in Patients with Congenital Heart Disease — Randall M. Bryant, Jacksonville, FL


168 GO for ACC.12!

AFTE

RNOO

N

CCS

SYMPOSIUM

668

ACHD for the General CardiologistSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N230CME/CNE Hours: 1.5

Co-Chairs: William R. Davidson, Hershey, PA Michael J. Landzberg, Boston, MA

4:30 The Imaging Approach to the Adult with repaired CHD — Karen K. Stout, Seattle, WA

4:50 The Approach to Arrhythmia Management in the Adult with repaired CHD — Paul Khairy, Montreal, Canada

5:10 Adult with TOF: Get with the Guidelines — Anne Marie Valente, Boston, MA

5:30 Management of ASDs in Adulthood — Curtis J. Daniels, Columbus, OH


HF

SYMPOSIUM

669

Joint Symposium of the Heart Failure Society of America and the American College of Cardiology: Management of Advanced Heart Failure and TransplantationSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S406bCME/CNE Hours: 1.5

Co-Chairs: Donna M. Mancini, New York, NY Randall C. Starling, Cleveland, OH

4:30 Medical Management — Lynne Warner Stevenson, Boston, MA

4:48 Cardiorenal Syndrome: Mechanisms and Management — Barry M. Massie, San Francisco, CA

5:06 lVADs: Which Patients? Which Device? What results? — Keith D. Aaronson, Ann Arbor, MI

5:24 Update on Transplantation: Patient Selection, Post-transplant Management — Sharon Hunt, Palo Alot, CA

5:42 regenerative Therapy: Is it a Dream? — Leslie W. Miller, Tampa, FL

HF

SYMPOSIUM

670

Heart Transplantation: Challenges in 2012Sunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S405CME/CNE Hours: 1.5

Co-Chairs: Jon A. Kobashigawa, Los Angeles, CA Michael Shullo, Pittsburgh, PA

4:30 Who Is a Candidate for Heart Transplantion? 2012 Criteria — Ravi Ramani, Pittsburgh, PA

4:48 Calcineurin-Free Immunosuppression after Transplantation: Why and Which Patients? — Sean Patrick Pinney, New York, NY

5:06 Single Agent Immunosuppression: How low Can You Go? — David Baran, Newark, NJ

5:24 Transplanting the “Untransplantable”: Technology and Pharmacology for Managing the Highly Sensitized Pre-transplant Patient — Savitri Fedson, Chicago, IL

5:42 Antibodies Post-transplant: Screening, Diagnosis and Current Treatment Options — Josef Stehlik, Salt Lake City, UT

HF

SYMPOSIUM

671

Personalized Medicine and the Future of Medical CareSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S404CME/CNE Hours: 1.5

Co-Chairs: Geoffrey S. Ginsburg, Durham, NC Jennifer L. Hall, Minneapolis, MN

4:30 Whole Genome Sequencing and the Impact on Clinical Care in the Next Decade — Elizabeth McNally, Chicago, IL

4:48 Sequencing and Personalized Medicine — Howard Jacob, Milwakuee, WI

5:06 Protemoics and Personalized Medicine — Jennifer Van Eyk, Baltimore, MD

5:24 Determining the Cost-Effectiveness of Genetic Testing — Mark A. Hlatky, Stanford, CA

5:42 Predicting the Future of Care for Individuals with Heart Failure — Jeffrey A. Towbin, Cincinnati, OH

IMAG

SYMPOSIUM

672

Joint Symposium of the American Society of Echocardiography and the American College of Cardiology: Echo in 2012 — What You Need to Know to Keep UpSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S406aCME/CNE Hours: 1.5

Co-Chairs: Allan L. Klein, Cleveland, OH Thomas Richard Porter, Omaha, NE

4:30 Case Presentation: Hand-Held Echocardiography in 2012 — Rosa Sicari, Pisa, Italy

4:40 review of Current Data and Future Use — Kirk T. Spencer, Chicago, IL

4:55 Case Presentation: 3-D Echocardiography in 2012 — Judy W. Hung, Boston, MA

5:05 review of Current Data and Future Use — Judy W. Hung, Boston, MA

5:20 Case Presentation: Appropriate Use Criteria for Echocardiography in 2012 — R. Parker Ward, Chicago, IL

5:30 review of Current Data and Future Considerations — Neil J. Weissman, Washington, DC




AFTERNOON

lIFElONG

SYMPOSIUM

737

Master Clinician: Clinical Cases IISunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S401aCME/CNE Hours: 1.5

Co-Chairs: John M. Miller, Indianapolis, IN Eric S. Williams, Indianapolis, IN

Panelists: Douglas E. Drachman, Boston, MA, Bernard J. Gersh, Rochester, MN, Michael J. Mack, Plano, TX, John M. Miller, Indianapolis, IN, Thomas John Ryan, Columbus, OH

4:30 Case Presentation: A 60 year-old Man with Heart Failure, Chest Pain and a Murmur


5:00 Case Presentation: A 56 Year-old Woman with Palpitations and Shock


5:30 Case Presentation: A 36 Year-old Woman with Near-Syncope


lIFElONG

COrE

817

Core Curriculum: Coronary Artery DiseaseSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N226CME/CNE Hours: 1.5


4:30 Evaluation and Management of Unstable Angina/NSTEMI — Michael Peter Hudson, Detroit, MI

4:55 Evaluation and Management of STEMI — Malcolm Bell, Rochester, MN

5:20 Management of Chronic CAD: Medical Therapy vs. PCI vs. CABG — Eric R. Bates, Ann Arbor, MI


lIFElONG

COrE

818

Core Curriculum: Nuclear CardiologySunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N229CME/CNE Hours: 1.5


4:30 risk Stratification and Prognosis — Alex J. Auseon, Columbus, OH

4:55 Myocardial Perfusion Imaging for Viability: SPECT and PET — Mouaz H. Al-Mallah, Riyadh, Saudi Arabia

5:20 CTA and Cardiac Mr: Basic Concepts — Mushabbar A. Syed, Oak Park, IL


PErI

ExPErTS

236

Genetic Evaluation of CardiomyopathySunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S505CME/CNE Hours: 1.5

Chair: Ray E. Hershberger, Miami, FL

Case Michael J. Ackerman, Rochester, MN, Ray E. Presenters: Hershberger, Miami, FL, Calum A. MacRae, Boston, MA

Panelists: Teresa Kruisselbrink, Rochester, MN, William McKenna, London, United Kingdom

PrACTICE

SYMPOSIUM

673

Future Compensation Under Health Care reformSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N227bCME/CNE Hours: 1.5

Co-Chairs: Paul Casale, Lancaster, PA Gregory D. Timmers, Springfield, IL Patrick J. White, South Lyon, MI

4:30 Fee for Service: Will It Survive — Gregory S. Thomas, Dana Point, CA

4:50 Your Fee Schedule: Why and How You Get Paid Now — Cathleen Biga, Woodridge, IL

5:10 New Payment Models — Paul Casale, Lancaster, PA

5:30 Value-based Purchasing — Gregory D. Timmers, Springfield, IL


PrEV

ExPErTS

237

reducing Disparities in Cardiovascular Preventive CareSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S501aCME/CNE Hours: 1.5

Chair: Keith C. Ferdinand, Atlanta, GA

Case Rosario Freeman, Seattle, WA, Kenneth A. Jamerson, Presenters: Ann Arbor, MI

Panelists: Eileen M. Handberg, Gainesville, FL, Jennifer H. Mieres, Lake Success, NY, Ileana L. Pina, Cleveland Heights, OH, Clyde W. Yancy, Chicago, IL

PrEV

SYMPOSIUM

675

What’s New in the ACCF/AHA GuidelinesSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place North, N228CME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-140-l04-P

Chair: Jeffrey L. Anderson, Murray, UT

4:30 Update on ACCF/AHA Clinical Practice Guideline Methodology — Alice K. Jacobs, Boston, MA

4:45 2011 ACCF/AHA/SCAI Guideline on Percutaneous Coronary Intervention — Glenn Levine, Houston, TX


5:05 2011 ACCF/AHA Guideline on Coronary Artery Bypass Graft Surgery — Peter K. Smith, Durham, NC


5:25 2011 ACCF/AHA Focused Update on Peripheral Artery Disease — Alan T. Hirsch, Minneapolis, MN


170 GO for ACC.12!

AFTE

RNOO

N


5:40 2012 ACCF/AHA Guideline on ST-Elevation Myocardial Infarction — Patrick T. O’Gara, Boston, MA


PrEV

SYMPOSIUM

730

The Difficult-to-Manage lipid PatientSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S100cCME/CNE/CPE Hours: 1.5 ACPE No. 0012-9999-12-147-l04-P

Co-Chairs: Andrew M. Kates, Saint Louis, MO Jeffrey T. Kuvin, Boston, MA

Panelists: Robert Sidney Rosenson, New York, NY, Anne C. Goldberg, St. Louis, MO

4:30 Case Presentation — Donna M. Polk, Hartford, CT



5:15 Case Presentation — Elizabeth A. Jackson, Ann Arbor, MI



SPECIAl

ExPErTS

263

The role of Therapeutic Hypothermia in the Treatment of Cardiac ArrestSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S502 CME/CNE Hours: 1.5

Co-Chairs: John A. McPherson, Nashville, TN Barbara T. Unger, Minneapolis, MN

Case Presenters: Jason Neil Katz, Morrisville, NC, Karl B. Kern, Tucson, AZ, Paul McMullan, New Orleans, LA, Michael R. Mooney, Minneapolis, MN, Nainesh C. Patel, Allentown, PA, David Seder, Portland, ME

SPECIAl

lEGENDS

403

legends of Cardiovascular Medicine lecture Series — Third Annual James T. Dove lectureSunday, March 25, 2012, 4:30 p.m. – 5:30 p.m.McCormick Place North, N427CME/CNE Hours: 1

The James T. Dove Lecture is supported by the James T. Dove Fund

Chair: Prediman K. Shah, Los Angeles, CA

4:30 Introduction of Dr. Valentin Fuster — Prediman K. Shah, Los Angeles, CA

4:35 Third Annual James T. Dove lecture: Transition from Cardiovascular Disease to Health (2012 – 2020): The Challenge of Identifying Subclinical Disease — Valentin Fuster, New York, NY

5:05 One-on-One Interview with Dr. Valentin Fuster — Prediman K. Shah, Los Angeles, CA


SPECIAl

SYMPOSIUM

744A

Clinical Decision Making for Fellows in Training: Part ASunday, March 25, 2012, 4:30 p.m. – 5:50 p.m.McCormick Place South, S403CME/CNE Hours: 1.25

Co-Chairs: John E. Brush, Norfolk, VA David R. Holmes, Jr., Rochester, MN Rick A. Nishimura, Rochester, MN Patrick T. O’Gara, Boston, MA

4:30 Management of late Complications in Adult Congenital Heart Disease: Surviving the Storm — Robert J. Mentz, Sudarshan Rajagopal, Tariq Ahmad, Christopher H. Swan, Duke University Medical Center, Durham, NC


4:46 Searching for the Etiology of Non-Ischemic Cardiomyopathy: When Zebras and Horses run Together — Nada Shaban, Saneka Chakravarty, Alireza Hosseini Khalili, Sabeena Arora, Richard Soucier, Hoffman Heart and Vascular Institute, St. Francis Hospital and Medical Center, Hartford, CT, University of Connecticut Health Center, Farmington, CT


5:02 High Output HF Secondary to a Hemodialysis Arteriovenous Fistula — Dawn Scantlebury, Mayo Clinic, Rochester, MN


5:18 Too Severe or Not Too Severe: “Grading” Aortic Stenosis — Ahmad M. Jeroudi, Sameer A. Gafoor, Gautam Kumar, Emory University, Atlanta, GA


5:34 Hypertrophic Cardiomyopathy or Hypertensive Heart Disease? Diagnostic Challenge in Older Patients Suspected of HCM and Therapeutic Implications — Farbod Raiszadeh, Krysthel Engstrom-Koch, Mario J. Garcia, Montefiore Einstein Heart Center, New York, NY, Jacobi Medical Center, New York, NY


SPECIAl

SYMPOSIUM

744B

Clinical Decision Making for Fellows in Training: Part BSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S403CME/CNE Hours: 1.5

5:50 Novel Presentation of Ventricular Tachycardia Due to Invasion of the right Ventricle by Aspergillosis — Kyle G. Ulveling, Jamil Y. Abuzetun, Venkata M. Alla, W. Paul Biddle, Aryan Mooss, The Cardiac Center of Creighton University Medical Center, Omaha, NE

5:50 Current of Injury Found Guilty of Perjury in a Case of Myocardial Infraction Committed by Non-hodgkin lymphoma — Morteza Farasat, Nada M. Shaban, Nishant Sethi, Carolyn Ray, Anthony F. Posteraro, III, Anita M. Kelsey, Saint Francis Hospital and Medical Center, Hartford, CT, University of Connecticut Health Center, Farmington, CT



Afternoon

5:50 Out-of-Hospital Cardiac Arrest Due to a Concealed Diagnosis: Clinical Decision-making from the Hospital to Home — Manoj Kesarwani, Mohan N. Viswanathan, University of Washington, Seattle, WA

5:50 Early repolarization and Anomalous right Coronary Artery: A Perfect Storm for Sudden Cardiac Death — Andrew Choi, Gaby Weissman, Robert Lowery, Susan O’Donoghue, Edriss Charaf, Federico Asch, Washington Hospital Center, Washington, DC, Georgetown University Medical Center, Washington, DC

5:50 A Case of Multiple Medical Issues and Percutaneous Coronary Intervention for restenosis: Is less Sometimes More? — Amit Noheria, Sanjay Kaul, Cedars-Sinai Medical Center, Los Angeles, CA

5:50 Severe Coronary Spasm and Sudden Cardiac Death: Is There a Concensus for Management? — Tarek M. Mousa, Emmanuel N. Moustakakis, Gregory Gustafson, Seth E. Goldbarg, Chong H. Park, New York Hospital Medical Center of Queens, New York, NY, Cornell University Weill Medical College, New York, NY

5:50 Mitral Valve Endocarditis in the Setting of Hypertrophic Cardiomyopathy — Neha Yadav, John H Stroger Hospital of Cook County, Chicago, IL

5:50 When Are Patients with Amyloidosis Eligible for Heart Transplant? — Michael A. Burke, Rodney H. Falk, Lynne W. Stevenson, Brigham and Women’s Hospital, Boston, MA

5:50 Heart Failure and Mitral regurgitation — Murali K. Senapathi, Gerard P. Aurigemma, Dennis Tighe, University of Massachusetts Medical Center, Worcester, MA

5:50 Dyspnea and Hemoptysis following Aortic and Mitral Valve Surgery with Atrial Fibrillation Ablation: Expanding the Differential Diagnosis — Megan Coylewright, Terrence D. Welch, Samuel J. Asirvatham, Mayo Clinic, Rochester, MN

TEST

ExPErTS

261

Cardiac Dilemmas in AthletesSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S503CME/CNE Hours: 1.5

Chair: Richard J. Kovacs, Indianapolis, IN

Panelists: Adolph M. Hutter, Boston, MA, Jonathan Rhodes, Boston, MA, Malissa Jane Wood, Boston, MA

Case Paolo Enzo Angelini, Houston, TX, Jeffrey Hastings, Presenters: Dallas, TX, Melanie S. Sulistio, Dallas, TX

VAlV

ExPErTS

238

Aortic Stenosis Case ManagementSunday, March 25, 2012, 4:30 p.m. – 6:00 p.m.McCormick Place South, S504aCME/CNE Hours: 1.5

Chair: Jean G. Dumesnil, Sainte Foy, Canada

Panelists: Marian Hawkey, New York, NY, Aaron V. Kaplan, Lebanon, NH

Case Kevin Greason, Rochester, MN, David Messika-Zeitoun,Presenters: France, Igor F. Palacios, Boston, MA

ACC-i2/TCT

SPECIAl

2105

Cardiac Care Team V: Structural Heart Disease — Mitral ValveSunday, March 25, 2012, 5:00 p.m. – 6:00 p.m.McCormick Place South, S103bCME/CNE Hours: 1

Co-Chairs: Julie A. Logan, La Jolla, CA Martina Speight, Stanford, CA

5:00 Pathophysiology: Understanding Mitral Anatomy — Russell A. Brandwein, New York, NY

5:20 When to Treat: Guidelines the Cardiologist Should live by — Steven F. Bolling, Ann Arbor, MI

5:40 What Is on the Horizon — Julie A. Logan, La Jolla, CA

ACS

ClINICAl FOCUS

1605

Innovations in Translation: Acute Coronary SyndromesSunday, March 25, 2012, 6:30 p.m. – 9:30 p.m.Fairmont Hotel, Imperial BallroomCME/CNE Hours: 2.5


6:30 registration and Dinner

7:00 Program Overview and Introductions —Ajay Kirtane, New York, NY

Focus #1: Pharmacoinvasive Management in NSTEACS

Moderator: Sunil Rao, Durham, NC

Panelists: Ajay Kirtane, New York, NY, Dirk Sibbing, Munich, Germany

7:05 Antiplatelet and Antithrombotic Strategies in NSTEACS —Dirk Sibbing, Munich, Germany

7:20 Case review and Panel Discussion

Focus #2: Pharmacologic Therapy in STEMI

Moderator: Gilles Montalescot, Paris, France

Panelists: Stefan James, Uppsala, Sweden, Stephen D. Wiviott, Boston, MA

7:50 Navigating Antithrombic and Antiplatelet Agents in STEMI —Stefan James, Uppsala, Sweden


Focus #3: Systems of Care for Patients with Acute Coronary Syndromes

Moderator: Gregg Stone, New York, NY

Panelists: Duane S. Pinto, Boston, MA, James A. de Lemos, Dallas, TX

8:35 Primary PCI vs Fibrinolytics: Making the right Choice for Individual Patients —Duane S. Pinto, Boston, MA


9:20 Concluding remarks —Ajay Kirtane, New York, NY


eVening

172 GO for ACC.12!

eVen

ing

Arr

ClINICAl FOCUS

1603

Joint Session of the Heart rhythm Society of America and the American College of Cardiology — Innovations in Translation: Atrial FibrillationSunday, March 25, 2012, 6:30 p.m. – 9:30 p.m.Fairmont Hotel, International BallroomCME/CNE Hours: 2.5


Chair: Peter Kowey, Wynnewood, PA

6:30 registration and Dinner

7:00 Opening remarks, General Introduction and Overview —Peter Kowey, Wynnewood, PA

7:05 Emerging Concepts in Stroke Prevention —Kenneth A. Ellenbogen, Richmond, VA

7:35 rate vs. rhythm Control: Which Strategy is Best for my Patient? —Albert L. Waldo, Cleveland, OH

8:05 Achieving rate Control —N. A. Mark Estes, Boston, MA

8:35 Achieving rhythm Control — Pharmacologic Options —Eric N. Prystowsky, Indianapolis, IN

8:55 Achieving rhythm Control — Non-pharmacologic Options —Douglas L. Packer, Rochester, MN

9:15 Questions and Answers —Peter Kowey, Wynnewood, PA


CV Innovations Educational ForumSouth Building, Hall A2, CV Theater, #22097

Device Development & Innovation9:30 a.m. – 10:45 a.m.

9:30 a.m. – 9:45 a.m.Translational Considerations for Medtech Financing and International Strategies — Nic Chronos, MD, FACC, FESC, FFAHA, FRCP, Atlanta, GA — President, St. Joseph’s Translational Research Institute

9:45 a.m. – 9:55 a.m.Selecting the Right Experimental Models for Device Testing and Validation — Juan F. Granada, MD, New York, NY — Executive Director and Chief Scientific Officer, The Jack H. Skirball Center for Cardiovascular Research, Cardiovascular Research Foundation

9:55 a.m. – 10:05 a.m.Device Strategies for the Management of Hypertension — Todd Brinton, MD, Palo Alto, CA — Clinical Assistant Professor of Medicine (Cardiology) and Lecturer in Bioengineering, Stanford University

10:05 a.m. – 10:15 a.m.Biodegradable Stents — Jai Pal Singh, PhD, Atlanta, GA — Chief Scientific Officer, St. Joseph’s Translational Research Institute

10:15 a.m. – 10:30 a.m.Innovation for the Mitral Valve — David Reuter, MD, PhD, Kirkland, WA — Co-Founder & Chief Medical Officer, Cardiac Dimensions

10:30 a.m. – 10:45 a.m.Panel Discussion

Challenges Associated with Treating Calcified Coronary Artery Disease 12:15 p.m. – 1:10 p.m.

12:15 p.m. – 12:23 p.m.Complications Associated with Treating Calcified Lesions During Coronary Intervention — Jeffrey W. Chambers, MD, Buffalo, NY — Cardiology

12:23 p.m. – 12:31 p.m.Long-Term Clinical Results of the Orbital Treatment for De Novo Calcified Coronary Lesions: ORBIT I Trial — Puneet Khanna, MD, FACC, Rancho Mirage, CA — Desert Cardiology Center

12:31 p.m. – 12:39 p.m.Clinical Study Design of the Orbital Treatment for De Novo Calcified Coronary Lesions: ORBIT II Trial — Stevan I. Himmelstein, MD, FACC, Southaven, TN — Memphis Heart Clinic

12:39 p.m. – 12:47 p.m.Orbital Atherectomy Case Study of Calcified Coronary Arteries Using IVUS — Richard A. Shlofmitz, MD, FACC, Roslyn, NY — Director, Department of Cardiology, St. Francis Hospital

12:47 p.m. – 12:55 p.m.Use of Intravascular Ultrasound to Identify Calcified Coronary Lesions for Treatment Using Orbital Atherectomy before Stenting — Gregg W. Stone, MD, FACC, FSCAI, New York, NY — Director of Cardiovascular Research and Education, Columbia University Medical Center

12:55 p.m. – 1:10 p.m.Panel Discussion

Current Approaches for Treating Calcified Peripheral Arterial Disease1:10 p.m. – 2:00 p.m.

1:10 p.m. – 1:18 p.m.Prevalence and Impact of Calcium on the Management of Peripheral Arterial Disease — William A. Gray, MD, New York, NY

1:18 p.m. – 1:26 p.m.Unique Challenges for Treating Patients with Critical Limb Ischemia: Clinical Considerations and Lesion Morphologies — Speaker to be announced

1:26 p.m. – 1:34 p.m.New Approaches for Treating Critical Limb Ischemia — Clinical Data — Tony S. Das, MD, FACC, FACP, Dallas, TX — Cardiology and Interventional Vascular Associates

1:34 p.m. – 1:42 p.m.Advanced Treatment Options for Lower Extremity Peripheral Arterial Disease — Jihad Mustapha, MD, Grand Rapids, MI — Director of Endovascular Interventions and Research, Metro Health Hospital

1:42 p.m. – 1:50 p.m.Peripheral Academic Research Consortium — Definitions in Trials in the Treatment of Patients with Lower Extremity Peripheral Arterial Disease — Manesh R. Patel, MD, Durham, NC — Duke University



Sunday, March 25, 2012Learning Destinations™ are diverse, non-accredited, educationally focused areas that offer new and creative venues in which you can expand your educational experience.*

Presentation schedules are current as of Feb. 29, 2012, and are subject to change. For more information, please check the ACC.12 ExpoGuide and ExpoGuide Addendum, available at Expo Hall entrances and in your official meeting bag, and the Heart of Innovation Resource Guide, available at the Heart of Innovation Learning Destination (South Building, Hall A1, #1076) and in your official meeting bag

174 GO for ACC.12!

The role of Innovative Technologies in a Novel Strategy to Prevent First Coronary Event3:30 p.m. – 4:30 p.m.

3:30 p.m. – 3:45 p.m.Genetic Testing and Other Novel Methods to Screen for Increased Coronary risks — Robert Roberts, MD, MACC, FRCPC, Ottawa, ON, Canada — President, Chief Executive Officer and Chief Scientific Officer, University of Ottawa Heart Institute

3:45 p.m. – 3:55 p.m.The role of Non-Invasive Imaging with CTA and Other Means to Identify Increased risks — Szilard Voros, MD, FACC, Atlanta, GA — Fuqua Heart Center at Piedmont Hospital

3:55 p.m. – 4:10 p.m.The role of Invasive Imaging with IVUS, NIr, and OCT to Confirm the Presence of Vulnerable Plaques — James Muller, MD, Burlington, MA — Chief Medical Officer, InfraReDx, Inc.

4:10 p.m. – 4:20 p.m.PrOSPECT Data: Potential local and Systemic Concepts for Stabilizing Vulnerable Plaques — Charles Simonton, MD, FACC, FSCAI, Abbott Park, IL — Divisional Vice President, Medical Affairs and Chief Medical Officer, Abbott Vascular



9:30 a.m. – 9:45 a.m.Educational content including taped cases, physician interviews, panel discussions and more

9:45 a.m. – 10:05 a.m.Presenting Options to Patients with Advanced Heart Failure — Lynne Warner Stevenson, MD, FACC, Boston, MA — Director, Cardiomyopathy and Heart Failure Program, Brigham and Women's Hospital; Professor, Harvard Medical School

10:05 a.m. – 10:30 a.m.Transcatheter Aortic Valve replacement: Where Are We and Where Do We Go? — G. Alain Cribier, MD, Rouen, France — Professor of Cardiology, University Hospital Charles Nicolle

10:30 a.m. – 12:30 p.m.Educational content including taped cases, physician interviews, panel discussions and more

12:30 p.m. – 12:55 p.m.Pharmacogenetic Development and Targeting of Cardiovascular Drugs — Michael R. Bristow, MD, PhD, FACC, FAHA, Aurora, CO — Professor of Medicine (Cardiology), Co-Director, CU Cardiovascular Institute, University of Colorado Anschultz Medical Campus

12:55 p.m. – 1:20 p.m.Cell Therapy for Chronic Ischemic Heart Disease from Concept to Clinic — Joshua M. Hare, MD, FACC, FAHA, Miami, FL — Louis

Lemberg Professor of Medicine; Director, Interdisciplinary Stem Cell Institute, University of Miami Miller School of Medicine

1:20 p.m. – 1:45 p.m.Devices Used for Heart Failure — Leslie W. Miller, MD, FACC, Tampa, FL — Professor of Medicine, Chief and Chairman, Department of Cardiovascular Sciences; CEO and Director of Cardiovascular Service, University of South Florida


3:45 p.m. – 4:15 p.m.Moderated Discussion: role of Genetics and Proteomics and How They Will Alter the Management of Heart Disease

Moderator: Jennifer L. Hall, PhD, FACC, FAHA, Minneapolis, MN — Associate Professor of Medicine, University of Minnesota; Director, Program in Translational Cardiovascular Genomics, Lillehei Heart Institute Developmental Biology Center

Panelists: Robert Roberts, MD, MACC, FACP, FAHA, FESC, FISHR, FRCPC, FRSM, Ottawa, ON, Canada — President and CEO, University of Ottawa Heart Institute; President, CEO and Chief Scientific Officer, Ottawa Heart Institute Research Corporation; Director, Ruddy Canadian Cardiovascular Genetics Centre; Professor of Medicine, University of Ottawa; Adjunct Professorship of Medicine, Baylor College of Medicine; Jennifer E. Van Eyk, PhD, Baltimore, MD — Director, Johns Hopkins NHLBI Proteomics Center, Johns Hopkins School of Medicine



9:45 a.m. – 10:45 a.m. (Morning Coffee Break)Antiplatelet Therapy Choices for High-risk PCI Patients in the Era of Generic Clopidogrel: The role of Platelet reactivity Testing

The Platelet reactivity Hypothesis — Paul A. Gurbel, MD , Baltimore, MD — Director, Sinai Center for Thrombosis Research; Associate Professor of Medicine, Johns Hopkins University

Platelet reactivity Testing: A Synthesis of the Data — Matthew J. Price, MD, FACC, FSCAI, La Jolla, CA — Director, Cardiac Catheterization Laboratory at Scripps Clinic; Assistant Professor at Scripps Translational Science Institute

Clinical Pathways for Platelet reactivity: real World Application — Speaker to be announced

Presented by Accumetrics



12:30 p.m. – 1:30 p.m. (Mid-Day Break)A Stroke Prevention Option in Nonvalvular Atrial Fibrillation — James A. Reiffel, MD, New York, NY — Professor of Clinical Medicine, Columbia University; Cardiologist, Electrophysiologist, and Co-Director ECG Laboratory, Columbia University Medical Center

Presented by Janssen Pharmaceuticals Inc.

3:30 p.m. – 4:30 p.m. (Afternoon Coffee Break)Emerging Procedures Today, Future Standard of Care

TAVR: Starting a Program and Beyond — Richard Smalling, MD, Houston, TX — Director of Interventional Cardiovascular Medicine, Memorial Hermann

Transradial Procedures: Fast Track to the Default Access — J. Chris McClish, MD, San Angelo, TX — Interventional Cardiologist, Shannon West Texas Memorial Hospital

Procedures Outside the Heart: The Optimal Cath Lab — Stephen Ramee, MD, New Orleans, LA — Interventional Cardiologist, Ochsner Clinic Interventional Cardiology

Presented by Toshiba Medical Systems


Actelion Pharmaceuticals US, Inc.Interactive Learning Lab #23027

9:30 a.m. – 11:30 a.m.Pulmonary Arterial Hypertension Associated with Adult Congenital Heart Disease: An Interactive Program — Wayne J. Franklin, MD, FACC, Houston, TX — Director, Texas Adult Congenital Heart Program, Texas Children’s Hospital; Assistant Professor of Medicine and Pediatrics, Baylor College of Medicine; Richard A. Krasuski, MD, FACC, FAHA, Cleveland, OH — Director of Adult Congenital Heart Disease Services, Cleveland Clinic Foundation; Michael J. Landzberg, MD, Boston, MA — Director, Boston Adult Congenital Heart Service, Children’s Hospital, Brigham & Women’s Hospital, Harvard Medical School

12:30 p.m. – 2:15 p.m.PAH: A Case-Based Exploration of Management Strategies — Michael Earing, MD, Milwaukee, WI — Medical College of Wisconsin; Ramagopal Tumuluri, MD, Milwaukee, WI — Aurora St. Luke’s Medical Center

Philips HealthcareInteractive Learning Lab #22035

9:30 a.m. – 10:30 a.m.Speckle Tracking Today for Myocardial Deformation — A Hands-On Guided Workshop — Roberto M. Lang, MD, FACC, FAHA, FASE, FESC, FRCP, Chicago, IL — Professor of Medicine and Radiology; Director, Noninvasive Cardiac Imaging Laboratories; Associate Director, Cardiology Fellowship Program; University of Chicago Medical Center; Ivan Salgo, MD, Andover MA — Senior Director, Cardiology; Philips Healthcare

11:00 a.m. – NoonHow Can Cardiology Informatics Enrich My Electronic Health records Strategy? — James E. Tcheng, MD, FACC, Durham, NC — Professor of Medicine; Professor of Community and Family Medicine (Informatics); Duke University Health System

12:30 p.m. – 1:30 p.m.Innovations in Cardiovascular Interventions — Speaker to be announced

2:00 p.m. – 3:00 p.m.Hypothermia for Cardiac Protection in Acute Myocardial Infarction — David Erlinge, MD, PhD, FESC, Sweden — Head, Department of Cardiology, Lund University Hospital

3:30 p.m. – 4:30 p.m.Clinical Application of real-Time 3D TEE for Percutaneous Structural Heart Interventions — David Liang, MD, PhD, Palo Alto, CA — Associate Professor, Cardiovascular Medicine, Stanford University School of Medicine; Robert J. Siegel, MD, Lost Angeles, CA — Director, Cardiac Noninvasive Laboratory, Cedars-Sinai Medical Center

Terumo Interventional Systems and The Medicines CompanyInteractive Learning Lab #22027

9:30 a.m. – 10:30 a.m.Hands-On radial Access Simulation

10:45 a.m. – 11:45 a.m.Hands-On radial Access Simulation

Noon – 1:00 p.m.Optimizing your Outpatient PCI: What You Need to Know and Consider

1:00 p.m. – 2:00 p.m.Hands-On radial Access Simulation

2:30 p.m. – 3:30 p.m.Hands-On radial Access Simulation



New for ACC.12! Heart of Innovation Featured Learning Destination| South Building, Hall A1, #1076

In this multi-vendor educational venue, explore the evolution of the standard of care for coronary artery disease and heart failure caused by valvular disease through the lenses of Personalized Medicine, TechnoBiology, Minimally Invasive Procedures and Physician-Patient Engagement. The adjoining Thought Leader TheaterTM will feature speakers discussing past, present and future advances in patient care.



New for ACC.12! CardioSmart Forum | South Building, Hall A2, CV Theater, #22097 Join Dr. Michelle May on Saturday for “Eat What You Love, Love What You Eat: How to Break the Eat-Repent-Repeat Cycle.” Learn strategies to help your patients change their eating patterns and improve their outcomes.

CV Innovations Educational Forum | South Building, Hall A2, CV Theater, #22097 Explore the future on Sunday and Monday during presentations and panel discussions on cutting-edge cardiovascular research and cardiovascular technologies in development.

Industry-Expert Theater | South Building, Hall A1, #22042 Connect with the experts as presenters share the latest in cardiovascular practices, services and technologies in a theater setting.

Interactive Learning Labs | South Building, Hall A1, #22027, #22035, #23027 Experience hands-on training and interactive didactic presentations. This unique educational opportunity puts new technology in your hands and new information in your arsenal.

©2012 American College of Cardiology. A12194

More information is available in the ACC.12 Final Program, the ACC.12 ExpoGuide and ExpoGuide Addendum, and at www.accscientificsession.org/learningdestinations.

Learning Destination presentations are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees. Learning Destination presentations do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.

ACC.12Learning DestinationsTM

Expand Your Educational Experience in These Diverse and Creative Venues

ACC.12

MondayMarch 26

Monday, M

arch 26

New for ACC.12! Heart of Innovation Featured Learning Destination| South Building, Hall A1, #1076

In this multi-vendor educational venue, explore the evolution of the standard of care for coronary artery disease and heart failure caused by valvular disease through the lenses of Personalized Medicine, TechnoBiology, Minimally Invasive Procedures and Physician-Patient Engagement. The adjoining Thought Leader TheaterTM will feature speakers discussing past, present and future advances in patient care.



New for ACC.12! CardioSmart Forum | South Building, Hall A2, CV Theater, #22097 Join Dr. Michelle May on Saturday for “Eat What You Love, Love What You Eat: How to Break the Eat-Repent-Repeat Cycle.” Learn strategies to help your patients change their eating patterns and improve their outcomes.

CV Innovations Educational Forum | South Building, Hall A2, CV Theater, #22097 Explore the future on Sunday and Monday during presentations and panel discussions on cutting-edge cardiovascular research and cardiovascular technologies in development.

Industry-Expert Theater | South Building, Hall A1, #22042 Connect with the experts as presenters share the latest in cardiovascular practices, services and technologies in a theater setting.

Interactive Learning Labs | South Building, Hall A1, #22027, #22035, #23027 Experience hands-on training and interactive didactic presentations. This unique educational opportunity puts new technology in your hands and new information in your arsenal.

©2012 American College of Cardiology. A12194

More information is available in the ACC.12 Final Program, the ACC.12 ExpoGuide and ExpoGuide Addendum, and at www.accscientificsession.org/learningdestinations.

Learning Destination presentations are not part of the official ACC Annual Scientific Session & Expo and/or ACC-i2 with TCT, as planned by their Program Committees. Learning Destination presentations do not qualify for continuing medical education (CME), continuing nursing education (CNE) or continuing education (CE) credit.

ACC.12Learning DestinationsTM

Expand Your Educational Experience in These Diverse and Creative Venues

Mon

day,

Mar

ch 2

6


Morning SeSSionS

ACC-i2/TCT

SpeCiAl

2111

Fellows Bootcamp: Coronary iMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S103bCMe Hours: 1.5

Co-Chairs: Sunil V. Rao, Durham, NC Duane S. Pinto, Boston, MA

8:00 Vascular Access: Femoral and Radial Approaches — Robert J. Applegate, Winston-Salem, NC

8:15 Balloons, Wires and Guides — Adam B. Greenbaum, Detroit, MI

8:30 Beyond Angiography: Using iVUS, OCT and FFR to Optimize Therapy — Marco A. Costa, Cleveland, OH

8:45 Tips and Tricks for Challenging Stent Delivery: Case Reviews — Duane S. Pinto, Boston, MA

9:00 The ABC’s of pCi pharmacology — Paul A. Gurbel, Baltimore, MD

9:15 Roundtable Discussion

ACC-i2/TCT

SpeCiAl

2121

Multi-Disciplinary Management of the Failing Heart: Team-based evaluation and Therapy of Advanced Heart Disease iMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S102cCMe/CNe Hours: 1.5

Chair: James A. Goldstein, Royal Oak, MI

Panelists: Jagat Narula, New York, NY, Paul Sorajja, Rochester, MN, Spencer B. King, Atlanta, GA, Neal Kleiman, Houston, TX, Simon R. Dixon, Royal Oak, MI, Gregg C. Fonarow, Los Angeles, CA, Gus J. Vlahakes, Boston, MA

8:00 Changing Nature of Advanced Heart Failure: The Need for Multi-disciplinary Management — James A. Goldstein, Royal Oak, MI

8:15 Case presentation 1 — Brian P. O’Neill, Miami, FL

8:20 panel Discussion

8:50 Case presentation 2 — Todd K. Zynda, Manhattan Beach, CA


ACC-i2/TCT

SyMpOSiUM

2625

left Main Disease: Role of imaging for Assessment, Treatment and Follow-UpMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S101aCMe/CNe Hours: 1.5

Co-Chairs: Robert J. Russo, La Jolla, CA Massoud A. Leesar, Cincinnati, OH

8:00 What do We Know about left Main Disease Subtypes and Natural History? — Akiko Maehara, New York, NY

8:12 What is the Role of MSCT in the Assessment and Follow-up of left Main Disease? — Stephan Achenbach, Erlangen, Germany

8:24 left Main evaluation with iVUS: What Cutoff Value Should i Use? — Jose de la Torre Hernandez, Santander, Spain

8:36 left Main evaluation with FFR: What is the impact of Downstream Disease? — John McB Hodgson, Wilkes-Barre, PA

8:48 iVUS Guidance for DeS implantation to Treat lMCA Disease: Optimal endpoints and long-term Results — Soo-Jin Kang, Suwon, Republic of Korea

9:00 Case presentation: How Much Adenosine is enough? — Michael J. Lim, Saint Louis, MO

9:07 Case presentation — Alaide Chieffo, Milan, Italy

9:14 Case presentation — Ning Guo, Xi’an Shaanxi, China, Cincinnati, OH


ACC-i2/TCT

SyMpOSiUM

2626

TAVR Complications: incidence, Management, and AvoidanceMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S102bCMe/CNe Hours: 1.5

Chair: Eric Roselli, Cleveland, OH

8:00 Vascular — Susheel Kodali, New York, NY

8:12 Ai-Assessment, imaging, Treatment — Raj R. Makkar, Los Angeles, CA

8:24 Stroke — Josep Rodes-Cabau, Quebec, Canada

8:36 Conduction System Abnormalities — Raoul Bonan, Montreal, Canada

8:48 Coronary Occlusion/Aortic Rupture — Samir R. Kapadia, Cleveland, OH

9:00 Device embolization/Migration — James B. Hermiller, Indianapolis, IN

9:12 Transapical — Wilson Y. Szeto, Philadelphia, PA


ACC-i2/TCT

SyMpOSiUM

2627

Management of Renovascular HypertensionMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S103cCMe/CNe Hours: 1.5

Co-Chairs: Christopher J. White, New Orleans, LA Joseph M. Garasic, Jamaica Plain, MA

8:00 predictors of Response to Renal Artery Revascularization — Ehtisham Mahmud, San Diego, CA


Monday, March 26, 2012Please Note: The following sessions are listed alphabetically by learning pathway abbreviation based on session start time.

Morning

178 GO for ACC.12!

Mor

ning

8:15 Debate: Stenting is the Treatment of Choice for ≥ 70% Renal Artery Stenosis with Uncontrolled Hypertension that has Failed 3-drug Therapy — Christopher J. Cooper, Toledo, OH

8:30 Debate: Stenting is NOT the Treatment of Choice for ≥ 70% Renal Artery Stenosis with Uncontrolled Hypertension that has Failed 3-drug Therapy — Lance Dworkin, Providence, RI

8:45 Renal Sympathetic Denervation: pro’s and Con’s — Deepak L. Bhatt, Boston, MA

9:00 Renal Stenting: Avoiding Complications — James S. Jenkins, River Ridge, LA

9:15 Renal Stenting: Case presentations: Techniques and pitfalls — Douglas E. Drachman, Boston, MA

ACC-i2/TCT

SyMpOSiUM

2628

left Main Coronary intervention: State-of-the-ArtMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S106bCMe/CNe Hours: 1.5

Co-Chairs: Patrick L. Whitlow, Cleveland, OH George D. Dangas, New York, NY

8:00 Review of Current Data and Guidelines — David E. Kandzari, Atlanta, GA

8:15 Risk Stratification of lMT pCi — Davide Capodanno, Jacksonville, FL

8:25 Review of lMT pCi Techniques — Matthew J. Price, La Jolla, CA

8:40 Functional and Anatomical Assessment — William Fuller Fearon, Stanford, CA

8:55 Case 1: A Case with low Syntax Score — Khaled M. Ziada, Lexington, KY


9:10 Case 2: A Case with High Syntax Score — Thierry Corcos, Paris, France


ACS

SyMpOSiUM

676

Shock in ACSMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S401aCMe/CNe Hours: 1.5

Co-Chairs: Jose P. Henriques, Amsterdam, Netherlands Annapoorna Subhash Kini, New York, NY

8:00 pathophysiology of Cardiogenic Shock and Adjunct Therapies — Michael C. Kim, New York, NY


8:15 primary pCi in STeMi: Does it Reduce Shock incidence? — Sameer Mehta, Miami, FL


8:30 Role of lV Assist Device in Cardiogenic Shock — John M. Lasala, Saint Louis, MO


8:45 portable lV Assist Devices: liFeBRiDGe, eCMO and Other — Semih Buz, Berlin, Germany


9:00 CHF illustrative Case presentations — Annapoorna Subhash Kini, New York, NY

9:12 CHF illustrative Case presentations — Jose P. Henriques, Amsterdam, Netherlands

9:25 Summary — Annapoorna Subhash Kini, New York, NY

ARR

expeRTS

239

Case-Oriented Gaps in the Guidelines: Who Should Get an iCD?Monday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S504aCMe/CNe Hours: 1.5

Chair: Bruce D. Lindsay, Cleveland, OH

Case Andrew E. Epstein, Philadelphia, PA, Mark S. Kremers,Presenters: Charlotte, NC, Andrea M. Russo, Moorestown, NJ

Panelists: Mandeep Bhargava, Cleveland, OH, Anne B. Curtis, Buffalo, NY, N. A. Mark Estes, Boston, MA, Paul A. Heidenreich, Palo Alto, CA

ARR

SyMpOSiUM

677

Clinical Management of the AF patient: Treating the patient and the Health Care providerMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N226CMe/CNe Hours: 1.5

Co-Chairs: Stephen C. Hammill, Rochester, MN Albert L. Waldo, Cleveland, OH

8:00 Reducing the Risk of Anticoagulation — Michael M. Ezekowitz, Wynnewood, PA

8:18 Drug Therapy for Difficult AF — James A. Reiffel, Scarsdale, NY

8:36 When to Give Up on Sinus Rhythm — Win-Kuang Shen, Phoenix, AZ

8:54 Utility of patient Care pathways in AF patients — Luigi Di Biase, Austin, TX

9:12 Reimbursement Considerations in AF Care — Richard I. Fogel, Carmel, IN

CCS

SyMpOSiUM

678

pulmonary Artery Stenosis Current Therapy and Future Directions: live CaseMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N231CMe/CNe Hours: 1.5

Co-Chairs: Frank F. Ing, Houston, TX Lisa T. Bergersen, Boston, MA Mathew Gillespie, Philadelphia, PA

8:00 live Case: pulmonary Artery Stenosis — Jonathan J. Rome, Philadelphia, PA

8:45 pulmonary Artery Rehabilitation Current State of Knowledge: What Do We Need to Know to improve This procedure — James E. Lock, Boston, MA

9:10 Devices Studies and pMA indications in Congenital Heart Disease: past Failures, Successes and Future Directions — Robert H. Beekman, Cincinnati, OH


Monday, March 26, 2012 • ACC.12


Morning

CCS

SyMpOSiUM

679

Women with Congenital Heart Disease: Fertility, pregnancy and MenopauseMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S501aCMe/CNe Hours: 1.5

Co-Chairs: Mary Canobbio, Los Angeles, CA Carole A. Warnes, Rochester, MN

8:00 Biomarkers: How They Can Be Utilized during pregnancy — Candice Silversides, Toronto, Canada

8:16 My Cardiologist Cleared Me for pregnancy but What the Obstetrician Needs to Know — Anthony Gregg, Gainesville, FL

8:32 The Menopause: Not All palpitations Are Cardiac! — Stephen C. Cook, Columbus, OH

8:48 Difficult Decisions i Have to Make in the Care of the pregnant ACHD patient — Katherine Economy, Boston, MA

9:04 psychological Challenges of the Childbearing years — Adrienne H. Kovacs, Toronto, Canada


HF

expeRTS

240

Myocarditis: When to Biopsy, Who to Treat, Which Therapy?Monday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S502CMe/CNe Hours: 1.5

Chair: Peter P. Liu, Toronto, Canada

Case Presenter: Lori Blauwet, Rochester, MN

Panelists: Leslie T. Cooper, Rochester, MN, Joshua M. Hare, Miami, FL, Hans Peter Schultheiss, Berlin, Germany, Guillermo Torre-Amione, TX, Jeffrey A. Towbin, Cincinnati, OH

HF

SyMpOSiUM

680

Controversies in the Management of Heart FailureMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S406bCMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-141-l04-p

Co-Chairs: Carl V. Leier, Columbus, OH Barry M. Massie, San Francisco, CA

8:00 Anemia is a Therapeutic Target in Heart Failure — Inder Anand, Minneapolis, MN

8:10 Anemia is Not a Therapeutic Target in Heart Failure — G. William Dec, Boston, MA

8:26 Role of Diuretics in Treatment of Heart Failure: A Necessary evil — Gadi Cotter, Durham, NC

8:36 Diuretics Are the Best Available Treatment for Heart Failure — Maya E. Guglin, Tampa, FL

8:52 Serial BNp Measurements Are Useful in Heart Failure Management — Alain Cohen-Solal, France

9:02 Serial BNp Measurements Are Not Useless in Heart Failure Management — Richard W. Troughton, Christchurch, New Zealand

9:18 Discussion

HF

SyMpOSiUM

681

Surgical Therapy of Heart FailureMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S404CMe/CNe Hours: 1.5

Co-Chairs: Michael A. Acker, Philadelphia, PA Steven F. Bolling, Ann Arbor, MI

8:00 Aortic Stenosis and low ejection Fraction — Blase A. Carabello, Houston, TX

8:15 Coronary Revascularization in the post-STiCH era — Eric J. Velazquez, Durham, NC

8:30 Mitral Regurgitation and low ejection Fraction — Ted Feldman, Evanston, IL

8:45 Destination Therapy for Advanced Heart Failure — Bartley P. Griffith, Baltimore, MD

9:00 Gene Therapy for Advanced Heart Failure — Roger J. Hajjar, New York, NY

9:15 Cellular Therapy of Heart Failure — Daniel J. Garry, Minneapolis, MN

iMAG

expeRTS

241

imaging the Right VentricleMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S505CMe/CNe Hours: 1.5

Chair: Lawrence G. Rudski, Montreal, QC, Canada

Case Presenter: Laxmi S. Mehta, Powell, OH

Panelists: Tal Geva, Boston, MA, Subha V. Raman, Columbus, OH, Nelson B. Schiller, San Francisco, CA, Dennis A. Tighe, Worcester, MA

iMAG

SyMpOSiUM

682

Advanced lV Dysfunction: A Multimodality ApproachMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S405CMe/CNe Hours: 1.5

Co-Chairs: Judy W. Hung, Boston, MA Issam A. Mikati, Chicago, IL

8:00 Role of MRi in Acute Heart Failure — Andrew E. Arai, Bethesda, MD

8:15 3-D echo — Roberto M. Lang, Chicago, IL

8:30 Strain and Strain Rate imaging: A Multimodality Approach — Thomas H. Marwick, Cleveland, OH

8:45 echo in VAD patients — William F. Armstrong, Ann Arbor, MI

9:00 How and When to Assess Viability — Eric J. Velazquez, Durham, NC

9:15 Cardiac CT in Advanced Heart Failure — Daniel S. Berman, Los Angeles, CA

ACC.12 • Monday, March 26, 2012

180 GO for ACC.12!

Mor

ning

iMAG

SyMpOSiUM

683

Future Directions for Cardiac CTMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S403CMe/CNe Hours: 1.5

Co-Chairs: Lawrence M. Boxt, Bronx, NY William Guy Weigold, Washington, DC

8:00 CT Viability and infarct Detection — Kelley Branch, Seattle, WA

8:18 Cardiac CT for Coronary Flow — James K. Min, New York, NY

8:36 CT Valve Morphology and Function — Mario J. Garcia, Bronx, NY

8:54 CTA plaque imaging: What We Know and Where it is Headed — Szilard Voros, Atlanta, GA

9:12 CT imaging for plaque progression — Matthew J. Budoff, Torrance, CA

liFelONG

BOOT CAMp

112

CCA Research Bootcamp Session i: Methods for engaging in ResearchMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S105dCMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-12-121-l04-p

Chair: Margo B. Minissian, Los Angeles, CA

8:00 Developing a Research project: Getting Started — Sandra M. Oliver-McNeil, Farmington Hills, MI

8:25 Methodology Development after Determining the Research Question — Eileen M. Handberg, Gainesville, FL

8:50 instrument Selection and investigator Developed Case Report Forms — Kay Blum, Baltimore, MD


pRACTiCe

SyMpOSiUM

684

ACC/MedAxiom/ACCA: Cardiovascular Service linesMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S105aCMe/CNe Hours: 1.5

Co-Chairs: Michael K. Schroyer, Zionsville, IN C. Michael Valentine, Lynchburg, VA

8:00 Structure and Models — Keith Churchwell, Nashville, TN, Robin Steaban, Nashville, TN

8:30 Defining Clinical Focus for the Future — Michael K. Schroyer, Zionsville, IN

8:45 Financial Opportunities/Value Based purchasing — Cathleen Biga, Woodridge, IL

9:00 Merging Cultures — Robert Gianguzzi, Fountain Hills, AZ


pReV

SyMpOSiUM

685

ACC China Chapter Session: Cardiovascular Clinical Research and practice in ChinaMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N229CMe/CNe Hours: 1.5

Co-Chairs: Dong Zhao, Beijing, China Dipti Itchhaporia, Newport Beach, CA

8:00 Opening Remarks — Dong Zhao, Beijing, China

8:05 Chinese Hypertension 3G Management: From Guideline to practice — Li Jianping, Beijing, China

8:25 Hypertension Treatment in China: China STATUS ii Study — Yong Huo, Beijing, China

8:45 The Return on expenditure Achieved for lipid Therapy in China Survey — Yujie Zhou, Beijing, China

9:05 A Randomized, Double-blinded Comparison of iopromide and iodixanol in Renally impaired patients Undergoing Cardiac Catheterization (DiReCT Study) — Chen Yundai, Beijing, China

9:25 Closing Remarks — Jack Lewin, Washington, DC

pReV

SyMpOSiUM

686

Global CVD prevention: Heart Disease and Risk Factors in Specific populationsMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S100cCMe/CNe Hours: 1.5

Co-Chairs: Krishnaswami Vijayaraghvan, Phoenix, AZ Salim Yusuf, Hamilton, Canada

8:00 CVD prevention in South Asia — Krishnaswami Vijayaraghvan, Phoenix, AZ

8:15 prevention Strategies in China — Dayi Hu, Beijing, China

8:30 prevention Trends in the Middle east — Mouaz H. Al-Mallah, Riyadh, Saudi Arabia

8:45 CVD prevention in South America — Hector O. Ventura, New Orleans, LA

9:00 Approaches to preventing CVD in Africa — Elizabeth Ofili, Atlanta, GA

9:15 World Wide Risk Factors: Do They Differ? — Salim Yusuf, Hamilton, Canada

QUAl

SyMpOSiUM

687

Where Will Cardiology Be in 2015?Monday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N427CMe/CNe Hours: 1.5

Co-Chairs: James B. Froehlich, Ann Arbor, MI Scott Wright, Rochester, MN

8:00 The Accountable Care Act (ACA) for Dummies — Jack Lewin, Washington, DC

8:18 Reimbursement in the era of Reform — Len Nichols, Washington, DC

8:36 public Reporting: What Does it Mean if My Hospital Gets A Bad Report Card? — Kalon K. L. Ho, Boston, MA

8:54 eHR: Meaningful Use or Meaningfully Useful? — Michael S. Blum, San Francisco, CA

9:12 putting it All Together: What Does This Mean for your practice? — Scott Wright, Rochester, MN



Morning

SpeCiAl

SpeCiAl

305

Joint American College of Cardiology/New England Journal of Medicine late-Breaking Clinical TrialsMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, Hall B, ACC.12 Main TentCMe/CNe Hours: 1.5

Co-Chairs: Patrick T. O’Gara, Boston, MA E. Murat Tuzcu, Cleveland, OH

Panelists: G. Alain Cribier, Rouen, France, Thomas C. Gerber, Jacksonville, FL, C. Michael Gibson, Boston, MA, Robert A. Guyton, Atlanta, GA

8:00 CORONARy: The Coronary Artery Bypass Grafting Surgery Off or On pump Revascularization Study — Andre Lamy, on behalf of the CORONARY Study Investigators, Population Health Research Institute, McMaster University, Hamilton Health Sciences, Hamilton, Canada


8:22 ACRiN pA 4005: Multicenter Randomized Controlled Study of a Rapid “Rule Out” Strategy Using CT Coronary Angiogram Versus Traditional Care for low-risk eD patients with potential ACS — Harold Litt, Chadwick Miller, Constantine Gatsonis, Brad Snyder, Harjit Singh, Laurence Gavin, Daniel Entrikin, James Leaming, Carlos Jamis-Dow, Joan Lacomis, Judd Hollander, University of Pennsylvania, Philadelphia, PA, American College of Radiology Imaging Network, Philadelphia, PA


8:44 Oral Rivaroxaban Alone for Symptomatic pulmonary embolism: The eiNSTeiN pe Study — Harry Roger Buller, Academic Medical Center, Amsterdam, The Netherlands


9:06 late (≥ 2 year) Clinical and echocardiographic Outcomes after Transcatheter vs. Surgical Aortic Valve Replacement: Results from the High-risk Cohort of the pARTNeR Trial — Martin Leon, John Webb, Jeffrey Moses, Michael Mack, D. Craig Miller, Lars Svensson, E. Murat Tuzcu, Craig Smith, Susheel K. Kodali, for the PARTNER Trial Investigators, Columbia University Medical Center and The Cardiovascular Research Foundation, New York, NY


SpeCiAl

SpeCiAl

407

young investigators Award Competition: Clinical investigations, Congenital Heart Disease, and Cardiovascular SurgeryMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N230CMe/CNe Hours: 1.5

Chair: Marc Steven Sabatine, Boston, MA

Judges: Brian H. Annex, Charlottesville, VA Nicholas L. Mills, Edinburgh, Scotland, United Kingdom

8:00 407–4 Sex Differences in Arterial Stiffness and Arterial-Ventricular interactions — Thais Coutinho, Patricia A. Pellikka, Iftikhar J. Kullo, Mayo Clinic, Rochester, MN

8:15 407–5 Coronary Arterial 18f-naf Uptake: A Novel Marker of plaque Biology — Marc R. Dweck, Marcus WL Chow, Nikhil V. Joshi, MIchelle C. Williams, Charlotte Jones, Alison M. Fletcher, Hamish Richardson, Audrey White, Graham McKillop, Edwin JR van Beek, Nicholas A. Boon, James HF Rudd, David E. Newby, University of Edinburgh, Edinburgh, United Kingdom, Univeristy of Cambridge, Cambridge, United Kingdom

8:30 407–6 impact of CT-guided Valve Sizing on post-procedural Aortic Regurgitation in Transcatheter Aortic Valve implantation — Kentaro Hayashida, Erik Bouvier, Thierry Lefevre, Thomas Hovasse, Marie-Claude Morice, Bernard Chevalier, Mauro Romano, Philippe Garot, Darren Mylotte, Arnaud Farge, Patrik Donzeau-Gouge, Bertrand Cormier, Institut Cardiovasculaire Paris Sud, Massy, France

8:45 407–7 impact of Jeopardized Myocardium on Therapeutic Benefit Associated with Completeness of Revascularization vs. Medical Therapy in patients with left Ventricular Systolic Dysfunction: A peT Myocardial perfusion and Metabolism Study — Lee Fong Ling, Thomas Cook, Thomas H. Marwick, Demetrio R. Flores, Weal A. Jaber, Richard C. Brunken, Manuel D. Cerqueira, Rory Hachamovitch, Cleveland Clinic, Cleveland, OH

9:00 407–8 Accuracy of Aortic Annuli Measurements Obtained from Three-dimensional echocardiography, Computed Tomography and Magnetic Resonance imaging Using an in Vitro Model — Wendy Tsang, Michael G. Bateman, Lynn Weinert, Gian Pellegrini, Victor Mor-Avi, Lissa Sugeng, Hubert Yeung, Amit R. Patel, Alexander J. Hill, Paul A. Iazzo, Roberto M. Lang, University of Chicago Medical Center, Chicago, IL

SpeCiAl

SyMpOSiUM

738

Joint Session of the european Society of Cardiology and the American College of Cardiology i: Management of Heart Disease in pregnancyMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N426CMe/CNe Hours: 1.5

Co-Chairs: Michel Komajda, Paris, France John Gordon Harold, Los Angeles, CA

8:00 Congenital Heart Disease — Elyse Foster, San Francisco, CA

8:18 Valvular Heart Disease — Petronella G. Pieper, Groningen, Netherlands

8:36 Cardiomyopathy and Heart Failure — Uri Elkayam, Los Angeles, CA

8:54 Arrhythmias — Speaker TBD

9:12 Hypertension — Irmtraut Kruck, Ludwigsburg, Germany


182 GO for ACC.12!

Mor

ning

TeST

SyMpOSiUM

688

Challenging Sports Cardiology Cases in Older AthletesMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N227bCMe/CNe Hours: 1.5

Co-Chairs: Joseph C. Marek, Oak Brook, IL Robert Vogel, Baltimore, MD

8:00 Case presentation: NFl Combine player with Abnormal eCG — Eugene H. Chung, Chapel Hill, NC

8:05 This player’s eCG is Abnormal: What Now? — Alfred A. Bove, Philadelphia, PA

8:30 Case presentation: 70 year-old Veteran of 114 Marathons, S/p RCA Stent — Stephen A. Siegel, New York, NY

8:35 Detecting CAD in Older Athletes and What to Recommend When you Find it — Paul D. Thompson, Hartford, CT

9:00 Case presentation: 52 year-old Cross Country Skier with Fatigue during the Birkebeiner — Thomas Allison, Rochester, MN

9:05 Should Atrial Arrhythmias be Treated Differently in Athletes? — Mark S. Link, Boston, MA

VAlV

expeRTS

242

Tricuspid Valve Disease Case ManagementMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S503CMe/CNe Hours: 1.5

Chair: Luc Pierard, Liège, Belgium

Case Grace Lin, Rochester, MN, Patrick M. McCarthy,Presenters: Chicago, IL, Yan Topilsky, MN

Panelists: Vera H. Rigolin, Chicago, IL, William J. Stewart, Cleveland, OH

VAlV

SyMpOSiUM

674

Valvular Heart Disease in the Older Adult (with Many DRG Codes): Navigating the OptionsMonday, March 26, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S402CMe/CNe Hours: 1.5

Co-Chairs: Maurice Enriquez-Sarano, Rochester, MN Daniel E. Forman, Boston, MA

8:00 Case presenter — Joseph Maalouf, Rochester, MN

8:05 evaluating the Older Adult Cardiac patient Who’s Failing Medical Therapy — Jeffrey S. Borer, New York, NY

8:14 What’s in the Registries: NCDR, Cath, pC and the Older Adult — Ralph G. Brindis, Oakland, CA

8:23 What’s in the Registries: STS Database, Valvular Outcomes and the Older Adult — Frederick L. Grover, Aurora, CO

8:32 Mitral Transcatheter Options and the Older Adult — Martin B. Leon, New York, NY

8:41 Mitral Surgical Options and the Older Adult — W. Randolph Chitwood, Greenville, NC

8:50 TAVi/TAVR Update — David R. Holmes, Jr., Rochester, MN

8:59 Surgical Aortic Valve Replacement and the Older Adult — Richard J. Shemin, Los Angeles, CA

9:08 Hybrid Approaches: Maximized Gain/Minimized pain? — Stephen Ball, Nashville, TN

9:17 Summary Discussion

VAlV

SelF-DiReCTeD

1503

Heart Songs at ACC.12: A Self-paced Multimedia learning experienceMonday, March 26, 2012, 9:00 a.m. – 5:00 p.m.McCormick Place, Vista Room LobbyCMe/CNe Hours: 2

Back by popular demand is the highly rated Heart Songs Self-Paced Learning Lab — a unique audio- visual program to refresh cardiac auscultation skills. After a pre-test, attendees will listen to Heart Sounds while viewing phonocardiograms, echoes, and more, on an iPod® Touch, iPad® or laptop computer. Attendees can view the sessions and take both the pre-test and post-test on their own device, or use devices provided in the room, to document improvement in their auscultation skills. This clinical skills workshop provides attendees with a choice of three sessions: the first on 5 common heart murmurs and the second on more advanced sounds including bicuspid aortic valve, mitral valve prolapse and hypertrophic cardiomyopathy, among others. The third session is for experts on topics such as combined aortic stenosis and regurgitation; and combined mitral stenosis and regurgitation. In addition, there will be a 3-D echo/auscultation training program available in the Self-Paced Learning Lab. This video program will combine 3-D echo images with the auscultation findings on 4 common valvular abnormalities. Studies have shown that the range of repetition needed to acquire auditory skills can vary four fold. This workshop will tailor the learning to each individual’s need for repetition. Each session takes approximately 30 minutes to complete. This workshop will appeal to cardiovascular specialists and cardiac care team members who want to improve their auscultation skill in both common and more advanced heart sounds.

Co-Chairs: Michael J. Barrett, Blue Bell, PA Carolyn S. Lacey, Fairfield, CA Tahmeed A. Contractor, Allentown, PA Garima Sharma, Philadelphia, PA

ACC-i2/TCT

SpeCiAl

2112

Fellows Bootcamp: Coronary iiMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S103bCMe Hours: 1.5

Co-Chairs: Susheel Kodali, New York, NY James Bernard Hermiller, Jr., Indianapolis, IN

10:30 Avoiding and Treating Complications — James Bernard Hermiller, Jr., Indianapolis, IN

10:45 Bifurcations: Simple and Complex — Thierry Lefevre, Massy, France

11:00 pCi in STeMi and Shock — Timothy D. Henry, Minneapolis, MN

11:15 The post CABG patient: pCi via the liMA and SVG intervention — Susheel Kodali, New York, NY



Morning

11:30 Chronic Total Occlusions: The Fundamentals — William L. Lombardi, Bellingham, WA


ACC-i2/TCT

SpeCiAl

2122

Multi-Disciplinary Management of the Failing Heart: Team-based evaluation and Therapy of Advanced Heart Disease iiMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S102cCMe/CNe Hours: 1.5

Chair: Srihari S. Naidu, New York, NY

Panelists: Juan Carlos Plana, Cleveland, OH, Michael J. Lim, Saint Louis, MO, Marc J. Semigran, Boston, MA, Mauricio G. Cohen, Miami, FL, Frank Pelosi, Ann Arbor, MI, John B. O’Connell, Atlanta, GA, Steven R. Bailey, San Antonio, TX, Michael J. Mack, Plano, TX

10:30 The Role of interventionalists in Heart Failure: From Assist Devices to Valves — Srihari S. Naidu, New York, NY

10:45 Case presentation 3 — James A. Watts, Boston, MA


11:15 Case presentation 4 — David Bartov, New York, NY


11:50 Where Do We Go From Here? — Morton J. Kern, Orange, CA

ACC-i2/TCT

SyMpOSiUM

2629

establishing a Cardiac Catheterization imaging/physiology programMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S101aCMe/CNe Hours: 1.5

Co-Chairs: Neil J. Weissman, Washington, DC Emmanouil S. Brilakis, Dallas, TX

10:30 intravascular Ultrasonography — Robert J. Russo, La Jolla, CA

10:40 Optical Coherence Tomography and Near-infrared Spectroscopy — Emmanouil S. Brilakis, Dallas, TX

10:50 Fractional Flow Reserve — Michael J. Lim, St. Louis, MO

11:00 imaging for Guiding Structural Heart Disease interventions: Tee and iCe — Rebecca T. Hahn, New York, NY

11:10 emerging imaging Applications in the Cardiac Catheterization laboratory — John D. Carroll, Aurora, CO

11:20 Training of Cath lab personnel and Setup for Cath lab Based imaging — Akiko Maehara, New York, NY

11:30 Case presentation: intravascular imaging — Kendrick A. Shunk, San Francisco, CA

11:35 Case presentation: echocardiography (Tee, TTe, etc.) — Amar Krishnaswamy, Cleveland, OH

11:40 Case presentation: FFR — Joel A. Garcia, Denver, CO

11:45 panel Discussion: What Are the Appropriate Real-world indications for These procedures?

ACC-i2/TCT

SyMpOSiUM

2630

Hemodynamics iii (pVl and ASD Closure)Monday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S102bCMe/CNe Hours: 1.5

Co-Chairs: Charanjit S. Rihal, Rochester, MN Igor F. Palacios, Boston, MA

10:30 Anatomy, prevalence, pathophysiology of pVl and ASD — Samir R. Kapadia, Cleveland, OH

10:45 imaging Considerations: echo — Nina Wunderlich, Frankfurt, Germany

10:55 imaging Considerations: CT Guidance — Carlos E. Ruiz, New York, NY

11:05 Case presentation: Transseptal Mitral — Steven L. Goldberg, Seattle, WA

11:10 Case presentation: Transapical Mitral — Chad Kliger, New York, NY

11:15 Case presentation: Retrograde Aortic — Oluseun O. Alli, Rochester, MN

11:20 Overall Results of pVl Closure: US experience — Paul Sorajja, Rochester, MN

11:30 Overall Results of pVl Closure: european experience — Horst Sievert, Frankfurt, Germany

11:40 Case presentation: VSD Closure — George S. Hanzel, Birmingham, MI

11:50 Results post infarct VSD Closure — Ziyad M. Hijazi, Chicago, IL

ACC-i2/TCT

SyMpOSiUM

2631

All you Need to Know About Carotid Artery StentingMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S103cCMe/CNe Hours: 1.5

Co-Chairs: Seemant Chaturvedi, Detroit, MI D. Christopher Metzger, Kingsport, TN

10:30 Carotid Stenting Case Selection: Which patients and Which Anatomy Should be Avoided? — Christopher J. White, New Orleans, LA

10:45 Debate: Carotid Stenting Should be Offered as an Alternative to CeA for Asymptomatic > 80% Average Surgical Risk patients — Kenneth Rosenfield, Boston, MA

11:00 Debate: Carotid Stenting Should Not be Offered as an Alternative to CeA for Asymptomatic > 80% Average Surgical Risk patients — Anthony J. Comerota, Toledo, OH

11:15 proximal Versus Distal protection during Carotid Artery Stenting: Does it Really Matter? — Marco Roffi, Geneva 1211, Switzerland

11:30 Hybrid Approach to Severe Carotid and Coronary Artery Disease — Case Selection — Jan Van der Heyden, Nieuwegein, Netherlands

11:45 Carotid Stenting: Case presentation — Management of Complications — William A. Gray, New York, NY


184 GO for ACC.12!

Mor

ning

ACC-i2/TCT

SyMpOSiUM

2632

DeS: Future DirectionsMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S106bCMe/CNe Hours: 1.5

Co-Chairs: Gregg W. Stone, New York, NY George D. Dangas, New York, NY

10:30 limitations of Current DeS: A pathologist’s View — Renu Virmani, Gaithersburg, MD

10:42 The Clinical perspective: 1st and 2nd Generation DeS Are Not perfect — Ron Waksman, Washington, DC

10:54 Challenges in Creating a Fully Bioresorbable effective Stent — John A. Ormiston, Auckland, New Zealand

11:06 Bioabsorbable Stents: What’s in the pipeline — Raimund A. Erbel, Essen, Germany

11:16 Bioresorbable Coatings and polymer-free DeS — Alexandre Abizaid, Sao Paulo, Brazil

11:26 Drug-eluting Balloons: Novel Techonology and Applications — Sigmund Silber, Zell, Germany

11:36 The Future is Here: BVS Update — Patrick W. Serruys, Rotterdam, Netherlands


ACS

SyMpOSiUM

689

improving STeMi Outcomes: Saving Myocardium and Attenuating RemodelingMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S401aCMe/CNe Hours: 1.5

Co-Chairs: Jane A. Linderbaum, Rochester, MN Debabrata Mukherjee, El Paso, TX

10:30 The importance of ischemic Time in Assessing STeMi Treatment Outcomes — Holger Thiele, Leipzig, Germany

10:43 Stem Cell Therapy for Mi — Warren Sherman, New York, NY

10:55 Stem Cell Therapy Not for Mi — Jochen Wöhrle, Ulm, Germany

11:13 Reducing post Mi Remodeling — Mitchell W. Krucoff, Durham, NC

11:27 Remote ischemic preconditioning in STeMi: Fact or Fiction — Hans Erik Botker, Skejby, Denmark

11:41 State-of-the-Art STeMi Care — Eric R. Bates, Ann Arbor, MI

11:55 Summary — Debabrata Mukherjee, El Paso, TX

ARR

expeRTS

243

perioperative Management of patients with Cardiac implantable electronic DeviceMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S504aCMe/CNe Hours: 1.5

Chair: George H. Crossley, Nashville, TN

Case Presenter: Michael Robert Gold, Charleston, SC

Panelists: Mina Chung, Cleveland, OH, Melanie T. Gura, Akron, OH, Jeanne E. Poole, Seattle, WA

ARR

SyMpOSiUM

690

Controversies in Device TherapyMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S406aCMe/CNe Hours: 1.5

Co-Chairs: Thomas F. Deering, Atlanta, GA Cara Pellegrini, San Francisco, CA

10:30 Should patients with RBBB Be Considered for CRT? — William T. Abraham, Columbus, OH

10:48 Should All patients Have an MRi Conditional Device implanted? — William R. Lewis, Cleveland, OH

11:06 Should the Contraindications for Device implantation for primary prevention Be expanded? — James P. Daubert, Durham, NC

11:24 Should every patient Receive a Dual Chamber iCD? — Bruce L. Wilkoff, Cleveland, OH

11:42 Should All Chronic leads Be extracted? — Charles J. Love, Columbus, OH

ARR

SyMpOSiUM

691

The Genetics of Sudden Cardiac Death: What Do We Know and How Best to evaluate and Manage Such patientsMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place North, N226CMe/CNe Hours: 1.5

Co-Chairs: Federico Gentile, Naples, Italy Arthur J. Moss, Rochester, NY

10:30 Sudden Death in the General population — Sumeet Chugh, Los Angeles, CA

10:48 Short QT Syndrome and early Repolarization — Michael Howard Gollob, London, Canada

11:06 long QT Syndrome — Michael J. Ackerman, Rochester, MN

11:24 Brugada Syndrome — Koonlawee Nadamanee, Inglewood, CA

11:42 Catecholaminergic polymorphic Ventricular Tachycardia — Arthur A. Wilde, Amsterdam, Netherlands

CCS

SyMpOSiUM

692

pulmonary Vein Stenosis: What Are Realistic expectations?Monday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place North, N229CMe/CNe Hours: 1.5

Co-Chairs: Piers E. F. Daubeney, London, United Kingdom James E. Lock, Boston, MA

10:30 Case presentation — Jeffrey Darst, Aurora, CO

10:48 epidemiology and Natural History of pulmonary Vein Stenosis: evolution in Our Understanding — Anna Seale, London, United Kingdom

11:06 pathology and pathogenesis of pulmonary Vein Stenosis: How Well Do We Know This enemy? — Stephen Sanders, Boston, MA

11:24 Surgery for pulmonary Vein Stenosis: Outcomes and expectations in the Current era — Christopher Caldarone, Toronto, Canada

11:42 Transcatheter pulmonary Vein interventions: Do They Help? How and When? — Alan William Nugent, Dallas, TX



Morning

CCS

SyMpOSiUM

693

Challenging imaging issues in Congenital Heart DiseaseMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place North, N231CMe/CNe Hours: 1.5

Co-Chairs: Nancy Ayres, Houston, TX William Mahle, Atlanta, GA

10:30 When 3-D imaging Can Make a Difference — Girish S. Shirali, Charleston, SC

10:48 Quantification of Collateral Flow in Congenital Heart Disease: When and How — Ashwin Prakash, Boston, MA

11:24 What Stress imaging Adds to echocardiography in CHD — Luc Mertens, Toronto, Canada

11:42 Cardiac MRi of Complex Congenital Heart Disease: Rules to live By — Andrew Powell, Boston, MA

HF

SyMpOSiUM

694

lVAD as Destination Therapy for Advanced Heart FailureMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S406bCMe/CNe Hours: 1.5

Co-Chairs: Joseph G. Rogers, Durham, NC Randall C. Starling, Cleveland, OH

10:30 Current State and Up and Coming in MCS — Paul J. Mather, Philadelphia, PA

10:45 When to Support — Andrew Boyle, Milwaukee, WI

11:00 Modeling Risk Assessment — Jennifer Cowger, MI

11:15 BTT and DT: is There a Difference? — Jeffrey Teuteberg, Pittsburgh, PA

11:30 long-term Support: What Are the pitfalls? — Shashank Desai, Fairfax, VA

11:45 Transitioning Back to the Community — Kathleen Grady, Chicago, IL

HF

SyMpOSiUM

695

Management of peripartum Cardiomyopathy: Update 2012Monday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S404CMe/CNe Hours: 1.5

Co-Chairs: Uri Elkayam, Los Angeles, CA Kismet Rasmusson, Salt Lake City, UT

10:30 Racial Differences in Risk and Outcomes in peripartum Cardiomyopathy — Kalgi A. Modi, Shreveport, LA

10:48 Bromocriptine and Recovery — Julie Damp, Nashville, TN

11:06 Risk of Subsequent pregnancies — Angela Kealey, Canada

11:24 internet as Clinical Resource and Research Tool — Jordan Safirstein, NJ

11:42 NHlBi ppCM Network and the ipAC Study — Dennis M. McNamara, Pittsburgh, PA

iMAG

SyMpOSiUM

696

Cardiac CT in 2012: State-of-the-ArtMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S405CMe/CNe Hours: 1.5

Co-Chairs: Ricardo C. Cury, Miami, FL Jack A. Ziffer, Miami, FL

10:30 Calcium Scoring in the Age of CT Angiography — Khurram Nasir, New Haven, CT

10:48 Cardiac Computed Tomographic Angiography: Diagnosis and prognosis of CAD — Benjamin J. W. Chow, Ottawa, Canada

11:06 ischemic Chest pain in the eR — Ronald P. Karlsberg, Beverly Hills, CA

11:24 Cardiac CT Radiation exposures — Sandra Halliburton, Cleveland, OH

11:42 Advances in CT Hardware — Stephan Achenbach, Erlangen, Germany

iMAG

SyMpOSiUM

697

Role of echo in the evaluation and Management of patients with Mitral RegurgitationMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S403CMe/CNe Hours: 1.5

Co-Chairs: Judy W. Hung, Boston, MA Robert A. Levine, Boston, MA

10:30 How echo Has Aided in Our Understanding of MR — Robert A. Levine, Boston, MA

10:45 Role of echo during percutaneous interventions — Judy W. Hung, Boston, MA

11:00 Qualitative versus Quantitative Approaches to Severity — Paul A. Grayburn, Dallas, TX

11:15 Debate: 3-D echo is indispensible for intraoperative evaluation — Roberto M. Lang, Chicago, IL

11:27 3-D echo is Not indispensible for intraoperative evaluation — Patrick M. McCarthy, Chicago, IL

11:45 physiology of Myxomatous Disease: insights from 3-D echo — Sunil V. Mankad, Rochester, MN

pRACTiCe

expeRTS

244

leadership and GovernanceMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S503CMe/CNe Hours: 1.5

Co-Chairs: Suzette Jaskie, Grand Rapids, MI Matthew Phillips, Austin, TX

Panelists: Robert Campbell, Atlanta, GA, C. Michael Valentine, Lynchburg, VA, Blair D. Erb, Bozeman, MT, Matthew Phillips, Austin, TX, Suzette Jaskie, Grand Rapids, MI

pReV

expeRTS

245

Women’s Cardiovascular HealthMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S501aCMe/CNe Hours: 1.5

Chair: Laxmi S. Mehta, Columbus, OH

Case Stacie L. Daugherty, Aurora, CO, Jennifer H. Mieres, Presenters: Lake Success, NY

Panelists: Claire S. Duvernoy, Ann Arbor, MI, Jennifer H. Mieres, Lake Success, NY, Mary N. Walsh, Indianapolis, IN


186 GO for ACC.12!

Mor

ning

pReV

SyMpOSiUM

698

Vitamins and Supplements in Cardiovascular Disease preventionMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S100cCMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-142-l04-p

Co-Chairs: Lynne Braun, Chicago, IL Elizabeth A. Jackson, Ann Arbor, MI

10:30 Vitamin D and CVD — Erin Michos, Baltimore, MD

10:48 Dietary Supplements: Use and Misuse — Rhonda M. Cooper-DeHoff, Gainesville, FL

11:06 Role of integrative Medicine in CVD prevention — Sara Warber, Ann Arbor, MI

11:24 intensive lifestyle Changes for the Treatment of Coronary Heart Disease — Dean Ornish, Sausalito, CA

pReV

SyMpOSiUM

699

Joint Symposium of the preventive Cardiovascular Nurses Association and the American College of CardiologyMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S105dCMe/CNe Hours: 1.5

Chair: Barbara Fletcher, Jacksonville Beach, FL

10:30 Welcome and Symposium Objectives — Barbara Fletcher, Jacksonville Beach, FL

10:35 Maximizing Team efforts for improving patient Outcomes — Alan S. Brown, Naperville, IL

10:50 improving patient Adherence to Complex Regimens — Cindy Lamendola, Palo Alto, CA

11:05 patient Centeredness: What Does it Mean in prevention? — Suzanne Hughes, Akron, OH

11:20 Team-based patient Care: Adhering to Guidelines — Sidney Smith, Jr., Chapel Hill, NC

11:35 patient education in 2012 — Sherry Bumpus, Ann Arbor, MI

11:50 Discussion/Question and Answer

QUAl

SyMpOSiUM

700

lies, Damned lies and Statistics: pitfalls in literature interpretationMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place North, N427CMe/CNe Hours: 1.5

Co-Chairs: Robert A. Harrington, Durham, NC Sharon-Lise T. Normand, Boston, MA

10:30 Non-inferiority Studies — Ralph B. D’Agostino, Boston, MA

10:48 propensity Scores and instrumental Variables — Robert W. Yeh, Boston, MA

11:06 Secondary endpoints and Subgroup Analyses in Clinical Trials — Salim Yusuf, Hamilton, Canada

11:24 Reclassification and Discrimination — Michael Pencina, Boston, MA

11:42 Small effect Size and Number Needed to Treat — Sanjay Kaul, Los Angeles, CA

QUAl

SyMpOSiUM

742

The Future of Cardiovascular Diseases: Where Are We Going (and Where Do We Want to Go)Monday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place North, N426CMe/CNe Hours: 1.5

Co-Chairs: John Gordon Harold, Los Angeles, CA William A. Zoghbi, Houston, TX

10:30 United Nations Summit: The prevention of Noncommunicable Diseases among Women — Nanette Kass Wenger, Atlanta, GA

10:50 Million Hearts: preventing a Million Hearts Attacks and Strokes in Five years — Janet S. Wright, Baltimore, MD

11:10 Transformation of Cardiovascular practice and Care in the emerging World — Jack Lewin, Washington, DC

11:30 Global prevention of Cardiovascular Diseases — Dorairaj Prabhakaran, New Delhi, India


SpeCiAl

SpeCiAl

306

late-Breaking Clinical Trials iVMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place North, Hall B, ACC.12 Main TentCMe/CNe Hours: 1.5

Co-Chairs: Peter A. Brady, Rochester, MN Karol E. Watson, Los Angeles, CA

Panelists: Christie M. Ballantyne, Houston, TX, C. Noel Bairey Merz, Los Angeles, CA, Jorge Plutzky, Boston, MA

10:30 Comparison of Bariatric Surgical procedures and Advanced Medical Therapy for the Treatment of Type 2 Diabetes in patients with Moderate Obesity: 1-year STAMpeDe Trial Results — Philip Raymond Schauer, Sangeeta Kashyap, Kathy Wolski, Stacy Brethauer, John Kirwanj, Claire Pothier, Susan Thomas, Beth Abood, Steven Nissen, Deepak Bhatt, Cleveland Clinic, Cleveland, OH


10:52 A Mendelian Randomized Controlled Trial of long-term Reduction in low-density lipoprotein Cholesterol Beginning early in life — Brian Anthony Ference, Nitin Mahajan, Issa Alesh, Wonsuk Yoo, Karolina K. Mirowska, Abhishek Mewada, Luis Afonso, Joel Kahn, Kim Williams, John Flack, Wayne State University School of Medicine, Detroit, MI


11:14 A Randomized, Double-blind, placebo-controlled Trial of the Safety and efficacy of a Monoclonal Antibody to proprotein Convertase Subtilisin/Kexin Type 9 Serine protease, ReGN727/SAR236553, in patients with primary Hypercholesterolemia (NCT: 01288443) — James McKenney, Michael Koren, Dean Kereiakes, Corinne Hanotin, ANNE-CATHERINE FERRAND, Evan Albert Stein, Regeneron Pharmaceuticals, Incorporated, Tarrytown, NY, Sanofi-aventis US Incorporated, Bridgewater, NJ




Morning

11:36 pacemaker Therapy in patients with Neurally-mediated Syncope and Documented Asystole — Michele Brignole, on the behalf of the ISSUE-3 Investigators, Ospedali del Tigullio, Lavagna, Italy


SpeCiAl

SpeCiAl

408

young investigators Award Competition: Cardiovascular Health Outcomes and population GeneticsMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place North, N230CMe/CNe Hours: 1.5

Chair: Paul Chan, Kansas City, MO

Judges: Rajendra Mehta, Ann Arbor, MI Leslee J. Shaw, Atlanta, GA

10:30 408 – 4 Temporal Relationship of Conduction System Disease and Ventricular Dysfunction in LMNA Cardiomyopathy — Chad R. Brodt, Cardiovascular Division, University of Miami Miller School of Medicine, Miami, FL

10:45 408 – 5 An indirect pooled Comparison of Clinical endpoints with eplerenone and Other Aldosterone Antagonists in Heart Failure: A Systematic Review — Saurav Chatterjee, Chaim Moeller, Nidhi Shah, Oluwaseyi Bolorunduro, Norbert Moskovits, Edgar Lichstein, Debabrata Mukherjee, Maimonides Medical Center, Brooklyn,NY, NY, Texas Tech University Health Sciences Center, El Paso, TX

11:00 408 – 6 Vitamin D Deficiency is Associated with Diastolic Dysfunction in Children with Chronic Kidney Disease — Amit Patange, Rudolph Valentini, Wei Du, Michael Pettersen, Children’s Hospital of Michigan, Detroit, MI

11:15 408 – 7 Differences in the Outcome of patients Undergoing percutaneous Coronary interventions at Teaching versus Non-teaching Hospitals — Amneet Sandhu, Dean Smith, Hitinder S. Gurm, University of Michigan, Ann Arbor, MI

11:30 408 – 8 Cardiac Transplantation in African Americans: A Single Center experience — Prakash Goutham Suryanarayana, Hannah Copeland, Mark Friedman, Jack Copeland, University of Arizona, Tucson, AZ, University of California San Diego, San Diego, CA

SpeCiAl

SyMpOSiUM

741

integrative MedicineMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place North, N227bCMe/CNe Hours: 1.5

Co-Chairs: Jeffery Dusek, Minneapolis, MN Erminia Guarneri, La Jolla, CA

10:30 A proactive, personalized preventive Approach to Cardiovascular Disease — Erminia Guarneri, La Jolla, CA

10:50 integrative Cardiology: Translating Science into improved Clinical Care — Kevin Barrows, San Francisco, CA

11:10 Rationale for Use of integrative Medicine along with Conventional Cardiac Care — Courtney Baechler, St. Paul, MN

11:30 The evidence Base for Use of integrative Medicine for Cardiovascular patients: Model of inpatient integrative Medicine — Jeffery Dusek, Minneapolis, MN


TeST

expeRTS

262

eCGs in Athletes: The Great eCG Screening Debate and Challenging CasesMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S502CMe/CNe Hours: 1.5

Chair: Sanjay Sharma, London, United Kingdom

Panelists: Joseph Atallah, Edmonton, Canada, Anthony Magalski, Leawood, KS, Barry J. Maron, Minneapolis, MN, Antonio Pelliccia, Rome, Italy

10:30 To eCG or Not To eCG: All Athletes Should Be Screened — Antonio Pelliccia, Rome, Italy

10:45 To eCG or Not To eCG: All Athletes Should Not Be Screened — Barry J. Maron, Minneapolis, MN

11:10 interpretation of eCGs in Athletes (with ARS) — Christine E. Lawless, Chicago, IL


VAlV

expeRTS

246

Complications of interventions for Valvular Heart DiseaseMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S505CMe/CNe Hours: 1.5

Chair: Maurice Enriquez-Sarano, Rochester, MN

Case Raoul Bonan, Montreal, Canada, Todd M. Dewey,Presenters: Dallas, TX

Panelists: Kevin Greason, Rochester, MN, David Messika-Zeitoun, Paris, France

VASC

expeRTS

264

Challenging Cases in Anticoagulation Management: Spotlight on the Novel AnticoagulantsMonday, March 26, 2012, 10:30 a.m. – NoonMcCormick Place South, S105aCMe/CNe Hours: 1.5

Chair: Heather L. Gornik, Cleveland, OH

Case Presenter: Aditya M. Sharma, Cleveland, OH

Panelists: Samuel Z. Goldhaber, Boston, MA, Jonathan L. Halperin, New York, NY, John Heit, Rochester, MN, Jeffrey I. Weitz, Hamilton, Canada


188 GO for ACC.12!

NooN

noon SeSSionS

ACC-i2/TCT

iNTl. lUNCH

502

Joint Session of the Argentine Society of Cardiology and the American College of Cardiology: CarotidsMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N226CMe/CNe Hours: 1.5

Co-Chairs: John R. Laird, El Macero, CA Carlos M. Barrero, Buenos Aires, Argentina

Panelists: Cesar A. Belziti, Buenos Aires, Argentina, Jorge Atilio Belardi, Buenos Aires, Argentina

12:15 introduction — John R. Laird, El Macero, CA

12:20 Carotid Disease: Argentine perspective — Oscar A. Mendiz, Buenos Aires, Argentina

12:32 Carotid Disease: US perspective — William A. Gray, New York, NY

12:44 Aortic Disease: Argentine perspective — Juan Carlos Parodi, Buenos Aires, Argentina

12:56 Aortic Disease: US perspective — Robert M. Bersin, Seattle, WA

1:08 lower extremity Vascular Disease: Argentinian perspective — Daniel H. Berrocal, Buenos Aires, Argentina

1:20 lower extremity Vascular Disease: US perspective — Mehdi H. Shishehbor, Cleveland, OH

1:32 Conclusion — Carlos M. Barrero, Buenos Aires, Argentina

ACC-i2/TCT

iNTl. lUNCH

503

Joint Session of the Brazilian Society of Cardiology and the American College of Cardiology: Drug-eluting Stents — From the early Beginning to New Stent platformsMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N426CMe/CNe Hours: 1.5

Co-Chairs: Patrick T. O’Gara, Boston, MA Jadelson P. Andrade, Salvador-Bahia, Brazil

Panelist: Antonio CP Chagas, Sao Paulo, Brazil

12:15 introduction — Patrick T. O’Gara, Boston, MA

12:20 From the Beginning Up to the Second Generation of Drug-eluting Stents: A Decade of learning — Luiz Alberto Mattos, Sao Paolo, Brazil

12:32 Current pattern of DeS Utilization in the United States — Ron Waksman, Washington, DC

12:44 Durable polymers versus Biodegradable Ones: Which is the Best for Device Selection? — Pedro A. Lemos, Sao Paulo, Brazil

12:56 impact of Changing Health Care economics in the United States on Future Use of Drug-eluting Stents — David J. Cohen, Kansas City, MO

1:08 Bioabsorbable everolimus-eluting Stent Research program: State-of-the-Art in 2012 — Alexandre Abizaid, Sao Paulo, Brazil

1:20 Rationale and Design of the Absorb iii Trial — Stephen G. Ellis, Cleveland, OH

1:32 Conclusion — Jadelson P. Andrade, Salvador-Bahia, Brazil

ACC-i2/TCT

iNTl. lUNCH

505

Joint Session of the Chinese Society of Cardiology and the American College of Cardiology: Coronary Total OcclusionsMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N228CMe/CNe Hours: 1.5

Co-Chairs: Jack Lewin, Washington, DC Dayi Hu, Beijing, China

Panelists: Jung Han Yoon, Seoul, Republic of Korea

12:15 introduction — Jack Lewin, Washington, DC

12:20 Current Status of Antegrade Approach for CTO pCi in China — Yaling Han, Shenyang, Liaoning, China

12:32 Complex Antegrade CTO Case example — Dimitri Karmpalotis, Atlanta, GA

12:44 TRi in China and for CTO lesions: Strategic and Technical experience — YueJin Yang, Beijing, China

12:56 prognosis of Successful CTO pCi — James Aaron Grantham, Kansas City, MO

1:08 Retrograde Approach in CTO — Jiyan Chen, Guangzhou, China

1:15 Radial pCi: is it Best Suited for AMi? — Michael C. Kim, New York, NY

1:20 Retrograde CTO Case example — William L. Lombardi, Bellingham, WA

1:32 Conclusion — Dayi Hu, Beijing, China

ACC-i2/TCT

iNTl. lUNCH

511

Joint Session of the Korean Society of Cardiology and the American College of Cardiology: Treating Complex lesionsMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N229CMe/CNe Hours: 1.5

Co-Chairs: Martin B. Leon, New York, NY Ki-Bae Seung, Seoul, Republic of Korea

12:15 introduction — Martin B. Leon, New York, NY

12:20 left Main Case presentation — Duk-Woo Park, Seoul 138-736, Republic of Korea

12:25 left Main Revascularization Decisions: What is on the Horizon? — David E. Kandzari, Atlanta, GA

12:35 left Main lecture — Seung-Jung Park, Songpa-Ku Seoul, Republic of Korea

12:45 imaging Guided Optimal pCi Case presentation — Jang-Ho Bae, Daejeon, Republic of Korea

1:00 imaging Guided Optimal pCi lecture — Myeong-Ki Hong, Seoul, Republic of Korea

1:10 AMi Case presentation — Young Keun Ahn, Gwangju, Republic of Korea



NooN

1:25 AMi lecture — Myung Ho Jeong, Gwang Ju, Republic of Korea

1:35 Conclusion — Ki-Bae Seung, Seoul, Republic of Korea

ACC-i2/TCT

iNTl. lUNCH

518

Joint Session of the Turkish Society of Cardiology and the American College of Cardiology: Devices: ASD’s, VSD’s, perivalvular leaksMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S505CMe/CNe Hours: 1.5

Co-Chairs: E. Murat Tuzcu, Cleveland, OH Omer Kozan, Izmir, Turkey

12:15 introduction — E. Murat Tuzcu, Cleveland, OH

12:20 percutaneous Closure of Multiple ASD Case presentation — Erdogan Ilkay, Ankara, Turkey

12:25 percutaneous Closure of Multiple ASD — Omer Goktekin, Eskisehir, Turkey

Panelists: Muzaffer Degertekin, Istanbul, Turkey, John F. Rhodes, Durham, NC

12:45 VSD Closure in Complex Cases Case presentation — Oktay Ergene, Izmir, Turkey

12:50 VSD Closure in Complex Cases — Levent Saltik, Istanbul, Turkey

Panelists: Baris Okcun, Istanbul, Turkey, Larry A. Latson, Cleveland, OH

1:15 percutaneous large prosthetic Mitral Valvular leak Closure Case presentation — Cevat Kirma, Istanbul, Turkey

1:20 percutaneous large prosthetic Mitral Valvular leak Closure — Mehmet Okzan, Istanbul, Turkey

Panelists: Kudret Aytemir, Ankara, Turkey, Charanjit S. Rihal, Rochester, MN

1:40 Conclusion — Omer Kozan, Izmir, Turkey

ACC-i2/TCT

MOC

819

ACCF Study Sessions for Maintenance of Certification: ABiM Recertification Made easy — interventional Cardiology 2010 Update (B2-K)Monday, March 26, 2012, 12:15 p.m. – 2:45 p.m.McCormick Place South, S105aCMe Hours: 2.5

Please refer to the full session listing, listed on page 192, for additional session information.

ACC-i2/TCT

expeRTS

2313

Non-Coronary Complications Case ReviewsMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S101aCMe/CNe Hours: 1.5

Co-Chairs: Ziyad M. Hijazi, Chicago, IL Larry Latson, Hollywood, FL

Case Frank J. Arena, Hammond, LA, Gamini Galappatthy,Presenters: Colombo, Sri Lanka, Ankur Kalra, Camden, NJ,

Rikesh Patel, San Antonio, TX, Suresh Vijaybasappa Patted, Belgaum, India

Panelists: Quang T. Bui, Torrance, CA, Jose Wiley, New York, NY, John M. Lasala, Saint Louis, MO

ACC-i2/TCT

expeRTS

2314

Structural Case ReviewsMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S102bCMe/CNe Hours: 1.5

Co-Chairs: Carlos E. Ruiz, New York, NY Peter C. Block, Atlanta, GA

Case Sammy Elmariah, Boston, MA, Prabhu Channabasappa Presenters: Halkati, Belgaum, India, Pranav Loyalka, Houston,

TX, Thomas S. Metkus, Baltimore, MD, Anvesha Singh, Derby, United Kingdom

Panelists: Steven R. Bailey, San Antonio, TX, Zahid Amin, Rush, IL, Samir R. Kapadia, Cleveland, OH

ACC-i2/TCT

expeRTS

2315

Shock and Hemodynamic Support Case ReviewsMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S102cCMe/CNe Hours: 1.5

Co-Chairs: William W. O’Neill, Miami, FL Srihari S. Naidu, New York, NY

Case M Chadi Alraies, Cleveland, OH, Joanne Ilustre, Park Presenters: Ridge, IL, Andrew Edward Kott, Chicago, IL,

Emanuele Meliga, Turin, Italy, Syed Tanveer Rab, Atlanta, GA

Panelists: Biswajit Kar, Houston, TX, Erik Magnus Ohman, Durham, NC, Simon R. Dixon, Royal Oak, MI

ACC-i2/TCT

SyMpOSiUM

2633

Controversies in Vascular and endovascular MedicineMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S103cCMe/CNe Hours: 1.5

Co-Chairs: Lawrence A. Garcia, Boston, MA Robert Schainfeld, waltham, MA

12:15 Renal Artery Stenting: Optimal patient Selection and Techniques for endovascular interventions — Herbert Aronow, Ypsilanti, MI

12:30 Asymptomatic Carotid Artery Stenting: Optimal patient Selection and Techniques for endovascular interventions — Marco Roffi, Geneva 1211, Switzerland

12:45 Deep Venous Thrombosis: Optimal patient Selection and Techniques for endovascular interventions — Mohsen Sharifi, Mesa, AZ

1:00 Acute Stroke intervention: Optimal patient Selection and Techniques for endovascular interventions — Alex Abou-Chebl, Louisville, KY

1:15 iliac and Femoral TASC C/D lesions: Optimal patient Selection and Techniques for endovascular interventions — Sahil A. Parikh, Cleveland, OH



190 GO for ACC.12!

NooN

ACC-i2/TCT

SyMpOSiUM

2634

Non-ST-elevation ACS in 2012: What you Need To KnowMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S106bCMe/CNe Hours: 1.5

Co-Chairs: Dean J. Kereiakes, Cincinnati, OH Christopher P. Cannon, Boston, MA

12:15 Routine invasive Treatment Strategy — Keith A. A. Fox, Edinburgh, Scotland, United Kingdom

12:30 Optimal periprocedural pharmacotherapy for pCi in NSTeACS — David J. Moliterno, Lexington, KY

12:45 Revascularization Strategy(s) for NSTeACS — Sorin J. Brener, Brooklyn, NY

1:00 Optimal Vascular Access for pCi in NSTeACS: pros and Cons of Radial Access — Sunil V. Rao, Durham, NC

1:10 Optimal Vascular Access for pCi in NSTeACS: pros and Cons of Femoral Access — Shing-Chiu Wong, New York, NY

1:20 Specific Risk Cohorts for Consideration — Roxana Mehran, New York, NY


ACS

iNTl. lUNCH

513

Joint Session of the Mexican Society of Cardiology and the American College of Cardiology: ACS — improving OutcomesMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S404CMe/CNe Hours: 1.5

Co-Chairs: Eric R. Bates, Ann Arbor, MI Carlos R. Martinez-Sanchez, Mexico City, Mexico Erick Alexanderson, Mexico, DF, Mexico

12:15 introduction to Session — Eric R. Bates, Ann Arbor, MI

12:20 STeMi — Juan P. Verdejo, Mexico City, Mexico

12:30 Guidelines for ACS: Translating the evidence to Best practice — Jeffrey L. Anderson, Murray, UT

12:45 Treatment Strategy of the Acute Coronary Syndrome patient with left Main Disease — Jorge Gaspar-Hernandez, Mexico, DF, Mexico

1:00 implementing Clinical practice Guidelines in ACS to improve Clinical Outcomes — Eric D. Peterson, Chapel Hill, NC

1:15 How to Select the Best Antiplatelet Therapy in Acute Coronary Syndrome — Jose Luis Leiva Pons, San Luis Potosi, Mexico

1:30 Conclusion: New insights Gained from the Mexican Society of Cardiology experience

ARR

iNTl. lUNCH

501

Joint Session of the Japanese College of Cardiology and the American College of Cardiology: Risk Stratification for Sudden Cardiac DeathMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S403CMe/CNe Hours: 1.5

Co-Chairs: Stuart Winston, Ann Arbor, MI Shunichi Miyazaki, Osaka, Japan

12:15 introduction to Session — Stuart Winston, Ann Arbor, MI

12:20 introduction: The Burden of Cardiovascular Disease in the Region, Membership in the Society and initiatives Ongoing or planned — Shunichi Miyazaki, Osaka, Japan

12:30 Noninvasive Testing in Conjunction with lV Function is the Best predictor — Eric N. Prystowsky, Indianapolis, IN

12:45 lV Function Alone is the Best predictor — Tohru Masuyama, Nishinomiya, Japan

1:00 iCDs Should be Used More Judiciously in the primary prevention population — Alfred E. Buxton, Boston, MA

1:15 prophylactic iCD implantation is the Best Way to Reduce the Risk for SCD — Takashi Kurita, Tokyo, Japan

1:30 Conclusion: New insights Gained from the Japanese College of Cardiology experience

ARR

iNTl. lUNCH

509

Joint Session of the Cardiological Society of india and the American College of Cardiology: AF — Medical, ep, Surgical OptionsMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S401aCMe/CNe Hours: 1.5

Co-Chairs: Dipti Itchhaporia, Newport Beach, CA Samuel K. Mathew, Chennai, India

12:15 introduction to Session — Dipti Itchhaporia, Newport Beach, CA

12:20 Case presentation: Nuance of AF, RHD, Moderate MS/MR in a 50 year-old — Navin C. Nanda, Birmingham, AL

12:30 AF Spectrum: primary and Associated With Valvular/Structural Heart Disease — Sanjeev Saksena, Warren, NJ

12:45 Case presentation: Rheumatic HD with AF and Valvular involvement — Amit Vora, Mumbai, India

1:00 Approaches to the patient with AF and Rheumatic Valvular Heart Disease — Ralph J. Damiano, St. Louis, MO

1:15 Approaches in india to AF Treatment in Rheumatic Heart Disease — Calambur Narasimhan, Hyderabad, India

1:30 New insights Gained from the Cardiological Society of india experience



NooN

CCS

iNTl. lUNCH

506

Joint Session of the egyptian Society of Cardiology and the American College of Cardiology: Adult Congenital Heart Disease: Where We Came from and Where We AreMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N231CMe/CNe Hours: 1.5

Co-Chairs: Gerard R. Martin, Washington, DC Mohamed Sobhy Aly, Alexandria, Egypt

12:15 introduction to Session — Gerard R. Martin, Washington, DC

12:20 Changing the Face of ACHD in egypt — Magdi H. Yacoub, Harefield, Middlesex, United Kingdom

12:30 Where We Are Now: The epidemiology and ACHD Databases in North America — Paul Khairy, Montreal, Canada

12:45 Multimodality Non-invasive imaging for Assessment of Adult Congenital Heart Disease — Magdy Rashwan, Alexandria, Egypt

1:00 Cath like an egyptian Congenital interventionalist — Makram R. Ebeid, Jackson, MS

1:15 Catheter intervention in Adult Congenital Heart Disease: Cairo University experience — Khaled Sorour, Cairo, Egypt

1:30 Conclusion: New insights Gained from the egyptian Society of Cardiology experience

HF

iNTl. lUNCH

517

Joint Session of the Spanish Society of Cardiology and the American College of Cardiology: Heart Failure — Devices to TransplantationMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S501aCMe/CNe Hours: 1.5

Co-Chairs: Juan M. Aranda, Gainesville, FL Nicolas Manito, Barcelona, Spain

12:15 introduction to Session — Juan M. Aranda, Gainesville, FL

12:20 Heart Failure: Devices to Transplantation — Akshay S. Desai, Boston, MA

12:30 Contemporary pharmacologic Management of Advanced Heart Failure — Lee R. Goldberg, Philadelphia, PA

12:45 Current indications and Controversies in CRT — Juan Delgado, Madrid, Spain

1:00 Hemodynamic Monitoring Devices in Heart Failure — Robert C. Bourge, Birmingham, AL

1:15 Destination lVAD and Current Role for Heart Transplantation — Javier Segovia, Madrid, Spain

1:30 Conclusion: New insights Gained from the Spanish Society of Cardiology experience

iMAG

iNTl. lUNCH

507

Joint Session of the German Cardiac Society and the American College of Cardiology: imaging — evolving StrategiesMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S406bCMe/CNe Hours: 1.5

Co-Chairs: William A. Zoghbi, Houston, TX Christoph Bode, Freiburg, Germany

12:15 introduction to Session — William A. Zoghbi, Houston, TX

12:20 Case presentation: imaging — evolving Strategies — Orlando Escarcega, Philadelphia, PA

12:30 emerging imaging Modalities in Guiding Valvular interventions — Linda D. Gillam, New York, NY

12:45 imaging: Cardiac Vessels — Raimund A. Erbel, Essen, Germany

1:00 Role of 3-D echo — Frank E. Silvestry, Wayne, PA

1:15 imaging: Myocardium — Georg Ertl, Wuerzburg, Germany

1:30 Conclusion: New insights Gained from the German Cardiac Society experience

iSCHeM

iNTl. lUNCH

508

Joint Session of the British Cardiovascular Society and the American College of Cardiology: NiCe GuidelinesMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N427CMe/CNe Hours: 1.5

Co-Chairs: John Gordon Harold, Los Angeles, CA Iain A. Simpson, Southampton, United Kingdom

12:15 introduction to Session — John Gordon Harold, Los Angeles, CA

12:20 introduction to Guideline preparation: A UK perspective — Huon Gray, Southampton, United Kingdom

12:30 Biomarkers of ischemia: Clinical practice and Guidelines — David A. Morrow, Boston, MA

12:45 Stable Angina: A UK perspective — Robert A. Henderson, Nottingham, United Kingdom

1:00 international participation in NiH and NHS Studies: Not Always NiCe (Applicability, ethical and Financial Considerations) — Richard A. Lange, San Antonio, TX

1:15 ACS: A UK perspective — Mark A. de Belder, Middlesbrough, United Kingdom

1:30 Conclusion: New insights Gained from the British Cardiovascular Society experience


192 GO for ACC.12!

NooN

liFelONG

MOC

819

ACCF Study Sessions for Maintenance of Certification: ABiM Recertification Made easy — interventional Cardiology 2010 Update (B2-K)Monday, March 26, 2012, 12:15 p.m. – 2:45 p.m.McCormick Place South, S105aCMe Hours: 2.5


MOC Faculty: John A. McPherson, Nashville, TN, Alan Zajarias, Saint Louis, MO






liFelONG

MOC

820

ACCF Study Session for Maintenance of Certification: ABiM Recertification Made easy—Clinical Cardiac electrophysiology, 2010 Update (B3-K)Monday, March 26, 2012, 12:15 p.m. – 2:45 p.m.McCormick Place South, S105dCMe Hours: 2.5

Chair: Peter A. Brady, Rochester, MN

MOC Faculty: Kristen K. Patton, Seattle, WA, Sherry Saxonhouse, Charlotte, NC


Attendees must be enrolled in the ABIM’s MOC program to claim MOC points. If you are not enrolled, please allow sufficient time to do this prior to the start

of the session. ABIM staffs are available onsite to answer your MOC questions and help with enrollment.




pReV

iNTl. lUNCH

512

Joint Session of the National Heart Association of Malaysia and the American College of Cardiology: Resistant HypertensionMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S504aCMe/CNe Hours: 1.5

Co-Chairs: Richard A. Chazal, Fort Myers, FL Kui-Hian Sim, Sarawak, Malaysia

12:15 introduction to Session — Richard A. Chazal, Fort Myers, FL

12:20 Challenging Cases from Malaysia — Wan Azman Wan Ahmad, Malaya, Malaysia

12:45 Hypertension Strategies: From Simple to Complex — David J. Becker, Philadelphia, PA

1:00 percutaneous Renal interventions — Robaayah Zambahari, Kuala Lumpur, Malaysia

1:15 Sequential Selections: Choosing/Adding Agents — Marc E. Shelton, Springfield, IL

1:30 Conclusion: New insights Gained from the National Heart Association of Malaysia experience

pReV

iNTl. lUNCH

516

Joint Session of the South American Society of Cardiology and the American College of Cardiology: prevention — Assessing and educating across RegionsMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S502CMe/CNe Hours: 1.5

Co-Chairs: Ralph G. Brindis, Oakland, CA Maria Paniagua de Decoud, Asuncion, Paraguay

12:15 introduction to Session — Ralph G. Brindis, Oakland, CA

12:22 Heart Failure in South America — Hector O. Ventura, New Orleans, LA

12:39 Cardio-prevention Strategies in South America — Paola Varleta, Santiago, Chile

12:56 Utilizing imaging for Cardiovascular prevention — Miguel A. Quinones, Houston, TX



NooN

1:13 Diet, exercise, Vitamins and Other Non-prescription Therapeutics — Jorge Lerman, Buenos Aires, Argentina

1:30 Conclusion: New insights Gained from the South American Society of Cardiology experience

pReV

SyMpOSiUM

701

Role of physical Activity in CVD preventionMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S100cCMe/CNe Hours: 1.5

Co-Chairs: Barbara Fletcher, Jacksonville Beach, FL Elizabeth A. Jackson, Ann Arbor, MI

12:15 Biophysiological effects of physical Activity on CVD Reduction — Gerald Fletcher, Jacksonville, FL

12:33 physical Activity in primary prevention — Vera Bittner, Birmingham, AL

12:51 Role of exercise Following ACS — Barry A. Franklin, Royal Oak, MI

1:09 Use of the internet to improve physical Activity — Caroline Richardson, Ann Arbor, MI

1:27 issues of Adherence and Quality of life — Jane Nelson Worel, Middleton, WI

QUAl

iNTl. lUNCH

510

Joint Session of the israel Heart Society and the American College of Cardiology: pCiMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N230CMe/CNe Hours: 1.5

Co-Chairs: George D. Dangas, New York, NY Chaim Lotan, Jerusalem, Israel

12:15 introduction to Session — George D. Dangas, New York, NY

12:20 Case presentation: Strategies to Reduce Bleeding in patients with ACS undergoing pCi — Aryeh Shalev, Los Angeles, CA

Panelists: Aaron D. Kugelmass, Springfield, MA, Amit Segev, Tel Aviv, Israel


12:40 establishing a Useful pCi Registry to inform Outcomes — John C. Messenger, Aurora, CO

12:55 Case presentation: Treatment of the Non-culprit lesion in patients with ACS — STeMi and NSTeMi — Mony Shuvy, Jerusalem, Israel

Panelists: Aaron D. Kugelmass, Springfield, MA, Yoseph Rozenman, Holon, Israel


1:15 Qi examples to improve pCi Outcomes — Steven P. Marso, Kansas City, MO

1:30 Conclusion: New insights Gained from the israel Heart Society experience

QUAl

iNTl. lUNCH

515

Joint Session of the Saudi Heart Association and the American College of Cardiology: Quality RegistriesMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place North, N227bCMe/CNe Hours: 1.5

Co-Chairs: Frederick A. Masoudi, Denver, CO Hani Najm, Riyadh, Saudi Arabia

12:15 introduction to Session — Frederick A. Masoudi, Denver, CO

12:20 Case Outcomes: Quality Registries — Paul D. Varosy, Denver, CO

12:30 establishing a Useful Quality Registry — John S. Rumsfeld, Denver, CO

12:45 Acute Heart Failure: Real life versus Clinical Trials — Khalid F. Alhabib, Riyadh, Saudi Arabia

1:00 Heart Function Clinic: Real life versus Clinical Trials — Abdelfatah A. Elasfar, Riyadh, Saudi Arabia

1:15 Using Registry Data to inform Quality improvement — Hitinder S. Gurm, Ann Arbor, MI

1:30 Conclusion: New insights Gained from the Saudi Heart Association experience

SpeCiAl

SpeCiAl

113

FiT Forum iV: Guidance for the First Steps of your Cardiology CareerMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S402CMe Hours: 1.5

12:15 Welcome — Justin Matthew Bachmann, Dallas, TX

12:20 How Do you pass the Boards? — David E. Winchester, Gainesville, FL

12:30 Another perspective on Boards — Joseph G. Murphy, Rochester, MN


12:45 interviewing Tips and Contract Negotiations — Susan Childs, Rougement, NC


1:15 Financial planning for Future Cardiologists — Michael F. Merrill, Portland, OR

1:27 Financial planning for Future Cardiologists — Anders Ramstad, Portland, OR


VAlV

iNTl. lUNCH

504

Joint Session of the Canadian Cardiovascular Society and the American College of Cardiology: Repairs/Replacement: Catheter-based or (Minimally invasive) SurgeryMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S405CMe/CNe Hours: 1.5

Co-Chairs: David R. Holmes, Jr., Rochester, MN Blair J. O’Neill, Edmonton, Canada

12:15 introduction to Session — David R. Holmes, Jr., Rochester, MN


194 GO for ACC.12!

AFTE

RNOO

N

12:20 Three-Dimensional echocardiographic imaging of Catheter-based Valve Treatment — Joseph Maalouf, Rochester, MN

12:30 Minimally invasive Mitral Repair — W. Randolph Chitwood, Greenville, NC

12:45 TAVi: World-wide and Canadian Results and existing and Changing indications — Josep Rodes-Cabau, Quebec, Canada

1:00 periprosthetic Regurgitation Closure — Charanjit S. Rihal, Rochester, MN

1:15 Structural Heart Disease interventions: Now and Over the Next Ten years — Anita W. Asgar, Montreal, Canada

1:30 Conclusion: New insights Gained from the Canadian Cardiovascular Society experience

VASC

iNTl. lUNCH

514

Joint Session of the pakistan Cardiac Society and the American College of Cardiology: VTe, pHTNMonday, March 26, 2012, 12:15 p.m. – 1:45 p.m.McCormick Place South, S503CMe/CNe Hours: 1.5

Co-Chairs: Shahbudin H. Rahimtoola, Los Angeles, CA Azhar Faruqui, Karachi, Pakistan

12:15 introduction to Session — Shahbudin H. Rahimtoola, Los Angeles, CA

12:20 A Case of Recurrent VTe Resulting in pHTN — Syed Zahid Jamal, Karachi, Pakistan

12:30 Clinical Recognition and prevention of DVT — Khan Shah Zaman, Karachi, Pakistan

12:45 Venous Thromboembolism (VTe) as it Related to Chronic Thromboembolic Disease — William R. Auger, San Diego, CA

1:00 US experience with endovascular Management of DVT — Riyaz Bashir, Philadelphia, PA

1:15 Medical Management and Device Treatment of Chronic Recurrent VTe — Syed Zahid Jamal, Karachi, Pakistan

1:30 Conclusion: New insights Gained from the pakistan Cardiac Society experience

Afternoon SeSSionS

ACC-i2/TCT

SpeCiAl

2113

Fellows Bootcamp: Case ReviewsMonday, March 26, 2012, 12:30 p.m. – 1:30 p.m.McCormick Place South, S103bCMe Hours: 1

Co-Chairs: Thomas Tu, Louisville, KY Ajay J. Kirtane, New York, NY

12:30 pCi left Main Radial pCi — Sunil V. Rao, Durham, NC

12:45 i Can’t Get the *?@# Stent There — Ajay J. Kirtane, New York, NY

1:00 Multi-vessel pCi Guided FFR — William Fuller Fearon, Stanford, CA

1:15 perforation — Thomas Tu, Louisville, KY

ACC-i2/TCT

CASe ReVieW

2203

live and Taped Case Sesion iii: Valvular Heart DiseaseMonday, March 26, 2012, 12:30 p.m. – 2:30 p.m.McCormick Place North, Hall B, ACC.12 Main TentCMe/CNe Hours: 2

Co-Chairs: John G. Webb, Vancouver, Canada Michael J. Mack, Plano, TX

Panelists: James Bernard Hermiller, Indianapolis, IN, Rebecca T. Hahn, New York, NY, Jonathon Leipsic, Vancouver, BC, Ganesh Manoharan, Belfast, United Kingdom, G. Alain Cribier, Rouen, France, John Carroll, Aurora, CO, Vasilis Babaliaros, Atlanta, GA, Augusto Pichard, Washington, DC

12:30 live Case from the University of pennsylvania, philadelphia, pA — Howard C. Herrmann, Philadelphia, PA

1:15 Requirements for a Successful TAVR program: The Multi-disciplinary Heart Team and Beyond — Samir R. Kapadia, Cleveland, OH

1:25 A Surgeon’s perspective of Aortic Valve Therapy in the era of TAVR — Vinod H. Thourani, Atlanta, GA

1:35 Status Update on Transcatheter Mitral Valve Therapies — Ted Feldman, Evanston, IL


2:00 Taped Case from Cedars-Sinai Medical Center, los Angeles, CA — Saibal Kar, Los Angeles, CA

ACC-i2/TCT

SpeCiAl

2114

Fellows Bootcamp: Structural HeartMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S103bCMe Hours: 1.5

Co-Chairs: Raoul Bonan, Montreal, Canada D. Scott Lim, Charlottesville, VA

2:00 Adult Congenital intervention (ASD/pFO⋯.) — D. Scott Lim, Charlottesville, VA

2:15 Transseptal Technique: Hemodynamic Aortic and Mitral Valve — Raoul Bonan, Montreal, Canada

2:30 TAVi and BAV — Jeffrey J. Popma, Newton, MA

2:45 percutaneous Mitral Repair and Replacement — Anita W. Asgar, Montreal, Canada

3:00 left Appendage Closure — Saibal Kar, Los Angeles, CA



noon


AFTERNOON

ACC-i2/TCT

SpeCiAl

2132

Anatomy and Transcatheter Therapy for the Structural Heart interventionalist ii: left Atrial Appendage Closure, pFO, ASD and Transseptal puncture (with Remote Demonstrations from the Seattle Science Foundation)Monday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S102cCMe/CNe Hours: 1.5

Remote Mark Reisman, Seattle, WADemonstrator:

Co-Chairs: John D. Carroll, Aurora, CO Carlos E. Ruiz, New York, NY

Panelists: Ziyad M. Hijazi, Chicago, IL, Steven J. Yakubov, Columbus, OH, Michael J. Landzberg, Boston, MA, Matthew J. Price, La Jolla, CA, Horst Sievert, Frankfurt, Germany, Saibal Kar, Los Angeles, CA

2:00 pFO and ASD Anatomy — Mark Reisman, Seattle, WA

2:15 Case presentation: pFO — John D. Carroll, Aurora, CO

2:20 Case presentation: ASD — Ziyad M. Hijazi, Chicago, IL

2:25 Anatomical perspectives for pFO and ASD Devices — Mark Reisman, Seattle, WA

2:40 left Atrial Appendage Anatomy — Mark Reisman, Seattle, WA

2:55 Case presentation: left Atrial Appendage Closure Device — Saibal Kar, Los Angeles, CA

3:00 Case presentation: left Atrial Appendage Closure Device — Horst Sievert, Frankfurt, Germany

3:05 Case presentation: left Atrial Appendage ligation Device — Steven J. Yakubov, Columbus, OH

3:10 Anatomical perspectives of left Atrial Appendage Devices — Mark Reisman, Seattle, WA


ACC-i2/TCT

SyMpOSiUM

2635

imaging Transcatheter Aortic Valve procedures ii: Selecting the Best patient, Valve and Vascular ApproachMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S101aCMe/CNe Hours: 1.5

Co-Chairs: Augusto Pichard, Washington, DC Igor F. Palacios, Boston, MA

2:00 life after pARTNeR: Where We Go from Here — Martin B. Leon, New York, NY

2:08 Aortic Valve Anatomy: Understanding the Transcatheter Valve landing Zone — Jeffrey J. Popma, Newton, MA

2:16 patient Selection for TAVR: Role of echocardiography — Robert J. Siegel, Los Angeles, CA

2:24 The Role of MRi and CT for the Aortic Valvular Complex and Arteries — Paul Schoenhagen, Cleveland, OH

2:32 The Role of imaging in THV Choice: it’s Not Just about the Annulus — Balloon-expandable THV — Robert R. Moss, Vancouver, Canada

2:38 The Role of imaging in THV Choice: it’s Not Just about the Annulus — Self-expanding THV — Ganesh Manoharan, Belfast, United Kingdom

2:44 The Role of imaging in THV Choice: it’s Not Just about the Annulus — imaging Clues to Select one Valve Over the Other — Stamatios Lerakis, Atlanta, GA

2:50 panel Discussion: Which imaging Modality is the Most Useful in TAVR? CT-MRi — Paul Schoenhagen, Cleveland, OH

2:58 panel Discussion: Which imaging Modality is the Most Useful in TAVR? Tee — Robert J. Siegel, Los Angeles, CA

3:06 panel Discussion: Which imaging Modality is the Most Useful in TAVR? Fluoroscopy/Angiography — Augusto Pichard, Washington, DC

3:14 imaging Approach to Choosing Vascular Access: Femoral Artery, Subclavian Artery, Aortic or Apical Access — Dominik Fleischmann, Stanford, CA

3:22 Role of imaging in predicting and preventing Stroke — Samir R. Kapadia, Cleveland, OH

ACC-i2/TCT

SyMpOSiUM

2636

Spotlight Session on TAVRMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S102bCMe/CNe Hours: 1.5

Co-Chairs: D. Craig Miller, Stanford, CA Lars G. Svensson, Cleveland, OH

2:00 How to Choose patients for TAVR vs Open AVR — Blase A. Carabello, Houston, TX

2:15 The procedure — Working Together, the Heart Valve Team Concept, is it Real? — Michael J. Mack, Plano, TX

2:30 Training Requirements: Training, Site Readiness — the Society’s View — Helene Eltchaninoff, Rouen, France

2:45 Debate:TAVR — The Future is Bright, TAVR Will Grow Well Beyond the inoperable patient — Martin B. Leon, New York, NY

3:00 Debate: TAVR — TAVR Will Remain limited to inoperable and Very High Risk patients Due to Complications — Neil E. Moat, London, United Kingdom

3:15 Can We Afford TAVR: impact on Hospitals and CMS — David J. Cohen, Kansas City, MO

ACC-i2/TCT

SyMpOSiUM

2637

Management of Symptomatic Severe Carotid Artery DiseaseMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S103cCMe/CNe Hours: 1.5

Co-Chairs: Daniel G. Clair, Cleveland, OH Jay S. Yadav, Atlanta, GA

2:00 patient and equipment Selection to Optimize Carotid Stent Outcomes in Symptomatic patients — Gary S. Roubin, New York, NY


196 GO for ACC.12!

AFTE

RNOO

N

2:15 Acute Stroke Therapy: State-of-the-Art — Stephen R. Ramee, New Orleans, LA

2:30 Debate: Carotid Stenting Should be Considered an Alternative to CeA for Symptomatic Carotid Disease in Average Surgical Risk patients — Herbert D. Aronow, Ypsilanti, MI

2:45 Debate: Carotid Stenting Should Not be Considered an Alternative to CeA for Symptomatic Carotid Disease in Average Surgical Risk patients — Anthony J. Comerota, Toldeo, OH

3:00 Case presentation: When and How to Treat Common Carotid, Subclavian and innominate Stenosis — Douglas E. Drachman, Boston, MA


ACC-i2/TCT

SyMpOSiUM

2638

State-of-the-Art STeMi: All you Need to KnowMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S106bCMe/CNe Hours: 1.5

Co-Chairs: Erik Magnus Ohman, Durham, NC Bruce R. Brodie, Greensboro, NC

2:00 Optimizing Time to Treatment for STeMi: emphasis on Total ischemic Time — Alice K. Jacobs, Boston, MA

2:15 Optimal Adjunctive pharmacotherapy for primary pCi — George Dangas, New York, NY

2:30 Strategies for Thrombus Removal — C. Michael Gibson, Boston, MA

2:45 Mechanical Support for Treatment of Cardiogenic Shock and Hemodynamic instability — John M. Lasala, Saint Louis, MO

3:00 protective and Reparative Therapies in STeMi — Timothy D. Henry, Minneapolis, MN

3:15 illustrative Case example and panel Discussion — Eric R. Bates, Ann Arbor, MI

ARR

SyMpOSiUM

702

Sudden Cardiac Death Risk Stratification in Heart Failure: past, present and Future DirectionsMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S406aCMe/CNe Hours: 1.5

Chair: A. John Camm, London, United Kingdom

2:00 Assessment of lV Function — Sumeet Chugh, CA

2:15 Markers of Autonomic Tone — Marek Malik, Surrey, United Kingdom

2:30 T Wave Alternans — Richard L. Verrier, Boston, MA

2:45 electrophysiologic Study — Ralph J. Verdino, Philadelphia, PA

3:00 imaging to predict Sudden Death: Going Beyond the ejection Fraction — Alan H. Kadish, Chicago, IL

3:15 Genomics — Dawood Darbar, Nashville, TN

ARR

SyMpOSiUM

703

Syncope in Special populationsMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N227bCMe/CNe Hours: 1.5

Co-Chairs: Stefan H. Hohnloser, Frankfurt am Main, Germany Robert Myerburg, Miami, FL

2:00 The ederly patient — Steven M. Markowitz, New York, NY

2:18 The Athlete with Syncope — Andrew E. Epstein, Philadelphia, PA

2:36 patients with Structural Heart Disease and lVeF >35% — Robert Myerburg, Miami, FL

2:54 patients with a Family History of Sudden Cardiac Death — Hugh Calkins, Baltimore, MD

3:12 eCG Features That May indicate a potenitally life Threatening Arrhythmia as the Cause for Syncope — Joseph Edward Marine, Baltimore, MD

CCS

expeRTS

247

Acquired Heart Disease in Childhood epidemiology: Current and Future ManagementMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S501aCMe/CNe Hours: 1.5

Chair: Jane Newburger, Boston, MA

Case Presenter: Agustin E. Rubio, Seattle, WA

Panelists: Sarah De Ferranti, Boston, MA, Peter Morelli, Stoneybrook, NY, Masato Takahashi, CA, Lloyd Y. Tani, Salt Lake City, UT

HF

SyMpOSiUM

704

Cardiac Resynchronization Therapy: Whom to Refer for implantation?Monday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S406bCMe/CNe Hours: 1.5

Co-Chairs: James P. Daubert, Durham, NC Marc Pfeffer, Boston, MA

2:00 Mechanical and eletrical effects of Cardiac Resynchronization Therapy — David Spragg, Baltimore, MD

2:16 echocardiographic evidence for CRT effects on Myocardial Structure and Function — Scott D. Solomon, Boston, MA

2:32 Role of QRS Duration and Morphology in Selecting patients for CRT-D — Wojciech Zareba, Rochester, NY

2:48 effect of CRT on Heart Failure and Arrhythmia endpoints — Michael Robert Gold, Charleston, SC

3:04 CRT in Atrial Fibrillation patients: Feasibility and effects — Jonathan S. Steinberg, New York, NY


HF

SyMpOSiUM

705

Understanding the Complexity of the Right Ventricle: Challenges and progressMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S404CMe/CNe Hours: 1.5

Co-Chairs: Teresa De Marco, San Francisco, CA Srinivas Murali, Pittsburgh, PA

2:00 Decompensated Right Heart Failure: pharmacologic Support — Paul R. Forfia, Philadelphia, PA



AFTERNOON

2:13 The Right Ventricle in pAH: The Determinant Factor — Vallerie V. McLaughlin, Ann Arbor, MI

2:26 Assessing the RV during exercise — Gregory D. Lewis, Boston, MA

2:40 Decompensated Right Heart Failure: Mechanical Approaches — Myung H. Park, Baltimore, MD

2:53 evaluation and Management of Right Heart Failure in Severe lV Dysfunction: is the RV Healthy enough for Advanced Therapies? — Marc A. Simon, Pittsburgh, PA

3:07 Clinical Scenarios of Concordant and Discordant RV and lV Failure — Navin Rajagopalan, Lexington, KY


HF

SyMpOSiUM

706

Joint Symposium of the italian Federation of Cardiology and the pennsylvania Chapter of the American College of Cardiology: Update on the Treatment of Atrial FibrillationMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N230CMe/CNe Hours: 1.5

Co-Chairs: Gerald V. Naccarelli, Hershey, PA Marino Scherillo, Benevento, Italy

2:00 Catheter Ablation for Atrial Fibrillation: patient Selection, efficacy and Anticoagulation Management — Francis E. Marchlinski, Bala Cynwyd, PA

2:20 Atrial Fibrillation Management: The Current Guidelines — Sandeep K. Jain, Pittsburgh, PA

2:40 The Role of New Antithrombotic Drugs in the Treatment of Atrial Fibrillation — Salvatore Novo, Rome, Italy

3:00 New insights in the pathogenesis of Atrial Fibrillation — Francesco Romeo, Rome, Italy


iMAG

SyMpOSiUM

707

Management of the patient with Valvular Heart Disease: Role of echoMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S405CMe/CNe Hours: 1.5

Co-Chairs: Linda D. Gillam, New York, NY Judy W. Hung, Boston, MA

2:00 Management of Degenerative Mitral Regurgitation Using 2-D and 3-D echocardiography — Vera H. Rigolin, Chicago, IL

2:15 ischemic Mitral Reurgitation Assessment by echocardiography — Judy W. Hung, Boston, MA

2:30 patient prosthesis Mismatch: Diagnosis and Scope of the problem — Philippe Pibarot, Sainte Foy, Canada

2:45 Stress echocardiography in Management of Valvular Heart Disease — Luc Pierard, Liège, Belgium

3:00 Update on prosthetic Valve Assessment by echocardiography Guidelines — Stephen H. Little, Houston, TX

3:15 echo Assessment of the Tricuspid Valve — Muhamed Saric, New York, NY

iMAG

SyMpOSiUM

708

Advances in Nuclear Cardiology: Current and Future ApplicationsMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S403CMe/CNe Hours: 1.5

Co-Chairs: George A. Beller, Charlottesville, VA E. Gordon DePuey, III, New York, NY

2:00 Advances in SpeCT Hardware and Software: Where Are We and What is Applicable ? — Milena J. Henzlova, New York, NY

2:15 Radiation Reduction in SpeCT: How to Maximize the yield with protocols and Technology Advances — John J. Mahmarian, Houston, TX

2:30 Non-Coronary Advances in SpeCT: emerging Role of MiBG imaging in Heart Failure Risk Stratification — Mark I. Travin, Pleasantville, NY

2:45 BMipp SpeCT imaging in Acute Chest pain imaging — Vasken Dilsizian, Baltimore, MD

3:00 SpeCT in Cardiac Dyssynchrony — Ernest V. Garcia, Atlanta, GA

3:15 Molecular Applications of SpeCT imaging: Atherosclerosis, Apoptosis and Beyond — Albert J. Sinusas, New Haven, CT

iSCHeM

SyMpOSiUM

709

Transitioning from ACS to Stable ischemic Heart DiseaseMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S401aCMe/CNe Hours: 1.5

Co-Chairs: Donna M. Polk, Hartford, CT Nanette Kass Wenger, Atlanta, GA

2:00 Antiplatelet Therapy: From Start to Finish — Stephen D. Wiviott, Boston, MA


2:23 Risk Stratification: Who Gets What and When? — Rita F. Redberg, San Francisco, CA


2:45 Sexual Activity: is “Don’t Ask, Don’t Tell” the Best policy? — Richard A. Lange, San Antonio, TX


3:08 Cardiac Rehabilitation: Why Break a Sweat? — Vera Bittner, Birmingham, AL


liFelONG

CORe

821

Core Curriculum: Cardiac CatheterizationMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N226CMe/CNe Hours: 1.5

Chair: Zoltan G. Turi, Camden, NJ

2:00 Angiography: Approach to interpretation and pitfalls — Ajay J. Kirtane, New York, NY


198 GO for ACC.12!

AFTE

RNOO

N

2:25 left Heart Hemodynamics: HCM, Aortic and Mitral Disease — Morton J. Kern, Orange, CA

2:50 Cardiac Constriction, Restriction, and Tamponade — Barry Borlaug, Rochester, MN


liFelONG

CORe

822

Core Curriculum: preventive CardiologyMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N229CMe/CNe Hours: 1.5

Chair: Karthikeyan Ananthasubramaniam, West Bloomfield, MI

2:00 lipids and Cardiovascular Disease — Elizabeth A. Jackson, Ann Arbor, MI

2:25 Diabetes and Cardiovascular Disease — David Aguilar, Houston, TX

2:50 Hypertension and Cardiovascular Disease — Andrew M. Kates, Saint Louis, MO


pHTN

expeRTS

249

pearls and Caveats in Managing patients with pulmonary HypertensionMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S505CMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-12-129-l01-p

Chair: Michael A. Mathier, Pittsburgh, PA

Case Presenter: Dana McGlothlin, San Francisco, CA

Panelists: Michael Cuttica, Chicago, IL, Robert P. Frantz, Rochester, MN, Mardi Gomberg-Maitland, Chicago, IL

pRACTiCe

expeRTS

248

issues That Have Caused Medical professional liability Claims: Are you at Risk? A Special presentation from The Doctors CompanyMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S504aCMe/CNe Hours: 1.5

Chair: Richard A. Chazal, Fort Myers, FL

Case Presenters: Robin Diamond, Napa, CA, David B. Troxel, Napa, CA

pRACTiCe

SyMpOSiUM

710

impact of Healthcare policy on the Academic Cardiovascular MissionMonday, March 26, 2012, 2:00 p.m. – 5:30 p.m.McCormick Place South, S402CMe/CNe Hours: 3.5

Co-Chairs: Joseph A. Hill, Dallas, TX Marvin A. Konstam, Boston, MA

2:00 Welcome and introduction — Joseph A. Hill, Dallas, TX

Training the Next Generation of Cardiovascular practitioners

2:05 Training Cardiovascular Specialists in 2012 — Chittur A. Sivaram, Oklahoma City, OK

2:20 perspective of ACGMe — Thomas J. Nasca, Chicago, IL

education for a lifetime

2:35 lifelong education — Eric S. Williams, Indianapolis, IN

2:50 Roundtable Discussion: Rising to the Challenge — What Will (Should) Training and education look like in 2022?

Panelists: Justin Matthew Bachmann, Dallas, TX, Lisa A. Mendes, Brentwood, TN, Rick A. Nishimura, Rochester, MN, Chittur A. Sivaram, Oklahoma City, OK, Eric S. Williams, Indianapolis, IN

Research: Novel Diagnostic and Therapeutic Strategies for the Future

3:15 Academic Cardiovascular Research: Where Are We Today? — Douglas L. Mann, St. Louis, MO

3:30 perspective of the NHlBi — Sonia I. Skarlatos, Bethesda, MD

3:45 Roundtable Discussion: Rising to the Challenge — What Will (Should) Academic CV Research look like in 2022?

Panelists: Robert O. Bonow, Chicago, IL, James A. De Lemos, Dallas, TX, Douglas L. Mann, Saint Louis, MO, Gordon Tomaselli, Baltimore, MD

4:05 Break

Delivery of Superior, Coordinated Clinical Care

4:20 efficient, Cost-effective, Coordinated Care in the Academic Setting — Marvin A. Konstam, Boston, MA

4:35 Roundtable Discussion: What Will (Should) Clinical Cardiovascular Care in an Academic Setting look like in 2022?

Panelists: Joseph P. Drozda, Saint Louis, MO, Blair D. Erb, Bozeman, MT, Gregory Ehle, Burlington, VT, Marvin A. Konstam, Boston, MA, Richard J. Kovacs, Indianapolis, IN, Jack Lewin, Washington, DC, Margo B. Minissian, Los Angeles, CA

Core principles That Define Our Mission

5:00 Quo Vadis Academis? — David R. Holmes, Jr., Rochester, MN

5:10 Roundtable Discussion: What Will (Should) the Academic Mission Be in 2022?

Panelists: Pamela S. Douglas, Durham, NC, David R. Holmes, Jr., Rochester, MN, Joseph A. Hill, Dallas, TX, Jack Lewin, Washington, DC

5:30 Summary and Closing Remarks — Joseph A. Hill, Dallas, TX

pReV

expeRTS

250

labile Hypertension: evaluation and ManagementMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S502CMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-12-130-l01-p

Chair: Franz H. Messerli, New York, NY

Case Ronald G. Victor, Los Angeles, CA, Wanpen Presenters: Vongpatanasin, Dallas, TX

Panelists: Joshua A. Beckman, Boston, MA, Suzanne Oparil, Birmingham, AL, Andrew R. Weintraub, Boston, MA



AFTERNOON

pReV

SyMpOSiUM

711

Joint Symposium of the American Association of Clinical endocrinologists and the American College of Cardiology: Cardiologists as endocrinologists — emerging Management of the Diabetic patientMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S100cCMe/CNe Hours: 1.5

Co-Chairs: Samuel Dagogo-Jack, Memphis, TN Mikhail Kosiborod, Leawood, KS

2:00 The Comprehensive Approach to Treating Diabetes — Samuel Dagogo-Jack, Memphis, TN

2:15 improving Metabolic Risk Factors through lifestyle — Vera Bittner, Birmingham, AL

2:30 Goals and Drugs for Glycemic Management: Cardiologists perspective — Amit Khera, Dallas, TX

2:45 Glycemic Control in the inpatient Setting: Consensus or Confusion? — Steven P. Marso, Kansas City, MO

3:00 Cardiovascular effects of New Agents in the Management of Diabetes — Elif Oral, Ann Arbor, MI

3:15 Bariatric Surgery: Cure for Obesity? — Peter A. McCullough, Novi, MI

QUAl

SyMpOSiUM

712

Bringing evidence to the Bedside: Making Guidelines More Accessible to CliniciansMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N427CMe/CNe Hours: 1.5

Co-Chairs: Jeffrey Anderson, Cincinnati, OH Frederick A. Masoudi, Denver, CO

2:00 Do Guidelines Contain enough level i evidence? — Sanjay Kaul, Los Angeles, CA

2:18 Balancing COi and Committee Responsibility — Robert A. Harrington, Durham, NC

2:36 incorporating evidence into a living Guideline Document — Scott Wright, Rochester, MN

2:54 Bridging Guidelines and practice with Appropriate Use Criteria — Frederick A. Masoudi, Denver, CO

3:12 Accessibility of Guidelines for Clinicians — Patrick T. O’Gara, Boston, MA

QUAl

SyMpOSiUM

713

Making a Difference: Cardiology leadership in the Community and the WorldMonday, March 26, 2012, 2:00 p.m. – 3:35 p.m.McCormick Place North, N228CMe/CNe Hours: 1.5

Co-Chairs: Valentin Fuster, New York, NY Eva M. Kline-Rogers, Ann Arbor, MI

2:00 project My Heart your Heart — Thomas C. Crawford, Ann Arbor, MI

2:15 indian Health Service — James M. Galloway, Chicago, IL

2:30 partners in Health — Gene Bukhman, Boston, MA

2:50 early Career/Kenya — Gerald S. Bloomfield, Durham, NC

3:05 project Healthy Schools: A Community/Health System Collaboration — Kim A. Eagle, Ann Arbor, MI

3:20 African initiatives — Edward P. Havranek, Denver, CO

SpeCiAl

leGeNDS

404

legends of Cardiovascular Medicine lecture Series — 11th Annual Maseri-Florio international lectureMonday, March 26, 2012, 2:00 p.m. – 3:00 p.m.McCormick Place North, N231CMe/CNe Hours: 1

Chair: Gregg W. Stone, New York, NY

2:00 Welcome, introduction of Dr. Attilio Maseri and History of the Maseri-Florio international lecture — Jack Lewin, Washington DC

2:04 Founder, Maseri-Florio endowment Fund of the American College of Cardiology — Attilio Maseri, Florence, Italy

2:05 introduction of Named lecturer/legend — Gregg W. Stone, New York, NY

2:07 11th Annual Maseri-Florio international lecture: personal insights leading to Scientific Developments — Antonio Colombo, Milan, Italy

2:37 One-on-One interview with Dr. Antonio Colombo — Gregg W. Stone, New York, NY


VAlV

expeRTS

251

Complex Valvular Heart DiseaseMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place South, S503CMe/CNe Hours: 1.5

Chair: Sorin Pislaru, Rochester, MN

Case Gilbert Habib, Marseille, France, Joseph Maalouf, Presenters: Rochester, MN, Josep Rodes-Cabau, Quebec, Canada

Panelists: Mario J. Garcia, Bronx, NY, Bernard Iung, Paris, France

VAlV

SyMpOSiUM

714

Calcific Aortic Stenosis: Diagnosis and Treatment in the 21st CenturyMonday, March 26, 2012, 2:00 p.m. – 3:30 p.m.McCormick Place North, N426CMe/CNe Hours: 1.5

Co-Chairs: David Newby, Edinburgh, Scotland, United Kingdom Andrew Wang, Durham, NC

2:00 The Role of epidemiology Risk Factors for Secondary prevention of Calcific Aortic Valve Disease — Catherine M. Otto, Seattle, WA

2:22 The Cellular Mechanisms of Calcific Aortic Valve Disease — Nalini Marie Rajamannan, Chicago, IL

2:44 The Role 3-D and 4-D echo imaging in Aortic Valve Disease — Jae K. Oh, Rochester, MN

3:07 The Role of TAVi in Calcific Aortic Valve Disease — Peter C. Block, Atlanta, GA


200 GO for ACC.12!

AFTE

RNOO

N

ACC-i2/TCT

MOC

823

ACCF Study Session for Maintenance of Certification: ABiM Recertification Made easy — interventional Cardiology 2011 Update (B2-l)Monday, March 26, 2012, 3:00 p.m. – 5:30 p.m.McCormick Place South, S105aCMe Hours: 2.5

Please refer to the full session listing, listed below, for additional session information.

liFelONG

MOC

823

ACCF Study Session for Maintenance of Certification: ABiM Recertification Made easy — interventional Cardiology 2011 Update (B2-l)Monday, March 26, 2012, 3:00 p.m. – 5:30 p.m.McCormick Place South, S105aCMe Hours: 2.5

Chair: Mehdi H. Shishehbor, Cleveland, OH

MOC Faculty: John P. Reilly, New Orleans, LA, Subhash Banerjee, Dallas, TX






liFelONG

MOC

824

ACCF Study Session for Maintenance of Certification: ABiM Recertification Made easy—Clinical Cardiac electrophysiology, 2011 Update (B3-l)Monday, March 26, 2012, 3:00 p.m. – 5:30 p.m.McCormick Place South, S105dCMe Hours: 2.5

Chair: Peter N. Smith, Marshfield, WI

MOC Faculty: Byron Kwock Lee, San Francisco, CA, Bindi K. Shah, Philadephia, PA

ACCF’s Maintenance of Certification Sessions allows you to easily obtain ABIM’s Maintenance of Certification (MOC) points during at ACC.12. Tickets

are required for admittance to this session. Ticketed registrants must arrive no later than 15 minutes before the start of the session. Seats will be released at this time and an “open seating” policy will apply.





ACC-i2/TCT

SyMpOSiUM

2640

Mitral interventionsMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S102bCMe/CNe Hours: 1.5

Co-Chairs: Ted Feldman, Evanston, IL Peter C. Block, Atlanta, GA

3:45 echo Anatomy for percutaneous MR Therapy — Nina Wunderlich, Frankfurt, Germany

4:00 Defining High-risk in MV Surgery — Maurice Enriquez-Sarano, Rochester, MN

4:15 pitfalls in Current Studies of percutaneous Therapy for MR — Gregg W. Stone, New York, NY

4:30 percutaneous Therapy (MitraClip and Carollion) is Best for High-risk RM patients — Olaf Franzen, Copenhagen, Denmark

4:45 Surgery is the Best Therapy for High Risk MR patients — Steven F. Bolling, Ann Arbor, MI


ACC-i2/TCT

SyMpOSiUM

2641

importance of Bleeding in patients with CV Disease: A personalized Approach for Treatment StrategiesMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S103bCMe/CNe Hours: 1.5

Co-Chairs: Robert A. Harrington, Durham, NC Roxana Mehran, New York, NY

3:45 importance of Bleeding — Thomas Tehsin Tsai, Denver, CO

3:58 predictors of Bleeding in ACS and elective pCi — Steven Vahe Manoukian, Nashville, TN



AFTERNOON

4:11 New Anti-platelet Agents: Which Drug and for Whom; Balancing Bleeding and ischemia — Deepak L. Bhatt, Boston, MA

4:24 Use of Risk Scores for Stratification: is it Feasbile? Which is the ideal Score To Use? — Steven P. Marso, Kansas City, MO

4:37 Bleeding Definitions: Which Component of Bleeding Matters? — Roxana Mehran, New York, NY

4:50 Strategies to Reduce Bleeding Complications in pCi: The Radial Approach — Sanjit S. Jolly, West Hamilton, Canada


ACC-i2/TCT

SyMpOSiUM

2642

endovascular Management of erectile DysfunctionMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S103cCMe/CNe Hours: 1.5

Co-Chairs: J. Michael Bacharach, Sioux Falls, SD Andrew J. Feiring, Milwaukee, WI

3:45 Appropriate patient Selection for pudendal Artery intervention — Krishna J. Rocha-Singh, Springfield, IL

4:05 patient Assessment to Diagnose Obstructive Atherosclerosis as the Cause of erectile Dysfunction — Aravinda Nanjundappa, Charleston, WV

4:25 Outcomes of the ZeN Trial: What Did We learn — James P. Zidar, Raleigh, NC


ACC-i2/TCT

SyMpOSiUM

2643

ACS: New insights and Novel TherapiesMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S106bCMe/CNe Hours: 1.5

Co-Chairs: A. Michael Lincoff, Cleveland, OH Eric R. Bates, Ann Arbor, MI

3:45 Determining the Adequacy of Myocardial Reperfusion in STeMi: Clinical, Angiographic and Tomographic Measures of Reperfusion — Correlation with Time to Treatment and Total ischemic Time — Manesh R. Patel, Durham, NC

3:57 Adjunctive Therapies to Mitigate ischemia-Reperfusion injury — William W. O’Neill, Miami, FL

4:09 limitations of Clopidogrel platelet inhibition: prevalence and Mechanisms prevalence and Mechanisms — Paul A. Gurbel, Baltimore, MD

4:19 limitations of Clopidogrel platelet inhibition: Therapeutic Options: New insights from GRAViTAS, TRiGGR-pCi, ARCTiC and ReClOSe-2 ACS — Dominick J. Angiolillo, Jacksonville, FL

4:29 Appropriate Utilization of Novel Anti-thrombotic Agents in ACS: Ticagrelor, Vorapaxar — Lars Wallentin, Uppsala, Sweden

4:41 The Role of platelet Gpiib/iiia Blockade in ACS: Valuable Adjunct — Jochen Woehrle, Ulm, Germany

4:51 The Role of platelet Gpiib/iiia Blockade in ACS: Not Necessary — Gilles Montalescot, Paris, France


ARR

SyMpOSiUM

715

Challenges in the Management of Ventricular ArrhythmiasMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S406aCMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-143-l04-p

Co-Chairs: Alfred E. Buxton, Boston, MA Paul A. Friedman, Rochester, MN

3:45 Ventricular ectopy in the patient with a Structurally Normal Heart — Francis E. Marchlinski, Bala Cynwyd, PA

4:03 Ablation of Ventricular Tachycardia in ischemic Cardiomyopathy — William G. Stevenson, Boston, MA

4:21 Ablation of Ventricular Tachycardia in Non-ischemic Cardiomyopathy — Kalyanam Shivkumar, Los Angeles, CA

4:39 All patients with iCD Shocks for VT Should Undergo Catheter Ablation — David J. Wilber, Maywood, IL

4:54 All patients with iCD Shocks for VT Should Not Undergo Catheter Ablation — Paul A. Friedman, Rochester, MN

ARR

SyMpOSiUM

716

issues in Cardiac Resynchronization TherapyMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place North, N227bCMe/CNe Hours: 1.5

Co-Chairs: Melanie T. Gura, Akron, OH Ralph J. Verdino, Philadelphia, PA

3:45 CRT for patients with NyHA i or ii — Andrew E. Epstein, Philadelphia, PA

4:00 Reducing Atrial Fibrillation and Hospitalization with CRT — Jonathan S. Steinberg, New York, NY

4:15 Gender Disparities with CRT — Jennifer E. Cummings, Akron, OH

4:30 Management of the CRT Non-Responder — William T. Abraham, Columbus, OH

4:45 Management of AF patients Referred for CRT implant: Ablation of Atrial Fibrillation versus AV Node Ablation — Andrea Natale, Austin, TX

5:00 Targeted left Ventricular lead placement to improve Response to CRT — Fakhar Z. Khan, Cambridge, United Kingdom

CCS

expeRTS

252

Golden Moments: When is the Right Time to intervene in Congenital Heart Disease?Monday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S501aCMe/CNe Hours: 1.5

Chair: Daniel J. Murphy, Palo Alto, CA

Case Presenter: Charles Shepard, Minneapolis, MN

Panelists: Bryan C. Cannon, Rochester, MN, Mark E. Galantowicz, Columbus, OH, Thomas K. Jones, Seattle, WA, Mark B. Lewin, Seattle, WA, William R. Morrow, Little Rock, AR, Anne Marie Valente, Boston, MA


202 GO for ACC.12!

AFTE

RNOO

N

HF

SyMpOSiUM

717

improving Outcomes and Reducing Heart Failure ReadmissionsMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S406bCMe/CNe Hours: 1.5

Co-Chairs: Katherine J. Hoercher, Cleveland, OH Rene J. Alvarez, Pittsburgh, PA

3:45 Heart Failure Readmissions: Scope of the problem — Gregg C. Fonarow, Los Angeles, CA

3:58 Does Telemonitoring Help prevent Readmissions? — Harlan M. Krumholz, New Haven, CT

4:12 Do implanted Device (Defibrillators and pacemakers) Help prevent Readmissions? — Niraj Varma, Cleveland, OH

4:25 Does Hemodynamic Monitoring Help prevent Readmissions? — Robert C. Bourge, Birmingham, AL

4:38 Transition from Hospital to Home — Sara Paul, Hickory, NC

4:51 performance Measures: Do they Assess Quality? — Nancy M. Albert, Cleveland, OH

5:03 Discussion

HF

SyMpOSiUM

718

Controversies in Treatment of Comorbidities in Heart Failure: paradoxes and Challenges in TreatmentMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S404CMe/CNe Hours: 1.5

Co-Chairs: Biykem Bozkurt, Houston, TX Akshay S. Desai, Boston, MA

3:45 Diabetes and Heart Failure — David Aguilar, Houston, TX


4:03 Obesity and Heart Failure — Tamara Horwich, Los Angeles, CA


4:21 Hypertension and Heart Failure — Biykem Bozkurt, Houston, TX


4:39 Sleep Apnea and Heart Failure — Shahrokh Javaheri, Cincinnatti, OH


4:57 Atrial Fibrillation and Heart Failure — Maya E. Guglin, Tampa, FL


iMAG

SyMpOSiUM

719

emerging Applications of CMRMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S403CMe/CNe Hours: 1.5

Co-Chairs: W. Gregory Hundley, Winston Salem, NC Sanjay Prasad, London, England, United Kingdom

3:45 New Approaches to Quantitate Systolic Function — Michael Markl, Chicago, IL

4:03 Assessment of ischemia and Viability — Daniel C. Lee, Chicago, IL

4:21 Molecular imaging — David E. Sosnovik, Charlestown, MA

4:39 Role of MRi in Valvular Heart Disease — Dipan J. Shah, Houston, TX

4:57 expanding Role of CMR in interventional Cardiology — Dara Kraitchman, Baltimore, MD

ACC-i2/TCT

SyMpOSiUM

2639

Controversies in intravascular imagingMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S101aCMe/CNe Hours: 1.5

Co-Chairs: John McB Hodgson, Wilkes-Barre, PA Jonathan M. Tobis, Los Angeles, CA

3:45 Assessing lesion Severity: FFR is the Gold Standard — Habib Samady, Atlanta, GA

3:55 Assessing lesion Severity: Are There any Anatomic Critieria — iVUS or OCT — That Can be Used instead of FFR? — Bon Kwon Koo, Chongno-gu, Seoul, Republic of Korea

4:05 Assessing lesion Severity: Can Cardiovascular CT provide insight into Stenosis Severity? — Szilard Voros, Atlanta, GA

4:10 panel Discussion with Case presentations — Habib Samady, Atlanta, GA

4:15 Case presentation — Itsik Ben-Dor, Rockville, MD

4:20 Case presentation — Muzaffer Degertekin, Istanbul, Turkey

4:25 Distal embolization during pCi: Definition of the problem: Frequency, Clinical Setting, Clinical predictors, etc. — Simon R. Dixon, Royal Oak, MI

4:30 Distal embolization during pCi: predicting Distal embolization Using Grayscale iVUS, RF-iVUS, OCT, and NiRS — Emmanouil S. Brilakis, Dallas, TX

4:40 Distal embolization during pCi: prediction of Distal embolization Based on CTA — Yukio Ozaki, Toyoake, Japan

4:45 Optimal endpoints for Stent implantation and Guidance: A Review of the iVUS literature — Kenichi Fujii, Nishinomiya Hyogo, Japan

4:55 Optimal endpoints for Stent implantation and Guidance: Can OCT Replace iVUS in Optimizing Stent implantation? — Marco A. Costa, Cleveland, OH


liFelONG

CORe

825

Core Curriculum: Vascular DiseaseMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place North, N226CMe/CNe Hours: 1.5


3:45 peripheral Arterial Disease — Douglas E. Drachman, Boston, MA

4:10 Aortopathies — Emile R. Mohler, III, Philadelphia, PA



AFTERNOON

4:35 Carotid and Cerebrovascular Disease — Michael R. Jaff, Boston, MA


liFelONG

CORe

826

Core Curriculum: landmark TrialsMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place North, N229CMe/CNe Hours: 1.5

Chair: Karthikeyan Ananthasubramaniam, West Bloomfield, MI

3:45 landmark Trials in Hyperlipidemia — Anand Rohatgi, Dallas, TX

4:05 landmark Trials in Heart Failure — David E. Lanfear, Detroit, MI

4:25 landmark Trials in ACS — Stephen D. Wiviott, Boston, MA

4:45 landmark Trials in electrophysiology — Joseph Edward Marine, Baltimore, MD


peRi

expeRTS

253

Challenges in Hypertrophic Cardiomyopathy: Case StudiesMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S505CMe/CNe Hours: 1.5

Chair: Barry J. Maron, Minneapolis, MN

Case Martin S. Maron, Boston, MA, Matthew W. Martinez, Presenters: Allentown, PA, Paul Sorajja, Rochester, MN

Panelists: Perry M. Elliott, London, United Kingdom, Harry M. Lever, Cleveland, OH, William McKenna, London, United Kingdom, Ulrich Sigwart, Geneva, Switzerland

peRi

SyMpOSiUM

720

New Directions in the evaluation and Management of the CardiomyopathiesMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place North, N231CMe/CNe Hours: 1.5

Co-Chairs: Nancy K. Sweitzer, Madison, WI Hector O. Ventura, New Orleans, LA

3:45 Familial Dilated Cardiomyopathy Syndromes: What is the Role for Genetic Testing? — Neal Lakdawala, Boston, MA

3:59 peripartum Cardiomyopathy: New Concepts in pathophysiology and Management — Uri Elkayam, Los Angeles, CA

4:13 Myocarditis and Other ‘Reversible’ Causes of Cardiomyopathy — Leslie T. Cooper, Rochester, MN

4:27 Cardiac Sarcoidosis: Diagnosis, evaluation and Management: Whom Should We Treat? — Andrew M. Freeman, Denver, CO

4:41 Arrhythmogenic Right Ventricular Cardiomyopathy: Genetics, pathophysiology, imaging and Management — Hugh Calkins, Baltimore, MD

4:55 Multidisciplinary evaluation of patients with Cardiomyopathies — Rodney Falk, Boston, MA


pHTN

expeRTS

254

pulmonary Hypertension Tools for the CardiologistMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S504aCMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-12-131-l01-p

Chair: Ronald J. Oudiz, Torrance, CA

Case Paul Forfia, Philadelphia, PA, Gregory D. Lewis, Presenters: Boston, MA, Vallerie V. McLaughlin, Ann Arbor, MI

pReV

SyMpOSiUM

729

Beyond Statins: lDl Management in the Challenging patientMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S100cCMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-12-146-l04-p

Co-Chairs: Amit Khera, Dallas, TX Donna M. Polk, Hartford, CT

3:45 Role of Genetic Testing — Christie M. Ballantyne, Houston, TX

4:03 Dietary effects and phytosterols — Michael J. Blaha, Baltimore, MD

4:21 Combination Therapy: When and Which Ones? — Jennifer Robinson, Iowa City, IA

4:39 lDl Apheresis as a Treatment Option — Patrick M. Moriarty, Kansas City, KS

4:57 Mipomersen and pCSK9 inhibitors — Evan A. Stein, Cincinnati, OH

pReV

SyMpOSiUM

745

World Hellenic Biomedical Association, the Hellenic Cardiological Society, the Cyprus Society of Cardiology and the American College of Cardiology: Mediterranean Diet and its protective effect on Cardiovascular DiseaseMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S405CMe/CNe Hours: 1.5

Co-Chairs: George D. Dangas, New York, NY George Parharidis, Athens, Greece

3:45 introduction to Session — George D. Dangas, New York, NY

3:50 The Role of Sodium and potassium in CV Health — George L. Bakris, Chicago, IL

4:05 The Role of Cardiovascular imaging in Coronary Heart Disease — Petros Nihoyannopoulos, London, United Kingdom

4:20 An Overview of the Cypriot Contribution to the Diet — Panayiotis Avraamides, Nicosia, Cyprus

4:35 Cardiovascular Mortality in Greece — Vlassios N. Pyrgakis, Nerantza Corinthias, Greece

4:50 effects of Diet, exercise and Weight loss on inflammation — Christie M. Ballantyne, Houston, TX



204 GO for ACC.12!

AFTE

RNOO

N

QUAl

SyMpOSiUM

721

Transforming Health Care Delivery through CV RegistriesMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place North, N427CMe/CNe Hours: 1.5

Co-Chairs: Eva M. Kline-Rogers, Ann Arbor, MI Eric D. Peterson, Durham, NC

3:45 The SCAAR Registry — Stefan K. James, Uppsala, Sweden

4:00 The Danish Registry experience — Leif Thuesen, Aarhus, Denmark

4:15 BMC2: The Michigan pCi Registry — Hitinder S. Gurm, Ann Arbor, MI

4:30 MSTCVS: The Michican Surgical Registry — Richard L. Prager, Ann Arbor, MI

4:45 CART-Cl: The VA Cath lab Quality program — Thomas M. Maddox, Denver, CO

5:00 Mandatory participation and Reporting of Registry Data — Ralph G. Brindis, Oakland, CA

QUAl

SyMpOSiUM

722

Applying Newer Cardiovascular Agents to Older AdultsMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place North, N228CMe/CNe/Cpe Hours: 1.5 ACpe No. 0012-9999-12-144-l04-p

Co-Chairs: Michael Chen, Seattle, WA Tracy Wang, Durham, NC

3:45 pharmacology in Older Adults — Jeffrey Washam, Durham, NC

4:00 pCi Medications in Older Adults — Harold L. Dauerman, Shelburne, VT

4:15 polypharmacy and Adherence — Jeffrey Washam, Durham, NC

4:30 AF Anticoagulants in Older Adults — James B. Froehlich, Ann Arbor, MI

4:45 Does My 90 year-old patient Need a Statin? — Michael W. Rich, Saint Louis, MO

5:00 Aldosterone Blockade in Older Adults — Milton Packer, Dallas, TX

SpeCiAl

SyMpOSiUM

740

Joint Symposium of the British Cardiovascular Society and the California Chapter of the American College of CardiologyMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place North, N230CMe/CNe Hours: 1.5

Co-Chairs: Daniel S. Berman, Los Angeles, CA Ronald P. Karlsberg, Beverly Hills, CA S. Richard Underwood, London, United Kingdom

3:45 Twinning of BCS and the California Chapter of the ACC — Huon Gray, Southampton, United Kingdom

3:50 New Frontiers in echocardiography — Anthony N. DeMaria, San Diego, CA

4:15 Future of Cardiac Magnetic Resonance — Dudley J. Pennell, London, United Kingdom

4:30 Coronary CT Angiography: Beyond Coronary Stenosis — James K. Min, New York, NY

4:45 New Directions in Cardiac peT-CT — David E. Newby, Edinburgh, Scotland, United Kingdom

5:00 Noninvasive Cardiac imaging in Great Britain — S. Richard Underwood, London, United Kingdom

5:05 Noninvasive Cardiac imaging in the US — Daniel S. Berman, Los Angeles, CA

5:10 Discussion

TeST

expeRTS

255

Stress Testing in WomenMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S502CMe/CNe Hours: 1.5

Chair: Alison Bailey, Lexington, KY

Case Presenter: Janet B. Long, Providence, RI

Panelists: C. Noel Bairey Merz, Los Angeles, CA, Martha Gulati, Columbus, OH, Jennifer H. Mieres, Lake Success, NY, Leslee J. Shaw, Atlanta, GA, Nanette Kass Wenger, Atlanta, GA

VAlV

expeRTS

256

Advanced Hemodynamics for Valvular Heart DiseaseMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place South, S503CMe/CNe Hours: 1.5

Chair: Salvatore Costa, Lebanon, NH

Case Jean G. Dumesnil, Sainte Foy, Canada, Rick A. Presenters: Nishimura, Rochester, MN, Luc Pierard, Liège, Belgium

Panelists: Salvatore Costa, Lebanon, NH, Steve R. Ommen, Rochester, MN

VAlV

SyMpOSiUM

723

importance of Registries for Valve Disease: A Glimpse into the ACC FutureMonday, March 26, 2012, 3:45 p.m. – 5:15 p.m.McCormick Place North, N426CMe/CNe Hours: 1.5

Co-Chairs: David J. Malenka, Lebanon, NH Hector I. Michelena, Rochester, MN

3:45 What ACC Needs to Do for Valve Registries — David R. Holmes, Jr., Rochester, MN

4:03 The euro-Heart Survey: What is the picture of Valve Disease practice in europe — Bernard Iung, Paris, France

4:21 MiDA: The Research and the practice in an international Registry of MR — Francesco Grigioni, Italy

4:39 The UK TAVi Registry — Jan Kovac, Leicestershire, United Kingdom

4:57 The Canadian Registry of TAVi — Josep Rodes-Cabau, Quebec, Canada



evening

ACC-i2/TCT

CliNiCAl FOCUS

1607

Joint Session of the American Association for Thoracic Surgery, the Society of Thoracic Surgery and the American College of Cardiology: Multidisciplinary Approach to the High-risk Aortic Stenosis patientMonday, March 26, 2012, 5:45 p.m. – 9:05 p.m.McCormick Place South, S401aCMe/CNe Hours: 2.5


Co-Chairs: Ralph J. Damiano, St. Louis, MO E. Murat Tuzcu, Cleveland, OH Todd M. Dewey, Dallas, TX| Raoul Bonan, Montreal, Canada

TAVR: Where Are We in 2012

6:15 Balloon expandable Valve — Samir R. Kapadia, Cleveland, OH

6:25 Self expanding Valve — Gregory P. Fontana, Los Angeles, CA


Risk Assessment of an Aortic Stenosis patient

6:45 Who is a Candidate for TAVR — Vinod H. Thourani, Atlanta, GA

6:55 pearls from echocardiography — Rebecca T. Hahn, New York, NY

7:05 Can’t do without CT imaging — Jonathan Leipsic, Vancouver, Canada


Complications, impact, precautions, Management

7:25 Vascular Trauma and Bleeding — Wilson Y. Szeto, Philadephia, PA

7:35 Stroke — Josep Rodes-Cabau, Quebec, Canada

7:45 Aortic Regurgitation — Jeffrey J. Popma, Newton, MA


Debates

8:05 Debate: TAVR Should be Reserved only for inoperable patients — Todd M. Dewey, Dallas, TX

8:15 Debate: TAVR Should be Reserved only for inoperable patients — Thierry Lefevre, Massy, France


8:35 Debate: Stroke Risk is prohibitive for all but a Small Fraction of Aortic Stenosis patients — D. Craig Miller, Stanford, CA

8:45 Debate: Stroke Risk is prohibitive for all but a Small Fraction of Aortic Stenosis patients — Martin B. Leon, New York, NY


SpeCiAl

SpeCiAl

307

61st Annual ConvocationMonday, March 26, 2012, 6:30 p.m. – 8:00 p.m.McCormick Place North, Hall B, ACC.12 Main Tent


206 GO for ACC.12!

CV Innovations Educational ForumSouth Building, Hall A2, CV Theater, #22097

The Role of Nanotechnology in Cardiovascular Diseases9:30 a.m. – 10:30 a.m.

9:30 a.m. – 9:40 a.m.Nanotechnology — Steven Bailey, MD, San Antonio, TX — University of Texas, San Antonio

9:40 a.m. – 9:50 a.m.Nano particle Delivery — Mauro Farrari, PhD, Houston, TX — President and CEO of The Methodist Hospital Research Institute (invited)

9:50 a.m. – 10:00 a.m.imaging of Stem Cells — Jeff W.M. Bulte, PhD, Baltimore, MD — Professor, Johns Hopkins University (invited)

10:00 a.m. – 10:10 a.m.imaging of Cells and plaque — Sam Wickline, MD, St. Louis, MO — Professor, Washington University (invited)

10:10 a.m. – 10:20 a.m.imaging of Vulnerable plaque — Todd D. Giorgio, PhD, Nashville, TN — Professor, Vanderbilt School of Engineering (invited)

10:20 a.m. – 10:30 a.m.panel Discussion

Cellular Therapy Noon – 1:00 p.m.

Noon – 12:10 p.m.Very Small embryonic-like Stem Cells for Cardiovascular Repair — Wojtek Wojakowski, MD, Katowice, Poland —Third Division of Cardiology, Medical University of Silesia

12:10 p.m. – 12:20 p.m.Methods of Stem Cell Therapy and Future Direction — Nabil Dib, MD, MSc, FACC, Gilbert, AZ — Director, Heart Sciences Center

12:20 p.m. – 12:30 p.m.ischemia Tolerant Mesenchymal Stem Cell — Nicholai Tankovich, MD, PhD, San Diego, CA — President and Chief Medical Officer, Stemedica Cell Technologies, Inc.

12:30 p.m. – 12:40 p.m.Role of Shock Wave/Ultrasound in Stem Cell Transplantation — Andreas M. Zeiher, MD, Frankfurt, Germany — Chairman, Department of Medicine III/Cardiology, University of Frankfurt

12:40 p.m. – 12:50 p.m.The Regulatory pathways of Stem Cells: industry point of View — Randal Mills, PhD, Columbia, MD — President and Chief Executive Officer, Osiris Therapeutics

12:50 p.m. – 1:00 p.m.panel Discussion

Tissue engineering 1:00 p.m. – 1:40 p.m.

1:00 p.m. – 1:10 p.m.The living Valve — Sir Magdi Yacoub, MD, FRCS, London, United Kingdom — Professor, Cardiothoracic Surgery, Imperial College

1:10 p.m. – 1:20 p.m.Myocardial Matrix — Karen Christman, PhD, San Diego, CA — Assistant Professor of Bioengineering, University of California San Diego

1:20 p.m. – 1:30 p.m.Abbott Vascular’s Bioresorbable Scaffold program… A New paradigm in pCi? — Richard J. Rapoza, PhD, Abbott Park, IL — Division Vice President of Research & Development, Abbott Vascular

1:30 p.m. – 1:40 p.m.panel Discussion

personalized Medicine 1:40 p.m. – 2:00 p.m.

1:40 p.m. – 1:50 p.m.personalized Medicine — Robert Roberts, MD, MACC, FRCPC, Ottawa, ON, Canada — President, Chief Executive Officer and Chief Scientific Officer, University of Ottawa Heart Institute

1:50 p.m. – 2:00 p.m.A New Gene expression Test to Detect Coronary Artery Disease — Mark Monane, MD, MS, FACP, Palo Alto, CA — Chief Medical Officer, CardioDx


Monday, March 26, 2012Learning Destinations™ are diverse, non-accredited, educationally focused areas that offer new and creative venues in which you can expand your educational experience.*

Presentation schedules are current as of Feb. 29, 2012, and are subject to change. For more information, please check the ACC.12 ExpoGuide and ExpoGuide Addendum, available at Expo Hall entrances and in your official meeting bag, and the Heart of Innovation Resource Guide, available at the Heart of Innovation Learning Destination (South Building, Hall A1, #1076) and in your official meeting bag



9:30 a.m. – 9:45 a.m.educational content including taped cases, physician interviews, panel discussions and more

9:45 a.m. – 10:15 a.m.Moderated Discussion: A New Approach to Delivering Stem Cell Therapy for patients with CHF

Moderator: Anthony N. DeMaria, MD, MACC, San Diego, CA — Judith and Jack White Chair in Cardiology; Founding Director, Sulpizio Cardiovascular Center, University of California San Diego

Panelists: Bernard J. Gersh, MB, ChB, DPhil, FACC, Rochester, MN — Professor of Medicine, Cardiovascular Diseases, Mayo Clinic; Andreas M. Zeiher, MD, Frankfurt, Germany — Chairman, Department of Medicine III/Cardiology, University of Frankfurt

10:15 a.m. – 12:15 p.m.educational content including taped cases, physician interviews, panel discussions and more

12:15 p.m. – 12:45 p.m.Biomarker Guided Heart Failure Management — James L. Januzzi, Jr., MD, FACC, Cambridge, MA — Director, Cardiac Intensive Care Unit, Massachusetts General Hospital; Associate Professor of Medicine, Harvard Medical School

12:45 p.m. – 1:05 p.m.physician-patient engagement and Shared Decision Making — John R. Windle, MD, FACC, Omaha, NE — Professor and Chief, Internal Medicine, Division of Cardiology, University of Nebraska Medical Center

1:05 p.m. – 1:25 p.m.The evolution of Radiation protection — Christian E. Machado, MD, FACC, FAHA, FHRS, Detroit, MI — Clinical Associate Professor, Wayne State University School of Medicine; Senior Partner, Heart Cardiology Consultants; Director, Cardiac Electrophysiology and Cardiac Rhythm Management Device Clinic, Providence Hospital

1:25 p.m. – 1:45 p.m.Current Status and Future Direction of Stem Cell Therapy for Cardiovascular Disease — Nabil Dib, MD, MSc, FACC, Gilbert, AZ — Director, Cardiovascular Research, Heart Sciences Center; Director; Clinical Cardiovascular Cell Therapy, Associate Professor of Medicine, University of California, San Diego; Medical Director, Celebration Stem Cell Centre; President, International Society for Cardiovascular Translational Research; Editor in Chief, Journal of Cardiovascular Translational Research

1:45 p.m. – 2:00 p.m.educational content including taped cases, physician interviews, panel discussions and more


9:45 a.m. – 10:30 a.m. (Morning Coffee Break)Managing Atherosclerotic Risk with a particle Focus — New Recommendations and emerging Data — Robert S. Rosenson, MD, New York, NY — Professor, Department of Medicine/Cardiology, Director, Cardiometabolic Disorders, Mount Sinai School of Medicine

presented by lipoScience

12:30 p.m. – 1:30 p.m. (lunch Break)Considerations for Radionuclide Myocardial perfusion imaging in patients with COpD/Asthma — Kim Williams, MD, Detroit, MI — Chair, Division of Cardiology and Professor of Medicine; Wayne State University School of Medicine

presented by Astellas pharma US, inc.


philips HealthcareInteractive Learning Lab #22035

9:30 a.m. – 10:30 a.m.Cardiac CT — The Journey from plaque Recognition to prognosis — Patrick Donnelly, MD, MB BCh, MRCP, United Kingdom — Consultant Cardiologist, Southeastern Health and Social Care Trust, Director Northern Ireland Cardiovascular Research Network; Honorary Senior Lecturer, The Queens University, Belfast Director, Belfast Cardiac CT Academy

11:00 a.m. – NoonBenefit of Cardiac Troponin point-of-Care Testing in the emergency Department — Charles B. Cairns, MD, FACEP, FAHA, Chapel Hill, NC — Professor and Chair, Department of Emergency Medicine, University of North Carolina

12:30 p.m. – 1:30 p.m.Sleep, Breathing and the Heart: Cardiovascular Consequences of Sleep-Disordered Breathing — Babak Mokhlesi, MD, MSc, Chicago, IL — Associate Professor of Medicine Director, Sleep Disorders Center and Sleep Fellowship Program; Section of Pulmonary and Critical Care, University of Chicago

Terumo interventional Systems and The Medicines CompanyInteractive Learning Lab #22027


10:30 a.m. – 11:00 a.m.Optimizing your Outpatient pCi: What you Need to Know and Consider

11:30 a.m. – 12:30 p.m.Hands-On Radial Access Simulation



©20

12 A

mer

ican

Col

lege

of C

ardi

olog

y Z

1207

©20

12 A

mer

ican

Col

lege

of C

ardi

olog

y Z

1207

TM

Manage your heart health with

CardioSmart National Care

Initiative

Impacting healthy lifestyles and providing patients everyday strategies for heart health.

Small changes add up to big results over time.

Brought to you by:

Everyday Strategies for Heart Health.Go to www.CardioSmart.org today.

Visit ACC Central - Booth #10027.

ACC.12

Tuesday March 27

Tuesday, March 27

Visit us at ACC Central

Booth 10027

quality chasm?WHAT

Achieving quality care is your challenge.

Take it on with NCDR.

With guidelines-focused clinical registries from the NCDR®,

you’ll always know which quality improvement steps to take and when to take them.

NCDR® is an initiative of the American College of Cardiology Foundation®, with partnering support from the following organizations: CARE Registry®—The Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, American Academy of Neurology, American Association of Neurological Surgeons/Congress of Neurological Surgeons, Society for Vascular Medicine, and Society of Vascular and Interventional Neurology; CathPCI Registry®—The Society for Cardiovascular Angiography and Interventions; ICD Registry™—Heart Rhythm Society; IMPACT Registry®—The Society for Cardiovascular Angiography and Interventions and American Academy of Pediatrics; PINNACLE Registry®—MedAxiom; STS/ACC TVT Registry™—An initiative of The Society of Thoracic Surgeons and the American College of Cardiology Foundation; ACTION Registry®–GWTG™—An initiative of the American College of Cardiology Foundation and the American Heart Association, with partnering support from Society of Chest Pain Centers, The American College of Emergency Physicians, and The Society of Hospital Medicine.© 2012 American College of Cardiology Foundation. All rights reserved. B12016

www.ncdr.com/takeiton

Tues

day,

Mar

ch 2

7


Morning SeSSionS

ACS

SympoSium

728

Joint Symposium of the American Association for Clinical Chemistry and the American College of Cardiology: How to use Cardiac BiomarkersTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N230CmE/CNE Hours: 1.5

Co-Chairs: Allan S. Jaffe, Rochester, MN L. Kristin Newby, Durham, NC

8:00 What Every Clinician Should Know about measuring Cardiac Troponin — Fred S. Apple, Minneapolis, MN

8:15 using Cardiac Troponin Clinically — Allan S. Jaffe, Rochester, MN


8:45 What Every Clinician Should Know about measuring Natriuretic peptides — John C. Burnett, Rochester, MN

9:00 using Cardiac Natriuretic peptides Clinically — James L. Januzzi, Jr., Boston, MA


ARR

SympoSium

747

Antithrombotic Therapies for Atrial Fibrillation: Current State-of-the-ArtTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S404CmE/CNE Hours: 1.5

Co-Chairs: Samuel Z. Goldhaber, Boston, MA Julia H. Indik, Tucson, AZ

8:00 Who Should Get Anti-thrombotic Rx for AF: CHADs2

vs. CHA2DS2-VASc and All Those Not meeting Trial Criteria — Jonathan L. Halperin, New York, NY

8:15 pros and Cons of Thrombin inhibitor versus. Warfarin — Samuel Z. Goldhaber, Boston, MA

8:30 pros and Cons of Xa inhibitor versus Warfarin — Lars Wallentin, Uppsala, Sweden

8:45 Time in Therapeutic Range for Warfarin: Effect of Home monitoring — Jack E. Ansell, New York, NY

9:00 putting it All Together: What Should We Do Now? — A. John Camm, London, United Kingdom


CCS

SympoSium

724

Complex Conotruncal malformations: What the Surgeon Needs to Know and How to Get the informationTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N229CmE/CNE Hours: 1.5

Co-Chairs: Leo Lopez, New York, NY James S. Tweddell, Milwaukee, WI

8:00 Complex Conotruncal malformations: pathologic Considerations — Paul M. Weinberg, Philadelphia, PA

8:18 Complex Conotruncal malformations: The Whole picture — Meryl Cohen, Philadelphia, PA

8:36 Double outlet Right Ventricle with Straddling Atrioventricular Valves: Surgical Considerations — Pedro Del Nido, Boston, MA

8:54 Double outlet Right Ventricle with Complete Atrioventricular Septal Defect: What i Need for a Two Ventricle Repair — Francois G. Lacour-Gayet, New York, NY

9:12 Transposition of the Great Arteries with Ventricular Septal Defect and pulmonary Stenosis: Surgical options — Victor O. Morell, Pittsburgh, PA

CCS

SympoSium

725

Coming of Age: The HLHS Turns 21Tuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N231CmE/CNE Hours: 1.5

Co-Chairs: Karen S. Kuehl, Washington, DC Erwin N. Oechslin, Toronto, ON

8:00 HLHS: At the Beginning.… — Peter Lang, Cambridge, MA

8:18 HLHS: What We Have Learned about the physiology — Jack Rychik, Philadelphia, PA

8:36 HLHS: How imaging the HLH patient Has Changed — Craig A. Sable, Washington, DC

8:54 Surgical Evolution in the past Two Decades: Striving for optimal Long-Term outcome — Kirk Kanter, Atlanta, GA

9:12 Failing Fontan: is the Hypoplastic Left Heart patient Any Different? — Gruschen R. Veldtman, Toronto, Canada

HF

EXpERTS

257

Cardiac AmyloidosisTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S502CmE/CNE Hours: 1.5

Chair: Rodney Falk, Boston, MA

Case Presenter: David C. Seldin, Boston, MA

Panelists: Jeffrey Alexis, Rochester, NY, Morie Gertz, MN, Raymond Y. K. Kwong, Boston, MA, Joseph Selvanayagam, Adelaide, Australia, Marc J. Semigran, Boston, MA


Tuesday, March 27, 2012Please Note: The following sessions are listed alphabetically by learning pathway abbreviation based on session start time.

Morning

210 GO for ACC.12!

Mor

ning

imAG

EXpERTS

258

Echo in Assessment of Low Gradient Aortic StenosisTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S505CmE/CNE Hours: 1.5

Chair: Catherine M. Otto, Seattle, WA

Case Sunil V. Mankad, Rochester, MN, Alan Zajarias, Presenters: Saint Louis, MO

Panelists: Ian G. Burwash, Ottawa, Canada, Patrick M. McCarthy, Chicago, IL, Rick A. Nishimura, Rochester, MN, Catherine M. Otto, Seattle, WA

iSCHEm

EXpERTS

259

innovations in Noninvasive Evaluation of Stable ischemic Heart DiseaseTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S503CmE/CNE Hours: 1.5

Chair: Albert C. Lardo, Baltimore, MD

Case Erin Bohula, Boston, MA, William Luke, Gainesville, FL,Presenters: J. Jacob Mancuso, San Antonio, TX

Panelists: Theodore P. Abraham, Baltimore, MD, Daniel S. Berman, Los Angeles, CA, Shelton D. Caruthers, Saint Louis, MO, Gregory M. Lanza, Saint Louis, MO

LiFELoNG

BooT CAmp

114

CCA Research Bootcamp Session ii: Successful Research Execution and DisseminationTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S105dCmE/CNE/CpE Hours: 1.5 ACpE No. 0012-9999-12-122-L04-p

Chair: Nancy M. Albert, Chesterland, OH

8:00 optimizing the Data Collection process — Desiree A. Fleck, Philadelphia, PA

8:25 Submitting a Competitive Abstract — Lynne Braun, Chicago, IL

8:50 Disseminating Research — Nancy M. Albert, Cleveland, OH


pHTN

SympoSium

726

Sesion Conjunta Con La Sociedad Espanola de Cardiología Sociedad interamerica de Cardiología/American College of Cardiology: problemas Relevantes en Cardiología — 2012Tuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S403CmE/CNE Hours: 1.5

Co-Chairs: Vicente Bertomeu Martinez, Madrid, Spain Valentin Fuster, New York, NY Daniel Pineiro, Buenos Aires, Argentina

8:00 Riesgo Cardiovascular, Como Causa de obstrucion de la microcirculacion Cerebral y Disfuncion Cognativa — Valentin Fuster, New York, NY

8:18 El Holter implantable: ¿Tenemos Claras las indicaciones? — Arcadio Garcia-Alberola, Madrid-Cartagena, Spain

8:36 Empleo de Cardiodesfibriladores en Latinoamérica y uSA: Semajanzas y Diferencias — Gabriel Vanerio, Montevideo, Uruguay

8:54 La Circulación pulmonar, el Ventrículo Derecho, y la Resonancia magnetica — Javier Sanz, New York, NY

9:12 Hipertensión pulmonar en Grandes Alturas — Dante Penaloza, Lima, Peru

pREV

SympoSium

727

Joint Symposium of the American Society of Hypertension and the American College of Cardiology: Hypertension in the Critically ill patientTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S406aCmE/CNE/CpE Hours: 1.5 ACpE No. 0012-9999-12-145-L04-p

Co-Chairs: Daniel A. Duprez, Minneapolis, MN C. Venkata S. Ram, Dallas, TX

8:00 perioperative Hypertension — James B. Froehlich, Ann Arbor, MI

8:18 Hypertension in patients with intracranial Hemorrhage — Phillip B. Gorelick, Chicago, IL

8:36 Hypertension in Acute ischemic Stroke — Thompson Robinson, Leicester, United Kingdom

8:54 Hypertensive urgency and Emergency — George L. Bakris, Chicago, IL

9:12 Hypertension in the Emergency Department and Critical Care unit — Stanley S. Franklin, Irvine, CA

SpECiAL

SpECiAL

308

Joint American College of Cardiology/Journal of the American Medical Association Late-Breaking Clinical TrialsTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, Hall B, ACC.12 Main TentCmE/CNE Hours: 1.5

Co-Chairs: Elliott M. Antman, Boston, MA Michael H. Crawford, San Francisco, CA

Panelists: Matthew J. Budoff, Torrance, CA, Bernard J. Gersh, Rochester, MN, Alice K. Jacobs, Boston, MA, Frans J. J. Van de Werf, Leuven, Belgium

8:00 Survival after pCi or CABG in older patients with Stable multivessel Coronary Disease: Results from the ACCF-STS Database Collaboration on the Comparative Effectiveness of Revascularization Strategies — William S. Weintraub, Maria V. Grau-Sepulveda, Jocelyn Weiss, Sean O’Brien, Eric Peterson, Paul Kolm, Zugui Zhang, Lloyd Klein, Richard Shaw, Charles McKay, Laura Ritzenthaler, Jeffrey Popma, John Messenger, David Shahian, Frederick Grover, John Mayer, Cynthia M. Shewan, Kirk Garratt, Issam Moussa, George Dangas, Fred Edwards, American College of Cardiology, Washington, DC, USA, The Society of Thoracic Surgeons, Chicago, IL, USA


8:22 multicenter Randomized Comparative Effectiveness Trial of Cardiac CT versus Alternative Triage Strategies in Acute Chest pain patients in the

Tuesday, March 27, 2012 • ACC.12


Morning

Emergency Department: Results from the RomiCAT ii Trial — Udo Hoffmann, Quynh Truong, Hang Lee, Eric Chou, Pamela Woodard, John Nagurney, James H. Pope, Thomas Hauser, Charles White, Scott Weiner, Alexander Goehler, Pearl Zakroysky, Ruth Kirby, Douglas Hayden, Stephen Wiviott, Jerome Fleg, Scott Gazelle, David Schoenfeld, James Udelson, Massachusetts General Hospital — Cardiac MR PET CT Program, Boston, MA, USA


8:44 Results of the immEDiATE (immediate myocardial metabolic Enhancement During initial Assessment and Treatment in Emergency Care) Trial: A Double-blind Randomized Controlled Trial of intravenous Glucose, insulin, and potassium (GiK) for ACS in Emergency medical Services — Harry P. Selker, Joni R. Beshansky, Patricia R. Sheehan, Robin Ruthazer, John L. Griffith, James E. Udelson, Joseph M. Massaro, Ralph B. D’Agostino, IMMEDIATE Trial Investigators, Tufts Medical Center, Boston, MA, USA


9:06 moderate pulmonary Embolism Treated with Thrombolysis (mopETT Study) — Mohsen Sharifi, Curt Bay, Laura Skrocki, Farnoosh Rahimi, Mahshid Mehdipour, Arizona Cardiovascular Consultants, Mesa, AZ, USA, A.T.Still University, Mesa, AZ, USA


SpECiAL

SympoSium

739

Joint Session of the European Society of Cardiology and the American College of Cardiology ii: pros and Cons of New Approaches for Antiplatelet and Anticoagulant TherapyTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place North, N426CmE/CNE Hours: 1.5

Chair: Marc Steven Sabatine, Boston, MA

8:00 New Anticoagulants — Michael M. Ezekowitz, Wynnewood, PA

8:18 New Antiplatelet Drugs — Christopher B. Granger, Durham, NC

8:36 Value of Functional Testing with Antiplatelet Drugs — Thomas Cuisset, Marseille, France

8:54 Value of Genetic Testing with Antiplatelet and Anticoagulant Drugs — Franz-Josef Neumann, Munich, Germany

9:12 Non-pharmacologic Approaches to Embolic Stroke prevention — Horst Sievert, Frankfurt, Germany

VALV

EXpERTS

260

Aortic Regurgitation/BAVTuesday, march 27, 2012, 8:00 a.m. – 9:30 a.m.McCormick Place South, S504aCmE/CNE Hours: 1.5

Chair: Robert O. Bonow, Chicago, IL

Case Anthony DiScipio, Lebanon, NH, Hector I. Michelena, Presenters: Rochester, MN, Agnès Pasquet, Brussels, Belgium

Panelists: Robert O. Bonow, Chicago, IL, Joseph S. Coselli, Houston, TX, Patrick T. O’Gara, Boston, MA

SpECiAL

SpECiAL

309

ACC.12 Closing Session: innovators in CardiologyTuesday, march 27, 2012, 9:45 a.m. – 11:45 a.m.McCormick Place North, Hall B, ACC.12 Main TentCmE/CNE/CpE Hours: 2 ACpE No. 0012-9999-12-133-L04-p

Chair: David R. Holmes, Jr., Rochester, MN

Panelists: Gary S. Mintz, Washington, DC, Rick A. Nishimura, Rochester, MN, Patrick T. O’Gara, Boston, MA, E. Murat Tuzcu, Cleveland, OH

9:45 innovators in Cardiology: Regenerative Tissue perspective — Kenneth Chien, Boston, MA


10:08 innovators in Cardiology: interventional perspective — Martin B. Leon, New York, NY


10:31 innovators in Cardiology: Surgical perspective — Michael J. Mack, Plano, TX


10:54 innovators in Cardiology: imaging perspective — A. Jamil Tajik, Milwaukee, WI


11:17 innovators in Cardiology: Clinical and Translational Research — Application to practice perspective — Robert M. Califf, Durham, NC


11:40 Closing Remarks — David R. Holmes, Rochester, MN

ACC.12 • Tuesday, March 27, 2012

Get Your DailY Dose of Quality at aCC.12

©2012 American College of Cardiology. E1204

Learn more about ACC’s quality improvement programs and how you

can get involved during ACC.12

aCC Central (Booth #10027)

American College of CardiologyIndustry Training Program

ACC’s Industry Training Program is helping to enhance and improve your interactions with industry personnel. Comprehensive, thorough and non-biased education will help medical and device representatives to function as your partners — supporting positive outcomes for your patients.

Key components of the ACC Industry Training program include —

• Cardiovascular clinical knowledge• Disease mechanisms• Clinical treatment options• Appropriate industry/professional organization interaction

Look for the Industry Training Seal on your representatives’ business cards.

Visit ACC Central, Booth 10027, or go to www.CardioSource.org/IndustryTraining for more information.

©2

01

2 A

mer

ican

Col

lege

of

Car

diol

ogy

C1

20

6

The European Society of Cardiology presents the world’s premier conference

on the science, management and prevention of cardiovascular disease.

ESC Congress 201225-29 AUGUST

munichG E R M A N Y

This year’s spotlight is “From bench to practice“

Win a free congress registrationScan this QR code (or visit www.escardio.org/esc2012-prizedraw) to enter the prize draw* for a free registration for ESC Congress 2012 in Munich*Rules and regulations available at www.escardio.org

Instructions: 1- Download a free QR code reader (ex: www.getscanlife.com) on to your smartphone 2- Launch the reader3- Scan this QR code with your phone camera.

www.escardio.org

Live interventions

Highly innovative poster area

Interaction with the audience

■ 32 000+ healthcare professionals from 150+ countries ▲ 1200+ faculty from around the globe ● 28 joint sessions organised with professional societies from the 5 continents ▲ 4 200+ abstracts to be presented

2011 Key figures: 5 days of scientific sessions ■ 400+ ESC sessions ▲ 10 800+ abstracts submitted■ 70 industry sponsored sessions ▲200 exhibiting companies ■ + unique & unlimited opportunities to network!

Register before 31 May at www.escardio.org

your next international Cardiology CongressOnly 5 months until

Advance programme now available online

Come see us

at booth

11080

Stay up-to-date with NEW official magazines of the American College of Cardiology — CardioSource WorldNews and CardioSource InterventionalNews! These complimentary, monthly magazines are edgy, provocative and deliver point and counter point perspectives on the latest in cardiovascular research, medicine and technology. Learn the latest advances with:

• Perspectivesfromthoughtleaders

• Debatesonthekeycontroversiesinmedicine

• Practicalinsightsintocomplexclinicaldata—implicationsforyourpractice

Visit www.cswnews.org and www.csinewslive.org to access the electronic versions today.

Stop by ACC CentrAl, booth #10027 to leArn more! ©

2012

American

College

ofC

ardiolog

y.G1

212

Chris’s CornerWelcome to CardioSource World NewsPAGE 2

Jack In The BackCreating the futurePAGE 48

Number CheckInteresting stats and tidbits to ponderPAGE 36

Patient FocusHow you can help your patients with obesity

PAGE 42

IN THIS ISSUE:

CLINICAL NEWS

JANUARY 2012VOLUME 1 | ISSUE 1

www.cswnews.org

PREMIER ISSUEYour Source for News and Views from the World of Cardiology

CardioSource WorldNews

THE

ISFUTURENOWHow new anticoagulants will impact stroke prevention in AF — PAGE 20

Gregg C. Fonarow, MD on Home Monitoring—page 13 Suzanne Oparil, MD

on JNC 8—page 31Steven E. Nissen, MD on Politics vs. Science—page 46

46%Reduction in Incidence of MI

50% Reduction in Sudden Cardiac Deaths

Cardiology Countdown 3JACC in a Flash 8Journal Scan 9ACCEL Summaries 10Hot Topic 13Special Meeting Coverage 14

George’s Take

Life after COURAGE

PAGE 2

Jack In The Back

Problems with

PCI reimbursement

PAGE 48

Number Check

New data points from

NCDR databases

PAGE 36

Novel Techniques:

Grasping transradial

access

PAGE 42

IN THIS ISSUE:

CLINICAL NEWS

MARCH 2012 VOLUME 1 | ISSUE 1

www.cswnews.org

PREMIER ISSUE

Your Source for News and Views from the World of Cardiology

CardioSource InterventionalNews

Stents

in the Elderly—page 18

What ACOs Mean

for Intervention—page 23

The Issue of

Clopidogrel Resistance —page 36

JACC in a Flash 8

Journal Scan 9

Cardiology Countdown 12

ACCEL Intervention 14

Hot Topic 15

The New Frontier:

Will Change Everything

How the Development of TAVI

Save 15% off select educational products and courses purchased on site!

Visit ACC Central, Booth #10027!

©2012 American College of Cardiology. J1204

ACC.12

Author Index

Author Index

Mobile AppPowered by Skyscape

FREE CardioSource Mobile App

The American College of Cardiology and Skyscape are pleased to offer a comprehensive suite of trusted resources for cardiovascular professionals!

Download CardioSource’s most popular and clinically relevant content on your mobile device today for FREE!

Scan the Microsoft Tag or visit http://bit.ly/csapp on your mobile device.


CardioSource©

2012

Am

eric

an C

olle

ge o

f Car

diol

ogy.

W12

05

Auth

or In

dex


Aaron, Jacob: 406 · 154

Aaronson, Keith D.: 669 · 168

Aaronson, Susan: 913 – 6 · 143

Abbas, Aamer: 917 · 148

Abbott, Brian G.: 651 · 160

Abdalla, Mohamed I.: 906 – 8 · 110

Abdel-Latif, Ahmed: 917 – 7 · 148

Abdelmoneim, Sahar S.: 929 – 8 · 154

Abdul-Nour, Khaled: 918 – 3 · 148

Abe, Mitsunori: 2504 – 7 · 138

Abidov, Aiden: 918 · 148

Abizaid, Alexandre: 2504 – 11 · 138, 2632 · 184, 2202 · 161, 2509 – 6 · 147, 503 · 188

Abood, Beth: 306 · 186

Abou-Chebl, Alex: 2633 · 189

Abraham, JoEllyn C.M.: 904 – 4 · 141

Abraham, Theodore P.: 259 · 210, 638 · 151, 907 · 142

Abraham, William: 922 – 5 · 150

Abraham, William T.: 614 · 121, 655 · 163, 716 · 201, 690 · 184

Abuzetun, Jamil Y.: 744b · 170

ACCESS EUROPE Investigators: 930 – 3 · 155

Achenbach, Stephan: 924 – 5 · 151, 2625 · 177, 696 · 185, 924 – 7 · 151

Acker, Michael A.: 213 · 122, 681 · 179

Ackerman, Michael J.: 222 · 141, 236 · 169, 648 · 159, 691 · 184

Adams, David H.: 632 · 129

Adams, Kirkwood: 921 – 4 · 150

Adamson, Phillip: 922 – 5 · 150

Addo, Tayo A.: 2509 · 147

Addonizio, Linda: 901 – 5 · 114

Adelstein, Evan C.: 922 – 6 · 150

Adir, Yochai: 912 – 6 · 142

Afonso, Luis: 2306 · 125, 306 · 186, 910 – 6 · 111

Agnihotri, Arvind: 2308 · 156, 2310 · 156

Agostoni, Pierfrancesco: 926 – 5 · 153

Aguilar, David: 203 · 109, 718 · 202, 822 · 198

Ahern, Jeanne: 616 · 122

Ahmad, Tariq: 744a · 170, 921 – 5 · 150

Ahmed, Ali: 225 · 150

Ahmed, Mohamed: 907 – 7 · 142

Ahmed, Mustafa: 234 · 163, 2306 · 125

Ahmed, Waqas: 2509 – 9 · 147

Ahn, Chul: 907 – 4 · 142

Ahn, Chul-Min: 405 · 144

Ahn, Jung-Min: 2645 · 120

Ahn, Young Keun: 917 – 4 · 148, 2505 – 14 · 139, 511 · 188

Ai, Tomohiko: 405 · 144

AI-Mallah, Mouaz: 918 – 3 · 148

Aikawa, Elena: 406 · 154

Akkaya, Mehmet: 918 – 6 · 148

Al Habib, Farida: 746 · 105

Al Suwaidi, Jassim M.: 746 · 105

Al-Khatib, Sana: 904 – 9 · 141, 919 · 149

Al-Mallah, Mouaz: 924 – 5 · 151, 924 – 7 · 151

Al-Mallah, Mouaz H.: 214 · 122, 686 · 180, 818 · 169

Alam, Mahboob: 925 – 6 · 152

Albert, Michelle: 664 · 165

Albert, Nancy M.: 114 · 210, 717 · 202

Alesh, Issa: 306 · 186

Alexander, Jay H.: 660 · 164

Alexander, John: 904 – 9 · 141

Alexander, Karen P.: 645 · 158

Alexanderson, Erick: 513 · 190

Alexis, Jeffrey: 257 · 209

Alexopoulos, Dimitrios: 903 – 4 · 108, 903 – 7 · 108

Alhabib, Khalid F.: 515 · 193

Ali, Ziad: 2508 – 6 · 139

Alizadehasl, Azin: 746 · 105

Alla, Venkata M.: 744b · 170

Allen, Larry A.: 224 · 143, 806 · 123

Alli, Oluseun O.: 2630 · 183

Allison, Thomas: 688 · 182, 929 – 8 · 154

Allocco, Dominic: 2506 – 7 · 146, 2506 – 13 · 146

Almendral, Jesus: 732 · 109, 804 · 118

Almonacid, Alexandra: 2509 – 11 · 147

Alpendurada, Francisco D.: 908 – 4 · 110

Alpert, Joseph S.: 732 · 109, 733 · 114, 734 · 116, 735 · 122, 736 · 125

Alraies, M Chadi: 2301 · 114, 2315 · 189

Alvarez, Paola: 2303 · 115

Alvarez, Rene J.: 717 · 202

Ambar, Sameer: 2310 · 156, 2313 · 189, 2314 · 189

Amin, Alpesh N.: 913 – 5 · 143

Amin, Amit: 2510 – 15 · 140

Amin, Amit P.: 2511 – 13 · 147

Amin, Zahid: 2314 · 189

Amir, Offer: 912 – 6 · 142

Amoroso, Nicholas: 2505 – 10 · 139

Amsterdam, Ezra A.: 231 · 162

Anand, Inder: 680 · 179

Ananthasubramaniam, Karthikeyan: 223 · 142, 813 · 164, 822 · 198, 826 · 203

Anderson, Allen: 2308 · 156

Anderson, Jeffrey: 616 · 122, 712 · 199

Anderson, Jeffrey L.: 513 · 190, 675 · 169

Anderson, Richard E.: 650 · 153

Andrade, Jadelson P.: 503 · 188

Angelini, Paolo E.: 261 · 171

Angelopoulos, Peter: 2620 · 161

Angiolillo, Dominick: 902 – 4 · 107

Angiolillo, Dominick J.: 2617 · 156, 2643 · 201

Anne, Godier: 904 – 8 · 141

Anne-Céline, Martin: 904 – 8 · 141

Anne-Marie, Fischer: 904 – 8 · 141

Annex, Brian H.: 407 · 181

Ansell, Jack: 904 – 9 · 141

Ansell, Jack E.: 747 · 209

Antman, Elliott: 902 – 3 · 107, 902 – 5 · 108

Antman, Elliott M.: 613 · 121, 308 · 210

Antoniucci, David: 903 – 6 · 108

Appelbaum, Evan: 925 – 4 · 152, 925 – 5 · 152

Apple, Fred S.: 728 · 209

Applegate, Robert J.: 2111 · 177, 2305 · 125, 2510 · 139

Aragon, Victor: 2504 – 15 · 138

Arai, Andrew E.: 605 · 116, 682 · 179

Aranda, Juan M.: 234 · 163, 517 · 191

Arbab-Zadeh, Armin: 909 – 8 · 111

Arbel, Yaron: 406 · 154

Arena, Frank J.: 2313 · 189

Arena, Ross: 651 · 160, 929 – 6 · 154

Armstrong, Aimee K.: 637 · 149

Armstrong, Paul: 916 – 5 · 140

Armstrong, Paul W.: 613 · 121, 639 · 156, 639 · 156

Armstrong, William F.: 682 · 179

Arnold, Alice M.: 905 – 5 · 109

Arnold, Suzanne V.: 219 · 128

Aronow, Herbert: 2511 – 15 · 147

Aronow, Herbert D.: 2637 · 195, 2620 · 161, 2633 · 189

Aronow, Wilbert: 907 – 4 · 142

Arora, Natasha P.: 2306 · 125

Arora, Rajat: 2310 · 156, 2313 · 189

Arora, Rajat: 2314 · 189

Arora, Sabeena: 744a · 170

Arrighi, James A.: 103 · 117

Artang, Ramin: 904 – 6 · 141

Arzamendi, Dabit: 2310 · 156, 2314 · 189

Asamoto, Lisa: 908 – 5 · 110

Asch, Federico: 744b · 170

Asgar, Anita W.: 2114 · 194, 504 · 193

Ashfield, Kyle: 919 – 8 · 149

Ashley, Euan: 929 – 6 · 154

Asirvatham, Samuel: 807 · 124

Asirvatham, Samuel J.: 744b · 170

Askew, John W.: 929 · 154

Assenza, M, Gabriele: 925 – 5 · 152

Assenza, Gabriele E.: 925 – 4 · 152

Asset, Gaelle: 911 – 5 · 143

ACC.12

Author Index

218 GO for ACC.12!

Last Name, First Name: Session # · Page #

Author Index • ACC.12

Atallah, Joseph: 262 · 187

ataya, ali: 2301 · 114

Ataya, Ali: 2315 · 189

Atsma, Douwe: 906 – 3 · 109

Attubato, Michael: 931 – 5 · 113

Atz, Andrew: 637 · 149, 901 – 4 · 114

Auger, Dominique: 922 – 8 · 150

Auger, William R.: 514 · 194, 662 · 164

Auguadro, Carla: 914 – 6 · 144

Aurigemma, Gerard P.: 744b · 170

Auseon, Alex J.: 638 · 151, 229 · 159, 805 · 123, 809 · 128, 814 · 164, 818 · 169, 825 · 202

Austin, Patrick W.: 914 – 5 · 144

Austria, Edgar: 932 – 4 · 155

Autore, Camillo: 925 – 5 · 152, 925 – 4 · 152

Aversano, Thomas: 2511 – 9 · 147, 304 · 143

Avraamides, Panayiotis: 2504 · 138, 745 · 203

Awata, Masaki: 2311 · 166

Ayres, Nancy: 693 · 185

Baba, Kenji: 901 – 3 · 114

Babaev, Anvar: 931 – 5 · 113

Babaliaros, Vasilis: 2203 · 194, 2308 · 156, 2619 · 161

Baber, Usman: 2501 · 137, 2508 – 6 · 139, 2501 – 10 · 137

Babu-Narayan, Sonya: 920 – 8 · 149

Bacharach, J. Michael: 2642 · 201, 931 – 8 · 113

Bachmann, Justin M.: 710 · 198, 113 · 193

Badimon, Juan: 902 – 6 · 108

Badri, Marwan: 912 – 4 · 142

Bae, Jang-Ho: 511 · 188, 2505 – 16 · 139

Bae, Jang-Whan: 917 – 4 · 148

Baechler, Courtney: 741 · 187

Baggish, Aaron: 914 – 8 · 144

Baggish, Aaron L.: 603 · 113, 929 – 4 · 154

Bahit, Cecilia: 904 – 9 · 141

Bai, Rong: 925 – 8 · 152

Bailey, Alison: 255 · 204, 746 · 105, 927 · 153

Bailey, Steven R.: 2608 · 119, 2619 · 161, 2122 · 183, 2314 · 189, 923 – 3 · 151

Bairey Merz, C. Noel: 227 · 152, 255 · 204, 620 · 123, 306 · 186

Baker, Joshua: 2308 · 156, 2310 · 156

Baklanov, Dmitri: 2510 – 7 · 139, 2511 – 13 · 147

Bakris, George L.: 631 · 128, 230 · 159, 727 · 210, 745 · 203, 926 · 153

Baldus, Stephan: 930 – 3 · 155, 930 – 6 · 155

Balke, C. William: 107 · 124

Ball, Stephen: 674 · 182

Ballantyne, Christie M.: 227 · 152, 729 · 203, 911 – 3 · 142, 911 – 10 · 143, 306 · 186, 611 · 117, 745 · 203

Baman, Timir: 918 – 3 · 148

Bamberg, Fabian: 909 – 6 · 111

Bandeali, Salman: 925 – 6 · 152

Banerjee, Subhash: 2302 · 114, 823 · 200, 923 · 151

Baran, David: 670 · 168

Baranowski, Bryan: 922 – 7 · 150

Barasch, Eddy: 905 – 6 · 109

Barbash, Israel: 2500 – 15 · 137, 2507 – 15 · 147

Barbeau, Gerald: 2510 – 9 · 139

Barker, Nancy: 920 – 7 · 149

Barman, Neil: 926 – 3 · 153

Baron, Julia: 2314 · 189

Barr, Laurie: 929 – 8 · 154

Barragan, Paul: 2509 – 9 · 147

Barrero, Carlos M.: 502 · 188, 502 · 188

Barrington, Sally: 908 – 3 · 110

Barrows, Kevin: 741 · 187

Bart, Bradley: 655 · 163

Bartoletti, Stefano: 925 – 8 · 152

Bartov, David: 2310 · 156, 2122 · 183

Bartz, Traci: 905 – 6 · 109

Bashir, Riyaz: 514 · 194

Basmadjian, Arsene J.: 930 · 155

Bassand, Jean-Pierre L.: 613 · 121

Bastiaenen, Rachel: 914 – 7 · 144

Batal, Omar: 912 – 5 · 142

Bateman, Michael G.: 407 · 181

Bateman, Timothy M.: 223 · 142

Bates, Eric R.: 200 · 107, 2638 · 196, 2643 · 201, 689 · 184, 2201 · 119, 513 · 190, 817 · 169

Batich, Christopher D.: 906 – 4 · 109

Bauer, Axel: 926 – 6 · 153

Bauer, Marcus: 924 – 4 · 151

Bauer, Wolfgang R.: 918 – 7 · 148

Bauernschmitt, Robert: 2644 · 107

Bax, Jeroen: 922 – 8 · 150

Bax, Matthijs: 2502 – 13 · 119

Bay, Curt: 308 · 210

Bayturan, Ozgur: 2608 · 119

Bdeir, Mohamad B.: 746 · 105

Beanlands, Rob S. B.: 223 · 142

Beaudoin, Jonathan: 406 · 154

Becker, Alexander: 909 – 6 · 111

Becker, Christoph: 909 – 6 · 111

Becker, David J.: 512 · 192

Becker, Richard: 903 – 8 · 108

Becker, Richard C.: 107A · 125, 2301 · 114

Beckman, Joshua A.: 250 · 198, 813 · 164, 743 · 129, 932 · 155

Beek, Aernout: 918 – 4 · 148

Beekman, Robert: 901 – 8 · 114

Beekman, Robert H.: 678 · 178, 901 · 114

Beer, Meinrad: 918 – 7 · 148

Beigel, Roy: 924 – 3 · 151

Belardi, Diego: 918 – 3 · 148

Belardi, Jorge A.: 502 · 188

Belardinelli, Luiz: 921 – 8 · 150

Belcik, Todd: 909 – 4 · 110

Belden, William: 918 – 5 · 148

Beliveau, Mary Ellen: 103 · 117

Belkin, MD, Robert: 907 – 4 · 142

Bell, Malcolm: 623 · 126, 817 · 169

Beller, George A.: 708 · 197

Belziti, Cesar A.: 502 · 188

Ben Dor, Itsik: 915 – 8 · 145

Ben-Dor, Itsik: 2308 · 156, 2500 – 15 · 137, 2507 – 15 · 147, 2639 · 202

Benamer, Hakim: 926 – 7 · 153

Benditt, David G.: 640 · 157

Benitez, R M.: 659 · 163

Benkeser, David: 905 – 5 · 109

Bennett, Mosi K.: 906 – 7 · 110

Bensimhon, Daniel: 929 – 6 · 154

Benson, Lee: 901 – 8 · 114

Berger, Peter B.: 623 · 126, 2301 · 114, 2501 · 137

Bergersen, Lisa: 901 – 8 · 114

Bergersen, Lisa T.: 678 · 178

Bergmeijer, Thomas: 902 – 4 · 107

Bergner, Daniel W.: 406 · 154

Berjeb, Nadia: 915 – 7 · 145

Berkstresser, Brant: 914 – 8 · 144

Berman, Daniel: 924 – 7 · 151

Berman, Daniel S.: 682 · 179, 259 · 210, 740 · 204, 924 – 5 · 151

Bernard, Le-Bonniec: 904 – 8 · 141

Bernhardt, Peter: 908 – 7 · 110, 903 – 3 · 108

Berrocal, Daniel H.: 502 · 188

Berry, Colin: 923 – 9 · 152

Bersin, Robert M.: 2613 · 126, 502 · 188

Bertomeu Martinez, Vicente: 726 · 210

Bertrand, Olivier: 2510 – 9 · 139

Berul, Charles: 625 · 127, 301 · 157

Berwanger, Otavio: 304 · 143

Beshansky, Joni R.: 308 · 210

Bhandare, Deepti: 2306 · 125

Bhargava, Mandeep: 239 · 178

Bhatt, Deepak: 306 · 186, 928 – 3 · 153

Bhatt, Deepak L.: 2627 · 177, 2641 · 200, 107A · 125

Bhatti, Tandeep K.: 233 · 163

Biagini, Elena: 925 – 4 · 152, 925 – 5 · 152

Biddle, W. P.: 744b · 170

Biederman, Robert: 918 – 5 · 148

Biederman, Robert W. W.: 605 · 116, 909 · 110

Biga, Cathleen: 609 · 117, 630 · 128, 673 · 169, 684 · 180, 621 · 123

Bilolikar, A Neil: 2508 – 11 · 139

Bischoff, Joyce: 406 · 154

Bisognano, John D.: 631 · 128

Bittl, John: 629 · 128

Bittner, Vera: 701 · 193, 711 · 199, 709 · 197

Blaha, Michael: 927 –3 · 153

Blaha, Michael J.: 729 · 203

Blankenberg, Stefan: 930 – 6 · 155, 930 – 6 · 155

Blankenship, James C.: 600 · 112, 600 · 112, 2305 · 125

Blankstein, Ron: 208 · 116, 910 – 3 · 111



ACC.12 • Author Index

Blauer, Joshua: 918 – 8 · 148, 918 – 6 · 148

Blauwet, Lori: 240 · 179

Bleiziffer, Sabine: 2507 – 13 · 147

Bliden, Kevin: 2501 – 12 · 137

Block, Peter C.: 2640 · 200, 714 · 199, 2314 · 189

Bloomfield, Gerald S.: 713 · 199

Bluemke, David: 908 – 8 · 110

Blum, Kay: 112 · 180

Blum, Michael S.: 687 · 180

Blumenthal, Roger: 927 –3 · 153

Bo, Yu: 916 – 7 · 140

Bode, Christoph: 507 · 191

Boden, Helèn: 917 – 5 · 148

Boden, William E.: 611 · 117

Bodi, Vicente: 908 – 6 · 110

boersma, eric: 922 – 8 · 150

Bogun, Frank: 918 – 3 · 148

Bohm, Michael: 926 – 4 · 153

Böhm, Michael: 2509 – 7 · 147

Bohula, Erin: 234 · 163, 259 · 210

Bolli, Roberto: 300 · 112

Bolling, Steven F.: 220 · 129, 2640 · 200, 681 · 179, 2105 · 171

Bolorunduro, Oluwaseyi: 408 · 187

Bonaca, Marc: 902 – 3 · 107

Bonan, Raoul: 2114 · 194, 246 · 187, 2626 · 177, 1607 · 205, 2308 · 156

Bonanad, Clara: 908 – 6 · 110

Bonello, Beatrice: 920 – 8 · 149

Bonow, Robert O.: 260 · 211, 606 · 116, 658 · 163, 107A · 125, 710 · 198

Booker, Julian: 2306 · 125

Boon, Nicholas A.: 407 · 181

Boothroyd, Derek: 903 – 5 · 108

Borden, William: 928 – 8 · 154

Borer, Jeffrey S.: 674 · 182

Borgia, Francesco: 916 – 5 · 140

Borlaug, Barry: 203 · 109, 821 · 197

Borlaug, Barry A.: 406 · 154

Bosa, Francisco: 2504 – 15 · 138

Bosmans, Johan: 2644 · 107

Botker, Hans E.: 916 – 4 · 140, 689 · 184

Bouchard, Alain: 2506 – 13 · 146

Bouchard, Marie-Pier: 2510 – 9 · 139

Boudreault, Jean-Rock: 2510 – 9 · 139

Bouleti, Claire: 930 – 5 · 155

Boura, Judy A.: 929 – 7 · 154

Bourge, Robert C.: 649 · 159, 517 · 191, 717 · 202

Bouvier, Erik: 2500 – 13 · 137, 407 · 181

Bove, Alfred A.: 302 · 165, 647 · 159, 688 · 182

Boxt, Lawrence M.: 683 · 180

Boyce, Steven: 2500 – 15 · 137, 2507 – 15 · 147

Boyle, Andrew: 694 · 185

Boyle, Noel G.: 216 · 126

Bozkurt, Biykem: 617 · 122, 626 · 127, 718 · 202, 816 · 166, 906 · 109

Bradley, Scott: 901 – 4 · 114

Brady, Peter A.: 306 · 186, 820 · 192

Branch, Kelley: 683 · 180

Brandwein, Russell A.: 2105 · 171

Brar, Somjot S.: 211 · 121

Braun, Lynne: 114 · 210, 698 · 186, 733 · 114

Braunwald, Eugene: 300 · 112, 400 · 106, 656 · 163, 902 – 3 · 107, 902 – 5 · 108, 916 – 8 · 140

Brecker, Stephen: 2644 · 107

Brener, Sorin J.: 2634 · 190, 916 – 4 · 140

Brennan, J. Matthew: 915 – 5 · 145, 928 – 5 · 154

Brethauer, Stacy: 306 · 186

Brignole, Michele: 306 · 186

Brilakis, Emmanouil: 2302 · 114

Brilakis, Emmanouil S.: 2201 · 119, 2504 · 138, 2629 · 183, 2639 · 202, 804 · 118

Brin, Kenneth P.: 600 · 112

Brindis, Ralph G.: 721 · 204, 516 · 192, 674 · 182

Brinker, Jeffrey: 909 – 8 · 111

Briole, Nicolas: 2502 – 9 · 119

Bristow, Michael R.: 104 · 117

Broberg, Craig S.: 202 · 108

Brochet, Eric: 930 – 5 · 155

Brockmann, Gernot: 2507 – 13 · 147

Brodie, Bruce: 2501 – 6 · 137, 2501 – 10 · 137, 2501 – 14 · 138, 2501 – 16 · 138

Brodie, Bruce R.: 2638 · 196

Brodt, Chad R.: 408 · 187

Brophy, James M.: 200 · 107, 653 · 162

Brosh, Sella: 924 – 3 · 151

Brown, Alan S.: 699 · 186

Brown, III, Charles L.: 621 · 123

Brown, David W.: 634 · 141

Brown, Patricia: 902 – 4 · 107

Brugaletta, Salvatore: 2503 – 13 · 146, 910 – 4 · 111

Brunken, Richard C.: 407 · 181

Brush, John E.: 219 · 128, 224 · 143, 609 · 117, 744a · 170

Bruyne, Bernard D.: 923 – 9 · 152

Bryant, Randall M.: 625 · 127, 667 · 167

Bryson, Christopher: 928 – 3 · 153

Buchanan, Kyle: 912 – 5 · 142

Buchbinder, Maurice: 2614 · 140

Budoff, Matthew: 924 – 7 · 151, 927 –3 · 153, 930 – 7 · 155

Budoff, Matthew J.: 644 · 158, 683 · 180, 924 – 4 · 151, 924 – 5 · 151, 308 · 210

Bui, Quang T.: 2612 · 125, 2313 · 189

Bukartyk, Jan: 406 · 154

Bukhman, Gene: 713 · 199

Buller, Harry R.: 305 · 181

Bullones, Juan A.: 2504 – 15 · 138

Bumpus, Sherry: 699 · 186

Buonamici, Piergiovanni: 903 – 6 · 108

Burgon, Nathan: 918 – 6 · 148

Burke, David A.: 2509 – 11 · 147

Burke, Martin C.: 216 · 126

Burke, Michael A.: 744b · 170

Burkhart, Harold M.: 210 · 118, 632 · 129

Burnett, John C.: 728 · 209

Burwash, Ian G.: 258 · 210

Bush, David E.: 664 · 165

Bush, Ruth: 743 · 129

Busman, Denise K.: 2104 · 165

Butler, Javed: 617 · 122, 906 · 109

Butter, Christian: 930 – 3 · 155

Buxton, Alfred E.: 715 · 201, 501 · 190

Buz, Semih: 676 · 178

Byrd, III, Benjamin F.: 657 · 163

Byrd, Charles L.: 624 · 126

Byrne, Barry: 300 · 112

Byrne, Barry J.: 906 – 4 · 109

Byrne, Robert: 2503 – 9 · 146

Byrne, Robert A.: 2645 · 120

Cademartiri, Filippo: 924 – 5 · 151, 924 – 7 · 151

Caiati, Carlo: 909 – 3 · 110

Calabresi, Marco: 2644 · 107

Calcagno, Simone: 2644 · 107

Caldarone, Christopher: 692 · 184, 901 – 3 · 114

Califf, Robert M.: 107A · 125, 300 · 112, 309 · 211, 746 · 105

Calkins, Hugh: 666 · 167, 703 · 196, 720 · 203

Callans, David: 212 · 121

Callister, Tracy: 924 – 5 · 151, 924 – 7 · 151

Calvino, Ramon: 2504 – 15 · 138

Camacho, Fabian T.: 910 – 7 · 111

Camm, A. John: 654 · 162, 702 · 196, 747 · 209

Campbell, Robert: 244 · 185

Canali, Emanuele: 2644 · 107

Cannon, Bryan C.: 252 · 201, 667 · 167

Cannon, Christopher: 916 – 8 · 140

Cannon, Christopher P.: 2634 · 190, 107A · 125

Cannon, Louis: 2506 – 7 · 146

Cano, Manuel: 2506 – 15 · 146

Canobbio, Mary: 679 · 179

Canter, Charles: 901 – 5 · 114

Cantor, Warren: 916 – 5 · 140

Capizzi, Jeffrey A.: 911 – 9 · 143

Capodanno, Davide: 2627 · 178, 2302 · 114, 2511 · 147

Caputo, Ronald: 2505 – 8 · 138

Carabello, Blase A.: 2636 · 195, 652 · 160, 681 · 179, 210 · 118

Carballo, Mariana: 304 · 143

Carlson, Eric B.: 104 · 117

Carr, James C.: 208 · 116

Carrabba, Nazario: 903 – 6 · 108

Carrie, Didier: 2506 · 146

Carrié, Didier: 2506 – 13 · 146

220 GO for ACC.12!



Carroll, John: 2507 – 9 · 146

Carrozza, Joseph: 2505 – 8 · 138

Carson, Andrew R.: 2644 · 107

Carson, Peter: 922 – 5 · 150

Caruthers, Shelton D.: 259 · 210

Carvalho, Ana L.: 911 – 8 · 143

Casale, Paul: 673 · 169, 673 · 169

Casali, Valentina: 914 – 6 · 144

Casella, Michela: 925 – 8 · 152

Casella-Filho, Antonio: 911 – 8 · 143

Casey, Donald E.: 226 · 152

Cassater, Daiana: 920 – 7 · 149

Cassel, Graham: 2509 – 9 · 147

Casserly, Ivan P.: 2620 · 161

Cavalcanti, Alexandre: 304 · 143

Cavender, Matthew: 2502 – 11 · 119

Cavendish, Jeffrey J.: 811 · 158

Cedarholm, John: 2502 – 7 · 119

Celada, Silvia: 914 – 6 · 144

Cercek, Bojan: 211 · 121

Cerisano, Giampaolo: 903 – 6 · 108

Cerqueira, Manuel D.: 407 · 181

Chae, In-Ho: 304 · 143

Chae, Jei Keon: 2505 – 14 · 139

Chae, Shung Chull: 2505 – 14 · 139

Chagas, Antonio C.: 503 · 188

Chakravarty, Saneka: 744a · 170

Challa, Karthik: 2311 · 166

Champion, Hunter C.: 662 · 164

Chan, David C.: 913 – 4 · 143

Chan, Paul: 205 · 112, 209 · 117, 408 · 187

Chan, Raymond: 925 – 4 · 152

Chan, Raymond H.: 925 – 5 · 152

Chandra, Navin: 914 – 7 · 144

Chang, Tara I.: 2511 – 11 · 147

Charaf, Edriss: 744b · 170

Chareonthaitawee, Panithaya: 223 · 142

Charles marc, Samama: 904 – 8 · 141

Chase, Paul: 929 – 6 · 154

Chatterjee, Saurav: 408 · 187

Chaturvedi, Seemant: 2631 · 183

Chaudhry, Farooq A.: 628 · 127

Chaustre, Fabian: 908 – 6 · 110

Chazal, Richard A.: 248 · 198, 302 · 165, 512 · 192

Cheema, Asim: 2644 · 107

Chehab, Bassem M.: 932 – 4 · 155

Chen, Chih-Ying: 922 – 4 · 150

Chen, Edmond: 903 – 8 · 108

Chen, James: 2507 – 9 · 146

Chen, Jiyan: 505 · 188

chen, lucia: 914 – 4 · 144

Chen, Michael: 230 · 159, 722 · 204

Chen, Peng-Sheng: 405 · 144

Chen, Stephen Y.: 2302 · 114

Cheng, Victor: 924 – 5 · 151, 924 – 7 · 151

cherukupalli, Raghu: 2311 · 166

Cheung, Anson: 2644 · 107

Chevalier, Bernard: 2500 – 13 · 137, 2503 – 13 · 146, 407 · 181

Chhatriwalla, Adnan: 2510 – 15 · 140, 2501 – 8 · 137, 2511 – 13 · 147

Chicos, Alexandru B.: 406 · 154

Chieffo, Alaide: 2202 · 161, 2503 · 145, 2625 · 177

Chien, Kenneth: 309 · 211

Childs, Susan: 113 · 193

Chin, Derek: 2314 · 189

Chin, Michael T.: 405 · 144

Chinnaiyan, Kavitha: 924 – 5 · 151, 924 – 7 · 151

Chipkin, Stuart: 911 – 9 · 143

Chiribiri, Amedeo: 908 – 3 · 110

Chisholm, Robert: 2644 · 107

Chiswell, Karen: 921 – 5 · 150

Chitwood, W. Randolph: 504 · 193, 674 · 182

Cho, Ae Shin: 917 – 4 · 148

Cho, Hyang Hee: 917 – 4 · 148

Cho, Jinman: 2608 · 119

Cho, Myeong Chan: 2505 – 14 · 139

Cho, Myeong-Chan: 917 – 4 · 148

Choi, Andrew: 744b · 170

Choi, Byoung Geol: 2505 – 12 · 139

Choi, Cheol Ung: 2505 – 12 · 139

Choi, Donghoon: 2508 – 9 · 139, 2644 · 107

Choi, Jin-Ho: 2504 – 13 · 138

Choi, Seung Cheol: 405 · 144

Choi, Seung-Hyuk: 2504 – 13 · 138

Chou, Eric: 308 · 210

Choudhury, Anirban: 2505 – 6 · 138

Choudhury, Lubna: 233 · 163

Chow, Benjamin: 924 – 7 · 151

Chow, Benjamin J.: 924 – 5 · 151

Chow, Benjamin J. W.: 696 · 185

Chow, Marcus W.: 407 · 181

Chowdhary, Saqib: 304 · 143

Chris, Feindel: 2644 · 107

Christenson, Robert: 905 – 4 · 109

Christiansen, Evald: 2506 – 11 · 146

Christie, Catherine: 235 · 164

Christman, Karen L.: 627 · 127

Chronos, Nicolas A. F.: 633 · 129

Chrysohoou, Christine: 931 – 3 · 113

Chu, Victor: 2644 · 107

Chua, Terrance: 905 – 8 · 109

Chugh, Atul: 908 – 8 · 110

Chugh, Sumeet: 691 · 184, 702 · 196

Chung, Eugene: 922 – 5 · 150

Chung, Eugene H.: 688 · 182

Chung, Mina: 243 · 184, 904 – 4 · 141, 922 – 7 · 150

Churchwell, Keith B.: 684 · 180

Cigarroa, Joaquin: 629 · 128, 910 · 111

CIMADEVILLA, Claire: 915 – 7 · 145

Clack, Lucy: 2645 · 120

Claessen, Bimmer E.: 2502 · 119

Clair, Daniel G.: 2637 · 195

Clark, Michael G.: 731 · 142

Clarkson, Priscilla M.: 911 – 9 · 143

Clayton, Tim: 2501 – 10 · 137

Clegg, Stacey D.: 2507 – 9 · 146

Cleland, John G. F.: 207 · 116

Clement-Guinaudeau, Stephanie: 406 · 154

Clever, Yvonne P.: 2509 – 7 · 147

Clouse, Melvin: 909 – 8 · 111

Clyne, Christopher: 919 – 5 · 149

Coelho-Filho, Otavio: 922 – 3 · 150

Cogle, Christopher: 300 · 112

Cohen, David: 2510 – 15 · 140, 2511 – 13 · 147

Cohen, David J.: 2636 · 195, 665 · 167, 503 · 188, 928 · 153

Cohen, Howard: 2510 – 13 · 140

Cohen, Marc: 623 · 126

Cohen, Mauricio G.: 2122 · 183

Cohen, Meryl: 724 · 209

Cohen-Solal, Alain: 680 · 179

Cohn, Lawrence H.: 401 · 124

Colan, Steven: 901 – 5 · 114

Cole, Stephanie M.: 911 – 9 · 143

Collier, Kevin: 2502 – 7 · 119

Collins, Tyrone J.: 2623 · 166

Colombo, Antonio: 2504 – 11 · 138, 2644 · 107, 400 · 106, 404 · 199

Comerota, Anthony J.: 2607 · 115, 2631 · 183, 2637 · 195

Comhair, Suzy: 912 – 8 · 142

Connolly, Stuart: 904 – 5 · 141, 904 – 7 · 141

Connor, Jean A.: 616 · 122

Conrad, Gibby: 907 – 5 · 142

Conrad, Michael J.: 905 – 7 · 109

Contant, Charles: 916 – 8 · 140

Conte, Michael S.: 2613 · 126, 2623 · 166

Conti, C. Richard: 214 · 122

Cook, E. Francis: 925 – 4 · 152

Cook, Earl Francis: 925 – 5 · 152

Cook, Stephen C.: 679 · 179

Cook, Thomas: 407 · 181

Cooke, Blaire: 923 – 4 · 151

Cooper, Christopher J.: 2627 · 177

Cooper, Leslie T.: 240 · 179, 720 · 203, 925 – 3 · 152

Cooper-Dehoff, Rhonda M.: 733 · 114

Cooper-DeHoff, Rhonda M.: 629 · 128, 663 · 165, 698 · 186, 731 · 142

Copeland, Hannah: 408 · 187

Copeland, Jack: 408 · 187

Coppens, Michiel: 904 – 5 · 141

Corcos, Thierry: 2627 · 178

Cormier, Bertrand: 2500 – 13 · 137, 407 · 181




Cornel, J.H.: 903 – 8 · 108

CORONARY Study Investigators: 305 · 181

Corrado, Domenico: 603 · 113

Corriveau, Nicole: 913 – 6 · 143

Corso, Paul: 2500 – 15 · 137, 2507 – 15 · 147

Corvaja, Nicola: 2310 · 156

Coselli, Joseph S.: 260 · 211

Costa, Jr., J. Ribamar: 2504 – 11 · 138

Costa, José de Ribamar: 2506 – 15 · 146

Costa, Marco A.: 2111 · 177, 2639 · 202, 2201 · 119, 2303 · 115

Costa, Ricardo: 2506 – 15 · 146

Costa, Ricardo A.: 2504 – 11 · 138

Costa, Salvatore: 256 · 204, 612 · 118, 814 · 164

Costantini, Costantino: 2309 · 156

Costanza, Salvatore: 906 – 5 · 110

Costanzo, Maria Rosa: 617 · 122

Côté, Mélanie: 915 – 6 · 145

Cotter, Gadi: 680 · 179

Cotts, William: 2315 · 189

Courchesne, Paul: 905 – 3 · 109

Coutinho, Thais: 407 · 181

Cowart, Pam: 922 – 5 · 150

Cowger, Jennifer: 694 · 185

Cox, David: 2501 – 10 · 137, 2501 – 14 · 138, 2501 – 16 · 138

Cox, David A.: 604 · 115, 2309 · 156

Coylewright, Megan: 744b · 170

Crawford, Michael H.: 308 · 210, 920 · 149

Crawford, Thomas: 918 – 3 · 148

Crawford, Thomas C.: 713 · 199

Crean, Andrew: 925 – 4 · 152, 925 – 5 · 152

Cremers, Bodo: 2509 – 7 · 147

Cribier, G. Alain: 2606 · 115, 2203 · 194, 305 · 181

Crispino, Caroline: 923 – 4 · 151

Cristea, Ecaterina: 916 – 4 · 140, 2501 – 14 · 138, 2501 – 16 · 138, 2508 – 15 · 139, 304 · 143

Cross, Russell R.: 901 – 7 · 114

Crossley, George H.: 243 · 184, 614 · 121

Crowley, Kevin: 916 – 8 · 140

Cueff, Caroline: 915 – 7 · 145

Cui, Lianqun: 2645 · 120

Cuisset, Thomas: 739 · 211

Cummings, Jennifer E.: 716 · 201

Cuni, Rezarta: 2503 – 9 · 146

Curb, J D.: 904 – 4 · 141

Currier, Jesse: 917 · 148

Curtis, Anne: 904 – 4 · 141

Curtis, Anne B.: 207 · 116, 239 · 178

Curtis, Jeptha P.: 919 – 4 · 149

Cury, Ricardo C.: 696 · 185

Cushman, William C.: 631 · 128

Cutlip, Donald: 2645 · 120

Cuttica, Michael: 249 · 198

D’Agostino, Ralph B.: 700 · 186, 308 · 210

D’Elia, Emilia E.: 914 – 6 · 144

Dager, William: 623 · 126

Dagogo-Jack, Samuel: 711 · 199, 711 · 199

Dai, Dadi (David): 928 – 5 · 154

Dal-Bianco, Jacob: 406 · 154

Damal, Kavitha: 918 – 6 · 148

Damelou, Anastasia: 903 – 7 · 108

Damiano, Ralph J.: 1607 · 205, 509 · 190

Damman, Peter: 2502 – 13 · 119

Damp, Julie: 204 · 110, 695 · 185

Danciu, Sorin: 2303 · 115

Dandel, Michael: 921 – 7 · 150

Daneault, Benoit: 2500 – 11 · 137, 2507 – 11 · 146

Dangas, George: 2508 – 6 · 139, 2501 – 6 · 137, 2501 – 10 · 137, 308 · 210

Dangas, George D.: 2627 · 178, 2632 · 184, 2638 · 196, 646 · 155, 2644 · 107, 304 · 143, 510 · 193, 745 · 203

Daniels, Curtis J.: 202 · 108, 668 · 168

Danik, Jacqueline S.: 911 – 6 · 143

Danik, Stephan: 922 – 3 · 150

Danoff, Ann: 2505 – 10 · 139

Darbar, Dawood: 702 · 196

Darst, Jeffrey: 692 · 184

Datta, Saurabh: 907 – 8 · 142

Daubeney, Piers E. F.: 692 · 184

Daubert, James: 919 – 6 · 149

Daubert, James P.: 704 · 196, 690 · 184

Dauerman, Harold L.: 2624 · 167, 722 · 204, 2305 · 125

Daugherty, Stacie L.: 245 · 185, 928 – 6 · 154

Davendralingam, Natasha: 908 – 4 · 110

Davidson, Brian: 909 – 4 · 110

Davidson, Charles J.: 2201 · 119, 2310 · 156

Davidson, Karina: 910 – 5 · 111

Davidson, Michael: 911 – 10 · 143

Davidson, Michael H.: 611 · 117

Davidson, William R.: 668 · 168, 920 · 149

Davies, Justin E.: 923 – 6 · 152

Davis, David: 106 · 123

Davis, Suresh: 2311 · 166

Davlouros, Periklis: 903 – 4 · 108, 903 – 7 · 108

Dawkins, Keith: 2506 – 7 · 146, 2506 – 13 · 146, 910 – 4 · 111

Dawn, Buddhadeb: 932 – 4 · 155

de Belder, Mark A.: 508 · 191

de Bruyne, Bernard: 2503 – 13 · 146, 916 – 4 · 140

De Bruyne, Bernard: 2508 – 7 · 139, 2511 – 7 · 147

De Carlo, Carlotta: 2644 · 107

De Caterina, Raffaele: 904 – 9 · 141

De Cecco, Carlo Nicola: 925 – 4 · 152, 925 – 5 · 152

De Ferranti, Sarah: 247 · 196

de la Torre Hernandez, Jose: 2625 · 177, 2504 – 15 · 138

de Lemos, James: 913 – 7 · 143

De Lemos, James A.: 653 · 162, 710 · 198, 1605 · 171, 911 · 142

De Marco, Teresa: 649 · 159, 705 · 196

De Michelis, Nathalie: 907 – 8 · 142

De Schutter, Alban: 927 – 5 · 153

de Vries, Antoine: 906 – 3 · 109

de Vries, Ton: 910 – 4 · 111

de Waha, Antoinette: 2645 · 120

de Waha, Suzanne: 902 – 8 · 108

de Winter, Robbert: 2502 – 13 · 119

Dearani, Joseph A.: 2615 · 148, 625 · 127, 661 · 164

Dec, G. William: 680 · 179

Decker, Carole: 2501 – 8 · 137

Deedwania, Prakash C.: 207 · 116

Deering, Thomas F.: 690 · 184

DeFilippi, Christopher: 905 – 6 · 109

DeFilippi, Christopher R.: 905 – 4 · 109

Degertekin, Muzaffer: 2639 · 202, 518 · 189

Dehmer, Gregory J.: 2104 · 165

Deitelzweig, Steven: 913 – 5 · 143

Del Nido, Pedro: 724 · 209

DeLa Rochellière, Robert: 2510 – 9 · 139

Delafontaine, Patrice: 916 – 6 · 140

Delago, Augustin: 924 – 5 · 151

DeLago, Augustin: 924 – 7 · 151

Delaney, Joseph: 924 – 4 · 151

Delaney, Joseph A.: 930 – 7 · 155

DeLarochellière, Robert: 2644 · 107, 915 – 6 · 145

Delewi, Ronak: 2502 – 13 · 119, 918 – 4 · 148

Delgado, Juan: 517 · 191

Delgado, Victoria: 2618 · 161, 922 – 8 · 150

Deliargyris, Efthymios: 2501 – 10 · 137

Della Rocca, Domenico G.: 906 – 4 · 109

Delli Fraine, Jami: 928 – 7 · 154

Dello Russo, Antonio: 925 – 8 · 152

Deluca, Carlos: 2310 · 156

DeMaria, Anthony N.: 610 · 117, 633 · 129, 111 · 159, 400 · 106, 740 · 204

Dembrink, Jan Henk: 304 · 143

DeNofrio, David: 213 · 122, 641 · 157

DePuey, III, E. Gordon: 658 · 163, 708 · 197

Dery, Jean-Pierre: 2510 – 9 · 139, 2624 · 167, 903 – 8 · 108

Dery, Ugo: 2510 – 9 · 139

Desai, Akshay S.: 732 · 109, 234 · 163, 718 · 202, 517 · 191, 806 · 123, 921 · 150

Desai, Milind Y.: 648 · 159, 619 · 122, 2612 · 125

Desai, Shashank: 694 · 185

Desch, Steffen: 902 – 8 · 108

DeSilva, Kalpa: 2645 · 120

Deswal, Anita: 203 · 109

DeVarennes, Benoit: 2644 · 107

Devendra, Ganesh: 920 – 6 · 149

Dewey, Marc: 909 – 8 · 111

Dewey, Todd M.: 246 · 187, 2606 · 115, 1607 · 205, 2102 · 160

Dey, Damini: 924 – 5 · 151

222 GO for ACC.12!



Dhar, Ritesh: 223 · 142

Di Biase, Luigi: 677 · 178, 925 – 8 · 152

Di Carli, Marcelo: 910 – 3 · 111

Di Carli, Marcelo F.: 223 · 142

Di Mario, Carlo: 916 – 5 · 140, 2505 · 138, 923 – 6 · 152

Diamond, Robin: 248 · 198

Dias, Clapton: 923 – 4 · 151

Dib, Nabil: 610 · 117, 618 · 121

DiCarlo, Lorenzo: 911 – 10 · 143

Dickerson, Jennifer: 204 · 110

Dieter, Robert S.: 2305 · 125

Dietz, Harry: 908 – 8 · 110

Dill, Karin: 619 · 122

Diller, Gerhard-Paul: 920 – 5 · 149, 920 – 8 · 149

Dilsizian, Vasken: 619 · 122, 658 · 163, 708 · 197

Dimas, Alexios P.: 2510 · 139

Dimitriadis, K.: 926 – 8 · 153

Dimopoulos, Konstantinos: 920 – 5 · 149

Ding, Jingzhong: 927 –3 · 153

Dion, Robert: 652 · 160

DiSciascio, Germano: 2511 · 147

DiScipio, Anthony: 260 · 211

Dixon, Simon: 2508 – 11 · 139

Dixon, Simon R.: 2639 · 202, 2121 · 177, 2315 · 189

Djousse, Luc: 905 – 5 · 109

Dobesh, Paul: 734 · 116

Dodson, John A.: 919 – 4 · 149

Doevendans, P.: 926 – 5 · 153

Dogan, Ozgen: 2506 · 146

Doh, Joon Hyung: 2303 · 115

Doherty, Caroline L.: 2104 · 165

Dohi, Tomoharu: 2311 · 166

Donzeau-Gouge, Patrick: 2500 – 13 · 137

Donzeau-Gouge, Patrik: 407 · 181

Dorange, Cecile: 2503 – 11 · 146, 2503 – 13 · 146

Dorbala, Sharmila: 223 · 142, 910 – 3 · 111

Dorian, Paul: 904 – 5 · 141

Dörner, Jonas: 917 – 3 · 148

Dote, Yoko: 2309 · 156

Douglas, Pamela: 915 – 5 · 145

Douglas, Pamela S.: 644 · 158, 710 · 198, 107A · 125

Dovellini, Emilio Vincenzo: 903 – 6 · 108

Downey, William: 2502 – 7 · 119

Doyle, Daniel: 2644 · 107

Doyle, Daniel: 915 – 6 · 145

Doyle, Mark: 918 – 5 · 148

Drachman, Douglas E.: 2610 · 120, 2627 · 177, 2637 · 195, 734 · 116, 737 · 169, 812 · 158, 825 · 202

Drazner, Mark H.: 922 · 150

Dressler, Ovidiu: 2508 – 15 · 139, 916 – 4 · 140

Drozda, Joseph P.: 710 · 198

Du, Wei: 408 · 187

Du-Russel-Weston, Jean: 913 – 6 · 143

Dubin, Anne M.: 603 · 113

Dudek, Dariusz: 2503 – 15 · 146

Duess, Mai-Ann: 405 · 144

Duffy, Peter: 2501 – 14 · 138, 2501 – 16 · 138

Dumesnil, Jean: 2644 · 107

Dumesnil, Jean G.: 238 · 171, 256 · 204

Dumont, Eric: 2644 · 107, 915 – 6 · 145

Dumonteil, Nicolas: 2500 · 137

Dunlap, Stephanie: 921 – 4 · 150

Dunn, Steven P.: 733 · 114

Dunning, Allison: 924 – 5 · 151, 924 – 7 · 151

Dupont, Matthias: 912 – 7 · 142

Duprez, Daniel A.: 727 · 210, 406 · 154

Dusek, Jeffery: 741 · 187

Dutka, David: 923 – 7 · 152

Duvernoy, Claire S.: 245 · 185

Dvir, Danny: 2500 – 15 · 137, 2507 – 15 · 147

Dweck, Marc R.: 407 · 181

Dworkin, Lance: 2627 · 177

Dzavik, Vladimir: 2505 – 6 · 138

Eagle, Kim: 2511 – 15 · 147, 913 – 6 · 143, 931 – 8 · 113

Eagle, Kim A.: 231 · 162, 713 · 199, 107A · 125

Eagle, Taylor F.: 913 – 6 · 143

Earing, Michael: 202 · 108, 625 · 127

Easton, J. Donald: 904 – 9 · 141

Ebeid, Makram R.: 506 · 191

Ebell, Wolfram: 921 – 7 · 150

Eberle, Balthasar: 2606 · 115

Economy, Katherine: 679 · 179, 920 – 7 · 149

Edelmann, Frank: 921 – 8 · 150

Edwards, Brooks: 234 · 163

Edwards, Fred: 308 · 210, 915 – 5 · 145

Egidy Assenza, Gabriele: 920 – 7 · 149

Ehle, Gregory: 710 · 198

Eick, Christian: 926 – 6 · 153

Eikelboom, John: 206 · 116, 904 – 5 · 141, 904 – 7 · 141

Einhorn, Bryce: 2510 – 13 · 140

Einstein, Andrew J.: 927 – 4 · 153

Eisenberg, Mark: 920 – 4 · 149

Eitel, Ingo: 902 – 8 · 108

El Etriby, Adel: 746 · 105

El-Omar, Magdi: 304 · 143

Elasfar, Abdelfatah A.: 515 · 193

Elashoff, Michael: 924 – 6 · 151

Elashoff, Michael R.: 923 – 8 · 152

Elbal, Luis: 2509 – 9 · 147

Elhmidi, Yacine: 2507 – 13 · 147

Elkayam, Uri: 695 · 185, 720 · 203, 738 · 181

Ellenbogen, Kenneth A.: 201 · 108, 232 · 162

Elliott, Andrea: 912 – 5 · 142

Elliott, Perry M.: 253 · 203, 648 · 159

Elliott, William: 663 · 165

Ellis, Stephen: 2502 – 11 · 119, 300 · 112, 923 – 8 · 152

Ellis, Stephen G.: 2309 · 156, 2502 · 119, 503 · 188

Elmariah, Sammy: 2308 · 156, 2310 · 156, 2314 · 189, 930 – 7 · 155, 902 – 6 · 108

Elnagar, Amro: 2505 – 12 · 139

Eltchaninoff, Hélène: 2502 – 9 · 119

Eltchaninoff, Helene: 2606 · 115, 2636 · 195

Emanuelsson, Hakan: 902 – 7 · 108

Emert, Jamie: 928 – 7 · 154

Emery, Maurice: 923 – 4 · 151

Emmanuel, Noel: 914 – 7 · 144

Engstrom-Koch, Krysthel: 744a · 170

Enriquez-Sarano, Maurice: 246 · 187, 2609 · 120, 2640 · 200, 612 · 118, 632 · 129, 674 · 182, 814 · 164, 915 – 3 · 145

Entrikin, Daniel: 305 · 181

Epstein, Andrew E.: 201 · 108, 239 · 178, 703 · 196, 716 · 201, 655 · 163

Epstein, Laurence M.: 624 · 126

Erb, Blair D.: 219 · 128, 244 · 185, 601 · 112, 609 · 117, 710 · 198

Erbel, Raimund: 924 – 4 · 151

Erbel, Raimund A.: 2632 · 184, 507 · 191

Ergene, Oktay: 518 · 189

Erlinge, David: 902 – 4 · 107

Erol, Cetin: 904 – 9 · 141

Ertl, Georg: 507 · 191

Erwin, Phillip: 931 – 7 · 113

Eryazici, Paula d.: 2303 · 115

Erzurum, Serpil C.: 912 – 8 · 142

Escalante, Jose Luis: 906 – 5 · 110

Escaned, Javier: 923 – 6 · 152

Escarcega, Orlando: 507 · 191

Esler, Murray: 926 – 3 · 153

Esler, Murray D.: 926 – 4 · 153

Estep, Jerry: 643 · 158

Estes, N. A. M.: 239 · 178

Evangelista, Artur: 908 – 8 · 110

EVEREST II Investigators: 930 – 4 · 155

Everett, Brendan: 911 – 4 · 143

Everitt, Melanie: 901 – 5 · 114

Exner, Derek V.: 232 · 162, 651 · 160

Ezekowitz, Justin: 904 – 9 · 141

Ezekowitz, Michael M.: 206 · 116, 654 · 162, 677 · 178, 739 · 211

Fadol, Anceta: 642 · 157

Fahy, Martin: 2506 – 9 · 146, 2511 – 7 · 147, 2501 – 6 · 137

Falk, Rodney: 257 · 209, 720 · 203

Falk, Rodney H.: 744b · 170

Fall, Khady: 2309 · 156

Fang, James C.: 203 · 109, 234 · 163, 801 · 105, 807 · 124

Fang, Weiyi: 2645 · 120

Fantana, Gregory P.: 2626 · 177

Farasat, Morteza: 744b · 170

Farge, Arnaud: 2500 – 13 · 137, 407 · 181

Farha, Samar: 912 – 8 · 142




Farhat, Naim: 916 – 4 · 140

Farmer, Jill: 608 · 116

Farooq, Vasim: 910 – 4 · 111, 2503 – 13 · 146

Faruqui, Azhar: 514 · 194

Fasules, James W.: 301 · 157, 650 · 153

Favarato, Desiderio: 911 – 8 · 143

Favero, Luca: 2510 – 11 · 140

Faxon, David P.: 903 · 108

Fearon, William: 923 – 9 · 152, 2508 – 7 · 139

Fearon, William F.: 2113 · 194, 2627 · 178, 2201 · 119

Fedele, Francesco: 2644 · 107

Fedson, Savitri: 670 · 168

Feigenbaum, Harvey: 107A · 125

Feiring, Andrew J.: 2623 · 166, 2642 · 201

Feit, Frederick: 2501 – 10 · 137, 931 – 5 · 113

Feldman, Dmitriy: 928 – 4 · 154

Feldman, Dmitriy N.: 2502 · 119

Feldman, Ted: 2131 · 160, 2203 · 194, 2609 · 120, 2640 · 200, 2644 · 107, 681 · 179, 930 – 4 · 155

Felker, G. Michael: 641 · 157, 617 · 122, 626 · 127

Fenrich, Arnold: 914 – 5 · 144

Ferdinand, Keith C.: 237 · 169, 645 · 158

Ference, Brian A.: 306 · 186, 910 – 6 · 111

Feres, Fausto: 2504 – 11 · 138

Fernandez Diaz, Jose A.: 2504 – 15 · 138

Fernandez-Aviles, Francisco: 916 – 5 · 140

Fernandez-Santos, Mª Eugenia: 906 – 5 · 110

Ferrand, Anne-Catherine: 306 · 186

Fifer, Michael A.: 2612 · 125

Figulla, Hans R.: 2645 · 120, 915 – 4 · 145

Fineberg, Tabitha: 106 · 123

Fitzgerald, Peter: 2645 · 120

Fiuzat, Mona: 921 – 5 · 150

Flack, John: 306 · 186, 910 – 6 · 111

Flaker, Greg C.: 654 · 162, 904 – 7 · 141

Flamm, Scott: 908 – 5 · 110, 920 – 6 · 149

Flato, Uri: 304 · 143

Fleck, Desiree A.: 114 · 210

Fleg, Jerome: 308 · 210

Fleischmann, Dominik: 2635 · 195

Fleischmann, Kirsten E.: 644 · 158

Fletcher, Alison M.: 407 · 181

Fletcher, Barbara: 699 · 186, 701 · 193

Fletcher, Gerald: 701 · 193

Fletcher, Gerald F.: 651 · 160

Flores, Demetrio R.: 407 · 181

Fogel, Richard I.: 654 · 162, 666 · 167, 677 · 178

Foley, David: 902 – 4 · 107

Fonarow, Gregg: 921 – 5 · 150

Fonarow, Gregg C.: 217 · 127, 617 · 122, 717 · 202, 2121 · 177

Fonger, James: 633 · 129

Foody, Joanne M.: 601 · 112, 629 · 128

for the PARTNER Trial Investigators: 2500 – 7 · 137, 2500 – 9 · 137, 305 · 181

Forfia, Paul: 254 · 203, 649 · 159

Forfia, Paul R.: 705 · 196

Forman, Daniel: 929 – 6 · 154

Forman, Daniel E.: 651 · 160, 674 · 182

Formisano, Francesco: 925 – 4 · 152, 925 – 5 · 152

Foster, Elyse: 2622 · 166, 612 · 118, 738 · 181, 930 – 4 · 155

Fox, James: 2511 – 15 · 147

Fox, Keith A. A.: 200 · 107, 2634 · 190

Frackelton, Edward C.: 916 – 8 · 140

Frame, Alissa A.: 405 · 144

francis, darrel: 923 – 6 · 152

Francis, Sanjeev A.: 228 · 157

Francisco, Fernandez-Aviles: 906 – 5 · 110

Franklin, Barry: 929 – 7 · 154

Franklin, Barry A.: 701 · 193

Franklin, Leonardo F.: 906 – 4 · 109

Franklin, Stanley S.: 230 · 159, 727 · 210

Franklin, Wayne J.: 202 · 108

Frantz, Robert P.: 249 · 198

Franzen, Olaf: 2622 · 166, 2640 · 200, 930 – 3 · 155

Freed, Benjamin: 2308 · 156

Freeman, Andrew M.: 601 · 112, 720 · 203

Freeman, Rosario: 237 · 169, 809 · 128, 908 · 110

French, William J.: 2306 · 125

Friedman, Mark: 408 · 187

Friedman, Paul A.: 715 · 201, 715 · 201

Friedrich, Matthias: 228 · 157, 605 · 116

Froehlich, James: 931 – 8 · 113

Froehlich, James B.: 687 · 180, 722 · 204, 727 · 210, 931 · 113

Frost, Kim A.: 914 – 5 · 144

Fu, Guosheng: 2645 · 120

Fuernau, Georg: 902 – 8 · 108

Fujii, Kenichi: 2639 · 202

Fujii, Kenshi: 2303 · 115

Fujimoto, Hajime: 2309 · 156

Fujita, Masashi: 2311 · 166

Fujita, Tsutomu: 2504 – 7 · 138

Fujiwara, Toshiki: 909 – 7 · 111

Furlan, Anthony: 2614 · 140

Fuster, Valentin: 613 · 121, 622 · 123, 713 · 199, 726 · 210, 107A · 125, 400 · 106, 403 · 170, 902 – 6 · 108, 930 – 7 · 155

Gaasch, William H.: 635 · 141

Gafoor, Sameer A.: 744a · 170

Galantowicz, Mark E.: 252 · 201

Galappatthy, Gamini: 2313 · 189

Galassi, Alfredo R.: 2621 · 162

Galati, Anastasia: 903 – 4 · 108, 903 – 7 · 108

Gallardo, Arsenio: 2504 – 15 · 138

Galloway, James M.: 713 · 199

Galper, Benjamin Z.: 927 – 4 · 153

Gan, Li-ming: 902 – 7 · 108

Ganz, Peter: 622 · 123

Gao, Bing: 923 – 4 · 151

Garasic, Joseph M.: 2627 · 177

garbarz, eric: 930 – 5 · 155

Garber, Alan M.: 903 – 5 · 108

Garcia, Ernest V.: 708 · 197

Garcia, Eva M.: 914 – 5 · 144

Garcia, Hector: 910 – 4 · 111

Garcia, Hector M.: 2645 · 120

Garcia, Joel A.: 2629 · 183

Garcia, Lawrence A.: 2633 · 189

Garcia, Mario J.: 744a · 170, 228 · 157, 233 · 163, 638 · 151, 683 · 180, 251 · 199

Garcia Camarero, Tamara: 2504 – 15 · 138

Garcia del Blanco, Bruno: 2504 – 15 · 138

Garcia-Alberola, Arcadio: 726 · 210

Gardin, Julius: 927 – 7 · 153

Gardin, Julius M.: 218 · 127

Garot, Philippe: 2500 – 13 · 137, 2502 – 9 · 119, 407 · 181

GArot, Philippe: 926 – 7 · 153

Garrand, Amanda: 921 – 4 · 150

Garratt, Kirk: 308 · 210

Garrido, Gregorio: 906 – 5 · 110

Garry, Daniel J.: 681 · 179

Garvey, J.: 2502 – 7 · 119

Gaspar-Hernandez, Jorge: 513 · 190

Gassdorf, Johannes: 2645 · 120

Gates-Striby, Linda: 600 · 112, 630 · 128

Gati, Sabiha: 914 – 7 · 144

Gatsonis, Constantine: 305 · 181

Gatzoulis, Michael: 920 – 5 · 149, 920 – 8 · 149

Gavin, Laurence: 305 · 181

Gawaz, Meinrad: 926 – 6 · 153

Gaynor, J. William: 901 – 6 · 114

Gazelle, Scott: 308 · 210

Gaztanaga, Juan: 2310 · 156

Gbadebo, T. David: 664 · 165

Ge, Junbo: 2645 · 120

Ge, Lei: 2645 · 120

Gee, Adrian: 300 · 112

Genereux, Philippe: 2500 – 7 · 137, 2500 – 9 · 137, 2500 – 11 · 137, 2507 – 11 · 146

Gentile, Federico: 691 · 184

George, Isaac: 2500 – 11 · 137, 2507 – 11 · 146

George, Richard T.: 214 · 122, 218 · 127

Gerber, Thomas C.: 305 · 181

Gerckens, Ulrich: 2644 · 107

German Transcatheter Aortic ValveInterventions-Registry Investigators: 915 – 4 · 145

Gersh, Bernard: 2501 – 6 · 137, 2501 – 10 · 137, 904 – 9 · 141

Gersh, Bernard J.: 222 · 141, 645 · 158, 661 · 164, 308 · 210, 737 · 169

Gershlick, Anthony: 902 · 107

Gertz, Morie: 257 · 209

Gertz, Zachary: 2609 · 120

224 GO for ACC.12!



Geva, Tal: 241 · 179, 920 – 7 · 149

Ghali, Jalal: 921 – 4 · 150

Ghali, Jalal K.: 225 · 150

Ghanem, Alexander: 917 – 3 · 148

Ghani, Saqib: 914 – 7 · 144, 914 – 4 · 144

Ghazzal, Ziyad: 746 · 105

Gheorghiade, Mihai: 626 · 127

Ghoshhajra, Brian: 922 – 3 · 150

Gialafos, Elias: 931 – 3 · 113

Gialde, Elizabeth: 2501 – 8 · 137

Gianguzzi, Robert: 684 · 180

Giannarelli, Chiara: 902 – 6 · 108

Gibbons, Raymond J.: 628 · 127

Gibbs, John: 923 – 4 · 151

Gibson, C. Michael: 2617 · 156, 2638 · 196, 613 · 121, 1605 · 171, 2501 – 10 · 137, 304 · 143, 305 · 181, 925 – 4 · 152, 925 – 5 · 152

Gilbert, Edward: 922 – 5 · 150

Gilchrist, Ian C.: 2624 · 167, 2305 · 125

Giles, Thomas D.: 631 · 128, 663 · 165

Gillam, Linda D.: 707 · 197, 507 · 191

Gillespie, Mathew: 634 · 141, 678 · 178

Gillis, Anne M.: 654 · 162, 666 · 167, 904 · 141, 904 – 3 · 141

Gimeno, Federico: 2504 – 15 · 138

Ginsburg, Geoffrey S.: 602 · 113, 671 · 168

Gitt, Anselm K.: 910 – 8 · 111

Giugliano, Robert P.: 629 · 128, 916-3· 140

Gkizas, Spyridon: 2314 · 189

Gleeton, Onil: 2510 – 9 · 139

Glick, Danielle: 905 – 4 · 109

Gloviczki, Peter: 2613 · 126

Glower, Donald: 930 – 4 · 155

Gnall, Eric: 912 – 4 · 142

Godlewski, Jan: 304 · 143

Goehler, Alexander: 308 · 210

Goel, Kashish: 927 – 6 · 153

Goessl, Mario: 231 · 162

Gogas, Bill D.: 2503 – 13 · 146

Goitein, Orly: 924 – 3 · 151

Goktekin, Omer: 518 · 189

Gold, Michael R.: 704 · 196, 243 · 184

Goldbarg, Seth E.: 744b · 170

Goldberg, Anne C.: 730 · 170

Goldberg, Caren: 913 – 6 · 143

Goldberg, Lee R.: 517 · 191, 660 · 164

Goldberg, Sheldon: 2645 · 120

Goldberg, Steven L.: 2630 · 183, 2131 · 160

Goldberger, Jeffrey J.: 406 · 154, 929 – 5 · 154

Goldhaber, Samuel Z.: 2607 · 115, 107A · 125, 264 · 187, 747 · 209

Goldstein, James: 2508 – 11 · 139

Goldstein, James A.: 2121 · 177

Goldstein, Steven: 2500 – 15 · 137, 2507 – 15 · 147, 915 – 8 · 145

Gollob, Michael H.: 691 · 184

Gomberg-Maitland, Mardi: 249 · 198

Gomes, Antoinette: 908 – 8 · 110

Gomez, Millie: 924 – 7 · 151

Goodlin, Sarah J.: 225 · 150

Goodman, Shaun: 916 – 5 · 140

Goodman, Shaun G.: 653 · 162

Gorcsan, John: 220 · 129, 907 – 7 · 142, 922 – 6 · 150

Gorelick, Phillip B.: 727 · 210

Gornik, Heather: 931 – 8 · 113

Gornik, Heather L.: 264 · 187

Goryo, Yutaka: 2309 · 156

Gottdiener, John: 905 – 4 · 109, 905 – 5 · 109

Gottdiener, John S.: 905 – 6 · 109

Gottlieb, Ilan: 909 – 8 · 111

Grady, Kathleen: 694 · 185

Graham, Dionne: 920 – 7 · 149

Graham, Eric M.: 901 – 4 · 114

Graham, John: 913 – 5 · 143, 916 – 5 · 140

Graham, Jr., Thomas P.: 920 – 3 · 149

Granada, Juan: 2503 · 145, 2505 – 8 · 138

Grando-Ting, Jennifer: 805 · 123

Granger, Christopher: 904 – 9 · 141

Granger, Christopher B.: 739 · 211

Gransar, Heidi: 924 – 5 · 151

Grantham, James A.: 2621 · 162, 2302 · 114, 505 · 188

Grapsas, Nikolaos: 903 – 4 · 108

Grasso, Francesco: 901 – 3 · 114

Grau-Sepulveda, Maria V.: 308 · 210

Gray, Bruce: 931 – 8 · 113

Gray, Huon: 404 · 199, 508 · 191, 740 · 204, 746 · 105

Gray, William A.: 2613 · 126, 2631 · 183, 2311 · 166, 502 · 188, 743 · 129

Grayburn, Paul: 930 – 4 · 155

Grayburn, Paul A.: 204 · 110, 697 · 185, 220 · 129

Greason, Kevin: 238 · 171, 246 · 187, 927 – 6 · 153

Green, Joseph S.: 106 · 123

Green, Philip: 2500 – 11 · 137

Greenbaum, Adam B.: 2111 · 177

Greenberg, Barry H.: 635 · 141

Greenspahn, Bruce: 2315 · 189

Gregg, Anthony: 679 · 179

Greif, Martin: 909 – 6 · 111

Griffin, Brian: 907 – 5 · 142

Griffin, Brian P.: 612 · 118

Griffith, Bartley P.: 681 · 179

Griffith, John L.: 308 · 210

Grigioni, Francesco: 723 · 204

Grimaldi, Adam: 911 – 9 · 143

Grimm, Richard: 907 – 5 · 142

Grines, Cindy L.: 211 · 121, 606 · 116

Grise, Mark: 931 – 8 · 113

Grossbard, Joseph: 911 – 4 · 143

Grossman, P. M.: 932 – 5 · 155

Grover, Frederick: 308 · 210

Grover, Frederick L.: 107A · 125, 674 · 182

Gruner, Christiane: 925 – 4 · 152, 925 – 5 · 152

Gu, Xiaokui: 931 – 8 · 113

Guagliumi, Giulio: 2501 – 6 · 137, 2508 – 15 · 139

Guagliumi, Giulio G.: 2303 · 115

Guang, Xuefeng: 2645 · 120

Guarneri, Erminia: 741 · 187

Guazzi, Marco: 929 – 6 · 154

Guchelaar, Henk-Jan: 917 – 5 · 148

Guerrero, James: 914 – 5 · 144

Guerrero, Luis: 406 · 154

Guglielmotti, Angelo: 2644 · 107

Guglin, Maya E.: 207 · 116, 617 · 122, 680 · 179, 718 · 202, 811 · 158, 905 · 109

Guimaraes, Helio: 304 · 143

Guiry, Michael: 2102 · 160

Gulati, Ankur: 908 – 4 · 110

Gulati, Martha: 255 · 204, 620 · 123, 929 – 8 · 154

Gulseth, Michael: 735 · 122

Guo, Ning: 2625 · 177

Gupta, Kamal: 932 – 4 · 155

Gupta, Sanjaya: 918 – 3 · 148

gupta, saurabh k.: 2310 · 156

Gura, Melanie T.: 736 · 125, 243 · 184, 716 · 201

Gurbel, Paul: 2501 – 12 · 137

Gurbel, Paul A.: 2111 · 177, 2617 · 156, 2643 · 201, 604 · 115

Gurm, Hitinder: 932 – 5 · 155, 2511 – 15 · 147

Gurm, Hitinder S.: 408 · 187, 515 · 193, 721 · 204

Gurm, Roopa: 913 – 6 · 143

Gurvitz, Michelle: 920 – 4 · 149, 202 · 108

Gustafson, Gregory: 744b · 170

Gustavson, Susan: 931 – 7 · 113

Gutierrez, Antonio: 928 – 3 · 153

Gutman, Einat: 924 – 3 · 151

Gutteridge, Daniel: 2301 · 114

Guyton, Robert A.: 305 · 181

Gwon, Hyeon-Cheol: 2504 – 13 · 138, 623 · 126

Ha, Jinyong: 2508 – 9 · 139

Haack-Sørensen, Mandana: 923 – 5 · 151

Haas, Tammy: 925 – 4 · 152, 925 – 5 · 152

Haber, Robert: 2502 – 7 · 119

Habib, Gilbert: 251 · 199

Hachamovitch, Rory: 407 · 181, 218 · 127, 644 · 158, 908 – 5 · 110

Hadamitzky, Martin: 924 – 5 · 151, 924 – 7 · 151

Hagege, Albert A.: 612 · 118

Hahalis, George: 903 – 4 · 108, 903 – 7 · 108

Hahn, Joo-Yong: 2504 – 13 · 138

Hahn, Rebecca: 2500 – 11 · 137, 2507 – 11 · 146

Hahn, Rebecca T.: 2618 · 161, 2622 · 166, 2629 · 183, 643 · 158, 2203 · 194, 2507 – 6 · 146

Hakonarson, Hakon: 916 – 8 · 140

Halkati, Prabhu: 2310 · 156, 2313 · 189




Halkati, Prabhu C.: 2314 · 189

Halkos, Michael E.: 2302 · 114

Hall, Jack: 2506 – 13 · 146

Hall, Jennifer L.: 602 · 113, 671 · 168

Halliburton, Sandra: 696 · 185

Halperin, Jonathan: 930 – 7 · 155

Halperin, Jonathan L.: 735 · 122, 264 · 187, 743 · 129, 747 · 209

halvorsen, Sigrun: 916 – 5 · 140

Hamburg, Naomi: 743 · 129

Hamburg, Naomi M.: 405 · 144

Hamirani, Yasmin: 930 – 7 · 155

Hammill, Stephen C.: 677 · 178, 919 – 4 · 149

Han, Eric: 2310 · 156

Han, Seongwoo: 2505 – 12 · 139

Han, Yaling: 505 · 188

han, zhigang: 916 – 7 · 140

Handberg, Eileen M.: 906 – 4 · 109, 731 · 142, 112 · 180, 237 · 169

Hannan, Edward: 910 – 7 · 111

Hanotin, Corinne: 306 · 186, 911 – 5 · 143

Hansen, Knud: 2506 – 11 · 146

Hanzel, George S.: 2630 · 183

Harahsheh, Ashraf: 901 – 7 · 114

Hare, Joshua M.: 240 · 179

Hargrove, Clark: 632 · 129

Harold, John G.: 609 · 117, 508 · 191, 607 · 116, 738 · 181, 742 · 186

Harrild, David M.: 667 · 167

Harrington, Robert A.: 2641 · 200, 639 · 156, 700 · 186, 107 · 124, 107A · 125, 304 · 143, 639 · 156, 712 · 199

Hart, Robert: 904 – 7 · 141, 904 – 5 · 141

Hart, Stephen A.: 920 – 6 · 149

Harvey, James: 2303 · 115

Hasan, Rani K.: 909 – 8 · 111

Hasenfuss, Gerd: 921 – 8 · 150

Hashimoto, Yukihiro: 2309 · 156

Hassanein, Mahmoud: 746 · 105

Hastings, Jeffrey: 261 · 171

Hatzopoulos, Antonis: 300 · 112

Hauser, Robert G.: 201 · 108, 215 · 123, 919 – 7 · 149

Hauser, Thomas: 308 · 210, 925 – 4 · 152, 925 – 5 · 152

Hausleiter, Joerg: 924 – 5 · 151, 924 – 7 · 151, 930 – 3 · 155

Havranek, Edward P.: 713 · 199

Hawkey, Marian: 238 · 171, 2102 · 160

Hawwa, Nael: 2301 · 114

Hayashida, Kentaro: 2500 – 13 · 137, 407 · 181

Hayden, Douglas: 308 · 210

Hayes, David L.: 201 · 108, 614 · 121, 624 · 126

He, Qing: 2645 · 120

Heath, R. Terry: 226 · 152

Hecht, Harvey S.: 214 · 122, 628 · 127

Hedstrom, Erik: 908 – 3 · 110

Heidenreich, Paul A.: 217 · 127, 239 · 178

Heit, John: 264 · 187

Heitner, Stephen: 2313 · 189

Held, Aaron: 405 · 144

Held, Maria: 2606 · 115

Hellenbrand, William E.: 2615 · 148

Heller, Gary V.: 658 · 163

Hendel, Robert C.: 214 · 122

Henderson, Robert A.: 508 · 191

Henriques, José: 2502 – 13 · 119

Henriques, Jose P.: 2502 · 119, 676 · 178, 676 · 178

Henry, Timothy: 2501 – 14 · 138, 2501 – 16 · 138, 300 · 112, 928 – 7 · 154

Henry, Timothy D.: 2112 · 182, 2638 · 196, 613 · 121, 604 · 115

Henzlova, Milena J.: 708 · 197

Heo, Jung Ho: 2503 – 13 · 146

Hermiller, James B.: 2203 · 194, 2309 · 156

Hermiller, Jr., James B.: 2112 · 182, 2626 · 177

Hernandez, Adrian F.: 224 · 143

Hernandez, Felipe: 2504 – 15 · 138

Herrmann, Howard C.: 2131 · 160, 2202 · 161, 2203 · 194

Hershberger, Ray E.: 236 · 169

Herweg, Bengt: 207 · 116

Hetzer, Roland: 921 – 7 · 150

Hewins, Benjamin: 908 – 4 · 110

Hickey, Edward: 901 – 3 · 114

Higuchi, Koji: 918 – 6 · 148

Hijazi, Ziyad M.: 2615 · 148, 2630 · 183, 2132 · 195, 2132 · 195, 2313 · 189

Hill, Alexander: 2507 – 13 · 147

Hill, Alexander J.: 407 · 181

Hill, Joseph A.: 109 · 128, 710 · 198

Himbert, Dominique: 930 – 5 · 155

Hines, Jerome L.: 226 · 152, 621 · 123

Hirsch, Alan T.: 675 · 169

Hirsch, Alexander: 918 – 4 · 148

Hirsch, Glenn A.: 902 · 107

Hirshfeld, John W.: 2609 · 120, 2306 · 125, 2310 · 156

Hlatky, Mark: 903 – 5 · 108

Hlatky, Mark A.: 671 · 168

Ho, Jennifer: 905 – 3 · 109

Ho, Kalon: 928 – 5 · 154

Ho, Kalon K.L.: 687 · 180

Hochman, Judith S.: 221 · 140, 107A · 125

Hod, Hanoch: 924 – 3 · 151

Hodgson, John M.: 2625 · 177, 2639 · 202, 2201 · 119, 2303 · 115

Hodkinson, Emily: 919 – 8 · 149

Hoercher, Katherine J.: 717 · 202

Hoffmann, Udo: 308 · 210

Hogan, Shea E.: 932 – 5 · 155

Hohnloser, Stefan: 904 – 9 · 141

Hohnloser, Stefan H.: 703 · 196

Höke, Ulas: 922 – 8 · 150

Holbrook, Monika: 405 · 144

Hollander, Judd: 231 · 162, 305 · 181

Hollis, Bruce W.: 901 – 4 · 114

Holmes, David R.: 107A · 125, 300 · 112, 302 · 165, 309 · 211, 504 · 193, 744a · 170, 746 · 105

Holmes, Jr., David R.: 2101 · 156, 300 · 112, 309 · 211, 606 · 116, 610 · 117, 674 · 182, 710 · 198, 723 · 204

Holzer, Ralf: 616 · 122, 901 · 114, 901 – 8 · 114

Hombach, Vinzenz: 903 – 3 · 108

Honda, Yasuhiro: 2611 · 125

Hong, Moon Hwa: 917 – 4 · 148

Hong, Mun K.: 511 · 188

Hong, Myeong-Ki: 2508 – 9 · 139, 2644 · 107, 511 · 188

Hong, Soon Jun: 405 · 144

Hong, Susie: 925 – 5 · 152

Hong-Zohlman, Susie N.: 925 – 4 · 152

Honjo, Osami: 901 – 3 · 114

Hoole, Stephen: 923 – 7 · 152

Hoosain, Jamael: 2310 · 156

Hopkins, L. Nelson: 2618 · 161

Hord, Edward: 903 – 8 · 108

Horie, Minoru: 405 · 144

Horii, Manabu: 917 – 8 · 148

Horlick, Eric: 2644 · 107

Horowitz, John: 904 – 9 · 141

Horwich, Tamara: 718 · 202

Hosseini Khalili, Alireza: 744a · 170

Hou, Jingbo: 916 – 7 · 140, 2611 · 125, 909 – 5 · 111

Hough, Stacyann S.: 929 – 4 · 154

Houghtaling, Penny: 2502 – 11 · 119

House, John: 2510 – 7 · 139, 2510 – 15 · 140, 2511 – 13 · 147

Hovasse, Thomas: 2500 – 13 · 137, 407 · 181

Hsich, Eileen: 925 – 7 · 152

Hu, Dayi: 505 · 188, 505 · 188, 686 · 180

Hu, Sining: 909 – 5 · 111

huang, henry: 925 – 6 · 152

Huber, Ken: 2614 · 140

Huber, Kurt: 903 – 8 · 108

Hudson, Michael P.: 817 · 169

Hueb, Whady: 911 – 8 · 143

Hughes, Alun: 923 – 6 · 152

Hughes, Suzanne: 601 · 112, 699 · 186

Humphrey, Angela: 2502 – 7 · 119

Humpl, Tilman: 901 – 3 · 114

Hundley, Greg: 908 – 8 · 110

Hundley, W. G.: 218 · 127, 719 · 202

Hung, Judy W.: 220 · 129, 672 · 168, 682 · 179, 697 · 185, 707 · 197

Hunt, Sharon: 669 · 168

Huo, Yong: 685 · 180

Hussain, Shazia: 908 – 3 · 110

Hutchings, Jennifer Y.: 914 – 5 · 144

Hutter, Adolph: 914 – 8 · 144

Hutter, Adolph M.: 261 · 171, 910 · 111, 929 – 4 · 154

Hwang, Jin-Yong: 2501 – 12 · 137

226 GO for ACC.12!



Hwang, Seok-Jae: 2501 – 12 · 137

Hylek, Elaine: 904 – 9 · 141

Hynes, Brian: 2308 · 156

Iazzo, Paul A.: 407 · 181

Igarashi, Yasumi: 2504 – 7 · 138

Ignacio Amat-Santos, Ignacio: 915 – 6 · 145

Igo, Stephen: 907 – 8 · 142

Iida, Osamu: 2311 · 166

iida, Osamu: 931 – 4 · 113, 931 – 6 · 113

Ijichi, Takeshi: 2503 – 7 · 145

Ikari, Yuji: 2503 – 7 · 145

Ilg, Karl: 918 – 3 · 148

Ilkay, Erdogan: 518 · 189

Ilustre, Joanne: 2315 · 189

Im, sung il: 2505 – 12 · 139

IMMEDIATE Trial Investigators: 308 · 210

Inaba, Yoichi: 909 – 4 · 110

Indermuehle, Andreas: 908 – 3 · 110

Indik, Julia H.: 640 · 157, 747 · 209, 808 · 124, 904 · 141

Ing, Frank: 901 – 8 · 114

Ing, Frank F.: 678 · 178

Inglessis, Ignacio: 2308 · 156, 2310 · 156, 2314 · 189

Iobst, William: 109 · 128

Ionescu-Ittu, Raluca: 920 – 4 · 149

Irimpen, Anand: 916 – 6 · 140

Ishida, Masaki: 908 – 3 · 110

Ishigami, Kenichi: 917 – 8 · 148

Ishihara, Takayuki: 2311 · 166

Ishimori, Hiroshi: 2504 – 9 · 138

Ishizawar, David: 912 – 5 · 142

Ismail, Tevfik F.: 908 – 4 · 110

Isojima, Takuya: 2309 · 156

ISSUE-3 investigators: 306 · 186

Itchhaporia, Dipti: 621 · 123, 509 · 190, 685 · 180

Ito, Matthew K.: 736 · 125

Ito, Shigenori: 2305 · 125

Iung, Bernard: 251 · 199, 930 – 5 · 155, 723 · 204, 915 – 7 · 145

Iwabuchi, Masashi: 2302 · 114

Iwai, Sei: 615 · 121

Iwakura, Katsuomi: 2303 · 115

Iwama, Hajime: 2309 · 156

Iwamura, Toshiharu: 909 – 7 · 111

Ix, Joachim: 905 – 5 · 109

Iyer, Sriram S.: 743 · 129

Jabbour, Andrew: 908 – 4 · 110

Jaber, Weal A.: 407 · 181

Jackson, Elizabeth: 913 – 6 · 143

Jackson, Elizabeth A.: 701 · 193, 698 · 186, 730 · 170, 803 · 118, 822 · 198, 927 · 153

Jackson, Greg: 922 – 7 · 150

Jackson, Marcia J.: 103 · 117, 106 · 123, 109 · 128

Jackson, Matthew S.: 907 – 8 · 142

Jacob, Howard: 671 · 168

Jacob, Jasmine R.: 2310 · 156

Jacobs, Alice K.: 2638 · 196, 653 · 162, 308 · 210, 675 · 169

Jacobshagen, Claudius: 921 – 8 · 150

Jacques, Frederic: 901 – 3 · 114

Jaff, Michael: 931 – 8 · 113

Jaff, Michael R.: 2613 · 126, 2613 · 126, 646 · 155, 825 · 202, 932 – 3 · 155

Jaffe, Allan S.: 659 · 163, 728 · 209

Jafri, Haseeb: 911 – 7 · 143

Jahangir, Arshad: 733 · 114

Jain, Sandeep: 922 – 6 · 150

Jain, Sandeep K.: 706 · 197

Jakubowski, Joe: 902 – 4 · 107

Jakubowski, Joseph: 902 – 6 · 108

Jalbert, Jessica: 922 – 4 · 150

Jama, Abdi A.: 406 · 154

Jamal, Syed Z.: 514 · 194, 514 · 194

Jamerson, Kenneth A.: 237 · 169, 631 · 128

James, Stefan: 902 – 4 · 107

James, Stefan K.: 1605 · 171, 623 · 126, 653 · 162, 721 · 204

Jamis-Dow, Carlos: 305 · 181

Janel, Lee: 2644 · 107

Jang, Ik-Kyung: 2608 · 119, 2611 · 125, 909 – 5 · 111, 916 – 7 · 140

Jang, Yangsoo: 2508 – 9 · 139, 2644 · 107

Janiak, Florian: 2645 · 120

Januzzi, Jr., James L.: 641 · 157, 728 · 209

Jarolim, Petr: 905 – 7 · 109

Jaskie, Suzette: 244 · 185, 621 · 123

Jassal, Davinder: 642 · 157

Javaheri, Shahrokh: 718 · 202

Jeevanandam, Valluvan: 2308 · 156

Jeevanantham, Vinodh: 932 – 4 · 155

Jefferies, John: 901 – 5 · 114

Jefferies, John L.: 301 · 157

Jeffries, Brad: 922 – 5 · 150

Jelnin, Vladimir: 2510 – 13 · 140

Jenkins, James S.: 2627 · 177

Jenkins, Kathy: 901 – 8 · 114

Jenkins, Kathy J.: 616 · 122, 402 · 162

Jennings, Lisa K.: 903 – 8 · 108

Jensen, Lisette: 2608 · 119

Jensen, Lisette Okkels: 2506 – 11 · 146

Jeong, Han Saem: 405 · 144

Jeong, Jin-Ok: 2504 – 13 · 138

Jeong, Myung Ho: 917 – 4 · 148, 2505 – 14 · 139, 511 · 188

Jeong, Young-Hoon: 2501 – 12 · 137

Jerosch-Herold, Michael: 922 – 3 · 150

Jeroudi, Ahmad M.: 744a · 170

Jessen, Michael: 629 · 128

Jessup, Mariell: 213 · 122

Jha, Ashish K.: 913 – 4 · 143

Jia, Haibo: 909 – 5 · 111, 916 – 7 · 140

Jianping, Li: 685 · 180

Jimenez Navarro, Manuel: 2504 – 15 · 138

Jing, Yonghua: 913 – 5 · 143

Jneid, Hani: 925 – 6 · 152

Jockel, Heinz Karl: 924 – 4 · 151

Johnson, Andrea: 924 – 6 · 151

Johnson, Paula: 245 · 185

Jollis, James G.: 204 · 110

Jolly, Sanjit S.: 2624 · 167, 2641 · 200

Jonasson, Jenny: 902 – 7 · 108

Jonathon, Leipsic: 2618 · 161

Joner, Michael: 2503 – 9 · 146

Jones, Charlotte: 407 · 181

Jones, Robert H.: 606 · 116

Jones, Thomas K.: 252 · 201

Jorgensen, Erik: 923 – 5 · 151

Joseph, Emmerich: 904 – 8 · 141

Joshi, Nikhil V.: 407 · 181

Joynt, Karen: 913 – 4 · 143

Juan, Gaibor C.: 2310 · 156

Judd, Suzanne: 910 – 5 · 111

Judge, Daniel P.: 234 · 163

Jukema, Johan: 917 – 5 · 148

Juni, Peter: 665 · 167, 2645 · 120

Junker, Anders: 2506 – 11 · 146

Justino, Henri: 634 · 141, 637 · 149

Kadish, Alan H.: 702 · 196

Kahn, Joel: 306 · 186

Kaji, Shuichiro: 909 – 7 · 111

Kala, Petr: 923 – 9 · 152

Kalahasti, Vidyasagar: 920 – 6 · 149

Kalil-Filho, Roberto: 911 – 8 · 143

Kallinen, Linda: 919 – 7 · 149

Kalra, Ankur: 2313 · 189

Kalsch, Hagen: 924 – 4 · 151

Kaltenbach, Lisa: 928 – 4 · 154, 928 – 8 · 154

Kaltoft, Anne: 2506 – 11 · 146

Kandzari, David: 2506 – 7 · 146

Kandzari, David E.: 2627 · 178, 604 · 115, 2202 · 161, 2302 · 114, 2504 – 6 · 138, 511 · 188

Kang, Hyun-Jae: 304 · 143

Kang, Soo-Jin: 2645 · 120, 2611 · 125, 2625 · 177, 2608 · 119

Kang, Wan Seok: 917 – 4 · 148

Kanter, Joshua: 634 · 141, 637 · 149

Kanter, Kirk: 725 · 209

Kantor, Paul F.: 901 – 5 · 114

Kanwal, Sunil: 2309 · 156

Kao, David P.: 925 – 7 · 152

Kapadia, Samir: 2303 · 115, 2308 · 156

Kapadia, Samir R.: 2630 · 183, 2635 · 195, 2203 · 194, 2314 · 189, 2626 · 177

Kaplan, Aaron V.: 238 · 171




Kapoor, Deepak: 2302 · 114

Kappetein, A.: 910 – 4 · 111

Kar, biswajit: 2315 · 189

Kar, Saibal: 2114 · 194, 2131 · 160, 2132 · 195, 2132 · 195, 220 · 129, 2203 · 194, 2622 · 166, 652 · 160

Kara, Tomas: 406 · 154

Karapetyan, Anush K.: 917 – 7 · 148

Karas, Maria G.: 905 – 5 · 109

Karas, Richard: 911 – 7 · 143

Karas, Richard H.: 611 · 117

Karlsberg, Ronald P.: 696 · 185, 740 · 204

Karmpaliotis, Dimitrios: 505 · 188

Karwatowska-Prokopczuk, Ewa: 921 – 8 · 150

Kashyap, Sangeeta: 306 · 186

Kassimis, George: 903 – 7 · 108

Kastrati, Adnan: 2503 – 9 · 146, 2645 · 120

Kastrup, Jens: 923 – 5 · 151

Kataoka, Yu: 2303 · 115

Kates, Andrew M.: 730 · 170, 822 · 198

Kato, Keiji: 917 – 8 · 148

Kato, Koji: 916 – 7 · 140

Katoh, Yoshihiro: 2509 – 13 · 147

Katsouli, Anthi: 912 – 5 · 142

Katus, Hugo A.: 2511 · 147

Katz, Jason N.: 263 · 170

Kaufman, Beth: 901 – 5 · 114, 901 – 6 · 114

Kaufmann, Beat: 909 – 4 · 110

Kaufmann, Philipp: 924 – 7 · 151

Kaul, Sanjay: 744b · 170, 2614 · 140, 604 · 115, 639 · 156, 665 · 167, 700 · 186, 712 · 199

Kaul, Sanjiv: 628 · 127

Kautzner, Josef: 905 – 7 · 109

Kawata, Hiroyuki: 917 – 8 · 148

Kayani, Waleed: 925 – 6 · 152

Kazi, Dhruv: 903 – 5 · 108

Keadle, Justin: 911 – 9 · 143

Kealey, Angela: 695 · 185

kedhi, elvin: 2506 – 9 · 146

Keeley, Ellen: 923 · 151

Kelly, Christopher: 2511 – 7 · 147

Kelsey, Anita M.: 744b · 170

Kemme, Michiel: 918 – 4 · 148

Kempny, Aleksander: 920 – 5 · 149, 920 – 8 · 149

kennedy, kevin: 2501 – 8 · 137, 2510 – 15 · 140, 2511 – 13 · 147, 932 – 7 · 155

Kennedy, Kevin F.: 2511 – 11 · 147

Kennett, Jerry D.: 650 · 153

Kereiakes, Dean: 2506 – 9 · 146, 306 · 186

Kereiakes, Dean J.: 2634 · 190, 646 · 155, 2506 – 7 · 146, 2202 · 161

Kern, Karl B.: 263 · 170

Kern, Morton J.: 2609 · 120, 107A · 125, 2122 · 183, 2303 · 115, 821 · 197

kesari, kavitha: 2301 · 114

Kesarwani, Manoj: 744b · 170

Khairy, Paul: 668 · 168, 506 · 191

Khalique, Omar: 907 – 4 · 142

Khan, Fakhar Z.: 716 · 201

Khann, Amber D.: 406 · 154

Khaw, Ban-An: 642 · 157

Khera, Amit: 711 · 199, 729 · 203

Kholmovski, Eugene: 918 – 6 · 148, 918 – 8 · 148

Khumri, Taiyeb M.: 2301 · 114

Kiernan, Michael: 2502 – 11 · 119

Kilner, Philip: 920 – 8 · 149

Kim, Brian H.: 405 · 144

Kim, Byeong-Keuk: 2508 – 9 · 139, 2644 · 107

Kim, Chong Jin: 2505 – 14 · 139

Kim, Donghan: 2505 – 14 · 139

Kim, Eung Ju: 2505 – 12 · 139

Kim, Henry: 918 – 3 · 148

Kim, Hyo Soo: 304 · 143

Kim, Hyo-Soo: 2504 – 13 · 138

Kim, Hyun-Sook: 2508 – 7 · 139

Kim, Hyung-Kwan: 930 – 8 · 155

Kim, Je Sang: 405 · 144

Kim, Jeong Sook: 917 – 4 · 148

Kim, Ji-Hyun: 930 – 8 · 155

Kim, Jin Won: 2505 – 12 · 139

Kim, Jong-Ho: 405 · 144

Kim, Jung-Sun: 2508 – 9 · 139

Kim, Kyung-Hee: 930 – 8 · 155

Kim, Luke: 928 – 4 · 154

Kim, Michael C.: 676 · 178, 511 · 188

Kim, Raymond J.: 233 · 163, 605 · 116

Kim, Soo Hyun: 931 – 8 · 113, 932 · 155

Kim, Soo Joong: 916 – 7 · 140

Kim, Sunghee: 928 – 6 · 154

Kim, Sunwon: 2505 – 12 · 139

Kim, Won-Jang: 2645 · 120

Kim, Yong Sook: 917 – 4 · 148

Kim, Yong-Jin: 930 – 8 · 155

Kim, Young Jo: 2505 – 14 · 139

Kim, Young-Hak: 2645 · 120

Kim, Young-Tae: 2645 · 120

Kim, Yuli: 920 – 6 · 149

Kimmelstiel, Carey: 2506 – 7 · 146

Kimmelstiel, Carey D.: 230 · 159, 2612 · 125

Kimura, Takeshi: 2509 – 13 · 147

King, Lamin: 2503 – 9 · 146

King, Richard: 928 – 7 · 154

King, Spencer B.: 610 · 117, 610 · 117, 111 · 159, 2121 · 177

Kingery, Joanna: 913 – 8 · 143

Kini, Annapoorna S.: 2508 – 6 · 139, 676 · 178

Kioufis, Stamatios: 931 – 3 · 113

Kirby, Ruth: 308 · 210

Kirma, Cevat: 518 · 189

Kirtane, Ajay: 2500 – 11 · 137

Kirtane, Ajay J.: 2113 · 194, 604 · 115, 613 · 121, 665 · 167, 1605 · 171, 821 · 197, 2501 – 14 · 138, 2501 – 16 · 138, 2201 · 119

Kirwanj, John: 306 · 186

Kitzman, Dalane: 905 – 6 · 109

Kizer, Jorge: 905 – 5 · 109

Klarich, Kyle W.: 812 · 158, 110 · 129

Kleiman, Neal S.: 2617 · 156, 2121 · 177, 2202 · 161, 2306 · 125

Klein, Allan L.: 208 · 116, 672 · 168

Klein, Lloyd: 308 · 210

Klein, Lloyd W.: 2502 · 119

Kliger, Chad: 931 – 5 · 113, 2630 · 183, 2510 – 13 · 140

Kligfield, Paul: 929 · 154

Kline-Rogers, Eva: 913 – 6 · 143, 931 – 8 · 113

Kline-Rogers, Eva M.: 713 · 199, 721 · 204

Kluge, Matthew A.: 405 · 144

Knap, Malgorzata: 930 – 6 · 155

Knight, Bradley P.: 615 · 121

Ko, Young-Guk: 2508 – 9 · 139, 2644 · 107

Kobashigawa, Jon A.: 670 · 168

Koch, Karel T.: 2502 – 13 · 119

Kociol, Robb D.: 656 · 163

Kodali, Susheel: 2112 · 182, 2618 · 161, 2626 · 177, 2131 · 160, 2500 – 7 · 137, 2500 – 9 · 137, 2500 – 11 · 137, 2507 – 11 · 146

Kodali, Susheel K.: 305 · 181

Kodama, Alessandra: 304 · 143

Kodoth, Vivek: 919 – 8 · 149

Kohl, III, Harold W.: 914 – 5 · 144

Kohli, Payal: 902 – 5 · 108

Kolluri, Raghu: 2607 · 115, 2616 · 156

Kolm, Paul: 308 · 210

Komajda, Michel: 738 · 181

Konecny, Tomas: 406 · 154

Konen, Eli: 924 – 3 · 151

Konstam, Marvin A.: 103 · 117, 635 · 141, 710 · 198, 110 · 129

Kontos, Michael C.: 628 · 127

Koo, Bon Kwon: 2639 · 202

Koo, Bon-Kwon: 304 · 143

Koolen, Jacques: 2503 – 13 · 146

Kop, Willem: 905 – 6 · 109

Koren, Michael: 306 · 186

Kornowski, Ran: 2501 – 6 · 137

Kosiborod, Mikhail: 711 · 199, 2511 – 11 · 147

Koss, Elana: 2507 – 11 · 146

Kostis, William J.: 2608 · 119

Kotha, Jayaprakash: 903 – 8 · 108

Kothari, Shyam S.: 2310 · 156

Kotowycz, Mark A.: 2505 – 6 · 138

Kotrc, Martin: 905 – 7 · 109

Kott, Andrew E.: 2315 · 189

Kottam, Anupama: 2306 · 125

Kovac, Jan: 2314 · 189, 2500 · 137, 2511 · 147, 2644 · 107, 723 · 204

228 GO for ACC.12!



Kovacic, Jason: 2508 – 6 · 139

Kovacs, Adrienne H.: 679 · 179

Kovacs, Richard: 913 – 8 · 143

Kovacs, Richard J.: 710 · 198, 261 · 171

Kowal, Robert C.: 212 · 121

Kowalchuk, Glen: 2502 – 7 · 119

Kowey, Peter: 206 · 116, 1603 · 172

Kozan, Omer: 518 · 189

Krahn, Andrew D.: 640 · 157, 816 · 166

Kraitchman, Dara: 719 · 202

Kramer, Christopher M.: 644 · 158

Krasuski, Richard: 920 – 6 · 149

Kraus, William E.: 923 – 8 · 152

Kremers, Mark S.: 239 · 178

Kren, Stefan: 906 – 5 · 110

Kreutzer, Jacqueline: 637 · 149

Krieger, Eric V.: 202 · 108

Krishna, Vamsi: 200 · 107

Krishnaswamy, Amar: 2308 · 156, 2629 · 183, 210 · 118

Kronenberg, Marvin: 300 · 112

Kronmal, Richard: 924 – 4 · 151, 930 – 7 · 155

Kronzon, Itzhak: 2510 – 13 · 140, 2619 · 161

Kruck, Irmtraut: 738 · 181

Krucoff, Mitchell W.: 633 · 129, 689 · 184

Kruisselbrink, Teresa: 236 · 169

Krum, Henry: 926 – 3 · 153, 663 · 165, 926 – 4 · 153

Krumholz, Harlan M.: 224 · 143, 717 · 202

Kuehl, Karen S.: 725 · 209

Kugelmass, Aaron D.: 510 · 193, 746 · 105

Kugler, John: 667 · 167

Kukucka, Marian: 921 – 7 · 150

Kullo, Iftikhar J.: 407 · 181

Kumar, Gautam: 2309 · 156, 744a · 170

Kurata, Mie: 932 – 6 · 155

Kurita, Takashi: 501 · 190

Kuvin, Jeffrey T.: 103 · 117, 106 · 123, 109 · 128, 730 · 170, 812 · 158

Kwak, Choong Hwan: 2501 – 12 · 137

Kwok, Bernard: 905 – 8 · 109

Kwolek, Christopher J.: 2623 · 166

Kwon, Deborah: 908 – 5 · 110

Kwon, Hyuck-Moon: 2644 · 107

Kwon, Jin-Sook: 917 – 4 · 148

Kwong, Raymond: 922 – 3 · 150

Kwong, Raymond Y. K.: 257 · 209, 605 · 116

Ky, Bonnie: 642 · 157

Kydd, Anna: 923 – 7 · 152

LaBounty, Troy: 924 – 5 · 151

LaBounty, Troy M.: 924 – 7 · 151

Lacomis, Joan: 305 · 181

Lacour-Gayet, Francois G.: 724 · 209

Ladd, Mark E.: 918 – 7 · 148

Laham, Roger J.: 221 · 140

Lahoti, Ankush: 912 – 4 · 142

Lahr, Brian: 927 – 6 · 153

Lai, Dejian: 300 · 112

Laird, John R.: 2311 · 166, 2613 · 126, 502 · 188

Lakdawala, Neal: 720 · 203

Lakshminarayan, Kamakshi: 904 – 4 · 141

Lamendola, Cindy: 699 · 186

Lamour, Jacqueline: 901 – 5 · 114

Lampert, Rachel: 919 – 4 · 149

Lampert, Rachel J.: 914 · 144

Lamy, Andre: 305 · 181

Lander, Matthew: 912 – 5 · 142

Landzberg, Michael: 662 · 164, 920 – 7 · 149

Landzberg, Michael J.: 2615 · 148, 668 · 168, 107A · 125, 2132 · 195

Lanfear, David E.: 826 · 203

Lang, Peter: 725 · 209

Lang, Roberto: 2308 · 156

Lang, Roberto M.: 682 · 179, 697 · 185, 407 · 181

Langabeer, James R.: 928 – 7 · 154

Lange, Richard A.: 508 · 191, 709 · 197

Lange, Rudiger: 2507 – 13 · 147

Lansky, Alexandra: 916 – 4 · 140, 923 – 8 · 152, 924 – 6 · 151

Lansky, Alexandra J.: 653 · 162, 2508 · 138

Lantin-Hermoso, M. Regina: 805 · 123

Lanza, Gregory M.: 259 · 210

Laranjeira, Ligia: 304 · 143

Lardo, Albert C.: 259 · 210

Larose, Eric: 2510 – 9 · 139, 915 – 6 · 145

Larson, Joseph: 904 – 4 · 141

larson, martin: 905 – 3 · 109

Lasala, John M.: 2638 · 196, 676 · 178, 2202 · 161, 2313 · 189

Lassen, Jens: 2506 – 11 · 146

Latson, Larry A.: 2313 · 189, 518 · 189

Lattouf, Omar M.: 746 · 105

Lau, Ernest: 919 – 8 · 149

Lau, Joe: 931 – 7 · 113

Lau, Yee How: 905 – 8 · 109

Lauck, Sandra: 2102 · 160

Lauer, Michael S.: 651 · 160, 929 – 3 · 154

Lauten, Alexander: 915 – 4 · 145

Lavie, Carl: 927 – 5 · 153

Lavigne, Paul M.: 911 – 7 · 143

Lawler, Patrick: 920 – 4 · 149

Lawless, Christine E.: 262 · 187

Lawrence, Silvana M.: 914 – 5 · 144

Laynez Carnicero, Ana: 2507 – 15 · 147

Layug, Beth: 921 – 8 · 150

Le May, Michel R.: 916 – 5 · 140

Leaming, James: 305 · 181

Lee, Byron K.: 824 · 200

Lee, Cheol Whan: 2645 · 120

Lee, Daniel C.: 719 · 202

Lee, Hang: 916 – 7 · 140, 308 · 210

Lee, John H.: 932 – 7 · 155

Lee, Jong-Young: 2645 · 120

Lee, Junsoo Alex: 915 – 8 · 145

Lee, Kerry: 656 · 163

Lee, Ki Hong: 2505 – 14 · 139

Lee, Randall J.: 201 · 108

Lee, Raymond: 905 – 8 · 109

Lee, Seung-Pyo: 930 – 8 · 155

Lee, Seung-Whan: 2645 · 120

Leesar, Massoud A.: 2625 · 177

Lefèvre, Thierry: 2500 – 13 · 137

Lefevre, Thierry: 2502 – 9 · 119, 407 · 181, 926 – 7 · 153, 2112 · 182, 2624 · 167

Leier, Carl V.: 680 · 179

Leipsic, Jonathon: 2203 · 194, 2618 · 161

Leiva Pons, Jose Luis: 513 · 190

Lemos, Pedro A.: 503 · 188

Lenihan, Daniel J.: 642 · 157

Leon, Martin: 2500 – 7 · 137, 2500 – 9 · 137, 2500 – 11 · 137, 2507 – 11 · 146, 2645 · 120, 305 · 181

Leon, Martin B.: 2606 · 115, 2635 · 195, 2636 · 195, 652 · 160, 2500 – 6 · 137, 309 · 211, 511 · 188, 674 · 182

Leor, Jonathan: 746 · 105

lepera, mario: 909 – 3 · 110

Lerakis, Stamatios: 2618 · 161, 2635 · 195

Lerman, Jorge: 516 · 192

Leschke, Matthias: 2509 – 9 · 147

Lesser, John: 925 – 4 · 152, 925 – 5 · 152

Lesser, John R.: 218 · 127

lettieri, corrado: 2644 · 107

Lever, Harry M.: 253 · 203, 648 · 159

Levi, Daniel S.: 2615 · 148

Levine, Glenn: 675 · 169

Levine, Paul A.: 614 · 121

Levine, Robert A.: 406 · 154, 697 · 185

Levit, Aaron D.: 405 · 144

Levy, Daniel: 905 – 3 · 109

Levy, Samuel: 2644 · 107

Levy, Wayne: 922 – 5 · 150

Lewin, Jack: 610 · 117, 687 · 180, 710 · 198, 404 · 199, 505 · 188, 647 · 159, 650 · 153, 685 · 180, 742 · 186

Lewin, Mark B.: 252 · 201, 802 · 111, 301 · 157, 301 · 157

Lewis, Gregory: 914 – 8 · 144

Lewis, Gregory D.: 254 · 203, 649 · 159, 705 · 196, 929 – 4 · 154

Lewis, William R.: 601 · 112, 690 · 184

Li, Hui: 2645 · 120

Li, Wei: 920 – 8 · 149, 920 – 5 · 149

Li, Yat Wa: 907 – 4 · 142

Li, Yigang: 2645 · 120

Liberman, Henry: 2302 · 114

Lichstein, Edgar: 408 · 187

Lichtenstein, Samuel: 2644 · 107




Lieber, Elizabeth: 2502 – 11 · 119

Lieu, Hsiao: 923 – 8 · 152

Lim, D. S.: 2114 · 194

Lim, Do-Sun: 405 · 144

Lim, Hong Euy: 2505 – 12 · 139

Lim, Michael J.: 2625 · 177, 2629 · 183, 2122 · 183

Lima, Joao: 908 – 8 · 110, 909 – 8 · 111

Lima, Joao A. C.: 214 · 122, 218 · 127, 641 · 157

Limaye, Atul: 2508 – 6 · 139

Limbruno, Ugo: 2644 · 107

Lin, Fay: 924 – 5 · 151, 924 – 7 · 151

Lin, Grace: 242 · 182

Lin, Jay: 913 – 5 · 143

Lin, Kimberly: 901 – 6 · 114

Lincoff, A.: 2501 – 10 · 137

Lincoff, A. M.: 2301 · 114, 2306 · 125, 2643 · 201

Lindahl, Bertil: 653 · 162

Lindenfeld, Joann: 925 – 7 · 152

Linderbaum, Jane A.: 689 · 184, 731 · 142

Lindner, Jonathan: 909 – 4 · 110

Lindner, Jonathan R.: 907 – 3 · 142

Lindsay, Bruce: 922 – 7 · 150

Lindsay, Bruce D.: 239 · 178

Ling, Lee Fong: 407 · 181

Link, Mark S.: 688 · 182

Linke, Axel: 2644 · 107

Liodakis, Emmanouil: 920 – 5 · 149

Lioy, Ernesto: 2644 · 107

Lip, Gregory: 904 – 5 · 141, 904 – 7 · 141

Lipshultz, Steven: 901 – 5 · 114

Litt, Harold: 305 · 181

Little, Stephen: 907 – 8 · 142

Little, Stephen H.: 707 · 197, 814 · 164

Little, William: 203 · 109, 229 · 159

Liu, Bin: 2645 · 120

Liu, Chia Ying: 908 – 8 · 110

Liu, Christopher: 614 · 121

Liu, Chunyu: 905 – 3 · 109

Liu, Huiliang: 2645 · 120

Liu, Peter P.: 240 · 179

Liu, Shizhen: 907 – 8 · 142

Liu, Ya Ni: 909 – 4 · 110

liu, yang: 906 – 8 · 110

Llacer, Angel: 908 – 6 · 110

Llanos, Alexander: 2308 · 156, 2310 · 156

Lloyd-Jones, Donald: 905 – 6 · 109

Lock, James E.: 678 · 178, 692 · 184

Locke, Amy: 235 · 164

Logan, Julie A.: 2105 · 171, 2105 · 171

Lomasney, Jon: 2315 · 189

Lombardi, William L.: 2112 · 182, 2621 · 162, 505 · 188

Long, Janet B.: 255 · 204, 736 · 125

Lopes, Renato: 304 · 143

Lopes, Renato D.: 904 – 9 · 141

Lopez, Leo: 724 · 209

López, Mª Pilar: 908 – 6 · 110

Lopez-Candales, Angel: 912 – 5 · 142

Lorin, Jeffrey: 2505 – 10 · 139

Losordo, Douglas W.: 2623 · 166, 618 · 121

Lotan, Chaim: 510 · 193, 746 · 105, 746 · 105

Louvard, Yves: 2502 – 9 · 119, 926 – 7 · 153

Love, Charles J.: 690 · 184

Lowery, Robert: 744b · 170

Loyalka, Pranav: 2314 · 189

Lu, Chengzhi: 2645 · 120

Lubos, Edith: 930 – 6 · 155

Lubs, Daniel: 930 – 6 · 155

Lucisano, Luigi: 2644 · 107

Luke, William: 259 · 210

Lumley, Matthew: 2645 · 120

Lundgrin, Erika: 912 – 8 · 142

Luo, Yanting: 927 – 7 · 153

Lurz, Philipp: 902 – 8 · 108

Lyass, Asya: 905 – 3 · 109

Lyden, Sean: 2613 · 126

Ma, Genshan: 2645 · 120

Ma, Yitong: 2645 · 120

Maalouf, Joseph: 251 · 199, 504 · 193, 674 · 182, 915 · 145

MacDougall, Diane: 911 – 10 · 143

Mace, Pamela: 931 – 8 · 113

MacFadyen, Jean: 911 – 4 · 143, 911 – 6 · 143

Mack, Michael: 2500 – 7 · 137, 2500 – 9 · 137, 305 · 181

Mack, Michael J.: 2122 · 183, 2131 · 160, 2636 · 195, 606 · 116, 737 · 169, 309 · 211

MacLeod, Rob: 918 – 6 · 148, 918 – 8 · 148

MacRae, Calum A.: 236 · 169

Madan, Mina: 916 – 5 · 140

Madan, Pankaj: 913 – 7 · 143

Madden, Sean: 2508 – 13 · 139

Madder, Ryan: 2610 · 120, 2508 – 11 · 139

Maddox, Thomas M.: 209 · 117, 219 · 128, 721 · 204, 913 · 143

Maeda, Mika: 909 – 7 · 111

Maehara, Akiko: 2303 · 115, 2508 – 15 · 139, 2511 – 7 · 147, 2625 · 177, 2629 · 183, 304 · 143, 916 – 4 · 140

Maeng, Michael: 2506 – 11 · 146

Magalski, Anthony: 262 · 187

Maganti, K: 208 · 116

Mahaffey, Kenneth: 903 – 8 · 108

Mahajan, Nitin: 306 · 186, 910 – 6 · 111

Mahfoud, Felix: 926 – 3 · 153

Mahle, William: 693 · 185

Mahmarian, John J.: 708 · 197

Mahmud, Ehtisham: 2627 · 177

Mai, Xingchen: 2505 – 10 · 139

Maier, Lars: 921 – 8 · 150

Maisano, Francesco: 930 – 3 · 155, 612 · 118

Makenbaeva, Dinara: 913 – 5 · 143

Makiyama, Takeru: 405 · 144

Makkar, Raj R.: 2609 · 120, 2626 · 177, 2202 · 161, 2308 · 156

Makris, George: 903 – 7 · 108

Maldonado, Galo: 2506 – 15 · 146

Malenka, David J.: 723 · 204

Malik, Iqbal: 923 – 6 · 152

Malik, Marek: 702 · 196

Mallorie, Amy: 908 – 4 · 110

Manankil, Marian: 2303 · 115

Mancini, Donna M.: 669 · 168

Mancone, Massimo: 2644 · 107

Mancuso, J. Jacob: 234 · 163, 259 · 210

Mandapaka, Sangeeta: 2305 · 125

Mandras, Stacy: 912 · 142

Manito, Nicolas: 517 · 191

Mankad, Rekha: 620 · 123

Mankad, Sunil V.: 229 · 159, 258 · 210, 632 · 129, 697 · 185, 815 · 165

Mann, Douglas L.: 710 · 198, 656 · 163, 746 · 105

Mann, Tift: 2624 · 167, 2305 · 125

Manning, Warren: 925 – 4 · 152, 925 – 5 · 152

Manoharan, Ganesh: 2203 · 194, 2500 · 137, 2635 · 195

Manoukian, Steven V.: 2641 · 200

Mansour, M. A.: 932 – 5 · 155

Manthripragada, Gopi: 2305 · 125

Mantzoros, Christos S.: 905 – 5 · 109

Maranan, Leandro: 2510 – 13 · 140

Maranhão, Raul C.: 911 – 8 · 143

Marban, Eduardo: 300 · 112, 618 · 121

Marchlinski, Francis E.: 706 · 197, 715 · 201

Marek, Josef: 907 – 7 · 142

Marek, Joseph C.: 688 · 182

Marelli, Ariane: 920 – 4 · 149

Margenet, Alain: 2502 – 9 · 119

Margey, Ronan: 2308 · 156, 2310 · 156, 2314 · 189

Margulies, Janice: 911 – 10 · 143

Marine, Joseph E.: 703 · 196, 826 · 203

Marinos, Georgios: 931 – 3 · 113

Markl, Michael: 719 · 202

Markovic, Sinisa: 903 – 3 · 108

Markowitz, Steven M.: 703 · 196

Maron, Barry: 925 – 4 · 152, 925 – 5 · 152

Maron, Barry J.: 253 · 203, 619 · 122, 262 · 187, 262 · 187, 914 – 3 · 144

Maron, Martin: 925 – 4 · 152, 925 – 5 · 152

Maron, Martin S.: 253 · 203, 648 · 159, 661 · 164

Marrouche, Nassir: 918 – 6 · 148

Marrouche, Nassir F.: 918 – 8 · 148

Marshall, J.: 2505 – 8 · 138

Marso, Steven: 2501 – 8 · 137, 2510 – 7 · 139, 2510 – 15 · 140, 916 – 4 · 140

Marso, Steven P.: 2641 · 200, 711 · 199, 510 · 193, 2511 – 13 · 147

Martin, Daniel: 300 · 112

230 GO for ACC.12!



Martin, Gerard: 616 · 122, 901 – 7 · 114

Martin, Gerard R.: 402 · 162, 506 · 191, 901 – 8 · 114

Martin, Joseph: 2303 · 115

Martin, Victoria: 2504 – 15 · 138

Martinez, Matthew W.: 253 · 203, 648 · 159, 816 · 166

Martinez-Sanchez, Carlos R.: 513 · 190

Martucci, Giussepe: 2644 · 107

Marwick, Thomas: 907 – 5 · 142, 908 – 5 · 110

Marwick, Thomas H.: 407 · 181, 682 · 179

marzullo, marco: 909 – 3 · 110

Mascette, Alice M.: 656 · 163

Maseri, Attilio: 404 · 199

masi, filippo: 909 – 3 · 110

Masotti, Monica: 2504 – 15 · 138

Masoudi, Frederick: 2511 – 11 · 147, 928 – 5 · 154, 928 – 6 · 154

Masoudi, Frederick A.: 205 · 112, 712 · 199, 515 · 193

Massaro, Joseph: 930 – 4 · 155, 2645 · 120

Massaro, Joseph M.: 308 · 210

Massberg, Steffen: 2645 · 120

Massie, Barry M.: 669 · 168, 680 · 179, 921 · 150, 921 – 3 · 150

Masuyama, Tohru: 501 · 190

Matesanz, Rafael: 906 – 5 · 110

Matetzky, Shlomi: 924 – 3 · 151

Matheny, Michael: 2511 – 11 · 147

Mather, Paul J.: 694 · 185

Mathew, Samuel K.: 509 · 190

Mathiasen, Anders B.: 923 – 5 · 151

Mathier, Michael: 912 – 5 · 142

Mathier, Michael A.: 249 · 198, 649 · 159, 912 – 3 · 142

matsubara, Tetsuo: 2504 – 7 · 138

Matsuda, Takehisa: 2509 – 15 · 147

Matsumoto, Alan: 931 – 8 · 113

Matsumoto, Daisuke: 2503 – 7 · 145

Mattos, Luiz A.: 503 · 188

Mauri, Laura: 2645 · 120, 2617 · 156, 2103 · 165, 2511 · 147, 930 – 4 · 155

Mavronasiou, Eleni: 903 – 7 · 108

May, David C.: 219 · 128

Mayer, John: 308 · 210

Mayet, Jamil: 923 – 6 · 152

Maytin, Melanie: 2502 – 11 · 119

Mazzaferri, Ernest: 2501 – 14 · 138, 2501 – 16 · 138

Mazzitelli, Domenico: 2507 – 13 · 147

McAllister, Todd: 627 · 127

McBane, Robert: 931 – 8 · 113

McBride, Patrick E.: 227 · 152

McCarter, Robert: 901 – 7 · 114

McCarthy, Patrick M.: 242 · 182, 258 · 210, 697 · 185, 632 · 129

McClelland, Robyn: 924 – 4 · 151

McClurken, James B.: 659 · 163

McCormick, Liam M.: 923 – 7 · 152

McCullough, Peter A.: 711 · 199

McDaniel, Michael C.: 2303 · 115

McElhinney, Doff B.: 2615 · 148, 634 · 141

mcelwee, sam: 2306 · 125

McEneaney, David: 919 – 8 · 149

McGlothlin, Dana: 249 · 198

McGowan, Jr, Francis X.: 901 – 4 · 114

McGrew, Frank: 921 – 4 · 150

McGuire, Darren K.: 645 · 158

McKay, Charles: 308 · 210

McKenna, William: 236 · 169, 253 · 203, 661 · 164

McKenney, James: 306 · 186, 911 – 5 · 143

McKillop, Graham: 407 · 181

McLaughlin, Vallerie V.: 705 · 196, 254 · 203

McLean, Rhondalyn: 645 · 158

McMullan, Paul: 263 · 170

McMurtry, M. Sean: 2607 · 115

McNally, Elizabeth: 671 · 168

McNamara, Dennis M.: 605 · 116, 635 · 141, 695 · 185, 664 · 165

Mcnitt, Scott: 919 – 5 · 149

McNitt, Scott: 919 – 6 · 149

McPherson, John: 2511 – 7 · 147, 916 – 4 · 140, 923 – 8 · 152, 924 – 6 · 151

McPherson, John A.: 806 · 123, 811 · 158, 819 · 192, 263 · 170

Meadows, Jeffrey: 2615 · 148

Mega, Jessica: 916 – 8 · 140

Mehdipour, Mahshid: 308 · 210

Mehra, Mandeep R.: 655 · 163

Mehran, Roxana: 200 · 107, 2634 · 190, 2641 · 200, 622 · 123, 2501 – 6 · 137, 2501 – 10 · 137, 2501 – 14 · 138, 2501 – 16 · 138, 2502 – 15 · 119, 2508 – 15 · 139

Mehrotra, Praveen: 2310 · 156

Mehta, Laxmi S.: 241 · 179, 245 · 185

Mehta, Rajendra: 408 · 187

Mehta, Sameer: 676 · 178

Mehta, Shamir R.: 903 · 108

Meier, Bernhard: 2645 · 120

Melenovsky, Vojtech: 905 – 7 · 109

meliga, emanuele: 2315 · 189

Mell, MD, Matthew W.: 903 – 5 · 108

Menard, Matthew T.: 2620 · 161, 2623 · 166

Mendes, Lisa A.: 710 · 198

Mendiz, Oscar A.: 502 · 188

Meng, Lingbo: 916 – 7 · 140

Menon, Venu: 2502 – 11 · 119, 916 · 140

Mentz, Robert J.: 744a · 170, 921 – 5 · 150

Meredith, Ian: 2506 – 7 · 146, 2506 – 13 · 146

Merrill, Michael F.: 113 · 193

Mertens, Luc: 693 · 185

Messenger, John: 2510 – 15 · 140, 2511 – 11 · 147, 308 · 210, 928 – 5 · 154, 928 – 6 · 154

Messenger, John C.: 510 · 193

Messer, Joseph V.: 659 · 163

Messerli, Franz H.: 250 · 198

Messika-Zeitoun, David: 238 · 171, 246 · 187, 915 · 145, 915 – 7 · 145, 930 – 5 · 155

Metkus, Thomas S.: 2314 · 189

Metzger, Christopher: 2505 – 8 · 138

Metzger, D. Christopher: 304 · 143, 2620 · 161, 2631 · 183

Metzger, David: 2501 – 14 · 138, 2501 – 16 · 138

Meuwissen, Martijn: 2502 – 13 · 119

Mewada, Abhishek: 306 · 186

Michael, Tesfaldet T.: 2302 · 114

Michelena, Hector I.: 260 · 211, 723 · 204

Michifumi, Tokuda: 922 – 3 · 150

Michos, Erin: 235 · 164, 698 · 186

Mieres, Jennifer H.: 237 · 169, 245 · 185, 255 · 204

Mietus-Snyder, Michele: 746 · 105

Mikati, Issam A.: 643 · 158, 682 · 179, 809 · 128, 908 · 110

Mikell, Frank L.: 630 · 128

Mila, Rafael: 923 – 6 · 152

Milani, Richard: 927 – 5 · 153

Millar, Lynne: 914 – 7 · 144

Miller, Alan: 921 – 4 · 150

Miller, Alan B.: 922 – 5 · 150

Miller, Amy Leigh: 107 · 124, 209 · 117

Miller, Chadwick: 305 · 181

Miller, D. Craig: 2636 · 195, 2500 – 7 · 137, 2500 – 9 · 137, 305 · 181

Miller, Denise: 2502 – 7 · 119

Miller, Fletcher A.: 204 · 110

Miller, John M.: 737·[page

Miller, Julie: 909 – 8 · 111

Miller, Leslie W.: 669 · 168

Miller, Todd D.: 651 · 160

Mills, Nicholas L.: 407 · 181

Mills, Rebecca: 2510 – 7 · 139, 2511 – 13 · 147

Min, James: 924 – 7 · 151

Min, James K.: 231 · 162, 683 · 180, 2507 · 146, 740 · 204, 924 – 5 · 151

Minissian, Margo B.: 112 · 180, 710 · 198

Mintz, Gary: 2508 – 15 · 139, 2511 – 7 · 147, 916 – 4 · 140

Mintz, Gary S.: 2201 · 119, 2201 · 119, 309 · 211, 646 · 155

Minutello, Robert: 928 – 4 · 154

Miquel-Hebert, Karine: 2503 – 11 · 146, 2503 – 13 · 146

Mira, Vera: 304 · 143

Mirowska, Karolina K.: 306 · 186

Mirro, Michael J.: 630 · 128, 647 · 159

Mishkel, Gregory J.: 2607 · 115, 2610 · 120

Mistry, Kshitij P.: 616 · 122

Mistry, Niraj: 908 – 4 · 110

Mitchell, Justin: 2315 · 189

Miyashita, Yusuke: 931 – 4 · 113, 931 – 6 · 113

Miyazaki, Shunichi: 501 · 190, 501 · 190

Mizuguchi, Yukio: 2301 · 114

Moat, Neil E.: 2636 · 195

Moccetti, Tiziano: 903 – 8 · 108

Moceri, Pamela: 920 – 5 · 149




Modi, Kalgi A.: 695 · 185

Moebius-Winkler, Sven: 2509 – 9 · 147

Moebus, Susanne: 924 – 4 · 151

Moeller, Chaim: 408 · 187

Moga, Michael-Alice: 901 – 3 · 114

Mohammed, Selma: 649 · 159

Mohan, Puneet: 904 – 9 · 141

Mohanty, Prasant: 925 – 8 · 152

Mohanty, Sanghamitra: 925 – 8 · 152

Möhlenkamp, Stefan: 924 – 4 · 151

Mohler, III, Emile R.: 825 · 202

Mok, Michael: 915 – 6 · 145

Moliterno, David: 903 – 8 · 108

Moliterno, David J.: 2201 · 119, 2301 · 114, 2509 · 147, 2617 · 156, 2634 · 190, 623 · 126, 2103 · 165

Möllmann, Helge: 2506 – 13 · 146

Monaghan, Mark J.: 2606 · 115

Monmeneu, JVicente: 908 – 6 · 110

Montalescot, Gilles: 2643 · 201, 623 · 126, 1605 · 171, 304 · 143

Mooney, Michael R.: 263 · 170

Moore, John: 901 – 8 · 114

Moore, Johnn W. M.: 2615 · 148

Mooss, Aryan: 744b · 170

Mor-Avi, Victor: 407 · 181

Mora, Samia: 911 – 4 · 143

Morady, Fred: 918 – 3 · 148

Morales, David: 625 · 127

Moravec, Christine: 906 – 7 · 110

Moreira, Adriana: 2506 – 15 · 146

Morel, Marie-angèle: 910 – 4 · 111

Morell, Victor O.: 724 · 209

Morelli, Peter: 247 · 196

Moreno, Pedro: 2508 – 6 · 139

Moreu, Jose: 2504 – 15 · 138

Moriarty, Patrick M.: 729 · 203

Morice, Marie Claude: 926 – 7 · 153

Morice, Marie-Claude: 2500 – 13 · 137, 2502 – 9 · 119, 407 · 181

Morillo, Carlos A.: 640 · 157

Morris, Andrew J.: 917 – 7 · 148

Morrison, Lauren M.: 2505 – 6 · 138

Morrow, David: 902 – 3 · 107, 905 – 7 · 109, 916 – 8 · 140

Morrow, David A.: 300 · 112, 508 · 191

Morrow, William R.: 252 · 201

Morton, Geraint: 908 – 3 · 110

Moscona, John: 916 – 6 · 140

Moser, Marvin: 230 · 159

Moses, Jeffrey: 2500 – 7 · 137, 2500 – 9 · 137, 2500 – 11 · 137, 2505 – 8 · 138, 2507 – 11 · 146, 305 · 181

Moses, Jeffrey W.: 2621 · 162

Moshkevich, Solomon: 903 – 5 · 108

Moskovits, Norbert: 408 · 187

Moss, Arthur: 919 – 5 · 149, 919 – 6 · 149

Moss, Arthur J.: 222 · 141, 655 · 163, 691 · 184

Moss, Richard: 906 – 8 · 110

Moss, Robert R.: 2635 · 195

Mostashari, Farzad: 647 · 159

Mota, Luiz: 304 · 143

Motz, Wolfgang: 2509 – 9 · 147

Mountis, Maria: 906 – 7 · 110

Mousa, Tarek M.: 744b · 170

Moussa, Issam: 308 · 210

Moussa, Issam D.: 2511 · 147

Moustakakis, Emmanuel N.: 744b · 170

Movahed, Mohammad R.: 2305 · 125

Moye, Lem: 300 · 112

Mueller, Gisela: 918 – 3 · 148

Mugnolo, Antonio: 2510 – 11 · 140

Mukamal, Kenneth J.: 905 – 5 · 109

Mukherjee, Debabrata: 408 · 187, 665 · 167, 689 · 184, 689 · 184

Mullens, Wilfried: 912 – 7 · 142

Muller, James: 2508 – 13 · 139

Mulvagh, Sharon: 929 – 8 · 154

Mulvagh, Sharon L.: 620 · 123

Munir, Khan: 932 – 5 · 155

Munshi, Kartik: 916 – 6 · 140

Muntner, Paul: 910 – 5 · 111

Murali, Srinivas: 705 · 196

Muramatsu, Toshiya: 2504 – 7 · 138, 2504 – 9 · 138

Murphy, Daniel J.: 252 · 201, 402 · 162

Murphy, Joseph G.: 113 · 193

Murphy, Ryan M.: 929 – 4 · 154

Murphy, Sabina: 902 – 3 · 107, 902 – 5 · 108

Murray, Sarah S.: 2644 · 107

Murthy, Venkatesh: 910 – 3 · 111

Mushlin, Alvin I.: 928 – 8 · 154

Muthappan, Palaniappan: 2511 – 15 · 147

Muthuchamy, Mariappan: 906 – 8 · 110

Muto, Makoto: 2504 – 7 · 138

Myerburg, Robert: 703 · 196, 703 · 196

Myers, Jonathan N.: 929 – 6 · 154

Mylotte, Darren: 2502 – 9 · 119, 407 · 181, 926 – 7 · 153

Na, Jin Oh: 2505 – 12 · 139

Naccarelli, Gerald V.: 206 · 116, 706 · 197

Nadamanee, Koonlawee: 691 · 184

Nagai, Hiroyuki: 2303 · 115

Nagavalli, Sravanthi: 932 – 4 · 155

Nagel, Eike: 908 – 3 · 110

Nagueh, Sherif F.: 2618 · 161, 619 · 122, 638 · 151

nagurney, john: 308 · 210

Naidu, Srihari: 2310 · 156

Naidu, Srihari S.: 2122 · 183, 2315 · 189, 2612 · 125

Naik, Sunil: 2309 · 156

Naito, Masaki: 2309 · 156

Najm, Hani: 515 · 193, 746 · 105

Nakagawa, Yoshihisa: 2509 – 13 · 147

Nakamura, Shigeru: 2504 – 7 · 138

Nakamura, Sunao: 2505 – 16 · 139

Nakanishi, Rine: 924 – 5 · 151

Nakatani, Shimpei: 2303 · 115

Nakazawa, Gaku: 2503 – 7 · 145, 2611 · 125

Nanda, Navin C.: 509 · 190

Nanjundappa, Aravinda: 2305 · 125, 2311 · 166, 2607 · 115, 2642 · 201

Nanto, Kiyonori: 931 – 4 · 113

Naofumi, Doi: 2309 · 156

Narasimhan, Calambur: 509 · 190

Narula, Jagat: 111 · 159, 2121 · 177

Nasir, Khurram: 696 · 185, 924 – 4 · 151, 927 –3 · 153, 930 – 7 · 155

Nasseri, Boris A.: 921 – 7 · 150

Natale, Andrea: 716 · 201, 212 · 121, 925 – 8 · 152

Natarajan, Madhu: 2644 · 107

Nath, Jayant: 932 – 4 · 155

Nathan, Sandeep: 2308 · 156

Natsuaki, Masahiro: 2509 – 13 · 147

Naya, Masanao: 910 – 3 · 111

Nazif, Tamim: 211 · 121

Neilan, Tomas G.: 922 – 3 · 150

Neish, Steven R.: 802 · 111

Nelson Worel, Jane: 701 · 193

Neumann, Franz-Josef: 739 · 211, 2501 – 14 · 138, 2501 – 16 · 138

Neunteuff, Thomas D: 304 · 143

Neville, Susan: 922 – 5 · 150

Newburger, Jane: 247 · 196, 107A · 125

Newby, David: 714 · 199

Newby, David E.: 407 · 181, 740 · 204

Newby, L. Kristin: 728 · 209

Newman, Jonathan: 904 – 4 · 141

Newton, Roger: 911 – 10 · 143

Ng, Jason: 406 · 154, 929 – 5 · 154

nguyen, can: 2510 – 9 · 139

Nicholas, Michael: 2311 · 166

Nicholls, Stephen: 2303 · 115

Nichols, Len: 687 · 180

Nickenig, Georg: 917 – 3 · 148

Nihoyannopoulos, Petros: 745 · 203

Niinuma, Hiroyuki: 909 – 8 · 111

Nijveldt, Robin: 918 – 4 · 148

Nikas, Dimitrios: 2510 – 11 · 140

Nikolsky, Eugenia: 2505 · 138

Nishimura, Rick A.: 103 · 117, 256 · 204, 258 · 210, 619 · 122, 710 · 198, 107A · 125, 309 · 211, 744a · 170, 801 · 105

Nissen, Steven: 306 · 186

Nissen, Steven E.: 215 · 123, 107A · 125

Nkomo, Vuyisile: 210 · 118, 220 · 129, 930 · 155

Nobuyoshi, Masakiyo: 2302 · 114

Noel, Bernard: 2510 – 9 · 139

Noheria, Amit: 744b · 170

232 GO for ACC.12!



Nohria, Anju: 626 · 127

Nombela-Franco, Luis: 915 – 6 · 145

Noohi Bezanjani, Feridoun: 746 · 105

Nordbeck, Peter: 918 – 7 · 148

Normand, Sharon-Lise T.: 700 · 186

Novak, Jan: 406 · 154

Novo, Salvatore: 706 · 197

Nugent, Alan W.: 692 · 184

Nunez, Julio: 908 – 6 · 110

Nuyles, Michael: 2311 · 166

Nyberg, Fredrik: 911 – 6 · 143

Nylander, Sven: 902 – 7 · 108

O’Brien, Kevin: 930 – 7 · 155

O’Brien, Sean: 308 · 210, 915 – 5 · 145, 928 – 5 · 154

O’Connell, John B.: 2122 · 183

O’Connor, Christopher: 921 – 5 · 150

O’Donoghue, Susan: 744b · 170

O’Gara, Patrick T.: 103 · 117, 260 · 211, 712 · 199, 107A · 125, 305 · 181, 309 · 211, 503 · 188, 675 · 169, 744a · 170, 801 · 105

O’Neill, Blair J.: 504 · 193

O’Neill, Brian P.: 2121 · 177, 2505 · 138

O’Neill, William W.: 213 · 122, 2643 · 201, 604 · 115, 2315 · 189

O’Riordan, Martin: 603 · 113

Ochala, Andrzej: 304 · 143

Ochiai, Masahiko: 2621 · 162

Oderich, Gustavo: 2613 · 126

Oechslin, Erwin N.: 725 · 209

Oetgen, William J.: 219 · 128, 607 · 116

Ofili, Elizabeth: 686 · 180, 656 · 163

Ogawa, Hisao: 2505 – 16 · 139

Ogle, James: 2314 · 189

Oh, Dong Joo: 2505 – 12 · 139

Oh, Jae K.: 208 · 116, 229 · 159, 714 · 199

Ohman, Erik M.: 2638 · 196, 2315 · 189, 304 · 143

Oieru, Dan: 924 – 3 · 151

Oikawa, Yuji: 2621 · 162

Oikonomou, Evangelos: 931 – 3 · 113

Okamoto, Shin: 2311 · 166

OKAMURA, ATSUNORI: 2504 – 7 · 138, 2303 · 115

Okubagzi, Petros: 915 – 8 · 145

Oldroyd, Keith: 2506 – 13 · 146, 923 – 9 · 152

Olin, Jeffrey: 931 – 7 · 113

Olin, Jeffrey W.: 2610 · 120, 931 – 8 · 113

Oliveira, Ricardo: 929 – 6 · 154

Oliver-McNeil, Sandra M.: 112 · 180, 2104 · 165

Olivotto, Iacopo: 925 – 4 · 152, 925 – 5 · 152

Olshansky, Brian: 914 · 144

Ommen, Steve R.: 256 · 204, 607 · 116, 607 · 116, 619 · 122, 648 · 159, 661 · 164, 801 · 105, 807 · 124

Onishi, Tetsuari: 907 – 7 · 142

Onishi, Toshinari: 907 – 7 · 142

Onsea, Kevin: 926 – 5 · 153

Onuma, Yoshinobu: 2503 – 11 · 146

Oparil, Suzanne: 926 · 153, 631 · 128, 250 · 198

Opitz, Anke: 2507 – 13 · 147

Opitz, Christian: 2509 – 9 · 147

Oral, Elif: 235 · 164, 711 · 199

Orav, Endel: 901 – 5 · 114

Orban, Marek: 406 · 154

Oren, Ron M.: 921 – 4 · 150

Ormiston, John: 2503 – 13 · 146

Ormiston, John A.: 2611 · 125, 2632 · 184, 2202 · 161

Ornish, Dean: 698 · 186

Orsinelli, David: 204 · 110

Oshinski, John N.: 406 · 154

Osten, Mark: 2505 – 6 · 138, 2644 · 107

Otake, Hiromasa: 2503 – 7 · 145

Otto, Catherine M.: 714 · 199, 258 · 210

Otto, Sylvia: 2645 · 120

Ou, Narith: 732 · 109

Oudiz, Ronald J.: 254 · 203

Overgaard, Chris: 2505 – 6 · 138

Overholser, Brian: 913 – 8 · 143

Owens, Douglas K.: 903 – 5 · 108

Ozaki, Yukio: 2639 · 202

Ozkan, Mehmet: 518 · 189

Pacchioni, Andrea: 2510 – 11 · 140

Pack, Quinn: 929 – 8 · 154

Pack, Quinn R.: 927 – 6 · 153

Packer, Douglas L.: 666 · 167

Packer, Milton: 722 · 204

Pagani, Francis D.: 213 · 122

Page, Richard L.: 666 · 167

Page, II, Robert L.: 225 · 150, 736 · 125

Pahl, Elfriede: 901 – 5 · 114

Palacios, Igor: 2308 · 156, 2310 · 156

Palacios, Igor F.: 2630 · 183, 2635 · 195, 2310 · 156, 238 · 171

Palma-Davis, LaVaughn: 913 – 6 · 143

Palmieri, Bruno: 2506 – 15 · 146

Pancholy, Samir B.: 2510 · 139

Paniagua de Decoud, Maria: 516 · 192

Papadakis, Michael: 914 – 4 · 144, 914 – 7 · 144

Papademetriou, Vasilios: 926 – 8 · 153

Papageorgiou, Nikolaos: 931 – 3 · 113

Papavassiliou, Athanasios G.: 931 – 3 · 113

Papp, Andrea: 910 – 8 · 111

Pappagianopoulos, Paul P.: 929 – 4 · 154

Pappas, Christos: 903 – 4 · 108

Paradis, Jean-Michel: 2500 – 11 · 137, 2507 – 11 · 146

Parharidis, George: 745 · 203

Paridon, Stephen: 901 – 6 · 114

Parikh, Manish A.: 2201 · 119, 2202 · 161, 2509 · 147

Parikh, Sahil A.: 2633 · 189

Parise, Helen: 665 · 167, 2501 – 6 · 137, 2501 – 14 · 138, 2501 – 16 · 138, 2502 – 15 · 119, 2506 – 9 · 146, 304 · 143, 665 · 167

Park, Chang Gyu: 2505 – 12 · 139

Park, Chong H.: 744b · 170

Park, Duk-Woo: 2645 · 120, 646 · 155, 511 · 188

Park, Euljoon: 926 – 8 · 153

Park, Hyo Eun: 930 – 8 · 155

Park, Jae Hyoung: 405 · 144

Park, Jae-Hyeong: 912 – 8 · 142

Park, Ji Young: 2505 – 12 · 139

Park, Jong-Seon: 2504 – 13 · 138

Park, Kyung Woo: 304 · 143

Park, Margaret: 912 – 8 · 142

Park, Myung H.: 705 · 196

Park, Seong-Wook: 2645 · 120, 2645 · 120

Park, Seung-Jung: 2645 · 120, 2202 · 161, 511 · 188

Park, Yonghwi: 2501 – 12 · 137

Parker, Beth A.: 911 – 9 · 143

Parodi, Juan Carlos: 502 · 188

Parra, David: 732 · 109, 733 · 114, 734 · 116, 735 · 122, 736 · 125

Pasquet, Agnès: 260 · 211

Passeri, Jonathan: 2308 · 156, 2310 · 156

Patange, Amit: 408 · 187

Patel, Amit R.: 407 · 181

Patel, Dharmendrakumar: 927 – 5 · 153

Patel, Hamang M.: 662 · 164

Patel, Kavita: 650 · 153

Patel, Manesh R.: 205 · 112, 2643 · 201

Patel, Nainesh C.: 263 · 170

Patel, Rikesh: 2313 · 189

Patel, Uptal: 2511 – 11 · 147

Patrick, Jonathan: 2306 · 125

Patrick-Lake, Bray: 601 · 112

Patted, Suresh: 2314 · 189

Patted, Suresh V.: 2310 · 156, 2313 · 189

Patterson, Cam: 405 · 144

Patterson, J. Herbert: 921 – 4 · 150

Patton, Kristen K.: 736 · 125, 918 · 148, 820 · 192

Paul, Jonathan: 2308 · 156

Paul, Sara: 217 · 127, 717 · 202

Peberdy, Mary Ann: 929 – 6 · 154

Pedrazzini, Giovanni: 930 – 3 · 155

Pehlivanoglu, Seckin: 518 · 189

Pelargonio, Gemma: 925 – 8 · 152

Pelchovitz, Daniel J.: 406 · 154

Pellegrini, Cara: 690 · 184

Pellegrini, Gian: 407 · 181

Pelliccia, Antonio: 262 · 187, 262 · 187

Pellikka, Patricia A.: 407 · 181, 643 · 158, 657 · 163

Pelosi, Frank: 2122 · 183

Pena, Tino: 2607 · 115, 2616 · 156

Penaloza, Dante: 726 · 210

Pencina, Michael: 700 · 186, 905 – 3 · 109




Peng, Szu-Po: 913 – 7 · 143

Penn, Marc: 300 · 112

Pennacchi, Mauro: 2644 · 107

Pennell, Dudley: 908 – 4 · 110

Pennell, Dudley J.: 920 – 8 · 149, 740 · 204

Penzo, Carlo: 2510 – 11 · 140

Pepine, Carl: 620 · 123, 300 · 112

Pepine, Carl J.: 906 – 4 · 109

Perera, Divaka: 2645 · 120, 908 – 3 · 110

Perez, Marco: 904 – 4 · 141

Perin, Emerson C.: 300 · 112

Peruga, Jan Z.: 2501 – 6 · 137

Pescatello, Linda S.: 911 – 9 · 143

Petersen, John W.: 906 – 4 · 109

Peterson, Eric: 664 · 165, 304 · 143, 308 · 210, 913 – 7 · 143

Peterson, Eric D.: 721 · 204

peterson, eric D.: 915 – 5 · 145

Peterson, Eric D.: 513 · 190, 928 – 5 · 154

Peterson, Mark: 2644 · 107

Pettersen, Michael: 408 · 187

Pfeffer, Marc: 704 · 196

Philippon, François: 915 – 6 · 145

Phillips, Matthew: 244 · 185, 244 · 185, 621 · 123

Phillips, Tierney: 2644 · 107

Piana, Robert N.: 600 · 112

Piazza, Nicolo: 2507 – 13 · 147, 2618 · 161, 2131 · 160

Pibarot, Philippe: 915 – 6 · 145, 707 · 197, 2644 · 107

Picard, Michael: 914 – 8 · 144

Picard, Michael H.: 657 · 163

Pichard, Augusto: 2606 · 115, 2635 · 195, 2203 · 194, 2308 · 156, 2500 – 15 · 137, 2507 – 15 · 147, 2635 · 195, 915 – 8 · 145

Piek, Jan: 2502 – 13 · 119, 918 – 4 · 148

Pieper, Petronella G.: 738 · 181

Pierard, Luc: 242 · 182, 256 · 204

Pierucci, Daniela: 2644 · 107

Pijls, Nico: 923 – 9 · 152, 2508 – 7 · 139

Pijnappels, Daniël: 906 – 3 · 109

Pilote, Louise: 920 – 4 · 149

Pina, Ileana: 921 – 4 · 150

Pina, Ileana L.: 217 · 127, 224 · 143, 237 · 169, 641 · 157

Pineiro, Daniel: 726 · 210

Pinney, Sean P.: 670 · 168

Pinto, Duane S.: 2111 · 177, 613 · 121, 1605 · 171

Piscione, Federico: 916 – 5 · 140

Pislaru, Sorin: 251 · 199

Pitsavos, Christos: 931 – 3 · 113

Pitt, Bertram: 107A · 125, 921 – 6 · 150

Placentino, Filippo: 2644 · 107

Plakomyti, Theodora E.: 903 – 4 · 108

Plana, Juan C.: 2122 · 183

Plutzky, Jorge: 306 · 186

Pocock, Stuart: 665 · 167, 2501 – 10 · 137

Poerner, Tudor C.: 2645 · 120

Poggio, Daniele: 914 – 6 · 144

Polk, Donna: 911 – 9 · 143

Polk, Donna M.: 709 · 197, 729 · 203, 730 · 170

Pollice, Paolo: 909 – 3 · 110

Poole, Jeanne E.: 216 · 126, 243 · 184

Pope, James H.: 308 · 210

Popma, Jeffrey: 2506 – 7 · 146, 2509 – 11 · 147, 2645 · 120, 308 · 210

Popma, Jeffrey J.: 2114 · 194, 2635 · 195, 2309 · 156

Popovic, Zoran: 908 – 5 · 110

Porter, Thomas R.: 672 · 168

Porvasnik, Stacy L.: 906 – 4 · 109

Posteraro, III, Anthony F.: 744b · 170

Postley, John: 927 – 7 · 153

Pothier, Claire: 306 · 186

Powell, Alex: 2623 · 166

Powell, Andrew: 693 · 185

Powell, Brian: 212 · 121, 815 · 165

Prabhakaran, Dorairaj: 742 · 186

Prager, Richard L.: 721 · 204

Prakash, Ashwin: 693 · 185

Prasad, Sanjay: 719 · 202, 908 – 4 · 110

Pratap, T.: 2306 · 125

Price, Matthew J.: 2617 · 156, 2627 · 178, 2644 · 107, 2132 · 195, 2202 · 161, 2506 – 6 · 146

Primitivo, Stefano Giuseppe: 909 – 3 · 110

Prince, Martin: 908 – 8 · 110

Proulx, Guy: 2510 – 9 · 139

Providencia, Luis: 903 – 8 · 108

Prystowsky, Eric N.: 615 · 121, 654 · 162, 501 · 190

Pump, Agnes: 925 – 8 · 152

Puri, Rishi: 2303 · 115

Puskas, John: 2302 · 114

Pyo, Robert: 2504 · 138

Pyrgakis, Vlassios N.: 745 · 203

Pyxaras, Stelios: 923 – 9 · 152

Qian, Juying: 2645 · 120

Qin, Yongwen: 2645 · 120

Quagliara, Donato: 909 – 3 · 110

Quaife, Robert: 2507 – 9 · 146

Quick, Harald H.: 918 – 7 · 148

Quinones, Miguel A.: 516 · 192

Quyyumi, Arshed A.: 406 · 154

Rab, Syed: 2303 · 115

Rab, Syed T.: 2306 · 125, 2315 · 189

Raber, Lorenz: 910 – 4 · 111

Raby, Khether E.: 205 · 112

Radtke, Wolfgang A. K.: 2615 · 148

Radu, Maria: 2503 – 13 · 146

Raff, Gilbert: 924 – 5 · 151, 628 · 127, 924 – 7 · 151

Rahimi, Farnoosh: 308 · 210

Rahimtoola, Shahbudin H.: 514 · 194, 659 · 163

Raichlen, Joel: 2508 – 13 · 139

Raiszadeh, Farbod: 744a · 170

Raj, Satish: 640 · 157

Rajagopal, Sudarshan: 744a · 170

Rajagopalan, Navin: 705 · 196

Rajagopalan, Sanjay: 406 · 154

Rajamannan, Nalini M.: 714 · 199

Rakowski, Harry: 925 – 4 · 152, 925 – 5 · 152

Ram, C. Venkata S.: 727 · 210

Ramachandran, Vasan: 905 – 3 · 109

Raman, Subha V.: 241 · 179, 228 · 157

Ramanathan, Kodangudi: 925 – 6 · 152

Ramani, Gautam V.: 912 · 142

Ramani, Ravi: 670 · 168

Ramee, Stephen R.: 2637 · 195, 2500 · 137

Ramires, Jose: 911 – 8 · 143

Ramkisoensing, Arti: 906 – 3 · 109

Ramstad, Anders: 113 · 193

Ranjan, Ravi: 918 – 8 · 148

Rao, Seshu: 2501 – 8 · 137

Rao, Sunil: 2510 – 9 · 139, 2510 – 15 · 140, 928 – 3 · 153, 928 – 6 · 154

Rao, Sunil V.: 109 · 128, 2111 · 177, 2113 · 194, 2624 · 167, 2634 · 190, 604 · 115, 639 · 156, 1605 · 171, 813 · 164

Rapezzi, Claudio: 925 – 5 · 152, 925 – 4 · 152

Rapoza, Richard: 2503 – 13 · 146

Rashwan, Magdy: 506 · 191

Rasmusson, Kismet: 217 · 127, 695 · 185

Raspanti, Silvia: 903 – 6 · 108

Rassi, Andrew: 2502 – 11 · 119

Ratajczak, Mariusz Z.: 917 – 7 · 148

Ravkilde, Jan: 2506 – 11 · 146

Ray, Carolyn: 744b · 170

Razavi, Mahmood K.: 2607 · 115

Read, Philip: 923 – 7 · 152

Reardon, Michael: 2203 · 194

Redberg, Rita: 928 – 8 · 154

Redberg, Rita F.: 644 · 158, 709 · 197

Reddy, M, Sahadev T.: 918 – 5 · 148

Redfield, Margaret M.: 203 · 109, 656 · 163, 107A · 125

Redheuil, Alban: 908 – 8 · 110

Redington, Andrew: 901 – 3 · 114

Redwood, Simon: 2645 · 120

reed, matthew: 914 – 4 · 144

Reed, Timm: 2103 · 165

Reeder, Guy: 406 · 154

Regar, Evelyn: 2503 – 13 · 146, 2611 · 125

Reiffel, James A.: 677 · 178

Reilly, John P.: 214 · 122, 823 · 200

Reimers, Bernhard: 2507 · 146, 2510 – 11 · 140

Reisman, Mark: 2131 · 160, 2132 · 195, 2505 – 8 · 138

Rene, A. Garvey: 2500 – 11 · 137

Resar, Jon: 2314 · 189

Resnic, Frederic S.: 215 · 123

Reuter, David: 633 · 129

234 GO for ACC.12!



Rexrode, Kathryn: 904 – 4 · 141

Rezende, Paulo C.: 911 – 8 · 143

Rha, Seung-Woon: 2504 – 13 · 138, 2505 – 12 · 139

Rhee, Ceron: 903 – 5 · 108

Rhodes, Denise A.: 2104 · 165

Rhodes, John F.: 634 · 141, 637 · 149, 518 · 189

Rhodes, Jonathan: 261 · 171

Rich, Michael: 924 – 8 · 151

Rich, Michael W.: 225 · 150, 722 · 204

Richardson, Caroline: 701 · 193

Richardson, Hamish: 407 · 181

Richman, Joshua: 910 – 5 · 111

Rickard, Jack: 922 – 7 · 150

Ricotta, John J.: 2613 · 126

Ridker, Paul: 911 – 4 · 143, 911 – 6 · 143

Riggs, Lisa A.: 2103 · 165

Rigolin, Vera H.: 242 · 182, 707 · 197

Rihal, Charanjit S.: 104 · 117, 211 · 121, 504 · 193, 518 · 189, 200 · 107, 2630 · 183

Rinaldi, Michael: 2501 – 14 · 138, 2501 – 16 · 138, 2502 – 7 · 119

Rinehart, Sarah: 924 – 6 · 151

Rinfret, Stephane: 2510 – 9 · 139

Ringel, Richard: 901 – 8 · 114

Ritter, Oliver: 918 – 7 · 148

Ritzenthaler, Laura: 308 · 210

Rivero, Fernando: 2504 – 15 · 138

Rizas, Konstantinos: 926 – 6 · 153

Rizzo, Caterina: 909 – 3 · 110

Robbers, Lourens: 918 – 4 · 148

Roberts, Michael: 919 – 8 · 149

Roberts, Robert: 602 · 113

Robinson, Jennifer: 227 · 152, 729 · 203

Robinson, Thompson: 727 · 210

Rocha-Singh, Krishna J.: 2610 · 120, 2642 · 201

Rochitte, Carlos: 909 – 8 · 111

Rodes-Cabau, Josep: 2644 · 107, 251 · 199, 2510 – 9 · 139, 2606 · 115, 2626 · 177, 504 · 193, 723 · 204

Rodés-Cabau, Josep: 915 – 6 · 145

Rodgers, George P.: 914 – 5 · 144

Rodgers, Jo E.: 732 · 109

Rodrigo, Maria E.: 2306 · 125

Rodriguez, Carlos J.: 664 · 165

Rodriguez, L. Leonardo: 907 – 5 · 142

Rodríguez-Abella, Hugo: 906 – 5 · 110

Roe, Matthew: 913 – 7 · 143, 928 – 8 · 154

Roe, Matthew T.: 653 · 162

Roffi, Marco: 2631 · 183, 2633 · 189

Rogers, Frances A.: 662 · 164

Rogers, Jason H.: 2619 · 161, 2510 · 139, 2610 · 120

Rogers, Joseph G.: 694 · 185

Rohatgi, Anand: 826 · 203

Rokos, Ivan: 613 · 121, 604 · 115

Romano, Mauro: 2500 – 13 · 137, 407 · 181

Rome, Eric: 904 – 6 · 141

Rome, Jonathan: 901 – 8 · 114

Romeo, Francesco: 906 – 4 · 109, 706 · 197

Rorick, Tyrus: 903 – 8 · 108

Roselli, Eric: 2619 · 161, 2626 · 177

Rosenberg, Steven: 923 – 8 · 152, 924 – 6 · 151

Rosenfield, Kenneth: 2616 · 156, 2631 · 183, 2310 · 156

Rosenson, Robert S.: 730 · 170

Rosenzweig, James L.: 405 · 144

Rossano, Joseph W.: 901 – 6 · 114

Roth, Eli M.: 911 – 5 · 143

Rothman, Andrew: 922 – 4 · 150

Rottbauer, Wolfgang: 903 – 3 · 108, 908 – 7 · 110

Roubin, Gary S.: 2637 · 195

Rouleau, Jacques: 2510 – 9 · 139

Rowin, Ethan: 925 – 4 · 152, 925 – 5 · 152

Roy, Denis: 207 · 116

Roy, Louis: 2510 – 9 · 139

Roy, Melanie: 2510 – 9 · 139

Rozehnal, John: 905 – 7 · 109

Rozenman, Yoseph: 510 · 193

Rubin, Jeffrey: 932 – 5 · 155

Rubio, Agustin E.: 247 · 196

Rudd, James H.: 407 · 181

Ruderman, Neil B.: 405 · 144

Rudolph, Volker: 930 – 6 · 155

Rudski, Lawrence G.: 241 · 179, 638 · 151

Ruff, Christian T.: 916 – 8 · 140

Ruge, Hendrik: 2507 – 13 · 147

Ruggiero, II, Nicholas J.: 2623 · 166

Ruiz, Carlos: 2510 – 13 · 140, 901 – 8 · 114

Ruiz, Carlos E.: 2630 · 183, 2132 · 195, 2314 · 189

Rumoroso, Jose R.: 2504 – 15 · 138

Rumsfeld, John: 2511 – 11 · 147, 928 – 3 · 153

Rumsfeld, John S.: 209 · 117, 515 · 193, 913 · 143, 913 – 3 · 143

Rundback, John: 2616 · 156

Rusconi, Paolo: 901 – 5 · 114

Russell, Raymond R.: 642 · 157

Russo, Andrea M.: 216 · 126, 239 · 178

Russo, Cesare: 907 – 4 · 142

Russo, Mark: 2308 · 156

Russo, Robert J.: 2625 · 177, 2629 · 183

Ruthazer, Robin: 308 · 210

Ryan, Thomas: 907 – 8 · 142

Ryan, Thomas J.: 657 · 163, 737 · 169

Rychik, Jack: 725 · 209

Saba, Samir: 907 – 7 · 142, 922 – 6 · 150

Sabatine, Marc: 916 – 8 · 140

Sabatine, Marc S.: 2617 · 156, 407 · 181, 739 · 211

Sabbah, Hani N.: 746 · 105

Sable, Craig A.: 725 · 209

Saccà, Salvatore: 2510 – 11 · 140

Saeed, Wajeeha: 912 – 4 · 142

Safford, Monika: 910 – 5 · 111

Safirstein, Jordan: 695 · 185

Safley, David: 2511 – 13 · 147

Safley, David M.: 2510 – 7 · 139

Saia, Theresa A.: 616 · 122

Saidi, Arwa S.: 667 · 167

Saito, Yoshihiko: 917 – 8 · 148

Sakai, Koyu: 2302 · 114

Sakamoto, Yasunari: 2504 – 9 · 138

Saksena, Sanjeev: 509 · 190

Sakwa, Marc P.: 929 – 7 · 154

Salamon, Jason: 912 – 4 · 142

Salcedo, Ernesto: 2507 – 9 · 146

Salisbury, Adam: 2511 – 13 · 147

Salman, Nabia: 912 – 6 · 142

Saltik, Levent: 518 · 189

Salustri, Alessandro: 746 · 105

Salvatella, Neus: 2504 – 15 · 138

Samady, Habib: 2608 · 119, 2639 · 202

Sanborn, Timothy A.: 2624 · 167, 2502 · 119

Sanchez, Pedro L.: 916 – 5 · 140

Sanchez, Pedro L: 906 – 5 · 110

Sanchez-Recalde, Angel: 2504 – 15 · 138

Sanchis, Juan: 908 – 6 · 110

Sanders, Stephen: 692 · 184

Sandhu, Amneet: 408 · 187

Sangli, Chithra: 930 – 4 · 155

Sanidas, Elias: 2508 · 139

Sanoski, Cynthia: 736 · 125

Santangeli, Pasquale: 925 – 8 · 152

Santarelli, Pietro: 925 – 8 · 152

Santini, Alberto: 903 – 6 · 108

Santoro, Daniela: 909 – 3 · 110

Santos-Gallego, Carlos: 902 – 6 · 108

Santucci, Eliana: 304 · 143

Sanz, Javier: 726 · 210

Sarafin, Jennifer: 2502 – 7 · 119

Sardar, Rizwan: 912 – 4 · 142

SARDELLA, GENNARO: 2644 · 107

Sardella, Gennaro: 2506 · 146

Saric, Muhamed: 707 · 197

Sarsam, Sinan: 918 – 3 · 148

Satler, Lowell: 2308 · 156, 2500 – 15 · 137, 2507 – 15 · 147, 915 – 8 · 145

Sato, Kei: 931 – 6 · 113, 2311 · 166

Saudye, Hammad: 2315 · 189

Sauer, William: 918 – 3 · 148

Sauer, William H.: 216 · 126

Sawyer, Douglas: 405 · 144

Saxena, Anita: 2310 · 156

Saxon, Leslie A.: 212 · 121

Saxonhouse, Sherry: 803 · 118, 810 · 128, 820 · 192

Scantlebury, Dawn: 744a · 170




Schafer, Ulrich: 930 – 3 · 155

Schainfeld, Robert: 2607 · 115, 2616 · 156, 2633 · 189

Schalij, Martin: 906 – 3 · 109, 917 – 5 · 148

Schauer, Philip R.: 306 · 186

Schauwecker, Peter: 903 – 3 · 108

Scheinman, Melvin M.: 615 · 121

Schelbert, Erik: 228 · 157

Scheller, Bruno: 2509 – 7 · 147, 2509 – 9 · 147, 916 – 5 · 140

Scherillo, Marino: 706 · 197

Scheurer, Mark: 634 · 141

Schiller, Nelson B.: 241 · 179

Schillinger, Wolfgang: 930 – 3 · 155

Schlaich, Markus: 926 – 3 · 153, 926 – 4 · 153

Schlüter, Michael: 930 – 6 · 155

Schmieder, Roland: 926 – 4 · 153

Schnell, Susan: 2102 · 160

Schoenfeld, David: 308 · 210

Schoenfeld, Mark H.: 614 · 121

Schoenhagen, Paul: 2635 · 195

Schomig, Albert: 2503 – 9 · 146

Schotborgh, Carl: 2502 – 13 · 119

Schreier, Jenna: 920 – 7 · 149

Schrezenmeier, Hubert: 903 – 3 · 108

Schroyer, Michael K.: 609 · 117, 684 · 180

Schuler, Gerhard: 902 – 8 · 108

Schuller, Joseph: 918 – 3 · 148

Schulman, Steven: 2314 · 189

Schultheiss, Hans Peter: 240 · 179

Schultz, Gregory: 906 – 4 · 109

Schuster, Andreas: 908 – 3 · 110

Schwartz, Allan: 2203 · 194, 2308 · 156, 2500 · 137

Schwartz, Robert S.: 923 – 8 · 152

Schwartz, Steven: 901 – 3 · 114

Schwartz, Todd: 921 – 4 · 150

Schwartzman, David: 907 – 7 · 142

Schwarz, Klaus: 903 – 3 · 108

Sciagrà, Roberto: 903 – 6 · 108

Scirica, Benjamin: 902 – 3 · 107, 916 – 8 · 140

Scirica, Benjamin M.: 604 · 115

Seale, Anna: 692 · 184

Seder, David: 263 · 170

Sedlis, Steven: 2505 – 10 · 139

Seeger, John: 922 – 4 · 150

Segev, Amit: 510 · 193, 924 – 3 · 151

Segovia, Javier: 517 · 191

Segre, Alexandre: 911 – 8 · 143

Segrest, Wendy: 928 – 7 · 154

Seldin, David C.: 257 · 209

Seliger, Stephen: 905 – 4 · 109, 905 – 6 · 109

Selim, Samy: 917 – 7 · 148

Selker, Harry P.: 308 · 210

Selvanayagam, Joseph: 257 · 209

Semigran, Marc J.: 257 · 209, 649 · 159, 2122 · 183, 905 · 109

Sen, Sayan: 923 – 6 · 152

Senapathi, Murali K.: 744b · 170

Senges, Jochen: 910 – 8 · 111, 915 – 4 · 145

Seo, Hong-Seog: 2505 – 12 · 139

Sera, Fusako: 2311 · 166

Serruys, Patrick: 916 – 4 · 140, 2506 – 9 · 146, 2511 – 7 · 147, 2645 · 120, 910 – 4 · 111

Serruys, Patrick W.: 2503 – 11 · 146, 2606 · 115, 2632 · 184, 2503 · 145, 2503 – 6 · 145, 2503 – 13 · 146

Seslar, Stephen P.: 667 · 167

Sethi, Nishant: 744b · 170

Sethi, Sanjum S.: 931 – 7 · 113

Setoguchi, Soko: 922 – 4 · 150

Seung, Ki-Bae: 511 · 188

Seyfarth, Melchior: 221 · 140

Sezer, Murat: 518 · 189

Shaban, Nada: 744a · 170

Shaban, Nada M.: 744b · 170

Shaddy, Robert: 901 – 6 · 114

Shah, Atman P.: 2308 · 156

Shah, Bindi K.: 615 · 121, 810 · 128, 813 · 164, 824 · 200

Shah, Binita: 2505 – 10 · 139, 931 – 5 · 113

Shah, Dipan J.: 719 · 202, 924 · 151

Shah, Moneal: 918 – 5 · 148

Shah, Nidhi: 408 · 187

Shah, Prediman K.: 221 · 140, 403 · 170, 611 · 117

Shah, Rashmee: 903 – 5 · 108

Shah, Ravi: 922 – 3 · 150

Shah, Sangeeta B.: 809 · 128

Shahian, David: 308 · 210

Shalaby, Alaa A.: 624 · 126

Shalev, Aryeh: 510 · 193

Shankar, Adurthy A.: 2306 · 125

Shannon, Francis L.: 929 – 7 · 154

Shara, Nawar: 904 – 4 · 141

Share, David: 2511 – 15 · 147

Sharifi, Mohsen: 308 · 210, 2616 · 156, 2633 · 189

Sharma, Aditya M.: 264 · 187

Sharma, Amit: 2311 · 166

Sharma, Mala: 907 – 4 · 142

Sharma, Samin: 2508 – 6 · 139

Sharma, Samin K.: 2504 · 138

Sharma, Sanjay: 262 · 187, 914 – 4 · 144, 914 – 7 · 144

Sharp, Jacqueline: 912 – 8 · 142

Shaw, Leslee: 924 – 7 · 151

Shaw, Leslee J.: 255 · 204, 620 · 123, 628 · 127, 408 · 187, 924 – 5 · 151

Shaw, Richard: 308 · 210

Shaywitz, Adam: 923 – 4 · 151

Sheehan, Patricia R.: 308 · 210

Shehadeh, Waseem: 912 – 6 · 142

Sheikh, Nabeel: 914 – 7 · 144, 914 – 4 · 144

Sheldon, Robert S.: 640 · 157

Shelton, Marc E.: 226 · 152, 512 · 192, 659 · 163

Shemin, Richard J.: 674 · 182

Shen, Win-Kuang: 677 · 178

Shenouda, Sherene M.: 405 · 144

Shepard, Charles: 252 · 201

Sherman, Warren: 689 · 184, 2309 · 156

Sherrid, Mark V.: 661 · 164

Sherwood, Matthew W.: 913 – 7 · 143

Shestakovska, Olga: 904 – 5 · 141

Shewan, Cynthia M.: 308 · 210

Shim, Eun-Bo: 2645 · 120

Shimbo, Daichi: 910 – 5 · 111

Shimizu, Wataru: 405 · 144

Shin, Dong-Ho: 2508 – 9 · 139, 2644 · 107

Shinke, Toshiro: 2503 – 7 · 145

Shirali, Girish S.: 301 · 157, 693 · 185

Shishehbor, Mehdi: 2502 – 11 · 119

Shishehbor, Mehdi H.: 2620 · 161, 2311 · 166, 2510 · 139, 502 · 188, 808 · 124, 823 · 200

Shite, Junya: 2503 – 7 · 145

Shivkumar, Kalyanam: 715 · 201

Shrivastava, Rakesh: 932 – 4 · 155

Shullo, Michael: 670 · 168

Shunk, Kendrick A.: 2629 · 183

Shuvy, Mony: 510 · 193

Siasos, Gerasimos: 931 – 3 · 113

Sibbing, Dirk: 1605 · 171

Sicari, Rosa: 672 · 168

Siddiqui, Danish: 2306 · 125

Siegel, Robert J.: 210 · 118, 2622 · 166, 2635 · 195

Siegel, Stephen A.: 688 · 182

Sievert, Horst: 930 – 3 · 155, 2619 · 161, 2630 · 183, 2132 · 195, 2132 · 195, 739 · 211

Sigwart, Ulrich: 253 · 203, 2612 · 125

Silber, Sigmund: 2632 · 184, 2201 · 119

Silversides, Candice: 679 · 179

Silvestry, Frank E.: 2609 · 120, 2622 · 166, 2622 · 166, 2131 · 160, 507 · 191, 643 · 158

Silvestry, Scott: 229 · 159, 922 · 150

Sim, David: 905 – 8 · 109

Sim, Kui-Hian: 512 · 192

Sim, Ling Ling: 905 – 8 · 109

Simari, Robert: 300 · 112

Simon, Jean-Philippe: 2509 – 9 · 147

Simon, Marc A.: 705 · 196

Simonton, Charles: 2506 – 9 · 146

Simprini, Lauren: 2306 · 125, 924 – 8 · 151

Simpson, Iain A.: 508 · 191

Simpson, Kathleen: 911 – 9 · 143

Singh, Anvesha: 2314 · 189

Singh, Harjit: 305 · 181

Singh, Jagmeet: 655 · 163

Singh, Tania: 915 – 8 · 145

Sinno, Mohamad: 918 – 3 · 148

Sinusas, Albert J.: 708 · 197

Siqueira, Dimytri: 2504 – 11 · 138

236 GO for ACC.12!



Siscovick, David: 905 – 5 · 109

Sivaram, Chittur A.: 710 · 198, 103 · 117, 106 · 123, 109 · 128, 710 · 198

Sivasubramanian, Ramakrishnan: 2310 · 156

Skarlatos, Sonia: 300 · 112

Skarlatos, Sonia I.: 710 · 198

Skelding, Kimberly A.: 2501 · 137

Skrocki, Laura: 308 · 210

Slater, James: 931 – 5 · 113

Slawnych, Mike: 603 · 113

Small, David: 902 – 6 · 108

Smedira, Nicholas G.: 2612 · 125

Smirnakis, Karen: 923 – 4 · 151

Smith, Brian: 923 – 4 · 151

Smith, Craig: 2500 – 7 · 137, 2500 – 9 · 137, 2500 – 11 · 137, 2507 – 11 · 146, 305 · 181

Smith, Cydni: 913 – 6 · 143

Smith, Dean: 408 · 187, 2511 – 15 · 147

Smith, James L.: 2508 – 11 · 139, 929 – 7 · 154

Smith, Peter K.: 675 · 169

Smith, Peter N.: 824 · 200

Smith, Jr., Sidney: 622 · 123, 699 · 186

Smits, Nicole C.: 405 · 144

Smits, Pieter: 2506 – 9 · 146

Smolensky, Alexander V.: 406 · 154

Smyth, Susan: 903 – 8 · 108, 917 – 7 · 148

Snyder, Brad: 305 · 181

Sobhy Aly, Mohamed: 506 · 191, 746 · 105

Sobotka, Paul: 926 – 3 · 153, 926 – 4 · 153

Sobotka, Paul A.: 2620 · 161

Soeda, Tsunenari: 917 – 8 · 148

Soendergaard, Lars: 930 – 3 · 155

Soga, Yoshimitsu: 2311 · 166, 931 – 4 · 113, 931 – 6 · 113

Sohn, Dae Won: 930 – 8 · 155

Solinas, Emilia: 2509 · 147

Solomon, Allen: 904 – 4 · 141

Solomon, Curtis: 2301 · 114

Solomon, Scott: 921 – 6 · 150

Solomon, Scott D.: 704 · 196, 641 · 157

Soman, Prem: 909 · 110

Somers, Virend K.: 406 · 154

Somerville, Jane: 400 · 106, 402 · 162

Song, Haegeun: 2645 · 120

Song, Pil Sang: 2504 – 13 · 138

Song, Young Bin: 2504 – 13 · 138

Sood, Nitesh: 919 – 5 · 149

Sood, Poornima: 2506 – 9 · 146

Sorajja, Paul: 253 · 203, 2630 · 183, 648 · 159, 661 · 164, 2121 · 177, 803 · 118, 817 · 169, 819 · 192

Sorour, Khaled: 506 · 191

Sosnovik, David E.: 719 · 202

Soucier, Richard: 744a · 170

Sousa, Amanda: 2504 – 11 · 138, 2506 – 15 · 146

Sousa, J Eduardo: 2506 – 15 · 146

Sousa, J. Eduardo: 2504 – 11 · 138

Specchia, Giuseppe: 914 – 6 · 144

Speight, Martina: 2102 · 160, 2105 · 171

Spencer, Kirk T.: 672 · 168, 107 · 124

Spertus, John: 2501 – 8 · 137, 2511 – 11 · 147, 2511 – 13 · 147, 928 – 8 · 154

Spertus, John A.: 107A · 125

Spiering, Wilko: 926 – 5 · 153

Spinler, Sarah A.: 623 · 126, 734 · 116

Spirito, Paolo: 925 – 4 · 152, 925 – 5 · 152

Spragg, David: 704 · 196

Sprandel, Marília C.: 911 – 8 · 143

Squires, Ray: 927 – 6 · 153

Sreekanth, Sowmya: 2309 · 156

Srivastav, Sudesh: 916 – 6 · 140

Stables, Rod: 2645 · 120

Stacey, Richard: 908 – 8 · 110

Staico, Rodolfo: 2504 – 11 · 138

Stamm, Christof: 921 – 7 · 150

Stanislawski, Maggie: 928 – 3 · 153

STAR-Study-Group: 910 – 8 · 111

Starling, Randall: 906 – 7 · 110, 908 – 5 · 110

Starling, Randall C.: 669 · 168, 694 · 185

Steaban, Robin: 684 · 180

Stecy, Peter: 2303 · 115

Stefanadis, C.: 926 – 8 · 153

Stefanadis, Christodoulos: 931 – 3 · 113, 2509 · 147

Stefanick, Marcia L.: 904 – 4 · 141

Stefanini, Giulio: 2645 · 120

Steg, Philippe G.: 304 · 143

Stegic, Jasminka: 2102 · 160

Stehlik, Josef: 670 · 168

Stein, Evan: 911 – 5 · 143, 923 – 4 · 151

Stein, Evan A.: 729 · 203, 306 · 186

Stein, James H.: 227 · 152

Steinberg, Jonathan S.: 704 · 196, 716 · 201

Stella, Pieter: 926 – 5 · 153

Stevens, Steven M.: 221 · 140

Stevenson, Lynne: 922 – 4 · 150

Stevenson, Lynne W.: 744b · 170, 669 · 168, 107A · 125

Stevenson, William: 922 – 3 · 150

Stevenson, William G.: 715 · 201

Stewart, Garrick: 922 – 4 · 150

Stewart, William J.: 242 · 182, 2618 · 161

Steyerberg, Ewout W.: 910 – 4 · 111

Stio, Rocco: 2644 · 107

Stone, Gregg: 2501 – 6 · 137, 2501 – 10 · 137, 2501 – 14 · 138, 2501 – 16 · 138, 2502 – 15 · 119, 2506 – 7 · 146, 2506 – 9 · 146, 2508 – 15 · 139, 2511 – 7 · 147, 916 – 4 · 140

Stone, Gregg W.: 2632 · 184, 2640 · 200, 604 · 115, 622 · 123, 623 · 126, 646 · 155, 404 · 199, 2506 – 13 · 146, 304 · 143

Stone, Neil: 911 · 142, 227 · 152, 235 · 164, 227 · 152

Storey, Robert: 903 – 8 · 108

Stout, Karen K.: 625 · 127, 668 · 168, 802 · 111, 805 · 123

Strony, John: 903 – 8 · 108

Stuart, Leilani: 928 – 7 · 154

Stuckey, Thomas: 2501 – 14 · 138, 2501 – 16 · 138

Stuckey, Thomas D.: 104 · 117

Subacius, Haris: 929 – 5 · 154

Subherwal, Sumeet: 928 – 6 · 154

Sudhir, Krishnan: 2506 – 9 · 146

Suematsu, Nobuhiro: 931 – 4 · 113, 931 – 6 · 113

Sueta, Carla: 921 – 4 · 150

Sugeng, Lissa: 407 · 181

Sulistio, Melanie S.: 261 · 171

Sullivan, Suzanne: 406 · 154

Sundt, Thoralf: 107A · 125, 652 · 160

Sundt, Thoralf M.: 210 · 118

Sung, Ji-Hee: 917 – 8 · 148

Sunkara, Manjula: 917 – 7 · 148

Superko, Robert: 602 · 113

Suri, Rakesh: 612 · 118

Suryanarayana, Prakash Goutham: 408 · 187

Suzuki, Kenji: 931 – 4 · 113, 931 – 6 · 113

Suzuki, Megumi: 2309 · 156

Svensson, Lars: 2500 – 7 · 137, 2500 – 9 · 137, 305 · 181

Svensson, Lars G.: 2619 · 161, 2636 · 195

Swaminathan, Rajesh V.: 928 – 4 · 154

Swan, Christopher H.: 744a · 170

Swart, Michael: 910 – 4 · 111

Sweeny, Joseph: 2508 – 6 · 139

Sweet, Wendy: 906 – 7 · 110

Sweitzer, Nancy K.: 720 · 203

Syed, Mushabbar A.: 818 · 169

Systrom, David M.: 929 – 4 · 154

Szeto, Wilson Y.: 2626 · 177

Szklo, Moyses: 927 –3 · 153

Tabata, Yasuhiko: 917 – 8 · 148

Tabit, Corey E.: 405 · 144

Tada, Tomohisa: 2503 – 9 · 146

Tadros, Peter: 932 – 4 · 155

Taggart, David: 2202 · 161

Tahirkheli, Naeem: 923 – 8 · 152

Tajik, A. Jamil: 309 · 211

Takabatake, Shu: 2509 – 15 · 147

Takahashi, Masato: 247 · 196

Takano, Masamichi: 2611 · 125

Takemoto, Yasuhiro: 917 – 8 · 148

Takimura, Hideyuki: 2504 – 9 · 138

Talajic, Mario: 666 · 167

Talameh, Jasmine: 921 – 4 · 150

Tamburino, Corrado: 2202 · 161, 2302 · 114, 2505 · 138, 2644 · 107

Tamita, Koichi: 909 – 7 · 111

Tan, Mary: 916 – 5 · 140

Tan, Ru-San: 905 – 8 · 109




Tanajura, Luiz F.: 2504 – 11 · 138

Tang, Jifei: 2645 · 120

Tang, Wai Hong: 906 – 7 · 110, 912 – 7 · 142, 912 – 8 · 142, 922 – 7 · 150

Tang, Wai Hong W.: 617 · 122, 626 · 127

Tani, Lloyd Y.: 247 · 196, 301 · 157

Tansuphaswadikul, Sudaratana: 2505 – 16 · 139

Tantry, Udaya: 2501 – 12 · 137

Tarbine, Sergio G.: 2309 · 156

TASMC Cardiology: 406 · 154

Tatsis, I.: 926 – 8 · 153

Tawakol, Ahmed A.: 743 · 129

Taylor, Allen: 915 – 8 · 145, 924 – 8 · 151

Taylor, Allen J.: 611 · 117, 815 · 165, 927 – 8 · 153

Taylor, Doris: 906 – 5 · 110, 300 · 112

Taylor, Michael D.: 605 · 116

Taylor, Sarah N.: 901 – 4 · 114

Taylor, William R.: 406 · 154

Tazaki, Junichi: 931 – 4 · 113, 931 – 6 · 113

Tazarourte, Karim: 2502 – 9 · 119

Tcheng, James E.: 2306 · 125, 647 · 159, 660 · 164

Tedrow, Usha: 922 – 3 · 150

Teerlink, John: 922 – 5 · 150

Teerlink, John R.: 626 · 127

Teirstein, Paul: 2506 – 7 · 146, 2506 – 13 · 146

Teirstein, Paul S.: 2309 · 156

Teixido, Gisela: 908 – 8 · 110

Tek, Chankevin: 918 – 6 · 148

Templin, Barry: 2511 – 7 · 147, 916 – 4 · 140

Ten Berg, Jurrien: 902 – 4 · 107

Tenuta, Marcos: 304 · 143

Teoh, Kevin: 2644 · 107

Terashima, Mitsuyasu: 2611 · 125

Terzic, Andre: 618 · 121

Teuteberg, Jeffrey: 213 · 122, 694 · 185

Texter, John: 909 – 8 · 111

Textor, Stephen: 2610 · 120, 663 · 165

Thavendiranathan, Paaladinesh: 907 – 8 · 142

Thayssen, Per: 2506 – 11 · 146

the ABSORB B investigators: 2503 – 11 · 146

Thébert, Dominique: 2502 – 9 · 119

Theodoropoulos, Konstantinos C.: 903 – 7 · 108

Therrien, Judith: 667 · 167

Thibault, Bernard: 232 · 162

Thiele, Holger: 221 · 140, 689 · 184, 902 – 8 · 108

Thomas, Gregory: 903 – 8 · 108, 924 – 6 · 151

Thomas, Gregory S.: 673 · 169

Thomas, James: 300 · 112, 912 – 8 · 142

Thomas, James D.: 638 · 151, 638 · 151

thomas, Lecompte: 904 – 8 · 141

Thomas, Martyn: 2645 · 120

Thomas, Randal: 927 – 6 · 153

Thomas, Susan: 306 · 186

Thomopoulos, C.: 926 – 8 · 153

Thompson, Chris R.: 2644 · 107

Thompson, Joseph J.: 603 · 113

Thompson, Lauren: 928 – 6 · 154

Thompson, Paul: 911 – 9 · 143

Thompson, Paul D.: 688 · 182, 746 · 105

Thourani, Vinod H.: 2203 · 194

Thuesen, Leif: 2503 – 13 · 146, 721 · 204, 2506 – 11 · 146

Tian, JinWei: 909 – 5 · 111

Tighe, Dennis: 744b · 170

Tighe, Dennis A.: 241 · 179

Tijssen, Jan: 2502 – 13 · 119

Tilsted, Hans-Henrik: 2506 – 11 · 146

Timmers, Gregory D.: 673 · 169, 673 · 169

Tisch, Rebecca: 2644 · 107

Tisdale, James: 913 – 8 · 143, 736 · 125

Tison, Geoffrey H.: 927 –3 · 153

Tiwari, Sumit: 916 – 6 · 140

Tobis, Jonathan M.: 2614 · 140, 2639 · 202, 2614 · 140

Toggweiler, Stefan: 2644 · 107

Tomaselli, Gordon: 710 · 198

Tomberli, Benedetta: 925 – 4 · 152, 925 – 5 · 152

Tompkins, Christine: 624 · 126, 919 – 6 · 149

Tong, Carl W.: 906 – 8 · 110

Tonino, Pim: 923 – 9 · 152, 2508 – 7 · 139

Topalian, Simon: 2313 · 189

Topilsky, Yan: 242 · 182

Topol, Eric: 2644 · 107, 923 – 8 · 152

Torguson, Rebecca: 915 – 8 · 145, 2500 – 15 · 137, 2507 – 15 · 147

Torii, Sho: 2503 – 7 · 145

Torner, James C.: 904 – 4 · 141

Torre-Amione, Guillermo: 240 · 179

Tousoulis, Dimitris: 931 – 3 · 113

Towbin, Jeffrey: 901 – 5 · 114

Towbin, Jeffrey A.: 222 · 141, 240 · 179, 107A · 125, 301 · 157, 301 · 157, 301 · 157, 671 · 168

Tracy, Russell: 905 – 5 · 109

Traverse, Jay: 300 · 112

Travin, Mark I.: 658 · 163, 708 · 197

Tremmel, Jennifer: 2508 – 7 · 139

Tresukosol, Damras: 2505 – 16 · 139

Tricoci, Pierluigi: 903 – 8 · 108

Troughton, Richard W.: 680 · 179

Troxel, David B.: 248 · 198

Trujillo, Tate N.: 913 – 8 · 143

Truong, Quynh: 308 · 210

Trupp, Robin: 217 · 127

Tsai, Thomas: 2511 – 11 · 147, 928 – 3 · 153, 928 – 6 · 154

Tsai, Thomas T.: 209 · 117, 2641 · 200

Tsang, Teresa S. M.: 638 · 151

Tsang, Wendy: 407 · 181

Tsiachris, D.: 926 – 8 · 153

Tsigkas, Grigorios: 903 – 4 · 108, 903 – 7 · 108

Tsioufis, Konstantinos P.: 926 – 8 · 153

Tsubokawa, Toshinari: 2509 – 15 · 147

Tsuchikane, Etsuo: 2621 · 162, 2504 · 138, 2504 – 7 · 138

Tsukahara, Reiko: 2504 – 9 · 138

Tu, Thomas: 2113 · 194, 2113 · 194

Turi, Zoltan G.: 2609 · 120, 2624 · 167, 2310 · 156, 2510 – 6 · 139, 821 · 197

Turker, Isik: 405 · 144

Turpie, Alexander G.: 304 · 143

Tuzcu, E. Murat: 2606 · 115, 646 · 155, 1607 · 205, 2303 · 115, 2308 · 156, 2500 – 7 · 137, 2500 – 9 · 137, 305 · 181, 309 · 211, 518 · 189

Tweddell, James S.: 724 · 209, 402 · 162

Uber, Patricia: 203 · 109

Uber, Patricia A.: 925 · 152

Udayachalerm, Wasan: 2505 – 16 · 139

Udell, Jacob: 902 – 5 · 108

Udelson, James: 308 · 210, 925 – 4 · 152, 925 – 5 · 152

Udelson, James E.: 658 · 163, 641 · 157, 308 · 210

Uebing, Anselm: 920 – 8 · 149

Uematsu, Masaaki: 931 – 6 · 113, 2311 · 166

Uemura, Shiro: 917 – 8 · 148

Uesugi, Yoshiko: 917 – 8 · 148

Ueyama, Takeshi: 405 · 144

Ulveling, Kyle G.: 744b · 170

Underwood, S. Richard: 740 · 204, 740 · 204

Unger, Barbara T.: 263 · 170

Unterseeh, Thierry: 926 – 7 · 153

Urena, Marina: 915 – 6 · 145

Uretsky, Seth: 233 · 163

Ussia, Gian Paolo: 930 – 3 · 155

Utsunomiya, Daisuke: 924 – 8 · 151

Uy, Stephen: 923 – 4 · 151

Vahanian, Alex: 915 – 7 · 145, 930 – 5 · 155

Valente, Anne Marie: 920 – 7 · 149, 252 · 201, 668 · 168, 806 · 123, 920 – 7 · 149

Valenti, Renato: 903 – 6 · 108

Valentine, C. Michael: 244 · 185, 621 · 123, 684 · 180, 104 · 117

Valentini, Rudolph: 408 · 187

Valgimigli, Marco: 910 – 4 · 111, 2644 · 107, 903 – 8 · 108

Valika, Ali: 2315 · 189

Van Arsdell, Glen: 901 – 3 · 114

Van Bakel, Adrian: 921 – 4 · 150

van Beek, Edwin J.: 407 · 181

Van Belle, Eric: 2507 · 146

van de Hoef, Tim P.: 2502 – 13 · 119

Van de Werf, Frans J.: 308 · 210

Van der Heyden, Jan: 2631 · 183

van der Hoeven, B. L.: 917 – 5 · 148

Van Der Laan, Anja: 918 – 4 · 148

van der Vleuten, Pieter: 918 – 4 · 148

Van Eyk, Jennifer: 671 · 168, 602 · 113

van Geuns, Robert Jan M.: 2503 – 13 · 146

van Nierkerk, Nicolene: 914 – 4 · 144

van Rossum, Albert: 918 – 4 · 148

238 GO for ACC.12!



Vanerio, Gabriel: 726 · 210

Vannan, Mani: 907 – 8 · 142

Varadarajan, Padmini: 110 · 129

Vardeny, Orly: 921 – 6 · 150

Varghese, Mithun J.: 2310 · 156

Varleta, Paola: 516 · 192

Varma, Niraj: 614 · 121, 717 · 202, 922 – 7 · 150

Varosy, Paul: 919 – 4 · 149

Varosy, Paul D.: 205 · 112, 215 · 123, 515 · 193, 928 · 153

Vavere, Andrea: 909 – 8 · 111

Veer, Marcel v.: 923 – 9 · 152

Velazquez, Eric J.: 681 · 179, 682 · 179, 924 · 151

Veldtman, Gruschen R.: 725 · 209

Velez, Mauricio: 229 · 159

Velianou, James L.: 2644 · 107

Ventura, Hector O.: 686 · 180, 720 · 203, 516 · 192, 664 · 165

Vercel, Mark: 2311 · 166

Verdejo, Juan P.: 513 · 190

Verdini, Daniel J.: 922 – 3 · 150

Verdino, Ralph J.: 702 · 196, 716 · 201, 804 · 118, 810 · 128

Vergouwe, Yvonne: 910 – 4 · 111

Verheugt, Freek W.A.: 211 · 121

Verheye, Stefan: 2506 – 7 · 146, 2511 – 7 · 147

Verloop, Willemien: 926 – 5 · 153

Verma, Atul: 615 · 121

Verrier, Richard L.: 702 · 196

Verrill, Thomas A.: 929 – 7 · 154

Versaci, Francesco: 2510 – 11 · 140

Verschuren, Jeffrey J.: 917 – 5 · 148

Vetrovec, George: 2505 – 8 · 138

Vetrovec, George W.: 2501 · 137

Victor, Elivane: 304 · 143

Victor, Ronald G.: 250 · 198, 631 · 128

Vidaillet, Humberto: 904 – 6 · 141

Vido, Diane: 918 – 5 · 148

Vidovich, Mladen: 928 – 3 · 153

Vij, Kamal: 918 – 8 · 148

Vijayakumar, Sathya: 918 – 8 · 148

Vijayaraghvan, Krishnaswami: 686 · 180, 686 · 180

Viles-Gonzalez, Juan: 902 – 6 · 108

Villines, Todd: 924 – 5 · 151, 924 – 7 · 151, 927 – 8 · 153

Vincent, Robert: 901 – 8 · 114

Vinereanu, Dragos: 904 – 9 · 141

Virani, Salim: 925 – 6 · 152

Virani, Salim S.: 227 · 152

Virmani, Renu: 2611 · 125, 2632 · 184, 622 · 123

Viswanathan, Mohan N.: 744b · 170

Vita, Joseph A.: 405 · 144, 622 · 123

Vlachojannis, Georgios: 2501 – 10 · 137

Vlachojannis, Georgios J.: 2501 – 6 · 137

Vlahakes, Gus: 2310 · 156

Vlahakes, Gus J.: 2121 · 177

Vogel, Robert: 688 · 182

Volpe, Massimo: 920 – 7 · 149

von Scheidt, Fabian: 903 – 3 · 108

von Ziegler, Franz: 909 – 6 · 111

Vongpatanasin, Wanpen: 250 · 198, 629 · 128, 663 · 165

Vora, Amit: 509 · 190

Vorchheimer, David: 902 – 6 · 108

Voros, Szilard: 923 – 8 · 152, 924 – 6 · 151, 683 · 180, 2608 · 119, 2639 · 202

Voskuil, Michiel: 926 – 5 · 153

Vrancx, Pascal: 910 – 4 · 111

Wachter, Rolf: 921 – 8 · 150

Wage, Ricardo: 908 – 4 · 110

Wagner, Henrik: 902 – 4 · 107

Wagner, William: 627 · 127

Waites, Thad: 302 · 165

Waksman, Ron: 2308 · 156, 2500 – 15 · 137, 2503 · 145, 2505 – 8 · 138, 2507 – 15 · 147, 2632 · 184, 2645 · 120, 503 · 188, 915 – 8 · 145, 923 – 8 · 152

Waldo, Albert L.: 677 · 178, 107A · 125

Wallentin, Lars: 2643 · 201, 639 · 156, 747 · 209, 904 – 9 · 141

Walpole, Howard T.: 621 · 123, 226 · 152

Walsh, Edward P.: 667 · 167

Walsh, Joseph: 2315 · 189

Walsh, Mary N.: 224 · 143, 245 · 185, 601 · 112

Walther, Thomas: 2619 · 161

Wan Ahmad, Wan Azman: 512 · 192

Wang, Andrew: 714 · 199, 808 · 124

Wang, Francis: 914 – 8 · 144

Wang, Paul: 919 – 6 · 149

Wang, Paul J.: 919 · 149

Wang, Thomas: 914 – 8 · 144

Wang, Thomas J.: 635 · 141

Wang, Tracy: 209 · 117, 722 · 204, 913 – 7 · 143, 928 – 4 · 154

Wang, Y. Claire: 927 – 4 · 153

Wang, Yongfei: 919 – 4 · 149

Wang, Zuyue: 2500 – 15 · 137, 2507 – 15 · 147, 915 – 8 · 145

Warber, Sara: 698 · 186

Ward, R. Parker: 644 · 158, 672 · 168

Ware, Stephanie: 901 – 5 · 114

Warnes, Carole A.: 679 · 179, 107A · 125, 402 · 162, 402 · 162, 608 · 116

Washam, Jeffrey: 722 · 204

Washington, Reginald L.: 603 · 113

Wasserman, Scott: 923 – 4 · 151

Wassertheil-Smoller, Sylvia: 904 – 4 · 141

Watanabe, Tetsuya: 2311 · 166

Wate, Prateek S.: 906 – 4 · 109

Watson, Karol E.: 736 · 125, 306 · 186, 664 · 165

Watta, Matteo: 405 · 144

Watts, James A.: 2122 · 183

Wazni, Oussama M.: 810 · 128

Weaver, W. Douglas: 928 – 5 · 154

Webb, Gary D.: 202 · 108

Webb, John: 2500 – 7 · 137, 2500 – 9 · 137, 2644 · 107, 305 · 181

Webb, John G.: 2619 · 161, 2308 · 156

Webber, Steven: 901 – 5 · 114

Wei, Xufeng: 906 – 6 · 110

Weigold, William Guy: 924 – 8 · 151, 2629 · 183, 683 · 180, 915 – 8 · 145

Weinberg, Paul M.: 724 · 209

Weiner, Rory: 2310 · 156

Weiner, Rory B.: 914 – 8 · 144, 929 – 4 · 154

Weiner, Scott: 308 · 210

Weinert, Lynn: 407 · 181

Weintraub, Andrew R.: 250 · 198

Weintraub, William S.: 308 · 210, 2505 · 138, 622 · 123

Weiss, Jocelyn: 308 · 210

Weissman, Gaby: 744b · 170, 915 – 8 · 145, 924 – 8 · 151

Weissman, Neil: 930 – 4 · 155

Weissman, Neil J.: 2608 · 119, 2629 · 183, 672 · 168, 657 · 163

Weisz, Giora: 2505 – 8 · 138, 2501 – 14 · 138, 2501 – 16 · 138, 2511 – 7 · 147, 2645 · 120, 639 · 156, 916 – 4 · 140

Weitz, Jeffrey I.: 264 · 187

Welch, Terrence D.: 744b · 170

Wenaweser, Peter: 2644 · 107

Wenger, Nanette K.: 255 · 204, 709 · 197, 1602 · 130, 742 · 186, 746 · 105

Wertz, Jonathon: 912 – 5 · 142

Wessels, Judith A.: 917 – 5 · 148

West, Erin: 929 – 6 · 154

West, Lori: 625 · 127

Westcott, R. Jeffrey: 660 · 164

Westernout, Cynthia M.: 916 – 5 · 140

Wharton, J. Marcus: 207 · 116

White, Audrey: 407 · 181

White, C. Michael: 911 – 9 · 143

White, Charles: 308 · 210

White, Christopher: 932 – 7 · 155

White, Christopher J.: 2627 · 177, 2631 · 183, 2311 · 166

White, Harvey D.: 2617 · 156

White, Patrick J.: 673 · 169

White, William B.: 663 · 165

Whitlow, Patrick: 2502 – 11 · 119

Whitlow, Patrick L.: 2627 · 178, 2302 · 114, 2621 · 162

Wicky, Stephan: 2616 · 156

Wiederkehr, Daniel: 913 – 5 · 143

Wiegers, Susan E.: 907 · 142

Wiesneth, Markus: 903 – 3 · 108

Wilber, David J.: 715 · 201

Wilde, Arthur A.: 691 · 184

Wiley, Jose: 2313 · 189

Wiley, Mark: 932 – 4 · 155

Wilkinson, James: 901 – 5 · 114

Wilkoff, Bruce: 904 – 4 · 141, 922 – 7 · 150

Wilkoff, Bruce L.: 205 · 112, 232 · 162, 690 · 184




Willenberg, Bradley J.: 906 – 4 · 109

Willerson, James: 300 · 112

Williams, Amy W.: 645 · 158

Williams, Eric S.: 109 · 128, 710 · 198, 737 · 169

Williams, Kim: 306 · 186

Williams, Kim A.: 658 · 163

Williams, Lauren: 922 – 4 · 150

Williams, Mathew: 2203 · 194, 2500 – 7 · 137, 2500 – 9 · 137, 2500 – 11 · 137, 2507 – 11 · 146, 2619 · 161

Williams, MIchelle C.: 407 · 181

Williams, Roberta G.: 402 · 162

Williams, M, Ronald: 918 – 5 · 148

Wilson, B. Hadley: 2502 – 7 · 119, 104 · 117

Wilson, Carol: 919 – 8 · 149

Winchester, David E.: 113 · 193

Windecker, Stefan: 2503 – 13 · 146

Windecker, Stephan: 2645 · 120, 910 – 4 · 111

Windle, John R.: 647 · 159

Wingate, Suzanne J.: 220 · 129, 225 · 150

Winitsky, Steve: 618 · 121

Winston, Stuart: 501 · 190

Winters, Kenneth: 902 – 4 · 107

Witt, Nils: 923 – 9 · 152

Wittfeldt, Ann: 902 – 7 · 108

Witzenbichler, Bernhard: 2501 – 6 · 137, 2501 – 14 · 138, 2501 – 16 · 138, 2508 – 15 · 139, 304 · 143

Wiviott, Stephen: 308 · 210, 902 – 3 · 107, 902 – 5 · 108, 913 – 7 · 143

Wiviott, Stephen D.: 623 · 126, 709 · 197, 1605 · 171, 659 · 163, 826 · 203

Woehrle, Jochen: 2502 – 15 · 119, 2509 – 9 · 147, 903 – 3 · 108, 908 – 7 · 110

Wohns, David: 2104 · 165, 2511 – 15 · 147

Wöhrle, Jochen: 689 · 184

Wojdyla, Daniel: 921 – 5 · 150

Wolf, Bethany: 901 – 4 · 114

Wolff, Steven: 304 · 143

Wolski, Kathy: 306 · 186

Wong, Michael J.: 235 · 164

Wong, Nathan: 927 – 7 · 153

Wong, Shing-Chiu: 2624 · 167, 2634 · 190

Wood, David: 2644 · 107

Wood, Malissa J.: 235 · 164, 261 · 171

Woodard, Pamela: 308 · 210

Woody, Walter: 928 – 3 · 153

Worle, Jochen: 2643 · 201

Wright, Janet S.: 742 · 186

Wright, Scott: 215 · 123, 687 · 180, 712 · 199

Wroblewski, Heather: 913 – 8 · 143

Wu, Chuntao: 910 – 7 · 111

Wu, Colin: 908 – 8 · 110

Wu, Xin: 906 – 8 · 110

Wu, Yuping: 912 – 7 · 142

Wunderlich, Nina: 2630 · 183, 2640 · 200

Wylie-Sears, Jill: 406 · 154

Wyman, Janet F.: 2101 · 156, 2102 · 160

Xanthopoulou, Ioanna: 903 – 4 · 108, 903 – 7 · 108

Xiang, Meixiang: 2645 · 120

Xie, Aris: 909 – 4 · 110

Xing, Lei: 916 – 7 · 140

Xu, Ke: 916 – 4 · 140, 2511 – 7 · 147

Yacoub, Magdi H.: 401 · 124, 506 · 191, 627 · 127, 400 · 106

Yadav, Jay: 922 – 5 · 150

Yadav, Jay S.: 2637 · 195, 633 · 129

Yadav, Neha: 744b · 170

Yakubov, Steven J.: 2132 · 195, 2606 · 115

Yakushiji, Tadayuki: 2508 – 15 · 139

Yamagishi, Masakazu: 2509 – 15 · 147

Yamane, Masahisa: 2504 – 7 · 138

Yamaoka, Terutoshi: 931 – 4 · 113, 931 – 6 · 113

Yamawaki, Masahiro: 2504 – 9 · 138

Yamrozik, June: 918 – 5 · 148

Yan, Andrew: 916 – 5 · 140

Yancy, Clyde W.: 237 · 169, 107A · 125

Yang, Hongqiu: 904 – 9 · 141

Yang, Jeong Hoon: 2504 – 13 · 138

Yang, Shuang: 916 – 7 · 140

Yang, YueJin: 505 · 188

Ye, Jian: 2644 · 107

Ye, Siqin: 910 – 5 · 111

Yeh, Edward T.: 642 · 157

Yeh, Robert W.: 209 · 117, 215 · 123, 700 · 186

Yeo, Hans: 2505 – 16 · 139

Yetman, Angela T.: 202 · 108

Yeung, Alan: 2645 · 120

Yeung, Alan C.: 2608 · 119, 2201 · 119

Yeung, Hubert: 407 · 181

Yingchoncharoen, Teerapat: 907 – 5 · 142

Yonetsu, Tiashi: 916 – 7 · 140

Yong, Andy: 2508 – 7 · 139

Yoo, Wonsuk: 306 · 186, 910 – 6 · 111

Yoon, Jung H.: 511 · 188

Yoon, Jung-Han: 2644 · 107

Yoon, Sung-Cheol: 2645 · 120

Yoshida, Takayuki: 2305 · 125

Yoshikawa, Ayako: 2503 – 7 · 145

Yoshikawa, Junichi: 909 – 7 · 111

Yu, Bo: 909 – 5 · 111

Yu, Cheol Woong: 2504 – 13 · 138

Yu, Jennifer: 2501 – 10 · 137

Yue, Qi: 909 – 4 · 110

Yundai, Chen: 685 · 180

Yusuf, Salim: 206 · 116, 665 · 167, 686 · 180, 700 · 186, 904 – 5 · 141, 904 – 7 · 141

Zafar, M. Urooj: 902 – 6 · 108

Zafrir, Barak: 912 – 6 · 142

Zahger, Doron: 916 · 140

Zahn, Ralf: 910 – 8 · 111, 915 – 4 · 145

Zaidi, Abbas: 914 – 7 · 144

Zaidi, Abbas: 914 – 4 · 144

Zajarias, Alan: 258 · 210, 2619 · 161, 646 · 155, 819 · 192

Zakroysky, Pearl: 308 · 210

Zaman, Khan S.: 514 · 194

Zambahari, Robaayah: 512 · 192

Zannad, Faiez: 921 – 6 · 150

Zareba, Wojciech: 704 · 196, 919 – 6 · 149

Zaromitidou, Marina: 931 – 3 · 113

Zaverio, Ruggeri M.: 909 – 4 · 110

Zazula, Ana: 304 · 143

Zeiher, Andreas M.: 618 · 121, 2506 · 146, 300 · 112

Zellers, Paul: 2315 · 189

Zeymer, Uwe: 910 – 8 · 111

Zhang, Dadong: 2645 · 120

Zhang, Shaosong: 909 – 5 · 111, 916 – 7 · 140

Zhang, Zhen: 916 – 4 · 140

Zhang, Zheng: 2645 · 120

Zhang, Zugui: 308 · 210

Zhao, David: 300 · 112

Zhao, Dong: 685 · 180, 685 · 180

Zhao, Songyang: 910 – 7 · 111

Zhao, Yan: 909 – 4 · 110

Zhao, Yue: 915 – 5 · 145

Zhong, Liang: 905 – 8 · 109

Zhou, Chunmei: 902 – 4 · 107

Zhou, Yujie: 2645 · 120, 685 · 180

Ziada, Khaled: 917 – 7 · 148

Ziada, Khaled M.: 2627 · 178

Zidar, James P.: 2642 · 201

Zieman, Susan: 905 – 5 · 109

Ziffer, Jack A.: 696 · 185

Zijlstra, Felix: 918 – 4 · 148

Zile, Michael R.: 635 · 141

Zipes, Douglas P.: 646 · 155, 746 · 105

Zisimos, Konstantinos: 931 – 3 · 113

Zoghbi, William A.: 652 · 160, 507 · 191, 742 · 186, 746 · 105

Zolty, Ronald: 912 – 4 · 142

Zuba-Surma, Ewa K.: 917 – 7 · 148

Zuckerman, Bram D.: 633 · 129

Zuern, Christine: 926 – 6 · 153

Zugwitz, Daša: 2645 · 120

Zwicke, Dianne L.: 662 · 164

Zyblewski, Sinai: 901 – 4 · 114

Zynda, Todd K.: 2121 · 177

The American College of Cardiology Proudly Welcomes the Newest

Physician Members of the CardioSurve Panel for 2012

©2012 American College of Cardiology. T1105

CardioSurve is a select panel of ACC members who provide important insights and perspectives on the issues that affect today’s cardiovascular professionals and assist the College in listening closely to the “voice of U.S. cardiologists.”

For more on CardioSurve and to learn about the newest panelists, visit CardioSource.org/CardioSurve.

TM


Help Shape the Future of CardioSmart (and win a free iPad!)� e ACC is re-launching CardioSmart, and we want your input. � e new CardioSmart will provide tools to improve the patient-clinician relationship.

If you’re a practicing clinician, come and tell us what you need. It only takes � ve minutes. We’ll give you a token of our appreciation and enter you in a drawing to win an iPad!

CARD-1023626-0000 01/12

See how the data connects with your practice.

Bring it all together at BOOTH 14008

Please pick up your complimentary medically relevant customized poster and informative CD.

vytorin.com zetia.com

Documents

ACC12 Final Program w TOC Links